data_2jxm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jxm _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.66 126.8 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 109.989 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.627 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.8 m -122.48 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 124.447 1.092 . . . . 0.0 109.22 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.99 150.8 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 110.318 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.76 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.13 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.337 1.023 . . . . 0.0 109.259 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.68 133.49 35.95 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.528 1.143 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.669 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 96.99 6.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 0.0 110.955 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.51 7.64 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.491 1.119 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.404 HG21 HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -108.08 160.63 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.389 0.699 . . . . 0.0 110.391 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.74 -16.03 24.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.399 1.062 . . . . 0.0 109.315 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.2 mttp -90.55 39.64 0.98 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 38.21 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.592 1.182 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.82 117.7 58.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HB3' HG12 ' A' ' 36' ' ' VAL . 36.0 Cg_endo -74.98 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.456 1.766 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.1 pp -150.74 151.24 32.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.119 . . . . 0.0 109.323 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.4 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.38 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.556 1.16 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.86 26.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.459 1.1 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.15 140.98 70.19 Favored 'Cis proline' 0 C--N 1.361 1.203 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.96 0.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.5 tttt -40.17 -40.04 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.58 1.175 . . . . 0.0 109.342 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.35 46.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.365 1.041 . . . . 0.0 109.273 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.31 141.32 30.94 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.517 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.93 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.554 1.159 . . . . 0.0 110.026 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.627 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.91 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 0.0 109.26 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.55 158.26 27.7 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.499 1.124 . . . . 0.0 109.968 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.866 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.44 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.452 1.095 . . . . 0.0 109.285 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.38 8.48 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.542 1.151 . . . . 0.0 110.961 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.09 174.16 11.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.48 0.753 . . . . 0.0 109.291 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.65 154.28 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.62 1.2 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.973 HG12 HD13 ' A' ' 94' ' ' ILE . 63.9 t -131.47 102.63 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.78 169.57 18.02 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.468 1.105 . . . . 0.0 110.313 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.27 121.48 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.515 1.134 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.57 1.169 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 11.7 ttp -97.96 119.21 36.18 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.433 1.083 . . . . 0.0 111.009 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.332 6.9 m-20 -79.36 -66.04 0.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.589 1.181 . . . . 0.0 109.243 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.716 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 35' ' ' LYS . 14.8 p 46.04 54.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 0.0 109.276 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.47 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.564 1.165 . . . . 0.0 111.033 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.009 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 30.0 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.93 -2.529 . . . . 0.0 111.03 -0.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.687 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.499 1.124 . . . . 0.0 109.575 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.95 167.05 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 0.0 109.253 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.924 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.1 t -104.18 114.41 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.163 . . . . 0.0 109.289 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mm -132.82 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.551 1.157 . . . . 0.0 109.305 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.0 m-85 -47.71 160.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.04 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.6 mtpt 167.35 143.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.6 1.187 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.01 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.3 m -128.55 158.08 72.98 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.436 1.085 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.3 Cg_endo -75.03 164.17 33.84 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.538 1.809 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.17 135.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.392 1.058 . . . . 0.0 109.276 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.44 -56.55 0.72 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.578 1.174 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.557 0.798 . . . . 0.0 110.279 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.594 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.25 77.76 1.75 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 110.001 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.994 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 109.353 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.01 50.82 2.63 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.466 1.772 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.34 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.48 1.113 . . . . 0.0 109.308 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.49 68.14 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.502 1.126 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 m -46.55 115.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 109.98 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.555 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.7 m120 -108.01 117.63 34.63 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.408 1.067 . . . . 0.0 109.315 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.73 21.73 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.41 1.069 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -85.87 64.32 8.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.455 1.097 . . . . 0.0 109.264 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.607 HD13 HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.37 102.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.427 1.079 . . . . 0.0 109.351 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.02 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.617 1.198 . . . . 0.0 109.339 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 60' ' ' LEU . 2.6 mm -68.65 -46.18 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.596 1.185 . . . . 0.0 109.282 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.63 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 109.265 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.95 139.1 24.01 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -67.97 0.17 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.502 1.126 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.672 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.511 0.771 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.21 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.587 1.179 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.924 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.42 175.18 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 111.044 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.478 1.112 . . . . 0.0 109.983 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.11 137.69 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 0.0 109.348 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.17 146.46 23.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 110.378 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.18 173.05 8.57 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 0.0 109.231 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.866 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.11 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.526 1.141 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.84 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.22 124.13 37.57 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.53 0.782 . . . . 0.0 110.424 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.5 26.8 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.437 1.756 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.6 20.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.93 120.07 40.54 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.571 0.806 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.01 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.74 30.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.545 1.153 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.099 . . . . 0.0 110.01 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.09 -171.48 3.72 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 1.128 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.755 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 38.7 p90 -171.9 165.4 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.973 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -93.52 122.27 35.78 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.116 . . . . 0.0 108.335 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.718 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.6 OUTLIER -51.26 -50.82 73.71 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.561 1.163 . . . . 0.0 110.408 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.713 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 37.7 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.576 1.829 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.641 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 25.4 m80 -75.06 57.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.57 1.169 . . . . 0.0 109.562 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.03 ' NH1' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.95 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.577 1.173 . . . . 0.0 110.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.86 32.73 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.462 1.101 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.2 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.489 0.758 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.12 63.14 1.83 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.431 1.082 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.669 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 0.798 . . . . 0.0 110.971 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.7 ' CG1' HH22 ' A' ' 86' ' ' ARG . 11.6 m -124.26 153.59 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 0.0 109.227 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.709 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.56 -174.75 19.77 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 124.546 1.154 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.709 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.82 162.0 37.19 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 0.792 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.973 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.57 122.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.496 1.122 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.9 m -105.07 144.47 31.83 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.814 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 124.559 1.162 . . . . 0.0 109.353 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 0.0 110.38 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.713 ' HE2' ' HB2' ' A' ' 84' ' ' PRO . 18.5 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.493 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.641 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 46.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.548 ' SG ' ' O ' ' B' ' 161' ' ' VAL . 46.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.67 HE22 ' HA2' ' B' ' 157' ' ' GLY . 13.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 65' ' ' SER . 7.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 4.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.687 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.2 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 1.03 HG13 ' HG ' ' B' ' 115' ' ' LEU . 65.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.707 HG21 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.71 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 1.03 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.71 HD11 ' HA ' ' B' ' 107' ' ' TYR . 1.1 mp -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.009 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 58.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.67 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.548 ' O ' ' SG ' ' B' ' 24' ' ' CYS . 1.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.694 ' CE1' ' HA ' ' B' ' 168' ' ' SER . 0.4 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.564 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.0 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.076 HG22 ' H ' ' B' ' 166' ' ' GLU . 0.4 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.076 ' H ' HG22 ' B' ' 164' ' ' THR . 2.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' SER . . . . . 0.694 ' HA ' ' CE1' ' B' ' 162' ' ' TYR . 95.9 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 55.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 1.9 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.011 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 8.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.803 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 52.2 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.715 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.1 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.011 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.444 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.83 29.06 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.466 1.104 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.629 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.39 177.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.89 40.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.768 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.36 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.407 1.067 . . . . 0.0 109.246 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.508 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.45 36.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.533 1.145 . . . . 0.0 109.388 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.456 ' CA ' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.141 . . . . 0.0 111.003 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 1.025 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.14 144.49 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.599 HG22 ' CD1' ' A' ' 15' ' ' LEU . 23.9 p -108.08 160.6 15.67 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.441 0.73 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -15.96 23.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ALA . 14.2 mttt -90.59 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 38.29 29.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 0.0 111.029 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.963 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.78 117.71 58.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 0.0 109.318 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HB3' HG11 ' A' ' 36' ' ' VAL . 24.7 Cg_endo -75.02 97.72 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.428 1.752 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.963 HD21 ' HB3' ' A' ' 13' ' ' ALA . 1.5 pp -150.87 151.26 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.18 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.465 1.103 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.549 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.46 134.82 26.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 124.467 1.104 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.92 69.94 Favored 'Cis proline' 0 C--N 1.359 1.12 0 C-N-CA 121.061 -2.474 . . . . 0.0 110.993 0.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.565 1.165 . . . . 0.0 109.306 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.34 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.264 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.1 tp -143.24 141.34 31.03 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.91 143.83 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.629 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.98 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.559 1.162 . . . . 0.0 109.205 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.804 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.64 158.28 27.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.531 1.144 . . . . 0.0 109.972 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.13 105.47 0.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.201 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.31 8.52 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.21 174.07 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.527 0.781 . . . . 0.0 109.238 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' VAL . 9.9 m -123.47 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.616 1.197 . . . . 0.0 110.491 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.988 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.44 102.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 109.322 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.5 18.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.768 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.18 121.4 9.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.502 1.126 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.32 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.442 1.089 . . . . 0.0 109.276 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.1 ttp -97.93 119.16 36.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.426 1.079 . . . . 0.0 111.046 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 1.025 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.31 -66.07 0.92 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.624 1.203 . . . . 0.0 109.268 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.454 1.096 . . . . 0.0 109.321 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' ' 14' ' ' PRO . 7.1 p 46.02 54.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 109.336 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.847 ' O ' ' HD2' ' B' ' 119' ' ' PRO . . . -92.94 -172.31 40.58 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.491 1.12 . . . . 0.0 111.079 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.196 ' HD3' ' O ' ' B' ' 119' ' ' PRO . 58.6 Cg_endo -74.97 -168.9 6.85 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.961 -2.516 . . . . 0.0 110.973 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.668 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.26 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.077 . . . . 0.0 109.617 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.438 HD22 ' HD3' ' A' ' 84' ' ' PRO . 1.5 p30 173.97 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.251 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.913 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.06 114.27 43.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.73 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 109.343 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.69 160.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.8 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.1 mttt 167.32 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.043 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.426 1.079 . . . . 0.0 109.21 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.06 164.22 33.67 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.493 1.786 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.2 135.58 1.38 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.444 1.09 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.591 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.63 0.72 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.492 1.12 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.26 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 0.816 . . . . 0.0 110.301 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.21 77.75 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.134 . . . . 0.0 110.031 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.043 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 0.0 109.358 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.72 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -74.99 50.74 2.6 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.478 1.778 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.32 -45.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 0.0 109.313 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.61 68.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -46.49 115.16 0.95 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.511 1.132 . . . . 0.0 109.966 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.93 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.452 1.095 . . . . 0.0 109.325 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -89.8 21.85 3.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.383 1.052 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 39.7 tttt -86.0 64.37 8.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.57 1.169 . . . . 0.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.437 HD22 ' ND2' ' A' ' 40' ' ' ASN . 3.4 mp -40.44 102.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.559 1.162 . . . . 0.0 109.322 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.48 6.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 109.284 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.727 HD13 ' HA ' ' B' ' 120' ' ' LEU . 0.7 OUTLIER -68.71 -46.15 80.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.601 1.188 . . . . 0.0 109.282 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.88 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 0.0 109.331 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.811 ' HG3' ' CD1' ' B' ' 102' ' ' TYR . 72.3 Cg_endo -75.06 139.16 23.81 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.389 1.731 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 32' ' ' VAL . . . 168.88 -68.01 0.17 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.501 1.126 . . . . 0.0 110.995 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.449 0.735 . . . . 0.0 110.014 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.793 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.1 m-85 -38.23 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.471 1.107 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.913 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.55 175.09 4.17 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.093 . . . . 0.0 111.009 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.757 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.29 20.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 0.0 109.95 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.08 137.71 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.486 1.116 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.33 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.583 1.177 . . . . 0.0 110.381 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.3 mt -124.14 173.1 8.52 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.536 1.148 . . . . 0.0 109.186 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.859 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.09 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.536 1.147 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.823 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.24 124.11 37.6 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.467 0.745 . . . . 0.0 110.426 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.52 26.8 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.527 1.804 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.62 20.05 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.415 1.072 . . . . 0.0 111.046 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.408 HG21 HG23 ' A' ' 93' ' ' THR . 29.7 m -104.84 120.04 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.776 . . . . 0.0 110.378 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.005 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.74 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.59 1.181 . . . . 0.0 111.021 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.86 145.17 49.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 110.019 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.52 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.496 1.122 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -171.83 165.41 6.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.113 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.55 122.3 35.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.4 1.063 . . . . 0.0 108.302 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.582 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.5 m -51.3 -50.79 73.97 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.482 1.114 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.567 1.825 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m170 -75.0 58.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.542 1.151 . . . . 0.0 109.602 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.538 ' NH2' HG11 ' A' ' 91' ' ' VAL . 1.5 tpm_? -88.0 -38.53 15.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.128 . . . . 0.0 110.305 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.51 -23.79 32.81 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.438 1.086 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.27 62.62 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.531 0.783 . . . . 0.0 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.21 1.82 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.464 1.103 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.456 ' HE3' ' CA ' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.0 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 0.72 . . . . 0.0 111.067 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.538 HG11 ' NH2' ' A' ' 86' ' ' ARG . 14.9 m -124.13 153.59 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.295 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.706 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.58 -174.69 19.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.482 1.114 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.706 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.83 162.09 36.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 0.772 . . . . 0.0 110.313 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.988 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.66 122.56 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -104.98 144.51 31.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 0.0 110.435 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.835 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.282 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.804 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.167 . . . . 0.0 110.3 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.557 ' CD2' ' HG3' ' B' ' 119' ' ' PRO . 56.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.778 ' CD2' ' HG3' ' B' ' 163' ' ' PRO . 4.2 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.676 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.793 ' HB2' HG22 ' B' ' 233' ' ' VAL . 14.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 15.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.462 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.462 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 68.7 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 32.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.7 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 0.811 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 2.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' B' ' 102' ' ' TYR . 0.4 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.895 HG12 ' HG ' ' B' ' 115' ' ' LEU . 39.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.572 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.895 ' HG ' HG12 ' B' ' 104' ' ' VAL . 3.4 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.553 HD22 HG22 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.621 ' CA ' HD13 ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.196 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.727 ' HA ' HD13 ' A' ' 62' ' ' ILE . 1.2 mp -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.579 ' HD2' ' HG2' ' B' ' 128' ' ' MET . 0.6 OUTLIER -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.579 ' HG2' ' HD2' ' B' ' 125' ' ' TYR . 10.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.419 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.615 HH12 ' ND2' ' B' ' 169' ' ' ASN . 33.0 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.69 HG22 ' H ' ' B' ' 162' ' ' TYR . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.69 ' H ' HG22 ' B' ' 161' ' ' VAL . 30.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.778 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.659 ' CG2' ' HB2' ' B' ' 162' ' ' TYR . 5.0 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.643 ' H ' HG22 ' B' ' 164' ' ' THR . 42.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD22 ' B' ' 171' ' ' ASN . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' SER . . . . . 0.663 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 96.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.615 ' ND2' HH12 ' B' ' 158' ' ' ARG . 0.8 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD22 HD12 ' B' ' 167' ' ' LEU 1.462 1.2 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.166 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 25.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.631 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.166 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 11.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.793 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.421 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.56 126.73 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 0.0 110.098 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.633 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.35 177.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.426 1.079 . . . . 0.0 109.263 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -143.05 150.87 40.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.38 112.16 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.398 1.061 . . . . 0.0 109.239 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.48 35.97 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.557 1.161 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.61 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.71 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 0.0 111.009 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.668 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.51 7.64 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.58 1.175 . . . . 0.0 110.967 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.03 160.58 15.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.469 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.7 -15.99 23.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.4 ttmt -90.58 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 38.25 29.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.548 1.155 . . . . 0.0 111.048 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.76 117.73 58.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.049 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.5 Cg_endo -75.02 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.492 1.785 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 4.2 pp -150.82 151.24 32.0 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.35 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.45 134.86 26.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.381 1.051 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.97 70.22 Favored 'Cis proline' 0 C--N 1.359 1.114 0 C-N-CA 120.989 -2.505 . . . . 0.0 110.949 0.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.19 -40.08 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.566 1.166 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.33 46.13 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.387 1.054 . . . . 0.0 109.24 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 22' ' ' SER . 11.1 tp -143.24 141.34 31.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 0.0 109.297 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.515 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.81 51.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.45 1.094 . . . . 0.0 110.038 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.95 -177.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.566 1.166 . . . . 0.0 109.242 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.79 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.514 1.134 . . . . 0.0 109.969 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.862 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.12 105.5 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.588 1.18 . . . . 0.0 109.262 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.39 8.51 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.458 1.099 . . . . 0.0 111.052 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.12 174.11 11.51 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 0.78 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.1 m -123.49 154.27 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 0.0 110.485 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.989 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.69 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.83 169.56 18.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.587 1.179 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 5' ' ' ILE . 64.1 m-85 -147.24 121.4 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.52 1.138 . . . . 0.0 110.981 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.35 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.248 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.755 ' HE3' ' HB3' ' A' ' 64' ' ' PRO . 3.4 ttp -97.98 119.15 36.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m120 -79.28 -66.09 0.91 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.145 . . . . 0.0 109.248 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.987 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.451 1.094 . . . . 0.0 109.333 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.049 HG21 ' HG3' ' A' ' 14' ' ' PRO . 7.4 p 45.93 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.352 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.0 -172.31 40.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.49 1.119 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.138 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 36.2 Cg_endo -75.03 -168.87 6.85 Favored 'Cis proline' 0 C--N 1.361 1.19 0 C-N-CA 120.938 -2.526 . . . . 0.0 111.003 0.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.651 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 73.2 m-70 -144.28 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.592 HD21 HD21 ' A' ' 60' ' ' LEU . 2.5 p30 173.99 166.95 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.536 1.147 . . . . 0.0 109.271 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.921 HG21 ' HH ' ' A' ' 68' ' ' TYR . 57.5 t -104.07 114.41 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 0.0 109.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.464 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -132.84 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.67 160.65 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.507 1.129 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.02 -50.01 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.574 1.171 . . . . 0.0 109.256 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 167.29 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 0.0 109.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.014 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.56 158.12 72.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.432 1.082 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 164.21 33.82 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.511 1.795 . . . . 0.0 111.008 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.26 135.56 1.41 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.438 1.086 . . . . 0.0 109.313 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.617 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.5 -56.54 0.72 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 0.0 110.972 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.22 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 0.807 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.591 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.23 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 110.024 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.998 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.04 -51.77 71.73 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.444 1.09 . . . . 0.0 109.359 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.04 50.84 2.65 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.452 1.764 . . . . 0.0 110.952 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.38 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.63 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.542 1.151 . . . . 0.0 109.259 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.2 m -46.44 115.11 0.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.59 1.181 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -107.92 117.68 34.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.335 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.731 HG22 ' NE2' ' B' ' 61' ' ' GLN . 9.1 t -89.81 21.85 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -86.03 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.516 1.135 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.592 HD21 HD21 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -40.4 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 0.0 109.326 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.731 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -78.46 98.44 6.06 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' B' ' 120' ' ' LEU . 3.2 mm -68.73 -46.06 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.554 1.159 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.63 4.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 0.0 109.303 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.755 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 55.5 Cg_endo -75.04 139.14 23.83 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.43 1.753 . . . . 0.0 111.042 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -68.02 0.17 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.471 1.107 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.67 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.8 t -178.66 97.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 0.747 . . . . 0.0 109.99 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CE2' ' HB1' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.19 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.401 1.063 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.921 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.49 175.1 4.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 0.0 111.055 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.771 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.445 1.091 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.72 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.423 1.077 . . . . 0.0 109.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.416 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.32 146.41 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 0.0 110.398 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.06 173.13 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 0.0 109.225 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.862 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.16 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.518 1.136 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.841 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.25 124.11 37.67 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.525 0.779 . . . . 0.0 110.381 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 141.49 26.73 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.796 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.433 1.083 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.4 m -104.76 120.04 40.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.465 0.744 . . . . 0.0 110.399 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.014 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.76 30.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 0.0 111.011 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.9 145.11 49.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 110.032 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.53 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.13 . . . . 0.0 110.989 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 1.388 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 15.3 p90 -171.82 165.45 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.62 122.3 35.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.381 1.051 . . . . 0.0 108.267 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 1.013 HG21 ' HB2' ' B' ' 62' ' ' ALA . 1.0 OUTLIER -51.25 -50.8 73.76 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.429 1.08 . . . . 0.0 110.466 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.602 1.843 . . . . 0.0 110.992 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.931 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 24.6 m80 -75.06 57.99 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.574 1.171 . . . . 0.0 109.546 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.388 ' NH2' ' HB2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.99 -38.47 15.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.525 1.14 . . . . 0.0 110.313 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 1.016 ' CA ' HG21 ' B' ' 164' ' ' THR . . . -89.49 -23.84 32.74 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.487 1.117 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.22 62.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 0.769 . . . . 0.0 109.346 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.19 1.82 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.542 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 8.0 ttt -121.58 74.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 0.0 111.043 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.726 HG13 HH22 ' A' ' 86' ' ' ARG . 11.7 m -124.18 153.5 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 0.0 109.283 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.718 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.5 -174.73 19.71 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.525 1.141 . . . . 0.0 111.004 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.718 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.78 162.11 36.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 0.0 110.39 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.989 HD13 HG12 ' A' ' 29' ' ' VAL . 92.5 mt -146.65 122.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.561 1.163 . . . . 0.0 109.311 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -105.02 144.52 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.477 1.111 . . . . 0.0 110.426 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.83 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.12 . . . . 0.0 109.24 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.79 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 110.349 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.863 ' CZ ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.792 ' CG ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.976 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 21.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 2.7 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.703 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.6 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.694 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' B' ' 233' ' ' VAL . 12.0 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.461 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 86.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.731 ' NE2' HG22 ' A' ' 58' ' ' THR . 7.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 1.013 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 65' ' ' SER . 0.2 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.466 ' HB2' ' OD2' ' B' ' 63' ' ' ASP . 17.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.694 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.5 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 8.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.704 HG21 ' CE ' ' B' ' 128' ' ' MET . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.42 HD23 HD12 ' B' ' 120' ' ' LEU . 1.1 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 1.037 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.1 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.765 HG21 ' HB2' ' B' ' 116' ' ' LEU . 1.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.594 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.8 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' B' ' 109' ' ' GLU . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 1.037 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.765 ' HB2' HG21 ' B' ' 105' ' ' THR . 71.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.138 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 62' ' ' ILE . 7.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.704 ' CE ' HG21 ' B' ' 71' ' ' VAL . 63.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 23.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.52 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 54.2 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.415 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 1.508 ' HG2' ' CG ' ' B' ' 160' ' ' GLN . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' B' ' 24' ' ' CYS . 2.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.54 ' HB2' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.976 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.016 HG21 ' CA ' ' A' ' 87' ' ' GLY . 2.1 p -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 4.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.354 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.561 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 37.9 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.986 ' CG ' ' HD3' ' B' ' 209' ' ' PRO 0.278 3.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.561 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.929 ' H ' HD21 ' B' ' 208' ' ' LEU . 0.9 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.986 ' HD3' ' CG ' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . 0.402 ' HA3' HG11 ' B' ' 60' ' ' VAL . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.674 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.57 126.8 28.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.616 1.197 . . . . 0.0 110.06 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.628 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.49 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.451 1.095 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.81 40.18 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.349 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.75 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.38 112.17 38.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.466 1.104 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.78 133.43 36.05 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.309 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.704 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.64 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 0.0 110.996 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.58 7.65 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.449 1.093 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.534 ' OG1' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -108.12 160.64 15.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 0.752 . . . . 0.0 110.413 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.8 -15.94 24.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.9 mttt -90.56 39.59 0.98 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.13 . . . . 0.0 109.371 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.32 29.7 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.489 1.118 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -104.83 117.71 58.11 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.223 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CB ' ' CD2' ' A' ' 85' ' ' HIS . 25.0 Cg_endo -75.03 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.457 1.767 . . . . 0.0 111.066 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 13' ' ' ALA . 2.0 pp -150.77 151.19 31.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.502 1.126 . . . . 0.0 109.322 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.405 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.15 30.47 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.533 1.146 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.48 134.84 26.53 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 0.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.11 140.97 70.16 Favored 'Cis proline' 0 C--N 1.36 1.18 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.938 0.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.15 -40.15 1.04 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.6 1.187 . . . . 0.0 109.267 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.17 146.32 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.361 1.038 . . . . 0.0 109.328 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.23 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.563 1.164 . . . . 0.0 109.219 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.97 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 110.055 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.93 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.786 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.33 27.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 0.0 109.971 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.17 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.592 1.183 . . . . 0.0 109.321 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.36 8.49 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.495 1.122 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.15 174.16 11.46 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.616 0.833 . . . . 0.0 109.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.59 154.21 39.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 0.0 110.464 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.976 HG12 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.37 102.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.8 169.5 18.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 110.319 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.75 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.23 121.53 9.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.55 1.156 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.14 155.31 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.654 1.221 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.805 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.2 ttp -98.0 119.21 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.479 1.112 . . . . 0.0 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.326 6.6 m-20 -79.31 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.243 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.663 ' O ' ' CE1' ' A' ' 85' ' ' HIS . 11.2 p 45.93 54.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 1.487 ' O ' ' CE1' ' B' ' 1' ' ' TYR . . . -92.9 -172.31 40.65 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.147 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 19.8 Cg_endo -74.93 -168.87 6.82 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 120.998 -2.501 . . . . 0.0 111.018 -0.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.805 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.1 m-70 -144.26 -170.38 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.457 HD21 ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.426 1.079 . . . . 0.0 109.251 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.921 HG21 ' HH ' ' A' ' 68' ' ' TYR . 56.7 t -104.01 114.33 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.595 1.185 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 42' ' ' ILE . 2.0 mm -132.8 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 0.0 109.256 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.7 160.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -49.99 4.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 12.1 mttt 167.22 143.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.57 1.169 . . . . 0.0 109.343 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.999 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.49 158.16 72.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.097 . . . . 0.0 109.275 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 164.26 33.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.427 1.751 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.35 135.67 1.42 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.47 1.106 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.54 0.72 Allowed Glycine 0 CA--C 1.532 1.128 0 O-C-N 124.565 1.166 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.546 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.621 0.836 . . . . 0.0 110.305 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.59 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.13 77.8 1.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.967 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.08 -51.79 71.68 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.463 1.102 . . . . 0.0 109.292 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.4 Cg_endo -75.01 50.74 2.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.392 1.733 . . . . 0.0 110.995 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.27 -45.73 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.609 1.193 . . . . 0.0 109.301 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.546 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.48 68.1 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.543 1.152 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.0 m -46.5 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.56 1.162 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.588 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 85.0 m-20 -107.94 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.418 1.074 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.425 ' O ' HD21 ' A' ' 60' ' ' LEU . 11.6 t -89.82 21.84 3.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.377 1.048 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -85.97 64.43 8.58 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.43 1.082 . . . . 0.0 109.251 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.5 102.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.307 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.41 98.37 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 60' ' ' LEU . 2.1 mm -68.7 -46.02 80.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.596 1.185 . . . . 0.0 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.12 111.59 4.85 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.33 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HB3' ' HE1' ' A' ' 33' ' ' MET . 10.1 Cg_endo -75.06 139.21 23.86 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.515 1.134 . . . . 0.0 110.957 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.673 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.539 0.788 . . . . 0.0 110.034 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.24 -86.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.921 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.58 175.12 4.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.359 1.037 . . . . 0.0 110.991 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.32 20.87 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 109.96 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.07 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.22 146.47 23.99 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.474 1.109 . . . . 0.0 110.394 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.11 173.06 8.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.464 1.102 . . . . 0.0 109.27 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.864 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.12 -44.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.505 1.128 . . . . 0.0 110.955 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.851 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.22 124.08 37.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.452 0.736 . . . . 0.0 110.418 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 141.46 26.69 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.523 1.802 . . . . 0.0 110.953 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.59 20.11 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.48 1.112 . . . . 0.0 110.985 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.86 120.07 40.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 0.742 . . . . 0.0 110.367 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.999 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.73 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.517 1.136 . . . . 0.0 110.995 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.85 145.08 49.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 0.0 110.03 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.16 -171.55 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.518 1.136 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.926 ' CB ' ' NH2' ' A' ' 86' ' ' ARG . 16.9 p90 -171.81 165.42 6.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 0.0 110.995 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 0.5 OUTLIER -93.55 122.3 35.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 0.0 108.276 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.937 HG21 ' HB3' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.21 -50.86 73.25 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.476 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 83' ' ' THR . 37.4 Cg_endo -75.04 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 0.0 110.953 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.681 ' CD2' ' CB ' ' A' ' 14' ' ' PRO . 49.1 m80 -75.04 57.94 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.164 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.02 -38.43 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 0.0 110.325 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.91 32.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.433 1.083 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.22 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 0.0 109.33 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.014 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.704 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 0.735 . . . . 0.0 111.018 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.164 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.24 153.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.565 1.166 . . . . 0.0 109.239 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.72 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.48 -174.76 19.72 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.525 1.14 . . . . 0.0 111.006 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.72 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.7 m -143.79 162.06 37.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 0.735 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.976 HD13 HG12 ' A' ' 29' ' ' VAL . 92.0 mt -146.65 122.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.52 31.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.441 1.088 . . . . 0.0 110.403 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.819 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.547 1.154 . . . . 0.0 109.255 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.786 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 O-C-N 124.604 1.19 . . . . 0.0 110.32 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.487 ' CE1' ' O ' ' A' ' 37' ' ' GLY 0.427 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.504 ' CG ' HG21 ' A' ' 36' ' ' VAL . 71.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 1.617 ' CZ ' ' HG2' ' B' ' 163' ' ' PRO . 0.1 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.5 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.753 ' HA ' HG12 ' B' ' 161' ' ' VAL . 47.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.705 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.989 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 17.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.422 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 84.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.937 ' HB3' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 26.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.705 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' B' ' 128' ' ' MET . 33.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 0.519 ' CD2' HD23 ' B' ' 103' ' ' LEU . 21.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' B' ' 102' ' ' TYR . 45.2 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.95 ' CG1' ' HG ' ' B' ' 115' ' ' LEU . 79.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.579 ' HB2' HG22 ' B' ' 114' ' ' ILE . 29.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 25.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.95 ' HG ' ' CG1' ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.409 ' O ' HD22 ' B' ' 115' ' ' LEU . 72.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.147 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.428 ' HE1' HG21 ' B' ' 71' ' ' VAL . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.9 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.989 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 1.508 ' HG2' ' CG ' ' B' ' 160' ' ' GLN . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' B' ' 24' ' ' CYS . 7.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.021 ' HB3' HG22 ' B' ' 164' ' ' THR . 0.9 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 1.617 ' HG2' ' CZ ' ' B' ' 4' ' ' TYR . 5.9 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.021 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.503 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.832 ' H ' HG21 ' B' ' 164' ' ' THR . 15.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.619 ' N ' HD22 ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 78.2 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.519 HD22 ' HA ' ' B' ' 62' ' ' ALA . 12.2 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.356 22.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.596 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 42.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.166 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 3.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.596 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.6 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.768 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.8 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.166 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 8.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.76 28.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.157 . . . . 0.0 109.998 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.624 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.8 m -122.48 177.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.416 1.073 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.82 40.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 110.324 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.404 1.065 . . . . 0.0 109.258 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.501 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.7 133.45 36.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.465 1.103 . . . . 0.0 109.323 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.693 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 0.0 110.952 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 1.031 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.06 160.58 15.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.417 0.716 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -59.71 -16.0 23.77 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.375 1.047 . . . . 0.0 109.357 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 20.7 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.521 1.138 . . . . 0.0 109.369 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 0.0 111.022 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.718 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.9 117.69 58.1 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 0.0 109.247 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.751 ' HB3' HG11 ' A' ' 36' ' ' VAL . 41.0 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.432 1.754 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 13' ' ' ALA . 1.7 pp -150.79 151.21 31.99 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.435 1.085 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.31 126.19 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.509 1.131 . . . . 0.0 110.991 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.553 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.419 0 O-C-N 124.457 1.098 . . . . 0.0 110.323 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.91 69.88 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 121.018 -2.493 . . . . 0.0 110.978 0.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.13 -40.06 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.58 1.175 . . . . 0.0 109.304 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.31 46.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.345 1.028 . . . . 0.0 109.227 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.31 30.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.92 143.73 50.96 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.519 1.137 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.624 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.89 -177.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.798 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.991 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.475 1.11 . . . . 0.0 109.313 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.45 8.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.551 1.157 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.13 174.16 11.47 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 0.745 . . . . 0.0 109.28 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 1.17 . . . . 0.0 110.437 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.938 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.81 169.55 18.05 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.551 1.157 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.27 121.53 9.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 0.0 110.888 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.13 155.31 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 0.0 109.275 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.875 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.3 ttp -97.98 119.19 36.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 1.031 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.37 -65.99 0.93 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 0.0 109.257 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -168.88 -167.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.751 HG11 ' HB3' ' A' ' 14' ' ' PRO . 12.1 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 0.0 109.327 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.03 -172.27 40.44 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.561 1.163 . . . . 0.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.979 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 5.5 Cg_endo -74.96 -168.85 6.81 Favored 'Cis proline' 0 C--N 1.361 1.226 0 C-N-CA 120.9 -2.542 . . . . 0.0 111.072 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.875 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.2 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.518 1.136 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.43 ' HB2' HD13 ' A' ' 42' ' ' ILE . 1.4 p30 173.98 167.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 1.135 . . . . 0.0 109.256 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.891 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.15 114.39 43.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.566 1.166 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.581 1.175 . . . . 0.0 109.318 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -47.79 160.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.03 -50.04 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.582 1.176 . . . . 0.0 109.255 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.015 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.3 m -128.57 158.12 72.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 109.259 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 164.26 33.53 Favored 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.541 1.811 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.437 1.086 . . . . 0.0 109.319 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.51 0.72 Allowed Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.597 1.186 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.554 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 0.784 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.21 77.67 1.74 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.015 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -52.95 -51.9 70.26 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.427 1.079 . . . . 0.0 109.281 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.5 Cg_endo -74.92 50.8 2.59 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.794 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.32 -45.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.598 1.187 . . . . 0.0 109.314 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.554 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.03 -27.57 68.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 109.285 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.8 m -46.43 115.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.575 1.172 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -107.95 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.467 1.104 . . . . 0.0 109.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 63' ' ' ASP . 9.1 t -89.75 21.77 3.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.372 1.045 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -85.98 64.36 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.452 1.095 . . . . 0.0 109.238 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.4 102.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.409 1.068 . . . . 0.0 109.388 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.43 98.4 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.586 1.178 . . . . 0.0 109.356 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG13 ' HB3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.66 -46.12 80.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.619 1.2 . . . . 0.0 109.318 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.15 111.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 124.547 1.154 . . . . 0.0 109.314 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.07 139.16 23.77 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.549 1.815 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -68.04 0.17 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.439 1.087 . . . . 0.0 110.945 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.67 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.66 97.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.438 0.728 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.2 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 0.0 110.932 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.891 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.343 1.027 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.771 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.32 20.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.476 1.11 . . . . 0.0 109.979 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.7 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.366 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.24 146.46 24.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 0.0 110.374 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.06 8.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.848 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.1 -44.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.5 1.125 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.818 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.15 124.08 36.81 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.523 0.778 . . . . 0.0 110.403 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 141.51 26.68 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.468 1.773 . . . . 0.0 111.05 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.15 -178.58 20.13 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.2 m -104.95 120.06 40.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.556 0.798 . . . . 0.0 110.402 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.994 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.503 1.127 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.432 1.083 . . . . 0.0 109.999 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.14 -171.5 3.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 14.9 p90 -171.89 165.42 6.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.56 122.26 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 0.0 108.285 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.511 HG21 ' HB1' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.25 -50.81 73.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.451 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 83' ' ' THR . 9.2 Cg_endo -75.04 -62.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.508 1.794 . . . . 0.0 111.009 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.9 m80 -75.06 57.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.593 1.183 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -87.89 -38.54 15.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 110.352 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 86' ' ' ARG . . . -89.52 -23.81 32.73 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.416 1.072 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.26 62.62 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.494 0.761 . . . . 0.0 109.325 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.21 1.82 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.458 1.099 . . . . 0.0 110.962 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.693 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 0.772 . . . . 0.0 110.994 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.18 153.59 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.268 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.709 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.57 -174.76 19.78 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.604 1.19 . . . . 0.0 110.883 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.709 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.8 162.04 37.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 0.772 . . . . 0.0 110.367 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.938 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.61 122.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.459 1.099 . . . . 0.0 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.6 m -105.01 144.51 31.72 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.415 1.072 . . . . 0.0 110.433 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.832 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.563 1.165 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.798 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 0.0 110.305 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.546 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 15.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.506 ' HE2' ' CE1' ' B' ' 4' ' ' TYR . 0.7 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.692 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 18.9 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 35.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' HA3' ' B' ' 159' ' ' GLY . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.694 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 84.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.824 ' HB2' HG22 ' B' ' 233' ' ' VAL . 23.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 85.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.665 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' A' ' 58' ' ' THR . 15.5 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.5 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.694 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.568 HD22 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.46 ' ND2' ' CG2' ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.845 HD21 ' CG1' ' B' ' 104' ' ' VAL . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 13.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.901 HG13 ' HG ' ' B' ' 115' ' ' LEU . 40.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.524 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.5 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.674 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.1 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 49.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.901 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.674 HD11 ' HA ' ' B' ' 107' ' ' TYR . 32.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.979 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . 0.536 ' HB3' HG13 ' A' ' 62' ' ' ILE . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.665 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 49.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 5.2 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.029 ' CB ' HG23 ' B' ' 164' ' ' THR . 8.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.692 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.029 HG23 ' CB ' ' B' ' 162' ' ' TYR . 3.3 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.4 ' N ' HG22 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.007 ' H ' HG22 ' B' ' 164' ' ' THR . 38.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' B' ' 167' ' ' LEU . 3.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.17 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.629 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.17 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.824 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -57.68 126.85 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 109.999 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.633 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.39 177.11 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 0.0 109.27 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.92 150.88 40.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.749 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 0.0 109.313 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.7 133.42 36.02 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.533 1.146 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.665 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.02 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 0.0 110.995 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.46 7.63 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 124.545 1.153 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.423 HG23 ' HG ' ' A' ' 15' ' ' LEU . 10.7 p -108.14 160.66 15.64 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.423 0.72 . . . . 0.0 110.41 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 46.2 t0 -59.8 -15.97 24.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.6 mttt -90.65 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.549 1.156 . . . . 0.0 109.365 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 38.32 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.67 58.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.832 ' HG3' ' CZ ' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.46 1.769 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.9 pp -150.76 151.27 32.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 0.0 109.365 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.41 126.2 30.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 0.0 110.932 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.95 26.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.401 1.063 . . . . 0.0 110.284 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -74.99 140.94 70.15 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.027 -2.489 . . . . 0.0 110.947 -0.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.13 -40.12 1.03 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.543 1.152 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.414 1.072 . . . . 0.0 109.283 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.36 31.0 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 0.0 109.264 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.512 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.76 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.53 1.144 . . . . 0.0 110.04 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.4 pt -154.95 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 0.0 109.324 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.78 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.33 27.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 109.936 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.857 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.11 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.38 8.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.481 1.113 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.562 0.801 . . . . 0.0 109.203 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.3 m -123.66 154.26 39.63 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.589 1.181 . . . . 0.0 110.367 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.994 HG12 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.46 102.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 0.0 109.24 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.8 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.531 1.144 . . . . 0.0 110.279 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.749 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.18 121.46 9.58 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 0.0 110.994 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.674 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.32 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.528 1.142 . . . . 0.0 109.25 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.558 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.5 ttp -98.04 119.21 36.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.32 -66.03 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 109.286 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.52 0.76 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 14' ' ' PRO . 1.2 p 46.04 54.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 0.0 109.345 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.9 -172.36 40.67 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.532 1.145 . . . . 0.0 111.046 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.1 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 25.3 Cg_endo -74.96 -168.95 6.89 Favored 'Cis proline' 0 C--N 1.361 1.184 0 C-N-CA 120.993 -2.503 . . . . 0.0 110.996 -0.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.588 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 71.2 m-70 -144.21 -170.33 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.505 1.128 . . . . 0.0 109.575 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.59 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.94 166.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.398 1.061 . . . . 0.0 109.285 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.925 HG21 ' HH ' ' A' ' 68' ' ' TYR . 57.0 t -104.05 114.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 1.152 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -132.82 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.126 . . . . 0.0 109.308 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.464 ' N ' ' HG ' ' A' ' 56' ' ' SER . 85.3 m-85 -47.55 160.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER 167.29 143.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.003 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.53 158.0 73.17 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 0.0 109.233 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 164.22 33.86 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.474 1.776 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.28 135.67 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 0.0 109.244 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.43 -56.52 0.73 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.538 1.149 . . . . 0.0 110.981 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.548 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.28 2.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 0.819 . . . . 0.0 110.249 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.597 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.24 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.382 1.052 . . . . 0.0 109.938 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.01 -51.86 70.81 Favored Pre-proline 0 C--N 1.323 -0.552 0 O-C-N 124.489 1.118 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.0 50.77 2.61 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.414 1.744 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.3 -45.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.579 1.174 . . . . 0.0 109.336 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.15 -27.51 68.08 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.316 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' A' ' 43' ' ' PHE . 47.1 m -46.52 115.13 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.494 1.121 . . . . 0.0 110.009 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 59' ' ' LYS . 21.7 t30 -107.92 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 0.0 109.358 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' B' ' 63' ' ' ASP . 1.4 t -89.75 21.85 3.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 0.0 110.343 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 28.8 tttt -86.04 64.43 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.093 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.737 HD13 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 0.0 109.332 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.42 98.5 6.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.311 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.69 -46.13 80.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.568 1.168 . . . . 0.0 109.319 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.16 111.61 4.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.48 1.113 . . . . 0.0 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -75.01 139.18 23.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.428 1.752 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.475 1.109 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.674 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.47 0.747 . . . . 0.0 110.06 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.13 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 0.0 111.039 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.925 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.51 175.18 4.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.418 1.073 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.775 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.69 161.2 21.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.567 1.167 . . . . 0.0 109.964 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.69 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 0.0 109.374 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.22 146.5 23.97 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.439 1.087 . . . . 0.0 110.388 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.19 173.06 8.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.857 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.13 -44.25 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.849 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.34 124.28 39.05 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.578 0.811 . . . . 0.0 110.385 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.15 141.49 26.3 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.549 1.815 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.66 20.02 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.89 120.05 40.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 0.787 . . . . 0.0 110.407 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.71 140.67 30.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 0.0 111.025 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.84 145.12 49.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.055 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.43 3.72 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.55 1.156 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 13.1 p90 -171.88 165.47 6.44 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 0.0 111.055 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.67 122.36 36.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 108.202 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.484 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 m -51.3 -50.73 74.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.441 1.088 . . . . 0.0 110.431 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 83' ' ' THR . 41.5 Cg_endo -75.13 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.565 1.824 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.828 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 27.0 m80 -75.03 57.99 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -38.56 15.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.554 1.159 . . . . 0.0 110.287 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.48 -23.85 32.72 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.533 1.146 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.492 0.76 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.16 1.82 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.478 1.111 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.665 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.66 75.12 1.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 0.761 . . . . 0.0 110.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.18 153.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.119 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.721 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.78 19.74 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.721 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.8 162.03 37.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.507 0.769 . . . . 0.0 110.425 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.994 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.62 122.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.561 1.163 . . . . 0.0 109.286 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.7 m -105.08 144.56 31.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.457 1.098 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.835 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.438 1.086 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.78 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 0.0 110.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.781 ' CE2' ' HD2' ' A' ' 38' ' ' PRO . 7.8 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.832 ' CZ ' ' HG3' ' A' ' 14' ' ' PRO . 3.8 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.828 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 1.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.504 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 33.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.764 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.731 ' HB2' HG22 ' B' ' 233' ' ' VAL . 20.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' B' ' 65' ' ' SER . 15.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.532 ' HA ' HD22 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.596 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 51.6 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.699 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.561 ' HG ' ' H ' ' B' ' 68' ' ' GLY . 2.1 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.561 ' H ' ' HG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.639 HG21 ' CE ' ' B' ' 128' ' ' MET . 23.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.922 ' CG1' ' HG ' ' B' ' 115' ' ' LEU . 68.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.745 HG21 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.629 ' HA ' HD13 ' B' ' 116' ' ' LEU . 28.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 31.8 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.922 ' HG ' ' CG1' ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.745 ' HB2' HG21 ' B' ' 105' ' ' THR . 0.4 OUTLIER -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.1 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.606 HD23 ' CE2' ' B' ' 125' ' ' TYR . 10.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.606 ' CE2' HD23 ' B' ' 120' ' ' LEU . 62.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.639 ' CE ' HG21 ' B' ' 71' ' ' VAL . 63.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.469 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.723 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 21.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.416 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.336 ' HH ' ' CB ' ' B' ' 168' ' ' SER . 3.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.037 ' CG2' ' HB2' ' B' ' 162' ' ' TYR . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.538 ' N ' HG22 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.047 ' O ' ' HD1' ' B' ' 162' ' ' TYR . 3.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.934 ' C ' ' HE1' ' B' ' 162' ' ' TYR . 4.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' SER . . . . . 1.336 ' CB ' ' HH ' ' B' ' 162' ' ' TYR . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.532 HD22 ' HA ' ' B' ' 62' ' ' ALA . 16.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 1.581 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.355 22.4 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 59.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.562 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 56.7 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.093 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 5.4 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.562 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.8 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.776 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.093 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 9.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.442 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.65 126.86 29.2 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.531 1.145 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.626 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.46 177.18 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.418 1.074 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.93 40.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.559 1.162 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.764 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.08 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.509 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.76 133.49 35.98 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.672 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 110.973 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.53 7.65 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.577 1.173 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -108.05 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.475 0.75 . . . . 0.0 110.42 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.83 -15.97 24.91 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 0.0 109.356 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -90.57 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 0.0 109.337 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER 38.23 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.169 . . . . 0.0 111.062 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.523 ' HB2' ' OG1' ' A' ' 9' ' ' THR . . . -104.8 117.71 58.16 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.064 ' HB3' HG12 ' A' ' 36' ' ' VAL . 34.7 Cg_endo -75.03 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.528 1.804 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 3.2 pp -150.78 151.23 32.04 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.48 1.113 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.431 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.34 126.15 30.47 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.509 1.131 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.41 134.9 26.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.505 1.128 . . . . 0.0 110.351 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.09 140.99 70.28 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 121.007 -2.497 . . . . 0.0 110.909 0.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.22 -40.11 1.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.531 1.145 . . . . 0.0 109.251 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.29 46.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.42 31.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.133 . . . . 0.0 109.247 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.473 1.108 . . . . 0.0 110.059 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.85 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.402 1.064 . . . . 0.0 109.259 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.789 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.53 158.29 27.62 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 0.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.32 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.44 8.45 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.469 1.105 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.21 174.14 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 0.733 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.53 154.25 39.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 0.0 110.436 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.41 102.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.566 1.167 . . . . 0.0 109.276 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.51 18.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.591 1.182 . . . . 0.0 110.334 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.764 ' CD2' HG21 ' A' ' 5' ' ' ILE . 64.0 m-85 -147.19 121.46 9.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.562 1.164 . . . . 0.0 110.986 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.01 155.35 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.565 1.166 . . . . 0.0 109.262 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.77 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.2 ttp -98.05 119.26 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.399 1.062 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.39 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.181 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.912 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.86 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.46 1.1 . . . . 0.0 109.228 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.064 HG12 ' HB3' ' A' ' 14' ' ' PRO . 9.3 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.455 1.097 . . . . 0.0 109.323 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.95 -172.3 40.58 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.51 1.131 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.95 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.913 -2.536 . . . . 0.0 111.034 -0.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.77 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.7 m-70 -144.23 -170.37 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.537 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.469 1.106 . . . . 0.0 109.338 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.886 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.06 114.35 43.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.543 1.152 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.544 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.0 OUTLIER -132.78 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.539 1.149 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -49.99 4.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.293 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.3 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.53 158.1 72.87 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.03 164.22 33.75 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.459 1.768 . . . . 0.0 110.974 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.21 135.62 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.597 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.59 0.72 Allowed Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.538 1.149 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.651 0.853 . . . . 0.0 110.25 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.603 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.426 1.079 . . . . 0.0 110.053 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.03 -51.81 71.31 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.415 1.072 . . . . 0.0 109.27 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.05 50.78 2.63 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.419 1.747 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.62 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.662 1.226 . . . . 0.0 109.358 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.13 -27.56 68.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 4.4 m -46.44 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 0.0 109.99 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 68' ' ' TYR 0.492 7.8 t30 -108.04 117.75 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.411 1.069 . . . . 0.0 109.312 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.896 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 4.0 t -89.82 21.87 3.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 0.0 110.311 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 60' ' ' LEU . 57.1 tttt -86.02 64.36 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.487 1.117 . . . . 0.0 109.287 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB3' HD21 ' A' ' 40' ' ' ASN . 0.0 OUTLIER -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.475 1.109 . . . . 0.0 109.296 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.42 6.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 1.097 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.521 HG22 HD12 ' A' ' 62' ' ' ILE . 5.9 mm -68.62 -46.07 80.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.526 1.141 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -62.13 111.64 4.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.285 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 5.1 Cg_exo -75.05 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.454 1.765 . . . . 0.0 111.025 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.86 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.55 1.157 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.661 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.8 t -178.65 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.527 0.781 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.612 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.449 1.093 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.886 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.7 p90 -171.5 175.16 4.18 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.767 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.95 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.474 1.109 . . . . 0.0 110.006 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.27 146.47 24.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.57 1.169 . . . . 0.0 110.382 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 1.126 . . . . 0.0 109.259 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.859 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.09 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.459 1.1 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.852 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.29 124.14 38.13 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.52 0.776 . . . . 0.0 110.388 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 141.5 26.78 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.438 1.757 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.64 20.05 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.459 1.1 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.3 m -104.81 120.11 40.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 0.776 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.996 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.66 31.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 111.03 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.88 145.15 49.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.406 1.066 . . . . 0.0 110.016 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.21 -171.59 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.114 . . . . 0.0 110.956 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 16.3 p90 -171.78 165.46 6.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.543 1.152 . . . . 0.0 110.995 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.54 122.34 35.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.448 1.093 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 2.9 m -51.38 -50.76 74.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.433 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.9 Cg_endo -75.02 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.234 0 O-C-N 124.492 1.785 . . . . 0.0 111.033 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HD2' ' HH ' ' B' ' 4' ' ' TYR . 22.1 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -38.44 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.536 1.147 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.52 -23.8 32.77 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.51 1.131 . . . . 0.0 110.995 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.18 62.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.512 0.772 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.1 1.83 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.456 1.097 . . . . 0.0 110.984 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.672 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.3 ttt -121.54 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 0.73 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.16 153.56 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 109.271 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.678 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.76 19.76 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.553 1.158 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.678 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.79 162.02 37.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.49 0.759 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.9 m -105.0 144.56 31.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.422 1.076 . . . . 0.0 110.429 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.804 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.31 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.523 1.139 . . . . 0.0 109.315 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.789 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.313 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.424 ' CD2' ' HE2' ' B' ' 4' ' ' TYR . 23.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.9 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 1.424 ' HE2' ' CD2' ' B' ' 1' ' ' TYR . 51.7 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 22.6 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.671 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.837 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.478 ' C ' HH11 ' B' ' 158' ' ' ARG . 0.0 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.491 ' HB1' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.896 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 5.7 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.3 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 65' ' ' SER 0.261 4.7 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 29.8 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.439 HD22 ' CD1' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.753 HG23 ' CE ' ' B' ' 128' ' ' MET . 33.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.624 HD22 HD12 ' B' ' 120' ' ' LEU . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.852 HG12 HD11 ' B' ' 115' ' ' LEU . 62.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.831 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.2 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.852 HD11 HG12 ' B' ' 104' ' ' VAL . 0.2 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.831 ' HB2' HG23 ' B' ' 105' ' ' THR . 70.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.672 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.624 HD12 HD22 ' B' ' 103' ' ' LEU . 39.3 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.753 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.457 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.837 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 14.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.954 ' CB ' HG22 ' B' ' 164' ' ' THR . 3.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.06 HG21 ' H ' ' B' ' 166' ' ' GLU . 5.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.06 ' H ' HG21 ' B' ' 164' ' ' THR . 44.6 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.7 ' N ' HD23 ' B' ' 167' ' ' LEU . 2.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.6 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.499 HD22 HH12 ' B' ' 158' ' ' ARG . 37.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.169 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.577 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.169 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.751 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.436 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.62 126.8 28.95 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.561 1.163 . . . . 0.0 110.056 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.625 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.41 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.413 1.071 . . . . 0.0 109.28 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.88 40.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.546 1.154 . . . . 0.0 110.3 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.771 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.3 112.12 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.457 1.098 . . . . 0.0 109.355 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.68 133.46 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.466 1.103 . . . . 0.0 109.377 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.692 ' HB3' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 0.0 111.007 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.52 7.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.543 1.152 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.698 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -108.1 160.71 15.6 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.478 0.752 . . . . 0.0 110.426 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.85 -15.96 25.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.436 1.085 . . . . 0.0 109.257 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 17.5 mttt -90.59 39.73 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' B' ' 3' ' ' PHE . 0.2 OUTLIER 38.26 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.58 1.175 . . . . 0.0 111.031 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.68 58.17 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 109.278 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HB3' HG11 ' A' ' 36' ' ' VAL . 37.3 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.497 1.788 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.448 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.4 pp -150.83 151.17 31.88 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.406 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.28 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.16 . . . . 0.0 111.018 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.43 134.95 26.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.565 1.166 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.06 140.98 70.28 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.939 0.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.16 -40.17 1.05 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.611 1.194 . . . . 0.0 109.252 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.29 46.09 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.462 1.101 . . . . 0.0 109.309 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.502 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.26 141.41 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 109.252 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.94 143.7 50.94 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 110.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 96' ' ' VAL . 11.2 pt -154.79 -177.44 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.504 1.128 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.802 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.37 27.5 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 0.0 110.002 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.15 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.606 1.191 . . . . 0.0 109.332 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.52 -7.48 8.44 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.515 1.134 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.16 174.13 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 0.753 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.52 154.26 39.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.509 1.131 . . . . 0.0 109.306 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.274 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.771 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.24 121.38 9.49 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.533 1.146 . . . . 0.0 110.98 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.34 33.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.515 1.134 . . . . 0.0 109.317 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.733 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.06 119.22 36.32 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.353 1.033 . . . . 0.0 111.026 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.35 -66.05 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 109.255 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.698 ' HD3' ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -168.89 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.44 1.087 . . . . 0.0 109.3 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.766 HG11 ' HB3' ' A' ' 14' ' ' PRO . 9.4 p 46.08 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.48 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.588 1.18 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.99 -168.86 6.83 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.934 -2.527 . . . . 0.0 110.969 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.733 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.5 m-70 -144.24 -170.33 3.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.542 1.151 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 p30 173.94 166.95 0.2 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.419 1.074 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -104.05 114.34 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.536 1.148 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.632 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.78 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 109.333 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.457 ' N ' ' HG ' ' A' ' 56' ' ' SER . 85.3 m-85 -47.62 160.59 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.568 1.167 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.571 1.17 . . . . 0.0 109.306 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.48 158.09 72.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 164.25 33.69 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.463 1.77 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 0.0 109.339 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.5 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.492 1.12 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.551 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.04 -173.34 2.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.593 0.819 . . . . 0.0 110.295 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.3 m -133.2 77.86 1.75 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.511 1.132 . . . . 0.0 109.994 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.993 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.12 -51.76 72.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.11 . . . . 0.0 109.262 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.12 50.86 2.67 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.487 1.783 . . . . 0.0 110.909 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.63 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.584 1.177 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.16 -27.52 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.117 . . . . 0.0 109.298 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.457 ' HG ' ' N ' ' A' ' 43' ' ' PHE . 47.7 m -46.46 115.15 0.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.523 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.6 m120 -108.02 117.71 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.438 1.086 . . . . 0.0 109.328 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 1.113 ' OG1' ' CB ' ' B' ' 63' ' ' ASP . 1.5 t -89.81 21.89 3.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.416 1.073 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -86.05 64.4 8.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.491 1.119 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.035 HD21 ' HB2' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -40.39 102.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.55 1.156 . . . . 0.0 109.332 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.44 98.38 6.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 0.0 109.343 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.6 -46.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 109.354 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.58 4.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.108 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.98 139.11 23.94 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.457 1.767 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.94 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.522 1.139 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.683 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.485 0.756 . . . . 0.0 109.985 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.616 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.16 -86.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.446 1.092 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.523 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.763 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.59 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.482 1.114 . . . . 0.0 110.029 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.73 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 109.428 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.41 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.3 146.53 23.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 110.344 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.19 173.06 8.57 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.492 1.12 . . . . 0.0 109.261 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.868 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.07 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.851 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.26 124.13 37.87 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 0.0 110.421 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.0 141.5 26.72 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.511 1.795 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.05 -178.67 20.0 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.335 1.022 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.87 120.04 40.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 0.746 . . . . 0.0 110.347 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.996 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.74 140.69 30.95 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.87 145.16 49.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.451 1.094 . . . . 0.0 109.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.23 -171.62 3.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.458 1.099 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.45 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 15.6 p90 -171.78 165.4 6.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.555 1.16 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 122.33 35.8 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.424 1.078 . . . . 0.0 108.326 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.632 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.9 m -51.38 -50.77 74.36 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.499 1.124 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 18.6 Cg_endo -75.03 -62.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 26.3 m80 -74.97 58.0 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.596 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -38.55 15.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.556 1.16 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.45 -23.72 33.18 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.505 1.128 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' OH ' ' B' ' 4' ' ' TYR . . . -65.73 -15.21 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 0.768 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.523 1.139 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.692 ' HE2' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.391 0.701 . . . . 0.0 111.021 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.59 30.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.589 1.181 . . . . 0.0 109.272 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.707 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.543 1.152 . . . . 0.0 111.006 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.707 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.74 162.08 36.93 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.968 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 0.0 109.238 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.1 m -105.1 144.57 31.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 110.372 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.818 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.32 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.497 1.123 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.802 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.56 1.163 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.481 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 16.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.979 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 16.2 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 88' ' ' ALA . 4.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.979 ' HG3' ' O ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.671 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.44 ' CZ ' HD12 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.69 ' HB2' HG22 ' B' ' 233' ' ' VAL . 18.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 1.035 ' HB2' HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.534 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 1.113 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 31.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.556 ' HB3' ' NE2' ' B' ' 61' ' ' GLN . 78.4 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.731 HD21 HG23 ' B' ' 233' ' ' VAL . 5.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.716 HG23 ' HE2' ' B' ' 128' ' ' MET . 35.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.697 HG22 HD22 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.8 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.658 HG13 ' HG ' ' B' ' 115' ' ' LEU . 98.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.697 HD22 HG22 ' B' ' 74' ' ' VAL . 19.0 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.745 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.464 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.745 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 38.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.716 ' HE2' HG23 ' B' ' 71' ' ' VAL . 36.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.446 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.534 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 46.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.8 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.625 ' HB2' ' CG2' ' B' ' 164' ' ' THR . 3.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.407 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.712 HG22 ' HB2' ' B' ' 166' ' ' GLU . 2.9 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.464 ' N ' HG23 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.712 ' HB2' HG22 ' B' ' 164' ' ' THR . 17.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.7 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.09 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 11.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.606 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.09 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.731 HG23 HD21 ' B' ' 69' ' ' LEU . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.441 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.55 126.8 28.94 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.535 1.147 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.623 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.42 177.19 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 0.0 109.273 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.87 40.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.14 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.412 1.07 . . . . 0.0 109.346 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.496 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.82 133.55 35.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 0.0 109.276 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.669 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.07 6.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 0.0 110.953 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.48 7.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.586 1.179 . . . . 0.0 110.973 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.704 HG22 ' CD1' ' A' ' 15' ' ' LEU . 17.2 p -108.07 160.7 15.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 0.741 . . . . 0.0 110.421 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -59.84 -15.92 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.402 1.064 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 23.9 mttt -90.58 39.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.137 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.603 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 22.9 m-85 38.37 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 0.0 111.015 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.84 117.65 58.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.075 ' HB3' HG11 ' A' ' 36' ' ' VAL . 22.3 Cg_endo -74.98 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.486 1.782 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.704 ' CD1' HG22 ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.21 31.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 0.0 109.357 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.34 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.473 1.108 . . . . 0.0 110.967 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.96 26.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.559 1.162 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.98 70.31 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.039 -2.484 . . . . 0.0 110.943 0.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.23 -40.1 1.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.554 1.159 . . . . 0.0 109.274 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.34 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.459 1.1 . . . . 0.0 109.302 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.29 141.43 31.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.553 1.158 . . . . 0.0 109.225 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.517 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.72 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.451 1.094 . . . . 0.0 110.036 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.623 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.88 -177.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 0.0 109.219 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.793 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.56 158.31 27.59 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.855 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.06 105.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.446 1.091 . . . . 0.0 110.999 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.25 174.09 11.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 0.747 . . . . 0.0 109.286 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.46 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 0.0 110.475 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.263 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.85 169.51 18.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.18 121.5 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.491 1.12 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.34 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.73 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.1 ttp -98.0 119.27 36.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.359 1.037 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -79.39 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.109 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.905 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.415 1.072 . . . . 0.0 109.279 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.075 HG11 ' HB3' ' A' ' 14' ' ' PRO . 9.7 p 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.615 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.538 1.149 . . . . 0.0 111.027 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.683 ' HD2' ' CE1' ' B' ' 1' ' ' TYR . 59.8 Cg_endo -74.99 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.931 -2.529 . . . . 0.0 110.963 -0.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.73 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.23 -170.4 3.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.569 1.168 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.99 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.9 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.8 t -104.07 114.33 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.534 1.146 . . . . 0.0 109.388 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.452 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.9 mm -132.75 75.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.59 160.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 110.98 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.99 -50.15 4.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 109.265 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.0 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.7 m -128.47 158.14 72.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.383 1.052 . . . . 0.0 109.291 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.07 164.22 33.67 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.505 1.792 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.19 135.6 1.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 0.0 109.328 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.537 1.148 . . . . 0.0 111.0 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.554 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.39 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.561 0.8 . . . . 0.0 110.263 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.46 1.1 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.993 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.11 -51.75 72.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 0.0 109.269 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.07 50.78 2.64 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.401 1.737 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.65 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.639 1.212 . . . . 0.0 109.381 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.554 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.06 -27.54 68.16 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 109.36 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.4 ' HG ' ' N ' ' A' ' 43' ' ' PHE . 45.3 m -46.45 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.531 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m120 -108.07 117.73 34.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.499 ' HG1' ' HB2' ' B' ' 63' ' ' ASP . 3.3 t -89.82 21.92 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.432 1.082 . . . . 0.0 110.317 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 1.7 tttt -86.04 64.41 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -40.45 102.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 0.0 109.297 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.702 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.43 98.43 6.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 109.316 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.6 OUTLIER -68.69 -46.06 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.594 1.184 . . . . 0.0 109.332 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.63 4.93 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.04 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.473 1.775 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.87 -67.9 0.17 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.591 1.182 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.683 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.493 0.761 . . . . 0.0 109.994 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.25 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.417 1.073 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.9 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.51 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.494 1.121 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.766 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.29 20.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.408 1.068 . . . . 0.0 110.015 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 0.0 109.412 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 110.347 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.11 173.08 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.514 1.134 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.855 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.488 1.117 . . . . 0.0 110.963 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.824 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.26 124.06 37.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.545 0.791 . . . . 0.0 110.403 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.97 141.51 26.82 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.483 1.781 . . . . 0.0 111.09 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.441 1.088 . . . . 0.0 111.007 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.9 120.08 40.57 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.484 0.755 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.0 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.68 30.97 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.491 1.119 . . . . 0.0 111.017 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.17 49.3 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 1.08 . . . . 0.0 109.97 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.55 3.74 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 15.7 p90 -171.86 165.35 6.46 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 122.36 35.81 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.445 1.091 . . . . 0.0 108.284 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.561 HG22 ' HB1' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.39 -50.82 74.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.456 1.098 . . . . 0.0 110.356 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 83' ' ' THR . 36.4 Cg_endo -74.93 -62.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.527 1.804 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 29.5 m80 -74.96 57.93 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 0.0 109.598 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.17 ' HD2' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.97 -38.49 15.49 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.559 1.162 . . . . 0.0 110.318 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.886 ' N ' ' HD2' ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.77 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' B' ' 3' ' ' PHE . . . -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 0.761 . . . . 0.0 109.425 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.08 63.17 1.83 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.444 1.09 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.669 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.61 75.03 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.4 0.706 . . . . 0.0 111.066 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.14 153.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.499 1.124 . . . . 0.0 109.305 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.68 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.79 19.77 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.571 1.169 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.68 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.74 162.03 37.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 0.748 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.968 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.61 122.63 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.02 144.49 31.75 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.427 1.079 . . . . 0.0 110.415 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.821 ' O ' HG11 ' A' ' 96' ' ' VAL . 5.0 t -128.2 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.53 1.144 . . . . 0.0 109.376 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.793 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.088 ' HD2' ' CE2' ' B' ' 4' ' ' TYR . 97.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.496 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.598 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 16.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 1.088 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 24.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.7 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.754 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 1.452 ' HG3' ' CG ' ' B' ' 58' ' ' GLN . 48.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.685 ' HB2' HG22 ' B' ' 233' ' ' VAL . 12.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.423 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 87.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.484 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 1.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.499 ' HB2' ' HG1' ' A' ' 58' ' ' THR . 2.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.4 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.694 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.531 HD22 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.457 ' ND2' ' CG2' ' A' ' 62' ' ' ILE . 4.9 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.822 HG21 ' CE ' ' B' ' 128' ' ' MET . 20.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.781 HD23 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.752 HG12 HD21 ' B' ' 83' ' ' LEU . 67.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.672 HG23 ' HB2' ' B' ' 116' ' ' LEU . 2.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 73.9 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.723 HD11 HG13 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.672 ' HB2' HG23 ' B' ' 105' ' ' THR . 52.1 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.823 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.817 HD22 ' CE2' ' B' ' 125' ' ' TYR . 17.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . 0.553 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.817 ' CE2' HD22 ' B' ' 120' ' ' LEU . 41.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.822 ' CE ' HG21 ' B' ' 71' ' ' VAL . 60.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.469 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.539 ' O ' HD12 ' B' ' 167' ' ' LEU . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' B' ' 24' ' ' CYS . 9.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.342 ' CD2' ' HD2' ' B' ' 163' ' ' PRO . 13.1 t80 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 1.342 ' HD2' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.174 ' CG2' ' HB3' ' B' ' 162' ' ' TYR . 0.2 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.693 ' H ' HG21 ' B' ' 164' ' ' THR . 36.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.539 HD12 ' O ' ' B' ' 160' ' ' GLN . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.917 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.752 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.917 ' HD3' ' CD2' ' B' ' 189' ' ' PHE 0.26 5.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.439 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.62 126.79 28.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.533 1.146 . . . . 0.0 109.99 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.628 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.46 177.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.426 1.079 . . . . 0.0 109.271 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.602 1.189 . . . . 0.0 110.296 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.458 1.099 . . . . 0.0 109.32 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.497 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.72 133.46 36.0 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.607 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.68 97.1 6.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 110.961 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.5 7.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.605 1.191 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.653 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 27.0 p -108.1 160.74 15.57 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.437 0.728 . . . . 0.0 110.398 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 45.5 t0 -59.85 -15.94 24.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.089 . . . . 0.0 109.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 13.1 mttt -90.64 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 38.27 29.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.72 58.07 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.483 1.115 . . . . 0.0 109.326 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.101 ' HB3' HG12 ' A' ' 36' ' ' VAL . 10.9 Cg_endo -75.0 97.62 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.498 1.788 . . . . 0.0 110.974 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD1' HG22 ' A' ' 9' ' ' THR . 1.2 pp -150.83 151.19 31.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.511 1.132 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.33 126.18 30.51 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.492 1.12 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.555 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.04 140.97 70.24 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.03 -2.488 . . . . 0.0 110.962 0.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.17 -40.1 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.545 1.153 . . . . 0.0 109.295 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.33 46.09 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.517 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.43 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.11 . . . . 0.0 109.226 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.517 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 110.029 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.12 . . . . 0.0 109.289 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.795 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.62 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.452 1.095 . . . . 0.0 109.994 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.85 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.05 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.59 1.181 . . . . 0.0 109.313 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.506 1.128 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.17 174.17 11.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 0.78 . . . . 0.0 109.288 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.55 154.23 39.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 0.0 110.427 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.963 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.592 1.182 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.86 169.49 18.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.17 121.49 9.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 0.0 110.962 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.04 155.28 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.693 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.5 ttp -98.01 119.26 36.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.373 1.046 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 35' ' ' LYS . 42.8 t30 -79.33 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.868 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.101 HG12 ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.04 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.092 . . . . 0.0 109.319 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.694 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.91 -172.31 40.63 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.487 1.117 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.452 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 56.3 Cg_endo -74.98 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.973 -0.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.693 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 68.8 m-70 -144.26 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.588 1.18 . . . . 0.0 109.574 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 174.01 167.07 0.21 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 109.338 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.897 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.16 114.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.586 1.179 . . . . 0.0 109.323 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 42' ' ' ILE . 1.1 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.61 160.63 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.562 1.163 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.05 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.997 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.381 1.051 . . . . 0.0 109.257 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 164.27 33.6 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.449 1.763 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.27 135.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 0.0 109.292 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.613 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.66 0.72 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.553 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.01 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.59 0.818 . . . . 0.0 110.282 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.582 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.2 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.426 1.079 . . . . 0.0 109.997 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.997 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.04 -51.83 71.14 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.417 1.073 . . . . 0.0 109.265 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.02 50.79 2.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.447 1.762 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.29 -45.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.659 1.224 . . . . 0.0 109.348 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.553 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.54 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -46.52 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.945 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.447 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -107.97 117.69 34.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.79 21.88 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.38 1.05 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -86.04 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.42 102.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.546 1.154 . . . . 0.0 109.337 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.718 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.954 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.64 -46.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.162 . . . . 0.0 109.353 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.04 111.61 4.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 0.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.05 139.15 23.81 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.468 1.772 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.567 1.167 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.68 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.7 97.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.438 0.728 . . . . 0.0 109.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.496 1.123 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.897 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.7 p90 -171.52 175.12 4.18 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.467 1.105 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.28 20.94 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.444 1.09 . . . . 0.0 109.988 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.04 137.69 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.106 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.26 146.48 23.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 110.331 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.11 8.53 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.449 1.093 . . . . 0.0 109.251 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.85 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.13 -44.31 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.823 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.27 124.07 37.65 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 0.0 110.37 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.49 26.79 Favored 'Trans proline' 0 C--N 1.359 1.092 0 O-C-N 124.498 1.789 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.452 1.095 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.02 40.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 0.742 . . . . 0.0 110.339 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.996 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.4 m-85 -96.68 140.75 30.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.97 145.16 49.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.56 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.422 1.077 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.1 p90 -171.82 165.41 6.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 1.12 . . . . 0.0 111.018 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.49 122.38 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 0.0 108.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.737 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.34 -50.84 73.84 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.506 1.129 . . . . 0.0 110.373 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CB ' ' OH ' ' B' ' 1' ' ' TYR . 40.2 Cg_endo -74.97 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.465 1.771 . . . . 0.0 111.01 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 2.5 m170 -75.03 58.01 0.85 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.346 HH12 ' CA ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -88.01 -38.46 15.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.57 1.169 . . . . 0.0 110.314 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 1.346 ' CA ' HH12 ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.465 1.103 . . . . 0.0 110.983 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.64 -15.26 62.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 0.751 . . . . 0.0 109.408 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.11 1.83 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.43 1.081 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.498 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.56 74.98 1.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.401 0.706 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.12 153.59 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.684 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.72 19.72 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.599 1.187 . . . . 0.0 110.984 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.684 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.81 162.07 37.01 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 0.793 . . . . 0.0 110.414 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.963 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.64 122.63 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.0 m -105.01 144.53 31.69 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.414 1.071 . . . . 0.0 110.404 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.825 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.515 1.134 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.795 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.572 1.17 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.903 ' H2 ' ' HD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.422 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 1.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.2 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.46 ' SG ' ' HA3' ' B' ' 159' ' ' GLY . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.664 ' CE2' HD13 ' B' ' 69' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 1.435 ' HG3' ' CG ' ' B' ' 58' ' ' GLN . 52.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.969 ' HB2' HG22 ' B' ' 233' ' ' VAL . 7.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 65' ' ' SER . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.65 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 69.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.56 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.664 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.667 ' ND2' HG22 ' A' ' 62' ' ' ILE . 2.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.562 HG22 ' CE ' ' B' ' 128' ' ' MET . 27.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.837 HG22 HD23 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.57 HD23 HD12 ' B' ' 120' ' ' LEU . 1.2 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.874 HG11 HD11 ' B' ' 115' ' ' LEU . 99.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.808 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.5 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.573 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.874 HD11 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.837 HD23 HG22 ' B' ' 74' ' ' VAL . 46.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.467 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.694 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.57 HD12 HD23 ' B' ' 103' ' ' LEU . 9.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . 0.954 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' B' ' 124' ' ' ASP . 4.1 pm0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.546 ' N ' ' HG2' ' B' ' 123' ' ' GLU . 8.7 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.562 ' CE ' HG22 ' B' ' 71' ' ' VAL . 42.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.521 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 6.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.884 ' CB ' HG22 ' B' ' 164' ' ' THR . 19.2 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.006 HG21 ' H ' ' B' ' 166' ' ' GLU . 14.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.006 ' H ' HG21 ' B' ' 164' ' ' THR . 25.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.522 HD22 ' HA ' ' B' ' 62' ' ' ALA . 10.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.171 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.841 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.171 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 8.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.969 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.423 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.58 126.79 28.88 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.549 1.155 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.39 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.267 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.86 40.25 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.529 1.143 . . . . 0.0 110.315 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.759 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.363 1.039 . . . . 0.0 109.267 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.502 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.74 133.47 35.99 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.614 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.69 96.99 6.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.458 1.099 . . . . 0.0 111.036 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.477 1.111 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.426 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 1.4 p -108.09 160.65 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.446 0.733 . . . . 0.0 110.439 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 13.4 t70 -59.78 -15.98 24.44 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.452 1.095 . . . . 0.0 109.361 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 29.1 mttp -90.57 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.313 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.24 29.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 0.0 111.054 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.653 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.85 117.7 58.12 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.736 ' HG3' HG22 ' A' ' 36' ' ' VAL . 28.0 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.429 1.752 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 13' ' ' ALA . 1.2 pp -150.81 151.22 31.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.109 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.17 30.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.552 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.44 134.82 26.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.406 1.066 . . . . 0.0 110.375 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.12 140.92 69.9 Favored 'Cis proline' 0 C--N 1.36 1.138 0 C-N-CA 121.031 -2.487 . . . . 0.0 110.96 0.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.17 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.32 46.11 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.425 1.078 . . . . 0.0 109.279 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 22' ' ' SER . 11.1 tp -143.21 141.4 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.137 . . . . 0.0 109.261 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.512 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 0.0 110.019 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.63 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.94 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 0.0 109.287 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.782 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.126 . . . . 0.0 109.923 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.525 1.141 . . . . 0.0 109.251 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.43 8.45 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.508 1.13 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.14 174.09 11.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.56 0.8 . . . . 0.0 109.282 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.43 154.29 39.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 110.51 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.957 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.52 102.6 6.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.099 . . . . 0.0 109.289 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.53 18.08 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.484 1.115 . . . . 0.0 110.28 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.759 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.23 121.39 9.5 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.516 1.135 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.38 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.723 ' HE3' ' HB3' ' A' ' 64' ' ' PRO . 6.8 ttp -98.0 119.17 36.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.427 1.079 . . . . 0.0 111.037 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -79.38 -66.05 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.571 1.17 . . . . 0.0 109.223 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.565 ' C ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 36' ' ' VAL . 2.7 p 45.97 54.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.505 1.128 . . . . 0.0 109.321 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.792 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -93.0 -172.37 40.51 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.478 1.111 . . . . 0.0 111.03 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HG3' HD11 ' A' ' 62' ' ' ILE . 19.0 Cg_endo -75.02 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.97 0.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.4 m-70 -144.23 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 0.0 109.644 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.703 ' HB3' HD21 ' A' ' 60' ' ' LEU . 1.2 p30 173.97 166.96 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 0.0 109.304 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.895 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.8 t -104.12 114.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.941 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.8 mm -132.75 75.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.402 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.72 160.59 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.01 -49.94 4.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 0.0 109.276 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.26 143.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.431 1.082 . . . . 0.0 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.015 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.56 158.14 72.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.39 1.056 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.9 Cg_endo -75.11 164.2 33.61 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.55 1.816 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.16 135.55 1.37 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.097 . . . . 0.0 109.307 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.596 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.52 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.566 1.166 . . . . 0.0 110.974 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.24 2.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.607 0.828 . . . . 0.0 110.243 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.6 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.27 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 0.0 109.963 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.008 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -52.99 -51.85 70.87 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.473 1.108 . . . . 0.0 109.353 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -74.97 50.71 2.58 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.446 1.761 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.31 -45.54 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.53 1.144 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.11 -27.61 68.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.593 1.183 . . . . 0.0 109.252 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.47 115.12 0.94 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.555 1.159 . . . . 0.0 109.995 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 1.426 HD21 ' ND2' ' A' ' 57' ' ' ASN 0.964 52.9 p-10 -107.94 117.66 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.442 1.088 . . . . 0.0 109.298 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.64 ' HG1' ' CB ' ' B' ' 63' ' ' ASP . 9.7 t -89.82 21.9 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.454 1.096 . . . . 0.0 110.301 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -86.01 64.37 8.54 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 0.0 109.239 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 40' ' ' ASN . 4.4 mt -40.39 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.722 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.52 98.49 6.11 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.563 1.164 . . . . 0.0 109.263 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 1.094 HG21 ' HB3' ' B' ' 121' ' ' PRO . 1.2 mm -68.64 -46.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.11 111.59 4.84 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.91 ' HD3' ' HG3' ' B' ' 121' ' ' PRO . 9.0 Cg_endo -74.97 139.15 24.02 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.466 1.771 . . . . 0.0 111.052 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 32' ' ' VAL . . . 168.88 -67.98 0.17 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.124 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.662 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.455 0.738 . . . . 0.0 110.008 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.722 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.16 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.463 1.102 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 1.025 ' OH ' ' OD1' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.11 4.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 0.0 111.021 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.57 161.31 20.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.462 1.101 . . . . 0.0 109.975 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.69 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.449 1.093 . . . . 0.0 110.332 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.09 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.518 1.136 . . . . 0.0 109.233 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.878 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.12 -44.34 0.02 OUTLIER Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.577 1.173 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.856 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.28 124.11 37.86 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.453 0.737 . . . . 0.0 110.39 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.51 26.77 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.504 1.792 . . . . 0.0 111.054 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.62 20.07 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.422 1.076 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.4 HG21 HG23 ' A' ' 93' ' ' THR . 29.9 m -104.83 120.07 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.556 0.798 . . . . 0.0 110.403 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.015 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.58 1.175 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.91 145.16 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.24 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.444 1.09 . . . . 0.0 110.927 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.538 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 15.0 p90 -171.84 165.38 6.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.52 122.27 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.469 1.106 . . . . 0.0 108.29 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.986 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 20.4 m -51.27 -50.79 73.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 110.429 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.648 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 30.3 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.554 1.818 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -75.04 57.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.139 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.986 ' CG ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -87.98 -38.5 15.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.558 1.161 . . . . 0.0 110.337 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.5 -23.77 32.91 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.423 1.077 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.31 62.66 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.487 0.757 . . . . 0.0 109.314 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.22 1.82 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.469 1.106 . . . . 0.0 110.979 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.424 ' HE3' ' CA ' ' A' ' 7' ' ' MET . 7.2 ttt -121.63 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 0.763 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.21 153.49 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.44 1.088 . . . . 0.0 109.298 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.723 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.46 -174.69 19.64 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.449 1.093 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.723 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.84 162.08 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 0.778 . . . . 0.0 110.382 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.957 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.56 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.51 1.131 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.01 144.53 31.68 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 0.0 110.43 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.816 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.25 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 0.0 109.283 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.782 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.498 1.123 . . . . 0.0 110.347 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.003 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.804 ' CE2' ' CE1' ' B' ' 1' ' ' TYR . 8.8 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.671 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.859 ' HB2' HG22 ' B' ' 233' ' ' VAL . 22.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 76.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.733 ' OE1' ' HB3' ' B' ' 65' ' ' SER . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.774 ' HB1' HG23 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.64 ' CB ' ' HG1' ' A' ' 58' ' ' THR . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.733 ' HB3' ' OE1' ' B' ' 61' ' ' GLN . 3.2 t -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.523 HD23 HG23 ' B' ' 233' ' ' VAL . 7.5 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.576 HD22 ' CD1' ' A' ' 62' ' ' ILE . 6.3 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.613 HG22 ' CE ' ' B' ' 128' ' ' MET . 21.3 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . 0.69 ' HB2' HD12 ' B' ' 103' ' ' LEU . 80.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.69 HD12 ' HB2' ' B' ' 99' ' ' ASP . 1.6 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.933 HG11 HD12 ' B' ' 115' ' ' LEU . 24.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.721 HG23 ' HB2' ' B' ' 116' ' ' LEU . 11.9 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.639 ' HA ' HD13 ' B' ' 116' ' ' LEU . 30.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.933 HD12 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' B' ' 105' ' ' THR . 5.3 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.792 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.7 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.478 HD12 HD23 ' B' ' 103' ' ' LEU . 4.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . 1.094 ' HB3' HG21 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.426 ' HH ' HD22 ' B' ' 103' ' ' LEU . 43.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.613 ' CE ' HG22 ' B' ' 71' ' ' VAL . 56.3 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 22.9 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.759 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 36.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.936 ' HB3' HG22 ' B' ' 164' ' ' THR . 6.7 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.542 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.936 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.0 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD21 ' B' ' 171' ' ' ASN . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.161 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.625 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.161 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.432 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.54 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.591 1.182 . . . . 0.0 110.045 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.633 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.49 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.418 1.074 . . . . 0.0 109.249 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.91 150.91 40.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.521 1.138 . . . . 0.0 110.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.754 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.09 38.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.442 1.089 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.71 133.54 35.92 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.615 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.76 97.01 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 0.0 110.996 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.52 7.63 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 0.0 110.967 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.48 ' HG1' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.12 160.65 15.64 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.462 0.742 . . . . 0.0 110.371 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.78 -15.98 24.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.402 1.064 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.6 mtpt -90.57 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 111.019 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.63 58.3 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.835 ' HB3' HG12 ' A' ' 36' ' ' VAL . 38.8 Cg_endo -74.97 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.496 1.787 . . . . 0.0 111.028 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' CD2' ' HG1' ' A' ' 9' ' ' THR . 3.4 pp -150.8 151.19 31.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.5 134.95 26.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 124.498 1.124 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.03 140.96 70.23 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 121.021 -2.491 . . . . 0.0 110.959 0.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.21 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.563 1.165 . . . . 0.0 109.271 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.12 146.3 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.424 1.078 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.22 141.44 31.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.115 . . . . 0.0 109.201 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.508 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.69 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.432 1.082 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.226 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.798 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.28 27.67 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.006 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.1 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.626 1.204 . . . . 0.0 109.36 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.43 8.46 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.542 1.151 . . . . 0.0 110.987 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.16 174.12 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 0.779 . . . . 0.0 109.287 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.5 154.27 39.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.964 HG12 HD13 ' A' ' 94' ' ' ILE . 64.0 t -131.43 102.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.28 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.84 169.49 18.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.531 1.145 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.754 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.458 1.099 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.37 33.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 0.0 109.347 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.474 ' SD ' ' HE1' ' A' ' 67' ' ' PHE . 1.1 ttp -98.07 119.28 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.384 1.053 . . . . 0.0 111.032 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.37 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 0.0 109.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.428 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.48 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.465 1.103 . . . . 0.0 109.23 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 14' ' ' PRO . 8.0 p 46.03 54.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 124.415 1.072 . . . . 0.0 109.359 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.494 1.121 . . . . 0.0 111.083 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -74.98 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.929 -2.53 . . . . 0.0 110.995 -0.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.619 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.9 m-70 -144.24 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.461 1.1 . . . . 0.0 109.586 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.97 167.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.14 114.37 43.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.513 1.133 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.602 HG13 ' OG1' ' A' ' 83' ' ' THR . 3.2 mm -132.81 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.312 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.55 1.156 . . . . 0.0 111.01 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.0 -50.01 4.79 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.597 1.185 . . . . 0.0 109.257 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.0 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.51 158.1 72.82 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.417 1.073 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.04 164.24 33.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.454 1.765 . . . . 0.0 110.994 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.44 1.087 . . . . 0.0 109.328 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.5 -56.61 0.72 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.564 1.165 . . . . 0.0 111.027 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.36 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.608 0.828 . . . . 0.0 110.289 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.592 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.18 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.414 1.071 . . . . 0.0 109.989 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.979 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.02 -51.76 71.82 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.07 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.487 1.782 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.24 -45.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 109.331 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -65.98 -27.62 68.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 0.0 109.369 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.0 m -46.45 115.09 0.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 0.0 110.028 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.719 ' HB2' ' HH ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -108.0 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.327 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.0 t -89.77 21.91 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.382 1.051 . . . . 0.0 110.342 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.438 1.086 . . . . 0.0 109.311 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.52 ' CD1' ' HB3' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.111 . . . . 0.0 109.287 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.727 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.43 98.42 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.502 1.126 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.445 HD11 ' NE2' ' B' ' 61' ' ' GLN . 2.6 mm -68.63 -46.08 80.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.568 1.167 . . . . 0.0 109.355 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.63 4.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 0.0 109.298 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -75.03 139.08 23.78 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.422 1.748 . . . . 0.0 111.046 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.9 0.17 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.542 1.151 . . . . 0.0 110.935 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.688 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 0.794 . . . . 0.0 109.99 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.23 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.451 1.094 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.719 ' HH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.08 4.19 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.478 1.111 . . . . 0.0 110.982 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.767 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.27 20.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.02 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.71 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.381 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.3 146.47 24.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.13 . . . . 0.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.12 173.06 8.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.871 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.09 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.517 1.135 . . . . 0.0 111.0 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.854 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.23 124.1 37.51 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 0.785 . . . . 0.0 110.42 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.97 141.44 26.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.415 1.745 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.63 20.09 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.386 1.054 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.403 HG21 HG23 ' A' ' 93' ' ' THR . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.449 0.735 . . . . 0.0 110.378 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.0 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.75 30.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.95 145.19 49.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.57 3.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 0.0 110.98 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -171.81 165.43 6.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 122.31 35.84 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.464 1.102 . . . . 0.0 108.284 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.602 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.1 m -51.36 -50.75 74.42 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 110.392 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 55.2 Cg_endo -75.08 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.541 1.811 . . . . 0.0 110.964 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 25.5 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.135 . . . . 0.0 109.616 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.784 ' HD3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -87.96 -38.53 15.47 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.486 1.116 . . . . 0.0 110.32 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.784 ' N ' ' HD3' ' A' ' 86' ' ' ARG . . . -89.45 -23.83 32.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' OH ' ' B' ' 4' ' ' TYR . . . -65.65 -15.21 62.55 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 0.776 . . . . 0.0 109.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.457 1.098 . . . . 0.0 110.983 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.521 ' HE3' ' HA ' ' A' ' 7' ' ' MET . 7.6 ttt -121.57 75.02 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 0.745 . . . . 0.0 111.068 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.14 153.57 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.251 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.72 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.76 19.73 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.55 1.156 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.72 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.76 162.09 36.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 0.778 . . . . 0.0 110.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.964 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 0.0 109.273 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.08 144.54 31.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.412 1.07 . . . . 0.0 110.411 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.832 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.579 1.175 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.798 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.164 . . . . 0.0 110.291 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.458 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 39.8 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.501 ' OH ' ' HB3' ' A' ' 88' ' ' ALA . 13.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 34.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.627 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 1.046 ' HG3' HG21 ' B' ' 233' ' ' VAL . 4.4 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.752 ' HG3' HD13 ' A' ' 60' ' ' LEU . 8.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.534 ' HA ' HD22 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 1.52 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 3.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.658 ' N ' HG12 ' B' ' 104' ' ' VAL . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.649 ' HB2' HG21 ' B' ' 105' ' ' THR . 83.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.662 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.464 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.662 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 82.1 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.414 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 66.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 43.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 1.362 ' C ' ' HD1' ' B' ' 162' ' ' TYR . 8.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.362 ' HD1' ' C ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.762 ' CG2' ' HB2' ' B' ' 162' ' ' TYR . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.405 ' N ' HG22 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.691 ' HB2' HH12 ' A' ' 86' ' ' ARG . 27.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.3 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.534 HD22 ' HA ' ' B' ' 62' ' ' ALA . 8.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.8 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 0.28 61.6 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.8 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.734 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 4.8 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.841 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.734 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.531 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.542 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 3.3 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.841 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.8 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 1.046 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.435 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.52 126.85 29.13 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.574 1.171 . . . . 0.0 110.022 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CG2' ' A' ' 23' ' ' ILE . 5.0 m -122.49 177.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.467 1.104 . . . . 0.0 109.295 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.83 40.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 0.0 110.321 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.11 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.434 1.084 . . . . 0.0 109.301 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.72 133.43 36.03 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.512 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.63 96.98 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.444 1.09 . . . . 0.0 111.008 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.57 7.65 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.504 1.127 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.464 ' HG1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.13 160.64 15.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.449 0.735 . . . . 0.0 110.371 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.69 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 7.5 t70 -59.81 -15.91 24.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.448 1.093 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 3.3 ttmt -90.6 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.118 . . . . 0.0 109.311 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.759 ' HD2' HG22 ' B' ' 105' ' ' THR . 0.0 OUTLIER 38.34 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.71 58.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 0.0 109.248 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.025 ' HB3' HG21 ' A' ' 36' ' ' VAL . 16.5 Cg_endo -74.94 97.66 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.407 1.74 . . . . 0.0 111.043 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.464 HD22 ' HG1' ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.18 31.93 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -77.25 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.558 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.43 134.84 26.53 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.391 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.07 140.95 70.09 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.032 -2.487 . . . . 0.0 110.954 0.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.3 tttt -40.19 -40.15 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 0.0 109.358 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.2 141.44 31.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 0.0 109.214 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.505 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.78 50.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.597 1.186 . . . . 0.0 110.052 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.63 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.87 -177.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.797 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.34 27.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.127 . . . . 0.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.19 105.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.575 1.172 . . . . 0.0 109.322 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.38 -7.25 8.55 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.523 1.14 . . . . 0.0 111.022 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.18 174.15 11.46 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.567 0.804 . . . . 0.0 109.294 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.1 m -123.61 154.2 39.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 0.0 110.466 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.948 HG12 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.32 102.59 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.562 1.164 . . . . 0.0 109.33 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.75 169.52 18.11 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.584 1.177 . . . . 0.0 110.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.22 121.48 9.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.597 1.186 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' A' ' 66' ' ' SER . 4.3 p -125.08 155.34 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.567 1.167 . . . . 0.0 109.276 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.612 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.8 ttt -98.0 119.19 36.19 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.475 1.11 . . . . 0.0 111.026 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.861 ' ND2' ' HD3' ' A' ' 35' ' ' LYS . 11.6 t30 -79.3 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 0.0 109.26 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.861 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.81 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 0.0 109.346 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 14' ' ' PRO . 0.9 OUTLIER 45.9 54.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.31 40.54 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.563 1.165 . . . . 0.0 111.062 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.865 ' HD2' ' ND2' ' B' ' 70' ' ' ASN . 73.5 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.974 -2.511 . . . . 0.0 111.062 -0.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.612 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.3 m-70 -144.28 -170.37 3.34 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.576 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.446 HD22 ' HD3' ' A' ' 84' ' ' PRO . 4.3 p30 173.99 167.05 0.21 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.421 1.076 . . . . 0.0 109.289 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.901 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.11 114.36 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.583 1.177 . . . . 0.0 109.416 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mm -132.84 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.67 160.6 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 111.008 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 4.1 t70 -97.08 -49.92 4.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.25 143.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.551 1.157 . . . . 0.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.008 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.53 158.08 72.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 0.0 109.276 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.0 164.24 33.74 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.408 1.741 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.57 1.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.467 1.104 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.601 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.51 -56.48 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.588 1.18 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.13 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.579 0.811 . . . . 0.0 110.295 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.572 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.08 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.006 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.003 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.06 -51.8 71.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -75.07 50.79 2.64 Favored 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.419 1.747 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.69 0.07 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.324 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.52 68.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.601 1.188 . . . . 0.0 109.316 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -46.45 115.13 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 110.008 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 117.6 34.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.365 1.04 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -89.77 21.86 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.404 1.065 . . . . 0.0 110.314 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' LEU . 61.7 tttt -86.04 64.42 8.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.416 1.072 . . . . 0.0 109.27 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.48 102.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.432 1.082 . . . . 0.0 109.335 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.4 98.4 5.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.531 1.144 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 1.053 HG22 ' HB2' ' B' ' 121' ' ' PRO . 1.7 mt -68.65 -46.1 80.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 0.0 109.365 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.51 4.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 43.0 Cg_endo -74.95 139.19 24.13 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.544 1.813 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 32' ' ' VAL . . . 168.85 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.475 1.109 . . . . 0.0 110.991 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.617 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.753 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 5.0 m-85 -38.28 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.901 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.54 175.16 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.42 1.075 . . . . 0.0 110.964 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.773 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.65 161.4 20.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.54 1.15 . . . . 0.0 109.931 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.15 137.65 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 0.0 109.376 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.411 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.2 146.44 24.0 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.376 1.048 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.09 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 0.0 109.22 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.87 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.11 -44.39 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.573 1.17 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.834 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.29 124.11 38.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.533 0.784 . . . . 0.0 110.439 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.51 26.74 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.543 1.812 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.66 20.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 124.501 1.125 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.402 HG21 HG23 ' A' ' 93' ' ' THR . 30.0 m -104.83 120.05 40.47 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.539 0.788 . . . . 0.0 110.436 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.008 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.83 145.07 49.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.448 1.092 . . . . 0.0 110.028 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.566 1.166 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -171.86 165.39 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 0.711 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -93.47 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 0.0 108.344 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.847 ' O ' ' CB ' ' B' ' 62' ' ' ALA . 0.8 OUTLIER -51.2 -50.84 73.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.544 1.153 . . . . 0.0 110.47 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' N ' HG21 ' A' ' 83' ' ' THR . 18.1 Cg_endo -75.04 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 30.3 m80 -75.12 57.98 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.581 1.175 . . . . 0.0 109.499 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -87.95 -38.47 15.53 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.523 1.14 . . . . 0.0 110.336 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.51 -23.88 32.53 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.379 1.049 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.19 62.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 0.774 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 63.14 1.83 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.523 1.14 . . . . 0.0 110.979 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.512 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.62 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.418 0.717 . . . . 0.0 111.0 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.19 153.57 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.549 1.156 . . . . 0.0 109.218 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.711 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.45 -174.73 19.67 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.508 1.13 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.711 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.7 m -143.77 162.04 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 0.794 . . . . 0.0 110.43 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.948 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.64 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.56 1.163 . . . . 0.0 109.27 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.6 m -105.06 144.56 31.7 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.84 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.29 73.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.158 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 O-C-N 124.581 1.176 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.112 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.423 ' HZ ' ' HD2' ' A' ' 11' ' ' LYS . 8.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.768 ' CG ' ' CD2' ' B' ' 1' ' ' TYR 0.283 12.5 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.671 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.698 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.44 ' CE2' HD12 ' B' ' 55' ' ' LEU . 46.8 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 3.2 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.667 ' HB2' HG22 ' B' ' 233' ' ' VAL . 26.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.462 HG13 HD21 ' B' ' 169' ' ' ASN . 50.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.787 ' OE1' ' HB2' ' B' ' 65' ' ' SER . 2.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.847 ' CB ' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.787 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 18.4 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.515 ' HB2' ' NE2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 4.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.865 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 2.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.573 HG21 ' HE1' ' B' ' 128' ' ' MET . 9.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 8.5 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.0 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.6 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 0.525 ' HD1' ' HG ' ' B' ' 103' ' ' LEU . 1.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.525 ' HG ' ' HD1' ' B' ' 102' ' ' TYR . 11.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.802 HG12 HD13 ' B' ' 115' ' ' LEU . 20.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.759 HG22 ' HD2' ' A' ' 12' ' ' TYR . 11.7 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.636 ' HA ' HD12 ' B' ' 116' ' ' LEU . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.1 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.802 HD13 HG12 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.664 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 26.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.551 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.792 ' HG2' HG23 ' A' ' 36' ' ' VAL . 1.1 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.551 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 8.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . 1.053 ' HB2' HG22 ' A' ' 62' ' ' ILE . 2.5 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 62' ' ' ILE . 4.6 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.753 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 2.4 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 20.8 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.573 ' HE1' HG21 ' B' ' 71' ' ' VAL . 36.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.698 ' CE2' HG22 ' B' ' 49' ' ' VAL . 21.5 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.581 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.442 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . 0.428 ' NE2' HD21 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.691 HG22 ' H ' ' B' ' 162' ' ' TYR . 13.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.027 ' CB ' HG22 ' B' ' 164' ' ' THR . 22.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.481 ' CG ' ' HH ' ' B' ' 1' ' ' TYR . 3.6 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.027 HG22 ' CB ' ' B' ' 162' ' ' TYR . 4.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.51 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.001 ' H ' HG21 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD22 ' B' ' 171' ' ' ASN . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.462 HD21 HG13 ' B' ' 60' ' ' VAL . 9.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.428 HD21 ' NE2' ' B' ' 160' ' ' GLN . 43.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD22 HD12 ' B' ' 167' ' ' LEU 1.475 1.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 62.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.894 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.103 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.258 3.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.448 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 76.5 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.614 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.4 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.103 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.862 ' HB2' ' HG1' ' B' ' 228' ' ' THR . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.862 ' HG1' ' HB2' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 9.4 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.441 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.6 126.82 29.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.44 177.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.91 150.87 40.36 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.4 112.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.42 1.075 . . . . 0.0 109.224 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.499 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.73 133.51 35.96 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.51 1.131 . . . . 0.0 109.285 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.656 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.01 6.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 0.0 111.001 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 1.028 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.0 144.48 7.65 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 124.501 1.126 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -108.16 160.68 15.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.405 0.709 . . . . 0.0 110.356 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.78 -15.99 24.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 0.0 109.324 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 19.7 mttt -90.58 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.358 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 38.25 29.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 111.059 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.71 58.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.152 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' SD ' ' A' ' 90' ' ' MET . 38.1 Cg_endo -75.06 97.63 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.478 1.778 . . . . 0.0 111.002 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.561 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 4.0 pp -150.74 151.31 32.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.496 1.122 . . . . 0.0 109.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.44 126.21 30.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.42 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.427 1.079 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.02 140.98 70.35 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.964 -2.515 . . . . 0.0 110.942 0.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.24 -40.03 1.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.27 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.381 1.051 . . . . 0.0 109.282 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.516 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.24 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.158 . . . . 0.0 109.26 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.516 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.02 143.81 51.0 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.564 1.165 . . . . 0.0 110.037 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.63 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.4 pt -154.97 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 0.0 109.32 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.799 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.38 27.44 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.476 1.11 . . . . 0.0 109.914 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.16 105.38 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.575 1.172 . . . . 0.0 109.304 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.47 -7.39 8.47 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 0.0 111.063 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.17 174.24 11.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.568 0.805 . . . . 0.0 109.2 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.3 m -123.66 154.26 39.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.574 1.172 . . . . 0.0 110.369 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.38 102.59 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.554 1.159 . . . . 0.0 109.268 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.25 121.52 9.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.08 155.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 0.0 109.302 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.471 ' HG3' ' CD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.01 119.2 36.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 111.005 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 1.028 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -79.34 -66.01 0.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.57 1.169 . . . . 0.0 109.237 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 0.0 109.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.703 HG22 ' HB2' ' B' ' 3' ' ' PHE . 7.2 p 46.1 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.104 . . . . 0.0 109.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.656 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.3 40.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.52 1.138 . . . . 0.0 111.031 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.029 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 9.2 Cg_endo -74.9 -168.99 6.91 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.986 -2.506 . . . . 0.0 110.998 -0.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.656 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 65.3 m-70 -144.13 -170.34 3.32 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 1.101 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.519 HD22 ' HD3' ' A' ' 84' ' ' PRO . 1.8 p30 173.9 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.904 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.03 114.29 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 109.394 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.463 HD11 HG23 ' A' ' 42' ' ' ILE . 1.8 mm -132.78 76.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.426 1.079 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.67 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.41 1.069 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.0 4.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.994 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.48 158.05 72.91 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.231 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 164.29 33.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.522 1.801 . . . . 0.0 111.032 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.29 135.61 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.47 -56.49 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.548 1.155 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.585 0.815 . . . . 0.0 110.27 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.581 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.2 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.388 1.055 . . . . 0.0 109.938 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.0 -51.88 70.62 Favored Pre-proline 0 C--N 1.323 -0.572 0 O-C-N 124.509 1.13 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -74.99 50.79 2.62 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.448 1.762 . . . . 0.0 110.966 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.34 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.58 1.175 . . . . 0.0 109.283 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.41 115.12 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.534 1.146 . . . . 0.0 110.014 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.579 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 6.2 m-20 -107.96 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 1.144 . . . . 0.0 109.303 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.993 ' CG2' ' HB3' ' B' ' 63' ' ' ASP . 7.2 t -89.75 21.86 3.34 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.379 1.05 . . . . 0.0 110.389 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 19.4 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 109.21 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.44 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.852 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -78.44 98.49 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.722 HD11 HD22 ' B' ' 70' ' ' ASN . 0.1 OUTLIER -68.73 -46.13 80.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 0.0 109.283 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -75.05 139.23 23.92 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.416 1.745 . . . . 0.0 111.001 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -68.0 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.472 1.108 . . . . 0.0 110.955 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.609 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.496 0.763 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.852 ' CE2' ' HB1' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.904 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.49 175.13 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 0.0 109.964 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.65 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.129 . . . . 0.0 109.388 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.19 146.48 23.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.15 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.558 1.161 . . . . 0.0 109.205 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.847 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.453 1.095 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.829 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.29 124.19 38.32 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.586 0.815 . . . . 0.0 110.413 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 141.43 26.41 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.543 1.812 . . . . 0.0 111.031 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.62 20.09 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.418 1.074 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.86 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 0.789 . . . . 0.0 110.356 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.994 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.78 140.77 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 1.158 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.05 49.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.996 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.46 3.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.497 1.123 . . . . 0.0 110.991 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -171.85 165.45 6.47 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 122.31 35.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.443 1.089 . . . . 0.0 108.245 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.605 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.9 OUTLIER -51.25 -50.83 73.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.421 1.075 . . . . 0.0 110.393 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.721 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 19.0 Cg_endo -75.08 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 110.98 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -75.07 57.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 0.0 109.619 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 83' ' ' THR . 2.5 ptm180 -87.96 -38.5 15.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.85 32.7 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.532 1.145 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.24 62.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.472 0.748 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.2 63.2 1.82 Allowed Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.423 1.077 . . . . 0.0 110.868 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.656 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 9.0 ttt -121.68 75.1 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.451 0.736 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.57 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.481 1.113 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.682 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.78 19.77 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.46 1.1 . . . . 0.0 111.022 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.682 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.8 161.99 37.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.526 0.78 . . . . 0.0 110.407 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.59 122.61 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.243 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.8 m -105.08 144.56 31.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.826 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.458 1.099 . . . . 0.0 109.291 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.799 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.796 ' N ' ' HD2' ' B' ' 4' ' ' TYR . 3.6 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 5.3 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 36' ' ' VAL . 2.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.796 ' HD2' ' N ' ' B' ' 1' ' ' TYR . 44.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' B' ' 107' ' ' TYR . 47.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 4' ' ' TYR . 1.5 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.44 ' SG ' ' HA3' ' B' ' 159' ' ' GLY . 43.9 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.669 ' HB2' HG22 ' B' ' 233' ' ' VAL . 10.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.512 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 89.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.76 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.993 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 0.4 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.76 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 28.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.468 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 38.4 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.53 HD22 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.722 HD22 HD11 ' A' ' 62' ' ' ILE . 36.6 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' B' ' 122' ' ' GLY . 4.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 7.2 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' B' ' 102' ' ' TYR . 0.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.718 HD23 HD21 ' B' ' 120' ' ' LEU . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.793 ' CB ' HD21 ' B' ' 83' ' ' LEU . 55.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 61.9 p -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' B' ' 114' ' ' ILE . 29.4 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.49 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.0 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.822 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.667 HD21 HG22 ' B' ' 74' ' ' VAL . 82.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.565 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.029 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.718 HD21 HD23 ' B' ' 103' ' ' LEU . 1.9 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' B' ' 71' ' ' VAL . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.494 ' HH ' HD11 ' B' ' 103' ' ' LEU . 59.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.555 ' HE2' HG12 ' B' ' 49' ' ' VAL . 15.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.1 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.416 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' B' ' 158' ' ' ARG . 0.1 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.44 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 4.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.833 ' CB ' HG23 ' B' ' 164' ' ' THR . 18.3 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.509 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 5.1 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.057 HG22 ' H ' ' B' ' 166' ' ' GLU . 5.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.057 ' H ' HG22 ' B' ' 164' ' ' THR . 34.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.768 ' N ' HD23 ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 168' ' ' SER . . . . . 0.872 ' HB3' ' H ' ' B' ' 170' ' ' ASN 0.684 0.1 OUTLIER -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.872 ' H ' ' HB3' ' B' ' 168' ' ' SER . 46.5 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.917 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.535 ' N ' HG21 ' B' ' 207' ' ' ILE . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.917 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.437 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.59 126.77 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.619 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.4 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 0.0 109.28 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.9 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.753 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.434 1.084 . . . . 0.0 109.3 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.79 133.46 36.02 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.53 1.144 . . . . 0.0 109.315 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.733 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.05 6.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 0.0 110.987 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.54 7.66 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.544 1.153 . . . . 0.0 110.992 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 15.9 p -108.04 160.67 15.61 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.389 0.699 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -59.87 -15.94 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 6.0 ttmt -90.57 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.353 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.491 ' HB3' ' CE1' ' B' ' 3' ' ' PHE . 0.5 OUTLIER 38.26 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 0.0 111.025 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.706 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -104.77 117.66 58.3 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 109.344 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.013 ' HB3' HG12 ' A' ' 36' ' ' VAL . 33.2 Cg_endo -74.94 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.551 1.816 . . . . 0.0 111.045 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.706 HD22 ' HB2' ' A' ' 13' ' ' ALA . 1.2 pp -150.84 151.19 31.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.12 . . . . 0.0 109.317 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.27 126.17 30.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.978 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.56 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.88 26.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.514 1.134 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.94 70.1 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.033 -2.486 . . . . 0.0 110.971 0.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.554 1.159 . . . . 0.0 109.264 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.32 46.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.428 1.08 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.496 HD23 HG22 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.38 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 0.0 109.235 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.495 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 0.0 110.065 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.631 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.85 -177.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.493 1.12 . . . . 0.0 109.284 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.801 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.34 27.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 0.0 110.009 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.876 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.11 105.36 0.27 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.6 1.187 . . . . 0.0 109.298 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.42 8.46 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.431 1.082 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.13 174.14 11.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 0.764 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.54 154.25 39.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 0.0 110.516 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.957 HG12 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.41 102.57 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.568 1.167 . . . . 0.0 109.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.54 18.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.753 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.21 121.41 9.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.12 . . . . 0.0 110.97 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.33 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.895 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.3 ttp -98.01 119.25 36.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.409 1.068 . . . . 0.0 111.0 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.36 -66.09 0.92 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 0.0 109.216 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.891 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.269 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.013 HG12 ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.02 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.419 1.075 . . . . 0.0 109.32 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.98 -172.29 40.52 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.51 1.131 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.268 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -74.99 -168.92 6.88 Favored 'Cis proline' 0 C--N 1.361 1.209 0 C-N-CA 120.919 -2.534 . . . . 0.0 110.975 -0.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 1.003 ' O ' HD11 ' A' ' 60' ' ' LEU . 71.0 m-70 -144.19 -170.36 3.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.614 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.477 HD22 ' HD3' ' A' ' 84' ' ' PRO . 3.7 p30 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.478 1.111 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.09 114.34 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.599 1.187 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 42' ' ' ILE . 9.0 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 0.0 109.345 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.65 160.62 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.569 1.168 . . . . 0.0 109.308 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.33 143.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.618 1.199 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.019 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.7 m -128.5 158.1 72.81 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.35 1.031 . . . . 0.0 109.25 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.01 164.26 33.7 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.495 1.787 . . . . 0.0 111.046 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.62 1.41 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.606 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.47 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.56 1.162 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.552 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.42 2.24 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.608 0.828 . . . . 0.0 110.26 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.09 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.451 1.095 . . . . 0.0 110.042 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.019 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.08 -51.77 71.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 O-C-N 124.491 1.12 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.04 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.427 1.751 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.25 -45.67 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.604 1.19 . . . . 0.0 109.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -46.47 115.11 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 1.126 . . . . 0.0 109.976 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.422 ' CB ' ' HH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -108.0 117.68 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 109.348 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -89.8 21.94 3.34 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.401 1.063 . . . . 0.0 110.304 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -86.07 64.45 8.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.268 ' CD1' ' HB2' ' A' ' 38' ' ' PRO . 17.6 tp -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 0.0 109.314 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.4 6.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.827 HG23 ' HG3' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -68.64 -46.09 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 0.0 109.362 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.446 ' N ' ' CD1' ' A' ' 62' ' ' ILE . . . -62.08 111.59 4.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.273 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.03 139.11 23.82 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.424 1.749 . . . . 0.0 111.05 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.93 -67.99 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.583 1.177 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.687 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.461 0.742 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.0 m-85 -38.23 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.422 ' HH ' ' CB ' ' A' ' 57' ' ' ASN . 3.7 p90 -171.5 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 0.0 111.006 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.458 1.099 . . . . 0.0 110.028 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.418 1.074 . . . . 0.0 109.403 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.26 146.52 23.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.11 8.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 109.276 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.876 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.13 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.848 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.25 124.09 37.61 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.5 0.765 . . . . 0.0 110.366 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 141.5 26.68 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.48 1.779 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.419 1.074 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.88 120.08 40.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 0.736 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.005 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.71 30.94 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.134 . . . . 0.0 111.043 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.94 145.12 49.37 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.461 1.101 . . . . 0.0 109.975 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.13 -171.53 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.428 1.08 . . . . 0.0 110.994 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -171.84 165.43 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.499 1.124 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 122.35 35.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.526 1.141 . . . . 0.0 108.328 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -51.33 -50.85 73.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 0.0 110.392 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.617 ' HB2' ' CE2' ' B' ' 162' ' ' TYR . 18.2 Cg_endo -75.0 -62.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.503 1.791 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 20.8 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.835 HH21 HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.0 -38.47 15.48 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.545 1.153 . . . . 0.0 110.322 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.8 32.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.498 1.124 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.67 -15.23 62.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.516 0.774 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.441 1.088 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.733 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.58 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.421 0.718 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.835 HG12 HH21 ' A' ' 86' ' ' ARG . 11.5 m -124.16 153.61 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 0.0 109.248 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.711 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.59 -174.8 19.83 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.711 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.71 162.05 36.97 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 0.764 . . . . 0.0 110.399 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.957 HD13 HG12 ' A' ' 29' ' ' VAL . 92.5 mt -146.59 122.67 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 0.0 109.283 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.07 144.51 31.77 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.382 1.051 . . . . 0.0 110.393 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.81 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.27 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 124.584 1.178 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.801 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.545 1.153 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.875 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 89.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 79.7 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' B' ' 4' ' ' TYR . 5.5 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.607 HE21 ' HA ' ' B' ' 107' ' ' TYR . 39.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.703 ' HA ' ' CG1' ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.965 ' HG3' ' CG2' ' B' ' 233' ' ' VAL . 1.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' B' ' 231' ' ' PRO . 44.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.827 ' HG3' HG23 ' A' ' 62' ' ' ILE . 4.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 1.202 ' HB1' ' CG ' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 14.9 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.556 ' HB2' ' OE1' ' B' ' 58' ' ' GLN 0.26 4.8 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.435 HD21 HD11 ' B' ' 120' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.661 ' N ' HG12 ' B' ' 104' ' ' VAL . 9.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.607 ' HA ' HE21 ' B' ' 6' ' ' GLN . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.605 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 77.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.474 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.875 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.474 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 87.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.426 ' HA2' ' NE2' ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.772 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 64.4 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.46 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.703 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 11.0 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.617 ' CE2' ' HB2' ' A' ' 84' ' ' PRO . 2.5 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.876 ' CG2' ' H ' ' B' ' 166' ' ' GLU . 2.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.538 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.876 ' H ' ' CG2' ' B' ' 164' ' ' THR . 4.0 tp10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' B' ' 169' ' ' ASN . 11.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.602 ' CG ' ' O ' ' B' ' 170' ' ' ASN . 16.9 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.714 ' HB2' ' CD2' ' B' ' 189' ' ' PHE . 5.2 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.315 ' CD1' ' HG3' ' B' ' 209' ' ' PRO . 0.0 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 5.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.534 HG21 ' N ' ' B' ' 208' ' ' LEU . 83.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.5 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.315 ' HG3' ' CD1' ' B' ' 189' ' ' PHE . 2.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 19.7 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' B' ' 60' ' ' VAL . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.965 ' CG2' ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.409 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.64 126.83 29.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.575 1.172 . . . . 0.0 110.04 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.632 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.47 177.2 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.431 1.082 . . . . 0.0 109.263 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.99 150.82 40.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 0.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.39 112.17 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.418 1.074 . . . . 0.0 109.213 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.498 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.74 133.48 35.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.563 1.165 . . . . 0.0 109.372 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.664 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.67 97.01 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.443 1.089 . . . . 0.0 110.951 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.524 1.14 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.465 HG22 HD13 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -108.08 160.64 15.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 0.743 . . . . 0.0 110.415 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -16.0 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 0.0 109.29 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.9 mttt -90.62 39.66 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.978 ' O ' ' CZ ' ' B' ' 3' ' ' PHE . 0.4 OUTLIER 38.28 29.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 0.0 110.996 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.86 117.66 58.21 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.049 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 6.3 Cg_exo -75.01 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.482 1.78 . . . . 0.0 111.057 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.3 pp -150.77 151.22 32.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 0.0 109.375 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.18 30.52 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.527 1.142 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.8 26.49 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.09 140.98 70.23 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.009 -2.496 . . . . 0.0 110.951 0.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.2 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 1.124 . . . . 0.0 109.278 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.423 1.077 . . . . 0.0 109.329 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.502 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.22 141.43 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.592 1.183 . . . . 0.0 109.209 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.77 50.97 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.553 1.158 . . . . 0.0 110.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.632 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.91 -177.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.112 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.803 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.981 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.873 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.19 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.603 1.19 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.44 -7.27 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.512 1.133 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.582 0.813 . . . . 0.0 109.29 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.62 154.16 39.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.97 HG12 HD13 ' A' ' 94' ' ' ILE . 63.4 t -131.3 102.57 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.601 1.188 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.73 169.53 18.09 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.539 1.149 . . . . 0.0 110.311 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.769 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.31 121.47 9.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.03 155.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.586 1.178 . . . . 0.0 109.315 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.3 ttp -97.99 119.22 36.24 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.625 ' HB3' ' HD3' ' A' ' 35' ' ' LYS 0.324 6.6 m-20 -79.33 -66.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 0.0 109.264 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.86 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.456 1.098 . . . . 0.0 109.396 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.049 ' CG2' ' HG3' ' A' ' 14' ' ' PRO . 2.4 p 45.9 54.89 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.63 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.93 -172.29 40.6 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.582 1.176 . . . . 0.0 111.047 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.942 ' HD3' ' CZ ' ' B' ' 1' ' ' TYR . 24.3 Cg_endo -74.94 -168.89 6.84 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 120.953 -2.52 . . . . 0.0 111.054 -0.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.63 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 68.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.969 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 167.02 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 0.0 109.258 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.92 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.1 114.42 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 109.399 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.918 HG13 ' OG1' ' A' ' 83' ' ' THR . 7.4 mm -132.87 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 0.0 109.311 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.476 ' H ' ' HG ' ' A' ' 56' ' ' SER . 85.2 m-85 -47.7 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.449 1.093 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 81' ' ' TYR . 1.7 t70 -96.98 -49.98 4.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.314 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.31 143.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 0.0 109.352 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.003 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.51 158.09 72.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 0.0 109.244 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 164.2 33.8 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.477 1.777 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.31 135.62 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.532 1.145 . . . . 0.0 109.297 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.621 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.53 -56.48 0.73 Allowed Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.521 1.138 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.554 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.584 0.814 . . . . 0.0 110.294 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.609 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.2 77.74 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 109.987 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.995 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.0 -51.86 70.75 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 124.514 1.134 . . . . 0.0 109.306 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.1 Cg_endo -75.03 50.82 2.64 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.45 1.763 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.31 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.573 1.171 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.554 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.54 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.517 1.136 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' HG ' ' H ' ' A' ' 43' ' ' PHE . 50.0 m -46.5 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.445 1.091 . . . . 0.0 110.002 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.93 117.61 34.59 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.38 1.05 . . . . 0.0 109.285 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.5 t -89.81 21.89 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.39 1.056 . . . . 0.0 110.341 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 8.4 tttm -86.06 64.47 8.6 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.429 1.081 . . . . 0.0 109.244 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.969 ' CD2' ' HB3' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -40.46 102.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 0.0 109.344 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.815 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . . . -78.44 98.39 6.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.68 -46.04 80.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.565 1.166 . . . . 0.0 109.35 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.04 139.17 23.86 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.527 1.803 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.89 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.504 1.128 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.667 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 0.767 . . . . 0.0 110.02 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.815 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 3.6 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.529 1.143 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.92 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.53 175.13 4.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.481 1.113 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.39 20.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.552 1.158 . . . . 0.0 109.939 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.67 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.18 146.44 23.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 0.0 109.251 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.11 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.546 1.154 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.82 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.27 124.12 37.89 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.508 0.77 . . . . 0.0 110.423 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 141.46 26.78 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.58 1.832 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.68 20.04 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.494 1.121 . . . . 0.0 110.993 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.439 0.729 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.78 140.75 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.06 49.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.538 1.149 . . . . 0.0 109.98 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.5 3.73 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.813 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 42.4 p90 -171.85 165.38 6.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.547 1.154 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . 1.332 ' O ' ' NE ' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -93.48 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.405 1.065 . . . . 0.0 108.326 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.964 ' O ' ' HB ' ' B' ' 164' ' ' THR . 5.7 m -51.23 -50.89 73.15 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.452 1.095 . . . . 0.0 110.396 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' B' ' 163' ' ' PRO . 40.5 Cg_endo -75.0 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 0.0 111.0 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.68 ' HE2' ' HE1' ' B' ' 4' ' ' TYR . 27.2 m80 -75.09 57.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.491 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.332 ' NE ' ' O ' ' A' ' 82' ' ' CYS . 0.2 OUTLIER -87.94 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.34 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.87 32.79 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.439 1.087 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.911 ' HB3' ' CD2' ' B' ' 7' ' ' TYR . . . -65.68 -15.21 62.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.525 0.78 . . . . 0.0 109.292 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.16 1.82 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.664 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.8 ttt -121.65 75.08 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.473 0.749 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 81' ' ' TYR . 14.0 m -124.24 153.61 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.558 1.161 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.678 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.76 19.72 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.461 1.101 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.678 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.77 162.06 37.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.568 0.805 . . . . 0.0 110.405 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.97 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.6 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.494 1.121 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.1 m -105.07 144.52 31.76 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.396 1.06 . . . . 0.0 110.407 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.822 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.24 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.16 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.803 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 O-C-N 124.594 1.184 . . . . 0.0 110.34 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.942 ' CZ ' ' HD3' ' A' ' 38' ' ' PRO . 42.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 0.978 ' CZ ' ' O ' ' A' ' 12' ' ' TYR . 1.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.68 ' HE1' ' HE2' ' A' ' 85' ' ' HIS . 4.4 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.942 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 1.1 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.994 ' CD1' HG13 ' B' ' 20' ' ' VAL . 85.1 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.994 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 1.478 ' CB ' ' CA ' ' B' ' 23' ' ' ASN 0.623 3.4 m-80 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.549 ' SG ' ' O ' ' B' ' 161' ' ' VAL . 47.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.793 ' HB2' HG22 ' B' ' 233' ' ' VAL . 13.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.605 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 99.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.818 ' HG3' ' H ' ' B' ' 62' ' ' ALA . 1.4 tt0 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 0.818 ' H ' ' HG3' ' B' ' 61' ' ' GLN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.528 ' H ' ' HG2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 39.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.468 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.555 HD21 HD11 ' B' ' 120' ' ' LEU . 84.1 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.658 ' N ' HG12 ' B' ' 104' ' ' VAL . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.504 ' HB2' HG23 ' B' ' 105' ' ' THR . 80.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.734 ' HG3' ' CD2' ' B' ' 1' ' ' TYR . 1.2 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.555 HD11 HD21 ' B' ' 103' ' ' LEU . 90.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.646 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 39.8 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.549 ' O ' ' SG ' ' B' ' 24' ' ' CYS . 0.5 OUTLIER -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.764 ' HB3' HG22 ' B' ' 164' ' ' THR . 9.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.687 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.964 ' HB ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . 0.42 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.521 ' HB2' HG23 ' B' ' 164' ' ' THR . 23.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD21 ' B' ' 171' ' ' ASN . 3.6 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 168' ' ' SER . . . . . 0.576 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 57.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' B' ' 169' ' ' ASN . 22.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.752 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.857 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.148 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.272 7.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.148 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.793 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.444 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.82 29.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 0.0 110.02 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.42 177.08 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.441 1.088 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.9 150.88 40.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 110.338 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.41 1.069 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.508 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.65 133.46 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.492 1.12 . . . . 0.0 109.351 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.709 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.73 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 111.034 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.45 7.63 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 124.514 1.134 . . . . 0.0 111.064 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.637 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -108.12 160.6 15.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.361 0.683 . . . . 0.0 110.443 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 9.8 t70 -59.79 -15.92 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 0.0 109.303 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 7.5 ttmt -90.64 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.545 1.153 . . . . 0.0 109.351 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.23 29.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.637 ' HB1' ' OG1' ' A' ' 9' ' ' THR . . . -104.89 117.66 58.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.464 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 44.6 Cg_endo -75.01 97.65 1.1 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 O-C-N 124.471 1.774 . . . . 0.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 9' ' ' THR . 1.3 pp -150.82 151.31 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.318 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.4 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.559 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 110.315 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.08 140.97 70.19 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 120.987 -2.505 . . . . 0.0 110.966 0.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 1.15 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.13 146.27 46.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.354 1.034 . . . . 0.0 109.335 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.25 141.33 31.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.512 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 96' ' ' VAL . 11.4 pt -154.92 -177.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.563 1.165 . . . . 0.0 109.335 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.785 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.21 105.44 0.28 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.117 . . . . 0.0 109.303 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.29 8.5 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.48 1.112 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.2 174.19 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 0.792 . . . . 0.0 109.232 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.59 154.23 39.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 110.409 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.978 HG12 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.44 102.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 0.0 109.277 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.462 1.101 . . . . 0.0 110.284 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.25 121.5 9.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.939 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.09 155.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 109.269 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.638 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 12.2 ttp -98.09 119.19 36.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 0.0 111.026 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 0.0 109.296 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.488 1.117 . . . . 0.0 109.248 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' HD2' ' B' ' 119' ' ' PRO . 11.6 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.403 1.064 . . . . 0.0 109.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.32 40.54 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.524 1.14 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.976 ' HD3' ' OD1' ' B' ' 70' ' ' ASN . 3.9 Cg_exo -74.92 -169.03 6.95 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.018 -2.492 . . . . 0.0 110.959 -0.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.638 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 69.3 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.488 1.117 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.435 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 173.93 166.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 0.0 109.307 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.923 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.06 114.37 43.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 0.0 109.343 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.502 HG13 ' OG1' ' A' ' 83' ' ' THR . 1.3 mm -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 87.1 m-85 -47.68 160.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.462 1.101 . . . . 0.0 111.008 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.605 1.191 . . . . 0.0 109.31 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.9 mttt 167.32 143.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.449 1.093 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.007 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.51 157.98 73.2 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.394 1.059 . . . . 0.0 109.265 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.91 164.28 33.78 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.509 1.794 . . . . 0.0 111.054 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.32 135.61 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.46 -56.5 0.73 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.492 1.12 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.1 -173.29 2.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.567 0.804 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.606 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.29 77.83 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.396 1.06 . . . . 0.0 109.945 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.003 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.0 -51.87 70.73 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.563 1.164 . . . . 0.0 109.274 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -75.05 50.81 2.64 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.443 1.759 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.34 -45.57 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.638 1.212 . . . . 0.0 109.344 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.58 68.15 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 m -46.47 115.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 1.141 . . . . 0.0 109.988 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.91 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.411 1.07 . . . . 0.0 109.322 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -89.69 21.81 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.458 1.099 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -85.95 64.38 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.417 1.073 . . . . 0.0 109.222 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -40.43 102.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.706 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.49 98.53 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 0.0 109.29 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.874 HG21 ' HG2' ' B' ' 121' ' ' PRO . 28.7 mt -68.78 -46.07 80.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.61 1.194 . . . . 0.0 109.304 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.18 111.61 4.91 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.117 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -75.0 139.19 23.98 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.413 1.744 . . . . 0.0 111.038 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.379 1.05 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.685 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.509 0.77 . . . . 0.0 110.048 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.706 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.11 -86.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.923 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.48 175.16 4.19 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.443 1.089 . . . . 0.0 111.014 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.764 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.25 20.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.979 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.67 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 0.0 109.412 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.19 146.53 23.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 110.404 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.08 8.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.179 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.871 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.14 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.539 1.149 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.831 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.23 124.21 37.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.561 0.801 . . . . 0.0 110.409 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.13 141.52 26.38 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.511 1.795 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.06 -178.68 20.0 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.508 1.13 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.81 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 0.764 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.007 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.89 145.13 49.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.45 3.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.581 1.176 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -171.89 165.39 6.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.59 122.39 35.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.112 . . . . 0.0 108.268 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 1.274 ' O ' ' HB2' ' B' ' 62' ' ' ALA . 1.2 m -51.29 -50.82 73.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.084 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 21.2 Cg_endo -75.06 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.574 1.829 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.3 m80 -75.1 58.05 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.99 -38.59 15.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.135 . . . . 0.0 110.292 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.89 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.48 -23.84 32.74 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.443 1.089 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.22 62.58 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.528 0.781 . . . . 0.0 109.357 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.503 1.127 . . . . 0.0 110.885 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.709 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.7 75.1 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 0.74 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.14 153.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.473 1.108 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.684 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.513 1.133 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.684 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.78 162.05 37.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.343 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.978 HD13 HG12 ' A' ' 29' ' ' VAL . 92.5 mt -146.7 122.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 109.275 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.46 31.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.455 1.097 . . . . 0.0 110.381 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.84 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.21 73.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 109.285 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.785 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.516 1.135 . . . . 0.0 110.325 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.419 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 32.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 4.9 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.668 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 6.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.671 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.415 ' CZ ' HD12 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 3.0 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.741 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.468 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 40.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 1.008 ' NE2' HG23 ' A' ' 83' ' ' THR . 3.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 1.274 ' HB2' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.803 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 16.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.3 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' B' ' 59' ' ' GLN . 9.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . 0.976 ' OD1' ' HD3' ' A' ' 38' ' ' PRO . 86.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 30.5 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . 0.442 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 1.134 HG13 ' CD1' ' B' ' 115' ' ' LEU . 20.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.764 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 1.134 ' CD1' HG13 ' B' ' 104' ' ' VAL . 0.0 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.764 ' HB2' HG23 ' B' ' 105' ' ' THR . 16.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 36' ' ' VAL . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.513 HD13 ' HE3' ' B' ' 128' ' ' MET . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . 0.874 ' HG2' HG21 ' A' ' 62' ' ' ILE . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 12.9 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . 0.451 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 21.6 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.513 ' HE3' HD13 ' B' ' 120' ' ' LEU . 20.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.741 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 27.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.692 HG22 ' H ' ' B' ' 162' ' ' TYR . 14.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.032 ' CB ' HG21 ' B' ' 164' ' ' THR . 7.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.668 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.2 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.032 HG21 ' CB ' ' B' ' 162' ' ' TYR . 2.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 1.005 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.653 HD12 HD22 ' B' ' 171' ' ' ASN . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 57.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.653 HD22 HD12 ' B' ' 167' ' ' LEU 1.503 3.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 66.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.777 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 18.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 1.164 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.27 20.2 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.777 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.479 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.634 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.9 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 1.164 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.888 ' HB2' ' HG1' ' B' ' 228' ' ' THR . 1.1 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.888 ' HG1' ' HB2' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . 0.593 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 2.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.714 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.61 126.83 29.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 1.16 . . . . 0.0 109.999 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.629 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.42 177.18 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.41 1.069 . . . . 0.0 109.285 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.88 40.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.76 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.15 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.387 1.054 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.77 133.49 35.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.51 1.131 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.635 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.105 . . . . 0.0 110.997 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.49 7.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.594 1.184 . . . . 0.0 110.974 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.595 ' HG1' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.06 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.409 0.711 . . . . 0.0 110.417 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.84 -15.94 24.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.322 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.5 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 38.3 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 0.0 111.009 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.595 ' HB1' ' HG1' ' A' ' 9' ' ' THR . . . -104.87 117.72 58.05 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.069 ' HG3' ' HE2' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.46 1.769 . . . . 0.0 111.022 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 2.8 pp -150.8 151.25 32.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.46 1.1 . . . . 0.0 109.32 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.402 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.39 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.89 26.59 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.55 1.156 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.99 70.35 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 120.995 -2.502 . . . . 0.0 110.944 0.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.16 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.243 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.05 146.28 46.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.516 HD12 ' H ' ' A' ' 22' ' ' SER . 10.9 tp -143.28 141.4 31.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.566 1.166 . . . . 0.0 109.202 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.516 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 0.0 110.063 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.629 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.93 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.54 158.31 27.57 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.602 1.189 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.41 8.46 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.443 1.09 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.17 174.11 11.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 0.735 . . . . 0.0 109.3 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 3' ' ' VAL . 9.9 m -123.44 154.27 39.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 1.119 . . . . 0.0 110.535 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.955 HG12 HD13 ' A' ' 94' ' ' ILE . 63.8 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.143 . . . . 0.0 109.332 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.82 169.52 18.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.21 121.39 9.51 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.484 1.115 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.96 155.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.07 119.26 36.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.413 1.07 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.333 6.9 m-20 -79.4 -66.03 0.92 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.412 1.07 . . . . 0.0 109.237 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.875 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.473 1.108 . . . . 0.0 109.235 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.042 HG23 ' HB3' ' A' ' 14' ' ' PRO . 19.0 m 46.02 54.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.33 40.62 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.558 1.161 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.632 ' HD2' ' CE2' ' B' ' 1' ' ' TYR . 19.5 Cg_endo -74.97 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.947 -2.522 . . . . 0.0 110.977 -0.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.624 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.5 m-70 -144.26 -170.36 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.403 1.064 . . . . 0.0 109.327 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.623 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.5 t -104.11 114.35 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 109.329 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -132.82 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.521 ' H ' ' HG ' ' A' ' 56' ' ' SER . 85.2 m-85 -47.61 160.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 0.0 110.959 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 6.9 mttt 167.32 143.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.473 1.108 . . . . 0.0 109.266 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.026 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.5 m -128.5 158.08 72.86 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.393 1.058 . . . . 0.0 109.284 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.03 164.25 33.68 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.42 1.748 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.67 1.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 0.0 109.33 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.47 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.485 1.116 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.556 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 0.822 . . . . 0.0 110.28 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.587 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.1 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 110.042 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.026 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -52.98 -51.84 70.88 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.441 1.088 . . . . 0.0 109.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.05 50.75 2.62 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.43 1.752 . . . . 0.0 110.966 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.26 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.587 1.179 . . . . 0.0 109.353 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.53 68.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 43' ' ' PHE . 57.9 m -46.52 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.455 1.097 . . . . 0.0 109.345 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 1.114 ' O ' ' HB2' ' B' ' 62' ' ' ALA . 4.6 t -89.77 21.84 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.393 1.058 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -86.08 64.44 8.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.229 ' CD2' ' HB3' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -40.44 102.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.44 98.47 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.891 HD13 ' CD1' ' A' ' 60' ' ' LEU . 4.3 mm -68.66 -46.11 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.602 1.189 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 0.0 109.278 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.03 139.1 23.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.431 1.753 . . . . 0.0 111.019 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.552 1.157 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.471 0.748 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.18 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.461 1.101 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.623 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.448 1.092 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.761 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.29 20.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.448 1.093 . . . . 0.0 109.99 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.72 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 0.0 109.389 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.546 1.154 . . . . 0.0 110.353 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.1 8.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 1.1 . . . . 0.0 109.235 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.877 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.14 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.497 1.123 . . . . 0.0 111.045 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.847 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.25 124.11 37.71 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.543 0.79 . . . . 0.0 110.37 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 141.5 26.7 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.483 1.781 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.415 1.072 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 HG23 ' A' ' 93' ' ' THR . 29.7 m -104.84 120.03 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 0.76 . . . . 0.0 110.379 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.69 140.73 30.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.21 -171.55 3.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 42' ' ' ILE . 9.3 p90 -171.83 165.43 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.514 1.134 . . . . 0.0 111.028 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.6 122.35 35.97 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.478 1.111 . . . . 0.0 108.243 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.478 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -51.31 -50.81 73.93 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 110.397 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 83' ' ' THR . 49.5 Cg_endo -75.05 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.531 1.806 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.457 ' NE2' ' HE1' ' B' ' 4' ' ' TYR . 27.3 m80 -74.95 57.96 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 0.0 109.601 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.161 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.01 -38.47 15.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.634 1.209 . . . . 0.0 110.276 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.54 -23.76 32.83 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.43 1.081 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.407 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -65.69 -15.19 62.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 0.765 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.06 1.83 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.438 1.086 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.635 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.07 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.454 0.738 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.161 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.18 153.62 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.564 1.165 . . . . 0.0 109.289 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.703 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.74 19.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.603 1.189 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.703 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.76 162.09 36.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 0.79 . . . . 0.0 110.382 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.955 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.64 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.255 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.2 m -105.01 144.55 31.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.393 1.058 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.829 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.537 1.148 . . . . 0.0 109.303 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 0.0 110.265 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 0.905 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 93.7 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 1.069 ' HE2' ' HG3' ' A' ' 14' ' ' PRO . 12.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.867 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 12.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.633 ' HB3' ' CD1' ' B' ' 9' ' ' TYR . 0.1 OUTLIER -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.711 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.3 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.807 ' HB2' HG22 ' B' ' 233' ' ' VAL . 21.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.757 ' HG2' ' O ' ' B' ' 65' ' ' SER . 4.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 1.229 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.754 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.757 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 9.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.468 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' B' ' 103' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 1.009 HG12 ' CG ' ' B' ' 115' ' ' LEU . 69.8 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.579 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 29.0 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.5 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 1.009 ' CG ' HG12 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.579 ' HB2' HG23 ' B' ' 105' ' ' THR . 11.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.623 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.905 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.623 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 47.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.405 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 68.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.6 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . 0.551 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.78 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . 0.413 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' B' ' 24' ' ' CYS . 8.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.603 ' HB3' ' HG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.024 HG22 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.712 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.7 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.942 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.942 ' HD1' ' HB2' ' B' ' 187' ' ' ASN . 0.4 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.826 HD22 ' N ' ' B' ' 208' ' ' LEU . 4.0 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.872 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.807 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.433 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.63 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 110.03 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.41 177.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.554 1.159 . . . . 0.0 110.342 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.31 112.16 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.408 1.068 . . . . 0.0 109.307 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.5 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.75 133.44 36.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.548 1.155 . . . . 0.0 109.306 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.561 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.66 97.0 6.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.469 1.106 . . . . 0.0 111.002 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.03 144.41 7.62 Favored Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.464 1.103 . . . . 0.0 111.074 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' CD1' ' A' ' 15' ' ' LEU . 17.3 p -108.09 160.69 15.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.422 0.719 . . . . 0.0 110.402 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.79 -15.96 24.41 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.441 1.088 . . . . 0.0 109.305 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 5.0 tppt? -90.64 39.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.298 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 1.438 ' HH ' ' CB ' ' B' ' 3' ' ' PHE . 12.3 m-30 38.29 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.125 . . . . 0.0 111.008 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.849 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -104.81 117.67 58.24 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.487 1.117 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.022 ' HB3' HG11 ' A' ' 36' ' ' VAL . 1.2 Cg_endo -75.03 97.56 1.09 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.455 1.766 . . . . 0.0 110.99 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.849 HD21 ' HB1' ' A' ' 13' ' ' ALA . 1.2 pp -150.73 151.29 32.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.41 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 0.0 110.934 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.47 134.91 26.61 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.445 1.091 . . . . 0.0 110.317 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.08 141.0 70.37 Favored 'Cis proline' 0 C--N 1.361 1.22 0 C-N-CA 120.947 -2.522 . . . . 0.0 111.013 0.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.21 -40.13 1.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 0.0 109.181 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.27 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.384 1.052 . . . . 0.0 109.281 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.514 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.21 141.41 31.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 0.0 109.216 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.514 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.78 50.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.544 1.152 . . . . 0.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.92 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.797 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.56 158.32 27.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 109.963 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.875 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.594 1.184 . . . . 0.0 109.313 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.36 8.46 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.465 1.103 . . . . 0.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.22 174.16 11.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 0.758 . . . . 0.0 109.182 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.3 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.577 1.173 . . . . 0.0 110.371 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.984 HG12 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.41 102.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 0.0 109.285 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.86 169.62 17.95 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.128 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 64.0 m-85 -147.24 121.42 9.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.135 . . . . 0.0 111.008 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.39 33.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 109.281 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.914 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.1 ttp -98.06 119.11 36.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 0.0 111.085 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -79.27 -66.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 109.291 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.461 1.1 . . . . 0.0 109.292 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.022 HG11 ' HB3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 0.0 109.338 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.556 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.3 40.54 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.555 1.16 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.035 ' HD2' ' HB3' ' B' ' 62' ' ' ALA . 7.8 Cg_endo -74.95 -168.96 6.9 Favored 'Cis proline' 0 C--N 1.36 1.169 0 C-N-CA 120.992 -2.503 . . . . 0.0 110.986 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.914 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.1 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.413 ' ND2' ' C ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 173.9 166.97 0.2 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.07 114.35 43.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.566 1.166 . . . . 0.0 109.347 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.0 mm -132.74 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.432 1.083 . . . . 0.0 109.306 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' H ' ' HG ' ' A' ' 56' ' ' SER . 85.1 m-85 -47.6 160.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.443 1.089 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 9.5 t70 -97.03 -50.01 4.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.595 1.184 . . . . 0.0 109.324 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.2 mttt 167.34 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.143 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.03 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.4 m -128.54 158.05 73.04 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.143 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 164.22 33.83 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.476 1.777 . . . . 0.0 111.027 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.33 135.64 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 109.252 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.599 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.46 -56.57 0.72 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.522 1.139 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.555 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.61 0.829 . . . . 0.0 110.238 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.596 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.15 77.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.371 1.045 . . . . 0.0 110.021 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 1.03 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.02 -51.85 70.93 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.486 1.116 . . . . 0.0 109.268 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.01 50.73 2.61 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.27 -45.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.562 1.164 . . . . 0.0 109.346 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.555 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.52 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.519 1.137 . . . . 0.0 109.344 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.573 ' HG ' ' H ' ' A' ' 43' ' ' PHE . 68.5 m -46.48 115.1 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.571 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.8 m120 -107.97 117.67 34.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 0.0 109.293 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.431 ' H ' ' HG1' ' A' ' 58' ' ' THR . 0.1 OUTLIER -89.68 21.78 3.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.412 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -85.93 64.4 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.446 1.091 . . . . 0.0 109.233 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.559 HD22 ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.41 102.45 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 0.0 109.346 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.753 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.39 98.46 6.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.342 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 38' ' ' PRO . 5.2 mm -68.7 -46.09 80.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 111.6 4.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.594 1.184 . . . . 0.0 109.303 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -74.99 139.14 23.95 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.384 1.729 . . . . 0.0 111.02 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.96 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.45 1.094 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.691 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.8 t -178.69 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 0.744 . . . . 0.0 110.037 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.753 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.8 m-85 -38.25 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.128 . . . . 0.0 110.978 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.571 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.13 4.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.461 1.1 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.774 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.26 20.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 109.994 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.68 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.5 1.125 . . . . 0.0 109.388 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.22 146.5 23.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.115 . . . . 0.0 110.426 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 0.0 109.222 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.875 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.21 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.501 1.126 . . . . 0.0 110.951 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.85 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.26 124.17 37.96 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.528 0.781 . . . . 0.0 110.411 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.09 141.5 26.45 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.558 1.82 . . . . 0.0 111.014 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.7 20.0 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.444 1.09 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.77 120.08 40.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 0.792 . . . . 0.0 110.405 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.014 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.79 140.74 30.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.61 1.194 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.12 49.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.442 1.089 . . . . 0.0 110.011 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.44 3.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.598 1.186 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.663 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 40.9 p90 -171.91 165.44 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -93.61 122.33 35.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.396 1.06 . . . . 0.0 108.296 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.497 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -51.26 -50.79 73.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.436 1.085 . . . . 0.0 110.378 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.679 ' HB3' ' O ' ' B' ' 62' ' ' ALA . 9.2 Cg_endo -75.1 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.564 1.823 . . . . 0.0 110.972 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -75.1 57.99 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.112 . . . . 0.0 109.577 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 1.242 HH22 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -87.97 -38.61 15.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 0.0 110.312 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.42 -23.84 32.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.427 1.079 . . . . 0.0 110.991 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.18 62.56 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.527 0.781 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.497 1.123 . . . . 0.0 110.927 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.561 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.64 75.05 1.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 0.778 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 1.242 ' CG1' HH22 ' A' ' 86' ' ' ARG . 13.1 m -124.17 153.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.294 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.69 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.82 19.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.501 1.126 . . . . 0.0 111.036 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.69 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.76 162.06 36.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 0.0 110.358 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.984 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.63 122.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.57 1.169 . . . . 0.0 109.284 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.08 144.52 31.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 0.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.837 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.28 73.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.431 1.082 . . . . 0.0 109.327 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 0.0 110.282 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.002 ' CD2' ' CZ ' ' B' ' 3' ' ' PHE . 2.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 3.7 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 1.438 ' CB ' ' HH ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 60.8 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.626 HE21 HD12 ' B' ' 116' ' ' LEU . 66.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.915 ' O ' ' CD1' ' B' ' 7' ' ' TYR . 1.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 4.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 61.4 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.683 ' HA ' HG12 ' B' ' 161' ' ' VAL . 46.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.651 ' HG3' HG21 ' B' ' 233' ' ' VAL . 10.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 71.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 1.223 ' NE2' ' CD1' ' A' ' 60' ' ' LEU . 1.2 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 1.035 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 1.559 ' CB ' HD22 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 1.184 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.663 ' HB3' ' CD ' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.733 HG22 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.435 HD21 HD11 ' B' ' 120' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.661 ' N ' HG12 ' B' ' 104' ' ' VAL . 15.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.616 ' HA ' HD12 ' B' ' 116' ' ' LEU . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.733 ' CD2' HG22 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.479 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 0.464 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.479 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 84.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 13.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 1.382 ' O ' ' CD1' ' B' ' 162' ' ' TYR 0.461 0.1 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 1.023 ' N ' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 1.271 HG22 ' CD1' ' B' ' 162' ' ' TYR . 13.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.845 ' HB2' HG21 ' B' ' 164' ' ' THR . 18.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.683 ' N ' HD23 ' B' ' 167' ' ' LEU . 2.2 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 84.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.556 HD22 ' HA ' ' B' ' 62' ' ' ALA . 5.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.754 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.626 ' H ' ' CG2' ' B' ' 228' ' ' THR . 21.1 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.8 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 0.4 OUTLIER -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.67 ' CB ' ' HD1' ' B' ' 189' ' ' PHE . 3.0 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.936 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' B' ' 187' ' ' ASN . 11.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.771 ' CG ' HG21 ' B' ' 204' ' ' VAL . 18.5 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.704 ' HB ' HG22 ' B' ' 205' ' ' THR . 89.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.771 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.704 HG22 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 2.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 48.3 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 0.576 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 18.3 mt -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.936 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 54.1 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' B' ' 227' ' ' LEU . 54.7 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.681 ' HG1' ' N ' ' B' ' 229' ' ' THR . 4.5 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.443 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.63 126.87 29.24 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.517 1.136 . . . . 0.0 110.022 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.626 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.48 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.369 1.043 . . . . 0.0 109.265 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.9 40.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.254 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.767 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.4 112.1 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.081 . . . . 0.0 109.35 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.72 133.55 35.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.485 1.116 . . . . 0.0 109.346 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.479 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.06 6.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 0.0 110.924 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.48 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.579 1.174 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 1.3 p -108.07 160.68 15.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 0.736 . . . . 0.0 110.431 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.82 -15.93 24.54 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.382 1.051 . . . . 0.0 109.328 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 35.2 mttt -90.63 39.7 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.536 1.148 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 1.426 ' HH ' ' CB ' ' B' ' 3' ' ' PHE . 0.8 OUTLIER 38.21 29.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.503 1.127 . . . . 0.0 111.016 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.685 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -104.86 117.69 58.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 0.0 109.34 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 1.073 ' HB3' HG11 ' A' ' 36' ' ' VAL . 9.3 Cg_endo -75.0 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.452 1.764 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.685 HD21 ' HB1' ' A' ' 13' ' ' ALA . 1.4 pp -150.75 151.25 32.1 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 0.0 109.307 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.428 ' HE1' ' HE1' ' A' ' 7' ' ' MET . 5.5 m-85 -77.34 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 1.132 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.92 26.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 124.47 1.106 . . . . 0.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.05 140.97 70.25 Favored 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.013 -2.494 . . . . 0.0 110.932 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.17 -40.16 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.548 1.155 . . . . 0.0 109.281 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.31 46.04 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.403 1.064 . . . . 0.0 109.358 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.26 141.38 31.03 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.509 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.7 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.461 1.101 . . . . 0.0 110.098 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.87 -177.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.442 1.089 . . . . 0.0 109.259 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.799 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.49 158.33 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.857 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.18 105.42 0.28 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.557 1.161 . . . . 0.0 109.297 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.47 8.44 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.5 1.125 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.16 174.14 11.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 0.754 . . . . 0.0 109.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 3' ' ' VAL . 9.9 m -123.49 154.26 39.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 110.544 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.941 HG12 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.43 102.58 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.576 1.172 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.49 18.15 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.59 1.181 . . . . 0.0 110.299 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.767 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.473 1.108 . . . . 0.0 110.953 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.5 ttp -97.99 119.26 36.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 1.057 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.41 -66.04 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.209 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.8 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 1.073 HG11 ' HB3' ' A' ' 14' ' ' PRO . 5.1 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.52 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.27 40.58 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.523 1.139 . . . . 0.0 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 1.007 ' CD ' ' HB3' ' B' ' 62' ' ' ALA . 9.5 Cg_endo -74.96 -168.9 6.86 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.993 -0.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.635 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 72.8 m-70 -144.21 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 0.0 109.584 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.858 ' HB3' ' OD2' ' B' ' 63' ' ' ASP . 0.9 OUTLIER 173.96 166.98 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.11 114.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.578 1.174 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.71 ' CG1' ' OD1' ' A' ' 40' ' ' ASN . 4.3 mm -132.77 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 0.0 109.308 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -47.66 160.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 2.5 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 0.0 109.253 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 1.017 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.45 158.09 72.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.372 1.045 . . . . 0.0 109.286 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 164.2 33.72 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.493 1.786 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.2 135.61 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.446 1.092 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.46 -56.68 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.535 1.147 . . . . 0.0 111.014 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.547 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.06 -173.32 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.595 0.82 . . . . 0.0 110.303 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.597 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.3 m -133.16 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.426 1.079 . . . . 0.0 109.954 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.985 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.02 -51.81 71.33 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.45 1.094 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.08 50.8 2.65 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.491 1.785 . . . . 0.0 110.887 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.23 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.591 1.182 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.05 -27.55 68.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 0.0 109.306 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -46.51 115.08 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.56 1.163 . . . . 0.0 109.988 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.472 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -107.96 117.7 34.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 109.358 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.77 21.94 3.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.438 1.086 . . . . 0.0 110.347 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -86.11 64.43 8.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.453 1.096 . . . . 0.0 109.244 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.959 ' CD1' ' OE1' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -40.51 102.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.35 98.44 5.97 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.64 ' CG1' HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -68.7 -46.07 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.326 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.62 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.316 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.489 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 27.6 Cg_endo -75.04 139.14 23.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.438 1.757 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.96 0.17 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.505 1.128 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.534 0.785 . . . . 0.0 109.989 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 1.11 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.51 175.1 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.773 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.58 161.31 20.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 0.0 109.978 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.475 1.109 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 0.0 110.387 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.12 8.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.482 1.114 . . . . 0.0 109.223 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.857 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.16 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.468 1.105 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.855 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.22 124.1 37.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.538 0.787 . . . . 0.0 110.412 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.06 141.53 26.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.465 1.771 . . . . 0.0 111.043 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.4 1.062 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.405 HG21 HG23 ' A' ' 93' ' ' THR . 29.6 m -104.88 120.06 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 0.761 . . . . 0.0 110.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 1.017 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.71 30.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.546 1.154 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.93 145.17 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.462 1.101 . . . . 0.0 109.966 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.2 -171.58 3.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.449 1.093 . . . . 0.0 110.951 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 30.5 p90 -171.84 165.42 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.57 122.38 35.96 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.425 1.078 . . . . 0.0 108.262 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.665 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -51.35 -50.8 74.08 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.398 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.638 ' CD ' HD22 ' A' ' 40' ' ' ASN . 12.8 Cg_endo -75.0 -62.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.237 0 O-C-N 124.498 1.788 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.468 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 22.0 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.732 HH11 ' CG ' ' A' ' 86' ' ' ARG . 2.7 ttt85 -88.01 -38.48 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.536 1.148 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.88 32.74 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.477 1.111 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.62 -15.24 62.55 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.505 0.768 . . . . 0.0 109.406 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.18 1.83 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.449 1.093 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' MET . . . . . 0.479 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.62 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.417 0.716 . . . . 0.0 111.003 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.15 153.58 30.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.153 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.705 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.78 19.77 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.705 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.73 162.05 37.0 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.485 0.756 . . . . 0.0 110.471 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.941 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.65 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 0.0 109.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.1 144.54 31.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.835 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.541 1.15 . . . . 0.0 109.333 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . 0.799 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 0.0 110.317 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' TYR . . . . . 1.171 ' CZ ' ' CG ' ' B' ' 119' ' ' PRO . 1.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' PHE . . . . . 1.426 ' CB ' ' HH ' ' A' ' 12' ' ' TYR . 23.0 m-85 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' TYR . . . . . 0.865 ' HH ' ' HD1' ' B' ' 162' ' ' TYR 0.347 0.3 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' GLN . . . . . 0.447 ' OE1' ' HA ' ' B' ' 3' ' ' PHE . 74.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.527 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 8.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' CYS . . . . . 0.655 ' HA ' HG12 ' B' ' 161' ' ' VAL . 42.1 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLN . . . . . 0.696 ' HB2' HG22 ' B' ' 233' ' ' VAL . 26.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 7.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' GLN . . . . . 0.959 ' OE1' ' CD1' ' A' ' 60' ' ' LEU . 2.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ALA . . . . . 1.007 ' HB3' ' CD ' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ASP . . . . . 0.858 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 5.0 m-20 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' SER . . . . . 0.946 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 10.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.46 ' CB ' ' NE2' ' B' ' 61' ' ' GLN . 54.2 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 8.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' LEU . . . . . 0.435 HD21 HD11 ' B' ' 120' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' THR . . . . . 0.661 ' N ' HG12 ' B' ' 104' ' ' VAL . 15.1 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' LEU . . . . . 0.649 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 72.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' PRO . . . . . 1.171 ' CG ' ' CZ ' ' B' ' 1' ' ' TYR . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' LEU . . . . . 0.445 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 48.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 158' ' ' ARG . . . . . 0.631 ' H ' HE22 ' B' ' 59' ' ' GLN . 51.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 161' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.6 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 162' ' ' TYR . . . . . 0.865 ' HD1' ' HH ' ' B' ' 4' ' ' TYR . 18.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 163' ' ' PRO . . . . . 0.671 ' HB3' ' CD1' ' B' ' 4' ' ' TYR . 1.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 164' ' ' THR . . . . . 0.768 HG23 ' CB ' ' B' ' 162' ' ' TYR . 1.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 166' ' ' GLU . . . . . 0.665 ' H ' HG22 ' B' ' 164' ' ' THR . 19.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD21 ' B' ' 171' ' ' ASN . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 53.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 169' ' ' ASN . . . . . 0.526 HD22 ' HA ' ' B' ' 62' ' ' ALA . 1.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 170' ' ' ASN . . . . . 0.753 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.1 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 39.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.47 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 56.1 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 56.9 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 187' ' ' ASN . . . . . 0.691 ' O ' ' CD1' ' B' ' 189' ' ' PHE . 5.4 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 189' ' ' PHE . . . . . 0.81 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.271 0.5 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 191' ' ' PHE . . . . . 0.416 ' C ' ' CG ' ' B' ' 192' ' ' ASP . 12.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 192' ' ' ASP . . . . . 0.837 ' HB3' HG21 ' B' ' 204' ' ' VAL . 0.0 OUTLIER -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 193' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 184' ' ' ILE . 92.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 204' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 205' ' ' THR . . . . . 0.439 HG22 ' O ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 207' ' ' ILE . . . . . 0.522 ' C ' HD13 ' B' ' 208' ' ' LEU . 76.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 208' ' ' LEU . . . . . 1.023 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 209' ' ' PRO . . . . . 0.81 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.0 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 211' ' ' PRO . . . . . 0.871 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 3.1 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 227' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' B' ' 227' ' ' LEU . 62.5 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 228' ' ' THR . . . . . 0.871 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 233' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.66 126.8 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 109.989 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.627 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.8 m -122.48 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 124.447 1.092 . . . . 0.0 109.22 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.99 150.8 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 110.318 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.76 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.13 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.337 1.023 . . . . 0.0 109.259 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.68 133.49 35.95 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.528 1.143 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.669 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 96.99 6.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 0.0 110.955 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.51 7.64 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.491 1.119 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.404 HG21 HD12 ' A' ' 15' ' ' LEU . 0.7 OUTLIER -108.08 160.63 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.389 0.699 . . . . 0.0 110.391 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.74 -16.03 24.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.399 1.062 . . . . 0.0 109.315 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.2 mttp -90.55 39.64 0.98 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 38.21 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.592 1.182 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.671 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.82 117.7 58.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.62 ' HB3' HG12 ' A' ' 36' ' ' VAL . 36.0 Cg_endo -74.98 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.456 1.766 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.671 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.1 pp -150.74 151.24 32.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.119 . . . . 0.0 109.323 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.4 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.38 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.556 1.16 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.86 26.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.459 1.1 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.15 140.98 70.19 Favored 'Cis proline' 0 C--N 1.361 1.203 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.96 0.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.5 tttt -40.17 -40.04 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.58 1.175 . . . . 0.0 109.342 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.35 46.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.365 1.041 . . . . 0.0 109.273 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.31 141.32 30.94 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.93 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.554 1.159 . . . . 0.0 110.026 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.627 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.91 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 0.0 109.26 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.55 158.26 27.7 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.499 1.124 . . . . 0.0 109.968 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.866 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.44 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.452 1.095 . . . . 0.0 109.285 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.38 8.48 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.542 1.151 . . . . 0.0 110.961 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.09 174.16 11.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.48 0.753 . . . . 0.0 109.291 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.65 154.28 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.62 1.2 . . . . 0.0 110.464 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.973 HG12 HD13 ' A' ' 94' ' ' ILE . 63.9 t -131.47 102.63 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.78 169.57 18.02 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.468 1.105 . . . . 0.0 110.313 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.27 121.48 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.515 1.134 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.672 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.57 1.169 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 11.7 ttp -97.96 119.21 36.18 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.433 1.083 . . . . 0.0 111.009 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.332 6.9 m-20 -79.36 -66.04 0.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.589 1.181 . . . . 0.0 109.243 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.716 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 35' ' ' LYS . 14.8 p 46.04 54.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 0.0 109.276 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.47 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.564 1.165 . . . . 0.0 111.033 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.009 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 30.0 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.93 -2.529 . . . . 0.0 111.03 -0.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.687 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.499 1.124 . . . . 0.0 109.575 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.95 167.05 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 0.0 109.253 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.924 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.1 t -104.18 114.41 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.163 . . . . 0.0 109.289 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.0 mm -132.82 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.551 1.157 . . . . 0.0 109.305 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.404 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.0 m-85 -47.71 160.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.04 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.6 mtpt 167.35 143.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.6 1.187 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.01 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.3 m -128.55 158.08 72.98 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.436 1.085 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.3 Cg_endo -75.03 164.17 33.84 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.538 1.809 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.17 135.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.392 1.058 . . . . 0.0 109.276 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.616 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.44 -56.55 0.72 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.578 1.174 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.557 0.798 . . . . 0.0 110.279 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.594 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.25 77.76 1.75 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 110.001 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.994 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 109.353 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.731 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.01 50.82 2.63 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.466 1.772 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.594 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.34 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.48 1.113 . . . . 0.0 109.308 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.49 68.14 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.502 1.126 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 m -46.55 115.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 109.98 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.555 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.7 m120 -108.01 117.63 34.63 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.408 1.067 . . . . 0.0 109.315 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.73 21.73 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.41 1.069 . . . . 0.0 110.381 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -85.87 64.32 8.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.455 1.097 . . . . 0.0 109.264 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.607 HD13 HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.37 102.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.427 1.079 . . . . 0.0 109.351 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.02 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.617 1.198 . . . . 0.0 109.339 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.607 HD12 HD13 ' A' ' 60' ' ' LEU . 2.6 mm -68.65 -46.18 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.596 1.185 . . . . 0.0 109.282 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.63 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 109.265 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.95 139.1 24.01 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -67.97 0.17 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.502 1.126 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.672 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.511 0.771 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.21 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.587 1.179 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.924 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.42 175.18 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 111.044 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.478 1.112 . . . . 0.0 109.983 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.11 137.69 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 0.0 109.348 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.425 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.17 146.46 23.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 110.378 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.18 173.05 8.57 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 0.0 109.231 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.866 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.11 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.526 1.141 . . . . 0.0 110.944 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.84 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.22 124.13 37.57 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.53 0.782 . . . . 0.0 110.424 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.5 26.8 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.437 1.756 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.6 20.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.93 120.07 40.54 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.571 0.806 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.01 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.74 30.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.545 1.153 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.099 . . . . 0.0 110.01 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.09 -171.48 3.72 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 1.128 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.755 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 38.7 p90 -171.9 165.4 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.973 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -93.52 122.27 35.78 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.116 . . . . 0.0 108.335 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.718 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.6 OUTLIER -51.26 -50.82 73.71 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.561 1.163 . . . . 0.0 110.408 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.713 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 37.7 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.576 1.829 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.641 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 25.4 m80 -75.06 57.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.57 1.169 . . . . 0.0 109.562 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.03 ' NH1' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.95 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.577 1.173 . . . . 0.0 110.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.86 32.73 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.462 1.101 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.2 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.489 0.758 . . . . 0.0 109.412 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.12 63.14 1.83 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.431 1.082 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.669 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 0.798 . . . . 0.0 110.971 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.7 ' CG1' HH22 ' A' ' 86' ' ' ARG . 11.6 m -124.26 153.59 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 0.0 109.227 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.709 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.56 -174.75 19.77 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 124.546 1.154 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.709 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.82 162.0 37.19 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 0.792 . . . . 0.0 110.432 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.973 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.57 122.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.496 1.122 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.9 m -105.07 144.47 31.83 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.814 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 124.559 1.162 . . . . 0.0 109.353 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 0.0 110.38 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.713 ' HE2' ' HB2' ' A' ' 84' ' ' PRO . 18.5 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.493 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.641 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 46.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 46.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.687 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.67 HE22 ' HA2' ' B' ' 157' ' ' GLY . 13.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 65' ' ' SER . 7.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.718 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.421 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 4.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.687 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.2 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.719 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 40.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 74.9 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 1.03 HG13 ' HG ' ' B' ' 115' ' ' LEU . 65.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.707 HG21 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.71 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 1.03 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.71 HD11 ' HA ' ' B' ' 107' ' ' TYR . 1.1 mp -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.009 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 58.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.67 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.548 ' O ' ' SG ' ' B' ' 24' ' ' CYS . 1.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.694 ' CE1' ' HA ' ' B' ' 168' ' ' SER . 0.4 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.564 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.0 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.076 HG22 ' H ' ' B' ' 166' ' ' GLU . 0.4 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.076 ' H ' HG22 ' B' ' 164' ' ' THR . 2.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 0.694 ' HA ' ' CE1' ' B' ' 162' ' ' TYR . 95.9 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 55.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 1.9 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.011 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 8.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.803 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 52.2 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.715 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.1 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.011 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.83 29.06 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.466 1.104 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.629 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.39 177.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.89 40.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.768 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.36 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.407 1.067 . . . . 0.0 109.246 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.508 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.45 36.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.533 1.145 . . . . 0.0 109.388 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.456 ' CA ' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.141 . . . . 0.0 111.003 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 1.025 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.14 144.49 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.599 HG22 ' CD1' ' A' ' 15' ' ' LEU . 23.9 p -108.08 160.6 15.67 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.441 0.73 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -15.96 23.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ALA . 14.2 mttt -90.59 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 38.29 29.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 0.0 111.029 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.963 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.78 117.71 58.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 0.0 109.318 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.755 ' HB3' HG11 ' A' ' 36' ' ' VAL . 24.7 Cg_endo -75.02 97.72 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.428 1.752 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.963 HD21 ' HB3' ' A' ' 13' ' ' ALA . 1.5 pp -150.87 151.26 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.18 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.465 1.103 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.549 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.46 134.82 26.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 124.467 1.104 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.92 69.94 Favored 'Cis proline' 0 C--N 1.359 1.12 0 C-N-CA 121.061 -2.474 . . . . 0.0 110.993 0.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.565 1.165 . . . . 0.0 109.306 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.34 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.264 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.1 tp -143.24 141.34 31.03 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.91 143.83 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.629 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.98 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.559 1.162 . . . . 0.0 109.205 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.804 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.64 158.28 27.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.531 1.144 . . . . 0.0 109.972 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.13 105.47 0.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.201 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.31 8.52 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.21 174.07 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.527 0.781 . . . . 0.0 109.238 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' VAL . 9.9 m -123.47 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.616 1.197 . . . . 0.0 110.491 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.988 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.44 102.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 109.322 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.5 18.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.768 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.18 121.4 9.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.502 1.126 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.628 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.32 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.442 1.089 . . . . 0.0 109.276 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.1 ttp -97.93 119.16 36.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.426 1.079 . . . . 0.0 111.046 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.025 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.31 -66.07 0.92 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.624 1.203 . . . . 0.0 109.268 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.454 1.096 . . . . 0.0 109.321 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG11 ' HB3' ' A' ' 14' ' ' PRO . 7.1 p 46.02 54.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 109.336 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.847 ' O ' ' HD2' ' B' ' 119' ' ' PRO . . . -92.94 -172.31 40.58 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.491 1.12 . . . . 0.0 111.079 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.196 ' HD3' ' O ' ' B' ' 119' ' ' PRO . 58.6 Cg_endo -74.97 -168.9 6.85 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.961 -2.516 . . . . 0.0 110.973 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.668 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.26 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.077 . . . . 0.0 109.617 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.438 HD22 ' HD3' ' A' ' 84' ' ' PRO . 1.5 p30 173.97 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.251 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.913 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.06 114.27 43.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.73 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 109.343 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.69 160.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.8 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.1 mttt 167.32 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.043 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.426 1.079 . . . . 0.0 109.21 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.06 164.22 33.67 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.493 1.786 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.2 135.58 1.38 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.444 1.09 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.591 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.63 0.72 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.492 1.12 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.26 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 0.816 . . . . 0.0 110.301 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.21 77.75 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.134 . . . . 0.0 110.031 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.043 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 0.0 109.358 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.72 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -74.99 50.74 2.6 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.478 1.778 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.32 -45.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 0.0 109.313 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.61 68.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -46.49 115.16 0.95 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.511 1.132 . . . . 0.0 109.966 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.93 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.452 1.095 . . . . 0.0 109.325 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -89.8 21.85 3.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.383 1.052 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 39.7 tttt -86.0 64.37 8.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.57 1.169 . . . . 0.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.437 HD22 ' ND2' ' A' ' 40' ' ' ASN . 3.4 mp -40.44 102.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.559 1.162 . . . . 0.0 109.322 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.793 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.48 6.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 109.284 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.727 HD13 ' HA ' ' B' ' 120' ' ' LEU . 0.7 OUTLIER -68.71 -46.15 80.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.601 1.188 . . . . 0.0 109.282 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.88 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 0.0 109.331 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.811 ' HG3' ' CD1' ' B' ' 102' ' ' TYR . 72.3 Cg_endo -75.06 139.16 23.81 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.389 1.731 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 32' ' ' VAL . . . 168.88 -68.01 0.17 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.501 1.126 . . . . 0.0 110.995 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.628 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.449 0.735 . . . . 0.0 110.014 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.793 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.1 m-85 -38.23 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.471 1.107 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.913 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.55 175.09 4.17 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.093 . . . . 0.0 111.009 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.757 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.29 20.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 0.0 109.95 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.08 137.71 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.486 1.116 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.33 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.583 1.177 . . . . 0.0 110.381 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.3 mt -124.14 173.1 8.52 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.536 1.148 . . . . 0.0 109.186 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.859 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.09 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.536 1.147 . . . . 0.0 110.923 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.823 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.24 124.11 37.6 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.467 0.745 . . . . 0.0 110.426 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.52 26.8 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.527 1.804 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.62 20.05 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.415 1.072 . . . . 0.0 111.046 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.408 HG21 HG23 ' A' ' 93' ' ' THR . 29.7 m -104.84 120.04 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.776 . . . . 0.0 110.378 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.005 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.74 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.59 1.181 . . . . 0.0 111.021 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.86 145.17 49.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 110.019 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.52 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.496 1.122 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -171.83 165.41 6.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.113 . . . . 0.0 110.959 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.55 122.3 35.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.4 1.063 . . . . 0.0 108.302 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.582 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.5 m -51.3 -50.79 73.97 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.482 1.114 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.567 1.825 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m170 -75.0 58.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.542 1.151 . . . . 0.0 109.602 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.538 ' NH2' HG11 ' A' ' 91' ' ' VAL . 1.5 tpm_? -88.0 -38.53 15.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.128 . . . . 0.0 110.305 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.51 -23.79 32.81 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.438 1.086 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.27 62.62 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.531 0.783 . . . . 0.0 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.21 1.82 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.464 1.103 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.456 ' HE3' ' CA ' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.0 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 0.72 . . . . 0.0 111.067 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.538 HG11 ' NH2' ' A' ' 86' ' ' ARG . 14.9 m -124.13 153.59 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.295 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.706 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.58 -174.69 19.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.482 1.114 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.706 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.83 162.09 36.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 0.772 . . . . 0.0 110.313 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.988 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.66 122.56 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -104.98 144.51 31.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 0.0 110.435 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.835 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.282 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.804 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.167 . . . . 0.0 110.3 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.596 ' HE1' HBD1 ' B' ' 250' ' ' HEC . 56.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.778 ' CD2' ' HG3' ' B' ' 163' ' ' PRO . 4.2 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 79.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.793 ' HB2' HG22 ' B' ' 233' ' ' VAL . 14.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.483 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 15.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.462 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.462 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 68.7 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 32.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.7 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.662 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 93.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 0.811 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 2.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.46 HD13 ' CD2' ' B' ' 102' ' ' TYR . 0.4 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.895 HG12 ' HG ' ' B' ' 115' ' ' LEU . 39.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.572 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.895 ' HG ' HG12 ' B' ' 104' ' ' VAL . 3.4 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.553 HD22 HG22 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.621 ' CA ' HD13 ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.196 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.727 ' HA ' HD13 ' A' ' 62' ' ' ILE . 1.2 mp -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.579 ' HD2' ' HG2' ' B' ' 128' ' ' MET . 0.6 OUTLIER -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.579 ' HG2' ' HD2' ' B' ' 125' ' ' TYR . 10.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.419 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.615 HH12 ' ND2' ' B' ' 169' ' ' ASN . 33.0 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.69 HG22 ' H ' ' B' ' 162' ' ' TYR . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.69 ' H ' HG22 ' B' ' 161' ' ' VAL . 30.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.778 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.659 ' CG2' ' HB2' ' B' ' 162' ' ' TYR . 5.0 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.643 ' H ' HG22 ' B' ' 164' ' ' THR . 42.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD22 ' B' ' 171' ' ' ASN . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 0.663 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 96.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.615 ' ND2' HH12 ' B' ' 158' ' ' ARG . 0.8 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD22 HD12 ' B' ' 167' ' ' LEU 1.462 1.2 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.166 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 25.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.631 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.166 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . 0.531 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 11.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.793 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.56 126.73 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 0.0 110.098 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.633 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.35 177.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.426 1.079 . . . . 0.0 109.263 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -143.05 150.87 40.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.38 112.16 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.398 1.061 . . . . 0.0 109.239 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.48 35.97 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.557 1.161 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.61 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.71 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 0.0 111.009 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.668 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.51 7.64 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.58 1.175 . . . . 0.0 110.967 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.424 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.03 160.58 15.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.469 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.7 -15.99 23.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.4 ttmt -90.58 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 38.25 29.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.548 1.155 . . . . 0.0 111.048 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.76 117.73 58.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.049 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.5 Cg_endo -75.02 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.492 1.785 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 4.2 pp -150.82 151.24 32.0 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.35 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.45 134.86 26.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.381 1.051 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.97 70.22 Favored 'Cis proline' 0 C--N 1.359 1.114 0 C-N-CA 120.989 -2.505 . . . . 0.0 110.949 0.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.19 -40.08 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.566 1.166 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.33 46.13 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.387 1.054 . . . . 0.0 109.24 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.515 HD12 ' H ' ' A' ' 22' ' ' SER . 11.1 tp -143.24 141.34 31.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 0.0 109.297 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.515 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.81 51.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.45 1.094 . . . . 0.0 110.038 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.95 -177.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.566 1.166 . . . . 0.0 109.242 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.79 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.514 1.134 . . . . 0.0 109.969 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.862 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.12 105.5 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.588 1.18 . . . . 0.0 109.262 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.39 8.51 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.458 1.099 . . . . 0.0 111.052 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.12 174.11 11.51 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 0.78 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.1 m -123.49 154.27 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 0.0 110.485 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.989 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.69 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.83 169.56 18.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.587 1.179 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 5' ' ' ILE . 64.1 m-85 -147.24 121.4 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.52 1.138 . . . . 0.0 110.981 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.35 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.248 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.755 ' HE3' ' HB3' ' A' ' 64' ' ' PRO . 3.4 ttp -97.98 119.15 36.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m120 -79.28 -66.09 0.91 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.145 . . . . 0.0 109.248 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.987 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.451 1.094 . . . . 0.0 109.333 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.049 HG21 ' HG3' ' A' ' 14' ' ' PRO . 7.4 p 45.93 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.352 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.0 -172.31 40.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.49 1.119 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.138 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 36.2 Cg_endo -75.03 -168.87 6.85 Favored 'Cis proline' 0 C--N 1.361 1.19 0 C-N-CA 120.938 -2.526 . . . . 0.0 111.003 0.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.651 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 73.2 m-70 -144.28 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.592 HD21 HD21 ' A' ' 60' ' ' LEU . 2.5 p30 173.99 166.95 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.536 1.147 . . . . 0.0 109.271 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.921 HG21 ' HH ' ' A' ' 68' ' ' TYR . 57.5 t -104.07 114.41 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 0.0 109.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.464 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -132.84 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.413 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.67 160.65 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.507 1.129 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.02 -50.01 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.574 1.171 . . . . 0.0 109.256 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 167.29 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 0.0 109.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.014 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.56 158.12 72.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.432 1.082 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 164.21 33.82 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.511 1.795 . . . . 0.0 111.008 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.26 135.56 1.41 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.438 1.086 . . . . 0.0 109.313 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.617 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.5 -56.54 0.72 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 0.0 110.972 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.22 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 0.807 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.591 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.23 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 110.024 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.998 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.04 -51.77 71.73 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.444 1.09 . . . . 0.0 109.359 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.04 50.84 2.65 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.452 1.764 . . . . 0.0 110.952 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.38 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.281 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.63 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.542 1.151 . . . . 0.0 109.259 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.2 m -46.44 115.11 0.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.59 1.181 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -107.92 117.68 34.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.335 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.731 HG22 ' NE2' ' B' ' 61' ' ' GLN . 9.1 t -89.81 21.85 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -86.03 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.516 1.135 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.592 HD21 HD21 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -40.4 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 0.0 109.326 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.731 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -78.46 98.44 6.06 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.475 HG22 ' HA ' ' B' ' 120' ' ' LEU . 3.2 mm -68.73 -46.06 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.554 1.159 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.63 4.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 0.0 109.303 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.755 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 55.5 Cg_endo -75.04 139.14 23.83 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.43 1.753 . . . . 0.0 111.042 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -68.02 0.17 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.471 1.107 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.67 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.8 t -178.66 97.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 0.747 . . . . 0.0 109.99 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.731 ' CE2' ' HB1' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.19 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.401 1.063 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.921 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.49 175.1 4.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 0.0 111.055 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.771 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.445 1.091 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.72 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.423 1.077 . . . . 0.0 109.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.416 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.32 146.41 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 0.0 110.398 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.06 173.13 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 0.0 109.225 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.862 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.16 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.518 1.136 . . . . 0.0 110.947 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.841 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.25 124.11 37.67 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.525 0.779 . . . . 0.0 110.381 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 141.49 26.73 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.796 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.433 1.083 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.4 m -104.76 120.04 40.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.465 0.744 . . . . 0.0 110.399 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.014 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.76 30.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 0.0 111.011 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.9 145.11 49.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 110.032 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.53 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.13 . . . . 0.0 110.989 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 1.388 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 15.3 p90 -171.82 165.45 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.62 122.3 35.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.381 1.051 . . . . 0.0 108.267 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 1.013 HG21 ' HB2' ' B' ' 62' ' ' ALA . 1.0 OUTLIER -51.25 -50.8 73.76 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.429 1.08 . . . . 0.0 110.466 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.602 1.843 . . . . 0.0 110.992 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.931 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 24.6 m80 -75.06 57.99 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.574 1.171 . . . . 0.0 109.546 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.388 ' NH2' ' HB2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.99 -38.47 15.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.525 1.14 . . . . 0.0 110.313 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 1.016 ' CA ' HG21 ' B' ' 164' ' ' THR . . . -89.49 -23.84 32.74 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.487 1.117 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.22 62.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 0.769 . . . . 0.0 109.346 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.19 1.82 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.542 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 8.0 ttt -121.58 74.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 0.0 111.043 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.726 HG13 HH22 ' A' ' 86' ' ' ARG . 11.7 m -124.18 153.5 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 0.0 109.283 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.718 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.5 -174.73 19.71 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.525 1.141 . . . . 0.0 111.004 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.718 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.78 162.11 36.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 0.0 110.39 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.989 HD13 HG12 ' A' ' 29' ' ' VAL . 92.5 mt -146.65 122.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.561 1.163 . . . . 0.0 109.311 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -105.02 144.52 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.477 1.111 . . . . 0.0 110.426 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.83 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.12 . . . . 0.0 109.24 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.79 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 110.349 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.863 ' CZ ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.792 ' CG ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.976 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 21.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.445 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 2.7 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.146 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.6 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.694 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' B' ' 233' ' ' VAL . 12.0 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.461 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 86.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.731 ' NE2' HG22 ' A' ' 58' ' ' THR . 7.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 1.013 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' B' ' 65' ' ' SER . 0.2 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.466 ' HB2' ' OD2' ' B' ' 63' ' ' ASP . 17.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.694 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.5 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 8.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.652 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 73.2 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.704 HG21 ' CE ' ' B' ' 128' ' ' MET . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.42 HD23 HD12 ' B' ' 120' ' ' LEU . 1.1 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 1.037 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.1 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.765 HG21 ' HB2' ' B' ' 116' ' ' LEU . 1.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.594 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.8 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.4 ' H ' ' HG2' ' B' ' 109' ' ' GLU . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 1.037 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.765 ' HB2' HG21 ' B' ' 105' ' ' THR . 71.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.138 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 62' ' ' ILE . 7.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.704 ' CE ' HG21 ' B' ' 71' ' ' VAL . 63.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 23.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.52 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 54.2 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 1.508 ' HG2' ' CG ' ' B' ' 160' ' ' GLN . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' B' ' 24' ' ' CYS . 2.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.664 ' CE1' HMD2 ' B' ' 250' ' ' HEC . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.976 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.016 HG21 ' CA ' ' A' ' 87' ' ' GLY . 2.1 p -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 4.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.354 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.561 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 37.9 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.986 ' CG ' ' HD3' ' B' ' 209' ' ' PRO 0.278 3.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.561 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.929 ' H ' HD21 ' B' ' 208' ' ' LEU . 0.9 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.986 ' HD3' ' CG ' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . 0.402 ' HA3' HG11 ' B' ' 60' ' ' VAL . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.674 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.146 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.57 126.8 28.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.616 1.197 . . . . 0.0 110.06 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.628 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.49 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.451 1.095 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.81 40.18 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.349 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.75 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.38 112.17 38.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.466 1.104 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.78 133.43 36.05 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.309 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.704 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.64 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 0.0 110.996 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.58 7.65 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.449 1.093 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.534 ' OG1' HD23 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -108.12 160.64 15.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 0.752 . . . . 0.0 110.413 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.8 -15.94 24.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.9 mttt -90.56 39.59 0.98 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.13 . . . . 0.0 109.371 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.32 29.7 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.489 1.118 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.586 ' HB2' HD21 ' A' ' 15' ' ' LEU . . . -104.83 117.71 58.11 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.223 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CB ' ' CD2' ' A' ' 85' ' ' HIS . 25.0 Cg_endo -75.03 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.457 1.767 . . . . 0.0 111.066 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 13' ' ' ALA . 2.0 pp -150.77 151.19 31.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.502 1.126 . . . . 0.0 109.322 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.405 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.15 30.47 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.533 1.146 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.48 134.84 26.53 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 0.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.11 140.97 70.16 Favored 'Cis proline' 0 C--N 1.36 1.18 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.938 0.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.15 -40.15 1.04 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.6 1.187 . . . . 0.0 109.267 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.17 146.32 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.361 1.038 . . . . 0.0 109.328 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.23 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.563 1.164 . . . . 0.0 109.219 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.97 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 110.055 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.93 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.786 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.33 27.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 0.0 109.971 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.864 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.17 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.592 1.183 . . . . 0.0 109.321 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.36 8.49 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.495 1.122 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.15 174.16 11.46 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.616 0.833 . . . . 0.0 109.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.59 154.21 39.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 0.0 110.464 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.976 HG12 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.37 102.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.8 169.5 18.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 110.319 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.75 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.23 121.53 9.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.55 1.156 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.673 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.14 155.31 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.654 1.221 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.805 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.2 ttp -98.0 119.21 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.479 1.112 . . . . 0.0 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.326 6.6 m-20 -79.31 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.243 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.603 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.663 ' O ' ' CE1' ' A' ' 85' ' ' HIS . 11.2 p 45.93 54.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 1.487 ' O ' ' CE1' ' B' ' 1' ' ' TYR . . . -92.9 -172.31 40.65 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.147 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 19.8 Cg_endo -74.93 -168.87 6.82 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 120.998 -2.501 . . . . 0.0 111.018 -0.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.805 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.1 m-70 -144.26 -170.38 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.457 HD21 ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.426 1.079 . . . . 0.0 109.251 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.921 HG21 ' HH ' ' A' ' 68' ' ' TYR . 56.7 t -104.01 114.33 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.595 1.185 . . . . 0.0 109.414 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG23 HD13 ' A' ' 42' ' ' ILE . 2.0 mm -132.8 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 0.0 109.256 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.7 160.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -49.99 4.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 12.1 mttt 167.22 143.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.57 1.169 . . . . 0.0 109.343 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.999 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.49 158.16 72.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.097 . . . . 0.0 109.275 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 164.26 33.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.427 1.751 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.35 135.67 1.42 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.47 1.106 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.615 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.54 0.72 Allowed Glycine 0 CA--C 1.532 1.128 0 O-C-N 124.565 1.166 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.546 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.621 0.836 . . . . 0.0 110.305 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.59 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.13 77.8 1.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 0.0 110.02 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.967 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.08 -51.79 71.68 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.463 1.102 . . . . 0.0 109.292 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.4 Cg_endo -75.01 50.74 2.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.392 1.733 . . . . 0.0 110.995 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.27 -45.73 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.609 1.193 . . . . 0.0 109.301 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.546 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.48 68.1 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.543 1.152 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.0 m -46.5 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.56 1.162 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.588 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 85.0 m-20 -107.94 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.418 1.074 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.425 ' O ' HD21 ' A' ' 60' ' ' LEU . 11.6 t -89.82 21.84 3.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.377 1.048 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -85.97 64.43 8.58 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.43 1.082 . . . . 0.0 109.251 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.5 102.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.307 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.41 98.37 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 60' ' ' LEU . 2.1 mm -68.7 -46.02 80.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.596 1.185 . . . . 0.0 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.12 111.59 4.85 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.33 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HB3' ' HE1' ' A' ' 33' ' ' MET . 10.1 Cg_endo -75.06 139.21 23.86 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.515 1.134 . . . . 0.0 110.957 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.673 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.539 0.788 . . . . 0.0 110.034 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.24 -86.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.921 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.58 175.12 4.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.359 1.037 . . . . 0.0 110.991 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.32 20.87 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 109.96 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.07 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.22 146.47 23.99 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.474 1.109 . . . . 0.0 110.394 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.11 173.06 8.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.464 1.102 . . . . 0.0 109.27 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.864 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.12 -44.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.505 1.128 . . . . 0.0 110.955 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.851 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.22 124.08 37.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.452 0.736 . . . . 0.0 110.418 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.99 141.46 26.69 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.523 1.802 . . . . 0.0 110.953 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.59 20.11 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.48 1.112 . . . . 0.0 110.985 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.86 120.07 40.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 0.742 . . . . 0.0 110.367 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.999 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.73 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.517 1.136 . . . . 0.0 110.995 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.85 145.08 49.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 0.0 110.03 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.16 -171.55 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.518 1.136 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.926 ' CB ' ' NH2' ' A' ' 86' ' ' ARG . 16.9 p90 -171.81 165.42 6.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 0.0 110.995 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 0.5 OUTLIER -93.55 122.3 35.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 0.0 108.276 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.937 HG21 ' HB3' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.21 -50.86 73.25 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.476 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 83' ' ' THR . 37.4 Cg_endo -75.04 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 0.0 110.953 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.681 ' CD2' ' CB ' ' A' ' 14' ' ' PRO . 49.1 m80 -75.04 57.94 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.164 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.02 -38.43 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 0.0 110.325 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.91 32.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.433 1.083 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.22 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 0.0 109.33 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.014 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.704 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 0.735 . . . . 0.0 111.018 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.164 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.24 153.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.565 1.166 . . . . 0.0 109.239 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.72 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.48 -174.76 19.72 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.525 1.14 . . . . 0.0 111.006 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.72 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.7 m -143.79 162.06 37.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 0.735 . . . . 0.0 110.441 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.976 HD13 HG12 ' A' ' 29' ' ' VAL . 92.0 mt -146.65 122.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.52 31.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.441 1.088 . . . . 0.0 110.403 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.819 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.547 1.154 . . . . 0.0 109.255 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.786 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 O-C-N 124.604 1.19 . . . . 0.0 110.32 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.487 ' CE1' ' O ' ' A' ' 37' ' ' GLY 0.427 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.504 ' CG ' HG21 ' A' ' 36' ' ' VAL . 71.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 1.617 ' CZ ' ' HG2' ' B' ' 163' ' ' PRO . 0.1 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.5 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 47.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.705 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.989 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 17.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.422 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 84.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.401 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.937 ' HB3' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.412 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 26.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.705 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.721 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.0 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.428 HG21 ' HE1' ' B' ' 128' ' ' MET . 33.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 0.519 ' CD2' HD23 ' B' ' 103' ' ' LEU . 21.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' B' ' 102' ' ' TYR . 45.2 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.95 ' CG1' ' HG ' ' B' ' 115' ' ' LEU . 79.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.579 ' HB2' HG22 ' B' ' 114' ' ' ILE . 29.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 25.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.95 ' HG ' ' CG1' ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.409 ' O ' HD22 ' B' ' 115' ' ' LEU . 72.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.147 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 1.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.428 ' HE1' HG21 ' B' ' 71' ' ' VAL . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.9 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.989 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 1.508 ' HG2' ' CG ' ' B' ' 160' ' ' GLN . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.753 HG12 ' HA ' ' B' ' 24' ' ' CYS . 7.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.021 ' HB3' HG22 ' B' ' 164' ' ' THR . 0.9 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 1.617 ' HG2' ' CZ ' ' B' ' 4' ' ' TYR . 5.9 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.021 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.503 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.832 ' H ' HG21 ' B' ' 164' ' ' THR . 15.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.619 ' N ' HD22 ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 78.2 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.519 HD22 ' HA ' ' B' ' 62' ' ' ALA . 12.2 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.356 22.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.596 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 42.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.166 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 3.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.596 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.6 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.768 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.8 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.166 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 8.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.76 28.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.157 . . . . 0.0 109.998 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.624 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.8 m -122.48 177.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.416 1.073 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.82 40.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 110.324 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.404 1.065 . . . . 0.0 109.258 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.501 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.7 133.45 36.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.465 1.103 . . . . 0.0 109.323 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.693 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 0.0 110.952 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 1.031 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.06 160.58 15.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.417 0.716 . . . . 0.0 110.413 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -59.71 -16.0 23.77 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.375 1.047 . . . . 0.0 109.357 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 20.7 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.521 1.138 . . . . 0.0 109.369 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 0.0 111.022 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.718 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.9 117.69 58.1 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 0.0 109.247 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.751 ' HB3' HG11 ' A' ' 36' ' ' VAL . 41.0 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.432 1.754 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.718 HD21 ' HB3' ' A' ' 13' ' ' ALA . 1.7 pp -150.79 151.21 31.99 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.435 1.085 . . . . 0.0 109.299 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.31 126.19 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.509 1.131 . . . . 0.0 110.991 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.553 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.419 0 O-C-N 124.457 1.098 . . . . 0.0 110.323 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.91 69.88 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 121.018 -2.493 . . . . 0.0 110.978 0.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.13 -40.06 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.58 1.175 . . . . 0.0 109.304 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.31 46.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.345 1.028 . . . . 0.0 109.227 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.31 30.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.92 143.73 50.96 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.519 1.137 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.624 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.89 -177.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.798 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.991 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.848 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.475 1.11 . . . . 0.0 109.313 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.45 8.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.551 1.157 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.43 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.13 174.16 11.47 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 0.745 . . . . 0.0 109.28 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 1.17 . . . . 0.0 110.437 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.938 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.81 169.55 18.05 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.551 1.157 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.27 121.53 9.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 0.0 110.888 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.13 155.31 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 0.0 109.275 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.875 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.3 ttp -97.98 119.19 36.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.031 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.37 -65.99 0.93 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 0.0 109.257 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.448 ' HG2' ' HB3' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -168.88 -167.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.751 HG11 ' HB3' ' A' ' 14' ' ' PRO . 12.1 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 0.0 109.327 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.595 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.03 -172.27 40.44 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.561 1.163 . . . . 0.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.979 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 5.5 Cg_endo -74.96 -168.85 6.81 Favored 'Cis proline' 0 C--N 1.361 1.226 0 C-N-CA 120.9 -2.542 . . . . 0.0 111.072 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.875 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.2 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.518 1.136 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.43 ' HB2' HD13 ' A' ' 42' ' ' ILE . 1.4 p30 173.98 167.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 1.135 . . . . 0.0 109.256 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.891 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.15 114.39 43.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.566 1.166 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.483 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.581 1.175 . . . . 0.0 109.318 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -47.79 160.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.03 -50.04 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.582 1.176 . . . . 0.0 109.255 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.015 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.3 m -128.57 158.12 72.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 109.259 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 164.26 33.53 Favored 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.541 1.811 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.437 1.086 . . . . 0.0 109.319 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.51 0.72 Allowed Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.597 1.186 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.554 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 0.784 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.21 77.67 1.74 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 110.035 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.015 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -52.95 -51.9 70.26 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.427 1.079 . . . . 0.0 109.281 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.735 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.5 Cg_endo -74.92 50.8 2.59 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.794 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.32 -45.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.598 1.187 . . . . 0.0 109.314 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.03 -27.57 68.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 109.285 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.8 m -46.43 115.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.575 1.172 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -107.95 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.467 1.104 . . . . 0.0 109.36 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.403 HG22 ' HB3' ' B' ' 63' ' ' ASP . 9.1 t -89.75 21.77 3.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.372 1.045 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -85.98 64.36 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.452 1.095 . . . . 0.0 109.238 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.4 102.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.409 1.068 . . . . 0.0 109.388 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.43 98.4 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.586 1.178 . . . . 0.0 109.356 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG13 ' HB3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.66 -46.12 80.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.619 1.2 . . . . 0.0 109.318 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.15 111.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 124.547 1.154 . . . . 0.0 109.314 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.07 139.16 23.77 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.549 1.815 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -68.04 0.17 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.439 1.087 . . . . 0.0 110.945 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.67 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.66 97.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.438 0.728 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.2 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 0.0 110.932 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.891 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.343 1.027 . . . . 0.0 110.997 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.771 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.32 20.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.476 1.11 . . . . 0.0 109.979 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.7 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.366 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.24 146.46 24.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 0.0 110.374 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.06 8.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.848 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.1 -44.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.5 1.125 . . . . 0.0 110.953 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.818 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.15 124.08 36.81 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.523 0.778 . . . . 0.0 110.403 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 141.51 26.68 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.468 1.773 . . . . 0.0 111.05 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.15 -178.58 20.13 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.2 m -104.95 120.06 40.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.556 0.798 . . . . 0.0 110.402 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.994 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.503 1.127 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.432 1.083 . . . . 0.0 109.999 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.14 -171.5 3.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 14.9 p90 -171.89 165.42 6.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.56 122.26 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 0.0 108.285 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.511 HG21 ' HB1' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.25 -50.81 73.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.451 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 83' ' ' THR . 9.2 Cg_endo -75.04 -62.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.508 1.794 . . . . 0.0 111.009 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.9 m80 -75.06 57.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.593 1.183 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.471 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -87.89 -38.54 15.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 110.352 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.471 ' N ' ' HG3' ' A' ' 86' ' ' ARG . . . -89.52 -23.81 32.73 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.416 1.072 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.26 62.62 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.494 0.761 . . . . 0.0 109.325 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.21 1.82 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.458 1.099 . . . . 0.0 110.962 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.693 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 0.772 . . . . 0.0 110.994 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.18 153.59 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.268 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.709 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.57 -174.76 19.78 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.604 1.19 . . . . 0.0 110.883 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.709 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.8 162.04 37.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 0.772 . . . . 0.0 110.367 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.938 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.61 122.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.459 1.099 . . . . 0.0 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.6 m -105.01 144.51 31.72 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.415 1.072 . . . . 0.0 110.433 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.832 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.563 1.165 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.798 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 0.0 110.305 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.546 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 15.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.506 ' HE2' ' CE1' ' B' ' 4' ' ' TYR . 0.7 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.692 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 18.9 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 35.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.694 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 84.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.824 ' HB2' HG22 ' B' ' 233' ' ' VAL . 23.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 85.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.665 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.403 ' HB3' HG22 ' A' ' 58' ' ' THR . 15.5 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.441 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.5 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.694 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.568 HD22 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.46 ' ND2' ' CG2' ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.845 HD21 ' CG1' ' B' ' 104' ' ' VAL . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 13.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.901 HG13 ' HG ' ' B' ' 115' ' ' LEU . 40.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.524 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.5 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.674 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.1 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 49.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.901 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.674 HD11 ' HA ' ' B' ' 107' ' ' TYR . 32.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.979 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . 0.536 ' HB3' HG13 ' A' ' 62' ' ' ILE . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.665 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 49.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 5.2 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.029 ' CB ' HG23 ' B' ' 164' ' ' THR . 8.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.692 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.029 HG23 ' CB ' ' B' ' 162' ' ' TYR . 3.3 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.4 ' N ' HG22 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.007 ' H ' HG22 ' B' ' 164' ' ' THR . 38.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' B' ' 167' ' ' LEU . 3.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.17 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.629 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.17 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.824 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -57.68 126.85 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 109.999 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.633 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.39 177.11 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 0.0 109.27 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.92 150.88 40.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.749 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 0.0 109.313 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.7 133.42 36.02 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.533 1.146 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.665 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.02 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 0.0 110.995 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.46 7.63 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 124.545 1.153 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.423 HG23 ' HG ' ' A' ' 15' ' ' LEU . 10.7 p -108.14 160.66 15.64 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.423 0.72 . . . . 0.0 110.41 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.502 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 46.2 t0 -59.8 -15.97 24.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.6 mttt -90.65 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.549 1.156 . . . . 0.0 109.365 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 38.32 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.67 58.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.832 ' HG3' ' CZ ' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.46 1.769 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.563 ' C ' HD13 ' A' ' 15' ' ' LEU . 3.9 pp -150.76 151.27 32.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 0.0 109.365 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -77.41 126.2 30.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 0.0 110.932 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.95 26.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.401 1.063 . . . . 0.0 110.284 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -74.99 140.94 70.15 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.027 -2.489 . . . . 0.0 110.947 -0.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.13 -40.12 1.03 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.543 1.152 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.414 1.072 . . . . 0.0 109.283 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.36 31.0 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 0.0 109.264 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.76 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.53 1.144 . . . . 0.0 110.04 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.4 pt -154.95 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 0.0 109.324 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.78 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.33 27.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 109.936 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.857 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.11 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.305 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.38 8.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.481 1.113 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.562 0.801 . . . . 0.0 109.203 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.3 m -123.66 154.26 39.63 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.589 1.181 . . . . 0.0 110.367 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.994 HG12 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.46 102.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 0.0 109.24 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.8 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.531 1.144 . . . . 0.0 110.279 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.749 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.18 121.46 9.58 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 0.0 110.994 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.674 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.32 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.528 1.142 . . . . 0.0 109.25 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.558 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.5 ttp -98.04 119.21 36.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.32 -66.03 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 109.286 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.52 0.76 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.733 HG23 ' HB3' ' A' ' 14' ' ' PRO . 1.2 p 46.04 54.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 0.0 109.345 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.588 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.9 -172.36 40.67 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.532 1.145 . . . . 0.0 111.046 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.1 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 25.3 Cg_endo -74.96 -168.95 6.89 Favored 'Cis proline' 0 C--N 1.361 1.184 0 C-N-CA 120.993 -2.503 . . . . 0.0 110.996 -0.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.588 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 71.2 m-70 -144.21 -170.33 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.505 1.128 . . . . 0.0 109.575 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.59 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.94 166.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.398 1.061 . . . . 0.0 109.285 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.925 HG21 ' HH ' ' A' ' 68' ' ' TYR . 57.0 t -104.05 114.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 1.152 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.608 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -132.82 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.126 . . . . 0.0 109.308 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.464 ' N ' ' HG ' ' A' ' 56' ' ' SER . 85.3 m-85 -47.55 160.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER 167.29 143.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.003 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.53 158.0 73.17 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 0.0 109.233 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 164.22 33.86 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.474 1.776 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.28 135.67 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 0.0 109.244 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.43 -56.52 0.73 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.538 1.149 . . . . 0.0 110.981 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.548 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.28 2.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 0.819 . . . . 0.0 110.249 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.597 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.24 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.382 1.052 . . . . 0.0 109.938 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.97 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.01 -51.86 70.81 Favored Pre-proline 0 C--N 1.323 -0.552 0 O-C-N 124.489 1.118 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.0 50.77 2.61 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.414 1.744 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.3 -45.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.579 1.174 . . . . 0.0 109.336 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.15 -27.51 68.08 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.316 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' A' ' 43' ' ' PHE . 47.1 m -46.52 115.13 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.494 1.121 . . . . 0.0 110.009 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' ND2' ' HB3' ' A' ' 59' ' ' LYS . 21.7 t30 -107.92 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 0.0 109.358 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.573 ' CG2' ' HB3' ' B' ' 63' ' ' ASP . 1.4 t -89.75 21.85 3.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 0.0 110.343 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 28.8 tttt -86.04 64.43 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.093 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.737 HD13 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 0.0 109.332 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.741 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.42 98.5 6.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.311 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.737 HD11 HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.69 -46.13 80.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.568 1.168 . . . . 0.0 109.319 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.16 111.61 4.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.48 1.113 . . . . 0.0 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -75.01 139.18 23.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.428 1.752 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.475 1.109 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.674 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.47 0.747 . . . . 0.0 110.06 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.741 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.13 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 0.0 111.039 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.925 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.51 175.18 4.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.418 1.073 . . . . 0.0 110.957 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.775 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.69 161.2 21.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.567 1.167 . . . . 0.0 109.964 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.69 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 0.0 109.374 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.22 146.5 23.97 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.439 1.087 . . . . 0.0 110.388 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.19 173.06 8.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.857 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.13 -44.25 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.849 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.34 124.28 39.05 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.578 0.811 . . . . 0.0 110.385 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.15 141.49 26.3 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.549 1.815 . . . . 0.0 110.976 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.66 20.02 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.89 120.05 40.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 0.787 . . . . 0.0 110.407 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.71 140.67 30.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 0.0 111.025 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.84 145.12 49.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.055 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.43 3.72 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.55 1.156 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.608 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 13.1 p90 -171.88 165.47 6.44 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 0.0 111.055 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.67 122.36 36.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 108.202 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.484 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 m -51.3 -50.73 74.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.441 1.088 . . . . 0.0 110.431 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 83' ' ' THR . 41.5 Cg_endo -75.13 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.565 1.824 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.828 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 27.0 m80 -75.03 57.99 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -38.56 15.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.554 1.159 . . . . 0.0 110.287 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.48 -23.85 32.72 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.533 1.146 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.492 0.76 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.16 1.82 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.478 1.111 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.665 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.66 75.12 1.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 0.761 . . . . 0.0 110.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.18 153.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.119 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.721 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.78 19.74 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.721 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.8 162.03 37.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.507 0.769 . . . . 0.0 110.425 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.994 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.62 122.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.561 1.163 . . . . 0.0 109.286 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.7 m -105.08 144.56 31.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.457 1.098 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.835 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.438 1.086 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.78 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 0.0 110.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.781 ' CE2' ' HD2' ' A' ' 38' ' ' PRO . 7.8 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.832 ' CZ ' ' HG3' ' A' ' 14' ' ' PRO . 3.8 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.828 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 1.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.504 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 33.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.146 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.699 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.731 ' HB2' HG22 ' B' ' 233' ' ' VAL . 20.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.596 ' HG2' ' O ' ' B' ' 65' ' ' SER . 15.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.532 ' HA ' HD22 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.573 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.596 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 51.6 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.699 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.561 ' HG ' ' H ' ' B' ' 68' ' ' GLY . 2.1 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.561 ' H ' ' HG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.664 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 69.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.639 HG21 ' CE ' ' B' ' 128' ' ' MET . 23.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 76.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.922 ' CG1' ' HG ' ' B' ' 115' ' ' LEU . 68.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.745 HG21 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.629 ' HA ' HD13 ' B' ' 116' ' ' LEU . 28.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.491 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 31.8 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.922 ' HG ' ' CG1' ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.745 ' HB2' HG21 ' B' ' 105' ' ' THR . 0.4 OUTLIER -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.1 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.606 HD23 ' CE2' ' B' ' 125' ' ' TYR . 10.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.606 ' CE2' HD23 ' B' ' 120' ' ' LEU . 62.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.639 ' CE ' HG21 ' B' ' 71' ' ' VAL . 63.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.469 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.723 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 21.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.336 ' HH ' ' CB ' ' B' ' 168' ' ' SER . 3.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.451 ' HG3' ' CG ' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.037 ' CG2' ' HB2' ' B' ' 162' ' ' TYR . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.538 ' N ' HG22 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.047 ' O ' ' HD1' ' B' ' 162' ' ' TYR . 3.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.934 ' C ' ' HE1' ' B' ' 162' ' ' TYR . 4.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 1.336 ' CB ' ' HH ' ' B' ' 162' ' ' TYR . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.532 HD22 ' HA ' ' B' ' 62' ' ' ALA . 16.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 1.581 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.355 22.4 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 59.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.562 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 56.7 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.093 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 5.4 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.562 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.8 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.776 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.093 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 9.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.731 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.146 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.65 126.86 29.2 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.531 1.145 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.626 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.46 177.18 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.418 1.074 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.93 40.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.559 1.162 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.764 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.08 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.509 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.76 133.49 35.98 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.672 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 110.973 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.53 7.65 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.577 1.173 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -108.05 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.475 0.75 . . . . 0.0 110.42 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.83 -15.97 24.91 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 0.0 109.356 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -90.57 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 0.0 109.337 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.477 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER 38.23 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.169 . . . . 0.0 111.062 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.523 ' HB2' ' OG1' ' A' ' 9' ' ' THR . . . -104.8 117.71 58.16 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.064 ' HB3' HG12 ' A' ' 36' ' ' VAL . 34.7 Cg_endo -75.03 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.528 1.804 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 3.2 pp -150.78 151.23 32.04 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.48 1.113 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.431 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.34 126.15 30.47 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.509 1.131 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.41 134.9 26.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.505 1.128 . . . . 0.0 110.351 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.09 140.99 70.28 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 121.007 -2.497 . . . . 0.0 110.909 0.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.22 -40.11 1.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.531 1.145 . . . . 0.0 109.251 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.29 46.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.42 31.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.133 . . . . 0.0 109.247 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.513 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.473 1.108 . . . . 0.0 110.059 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.85 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.402 1.064 . . . . 0.0 109.259 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.789 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.53 158.29 27.62 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 0.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.859 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.32 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.44 8.45 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.469 1.105 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.21 174.14 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 0.733 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.466 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.53 154.25 39.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 0.0 110.436 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.41 102.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.566 1.167 . . . . 0.0 109.276 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.51 18.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.591 1.182 . . . . 0.0 110.334 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.764 ' CD2' HG21 ' A' ' 5' ' ' ILE . 64.0 m-85 -147.19 121.46 9.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.562 1.164 . . . . 0.0 110.986 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.661 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.01 155.35 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.565 1.166 . . . . 0.0 109.262 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.77 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.2 ttp -98.05 119.26 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.399 1.062 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.39 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.181 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.912 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.86 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.46 1.1 . . . . 0.0 109.228 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.064 HG12 ' HB3' ' A' ' 14' ' ' PRO . 9.3 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.455 1.097 . . . . 0.0 109.323 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.672 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.95 -172.3 40.58 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.51 1.131 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -74.95 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.913 -2.536 . . . . 0.0 111.034 -0.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.77 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.7 m-70 -144.23 -170.37 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.537 ' HB2' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.469 1.106 . . . . 0.0 109.338 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.886 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.06 114.35 43.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.543 1.152 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.544 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.0 OUTLIER -132.78 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.539 1.149 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -49.99 4.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.293 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.3 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.53 158.1 72.87 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.03 164.22 33.75 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.459 1.768 . . . . 0.0 110.974 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.21 135.62 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.597 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.59 0.72 Allowed Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.538 1.149 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.651 0.853 . . . . 0.0 110.25 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.603 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.426 1.079 . . . . 0.0 110.053 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.03 -51.81 71.31 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.415 1.072 . . . . 0.0 109.27 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.739 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.05 50.78 2.63 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.419 1.747 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.603 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.62 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.662 1.226 . . . . 0.0 109.358 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.13 -27.56 68.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.409 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 4.4 m -46.44 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 0.0 109.99 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 68' ' ' TYR 0.492 7.8 t30 -108.04 117.75 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.411 1.069 . . . . 0.0 109.312 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.896 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 4.0 t -89.82 21.87 3.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 0.0 110.311 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 60' ' ' LEU . 57.1 tttt -86.02 64.36 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.487 1.117 . . . . 0.0 109.287 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB3' HD21 ' A' ' 40' ' ' ASN . 0.0 OUTLIER -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.475 1.109 . . . . 0.0 109.296 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.42 6.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 1.097 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.521 HG22 HD12 ' A' ' 62' ' ' ILE . 5.9 mm -68.62 -46.07 80.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.526 1.141 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.442 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -62.13 111.64 4.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.285 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 5.1 Cg_exo -75.05 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.454 1.765 . . . . 0.0 111.025 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.86 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.55 1.157 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.661 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.8 t -178.65 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.527 0.781 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.612 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.449 1.093 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.886 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.7 p90 -171.5 175.16 4.18 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.767 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.95 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.474 1.109 . . . . 0.0 110.006 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.27 146.47 24.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.57 1.169 . . . . 0.0 110.382 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 1.126 . . . . 0.0 109.259 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.859 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.09 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.459 1.1 . . . . 0.0 110.98 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.852 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.29 124.14 38.13 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.52 0.776 . . . . 0.0 110.388 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.98 141.5 26.78 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.438 1.757 . . . . 0.0 111.056 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.64 20.05 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.459 1.1 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.3 m -104.81 120.11 40.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 0.776 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.996 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.66 31.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 111.03 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.88 145.15 49.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.406 1.066 . . . . 0.0 110.016 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.21 -171.59 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.114 . . . . 0.0 110.956 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.487 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 16.3 p90 -171.78 165.46 6.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.543 1.152 . . . . 0.0 110.995 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.54 122.34 35.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.448 1.093 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.593 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 2.9 m -51.38 -50.76 74.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.433 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.9 Cg_endo -75.02 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.234 0 O-C-N 124.492 1.785 . . . . 0.0 111.033 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.547 ' HD2' ' HH ' ' B' ' 4' ' ' TYR . 22.1 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.631 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -38.44 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.536 1.147 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.52 -23.8 32.77 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.51 1.131 . . . . 0.0 110.995 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.18 62.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.512 0.772 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.1 1.83 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.456 1.097 . . . . 0.0 110.984 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.672 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.3 ttt -121.54 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 0.73 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.16 153.56 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 109.271 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.678 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.76 19.76 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.553 1.158 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.678 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.79 162.02 37.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.49 0.759 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.9 m -105.0 144.56 31.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.422 1.076 . . . . 0.0 110.429 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.804 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.31 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.523 1.139 . . . . 0.0 109.315 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.789 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.313 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.424 ' CD2' ' HE2' ' B' ' 4' ' ' TYR . 23.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.9 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 1.424 ' HE2' ' CD2' ' B' ' 1' ' ' TYR . 51.7 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 22.6 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.837 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.478 ' C ' HH11 ' B' ' 158' ' ' ARG . 0.0 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.491 ' HB1' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.896 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 5.7 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.3 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' B' ' 65' ' ' SER 0.261 4.7 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.409 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 29.8 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.439 HD22 ' CD1' ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.753 HG23 ' CE ' ' B' ' 128' ' ' MET . 33.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.624 HD22 HD12 ' B' ' 120' ' ' LEU . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.852 HG12 HD11 ' B' ' 115' ' ' LEU . 62.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.831 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.2 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.852 HD11 HG12 ' B' ' 104' ' ' VAL . 0.2 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.831 ' HB2' HG23 ' B' ' 105' ' ' THR . 70.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.672 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.624 HD12 HD22 ' B' ' 103' ' ' LEU . 39.3 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.753 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.457 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.837 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 14.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.954 ' CB ' HG22 ' B' ' 164' ' ' THR . 3.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.06 HG21 ' H ' ' B' ' 166' ' ' GLU . 5.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.06 ' H ' HG21 ' B' ' 164' ' ' THR . 44.6 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.7 ' N ' HD23 ' B' ' 167' ' ' LEU . 2.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.6 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.499 HD22 HH12 ' B' ' 158' ' ' ARG . 37.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.169 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.577 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.169 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.751 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.62 126.8 28.95 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.561 1.163 . . . . 0.0 110.056 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.625 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.41 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.413 1.071 . . . . 0.0 109.28 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.88 40.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.546 1.154 . . . . 0.0 110.3 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.771 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.3 112.12 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.457 1.098 . . . . 0.0 109.355 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.68 133.46 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.466 1.103 . . . . 0.0 109.377 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.692 ' HB3' ' HE2' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 0.0 111.007 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.52 7.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.543 1.152 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.698 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -108.1 160.71 15.6 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.478 0.752 . . . . 0.0 110.426 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.85 -15.96 25.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.436 1.085 . . . . 0.0 109.257 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 17.5 mttt -90.59 39.73 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.416 ' O ' ' CD1' ' B' ' 3' ' ' PHE . 0.2 OUTLIER 38.26 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.58 1.175 . . . . 0.0 111.031 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.68 58.17 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 109.278 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.766 ' HB3' HG11 ' A' ' 36' ' ' VAL . 37.3 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.497 1.788 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.448 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.4 pp -150.83 151.17 31.88 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.406 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.28 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.16 . . . . 0.0 111.018 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.43 134.95 26.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.565 1.166 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.06 140.98 70.28 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.939 0.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.16 -40.17 1.05 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.611 1.194 . . . . 0.0 109.252 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.29 46.09 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.462 1.101 . . . . 0.0 109.309 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.502 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.26 141.41 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 109.252 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.94 143.7 50.94 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 110.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.63 HG13 HG23 ' A' ' 96' ' ' VAL . 11.2 pt -154.79 -177.44 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.504 1.128 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.802 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.37 27.5 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 0.0 110.002 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.868 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.15 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.606 1.191 . . . . 0.0 109.332 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.52 -7.48 8.44 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.515 1.134 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.16 174.13 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 0.753 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.52 154.26 39.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 0.0 110.485 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.509 1.131 . . . . 0.0 109.306 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.274 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.771 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.24 121.38 9.49 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.533 1.146 . . . . 0.0 110.98 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.34 33.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.515 1.134 . . . . 0.0 109.317 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.733 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.06 119.22 36.32 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.353 1.033 . . . . 0.0 111.026 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.35 -66.05 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 109.255 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.698 ' HD3' ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -168.89 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.44 1.087 . . . . 0.0 109.3 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.766 HG11 ' HB3' ' A' ' 14' ' ' PRO . 9.4 p 46.08 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.48 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.588 1.18 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.99 -168.86 6.83 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.934 -2.527 . . . . 0.0 110.969 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.733 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.5 m-70 -144.24 -170.33 3.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.542 1.151 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 p30 173.94 166.95 0.2 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.419 1.074 . . . . 0.0 109.355 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 57.0 t -104.05 114.34 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.536 1.148 . . . . 0.0 109.385 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.632 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.78 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 109.333 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.457 ' N ' ' HG ' ' A' ' 56' ' ' SER . 85.3 m-85 -47.62 160.59 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.568 1.167 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.571 1.17 . . . . 0.0 109.306 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.996 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.48 158.09 72.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 164.25 33.69 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.463 1.77 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 0.0 109.339 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.611 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.5 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.492 1.12 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.551 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.04 -173.34 2.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.593 0.819 . . . . 0.0 110.295 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.604 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.3 m -133.2 77.86 1.75 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.511 1.132 . . . . 0.0 109.994 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.993 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.12 -51.76 72.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.11 . . . . 0.0 109.262 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.728 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.12 50.86 2.67 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.487 1.783 . . . . 0.0 110.909 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.604 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.63 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.584 1.177 . . . . 0.0 109.38 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.16 -27.52 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.117 . . . . 0.0 109.298 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.457 ' HG ' ' N ' ' A' ' 43' ' ' PHE . 47.7 m -46.46 115.15 0.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 0.0 109.976 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.523 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.6 m120 -108.02 117.71 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.438 1.086 . . . . 0.0 109.328 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 1.113 ' OG1' ' CB ' ' B' ' 63' ' ' ASP . 1.5 t -89.81 21.89 3.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.416 1.073 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -86.05 64.4 8.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.491 1.119 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.035 HD21 ' HB2' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -40.39 102.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.55 1.156 . . . . 0.0 109.332 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.44 98.38 6.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 0.0 109.343 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.5 mt -68.6 -46.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 109.354 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.58 4.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.108 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.98 139.11 23.94 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.457 1.767 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.94 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.522 1.139 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.683 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.485 0.756 . . . . 0.0 109.985 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.616 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.16 -86.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.446 1.092 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.523 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.763 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.59 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.482 1.114 . . . . 0.0 110.029 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.763 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.73 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 109.428 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.41 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.3 146.53 23.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 110.344 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.19 173.06 8.57 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.492 1.12 . . . . 0.0 109.261 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.868 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.07 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.851 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.26 124.13 37.87 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 0.0 110.421 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.0 141.5 26.72 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.511 1.795 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.05 -178.67 20.0 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.335 1.022 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.87 120.04 40.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 0.746 . . . . 0.0 110.347 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.996 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.74 140.69 30.95 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.87 145.16 49.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.451 1.094 . . . . 0.0 109.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.23 -171.62 3.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.458 1.099 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.45 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 15.6 p90 -171.78 165.4 6.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.555 1.16 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 122.33 35.8 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.424 1.078 . . . . 0.0 108.326 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.632 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.9 m -51.38 -50.77 74.36 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.499 1.124 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 18.6 Cg_endo -75.03 -62.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 26.3 m80 -74.97 58.0 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.596 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.0 -38.55 15.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.556 1.16 . . . . 0.0 110.314 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.45 -23.72 33.18 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.505 1.128 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.566 ' HB3' ' OH ' ' B' ' 4' ' ' TYR . . . -65.73 -15.21 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 0.768 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.523 1.139 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.692 ' HE2' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.391 0.701 . . . . 0.0 111.021 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.59 30.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.589 1.181 . . . . 0.0 109.272 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.707 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.543 1.152 . . . . 0.0 111.006 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.707 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.74 162.08 36.93 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.426 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.968 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 0.0 109.238 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.1 m -105.1 144.57 31.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 110.372 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.818 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.32 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.497 1.123 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.802 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.56 1.163 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.539 ' OH ' HBD1 ' B' ' 250' ' ' HEC . 16.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.979 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 16.2 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.566 ' OH ' ' HB3' ' A' ' 88' ' ' ALA . 4.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.979 ' HG3' ' O ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.44 ' CZ ' HD12 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.69 ' HB2' HG22 ' B' ' 233' ' ' VAL . 18.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 1.035 ' HB2' HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.534 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 1.113 ' CB ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.431 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 31.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.556 ' HB3' ' NE2' ' B' ' 61' ' ' GLN . 78.4 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.731 HD21 HG23 ' B' ' 233' ' ' VAL . 5.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.583 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 1.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.716 HG23 ' HE2' ' B' ' 128' ' ' MET . 35.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.697 HG22 HD22 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.8 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.658 HG13 ' HG ' ' B' ' 115' ' ' LEU . 98.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.658 ' HG ' HG13 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.697 HD22 HG22 ' B' ' 74' ' ' VAL . 19.0 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.745 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.509 ' HB3' HMA1 ' B' ' 250' ' ' HEC . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.745 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 38.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.716 ' HE2' HG23 ' B' ' 71' ' ' VAL . 36.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.446 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.534 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 46.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.8 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.625 ' HB2' ' CG2' ' B' ' 164' ' ' THR . 3.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.407 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.712 HG22 ' HB2' ' B' ' 166' ' ' GLU . 2.9 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.464 ' N ' HG23 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.712 ' HB2' HG22 ' B' ' 164' ' ' THR . 17.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.468 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.7 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.09 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 11.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.606 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.09 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.731 HG23 HD21 ' B' ' 69' ' ' LEU . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.55 126.8 28.94 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.535 1.147 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.623 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.42 177.19 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 0.0 109.273 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.87 40.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.14 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.412 1.07 . . . . 0.0 109.346 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.82 133.55 35.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 0.0 109.276 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.669 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.07 6.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 0.0 110.953 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.48 7.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.586 1.179 . . . . 0.0 110.973 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.704 HG22 ' CD1' ' A' ' 15' ' ' LEU . 17.2 p -108.07 160.7 15.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 0.741 . . . . 0.0 110.421 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -59.84 -15.92 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.402 1.064 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 23.9 mttt -90.58 39.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.137 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.603 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 22.9 m-85 38.37 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 0.0 111.015 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.84 117.65 58.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.075 ' HB3' HG11 ' A' ' 36' ' ' VAL . 22.3 Cg_endo -74.98 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.486 1.782 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.704 ' CD1' HG22 ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.21 31.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 0.0 109.357 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.34 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.473 1.108 . . . . 0.0 110.967 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.96 26.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.559 1.162 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.98 70.31 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.039 -2.484 . . . . 0.0 110.943 0.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.23 -40.1 1.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.554 1.159 . . . . 0.0 109.274 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.34 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.459 1.1 . . . . 0.0 109.302 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.29 141.43 31.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.553 1.158 . . . . 0.0 109.225 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.72 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.451 1.094 . . . . 0.0 110.036 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.623 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.88 -177.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 0.0 109.219 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.793 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.56 158.31 27.59 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.855 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.06 105.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 0.0 109.337 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.446 1.091 . . . . 0.0 110.999 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.25 174.09 11.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 0.747 . . . . 0.0 109.286 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.46 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 0.0 110.475 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.263 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.85 169.51 18.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.18 121.5 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.491 1.12 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.683 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.34 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.73 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.1 ttp -98.0 119.27 36.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.359 1.037 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -79.39 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.109 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.905 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.415 1.072 . . . . 0.0 109.279 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.075 HG11 ' HB3' ' A' ' 14' ' ' PRO . 9.7 p 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.615 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.538 1.149 . . . . 0.0 111.027 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.683 ' HD2' ' CE1' ' B' ' 1' ' ' TYR . 59.8 Cg_endo -74.99 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.931 -2.529 . . . . 0.0 110.963 -0.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.73 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.23 -170.4 3.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.569 1.168 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.99 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.9 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.8 t -104.07 114.33 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.534 1.146 . . . . 0.0 109.388 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.452 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.9 mm -132.75 75.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.59 160.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 110.98 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.99 -50.15 4.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 109.265 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.0 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.7 m -128.47 158.14 72.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.383 1.052 . . . . 0.0 109.291 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.07 164.22 33.67 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.505 1.792 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.19 135.6 1.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 0.0 109.328 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.537 1.148 . . . . 0.0 111.0 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.554 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.39 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.561 0.8 . . . . 0.0 110.263 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.583 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.46 1.1 . . . . 0.0 109.98 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.993 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.11 -51.75 72.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 0.0 109.269 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.07 50.78 2.64 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.401 1.737 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.583 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.65 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.639 1.212 . . . . 0.0 109.381 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.06 -27.54 68.16 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 109.36 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.4 ' HG ' ' N ' ' A' ' 43' ' ' PHE . 45.3 m -46.45 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.965 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.531 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m120 -108.07 117.73 34.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.499 ' HG1' ' HB2' ' B' ' 63' ' ' ASP . 3.3 t -89.82 21.92 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.432 1.082 . . . . 0.0 110.317 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 1.7 tttt -86.04 64.41 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -40.45 102.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 0.0 109.297 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.702 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.43 98.43 6.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 109.316 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.6 OUTLIER -68.69 -46.06 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.594 1.184 . . . . 0.0 109.332 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.63 4.93 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.04 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.473 1.775 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.87 -67.9 0.17 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.591 1.182 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.683 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.493 0.761 . . . . 0.0 109.994 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.25 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.417 1.073 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.9 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.51 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.494 1.121 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.766 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.29 20.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.408 1.068 . . . . 0.0 110.015 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.766 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 0.0 109.412 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.417 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 110.347 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.11 173.08 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.514 1.134 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.855 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.488 1.117 . . . . 0.0 110.963 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.824 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.26 124.06 37.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.545 0.791 . . . . 0.0 110.403 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.97 141.51 26.82 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.483 1.781 . . . . 0.0 111.09 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.441 1.088 . . . . 0.0 111.007 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.9 120.08 40.57 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.484 0.755 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.0 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.68 30.97 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.491 1.119 . . . . 0.0 111.017 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.17 49.3 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 1.08 . . . . 0.0 109.97 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.55 3.74 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.419 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 15.7 p90 -171.86 165.35 6.46 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 122.36 35.81 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.445 1.091 . . . . 0.0 108.284 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.561 HG22 ' HB1' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.39 -50.82 74.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.456 1.098 . . . . 0.0 110.356 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 83' ' ' THR . 36.4 Cg_endo -74.93 -62.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.527 1.804 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 29.5 m80 -74.96 57.93 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 0.0 109.598 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.17 ' HD2' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.97 -38.49 15.49 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.559 1.162 . . . . 0.0 110.318 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.886 ' N ' ' HD2' ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.77 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' B' ' 3' ' ' PHE . . . -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 0.761 . . . . 0.0 109.425 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.08 63.17 1.83 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.444 1.09 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.669 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.61 75.03 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.4 0.706 . . . . 0.0 111.066 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.14 153.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.499 1.124 . . . . 0.0 109.305 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.68 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.79 19.77 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.571 1.169 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.68 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.74 162.03 37.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 0.748 . . . . 0.0 110.432 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.968 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.61 122.63 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.02 144.49 31.75 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.427 1.079 . . . . 0.0 110.415 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.821 ' O ' HG11 ' A' ' 96' ' ' VAL . 5.0 t -128.2 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.53 1.144 . . . . 0.0 109.376 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.793 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.088 ' HD2' ' CE2' ' B' ' 4' ' ' TYR . 97.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.496 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.598 ' HE2' ' HB1' ' A' ' 88' ' ' ALA . 16.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 1.088 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 24.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.7 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.533 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 1.452 ' HG3' ' CG ' ' B' ' 58' ' ' GLN . 48.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.685 ' HB2' HG22 ' B' ' 233' ' ' VAL . 12.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.423 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 87.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.484 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 1.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.499 ' HB2' ' HG1' ' A' ' 58' ' ' THR . 2.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.4 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.694 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.531 HD22 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.672 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 4.9 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.822 HG21 ' CE ' ' B' ' 128' ' ' MET . 20.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.781 HD23 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.752 HG12 HD21 ' B' ' 83' ' ' LEU . 67.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.672 HG23 ' HB2' ' B' ' 116' ' ' LEU . 2.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.571 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 73.9 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.723 HD11 HG13 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.672 ' HB2' HG23 ' B' ' 105' ' ' THR . 52.1 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.823 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.817 HD22 ' CE2' ' B' ' 125' ' ' TYR . 17.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . 0.553 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.817 ' CE2' HD22 ' B' ' 120' ' ' LEU . 41.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.822 ' CE ' HG21 ' B' ' 71' ' ' VAL . 60.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.469 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.481 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 38.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.539 ' O ' HD12 ' B' ' 167' ' ' LEU . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' B' ' 24' ' ' CYS . 9.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.342 ' CD2' ' HD2' ' B' ' 163' ' ' PRO . 13.1 t80 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 1.342 ' HD2' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.174 ' CG2' ' HB3' ' B' ' 162' ' ' TYR . 0.2 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.693 ' H ' HG21 ' B' ' 164' ' ' THR . 36.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.539 HD12 ' O ' ' B' ' 160' ' ' GLN . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.917 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.752 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.917 ' HD3' ' CD2' ' B' ' 189' ' ' PHE 0.26 5.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.685 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.439 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.62 126.79 28.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.533 1.146 . . . . 0.0 109.99 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.628 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.46 177.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.426 1.079 . . . . 0.0 109.271 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.602 1.189 . . . . 0.0 110.296 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.458 1.099 . . . . 0.0 109.32 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.497 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.72 133.46 36.0 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.607 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.68 97.1 6.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 110.961 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.5 7.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.605 1.191 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.653 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 27.0 p -108.1 160.74 15.57 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.437 0.728 . . . . 0.0 110.398 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.483 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 45.5 t0 -59.85 -15.94 24.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.089 . . . . 0.0 109.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 13.1 mttt -90.64 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 38.27 29.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.72 58.07 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.483 1.115 . . . . 0.0 109.326 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.101 ' HB3' HG12 ' A' ' 36' ' ' VAL . 10.9 Cg_endo -75.0 97.62 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.498 1.788 . . . . 0.0 110.974 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.603 ' CD1' HG22 ' A' ' 9' ' ' THR . 1.2 pp -150.83 151.19 31.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.511 1.132 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.33 126.18 30.51 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.492 1.12 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.555 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.04 140.97 70.24 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.03 -2.488 . . . . 0.0 110.962 0.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.17 -40.1 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.545 1.153 . . . . 0.0 109.295 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.33 46.09 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.517 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.28 141.43 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.11 . . . . 0.0 109.226 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.517 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 110.029 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.628 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.12 . . . . 0.0 109.289 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.795 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.62 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.452 1.095 . . . . 0.0 109.994 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.85 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.05 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.59 1.181 . . . . 0.0 109.313 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.506 1.128 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.17 174.17 11.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 0.78 . . . . 0.0 109.288 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.47 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.55 154.23 39.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 0.0 110.427 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.963 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.592 1.182 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.86 169.49 18.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.17 121.49 9.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 0.0 110.962 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.04 155.28 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.693 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.5 ttp -98.01 119.26 36.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.373 1.046 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 35' ' ' LYS . 42.8 t30 -79.33 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.868 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.101 HG12 ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.04 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.092 . . . . 0.0 109.319 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.694 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.91 -172.31 40.63 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.487 1.117 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.452 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 56.3 Cg_endo -74.98 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.973 -0.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.693 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 68.8 m-70 -144.26 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.588 1.18 . . . . 0.0 109.574 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 174.01 167.07 0.21 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 109.338 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.897 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.16 114.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.586 1.179 . . . . 0.0 109.323 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.435 HD11 HG23 ' A' ' 42' ' ' ILE . 1.1 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.61 160.63 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.562 1.163 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.05 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.997 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.381 1.051 . . . . 0.0 109.257 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 164.27 33.6 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.449 1.763 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.27 135.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 0.0 109.292 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.613 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.48 -56.66 0.72 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.553 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.01 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.59 0.818 . . . . 0.0 110.282 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.582 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.2 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.426 1.079 . . . . 0.0 109.997 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.997 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.04 -51.83 71.14 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.417 1.073 . . . . 0.0 109.265 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.733 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.02 50.79 2.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.447 1.762 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.29 -45.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.659 1.224 . . . . 0.0 109.348 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.553 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.54 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -46.52 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.945 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.447 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -107.97 117.69 34.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.79 21.88 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.38 1.05 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -86.04 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.42 102.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.546 1.154 . . . . 0.0 109.337 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.718 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.954 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.64 -46.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.162 . . . . 0.0 109.353 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.04 111.61 4.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 0.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.05 139.15 23.81 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.468 1.772 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.567 1.167 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.68 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.7 97.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.438 0.728 . . . . 0.0 109.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.496 1.123 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.897 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.7 p90 -171.52 175.12 4.18 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.467 1.105 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.28 20.94 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.444 1.09 . . . . 0.0 109.988 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.04 137.69 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.106 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.421 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.26 146.48 23.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 110.331 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.11 8.53 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.449 1.093 . . . . 0.0 109.251 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.85 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.13 -44.31 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.823 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.27 124.07 37.65 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 0.0 110.37 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.49 26.79 Favored 'Trans proline' 0 C--N 1.359 1.092 0 O-C-N 124.498 1.789 . . . . 0.0 111.107 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.452 1.095 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.02 40.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 0.742 . . . . 0.0 110.339 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.996 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.4 m-85 -96.68 140.75 30.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.97 145.16 49.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.56 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.422 1.077 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.1 p90 -171.82 165.41 6.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 1.12 . . . . 0.0 111.018 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.49 122.38 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 0.0 108.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.737 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.34 -50.84 73.84 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.506 1.129 . . . . 0.0 110.373 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CB ' ' OH ' ' B' ' 1' ' ' TYR . 40.2 Cg_endo -74.97 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.465 1.771 . . . . 0.0 111.01 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 2.5 m170 -75.03 58.01 0.85 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.346 HH12 ' CA ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -88.01 -38.46 15.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.57 1.169 . . . . 0.0 110.314 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 1.346 ' CA ' HH12 ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.465 1.103 . . . . 0.0 110.983 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.64 -15.26 62.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 0.751 . . . . 0.0 109.408 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.11 1.83 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.43 1.081 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.498 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.56 74.98 1.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.401 0.706 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.12 153.59 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.684 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.72 19.72 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.599 1.187 . . . . 0.0 110.984 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.684 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.81 162.07 37.01 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 0.793 . . . . 0.0 110.414 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.963 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.64 122.63 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.0 m -105.01 144.53 31.69 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.414 1.071 . . . . 0.0 110.404 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.825 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.515 1.134 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.795 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.572 1.17 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.903 ' H2 ' ' HD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.422 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 1.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.2 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.664 ' CE2' HD13 ' B' ' 69' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 1.435 ' HG3' ' CG ' ' B' ' 58' ' ' GLN . 52.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.969 ' HB2' HG22 ' B' ' 233' ' ' VAL . 7.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.65 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 65' ' ' SER . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.65 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 69.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.56 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.664 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.667 ' ND2' HG22 ' A' ' 62' ' ' ILE . 2.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.562 HG22 ' CE ' ' B' ' 128' ' ' MET . 27.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.837 HG22 HD23 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.57 HD23 HD12 ' B' ' 120' ' ' LEU . 1.2 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.874 HG11 HD11 ' B' ' 115' ' ' LEU . 99.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.808 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.5 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.573 ' HB2' HG22 ' B' ' 114' ' ' ILE . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.874 HD11 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.837 HD23 HG22 ' B' ' 74' ' ' VAL . 46.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.467 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.694 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.57 HD12 HD23 ' B' ' 103' ' ' LEU . 9.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . 0.954 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.546 ' HG2' ' N ' ' B' ' 124' ' ' ASP . 4.1 pm0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.546 ' N ' ' HG2' ' B' ' 123' ' ' GLU . 8.7 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.562 ' CE ' HG22 ' B' ' 71' ' ' VAL . 42.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.521 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 6.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.884 ' CB ' HG22 ' B' ' 164' ' ' THR . 19.2 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.006 HG21 ' H ' ' B' ' 166' ' ' GLU . 14.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.006 ' H ' HG21 ' B' ' 164' ' ' THR . 25.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.549 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.522 HD22 ' HA ' ' B' ' 62' ' ' ALA . 10.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.171 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.841 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.171 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 8.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.969 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.423 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.58 126.79 28.88 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.549 1.155 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.39 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.267 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.86 40.25 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.529 1.143 . . . . 0.0 110.315 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.759 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.363 1.039 . . . . 0.0 109.267 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.502 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.74 133.47 35.99 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.614 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.69 96.99 6.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.458 1.099 . . . . 0.0 111.036 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.477 1.111 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.426 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 1.4 p -108.09 160.65 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.446 0.733 . . . . 0.0 110.439 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 13.4 t70 -59.78 -15.98 24.44 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.452 1.095 . . . . 0.0 109.361 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 29.1 mttp -90.57 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.313 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.24 29.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 0.0 111.054 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.653 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.85 117.7 58.12 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.736 ' HG3' HG22 ' A' ' 36' ' ' VAL . 28.0 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.429 1.752 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 13' ' ' ALA . 1.2 pp -150.81 151.22 31.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.109 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.17 30.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.552 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.44 134.82 26.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.406 1.066 . . . . 0.0 110.375 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.12 140.92 69.9 Favored 'Cis proline' 0 C--N 1.36 1.138 0 C-N-CA 121.031 -2.487 . . . . 0.0 110.96 0.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.17 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.32 46.11 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.425 1.078 . . . . 0.0 109.279 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 22' ' ' SER . 11.1 tp -143.21 141.4 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.137 . . . . 0.0 109.261 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 0.0 110.019 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.63 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.94 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 0.0 109.287 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.782 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.126 . . . . 0.0 109.923 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.878 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.525 1.141 . . . . 0.0 109.251 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.43 8.45 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.508 1.13 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.14 174.09 11.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.56 0.8 . . . . 0.0 109.282 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.43 154.29 39.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 110.51 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.957 HG12 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.52 102.6 6.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.099 . . . . 0.0 109.289 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.53 18.08 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.484 1.115 . . . . 0.0 110.28 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.759 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.23 121.39 9.5 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.516 1.135 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.662 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.38 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.723 ' HE3' ' HB3' ' A' ' 64' ' ' PRO . 6.8 ttp -98.0 119.17 36.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.427 1.079 . . . . 0.0 111.037 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -79.38 -66.05 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.571 1.17 . . . . 0.0 109.223 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.565 ' C ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.749 HG21 ' O ' ' A' ' 36' ' ' VAL . 2.7 p 45.97 54.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.505 1.128 . . . . 0.0 109.321 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.792 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -93.0 -172.37 40.51 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.478 1.111 . . . . 0.0 111.03 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HG3' HD11 ' A' ' 62' ' ' ILE . 19.0 Cg_endo -75.02 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.97 0.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.593 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.4 m-70 -144.23 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 0.0 109.644 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.703 ' HB3' HD21 ' A' ' 60' ' ' LEU . 1.2 p30 173.97 166.96 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 0.0 109.304 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.895 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.8 t -104.12 114.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.941 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.8 mm -132.75 75.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.402 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.72 160.59 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.01 -49.94 4.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 0.0 109.276 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.26 143.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.431 1.082 . . . . 0.0 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.015 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.56 158.14 72.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.39 1.056 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.9 Cg_endo -75.11 164.2 33.61 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.55 1.816 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.16 135.55 1.37 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.097 . . . . 0.0 109.307 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.596 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.52 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.566 1.166 . . . . 0.0 110.974 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.24 2.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.607 0.828 . . . . 0.0 110.243 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.6 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.27 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 0.0 109.963 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.008 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -52.99 -51.85 70.87 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.473 1.108 . . . . 0.0 109.353 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.743 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -74.97 50.71 2.58 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.446 1.761 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.6 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.31 -45.54 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.53 1.144 . . . . 0.0 109.392 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.11 -27.61 68.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.593 1.183 . . . . 0.0 109.252 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.47 115.12 0.94 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.555 1.159 . . . . 0.0 109.995 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 1.426 HD21 ' ND2' ' A' ' 57' ' ' ASN 0.964 52.9 p-10 -107.94 117.66 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.442 1.088 . . . . 0.0 109.298 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.64 ' HG1' ' CB ' ' B' ' 63' ' ' ASP . 9.7 t -89.82 21.9 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.454 1.096 . . . . 0.0 110.301 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -86.01 64.37 8.54 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 0.0 109.239 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.703 HD21 ' HB3' ' A' ' 40' ' ' ASN . 4.4 mt -40.39 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.722 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.52 98.49 6.11 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.563 1.164 . . . . 0.0 109.263 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 1.094 HG21 ' HB3' ' B' ' 121' ' ' PRO . 1.2 mm -68.64 -46.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.11 111.59 4.84 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.91 ' HD3' ' HG3' ' B' ' 121' ' ' PRO . 9.0 Cg_endo -74.97 139.15 24.02 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.466 1.771 . . . . 0.0 111.052 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 32' ' ' VAL . . . 168.88 -67.98 0.17 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.124 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.662 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.455 0.738 . . . . 0.0 110.008 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.722 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.16 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.463 1.102 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 1.025 ' OH ' ' OD1' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.11 4.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 0.0 111.021 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.57 161.31 20.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.462 1.101 . . . . 0.0 109.975 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.69 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.449 1.093 . . . . 0.0 110.332 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.09 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.518 1.136 . . . . 0.0 109.233 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.878 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.12 -44.34 0.02 OUTLIER Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.577 1.173 . . . . 0.0 110.953 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.856 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.28 124.11 37.86 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.453 0.737 . . . . 0.0 110.39 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.51 26.77 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.504 1.792 . . . . 0.0 111.054 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.62 20.07 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.422 1.076 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.4 HG21 HG23 ' A' ' 93' ' ' THR . 29.9 m -104.83 120.07 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.556 0.798 . . . . 0.0 110.403 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.015 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.58 1.175 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.91 145.16 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.24 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.444 1.09 . . . . 0.0 110.927 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.538 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 15.0 p90 -171.84 165.38 6.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.52 122.27 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.469 1.106 . . . . 0.0 108.29 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.986 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 20.4 m -51.27 -50.79 73.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 110.429 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.648 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 30.3 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.554 1.818 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -75.04 57.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.139 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.986 ' CG ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -87.98 -38.5 15.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.558 1.161 . . . . 0.0 110.337 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.5 -23.77 32.91 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.423 1.077 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.31 62.66 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.487 0.757 . . . . 0.0 109.314 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.22 1.82 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.469 1.106 . . . . 0.0 110.979 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.424 ' HE3' ' CA ' ' A' ' 7' ' ' MET . 7.2 ttt -121.63 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 0.763 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.21 153.49 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.44 1.088 . . . . 0.0 109.298 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.723 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.46 -174.69 19.64 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.449 1.093 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.723 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.84 162.08 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 0.778 . . . . 0.0 110.382 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.957 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.56 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.51 1.131 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.01 144.53 31.68 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 0.0 110.43 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.816 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.25 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 0.0 109.283 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.782 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.498 1.123 . . . . 0.0 110.347 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.003 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.804 ' CE2' ' CE1' ' B' ' 1' ' ' TYR . 8.8 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.479 ' CZ ' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.859 ' HB2' HG22 ' B' ' 233' ' ' VAL . 22.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.471 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 76.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.733 ' OE1' ' HB3' ' B' ' 65' ' ' SER . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.774 ' HB1' HG23 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.64 ' CB ' ' HG1' ' A' ' 58' ' ' THR . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.733 ' HB3' ' OE1' ' B' ' 61' ' ' GLN . 3.2 t -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.523 HD23 HG23 ' B' ' 233' ' ' VAL . 7.5 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.576 HD22 ' CD1' ' A' ' 62' ' ' ILE . 6.3 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.613 HG22 ' CE ' ' B' ' 128' ' ' MET . 21.3 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . 0.69 ' HB2' HD12 ' B' ' 103' ' ' LEU . 80.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.69 HD12 ' HB2' ' B' ' 99' ' ' ASP . 1.6 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.933 HG11 HD12 ' B' ' 115' ' ' LEU . 24.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.721 HG23 ' HB2' ' B' ' 116' ' ' LEU . 11.9 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.639 ' HA ' HD13 ' B' ' 116' ' ' LEU . 30.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.933 HD12 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' B' ' 105' ' ' THR . 5.3 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.792 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.7 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.478 HD12 HD23 ' B' ' 103' ' ' LEU . 4.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . 1.094 ' HB3' HG21 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.426 ' HH ' HD22 ' B' ' 103' ' ' LEU . 43.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.613 ' CE ' HG22 ' B' ' 71' ' ' VAL . 56.3 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 22.9 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.759 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 36.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.936 ' HB3' HG22 ' B' ' 164' ' ' THR . 6.7 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.542 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.936 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.0 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD21 ' B' ' 171' ' ' ASN . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.161 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.625 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.161 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.859 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.54 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.591 1.182 . . . . 0.0 110.045 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.633 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.49 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.418 1.074 . . . . 0.0 109.249 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.91 150.91 40.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.521 1.138 . . . . 0.0 110.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.754 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.09 38.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.442 1.089 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.71 133.54 35.92 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.615 ' HE3' ' CD1' ' A' ' 67' ' ' PHE . 0.0 OUTLIER -105.76 97.01 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 0.0 110.996 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.52 7.63 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 0.0 110.967 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.48 ' HG1' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.12 160.65 15.64 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.462 0.742 . . . . 0.0 110.371 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.78 -15.98 24.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.402 1.064 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.6 mtpt -90.57 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 111.019 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.63 58.3 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.835 ' HB3' HG12 ' A' ' 36' ' ' VAL . 38.8 Cg_endo -74.97 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.496 1.787 . . . . 0.0 111.028 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' CD2' ' HG1' ' A' ' 9' ' ' THR . 3.4 pp -150.8 151.19 31.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.544 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.5 134.95 26.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 124.498 1.124 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.03 140.96 70.23 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 121.021 -2.491 . . . . 0.0 110.959 0.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.21 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.563 1.165 . . . . 0.0 109.271 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.12 146.3 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.424 1.078 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.22 141.44 31.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.115 . . . . 0.0 109.201 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.508 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.69 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.432 1.082 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.633 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.226 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.798 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.28 27.67 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.006 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.1 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.626 1.204 . . . . 0.0 109.36 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.43 8.46 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.542 1.151 . . . . 0.0 110.987 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.16 174.12 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 0.779 . . . . 0.0 109.287 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.5 154.27 39.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 0.0 110.472 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.964 HG12 HD13 ' A' ' 94' ' ' ILE . 64.0 t -131.43 102.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.28 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.84 169.49 18.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.531 1.145 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.754 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.458 1.099 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.688 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.37 33.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 0.0 109.347 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.474 ' SD ' ' HE1' ' A' ' 67' ' ' PHE . 1.1 ttp -98.07 119.28 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.384 1.053 . . . . 0.0 111.032 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.37 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 0.0 109.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.48 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.465 1.103 . . . . 0.0 109.23 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.835 HG12 ' HB3' ' A' ' 14' ' ' PRO . 8.0 p 46.03 54.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 124.415 1.072 . . . . 0.0 109.359 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.619 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.494 1.121 . . . . 0.0 111.083 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -74.98 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.929 -2.53 . . . . 0.0 110.995 -0.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.619 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.9 m-70 -144.24 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.461 1.1 . . . . 0.0 109.586 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.97 167.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 109.305 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.14 114.37 43.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.513 1.133 . . . . 0.0 109.34 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.602 HG13 ' OG1' ' A' ' 83' ' ' THR . 3.2 mm -132.81 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.312 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.55 1.156 . . . . 0.0 111.01 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.0 -50.01 4.79 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.597 1.185 . . . . 0.0 109.257 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.0 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.51 158.1 72.82 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.417 1.073 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.04 164.24 33.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.454 1.765 . . . . 0.0 110.994 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.44 1.087 . . . . 0.0 109.328 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.5 -56.61 0.72 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.564 1.165 . . . . 0.0 111.027 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.549 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.36 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.608 0.828 . . . . 0.0 110.289 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.592 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.18 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.414 1.071 . . . . 0.0 109.989 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.979 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.02 -51.76 71.82 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.725 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.07 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.487 1.782 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.592 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.24 -45.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 109.331 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -65.98 -27.62 68.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 0.0 109.369 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.0 m -46.45 115.09 0.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 0.0 110.028 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.719 ' HB2' ' HH ' ' A' ' 68' ' ' TYR . 0.7 OUTLIER -108.0 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.327 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.0 t -89.77 21.91 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.382 1.051 . . . . 0.0 110.342 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.438 1.086 . . . . 0.0 109.311 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.52 ' CD1' ' HB3' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.111 . . . . 0.0 109.287 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.727 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.43 98.42 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.502 1.126 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.445 HD11 ' NE2' ' B' ' 61' ' ' GLN . 2.6 mm -68.63 -46.08 80.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.568 1.167 . . . . 0.0 109.355 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.63 4.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 0.0 109.298 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -75.03 139.08 23.78 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.422 1.748 . . . . 0.0 111.046 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.9 0.17 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.542 1.151 . . . . 0.0 110.935 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.688 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 0.794 . . . . 0.0 109.99 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.727 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.23 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.451 1.094 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.719 ' HH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.08 4.19 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.478 1.111 . . . . 0.0 110.982 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.767 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.27 20.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.02 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.767 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.71 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.381 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.3 146.47 24.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.13 . . . . 0.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.12 173.06 8.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.871 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.09 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.517 1.135 . . . . 0.0 111.0 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.854 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.23 124.1 37.51 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 0.785 . . . . 0.0 110.42 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.97 141.44 26.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.415 1.745 . . . . 0.0 111.084 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.63 20.09 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.386 1.054 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.403 HG21 HG23 ' A' ' 93' ' ' THR . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.449 0.735 . . . . 0.0 110.378 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.0 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.75 30.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.95 145.19 49.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.57 3.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 0.0 110.98 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -171.81 165.43 6.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 122.31 35.84 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.464 1.102 . . . . 0.0 108.284 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.602 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.1 m -51.36 -50.75 74.42 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 110.392 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.588 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 55.2 Cg_endo -75.08 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.541 1.811 . . . . 0.0 110.964 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 25.5 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.135 . . . . 0.0 109.616 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.784 ' HD3' ' N ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -87.96 -38.53 15.47 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.486 1.116 . . . . 0.0 110.32 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.784 ' N ' ' HD3' ' A' ' 86' ' ' ARG . . . -89.45 -23.83 32.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.501 ' HB3' ' OH ' ' B' ' 4' ' ' TYR . . . -65.65 -15.21 62.55 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 0.776 . . . . 0.0 109.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.457 1.098 . . . . 0.0 110.983 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.521 ' HE3' ' HA ' ' A' ' 7' ' ' MET . 7.6 ttt -121.57 75.02 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 0.745 . . . . 0.0 111.068 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.14 153.57 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.251 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.72 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.76 19.73 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.55 1.156 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.72 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.76 162.09 36.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 0.778 . . . . 0.0 110.393 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.964 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 0.0 109.273 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.08 144.54 31.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.412 1.07 . . . . 0.0 110.411 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.832 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.579 1.175 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.798 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.164 . . . . 0.0 110.291 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.578 ' CE1' HBD1 ' B' ' 250' ' ' HEC . 39.8 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.501 ' OH ' ' HB3' ' A' ' 88' ' ' ALA . 13.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 34.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 1.046 ' HG3' HG21 ' B' ' 233' ' ' VAL . 4.4 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.752 ' HG3' HD13 ' A' ' 60' ' ' LEU . 8.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.534 ' HA ' HD22 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 1.52 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 3.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.705 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 2.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.658 ' N ' HG12 ' B' ' 104' ' ' VAL . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.649 ' HB2' HG21 ' B' ' 105' ' ' THR . 83.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.662 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.518 ' HB3' HMA1 ' B' ' 250' ' ' HEC . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.662 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 82.1 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.414 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.414 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 66.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.515 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 43.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 1.362 ' C ' ' HD1' ' B' ' 162' ' ' TYR . 8.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.362 ' HD1' ' C ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.762 ' CG2' ' HB2' ' B' ' 162' ' ' TYR . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.405 ' N ' HG22 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.691 ' HB2' HH12 ' A' ' 86' ' ' ARG . 27.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.3 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.534 HD22 ' HA ' ' B' ' 62' ' ' ALA . 8.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.8 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 0.28 61.6 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.8 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.734 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 4.8 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.841 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.734 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.531 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.542 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 3.3 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.841 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.8 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 1.046 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.435 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.52 126.85 29.13 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.574 1.171 . . . . 0.0 110.022 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CG2' ' A' ' 23' ' ' ILE . 5.0 m -122.49 177.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.467 1.104 . . . . 0.0 109.295 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.83 40.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 0.0 110.321 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.762 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.11 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.434 1.084 . . . . 0.0 109.301 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.72 133.43 36.03 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.512 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.63 96.98 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.444 1.09 . . . . 0.0 111.008 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.57 7.65 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.504 1.127 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.464 ' HG1' HD22 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -108.13 160.64 15.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.449 0.735 . . . . 0.0 110.371 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.69 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 7.5 t70 -59.81 -15.91 24.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.448 1.093 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 3.3 ttmt -90.6 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.118 . . . . 0.0 109.311 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.759 ' HD2' HG22 ' B' ' 105' ' ' THR . 0.0 OUTLIER 38.34 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.71 58.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 0.0 109.248 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.025 ' HB3' HG21 ' A' ' 36' ' ' VAL . 16.5 Cg_endo -74.94 97.66 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.407 1.74 . . . . 0.0 111.043 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD22 ' HG1' ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.18 31.93 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -77.25 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.558 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.43 134.84 26.53 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.391 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.07 140.95 70.09 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.032 -2.487 . . . . 0.0 110.954 0.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.3 tttt -40.19 -40.15 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 0.0 109.358 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.505 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.2 141.44 31.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 0.0 109.214 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.505 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.78 50.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.597 1.186 . . . . 0.0 110.052 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.63 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.2 pt -154.87 -177.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.797 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.34 27.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.127 . . . . 0.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.87 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.19 105.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.575 1.172 . . . . 0.0 109.322 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.38 -7.25 8.55 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.523 1.14 . . . . 0.0 111.022 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.18 174.15 11.46 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.567 0.804 . . . . 0.0 109.294 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.1 m -123.61 154.2 39.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 0.0 110.466 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.948 HG12 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.32 102.59 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.562 1.164 . . . . 0.0 109.33 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.75 169.52 18.11 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.584 1.177 . . . . 0.0 110.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.22 121.48 9.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.597 1.186 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' A' ' 66' ' ' SER . 4.3 p -125.08 155.34 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.567 1.167 . . . . 0.0 109.276 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.612 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.8 ttt -98.0 119.19 36.19 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.475 1.11 . . . . 0.0 111.026 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.861 ' ND2' ' HD3' ' A' ' 35' ' ' LYS . 11.6 t30 -79.3 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 0.0 109.26 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.861 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.81 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 0.0 109.346 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.025 HG21 ' HB3' ' A' ' 14' ' ' PRO . 0.9 OUTLIER 45.9 54.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.6 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.31 40.54 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.563 1.165 . . . . 0.0 111.062 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.865 ' HD2' ' ND2' ' B' ' 70' ' ' ASN . 73.5 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.974 -2.511 . . . . 0.0 111.062 -0.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.612 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.3 m-70 -144.28 -170.37 3.34 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.576 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.446 HD22 ' HD3' ' A' ' 84' ' ' PRO . 4.3 p30 173.99 167.05 0.21 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.421 1.076 . . . . 0.0 109.289 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.901 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.11 114.36 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.583 1.177 . . . . 0.0 109.416 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.4 mm -132.84 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.67 160.6 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 111.008 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 4.1 t70 -97.08 -49.92 4.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.25 143.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.551 1.157 . . . . 0.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.008 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.53 158.08 72.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 0.0 109.276 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.0 164.24 33.74 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.408 1.741 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.57 1.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.467 1.104 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.601 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.51 -56.48 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.588 1.18 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.13 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.579 0.811 . . . . 0.0 110.295 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.572 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.7 m -133.08 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.006 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.003 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.06 -51.8 71.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -75.07 50.79 2.64 Favored 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.419 1.747 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.572 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.28 -45.69 0.07 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.324 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.52 68.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.601 1.188 . . . . 0.0 109.316 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -46.45 115.13 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 110.008 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 117.6 34.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.365 1.04 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -89.77 21.86 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.404 1.065 . . . . 0.0 110.314 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' LEU . 61.7 tttt -86.04 64.42 8.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.416 1.072 . . . . 0.0 109.27 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.627 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.48 102.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.432 1.082 . . . . 0.0 109.335 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.581 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.4 98.4 5.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.531 1.144 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 1.053 HG22 ' HB2' ' B' ' 121' ' ' PRO . 1.7 mt -68.65 -46.1 80.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 0.0 109.365 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.51 4.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 43.0 Cg_endo -74.95 139.19 24.13 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.544 1.813 . . . . 0.0 111.04 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 32' ' ' VAL . . . 168.85 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.475 1.109 . . . . 0.0 110.991 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.617 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.753 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 5.0 m-85 -38.28 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.901 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.54 175.16 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.42 1.075 . . . . 0.0 110.964 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.773 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.65 161.4 20.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.54 1.15 . . . . 0.0 109.931 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.15 137.65 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 0.0 109.376 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.411 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.2 146.44 24.0 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.376 1.048 . . . . 0.0 110.406 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.09 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 0.0 109.22 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.87 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.11 -44.39 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.573 1.17 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.834 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.29 124.11 38.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.533 0.784 . . . . 0.0 110.439 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.51 26.74 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.543 1.812 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.66 20.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 124.501 1.125 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.402 HG21 HG23 ' A' ' 93' ' ' THR . 30.0 m -104.83 120.05 40.47 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.539 0.788 . . . . 0.0 110.436 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.008 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.83 145.07 49.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.448 1.092 . . . . 0.0 110.028 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.566 1.166 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -171.86 165.39 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 0.0 111.028 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 0.711 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -93.47 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 0.0 108.344 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.847 ' O ' ' CB ' ' B' ' 62' ' ' ALA . 0.8 OUTLIER -51.2 -50.84 73.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.544 1.153 . . . . 0.0 110.47 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' N ' HG21 ' A' ' 83' ' ' THR . 18.1 Cg_endo -75.04 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 30.3 m80 -75.12 57.98 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.581 1.175 . . . . 0.0 109.499 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.711 ' HG2' ' O ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -87.95 -38.47 15.53 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.523 1.14 . . . . 0.0 110.336 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.6 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.51 -23.88 32.53 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.379 1.049 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.19 62.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 0.774 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 63.14 1.83 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.523 1.14 . . . . 0.0 110.979 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.512 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.62 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.418 0.717 . . . . 0.0 111.0 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.0 m -124.19 153.57 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.549 1.156 . . . . 0.0 109.218 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.711 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.45 -174.73 19.67 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.508 1.13 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.711 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.7 m -143.77 162.04 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 0.794 . . . . 0.0 110.43 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.948 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.64 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.56 1.163 . . . . 0.0 109.27 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.6 m -105.06 144.56 31.7 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.84 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.29 73.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.158 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 O-C-N 124.581 1.176 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.112 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.423 ' HZ ' ' HD2' ' A' ' 11' ' ' LYS . 8.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.768 ' CG ' ' CD2' ' B' ' 1' ' ' TYR 0.283 12.5 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.155 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.698 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.44 ' CE2' HD12 ' B' ' 55' ' ' LEU . 46.8 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 3.2 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.667 ' HB2' HG22 ' B' ' 233' ' ' VAL . 26.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.462 HG13 HD21 ' B' ' 169' ' ' ASN . 50.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.787 ' OE1' ' HB2' ' B' ' 65' ' ' SER . 2.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.847 ' CB ' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.787 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 18.4 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.515 ' HB2' ' NE2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 4.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.865 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 2.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.573 HG21 ' HE1' ' B' ' 128' ' ' MET . 9.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 8.5 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.0 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.6 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 0.525 ' HD1' ' HG ' ' B' ' 103' ' ' LEU . 1.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.525 ' HG ' ' HD1' ' B' ' 102' ' ' TYR . 11.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.802 HG12 HD13 ' B' ' 115' ' ' LEU . 20.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.759 HG22 ' HD2' ' A' ' 12' ' ' TYR . 11.7 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.636 ' HA ' HD12 ' B' ' 116' ' ' LEU . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.1 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.802 HD13 HG12 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.664 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 26.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.551 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.792 ' HG2' HG23 ' A' ' 36' ' ' VAL . 1.1 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.551 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 8.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . 1.053 ' HB2' HG22 ' A' ' 62' ' ' ILE . 2.5 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.442 ' HB3' ' CD1' ' A' ' 62' ' ' ILE . 4.6 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.753 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 2.4 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . 0.466 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 20.8 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.573 ' HE1' HG21 ' B' ' 71' ' ' VAL . 36.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.698 ' CE2' HG22 ' B' ' 49' ' ' VAL . 21.5 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.581 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . 0.428 ' NE2' HD21 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.691 HG22 ' H ' ' B' ' 162' ' ' TYR . 13.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.027 ' CB ' HG22 ' B' ' 164' ' ' THR . 22.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.481 ' CG ' ' HH ' ' B' ' 1' ' ' TYR . 3.6 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.027 HG22 ' CB ' ' B' ' 162' ' ' TYR . 4.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.51 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.001 ' H ' HG21 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD22 ' B' ' 171' ' ' ASN . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.462 HD21 HG13 ' B' ' 60' ' ' VAL . 9.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.428 HD21 ' NE2' ' B' ' 160' ' ' GLN . 43.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD22 HD12 ' B' ' 167' ' ' LEU 1.475 1.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 62.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.894 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.103 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.258 3.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.448 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 76.5 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.614 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.4 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.103 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.862 ' HB2' ' HG1' ' B' ' 228' ' ' THR . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.862 ' HG1' ' HB2' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . 0.507 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 9.4 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.667 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.155 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.441 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.6 126.82 29.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.63 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.44 177.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.91 150.87 40.36 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.4 112.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.42 1.075 . . . . 0.0 109.224 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.499 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.73 133.51 35.96 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.51 1.131 . . . . 0.0 109.285 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.656 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.01 6.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 0.0 111.001 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 1.028 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.0 144.48 7.65 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 124.501 1.126 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -108.16 160.68 15.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.405 0.709 . . . . 0.0 110.356 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.78 -15.99 24.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 0.0 109.324 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 19.7 mttt -90.58 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.358 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 38.25 29.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 111.059 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.71 58.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.152 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' SD ' ' A' ' 90' ' ' MET . 38.1 Cg_endo -75.06 97.63 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.478 1.778 . . . . 0.0 111.002 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.561 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 4.0 pp -150.74 151.31 32.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.496 1.122 . . . . 0.0 109.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.446 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.44 126.21 30.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.42 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.427 1.079 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.02 140.98 70.35 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.964 -2.515 . . . . 0.0 110.942 0.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.24 -40.03 1.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.27 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.381 1.051 . . . . 0.0 109.282 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.516 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.24 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.158 . . . . 0.0 109.26 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.516 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.02 143.81 51.0 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.564 1.165 . . . . 0.0 110.037 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.63 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.4 pt -154.97 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 0.0 109.32 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.799 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.38 27.44 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.476 1.11 . . . . 0.0 109.914 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.847 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.16 105.38 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.575 1.172 . . . . 0.0 109.304 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.47 -7.39 8.47 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 0.0 111.063 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.17 174.24 11.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.568 0.805 . . . . 0.0 109.2 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.3 m -123.66 154.26 39.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.574 1.172 . . . . 0.0 110.369 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.972 HG12 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.38 102.59 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.554 1.159 . . . . 0.0 109.268 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.25 121.52 9.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.08 155.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 0.0 109.302 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.471 ' HG3' ' CD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.01 119.2 36.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 111.005 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 1.028 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -79.34 -66.01 0.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.57 1.169 . . . . 0.0 109.237 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 0.0 109.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.703 HG22 ' HB2' ' B' ' 3' ' ' PHE . 7.2 p 46.1 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.104 . . . . 0.0 109.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.656 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.3 40.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.52 1.138 . . . . 0.0 111.031 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.029 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 9.2 Cg_endo -74.9 -168.99 6.91 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.986 -2.506 . . . . 0.0 110.998 -0.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.656 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 65.3 m-70 -144.13 -170.34 3.32 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 1.101 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.519 HD22 ' HD3' ' A' ' 84' ' ' PRO . 1.8 p30 173.9 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.904 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.03 114.29 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 109.394 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.463 HD11 HG23 ' A' ' 42' ' ' ILE . 1.8 mm -132.78 76.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.426 1.079 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.67 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.41 1.069 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.0 4.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.994 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.6 m -128.48 158.05 72.91 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.231 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 164.29 33.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.522 1.801 . . . . 0.0 111.032 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.29 135.61 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.612 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.47 -56.49 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.548 1.155 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.585 0.815 . . . . 0.0 110.27 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.581 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.2 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.388 1.055 . . . . 0.0 109.938 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.983 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.0 -51.88 70.62 Favored Pre-proline 0 C--N 1.323 -0.572 0 O-C-N 124.509 1.13 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.732 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -74.99 50.79 2.62 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.448 1.762 . . . . 0.0 110.966 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.34 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.58 1.175 . . . . 0.0 109.283 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.45 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.41 115.12 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.534 1.146 . . . . 0.0 110.014 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.579 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 6.2 m-20 -107.96 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 1.144 . . . . 0.0 109.303 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.993 ' CG2' ' HB3' ' B' ' 63' ' ' ASP . 7.2 t -89.75 21.86 3.34 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.379 1.05 . . . . 0.0 110.389 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 19.4 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 109.21 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.646 ' O ' HD12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.44 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.852 ' HB1' ' CE2' ' A' ' 67' ' ' PHE . . . -78.44 98.49 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.722 HD11 HD22 ' B' ' 70' ' ' ASN . 0.1 OUTLIER -68.73 -46.13 80.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 0.0 109.283 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -75.05 139.23 23.92 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.416 1.745 . . . . 0.0 111.001 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -68.0 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.472 1.108 . . . . 0.0 110.955 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.609 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.496 0.763 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.852 ' CE2' ' HB1' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.904 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.49 175.13 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.77 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 0.0 109.964 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.77 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.65 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.129 . . . . 0.0 109.388 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.19 146.48 23.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 110.395 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.15 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.558 1.161 . . . . 0.0 109.205 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.847 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.453 1.095 . . . . 0.0 110.987 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.829 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.29 124.19 38.32 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.586 0.815 . . . . 0.0 110.413 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.07 141.43 26.41 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.543 1.812 . . . . 0.0 111.031 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.62 20.09 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.418 1.074 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.86 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 0.789 . . . . 0.0 110.356 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.994 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.78 140.77 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 1.158 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.05 49.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.996 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.46 3.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.497 1.123 . . . . 0.0 110.991 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -171.85 165.45 6.47 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 122.31 35.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.443 1.089 . . . . 0.0 108.245 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.605 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.9 OUTLIER -51.25 -50.83 73.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.421 1.075 . . . . 0.0 110.393 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.721 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 19.0 Cg_endo -75.08 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 110.98 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -75.07 57.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 0.0 109.619 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.605 ' HG2' ' O ' ' A' ' 83' ' ' THR . 2.5 ptm180 -87.96 -38.5 15.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.85 32.7 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.532 1.145 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.24 62.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.472 0.748 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.2 63.2 1.82 Allowed Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.423 1.077 . . . . 0.0 110.868 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.656 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 9.0 ttt -121.68 75.1 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.451 0.736 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.57 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.481 1.113 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.682 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.78 19.77 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.46 1.1 . . . . 0.0 111.022 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.682 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.8 161.99 37.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.526 0.78 . . . . 0.0 110.407 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.972 HD13 HG12 ' A' ' 29' ' ' VAL . 92.2 mt -146.59 122.61 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.243 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.8 m -105.08 144.56 31.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.826 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.458 1.099 . . . . 0.0 109.291 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.799 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.796 ' N ' ' HD2' ' B' ' 4' ' ' TYR . 3.6 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 5.3 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.703 ' HB2' HG22 ' A' ' 36' ' ' VAL . 2.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.796 ' HD2' ' N ' ' B' ' 1' ' ' TYR . 44.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.404 HE21 ' HA ' ' B' ' 107' ' ' TYR . 47.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' B' ' 4' ' ' TYR . 1.5 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.9 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.669 ' HB2' HG22 ' B' ' 233' ' ' VAL . 10.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.512 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 89.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.76 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.993 ' HB3' ' CG2' ' A' ' 58' ' ' THR . 0.4 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.76 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 28.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.468 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 38.4 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.53 HD22 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.722 HD22 HD11 ' A' ' 62' ' ' ILE . 36.6 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.497 HG12 ' HA2' ' B' ' 122' ' ' GLY . 4.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 7.2 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' B' ' 102' ' ' TYR . 0.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.718 HD23 HD21 ' B' ' 120' ' ' LEU . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.793 ' CB ' HD21 ' B' ' 83' ' ' LEU . 55.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.448 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 61.9 p -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.62 ' HB2' HG22 ' B' ' 114' ' ' ILE . 29.4 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.49 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.0 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.822 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.667 HD21 HG22 ' B' ' 74' ' ' VAL . 82.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.565 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.029 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.718 HD21 HD23 ' B' ' 103' ' ' LEU . 1.9 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . 0.497 ' HA2' HG12 ' B' ' 71' ' ' VAL . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.494 ' HH ' HD11 ' B' ' 103' ' ' LEU . 59.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.555 ' HE2' HG12 ' B' ' 49' ' ' VAL . 15.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.1 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.416 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.464 ' NH2' ' HB3' ' B' ' 158' ' ' ARG . 0.1 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 4.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.833 ' CB ' HG23 ' B' ' 164' ' ' THR . 18.3 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.509 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 5.1 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.057 HG22 ' H ' ' B' ' 166' ' ' GLU . 5.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.057 ' H ' HG22 ' B' ' 164' ' ' THR . 34.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.768 ' N ' HD23 ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 0.872 ' HB3' ' H ' ' B' ' 170' ' ' ASN 0.684 0.1 OUTLIER -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.872 ' H ' ' HB3' ' B' ' 168' ' ' SER . 46.5 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.917 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.535 ' N ' HG21 ' B' ' 207' ' ' ILE . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.917 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.669 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.437 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.59 126.77 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.619 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.4 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 0.0 109.28 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.9 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.753 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.434 1.084 . . . . 0.0 109.3 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.79 133.46 36.02 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.53 1.144 . . . . 0.0 109.315 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.733 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.05 6.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 0.0 110.987 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.54 7.66 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.544 1.153 . . . . 0.0 110.992 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 15.9 p -108.04 160.67 15.61 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.389 0.699 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -59.87 -15.94 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 6.0 ttmt -90.57 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.353 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.491 ' HB3' ' CE1' ' B' ' 3' ' ' PHE . 0.5 OUTLIER 38.26 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 0.0 111.025 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.706 ' HB2' HD22 ' A' ' 15' ' ' LEU . . . -104.77 117.66 58.3 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 109.344 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.013 ' HB3' HG12 ' A' ' 36' ' ' VAL . 33.2 Cg_endo -74.94 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.551 1.816 . . . . 0.0 111.045 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.706 HD22 ' HB2' ' A' ' 13' ' ' ALA . 1.2 pp -150.84 151.19 31.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.12 . . . . 0.0 109.317 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.27 126.17 30.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.978 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.56 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.88 26.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.514 1.134 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.94 70.1 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.033 -2.486 . . . . 0.0 110.971 0.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.554 1.159 . . . . 0.0 109.264 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.32 46.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.428 1.08 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.496 HD23 HG22 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.38 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 0.0 109.235 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.495 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 0.0 110.065 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.631 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.85 -177.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.493 1.12 . . . . 0.0 109.284 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.801 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.34 27.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 0.0 110.009 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.876 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.11 105.36 0.27 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.6 1.187 . . . . 0.0 109.298 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.42 8.46 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.431 1.082 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.13 174.14 11.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 0.764 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.54 154.25 39.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 0.0 110.516 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.957 HG12 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.41 102.57 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.568 1.167 . . . . 0.0 109.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.54 18.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.753 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.21 121.41 9.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.12 . . . . 0.0 110.97 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.687 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.33 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.895 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.3 ttp -98.01 119.25 36.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.409 1.068 . . . . 0.0 111.0 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.36 -66.09 0.92 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 0.0 109.216 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.891 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.269 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.013 HG12 ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.02 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.419 1.075 . . . . 0.0 109.32 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.98 -172.29 40.52 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.51 1.131 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.268 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -74.99 -168.92 6.88 Favored 'Cis proline' 0 C--N 1.361 1.209 0 C-N-CA 120.919 -2.534 . . . . 0.0 110.975 -0.067 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 1.003 ' O ' HD11 ' A' ' 60' ' ' LEU . 71.0 m-70 -144.19 -170.36 3.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.614 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.477 HD22 ' HD3' ' A' ' 84' ' ' PRO . 3.7 p30 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.478 1.111 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.09 114.34 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.599 1.187 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 HD12 HG23 ' A' ' 42' ' ' ILE . 9.0 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 0.0 109.345 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.65 160.62 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.569 1.168 . . . . 0.0 109.308 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.33 143.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.618 1.199 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.019 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.7 m -128.5 158.1 72.81 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.35 1.031 . . . . 0.0 109.25 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.01 164.26 33.7 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.495 1.787 . . . . 0.0 111.046 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.62 1.41 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.606 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.47 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.56 1.162 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.552 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.42 2.24 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.608 0.828 . . . . 0.0 110.26 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.589 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.09 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.451 1.095 . . . . 0.0 110.042 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.019 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.08 -51.77 71.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 O-C-N 124.491 1.12 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.04 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.427 1.751 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.25 -45.67 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.604 1.19 . . . . 0.0 109.377 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -46.47 115.11 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 1.126 . . . . 0.0 109.976 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.422 ' CB ' ' HH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -108.0 117.68 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 109.348 179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -89.8 21.94 3.34 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.401 1.063 . . . . 0.0 110.304 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -86.07 64.45 8.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.268 ' CD1' ' HB2' ' A' ' 38' ' ' PRO . 17.6 tp -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 0.0 109.314 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.4 6.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.827 HG23 ' HG3' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -68.64 -46.09 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 0.0 109.362 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.446 ' N ' ' CD1' ' A' ' 62' ' ' ILE . . . -62.08 111.59 4.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.273 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.03 139.11 23.82 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.424 1.749 . . . . 0.0 111.05 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.93 -67.99 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.583 1.177 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.687 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.461 0.742 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.0 m-85 -38.23 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.422 ' HH ' ' CB ' ' A' ' 57' ' ' ASN . 3.7 p90 -171.5 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 0.0 111.006 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.768 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.458 1.099 . . . . 0.0 110.028 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.768 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.418 1.074 . . . . 0.0 109.403 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.26 146.52 23.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 110.391 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.11 8.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 109.276 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.876 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.13 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.848 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.25 124.09 37.61 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.5 0.765 . . . . 0.0 110.366 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.01 141.5 26.68 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.48 1.779 . . . . 0.0 111.091 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.419 1.074 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.88 120.08 40.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 0.736 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.005 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.71 30.94 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.134 . . . . 0.0 111.043 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.94 145.12 49.37 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.461 1.101 . . . . 0.0 109.975 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.13 -171.53 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.428 1.08 . . . . 0.0 110.994 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -171.84 165.43 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.499 1.124 . . . . 0.0 110.995 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 122.35 35.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.526 1.141 . . . . 0.0 108.328 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -51.33 -50.85 73.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 0.0 110.392 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.617 ' HB2' ' CE2' ' B' ' 162' ' ' TYR . 18.2 Cg_endo -75.0 -62.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.503 1.791 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 20.8 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.835 HH21 HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.0 -38.47 15.48 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.545 1.153 . . . . 0.0 110.322 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.8 32.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.498 1.124 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.67 -15.23 62.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.516 0.774 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.441 1.088 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.733 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.58 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.421 0.718 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.835 HG12 HH21 ' A' ' 86' ' ' ARG . 11.5 m -124.16 153.61 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 0.0 109.248 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.711 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.59 -174.8 19.83 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.711 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.71 162.05 36.97 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 0.764 . . . . 0.0 110.399 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.957 HD13 HG12 ' A' ' 29' ' ' VAL . 92.5 mt -146.59 122.67 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 0.0 109.283 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.07 144.51 31.77 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.382 1.051 . . . . 0.0 110.393 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.81 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.27 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 124.584 1.178 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.801 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.545 1.153 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.875 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 89.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.491 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 79.7 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.41 ' HD1' ' HA ' ' B' ' 4' ' ' TYR . 5.5 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.607 HE21 ' HA ' ' B' ' 107' ' ' TYR . 39.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.556 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.965 ' HG3' ' CG2' ' B' ' 233' ' ' VAL . 1.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.499 HG23 ' HB2' ' B' ' 231' ' ' PRO . 44.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.827 ' HG3' HG23 ' A' ' 62' ' ' ILE . 4.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 1.202 ' HB1' ' CG ' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 14.9 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.556 ' HB2' ' OE1' ' B' ' 58' ' ' GLN 0.26 4.8 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.557 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.721 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.435 HD21 HD11 ' B' ' 120' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.661 ' N ' HG12 ' B' ' 104' ' ' VAL . 9.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.607 ' HA ' HE21 ' B' ' 6' ' ' GLN . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.605 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 77.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.474 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.875 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.474 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 87.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.426 ' HA2' ' NE2' ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.772 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 64.4 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.703 ' CG1' ' HA ' ' B' ' 24' ' ' CYS . 11.0 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.617 ' CE2' ' HB2' ' A' ' 84' ' ' PRO . 2.5 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.876 ' CG2' ' H ' ' B' ' 166' ' ' GLU . 2.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.538 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.876 ' H ' ' CG2' ' B' ' 164' ' ' THR . 4.0 tp10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.496 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' B' ' 169' ' ' ASN . 11.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.602 ' CG ' ' O ' ' B' ' 170' ' ' ASN . 16.9 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.714 ' HB2' ' CD2' ' B' ' 189' ' ' PHE . 5.2 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.315 ' CD1' ' HG3' ' B' ' 209' ' ' PRO . 0.0 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 5.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.534 HG21 ' N ' ' B' ' 208' ' ' LEU . 83.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.5 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.315 ' HG3' ' CD1' ' B' ' 189' ' ' PHE . 2.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 19.7 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' B' ' 60' ' ' VAL . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.965 ' CG2' ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.409 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.64 126.83 29.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.575 1.172 . . . . 0.0 110.04 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.632 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.47 177.2 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.431 1.082 . . . . 0.0 109.263 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.99 150.82 40.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 0.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.769 HG21 ' CD2' ' A' ' 31' ' ' PHE . 8.9 mm -115.39 112.17 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.418 1.074 . . . . 0.0 109.213 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.498 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.74 133.48 35.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.563 1.165 . . . . 0.0 109.372 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.664 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.67 97.01 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.443 1.089 . . . . 0.0 110.951 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.524 1.14 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.465 HG22 HD13 ' A' ' 15' ' ' LEU . 1.0 OUTLIER -108.08 160.64 15.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 0.743 . . . . 0.0 110.415 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -16.0 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 0.0 109.29 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.9 mttt -90.62 39.66 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.978 ' O ' ' CZ ' ' B' ' 3' ' ' PHE . 0.4 OUTLIER 38.28 29.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 0.0 110.996 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB3' HD21 ' A' ' 15' ' ' LEU . . . -104.86 117.66 58.21 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.049 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 6.3 Cg_exo -75.01 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.482 1.78 . . . . 0.0 111.057 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.654 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.3 pp -150.77 151.22 32.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 0.0 109.375 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.18 30.52 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.527 1.142 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.8 26.49 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.09 140.98 70.23 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.009 -2.496 . . . . 0.0 110.951 0.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.2 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 1.124 . . . . 0.0 109.278 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.423 1.077 . . . . 0.0 109.329 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.502 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.22 141.43 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.592 1.183 . . . . 0.0 109.209 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.502 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.77 50.97 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.553 1.158 . . . . 0.0 110.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.632 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.91 -177.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.112 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.803 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.981 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.873 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.19 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.603 1.19 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.44 -7.27 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.512 1.133 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.409 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.582 0.813 . . . . 0.0 109.29 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.2 m -123.62 154.16 39.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.455 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.97 HG12 HD13 ' A' ' 94' ' ' ILE . 63.4 t -131.3 102.57 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.601 1.188 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.73 169.53 18.09 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.539 1.149 . . . . 0.0 110.311 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.769 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.31 121.47 9.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.03 155.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.586 1.178 . . . . 0.0 109.315 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.3 ttp -97.99 119.22 36.24 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.625 ' HB3' ' HD3' ' A' ' 35' ' ' LYS 0.324 6.6 m-20 -79.33 -66.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 0.0 109.264 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.625 ' HD3' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.86 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.456 1.098 . . . . 0.0 109.396 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.049 ' CG2' ' HG3' ' A' ' 14' ' ' PRO . 2.4 p 45.9 54.89 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.63 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.93 -172.29 40.6 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.582 1.176 . . . . 0.0 111.047 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.942 ' HD3' ' CZ ' ' B' ' 1' ' ' TYR . 24.3 Cg_endo -74.94 -168.89 6.84 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 120.953 -2.52 . . . . 0.0 111.054 -0.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.63 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 68.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.969 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 167.02 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 0.0 109.258 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.92 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.7 t -104.1 114.42 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 109.399 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.918 HG13 ' OG1' ' A' ' 83' ' ' THR . 7.4 mm -132.87 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 0.0 109.311 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.476 ' H ' ' HG ' ' A' ' 56' ' ' SER . 85.2 m-85 -47.7 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.449 1.093 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 81' ' ' TYR . 1.7 t70 -96.98 -49.98 4.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.314 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.31 143.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 0.0 109.352 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.003 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.51 158.09 72.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 0.0 109.244 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 164.2 33.8 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.477 1.777 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.31 135.62 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.532 1.145 . . . . 0.0 109.297 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.621 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.53 -56.48 0.73 Allowed Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.521 1.138 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.554 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.584 0.814 . . . . 0.0 110.294 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.609 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.2 77.74 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 109.987 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.995 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.0 -51.86 70.75 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 124.514 1.134 . . . . 0.0 109.306 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.1 Cg_endo -75.03 50.82 2.64 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.45 1.763 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.609 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.31 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.573 1.171 . . . . 0.0 109.315 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.554 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.54 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.517 1.136 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HG ' ' H ' ' A' ' 43' ' ' PHE . 50.0 m -46.5 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.445 1.091 . . . . 0.0 110.002 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.93 117.61 34.59 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.38 1.05 . . . . 0.0 109.285 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.5 t -89.81 21.89 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.39 1.056 . . . . 0.0 110.341 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 8.4 tttm -86.06 64.47 8.6 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.429 1.081 . . . . 0.0 109.244 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.969 ' CD2' ' HB3' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -40.46 102.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 0.0 109.344 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.815 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . . . -78.44 98.39 6.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.447 HD13 HG22 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.68 -46.04 80.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.565 1.166 . . . . 0.0 109.35 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.04 139.17 23.86 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.527 1.803 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.89 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.504 1.128 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.667 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 0.767 . . . . 0.0 110.02 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.815 ' CE1' ' HB2' ' A' ' 61' ' ' ALA . 3.6 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.529 1.143 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.92 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.53 175.13 4.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.481 1.113 . . . . 0.0 110.939 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.772 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.39 20.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.552 1.158 . . . . 0.0 109.939 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.67 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.18 146.44 23.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 0.0 109.251 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.11 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.546 1.154 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.82 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.27 124.12 37.89 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.508 0.77 . . . . 0.0 110.423 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.96 141.46 26.78 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.58 1.832 . . . . 0.0 111.041 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.68 20.04 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.494 1.121 . . . . 0.0 110.993 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.439 0.729 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.78 140.75 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.06 49.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.538 1.149 . . . . 0.0 109.98 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.5 3.73 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.813 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 42.4 p90 -171.85 165.38 6.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.547 1.154 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . 1.332 ' O ' ' NE ' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -93.48 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.405 1.065 . . . . 0.0 108.326 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.964 ' O ' ' HB ' ' B' ' 164' ' ' THR . 5.7 m -51.23 -50.89 73.15 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.452 1.095 . . . . 0.0 110.396 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.687 ' O ' ' HG2' ' B' ' 163' ' ' PRO . 40.5 Cg_endo -75.0 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 0.0 111.0 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.68 ' HE2' ' HE1' ' B' ' 4' ' ' TYR . 27.2 m80 -75.09 57.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.491 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.332 ' NE ' ' O ' ' A' ' 82' ' ' CYS . 0.2 OUTLIER -87.94 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.34 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.87 32.79 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.439 1.087 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.911 ' HB3' ' CD2' ' B' ' 7' ' ' TYR . . . -65.68 -15.21 62.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.525 0.78 . . . . 0.0 109.292 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.16 1.82 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.664 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.8 ttt -121.65 75.08 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.473 0.749 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 81' ' ' TYR . 14.0 m -124.24 153.61 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.558 1.161 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.678 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.76 19.72 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.461 1.101 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.678 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.77 162.06 37.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.568 0.805 . . . . 0.0 110.405 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.97 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.6 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.494 1.121 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.1 m -105.07 144.52 31.76 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.396 1.06 . . . . 0.0 110.407 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.822 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.8 t -128.24 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.16 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.803 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 O-C-N 124.594 1.184 . . . . 0.0 110.34 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.942 ' CZ ' ' HD3' ' A' ' 38' ' ' PRO . 42.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.978 ' CZ ' ' O ' ' A' ' 12' ' ' TYR . 1.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.68 ' HE1' ' HE2' ' A' ' 85' ' ' HIS . 4.4 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.942 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.561 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 1.1 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.994 ' CD1' HG13 ' B' ' 20' ' ' VAL . 85.1 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.994 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 1.478 ' CB ' ' CA ' ' B' ' 23' ' ' ASN 0.623 3.4 m-80 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 47.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.793 ' HB2' HG22 ' B' ' 233' ' ' VAL . 13.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.605 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 99.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.818 ' HG3' ' H ' ' B' ' 62' ' ' ALA . 1.4 tt0 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 0.818 ' H ' ' HG3' ' B' ' 61' ' ' GLN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.528 ' H ' ' HG2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 39.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.468 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.643 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 73.2 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.555 HD21 HD11 ' B' ' 120' ' ' LEU . 84.1 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.658 ' N ' HG12 ' B' ' 104' ' ' VAL . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.504 ' HB2' HG23 ' B' ' 105' ' ' THR . 80.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.734 ' HG3' ' CD2' ' B' ' 1' ' ' TYR . 1.2 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.555 HD11 HD21 ' B' ' 103' ' ' LEU . 90.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.646 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 39.8 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.549 ' O ' ' SG ' ' B' ' 24' ' ' CYS . 0.5 OUTLIER -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.764 ' HB3' HG22 ' B' ' 164' ' ' THR . 9.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.687 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.964 ' HB ' ' O ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . 0.42 ' N ' HG21 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.521 ' HB2' HG23 ' B' ' 164' ' ' THR . 23.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD21 ' B' ' 171' ' ' ASN . 3.6 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 168' ' ' SER . . . . . 0.576 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 57.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.404 ' OD1' ' N ' ' B' ' 169' ' ' ASN . 22.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.752 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.857 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.148 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.272 7.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.53 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.557 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.148 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.793 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.444 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.82 29.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 0.0 110.02 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.42 177.08 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.441 1.088 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.9 150.88 40.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 110.338 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.761 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.41 1.069 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.508 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.65 133.46 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.492 1.12 . . . . 0.0 109.351 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.709 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.73 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 111.034 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.45 7.63 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 124.514 1.134 . . . . 0.0 111.064 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.637 ' OG1' ' HB1' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -108.12 160.6 15.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.361 0.683 . . . . 0.0 110.443 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 9.8 t70 -59.79 -15.92 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 0.0 109.303 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 7.5 ttmt -90.64 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.545 1.153 . . . . 0.0 109.351 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.23 29.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.637 ' HB1' ' OG1' ' A' ' 9' ' ' THR . . . -104.89 117.66 58.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.464 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 44.6 Cg_endo -75.01 97.65 1.1 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 O-C-N 124.471 1.774 . . . . 0.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.537 HD11 HG22 ' A' ' 9' ' ' THR . 1.3 pp -150.82 151.31 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.318 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.4 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.559 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 110.315 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.559 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.08 140.97 70.19 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 120.987 -2.505 . . . . 0.0 110.966 0.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 1.15 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.13 146.27 46.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.354 1.034 . . . . 0.0 109.335 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.25 141.33 31.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 96' ' ' VAL . 11.4 pt -154.92 -177.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.563 1.165 . . . . 0.0 109.335 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.785 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.21 105.44 0.28 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.117 . . . . 0.0 109.303 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.29 8.5 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.48 1.112 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.1 m-20 -82.2 174.19 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 0.792 . . . . 0.0 109.232 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.464 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.0 m -123.59 154.23 39.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 110.409 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.978 HG12 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.44 102.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 0.0 109.277 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.462 1.101 . . . . 0.0 110.284 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.761 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.7 m-85 -147.25 121.5 9.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.939 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.09 155.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 109.269 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.638 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 12.2 ttp -98.09 119.19 36.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 0.0 111.026 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 0.0 109.296 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' NZ ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.488 1.117 . . . . 0.0 109.248 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 HG22 ' HD2' ' B' ' 119' ' ' PRO . 11.6 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.403 1.064 . . . . 0.0 109.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.636 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.32 40.54 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.524 1.14 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.976 ' HD3' ' OD1' ' B' ' 70' ' ' ASN . 3.9 Cg_exo -74.92 -169.03 6.95 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.018 -2.492 . . . . 0.0 110.959 -0.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.638 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 69.3 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.488 1.117 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.435 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 173.93 166.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 0.0 109.307 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.923 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.9 t -104.06 114.37 43.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 0.0 109.343 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.502 HG13 ' OG1' ' A' ' 83' ' ' THR . 1.3 mm -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 87.1 m-85 -47.68 160.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.462 1.101 . . . . 0.0 111.008 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.605 1.191 . . . . 0.0 109.31 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.9 mttt 167.32 143.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.449 1.093 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.007 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.51 157.98 73.2 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.394 1.059 . . . . 0.0 109.265 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.91 164.28 33.78 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.509 1.794 . . . . 0.0 111.054 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.32 135.61 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.618 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.46 -56.5 0.73 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.492 1.12 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.55 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.1 -173.29 2.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.567 0.804 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.606 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.4 m -133.29 77.83 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.396 1.06 . . . . 0.0 109.945 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.003 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.0 -51.87 70.73 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.563 1.164 . . . . 0.0 109.274 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.721 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -75.05 50.81 2.64 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.443 1.759 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.606 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.34 -45.57 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.638 1.212 . . . . 0.0 109.344 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.55 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.58 68.15 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 m -46.47 115.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 1.141 . . . . 0.0 109.988 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.91 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.411 1.07 . . . . 0.0 109.322 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -89.69 21.81 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.458 1.099 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -85.95 64.38 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.417 1.073 . . . . 0.0 109.222 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -40.43 102.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.706 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.49 98.53 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 0.0 109.29 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.874 HG21 ' HG2' ' B' ' 121' ' ' PRO . 28.7 mt -68.78 -46.07 80.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.61 1.194 . . . . 0.0 109.304 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.18 111.61 4.91 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.117 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -75.0 139.19 23.98 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.413 1.744 . . . . 0.0 111.038 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.379 1.05 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.685 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.509 0.77 . . . . 0.0 110.048 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.706 ' CE2' ' HB2' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.11 -86.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.923 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.48 175.16 4.19 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.443 1.089 . . . . 0.0 111.014 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.764 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.25 20.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.979 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.67 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 0.0 109.412 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.424 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.19 146.53 23.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 110.404 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.08 8.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.179 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.871 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.14 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.539 1.149 . . . . 0.0 110.996 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.831 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.23 124.21 37.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.561 0.801 . . . . 0.0 110.409 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.13 141.52 26.38 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.511 1.795 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.06 -178.68 20.0 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.508 1.13 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.81 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 0.764 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.007 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.89 145.13 49.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.45 3.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.581 1.176 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 39.5 p90 -171.89 165.39 6.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 111.042 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.59 122.39 35.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.112 . . . . 0.0 108.268 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 1.274 ' O ' ' HB2' ' B' ' 62' ' ' ALA . 1.2 m -51.29 -50.82 73.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.084 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.516 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 21.2 Cg_endo -75.06 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.574 1.829 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.3 m80 -75.1 58.05 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.99 -38.59 15.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.135 . . . . 0.0 110.292 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.89 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.48 -23.84 32.74 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.443 1.089 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.22 62.58 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.528 0.781 . . . . 0.0 109.357 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.503 1.127 . . . . 0.0 110.885 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.709 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.7 75.1 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 0.74 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 15.3 m -124.14 153.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.473 1.108 . . . . 0.0 109.287 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.684 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.513 1.133 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.684 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.78 162.05 37.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.343 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.978 HD13 HG12 ' A' ' 29' ' ' VAL . 92.5 mt -146.7 122.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 109.275 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.46 31.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.455 1.097 . . . . 0.0 110.381 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.84 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.21 73.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 109.285 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.785 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.516 1.135 . . . . 0.0 110.325 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.436 ' HE1' HAA2 ' B' ' 250' ' ' HEC . 32.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 4.9 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.668 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 6.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.486 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.415 ' CZ ' HD12 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 3.0 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.741 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.468 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 40.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 1.008 ' NE2' HG23 ' A' ' 83' ' ' THR . 3.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 1.274 ' HB2' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.803 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 16.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.3 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.711 HD12 ' HB2' ' B' ' 59' ' ' GLN . 9.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.976 ' OD1' ' HD3' ' A' ' 38' ' ' PRO . 86.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 30.5 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . 0.442 ' HH ' ' HB2' ' A' ' 35' ' ' LYS . 26.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 1.134 HG13 ' CD1' ' B' ' 115' ' ' LEU . 20.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.764 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 1.134 ' CD1' HG13 ' B' ' 104' ' ' VAL . 0.0 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.764 ' HB2' HG23 ' B' ' 105' ' ' THR . 16.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 36' ' ' VAL . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.513 HD13 ' HE3' ' B' ' 128' ' ' MET . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . 0.874 ' HG2' HG21 ' A' ' 62' ' ' ILE . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.472 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 12.9 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . 0.451 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 21.6 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.513 ' HE3' HD13 ' B' ' 120' ' ' LEU . 20.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.858 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 27.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.692 HG22 ' H ' ' B' ' 162' ' ' TYR . 14.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.032 ' CB ' HG21 ' B' ' 164' ' ' THR . 7.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.668 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.2 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.032 HG21 ' CB ' ' B' ' 162' ' ' TYR . 2.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 1.005 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.653 HD12 HD22 ' B' ' 171' ' ' ASN . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 57.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.653 HD22 HD12 ' B' ' 167' ' ' LEU 1.503 3.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 66.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.777 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 18.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 1.164 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.27 20.2 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.777 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.479 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.634 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.9 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 1.164 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.888 ' HB2' ' HG1' ' B' ' 228' ' ' THR . 1.1 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.888 ' HG1' ' HB2' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . 0.593 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 2.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.714 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.425 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.61 126.83 29.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 1.16 . . . . 0.0 109.999 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.629 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.42 177.18 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.41 1.069 . . . . 0.0 109.285 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.88 40.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.76 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.15 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.387 1.054 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.77 133.49 35.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.51 1.131 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.635 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.105 . . . . 0.0 110.997 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.49 7.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.594 1.184 . . . . 0.0 110.974 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.595 ' HG1' ' HB1' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.06 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.409 0.711 . . . . 0.0 110.417 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.84 -15.94 24.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.322 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.5 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 38.3 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 0.0 111.009 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.595 ' HB1' ' HG1' ' A' ' 9' ' ' THR . . . -104.87 117.72 58.05 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.069 ' HG3' ' HE2' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.46 1.769 . . . . 0.0 111.022 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 2.8 pp -150.8 151.25 32.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.46 1.1 . . . . 0.0 109.32 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.402 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.39 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.556 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.89 26.59 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.55 1.156 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.99 70.35 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 120.995 -2.502 . . . . 0.0 110.944 0.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.16 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.243 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.05 146.28 46.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.516 HD12 ' H ' ' A' ' 22' ' ' SER . 10.9 tp -143.28 141.4 31.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.566 1.166 . . . . 0.0 109.202 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.516 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 0.0 110.063 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.629 ' CG2' HG21 ' A' ' 3' ' ' VAL . 11.3 pt -154.93 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.54 158.31 27.57 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.877 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.602 1.189 . . . . 0.0 109.299 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.41 8.46 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.443 1.09 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.17 174.11 11.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 0.735 . . . . 0.0 109.3 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 3' ' ' VAL . 9.9 m -123.44 154.27 39.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 1.119 . . . . 0.0 110.535 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.955 HG12 HD13 ' A' ' 94' ' ' ILE . 63.8 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.143 . . . . 0.0 109.332 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.82 169.52 18.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.76 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.9 m-85 -147.21 121.39 9.51 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.484 1.115 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.96 155.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.07 119.26 36.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.413 1.07 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.333 6.9 m-20 -79.4 -66.03 0.92 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.412 1.07 . . . . 0.0 109.237 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.875 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.473 1.108 . . . . 0.0 109.235 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.042 HG23 ' HB3' ' A' ' 14' ' ' PRO . 19.0 m 46.02 54.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.624 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.33 40.62 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.558 1.161 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.632 ' HD2' ' CE2' ' B' ' 1' ' ' TYR . 19.5 Cg_endo -74.97 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.947 -2.522 . . . . 0.0 110.977 -0.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.624 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.5 m-70 -144.26 -170.36 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.403 1.064 . . . . 0.0 109.327 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.623 HG21 ' HH ' ' A' ' 68' ' ' TYR . 58.5 t -104.11 114.35 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 109.329 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -132.82 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.521 ' H ' ' HG ' ' A' ' 56' ' ' SER . 85.2 m-85 -47.61 160.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 0.0 110.959 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 6.9 mttt 167.32 143.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.473 1.108 . . . . 0.0 109.266 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.026 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.5 m -128.5 158.08 72.86 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.393 1.058 . . . . 0.0 109.284 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.03 164.25 33.68 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.42 1.748 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.67 1.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 0.0 109.33 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.47 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.485 1.116 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.556 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 0.822 . . . . 0.0 110.28 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.587 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.5 m -133.1 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 110.042 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.026 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -52.98 -51.84 70.88 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.441 1.088 . . . . 0.0 109.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.734 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.05 50.75 2.62 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.43 1.752 . . . . 0.0 110.966 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.26 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.587 1.179 . . . . 0.0 109.353 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.53 68.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.521 ' HG ' ' H ' ' A' ' 43' ' ' PHE . 57.9 m -46.52 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.974 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.455 1.097 . . . . 0.0 109.345 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 1.114 ' O ' ' HB2' ' B' ' 62' ' ' ALA . 4.6 t -89.77 21.84 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.393 1.058 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -86.08 64.44 8.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.229 ' CD2' ' HB3' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -40.44 102.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.415 ' HB2' ' CE2' ' A' ' 67' ' ' PHE . . . -78.44 98.47 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.891 HD13 ' CD1' ' A' ' 60' ' ' LEU . 4.3 mm -68.66 -46.11 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.602 1.189 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 0.0 109.278 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.03 139.1 23.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.431 1.753 . . . . 0.0 111.019 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.552 1.157 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.471 0.748 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.608 ' CD1' ' HE3' ' A' ' 7' ' ' MET . 4.2 m-85 -38.18 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.461 1.101 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.623 ' HH ' HG21 ' A' ' 41' ' ' VAL . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.448 1.092 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.761 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.29 20.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.448 1.093 . . . . 0.0 109.99 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.72 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 0.0 109.389 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.423 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.546 1.154 . . . . 0.0 110.353 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.1 8.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 1.1 . . . . 0.0 109.235 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.877 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.14 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.497 1.123 . . . . 0.0 111.045 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.847 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.25 124.11 37.71 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.543 0.79 . . . . 0.0 110.37 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 141.5 26.7 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.483 1.781 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.415 1.072 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.406 HG21 HG23 ' A' ' 93' ' ' THR . 29.7 m -104.84 120.03 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 0.76 . . . . 0.0 110.379 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.003 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.69 140.73 30.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.21 -171.55 3.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 42' ' ' ILE . 9.3 p90 -171.83 165.43 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.514 1.134 . . . . 0.0 111.028 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.6 122.35 35.97 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.478 1.111 . . . . 0.0 108.243 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.478 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -51.31 -50.81 73.93 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 110.397 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 83' ' ' THR . 49.5 Cg_endo -75.05 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.531 1.806 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.457 ' NE2' ' HE1' ' B' ' 4' ' ' TYR . 27.3 m80 -74.95 57.96 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 0.0 109.601 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.161 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.01 -38.47 15.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.634 1.209 . . . . 0.0 110.276 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.54 -23.76 32.83 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.43 1.081 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.407 ' HB2' ' HG2' ' A' ' 14' ' ' PRO . . . -65.69 -15.19 62.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 0.765 . . . . 0.0 109.426 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.06 1.83 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.438 1.086 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.635 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.07 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.454 0.738 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.161 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.18 153.62 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.564 1.165 . . . . 0.0 109.289 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.703 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.74 19.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.603 1.189 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.703 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.76 162.09 36.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 0.79 . . . . 0.0 110.382 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.955 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.64 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.255 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.2 m -105.01 144.55 31.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.393 1.058 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.829 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.537 1.148 . . . . 0.0 109.303 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 0.0 110.265 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 0.905 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 93.7 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.069 ' HE2' ' HG3' ' A' ' 14' ' ' PRO . 12.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.867 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 12.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.633 ' HB3' ' CD1' ' B' ' 9' ' ' TYR . 0.1 OUTLIER -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.144 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.3 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.468 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.807 ' HB2' HG22 ' B' ' 233' ' ' VAL . 21.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.757 ' HG2' ' O ' ' B' ' 65' ' ' SER . 4.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 1.229 ' HB3' ' CD2' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.754 ' HA ' HG21 ' A' ' 58' ' ' THR . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.757 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 9.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.468 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.645 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 33.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' B' ' 103' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 1.009 HG12 ' CG ' ' B' ' 115' ' ' LEU . 69.8 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.579 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 29.0 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.5 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 1.009 ' CG ' HG12 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.579 ' HB2' HG23 ' B' ' 105' ' ' THR . 11.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.623 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.905 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.623 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 47.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.405 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . 0.405 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 68.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.6 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.551 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.78 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' B' ' 24' ' ' CYS . 8.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.603 ' HB3' ' HG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.024 HG22 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 3.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.712 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.7 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.499 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.942 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.942 ' HD1' ' HB2' ' B' ' 187' ' ' ASN . 0.4 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.865 ' CG ' HG21 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.633 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.865 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.699 HG23 HD11 ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.535 HG21 ' N ' ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.826 HD22 ' N ' ' B' ' 208' ' ' LEU . 4.0 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.872 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.689 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.699 HD11 HG23 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.689 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.807 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.144 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.63 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 110.03 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.622 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.41 177.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.554 1.159 . . . . 0.0 110.342 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.31 112.16 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.408 1.068 . . . . 0.0 109.307 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.5 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.75 133.44 36.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.548 1.155 . . . . 0.0 109.306 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.561 ' HB3' ' HE3' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.66 97.0 6.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.469 1.106 . . . . 0.0 111.002 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.03 144.41 7.62 Favored Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.464 1.103 . . . . 0.0 111.074 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.548 HG22 ' CD1' ' A' ' 15' ' ' LEU . 17.3 p -108.09 160.69 15.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.422 0.719 . . . . 0.0 110.402 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.79 -15.96 24.41 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.441 1.088 . . . . 0.0 109.305 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 5.0 tppt? -90.64 39.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.298 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 1.438 ' HH ' ' CB ' ' B' ' 3' ' ' PHE . 12.3 m-30 38.29 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.125 . . . . 0.0 111.008 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.849 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -104.81 117.67 58.24 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.487 1.117 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.022 ' HB3' HG11 ' A' ' 36' ' ' VAL . 1.2 Cg_endo -75.03 97.56 1.09 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.455 1.766 . . . . 0.0 110.99 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.849 HD21 ' HB1' ' A' ' 13' ' ' ALA . 1.2 pp -150.73 151.29 32.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.41 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 0.0 110.934 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.47 134.91 26.61 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.445 1.091 . . . . 0.0 110.317 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.08 141.0 70.37 Favored 'Cis proline' 0 C--N 1.361 1.22 0 C-N-CA 120.947 -2.522 . . . . 0.0 111.013 0.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.21 -40.13 1.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 0.0 109.181 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.27 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.384 1.052 . . . . 0.0 109.281 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.514 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.21 141.41 31.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 0.0 109.216 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.514 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.78 50.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.544 1.152 . . . . 0.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.632 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.92 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.797 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.56 158.32 27.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 109.963 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.875 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.14 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.594 1.184 . . . . 0.0 109.313 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.36 8.46 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.465 1.103 . . . . 0.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.22 174.16 11.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 0.758 . . . . 0.0 109.182 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 3' ' ' VAL . 10.3 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.577 1.173 . . . . 0.0 110.371 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.984 HG12 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.41 102.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 0.0 109.285 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.86 169.62 17.95 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.128 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.763 ' CD2' HG21 ' A' ' 5' ' ' ILE . 64.0 m-85 -147.24 121.42 9.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.135 . . . . 0.0 111.008 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.691 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.39 33.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 109.281 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.914 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.1 ttp -98.06 119.11 36.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 0.0 111.085 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -79.27 -66.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 109.291 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.461 1.1 . . . . 0.0 109.292 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.022 HG11 ' HB3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 0.0 109.338 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 1.184 ' O ' ' CGD' ' B' ' 250' ' ' HEC . . . -92.97 -172.3 40.54 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.555 1.16 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.035 ' HD2' ' HB3' ' B' ' 62' ' ' ALA . 7.8 Cg_endo -74.95 -168.96 6.9 Favored 'Cis proline' 0 C--N 1.36 1.169 0 C-N-CA 120.992 -2.503 . . . . 0.0 110.986 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.914 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.1 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.413 ' ND2' ' C ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 173.9 166.97 0.2 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 61.2 t -104.07 114.35 43.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.566 1.166 . . . . 0.0 109.347 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.0 mm -132.74 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.432 1.083 . . . . 0.0 109.306 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' H ' ' HG ' ' A' ' 56' ' ' SER . 85.1 m-85 -47.6 160.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.443 1.089 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 9.5 t70 -97.03 -50.01 4.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.595 1.184 . . . . 0.0 109.324 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.2 mttt 167.34 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.143 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.03 HG11 ' HB3' ' A' ' 52' ' ' ALA . 14.4 m -128.54 158.05 73.04 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.143 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 164.22 33.83 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.476 1.777 . . . . 0.0 111.027 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.33 135.64 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 109.252 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.599 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.46 -56.57 0.72 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.522 1.139 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.555 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.61 0.829 . . . . 0.0 110.238 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.596 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.6 m -133.15 77.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.371 1.045 . . . . 0.0 110.021 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 1.03 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.02 -51.85 70.93 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.486 1.116 . . . . 0.0 109.268 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.706 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.01 50.73 2.61 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.596 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.27 -45.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.562 1.164 . . . . 0.0 109.346 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.555 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.52 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.519 1.137 . . . . 0.0 109.344 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.573 ' HG ' ' H ' ' A' ' 43' ' ' PHE . 68.5 m -46.48 115.1 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.571 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.8 m120 -107.97 117.67 34.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 0.0 109.293 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.431 ' H ' ' HG1' ' A' ' 58' ' ' THR . 0.1 OUTLIER -89.68 21.78 3.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.412 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -85.93 64.4 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.446 1.091 . . . . 0.0 109.233 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.559 HD22 ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.41 102.45 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 0.0 109.346 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.753 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.39 98.46 6.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.342 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 38' ' ' PRO . 5.2 mm -68.7 -46.09 80.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 111.6 4.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.594 1.184 . . . . 0.0 109.303 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -74.99 139.14 23.95 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.384 1.729 . . . . 0.0 111.02 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.96 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.45 1.094 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.691 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.8 t -178.69 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 0.744 . . . . 0.0 110.037 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.753 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.8 m-85 -38.25 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.128 . . . . 0.0 110.978 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.571 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.13 4.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.461 1.1 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.774 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.26 20.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 109.994 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.774 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.68 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.5 1.125 . . . . 0.0 109.388 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.42 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.8 m -94.22 146.5 23.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.115 . . . . 0.0 110.426 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 0.0 109.222 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.875 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.21 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.501 1.126 . . . . 0.0 110.951 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.85 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.26 124.17 37.96 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.528 0.781 . . . . 0.0 110.411 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.09 141.5 26.45 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.558 1.82 . . . . 0.0 111.014 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.7 20.0 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.444 1.09 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.77 120.08 40.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 0.792 . . . . 0.0 110.405 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.014 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.79 140.74 30.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.61 1.194 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.12 49.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.442 1.089 . . . . 0.0 110.011 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.44 3.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.598 1.186 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.663 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 40.9 p90 -171.91 165.44 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -93.61 122.33 35.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.396 1.06 . . . . 0.0 108.296 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.497 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -51.26 -50.79 73.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.436 1.085 . . . . 0.0 110.378 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.679 ' HB3' ' O ' ' B' ' 62' ' ' ALA . 9.2 Cg_endo -75.1 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.564 1.823 . . . . 0.0 110.972 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -75.1 57.99 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.112 . . . . 0.0 109.577 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 1.242 HH22 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -87.97 -38.61 15.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 0.0 110.312 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.42 -23.84 32.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.427 1.079 . . . . 0.0 110.991 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.18 62.56 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.527 0.781 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.497 1.123 . . . . 0.0 110.927 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.561 ' HE3' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.64 75.05 1.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 0.778 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 1.242 ' CG1' HH22 ' A' ' 86' ' ' ARG . 13.1 m -124.17 153.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.294 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.69 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.49 -174.82 19.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.501 1.126 . . . . 0.0 111.036 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.69 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.76 162.06 36.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 0.0 110.358 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.984 HD13 HG12 ' A' ' 29' ' ' VAL . 92.3 mt -146.63 122.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.57 1.169 . . . . 0.0 109.284 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.08 144.52 31.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 0.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.837 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.28 73.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.431 1.082 . . . . 0.0 109.327 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.797 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 0.0 110.282 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.002 ' CD2' ' CZ ' ' B' ' 3' ' ' PHE . 2.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 3.7 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.438 ' CB ' ' HH ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.833 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 60.8 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.626 HE21 HD12 ' B' ' 116' ' ' LEU . 66.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.915 ' O ' ' CD1' ' B' ' 7' ' ' TYR . 1.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.431 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 4.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 61.4 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.103 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 46.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.651 ' HG3' HG21 ' B' ' 233' ' ' VAL . 10.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 71.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 1.223 ' NE2' ' CD1' ' A' ' 60' ' ' LEU . 1.2 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 1.035 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 1.559 ' CB ' HD22 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 1.184 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.663 ' HB3' ' CD ' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 7.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.723 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 43.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.733 HG22 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.435 HD21 HD11 ' B' ' 120' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.661 ' N ' HG12 ' B' ' 104' ' ' VAL . 15.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.616 ' HA ' HD12 ' B' ' 116' ' ' LEU . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.733 ' CD2' HG22 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.479 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 0.475 ' HB3' HMA1 ' B' ' 250' ' ' HEC . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.479 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 84.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 13.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.434 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 29.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 1.382 ' O ' ' CD1' ' B' ' 162' ' ' TYR 0.461 0.1 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 1.023 ' N ' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 1.271 HG22 ' CD1' ' B' ' 162' ' ' TYR . 13.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.845 ' HB2' HG21 ' B' ' 164' ' ' THR . 18.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.683 ' N ' HD23 ' B' ' 167' ' ' LEU . 2.2 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 84.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.556 HD22 ' HA ' ' B' ' 62' ' ' ALA . 5.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.754 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.626 ' H ' ' CG2' ' B' ' 228' ' ' THR . 21.1 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.8 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 0.4 OUTLIER -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.67 ' CB ' ' HD1' ' B' ' 189' ' ' PHE . 3.0 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.936 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' B' ' 187' ' ' ASN . 11.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.771 ' CG ' HG21 ' B' ' 204' ' ' VAL . 18.5 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.704 ' HB ' HG22 ' B' ' 205' ' ' THR . 89.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.771 HG21 ' CG ' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.704 HG22 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 2.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 48.3 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 0.576 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 18.3 mt -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.936 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.576 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 54.1 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' B' ' 227' ' ' LEU . 54.7 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.681 ' HG1' ' N ' ' B' ' 229' ' ' THR . 4.5 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.651 HG21 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.184 ' CGD' ' O ' ' A' ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.443 ' N ' ' OD2' ' A' ' 27' ' ' ASP . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.63 126.87 29.24 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.517 1.136 . . . . 0.0 110.022 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.626 HG21 ' CG2' ' A' ' 23' ' ' ILE . 4.9 m -122.48 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.369 1.043 . . . . 0.0 109.265 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.9 40.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.254 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.767 HG21 ' CD2' ' A' ' 31' ' ' PHE . 9.0 mm -115.4 112.1 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.081 . . . . 0.0 109.35 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.72 133.55 35.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.485 1.116 . . . . 0.0 109.346 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.479 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.06 6.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 0.0 110.924 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.48 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.579 1.174 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 13' ' ' ALA . 1.3 p -108.07 160.68 15.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 0.736 . . . . 0.0 110.431 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.82 -15.93 24.54 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.382 1.051 . . . . 0.0 109.328 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 35.2 mttt -90.63 39.7 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.536 1.148 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 1.426 ' HH ' ' CB ' ' B' ' 3' ' ' PHE . 0.8 OUTLIER 38.21 29.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.503 1.127 . . . . 0.0 111.016 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.685 ' HB1' HD21 ' A' ' 15' ' ' LEU . . . -104.86 117.69 58.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 0.0 109.34 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 1.073 ' HB3' HG11 ' A' ' 36' ' ' VAL . 9.3 Cg_endo -75.0 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.452 1.764 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.685 HD21 ' HB1' ' A' ' 13' ' ' ALA . 1.4 pp -150.75 151.25 32.1 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 0.0 109.307 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.428 ' HE1' ' HE1' ' A' ' 7' ' ' MET . 5.5 m-85 -77.34 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 1.132 . . . . 0.0 110.965 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.557 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.92 26.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 124.47 1.106 . . . . 0.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.557 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.05 140.97 70.25 Favored 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.013 -2.494 . . . . 0.0 110.932 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.17 -40.16 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.548 1.155 . . . . 0.0 109.281 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.31 46.04 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.403 1.064 . . . . 0.0 109.358 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.509 HD12 ' H ' ' A' ' 22' ' ' SER . 11.0 tp -143.26 141.38 31.03 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.509 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.7 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.461 1.101 . . . . 0.0 110.098 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 96' ' ' VAL . 11.3 pt -154.87 -177.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.442 1.089 . . . . 0.0 109.259 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.799 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.49 158.33 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.857 ' HB2' ' O ' ' A' ' 73' ' ' GLY . . . -58.18 105.42 0.28 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.557 1.161 . . . . 0.0 109.297 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.47 8.44 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.5 1.125 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.443 ' OD2' ' N ' ' A' ' 1' ' ' ALA . 9.0 m-20 -82.16 174.14 11.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 0.754 . . . . 0.0 109.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 3' ' ' VAL . 9.9 m -123.49 154.26 39.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 110.544 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.941 HG12 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.43 102.58 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.576 1.172 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.49 18.15 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.59 1.181 . . . . 0.0 110.299 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.767 ' CD2' HG21 ' A' ' 5' ' ' ILE . 63.8 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.473 1.108 . . . . 0.0 110.953 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.5 ttp -97.99 119.26 36.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 1.057 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.41 -66.04 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.209 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.8 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 1.073 HG11 ' HB3' ' A' ' 14' ' ' PRO . 5.1 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 1.225 ' O ' ' CGD' ' B' ' 250' ' ' HEC . . . -92.94 -172.27 40.58 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.523 1.139 . . . . 0.0 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 1.007 ' CD ' ' HB3' ' B' ' 62' ' ' ALA . 9.5 Cg_endo -74.96 -168.9 6.86 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.993 -0.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.635 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 72.8 m-70 -144.21 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 0.0 109.584 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.858 ' HB3' ' OD2' ' B' ' 63' ' ' ASP . 0.9 OUTLIER 173.96 166.98 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 60.5 t -104.11 114.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.578 1.174 . . . . 0.0 109.356 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.71 ' CG1' ' OD1' ' A' ' 40' ' ' ASN . 4.3 mm -132.77 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 0.0 109.308 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -47.66 160.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 0.0 110.939 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 2.5 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 0.0 109.253 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 1.017 HG13 ' CD2' ' A' ' 78' ' ' TYR . 14.5 m -128.45 158.09 72.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.372 1.045 . . . . 0.0 109.286 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 164.2 33.72 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.493 1.786 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.2 135.61 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.446 1.092 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.604 ' HA3' HG22 ' A' ' 74' ' ' THR . . . 133.46 -56.68 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.535 1.147 . . . . 0.0 111.014 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.547 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.06 -173.32 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.595 0.82 . . . . 0.0 110.303 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.597 ' HB3' ' HB1' ' A' ' 54' ' ' ALA . 14.3 m -133.16 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.426 1.079 . . . . 0.0 109.954 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.985 ' HB3' HG11 ' A' ' 46' ' ' VAL . . . -53.02 -51.81 71.33 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.45 1.094 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.712 ' HD3' ' HB2' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.08 50.8 2.65 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.491 1.785 . . . . 0.0 110.887 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.597 ' HB1' ' HB3' ' A' ' 51' ' ' SER . . . -157.23 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.591 1.182 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.547 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.05 -27.55 68.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 0.0 109.306 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -46.51 115.08 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.56 1.163 . . . . 0.0 109.988 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.472 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -107.96 117.7 34.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 109.358 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.77 21.94 3.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.438 1.086 . . . . 0.0 110.347 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -86.11 64.43 8.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.453 1.096 . . . . 0.0 109.244 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.959 ' CD1' ' OE1' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -40.51 102.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.684 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.35 98.44 5.97 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.64 ' CG1' HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -68.7 -46.07 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.326 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.62 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.316 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.489 ' HB3' ' HE3' ' A' ' 33' ' ' MET . 27.6 Cg_endo -75.04 139.14 23.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.438 1.757 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.96 0.17 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.505 1.128 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.695 ' HA ' HG21 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.534 0.785 . . . . 0.0 109.989 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.684 ' CZ ' ' HB2' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 1.11 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.472 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.51 175.1 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.773 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.58 161.31 20.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 0.0 109.978 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.773 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.475 1.109 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.412 ' OG1' HG21 ' A' ' 28' ' ' THR . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 0.0 110.387 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.12 8.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.482 1.114 . . . . 0.0 109.223 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.857 ' O ' ' HB2' ' A' ' 25' ' ' ALA . . . -153.16 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.468 1.105 . . . . 0.0 110.953 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.855 HG21 ' HH ' ' A' ' 78' ' ' TYR . 0.9 OUTLIER -53.22 124.1 37.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.538 0.787 . . . . 0.0 110.412 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.06 141.53 26.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.465 1.771 . . . . 0.0 111.043 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.4 1.062 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.405 HG21 HG23 ' A' ' 93' ' ' THR . 29.6 m -104.88 120.06 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 0.761 . . . . 0.0 110.318 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 1.017 ' CD2' HG13 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.71 30.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.546 1.154 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.93 145.17 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.462 1.101 . . . . 0.0 109.966 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.2 -171.58 3.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.449 1.093 . . . . 0.0 110.951 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 30.5 p90 -171.84 165.42 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.57 122.38 35.96 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.425 1.078 . . . . 0.0 108.262 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.665 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -51.35 -50.8 74.08 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.398 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.638 ' CD ' HD22 ' A' ' 40' ' ' ASN . 12.8 Cg_endo -75.0 -62.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.237 0 O-C-N 124.498 1.788 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.468 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 22.0 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.732 HH11 ' CG ' ' A' ' 86' ' ' ARG . 2.7 ttt85 -88.01 -38.48 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.536 1.148 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.88 32.74 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.477 1.111 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.62 -15.24 62.55 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.505 0.768 . . . . 0.0 109.406 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.18 1.83 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.449 1.093 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' MET . . . . . 0.479 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.62 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.417 0.716 . . . . 0.0 111.003 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.15 153.58 30.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.153 . . . . 0.0 109.277 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.705 ' C ' ' HG1' ' A' ' 93' ' ' THR . . . -147.53 -174.78 19.77 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.705 ' HG1' ' C ' ' A' ' 92' ' ' GLY . 1.8 m -143.73 162.05 37.0 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.485 0.756 . . . . 0.0 110.471 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.941 HD13 HG12 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.65 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 0.0 109.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.1 144.54 31.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.835 ' O ' HG11 ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.541 1.15 . . . . 0.0 109.333 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . 0.799 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 0.0 110.317 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' TYR . . . . . 1.171 ' CZ ' ' CG ' ' B' ' 119' ' ' PRO . 1.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 1.426 ' CB ' ' HH ' ' A' ' 12' ' ' TYR . 23.0 m-85 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' TYR . . . . . 0.865 ' HH ' ' HD1' ' B' ' 162' ' ' TYR 0.347 0.3 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLN . . . . . 0.447 ' OE1' ' HA ' ' B' ' 3' ' ' PHE . 74.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.527 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 8.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . 0.965 ' CD1' HG13 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.439 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' PRO . . . . . 0.653 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ARG . . . . . 0.489 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' LYS . . . . . . . . . . . . . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' ILE . . . . . 0.821 ' H ' HE22 ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.965 HG13 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' CYS . . . . . . . . . . . . . 61.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASN . . . . . 0.566 HD21 HG11 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' CYS . . . . . 1.116 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 42.1 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' B' ' 26' ' ' LEU . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.643 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.827 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.712 ' O ' HG21 ' B' ' 31' ' ' VAL . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 1.02 ' HA ' ' HE2' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' ILE . . . . . 0.832 HD12 HD11 ' B' ' 75' ' ' LEU . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' VAL . . . . . . . . . . . . . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' B' ' 244' ' ' VAL . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.47 HG13 HD13 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.947 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' PRO . . . . . 0.947 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.826 HG23 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 132' ' ' ILE . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' VAL . . . . . 0.808 HG11 ' OE2' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' VAL . . . . . 0.632 HG22 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' LYS . . . . . 0.448 ' N ' HG11 ' B' ' 49' ' ' VAL . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' VAL . . . . . 0.838 HG21 HH21 ' B' ' 156' ' ' ARG . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.827 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' TYR . . . . . 0.525 ' CE2' HD11 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' LEU . . . . . 0.787 ' H ' HD22 ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ILE . . . . . 0.58 HG22 ' O ' ' B' ' 57' ' ' ILE . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLN . . . . . 0.696 ' HB2' HG22 ' B' ' 233' ' ' VAL . 26.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' VAL . . . . . 0.426 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 7.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' GLN . . . . . 0.959 ' OE1' ' CD1' ' A' ' 60' ' ' LEU . 2.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ALA . . . . . 1.007 ' HB3' ' CD ' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ASP . . . . . 0.858 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 5.0 m-20 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' SER . . . . . 0.946 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 10.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.46 ' CB ' ' NE2' ' B' ' 61' ' ' GLN . 54.2 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.567 HD22 HG23 ' B' ' 233' ' ' VAL . 8.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASN . . . . . 0.677 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 1.1 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . 0.882 HG23 ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' VAL . . . . . 0.687 ' O ' HG11 ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.832 HD11 HD12 ' B' ' 33' ' ' ILE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.507 HD13 HG21 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' PRO . . . . . 0.555 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' PHE . . . . . 0.555 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.805 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' PRO . . . . . 0.691 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' PRO . . . . . 0.934 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.691 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' VAL . . . . . . . . . . . . . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' ASP . . . . . 0.569 ' OD1' HD11 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' LEU . . . . . 0.569 HD11 ' OD1' ' B' ' 90' ' ' ASP . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' VAL . . . . . 0.959 ' HA ' HG23 ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' GLY . . . . . 0.666 ' H ' HG21 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' PHE . . . . . 0.934 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.785 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' LEU . . . . . 0.435 HD21 HD11 ' B' ' 120' ' ' LEU . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' VAL . . . . . 0.975 HG11 ' CG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' THR . . . . . 0.661 ' N ' HG12 ' B' ' 104' ' ' VAL . 15.1 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . 0.468 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' TYR . . . . . 0.585 ' HB2' HG22 ' B' ' 114' ' ' ILE . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' SER . . . . . 0.495 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' THR . . . . . 0.588 HG21 ' N ' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ASP . . . . . 0.588 ' N ' HG21 ' B' ' 110' ' ' THR . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.468 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . 0.7 ' ND2' HD13 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.7 HD13 ' ND2' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' LEU . . . . . 0.975 ' CG ' HG11 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' LEU . . . . . 0.649 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 72.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' GLY . . . . . 0.464 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' PRO . . . . . 1.171 ' CG ' ' CZ ' ' B' ' 1' ' ' TYR . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' LEU . . . . . 0.445 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 48.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' ASP . . . . . 0.421 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' GLU . . . . . 0.808 ' OE2' HG11 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' MET . . . . . 0.882 ' CE ' HG23 ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ILE . . . . . 0.959 HG23 ' HA ' ' B' ' 97' ' ' VAL . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PHE . . . . . 0.663 ' HD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' PRO . . . . . 0.805 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' B' ' 47' ' ' ALA . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' LEU . . . . . 0.469 HD12 HG21 ' B' ' 44' ' ' VAL . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' SER . . . . . 0.685 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' ASN . . . . . 0.546 ' HB3' ' HG1' ' B' ' 139' ' ' THR . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' THR . . . . . 0.546 ' HG1' ' HB3' ' B' ' 136' ' ' ASN . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' VAL . . . . . 0.433 ' O ' HG23 ' B' ' 143' ' ' VAL . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' ILE . . . . . 0.474 HG21 ' N ' ' B' ' 151' ' ' HIS . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' HIS . . . . . 0.474 ' N ' HG21 ' B' ' 150' ' ' ILE . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' LEU . . . . . . . . . . . . . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ASN . . . . . 0.747 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 156' ' ' ARG . . . . . 0.838 HH21 HG21 ' B' ' 51' ' ' VAL . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 158' ' ' ARG . . . . . 0.631 ' H ' HE22 ' B' ' 59' ' ' GLN . 51.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . 0.486 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . 0.655 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.6 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 162' ' ' TYR . . . . . 0.865 ' HD1' ' HH ' ' B' ' 4' ' ' TYR . 18.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 163' ' ' PRO . . . . . 0.671 ' HB3' ' CD1' ' B' ' 4' ' ' TYR . 1.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 164' ' ' THR . . . . . 0.768 HG23 ' CB ' ' B' ' 162' ' ' TYR . 1.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 166' ' ' GLU . . . . . 0.665 ' H ' HG22 ' B' ' 164' ' ' THR . 19.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 167' ' ' LEU . . . . . 0.619 HD12 HD21 ' B' ' 171' ' ' ASN . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 53.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 169' ' ' ASN . . . . . 0.526 HD22 ' HA ' ' B' ' 62' ' ' ALA . 1.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 170' ' ' ASN . . . . . 0.753 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.1 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 171' ' ' ASN . . . . . 0.619 HD21 HD12 ' B' ' 167' ' ' LEU . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 173' ' ' PHE . . . . . 0.641 ' H ' ' CG2' ' B' ' 228' ' ' THR . 39.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.811 HG21 HG13 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . 0.484 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.727 HD11 HG21 ' B' ' 215' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 182' ' ' ALA . . . . . 0.52 ' HB1' HE21 ' B' ' 196' ' ' GLN . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . 0.76 ' HA ' HG21 ' B' ' 217' ' ' VAL . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.47 HG23 HG22 ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . 0.492 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 56.1 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 186' ' ' ASP . . . . . 0.552 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 56.9 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 187' ' ' ASN . . . . . 0.691 ' O ' ' CD1' ' B' ' 189' ' ' PHE . 5.4 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 189' ' ' PHE . . . . . 0.81 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.271 0.5 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' B' B ' 190' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 191' ' ' PHE . . . . . 0.416 ' C ' ' CG ' ' B' ' 192' ' ' ASP . 12.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 192' ' ' ASP . . . . . 0.837 ' HB3' HG21 ' B' ' 204' ' ' VAL . 0.0 OUTLIER -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . 0.47 HG22 HG23 ' B' ' 184' ' ' ILE . 92.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 194' ' ' THR . . . . . 0.581 HG23 ' O ' ' B' ' 194' ' ' THR . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 195' ' ' ILE . . . . . 0.615 HG22 ' N ' ' B' ' 196' ' ' GLN . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . 0.615 ' N ' HG22 ' B' ' 195' ' ' ILE . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 197' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 198' ' ' GLU . . . . . 0.5 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 201' ' ' ASP . . . . . 0.617 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 203' ' ' VAL . . . . . 0.811 HG13 HG21 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . 0.837 HG21 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 205' ' ' THR . . . . . 0.439 HG22 ' O ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 207' ' ' ILE . . . . . 0.522 ' C ' HD13 ' B' ' 208' ' ' LEU . 76.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 208' ' ' LEU . . . . . 1.023 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 209' ' ' PRO . . . . . 0.81 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.0 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 211' ' ' PRO . . . . . 0.871 ' CB ' ' HG1' ' B' ' 228' ' ' THR . 3.1 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . 1.007 ' HG2' HG22 ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . 0.565 HG22 ' O ' ' B' ' 214' ' ' ILE . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 215' ' ' VAL . . . . . 0.727 HG21 HD11 ' B' ' 181' ' ' ILE . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 217' ' ' VAL . . . . . 0.76 HG21 ' HA ' ' B' ' 183' ' ' ALA . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . 0.433 ' N ' HG11 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 220' ' ' THR . . . . . 0.463 HG23 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 221' ' ' VAL . . . . . 0.581 HG23 HE21 ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 222' ' ' GLU . . . . . 0.736 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . 0.418 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 225' ' ' GLN . . . . . 0.736 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 226' ' ' LEU . . . . . 0.735 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 227' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' B' ' 227' ' ' LEU . 62.5 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 228' ' ' THR . . . . . 0.871 ' HG1' ' CB ' ' B' ' 211' ' ' PRO . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 229' ' ' THR . . . . . 1.007 HG22 ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 233' ' ' VAL . . . . . 0.696 HG22 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 234' ' ' GLY . . . . . 0.643 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 235' ' ' GLY . . . . . 0.656 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 236' ' ' PHE . . . . . 0.747 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 237' ' ' GLY . . . . . 0.621 ' O ' HG13 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 238' ' ' GLN . . . . . 0.821 HE22 ' H ' ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 239' ' ' MET . . . . . 1.02 ' HE2' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 243' ' ' ILE . . . . . 0.47 HD13 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 244' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' B' ' 38' ' ' ALA . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 245' ' ' LEU . . . . . 0.42 HD23 ' CG ' ' B' ' 137' ' ' PRO . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 246' ' ' GLN . . . . . 0.417 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 247' ' ' SER . . . . . 0.417 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 250' ' ' HEC . . . . . 1.225 ' CGD' ' O ' ' A' ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.66 126.8 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 109.989 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 124.447 1.092 . . . . 0.0 109.22 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.99 150.8 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 110.318 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.13 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.337 1.023 . . . . 0.0 109.259 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.68 133.49 35.95 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.528 1.143 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 96.99 6.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 0.0 110.955 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.51 7.64 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.491 1.119 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.08 160.63 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.389 0.699 . . . . 0.0 110.391 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.74 -16.03 24.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.399 1.062 . . . . 0.0 109.315 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.2 mttp -90.55 39.64 0.98 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 38.21 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.592 1.182 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.625 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.82 117.7 58.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HG3' ' CE2' ' B' ' 3' ' ' PHE . 36.0 Cg_endo -74.98 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.456 1.766 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.1 pp -150.74 151.24 32.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.119 . . . . 0.0 109.323 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.38 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.556 1.16 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.86 26.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.459 1.1 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.15 140.98 70.19 Favored 'Cis proline' 0 C--N 1.361 1.203 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.96 0.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.5 tttt -40.17 -40.04 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.58 1.175 . . . . 0.0 109.342 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.35 46.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.365 1.041 . . . . 0.0 109.273 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.31 141.32 30.94 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.93 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.554 1.159 . . . . 0.0 110.026 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 0.0 109.26 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.55 158.26 27.7 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.499 1.124 . . . . 0.0 109.968 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.44 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.452 1.095 . . . . 0.0 109.285 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.38 8.48 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.542 1.151 . . . . 0.0 110.961 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.09 174.16 11.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.48 0.753 . . . . 0.0 109.291 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.65 154.28 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.62 1.2 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.9 t -131.47 102.63 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.78 169.57 18.02 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.468 1.105 . . . . 0.0 110.313 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.48 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.515 1.134 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.57 1.169 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.689 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 11.7 ttp -97.96 119.21 36.18 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.433 1.083 . . . . 0.0 111.009 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.332 6.9 m-20 -79.36 -66.04 0.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.589 1.181 . . . . 0.0 109.243 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 14.8 p 46.04 54.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 0.0 109.276 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.47 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.564 1.165 . . . . 0.0 111.033 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.002 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 30.0 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.93 -2.529 . . . . 0.0 111.03 -0.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.499 1.124 . . . . 0.0 109.575 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.95 167.05 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 0.0 109.253 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.623 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.1 t -104.18 114.41 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.163 . . . . 0.0 109.289 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.0 mm -132.82 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.551 1.157 . . . . 0.0 109.305 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.0 m-85 -47.71 160.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.04 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.6 mtpt 167.35 143.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.6 1.187 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.022 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.55 158.08 72.98 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.436 1.085 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.3 Cg_endo -75.03 164.17 33.84 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.538 1.809 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.17 135.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.392 1.058 . . . . 0.0 109.276 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.44 -56.55 0.72 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.578 1.174 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.557 0.798 . . . . 0.0 110.279 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.25 77.76 1.75 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 110.001 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.022 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 109.353 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.01 50.82 2.63 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.466 1.772 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.48 1.113 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.49 68.14 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.502 1.126 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 m -46.55 115.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 109.98 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.7 m120 -108.01 117.63 34.63 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.408 1.067 . . . . 0.0 109.315 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 60' ' ' LEU . 8.8 t -89.73 21.73 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.41 1.069 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -85.87 64.32 8.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.455 1.097 . . . . 0.0 109.264 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.37 102.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.427 1.079 . . . . 0.0 109.351 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.02 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.617 1.198 . . . . 0.0 109.339 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.67 HD11 HD12 ' A' ' 60' ' ' LEU . 2.6 mm -68.65 -46.18 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.596 1.185 . . . . 0.0 109.282 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.63 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 109.265 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.95 139.1 24.01 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.95 -67.97 0.17 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.502 1.126 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.679 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.511 0.771 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.587 1.179 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.42 175.18 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 111.044 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.478 1.112 . . . . 0.0 109.983 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.11 137.69 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 0.0 109.348 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.17 146.46 23.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.18 173.05 8.57 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 0.0 109.231 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.526 1.141 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.13 37.57 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.53 0.782 . . . . 0.0 110.424 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.5 26.8 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.437 1.756 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.6 20.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.93 120.07 40.54 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.571 0.806 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.834 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.74 30.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.545 1.153 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.099 . . . . 0.0 110.01 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.09 -171.48 3.72 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 1.128 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 38.7 p90 -171.9 165.4 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.973 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -93.52 122.27 35.78 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.116 . . . . 0.0 108.335 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.83 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.6 OUTLIER -51.26 -50.82 73.71 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.561 1.163 . . . . 0.0 110.408 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.74 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 37.7 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.576 1.829 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.67 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 72.6 m-70 -75.06 57.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.57 1.169 . . . . 0.0 109.562 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.019 ' NH1' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.95 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.577 1.173 . . . . 0.0 110.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.86 32.73 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.462 1.101 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' ' HE1' ' B' ' 4' ' ' TYR . . . -65.65 -15.2 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.489 0.758 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.12 63.14 1.83 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.431 1.082 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 0.798 . . . . 0.0 110.971 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.722 ' CG1' HH22 ' A' ' 86' ' ' ARG . 11.6 m -124.26 153.59 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 0.0 109.227 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.56 -174.75 19.77 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 124.546 1.154 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.82 162.0 37.19 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 0.792 . . . . 0.0 110.432 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.57 122.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.496 1.122 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.9 m -105.07 144.47 31.83 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 124.559 1.162 . . . . 0.0 109.353 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 0.0 110.38 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.868 ' H3 ' ' HD2' ' B' ' 4' ' ' TYR . 18.5 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.522 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.868 ' HD2' ' H3 ' ' B' ' 1' ' ' TYR . 46.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.602 ' HA ' HG12 ' B' ' 161' ' ' VAL . 46.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.71 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.722 HE22 ' HA2' ' B' ' 157' ' ' GLY . 13.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 65' ' ' SER . 7.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 4.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.71 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.2 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.401 ' CE2' HD23 ' B' ' 103' ' ' LEU . 6.7 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.401 HD23 ' CE2' ' B' ' 102' ' ' TYR . 74.9 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.035 HG13 ' HG ' ' B' ' 115' ' ' LEU . 65.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.777 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.891 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.035 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.891 HD11 ' HA ' ' B' ' 107' ' ' TYR . 1.1 mp -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.002 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.0 OUTLIER -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.402 ' HD3' HG21 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.472 ' CE1' HD22 ' B' ' 120' ' ' LEU . 20.7 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 58.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.722 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.404 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.406 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' B' ' 24' ' ' CYS . 1.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' B' ' 168' ' ' SER . 0.4 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.0 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.008 HG22 ' H ' ' B' ' 166' ' ' GLU . 0.4 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.008 ' H ' HG22 ' B' ' 164' ' ' THR . 2.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.678 ' HA ' ' CE1' ' B' ' 162' ' ' TYR . 95.9 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 16.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 55.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 1.9 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.047 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 8.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.803 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 52.2 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.788 HD22 ' H ' ' B' ' 208' ' ' LEU . 1.1 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.047 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.83 29.06 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.466 1.104 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.89 40.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.36 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.407 1.067 . . . . 0.0 109.246 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.45 36.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.533 1.145 . . . . 0.0 109.388 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.55 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.141 . . . . 0.0 111.003 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 1.025 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.14 144.49 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.705 ' CG2' HD11 ' A' ' 15' ' ' LEU . 23.9 p -108.08 160.6 15.67 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.441 0.73 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -15.96 23.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ALA . 14.2 mttt -90.59 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 38.29 29.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 0.0 111.029 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.78 117.71 58.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 0.0 109.318 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 24.7 Cg_endo -75.02 97.72 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.428 1.752 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.705 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.5 pp -150.87 151.26 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.18 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.465 1.103 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.46 134.82 26.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 124.467 1.104 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.92 69.94 Favored 'Cis proline' 0 C--N 1.359 1.12 0 C-N-CA 121.061 -2.474 . . . . 0.0 110.993 0.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.565 1.165 . . . . 0.0 109.306 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.34 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.264 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.03 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.625 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.91 143.83 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.98 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.559 1.162 . . . . 0.0 109.205 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.64 158.28 27.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.531 1.144 . . . . 0.0 109.972 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 105.47 0.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.201 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.31 8.52 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.07 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.527 0.781 . . . . 0.0 109.238 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.47 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.616 1.197 . . . . 0.0 110.491 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.44 102.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 109.322 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.5 18.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.4 9.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.502 1.126 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.32 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.442 1.089 . . . . 0.0 109.276 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.1 ttp -97.93 119.16 36.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.426 1.079 . . . . 0.0 111.046 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 1.025 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.31 -66.07 0.92 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.624 1.203 . . . . 0.0 109.268 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.454 1.096 . . . . 0.0 109.321 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 7.1 p 46.02 54.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 109.336 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.84 ' O ' ' HD2' ' B' ' 119' ' ' PRO . . . -92.94 -172.31 40.58 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.491 1.12 . . . . 0.0 111.079 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.176 ' HD3' ' O ' ' B' ' 119' ' ' PRO . 58.6 Cg_endo -74.97 -168.9 6.85 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.961 -2.516 . . . . 0.0 110.973 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.671 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.26 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.077 . . . . 0.0 109.617 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.482 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.5 p30 173.97 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.251 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.06 114.27 43.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.571 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.73 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 109.343 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.69 160.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.8 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.1 mttt 167.32 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.121 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.426 1.079 . . . . 0.0 109.21 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.06 164.22 33.67 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.493 1.786 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.2 135.58 1.38 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.444 1.09 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.63 0.72 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.492 1.12 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.26 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 0.816 . . . . 0.0 110.301 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.21 77.75 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.134 . . . . 0.0 110.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.121 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 0.0 109.358 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -74.99 50.74 2.6 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.478 1.778 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 0.0 109.313 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.61 68.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -46.49 115.16 0.95 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.511 1.132 . . . . 0.0 109.966 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.93 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.452 1.095 . . . . 0.0 109.325 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -89.8 21.85 3.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.383 1.052 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 39.7 tttt -86.0 64.37 8.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.57 1.169 . . . . 0.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 60' ' ' LEU . 3.4 mp -40.44 102.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.559 1.162 . . . . 0.0 109.322 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.48 6.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 109.284 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' B' ' 120' ' ' LEU . 0.7 OUTLIER -68.71 -46.15 80.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.601 1.188 . . . . 0.0 109.282 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.88 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 0.0 109.331 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.835 ' HG3' ' CD1' ' B' ' 102' ' ' TYR . 72.3 Cg_endo -75.06 139.16 23.81 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.389 1.731 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -68.01 0.17 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.501 1.126 . . . . 0.0 110.995 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.622 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.449 0.735 . . . . 0.0 110.014 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.1 m-85 -38.23 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.471 1.107 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.55 175.09 4.17 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.093 . . . . 0.0 111.009 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.29 20.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 0.0 109.95 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.08 137.71 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.486 1.116 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.33 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.583 1.177 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.3 mt -124.14 173.1 8.52 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.536 1.148 . . . . 0.0 109.186 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.536 1.147 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.462 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.24 124.11 37.6 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.467 0.745 . . . . 0.0 110.426 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.52 26.8 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.527 1.804 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.62 20.05 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.415 1.072 . . . . 0.0 111.046 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.04 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.776 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.74 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.59 1.181 . . . . 0.0 111.021 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.86 145.17 49.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 110.019 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.52 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.496 1.122 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.42 ' CB ' HG12 ' A' ' 91' ' ' VAL . 38.5 p90 -171.83 165.41 6.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.113 . . . . 0.0 110.959 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.55 122.3 35.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.4 1.063 . . . . 0.0 108.302 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.5 m -51.3 -50.79 73.97 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.482 1.114 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.567 1.825 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -75.0 58.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.542 1.151 . . . . 0.0 109.602 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.512 ' NE ' ' O ' ' A' ' 86' ' ' ARG . 1.5 tpm_? -88.0 -38.53 15.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.128 . . . . 0.0 110.305 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.51 -23.79 32.81 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.438 1.086 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.27 62.62 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.531 0.783 . . . . 0.0 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.21 1.82 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.464 1.103 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.55 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.0 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 0.72 . . . . 0.0 111.067 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 81' ' ' TYR . 14.9 m -124.13 153.59 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.295 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.58 -174.69 19.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.482 1.114 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.83 162.09 36.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 0.772 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.66 122.56 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -104.98 144.51 31.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 0.0 110.435 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.282 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.167 . . . . 0.0 110.3 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.589 ' CD2' ' HG3' ' B' ' 119' ' ' PRO . 56.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.789 ' CD2' ' HG3' ' B' ' 163' ' ' PRO . 4.2 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.6 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.767 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.559 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 79.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.786 ' HB2' HG21 ' B' ' 233' ' ' VAL . 14.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 15.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.478 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 68.7 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 32.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.7 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.77 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.835 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 2.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.722 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.4 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.088 HG13 ' HG ' ' B' ' 115' ' ' LEU . 39.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.088 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.4 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.761 ' N ' HD23 ' B' ' 115' ' ' LEU . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.176 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 1.032 ' HA ' HD11 ' A' ' 62' ' ' ILE . 1.2 mp -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.574 ' HD2' ' HG2' ' B' ' 128' ' ' MET . 0.6 OUTLIER -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.574 ' HG2' ' HD2' ' B' ' 125' ' ' TYR . 10.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.453 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.665 HH22 HD22 ' B' ' 169' ' ' ASN . 33.0 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.452 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 0.984 ' CB ' HG22 ' B' ' 164' ' ' THR . 30.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.789 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.117 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.0 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.117 ' H ' HG23 ' B' ' 164' ' ' THR . 42.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 96.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.665 HD22 HH22 ' B' ' 158' ' ' ARG . 4.6 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.462 1.2 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.193 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 25.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.686 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.193 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 11.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.56 126.73 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 0.0 110.098 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.35 177.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.426 1.079 . . . . 0.0 109.263 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -143.05 150.87 40.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.38 112.16 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.398 1.061 . . . . 0.0 109.239 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.48 35.97 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.557 1.161 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.696 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 0.0 111.009 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.668 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.51 7.64 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.58 1.175 . . . . 0.0 110.967 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.03 160.58 15.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.469 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.7 -15.99 23.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.4 ttmt -90.58 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 38.25 29.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.548 1.155 . . . . 0.0 111.048 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.76 117.73 58.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 1.023 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.5 Cg_endo -75.02 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.492 1.785 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.611 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.2 pp -150.82 151.24 32.0 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.35 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.45 134.86 26.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.381 1.051 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.97 70.22 Favored 'Cis proline' 0 C--N 1.359 1.114 0 C-N-CA 120.989 -2.505 . . . . 0.0 110.949 0.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.19 -40.08 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.566 1.166 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.33 46.13 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.387 1.054 . . . . 0.0 109.24 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 0.0 109.297 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.81 51.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.45 1.094 . . . . 0.0 110.038 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.95 -177.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.566 1.166 . . . . 0.0 109.242 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.809 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.514 1.134 . . . . 0.0 109.969 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.5 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.588 1.18 . . . . 0.0 109.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.39 8.51 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.458 1.099 . . . . 0.0 111.052 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.12 174.11 11.51 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 0.78 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.49 154.27 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 0.0 110.485 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.69 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.83 169.56 18.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.587 1.179 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.1 m-85 -147.24 121.4 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.52 1.138 . . . . 0.0 110.981 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.35 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.248 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.649 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.4 ttp -97.98 119.15 36.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m120 -79.28 -66.09 0.91 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.145 . . . . 0.0 109.248 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.451 1.094 . . . . 0.0 109.333 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.023 HG21 ' HG3' ' A' ' 14' ' ' PRO . 7.4 p 45.93 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.352 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.0 -172.31 40.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.49 1.119 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.157 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 36.2 Cg_endo -75.03 -168.87 6.85 Favored 'Cis proline' 0 C--N 1.361 1.19 0 C-N-CA 120.938 -2.526 . . . . 0.0 111.003 0.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.649 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 73.2 m-70 -144.28 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 60' ' ' LEU . 2.5 p30 173.99 166.95 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.536 1.147 . . . . 0.0 109.271 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.662 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.5 t -104.07 114.41 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 0.0 109.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -132.84 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.414 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.67 160.65 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.507 1.129 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.02 -50.01 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.574 1.171 . . . . 0.0 109.256 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 167.29 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 0.0 109.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.432 1.082 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 164.21 33.82 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.511 1.795 . . . . 0.0 111.008 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.26 135.56 1.41 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.438 1.086 . . . . 0.0 109.313 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.54 0.72 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 0.0 110.972 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.22 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 0.807 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.23 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 110.024 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.013 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.77 71.73 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.444 1.09 . . . . 0.0 109.359 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.04 50.84 2.65 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.452 1.764 . . . . 0.0 110.952 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.38 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.281 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.63 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.542 1.151 . . . . 0.0 109.259 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.2 m -46.44 115.11 0.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.59 1.181 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -107.92 117.68 34.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.335 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.674 HG21 ' OD2' ' B' ' 63' ' ' ASP . 9.1 t -89.81 21.85 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -86.03 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.516 1.135 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -40.4 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 0.0 109.326 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.46 98.44 6.06 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' B' ' 119' ' ' PRO . 3.2 mm -68.73 -46.06 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.554 1.159 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.63 4.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 0.0 109.303 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.04 139.14 23.83 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.43 1.753 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -68.02 0.17 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.471 1.107 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.66 97.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 0.747 . . . . 0.0 109.99 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.19 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.401 1.063 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.49 175.1 4.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 0.0 111.055 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.445 1.091 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.72 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.423 1.077 . . . . 0.0 109.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.32 146.41 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 0.0 110.398 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.06 173.13 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 0.0 109.225 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.518 1.136 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.67 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.525 0.779 . . . . 0.0 110.381 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 141.49 26.73 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.796 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.433 1.083 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.4 m -104.76 120.04 40.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.465 0.744 . . . . 0.0 110.399 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.76 30.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 0.0 111.011 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.9 145.11 49.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 110.032 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.53 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.13 . . . . 0.0 110.989 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 1.374 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 15.3 p90 -171.82 165.45 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.62 122.3 35.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.381 1.051 . . . . 0.0 108.267 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.97 HG21 ' CB ' ' B' ' 62' ' ' ALA . 1.0 OUTLIER -51.25 -50.8 73.76 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.429 1.08 . . . . 0.0 110.466 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.602 1.843 . . . . 0.0 110.992 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.955 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 69.7 m-70 -75.06 57.99 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.574 1.171 . . . . 0.0 109.546 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.374 ' NH2' ' HB2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.99 -38.47 15.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.525 1.14 . . . . 0.0 110.313 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 1.049 ' CA ' HG23 ' B' ' 164' ' ' THR . . . -89.49 -23.84 32.74 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.487 1.117 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.22 62.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 0.769 . . . . 0.0 109.346 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.19 1.82 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.696 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.58 74.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 0.0 111.043 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.537 ' CG1' ' NH2' ' A' ' 86' ' ' ARG . 11.7 m -124.18 153.5 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 0.0 109.283 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.5 -174.73 19.71 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.525 1.141 . . . . 0.0 111.004 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.11 36.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 0.0 110.39 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.712 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.65 122.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.561 1.163 . . . . 0.0 109.311 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -105.02 144.52 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.477 1.111 . . . . 0.0 110.426 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.12 . . . . 0.0 109.24 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.809 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 110.349 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.868 ' CZ ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.795 ' CG ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 1.007 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 21.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 2.7 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.662 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.6 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.718 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.811 ' HG3' HG22 ' B' ' 233' ' ' VAL . 12.0 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 86.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.674 ' OD2' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.467 ' HB2' ' OD2' ' B' ' 63' ' ' ASP . 17.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.5 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.552 ' HD2' HD12 ' B' ' 103' ' ' LEU . 3.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.552 HD12 ' HD2' ' B' ' 102' ' ' TYR . 1.1 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.1 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.842 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.516 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.8 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' B' ' 105' ' ' THR . 71.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.157 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' B' ' 125' ' ' TYR . 7.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.708 ' CE2' HD22 ' B' ' 120' ' ' LEU . 47.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.527 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 54.2 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.425 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLN . . . . . 0.484 ' O ' HD13 ' B' ' 167' ' ' LEU . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' B' ' 24' ' ' CYS . 2.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 0.568 ' HB2' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 1.007 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.049 HG23 ' CA ' ' A' ' 87' ' ' GLY . 2.1 p -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.484 HD13 ' O ' ' B' ' 160' ' ' GLN . 4.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.354 16.2 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.565 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 37.9 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 0.994 ' CG ' ' HD3' ' B' ' 209' ' ' PRO 0.278 3.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.565 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.877 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.9 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.994 ' HD3' ' CG ' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.811 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.57 126.8 28.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.616 1.197 . . . . 0.0 110.06 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.451 1.095 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.81 40.18 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.349 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.38 112.17 38.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.466 1.104 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.78 133.43 36.05 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.309 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.709 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.64 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 0.0 110.996 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.58 7.65 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.449 1.093 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.51 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -108.12 160.64 15.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 0.752 . . . . 0.0 110.413 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.8 -15.94 24.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.9 mttt -90.56 39.59 0.98 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.13 . . . . 0.0 109.371 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.32 29.7 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.489 1.118 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.83 117.71 58.11 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.223 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CB ' ' CD2' ' A' ' 85' ' ' HIS . 25.0 Cg_endo -75.03 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.457 1.767 . . . . 0.0 111.066 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD21 ' OG1' ' A' ' 9' ' ' THR . 2.0 pp -150.77 151.19 31.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.502 1.126 . . . . 0.0 109.322 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.41 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.15 30.47 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.533 1.146 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.48 134.84 26.53 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 0.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.11 140.97 70.16 Favored 'Cis proline' 0 C--N 1.36 1.18 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.938 0.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.15 -40.15 1.04 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.6 1.187 . . . . 0.0 109.267 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.17 146.32 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.361 1.038 . . . . 0.0 109.328 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.23 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.563 1.164 . . . . 0.0 109.219 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.97 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 110.055 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.93 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.807 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.33 27.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 0.0 109.971 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.592 1.183 . . . . 0.0 109.321 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.36 8.49 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.495 1.122 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.657 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.15 174.16 11.46 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.616 0.833 . . . . 0.0 109.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.21 39.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 0.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.37 102.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.8 169.5 18.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 110.319 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.23 121.53 9.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.55 1.156 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.14 155.31 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.654 1.221 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 4.2 ttp -98.0 119.21 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.479 1.112 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.326 6.6 m-20 -79.31 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.243 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.73 ' O ' ' HE1' ' A' ' 39' ' ' HIS . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.663 ' O ' ' CE1' ' A' ' 85' ' ' HIS . 11.2 p 45.93 54.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 1.487 ' O ' ' CE1' ' B' ' 1' ' ' TYR . . . -92.9 -172.31 40.65 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.164 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 19.8 Cg_endo -74.93 -168.87 6.82 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 120.998 -2.501 . . . . 0.0 111.018 -0.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.73 ' HE1' ' O ' ' A' ' 35' ' ' LYS . 76.6 m80 -144.26 -170.38 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.426 1.079 . . . . 0.0 109.251 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.7 t -104.01 114.33 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.595 1.185 . . . . 0.0 109.414 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mm -132.8 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.7 160.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -49.99 4.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 12.1 mttt 167.22 143.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.57 1.169 . . . . 0.0 109.343 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.034 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.49 158.16 72.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.097 . . . . 0.0 109.275 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 164.26 33.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.427 1.751 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.35 135.67 1.42 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.47 1.106 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.54 0.72 Allowed Glycine 0 CA--C 1.532 1.128 0 O-C-N 124.565 1.166 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.621 0.836 . . . . 0.0 110.305 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.13 77.8 1.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 0.0 110.02 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.79 71.68 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.463 1.102 . . . . 0.0 109.292 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.4 Cg_endo -75.01 50.74 2.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.392 1.733 . . . . 0.0 110.995 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.73 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.609 1.193 . . . . 0.0 109.301 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.48 68.1 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.543 1.152 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.0 m -46.5 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.56 1.162 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.604 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 85.0 m-20 -107.94 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.418 1.074 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.508 HG23 ' NE2' ' B' ' 61' ' ' GLN . 11.6 t -89.82 21.84 3.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.377 1.048 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -85.97 64.43 8.58 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.43 1.082 . . . . 0.0 109.251 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.5 102.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.307 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.37 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.911 HD11 HD12 ' A' ' 60' ' ' LEU . 2.1 mm -68.7 -46.02 80.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.596 1.185 . . . . 0.0 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.12 111.59 4.85 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.33 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -75.06 139.21 23.86 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.515 1.134 . . . . 0.0 110.957 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.539 0.788 . . . . 0.0 110.034 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.24 -86.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.604 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.58 175.12 4.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.359 1.037 . . . . 0.0 110.991 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.32 20.87 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 109.96 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.07 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.47 23.99 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.474 1.109 . . . . 0.0 110.394 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.11 173.06 8.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.464 1.102 . . . . 0.0 109.27 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.505 1.128 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.08 37.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.452 0.736 . . . . 0.0 110.418 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -74.99 141.46 26.69 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.523 1.802 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.59 20.11 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.48 1.112 . . . . 0.0 110.985 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.86 120.07 40.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 0.742 . . . . 0.0 110.367 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.83 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.73 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.517 1.136 . . . . 0.0 110.995 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.85 145.08 49.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 0.0 110.03 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.16 -171.55 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.518 1.136 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.926 ' CB ' ' NH2' ' A' ' 86' ' ' ARG . 16.9 p90 -171.81 165.42 6.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 0.0 110.995 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 0.5 OUTLIER -93.55 122.3 35.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 0.0 108.276 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.758 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.21 -50.86 73.25 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.476 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 83' ' ' THR . 37.4 Cg_endo -75.04 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 0.0 110.953 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.681 ' CD2' ' CB ' ' A' ' 14' ' ' PRO . 49.1 m80 -75.04 57.94 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.185 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.02 -38.43 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 0.0 110.325 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.91 32.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.433 1.083 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.22 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 0.0 109.33 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.014 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.709 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 0.735 . . . . 0.0 111.018 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.185 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.24 153.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.565 1.166 . . . . 0.0 109.239 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.48 -174.76 19.72 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.525 1.14 . . . . 0.0 111.006 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.79 162.06 37.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 0.735 . . . . 0.0 110.441 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.0 mt -146.65 122.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.52 31.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.441 1.088 . . . . 0.0 110.403 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.547 1.154 . . . . 0.0 109.255 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.807 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 O-C-N 124.604 1.19 . . . . 0.0 110.32 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.487 ' CE1' ' O ' ' A' ' 37' ' ' GLY 0.427 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.493 ' HB3' HD22 ' B' ' 116' ' ' LEU . 3.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 14' ' ' PRO . 71.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 1.612 ' CZ ' ' HG2' ' B' ' 163' ' ' PRO . 0.1 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 52.8 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.751 ' HA ' HG12 ' B' ' 161' ' ' VAL . 47.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.73 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 1.004 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 17.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.434 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 84.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.508 ' NE2' HG23 ' A' ' 58' ' ' THR . 8.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.758 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 26.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.73 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.544 ' CD2' HD23 ' B' ' 103' ' ' LEU . 21.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' B' ' 102' ' ' TYR . 45.2 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.044 HG13 ' HG ' ' B' ' 115' ' ' LEU . 79.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.42 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.1 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 25.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.044 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.711 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.164 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.611 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.611 ' CE1' HD22 ' B' ' 120' ' ' LEU . 69.1 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 1.004 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' B' ' 24' ' ' CYS . 7.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.147 ' HB3' HG22 ' B' ' 164' ' ' THR . 0.9 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 1.612 ' HG2' ' CZ ' ' B' ' 4' ' ' TYR . 5.9 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.147 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.993 ' H ' HG23 ' B' ' 164' ' ' THR . 15.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.476 ' N ' HD22 ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 78.2 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.566 HD21 ' HA ' ' B' ' 62' ' ' ALA . 12.2 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.356 16.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.599 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 42.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.183 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 3.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.599 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.6 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.895 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.8 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.183 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 8.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.76 28.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.157 . . . . 0.0 109.998 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.416 1.073 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.82 40.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 110.324 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.404 1.065 . . . . 0.0 109.258 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.7 133.45 36.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.465 1.103 . . . . 0.0 109.323 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.638 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 0.0 110.952 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 1.031 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -108.06 160.58 15.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.417 0.716 . . . . 0.0 110.413 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -59.71 -16.0 23.77 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.375 1.047 . . . . 0.0 109.357 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 20.7 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.521 1.138 . . . . 0.0 109.369 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.529 ' OH ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 0.0 111.022 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.9 117.69 58.1 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 0.0 109.247 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 41.0 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.432 1.754 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.79 151.21 31.99 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.435 1.085 . . . . 0.0 109.299 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.405 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.31 126.19 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.509 1.131 . . . . 0.0 110.991 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.419 0 O-C-N 124.457 1.098 . . . . 0.0 110.323 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.91 69.88 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 121.018 -2.493 . . . . 0.0 110.978 0.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.13 -40.06 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.58 1.175 . . . . 0.0 109.304 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.31 46.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.345 1.028 . . . . 0.0 109.227 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.31 30.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.613 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.92 143.73 50.96 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.519 1.137 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.89 -177.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.823 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.991 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.475 1.11 . . . . 0.0 109.313 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.45 8.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.551 1.157 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.13 174.16 11.47 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 0.745 . . . . 0.0 109.28 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 1.17 . . . . 0.0 110.437 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.718 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.81 169.55 18.05 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.551 1.157 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.53 9.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 0.0 110.888 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.13 155.31 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 0.0 109.275 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.876 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.3 ttp -97.98 119.19 36.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 1.031 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.37 -65.99 0.93 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 0.0 109.257 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -168.88 -167.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 12.1 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 0.0 109.327 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.03 -172.27 40.44 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.561 1.163 . . . . 0.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.98 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 5.5 Cg_endo -74.96 -168.85 6.81 Favored 'Cis proline' 0 C--N 1.361 1.226 0 C-N-CA 120.9 -2.542 . . . . 0.0 111.072 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.876 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.2 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.518 1.136 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 173.98 167.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 1.135 . . . . 0.0 109.256 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.15 114.39 43.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.566 1.166 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.581 1.175 . . . . 0.0 109.318 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.79 160.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.03 -50.04 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.582 1.176 . . . . 0.0 109.255 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.57 158.12 72.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 109.259 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 164.26 33.53 Favored 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.541 1.811 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.437 1.086 . . . . 0.0 109.319 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.51 0.72 Allowed Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.597 1.186 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 0.784 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.21 77.67 1.74 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 110.035 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.041 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.95 -51.9 70.26 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.427 1.079 . . . . 0.0 109.281 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.5 Cg_endo -74.92 50.8 2.59 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.794 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.598 1.187 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.03 -27.57 68.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 109.285 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.8 m -46.43 115.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.575 1.172 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.95 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.467 1.104 . . . . 0.0 109.36 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.429 HG21 ' HB3' ' B' ' 63' ' ' ASP . 9.1 t -89.75 21.77 3.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.372 1.045 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -85.98 64.36 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.452 1.095 . . . . 0.0 109.238 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.4 102.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.409 1.068 . . . . 0.0 109.388 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.4 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.586 1.178 . . . . 0.0 109.356 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.535 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -68.66 -46.12 80.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.619 1.2 . . . . 0.0 109.318 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.15 111.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 124.547 1.154 . . . . 0.0 109.314 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.07 139.16 23.77 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.549 1.815 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -68.04 0.17 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.439 1.087 . . . . 0.0 110.945 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.66 97.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.438 0.728 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.2 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 0.0 110.932 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.343 1.027 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.32 20.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.476 1.11 . . . . 0.0 109.979 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.7 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.366 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.24 146.46 24.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 0.0 110.374 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.06 8.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.1 -44.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.5 1.125 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.47 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.15 124.08 36.81 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.523 0.778 . . . . 0.0 110.403 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 141.51 26.68 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.468 1.773 . . . . 0.0 111.05 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.15 -178.58 20.13 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.2 m -104.95 120.06 40.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.556 0.798 . . . . 0.0 110.402 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.503 1.127 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.432 1.083 . . . . 0.0 109.999 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.14 -171.5 3.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 14.9 p90 -171.89 165.42 6.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.56 122.26 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 0.0 108.285 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.667 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.25 -50.81 73.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.451 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 83' ' ' THR . 9.2 Cg_endo -75.04 -62.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.508 1.794 . . . . 0.0 111.009 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.9 m80 -75.06 57.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.593 1.183 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -87.89 -38.54 15.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 110.352 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 86' ' ' ARG . . . -89.52 -23.81 32.73 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.416 1.072 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.26 62.62 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.494 0.761 . . . . 0.0 109.325 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.21 1.82 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.458 1.099 . . . . 0.0 110.962 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.638 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 0.772 . . . . 0.0 110.994 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.18 153.59 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.268 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.57 -174.76 19.78 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.604 1.19 . . . . 0.0 110.883 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.04 37.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 0.772 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.61 122.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.459 1.099 . . . . 0.0 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.6 m -105.01 144.51 31.72 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.415 1.072 . . . . 0.0 110.433 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.563 1.165 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.823 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 0.0 110.305 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 15.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.509 ' HE2' ' CE1' ' B' ' 4' ' ' TYR . 0.7 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.724 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 18.9 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.515 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 35.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.764 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.717 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 84.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.808 ' HB2' HG21 ' B' ' 233' ' ' VAL . 23.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 85.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.671 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 58' ' ' THR . 15.5 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.5 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.717 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.599 HD21 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.525 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 13.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' B' ' 103' ' ' LEU . 0.1 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.046 HG13 ' HG ' ' B' ' 115' ' ' LEU . 40.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.812 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.5 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.568 ' CD1' HD11 ' B' ' 116' ' ' LEU . 29.1 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 49.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.046 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.812 ' HB2' HG23 ' B' ' 105' ' ' THR . 32.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.98 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.517 ' HB3' HG13 ' A' ' 62' ' ' ILE . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.671 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 49.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.2 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.032 ' CB ' HG22 ' B' ' 164' ' ' THR . 8.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.3 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 38.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.551 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.2 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.879 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.7 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.2 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -57.68 126.85 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 109.999 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.971 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.11 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 0.0 109.27 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.92 150.88 40.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 0.0 109.313 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.7 133.42 36.02 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.533 1.146 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.02 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 0.0 110.995 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.46 7.63 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 124.545 1.153 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.71 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 10.7 p -108.14 160.66 15.64 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.423 0.72 . . . . 0.0 110.41 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.527 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 46.2 t0 -59.8 -15.97 24.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.6 mttt -90.65 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.549 1.156 . . . . 0.0 109.365 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 38.32 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.87 117.67 58.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HG3' ' CZ ' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.46 1.769 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 9' ' ' THR . 3.9 pp -150.76 151.27 32.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 0.0 109.365 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.3 m-85 -77.41 126.2 30.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.95 26.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.401 1.063 . . . . 0.0 110.284 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -74.99 140.94 70.15 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.027 -2.489 . . . . 0.0 110.947 -0.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.13 -40.12 1.03 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.543 1.152 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.414 1.072 . . . . 0.0 109.283 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.971 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.36 31.0 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 0.0 109.264 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.76 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.53 1.144 . . . . 0.0 110.04 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.95 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 0.0 109.324 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.33 27.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 109.936 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.305 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.38 8.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.481 1.113 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.649 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.562 0.801 . . . . 0.0 109.203 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.63 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.589 1.181 . . . . 0.0 110.367 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.711 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.46 102.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 0.0 109.24 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.8 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.531 1.144 . . . . 0.0 110.279 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.46 9.58 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 0.0 110.994 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.32 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.528 1.142 . . . . 0.0 109.25 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.5 ttp -98.04 119.21 36.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.32 -66.03 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 109.286 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.52 0.76 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 36' ' ' VAL . 1.2 p 46.04 54.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 0.0 109.345 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.9 -172.36 40.67 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.532 1.145 . . . . 0.0 111.046 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.126 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 25.3 Cg_endo -74.96 -168.95 6.89 Favored 'Cis proline' 0 C--N 1.361 1.184 0 C-N-CA 120.993 -2.503 . . . . 0.0 110.996 -0.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 71.2 m-70 -144.21 -170.33 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.505 1.128 . . . . 0.0 109.575 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.94 166.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.398 1.061 . . . . 0.0 109.285 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.597 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 1.152 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.617 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -132.82 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.126 . . . . 0.0 109.308 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER 167.29 143.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.0 73.17 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 0.0 109.233 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 164.22 33.86 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.474 1.776 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.28 135.67 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 0.0 109.244 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.43 -56.52 0.73 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.538 1.149 . . . . 0.0 110.981 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.28 2.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 0.819 . . . . 0.0 110.249 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.24 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.382 1.052 . . . . 0.0 109.938 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.018 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.86 70.81 Favored Pre-proline 0 C--N 1.323 -0.552 0 O-C-N 124.489 1.118 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.0 50.77 2.61 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.414 1.744 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.3 -45.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.579 1.174 . . . . 0.0 109.336 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.15 -27.51 68.08 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.316 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 m -46.52 115.13 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.494 1.121 . . . . 0.0 110.009 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -107.92 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.775 HG21 ' HB3' ' B' ' 63' ' ' ASP . 1.4 t -89.75 21.85 3.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 0.0 110.343 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -86.04 64.43 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.093 . . . . 0.0 109.233 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 0.0 109.332 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.5 6.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.311 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.717 HD11 HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.69 -46.13 80.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.568 1.168 . . . . 0.0 109.319 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.16 111.61 4.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.48 1.113 . . . . 0.0 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -75.01 139.18 23.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.428 1.752 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.475 1.109 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.673 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.47 0.747 . . . . 0.0 110.06 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.13 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 0.0 111.039 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.51 175.18 4.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.418 1.073 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.69 161.2 21.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.567 1.167 . . . . 0.0 109.964 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.69 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 0.0 109.374 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.22 146.5 23.97 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.439 1.087 . . . . 0.0 110.388 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.19 173.06 8.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.25 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.34 124.28 39.05 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.578 0.811 . . . . 0.0 110.385 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.1 Cg_endo -75.15 141.49 26.3 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.549 1.815 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.66 20.02 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.89 120.05 40.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 0.787 . . . . 0.0 110.407 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.71 140.67 30.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 0.0 111.025 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.84 145.12 49.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.055 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.43 3.72 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.55 1.156 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.617 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 13.1 p90 -171.88 165.47 6.44 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 0.0 111.055 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.67 122.36 36.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 108.202 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.484 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 m -51.3 -50.73 74.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.441 1.088 . . . . 0.0 110.431 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 83' ' ' THR . 41.5 Cg_endo -75.13 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.565 1.824 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.871 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 27.0 m80 -75.03 57.99 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -38.56 15.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.554 1.159 . . . . 0.0 110.287 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.48 -23.85 32.72 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.533 1.146 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.492 0.76 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.16 1.82 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.478 1.111 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.66 75.12 1.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 0.761 . . . . 0.0 110.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.18 153.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.119 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.78 19.74 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.03 37.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.507 0.769 . . . . 0.0 110.425 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.711 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.62 122.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.561 1.163 . . . . 0.0 109.286 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.7 m -105.08 144.56 31.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.457 1.098 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.438 1.086 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 0.0 110.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.783 ' CE2' ' HD2' ' A' ' 38' ' ' PRO . 7.8 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.843 ' CZ ' ' HG3' ' A' ' 14' ' ' PRO . 3.8 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.871 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 1.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 33.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.777 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.72 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.733 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 20.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' B' ' 65' ' ' SER . 15.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.775 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 51.6 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.72 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 2.1 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.556 ' CE2' HD23 ' B' ' 103' ' ' LEU . 2.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.556 HD23 ' CE2' ' B' ' 102' ' ' TYR . 76.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.031 HG13 ' HG ' ' B' ' 115' ' ' LEU . 68.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.979 ' HA ' HD11 ' B' ' 116' ' ' LEU . 28.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 31.8 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.031 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.979 HD11 ' HA ' ' B' ' 107' ' ' TYR . 0.4 OUTLIER -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.126 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' B' ' 125' ' ' TYR . 10.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' B' ' 120' ' ' LEU . 62.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.733 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 21.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.426 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.299 ' OH ' ' HA ' ' B' ' 168' ' ' SER . 3.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.478 ' HG3' ' CG ' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 3.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.938 ' C ' ' HE1' ' B' ' 162' ' ' TYR . 4.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 168' ' ' SER . . . . . 1.299 ' HA ' ' OH ' ' B' ' 162' ' ' TYR . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 16.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 1.581 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.355 16.2 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 59.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.566 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 56.7 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.108 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 5.4 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.566 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.8 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.789 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.108 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 9.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.65 126.86 29.2 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.531 1.145 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.18 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.418 1.074 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.93 40.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.559 1.162 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.08 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.76 133.49 35.98 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.526 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 110.973 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.53 7.65 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.577 1.173 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.528 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -108.05 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.475 0.75 . . . . 0.0 110.42 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.83 -15.97 24.91 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 0.0 109.356 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -90.57 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 0.0 109.337 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER 38.23 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.169 . . . . 0.0 111.062 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.8 117.71 58.16 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.67 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 34.7 Cg_endo -75.03 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.528 1.804 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.438 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.2 pp -150.78 151.23 32.04 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.48 1.113 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.34 126.15 30.47 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.509 1.131 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.41 134.9 26.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.505 1.128 . . . . 0.0 110.351 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.09 140.99 70.28 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 121.007 -2.497 . . . . 0.0 110.909 0.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.22 -40.11 1.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.531 1.145 . . . . 0.0 109.251 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.29 46.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.42 31.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.133 . . . . 0.0 109.247 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.473 1.108 . . . . 0.0 110.059 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.402 1.064 . . . . 0.0 109.259 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.53 158.29 27.62 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 0.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.32 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.44 8.45 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.469 1.105 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.642 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.14 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 0.733 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.53 154.25 39.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 0.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.41 102.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.566 1.167 . . . . 0.0 109.276 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.51 18.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.591 1.182 . . . . 0.0 110.334 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.19 121.46 9.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.562 1.164 . . . . 0.0 110.986 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.01 155.35 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.565 1.166 . . . . 0.0 109.262 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.77 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.2 ttp -98.05 119.26 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.399 1.062 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.39 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.181 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.86 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.46 1.1 . . . . 0.0 109.228 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.67 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.3 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.455 1.097 . . . . 0.0 109.323 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.95 -172.3 40.58 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.51 1.131 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HB3' HD13 ' A' ' 62' ' ' ILE . 42.8 Cg_endo -74.95 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.913 -2.536 . . . . 0.0 111.034 -0.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.77 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.7 m-70 -144.23 -170.37 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.568 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.469 1.106 . . . . 0.0 109.338 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.35 43.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.543 1.152 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -132.78 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.539 1.149 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -49.99 4.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.293 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.3 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.061 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.87 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.03 164.22 33.75 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.459 1.768 . . . . 0.0 110.974 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.21 135.62 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.59 0.72 Allowed Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.538 1.149 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.651 0.853 . . . . 0.0 110.25 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.426 1.079 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.061 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.03 -51.81 71.31 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.415 1.072 . . . . 0.0 109.27 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.05 50.78 2.63 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.419 1.747 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.62 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.662 1.226 . . . . 0.0 109.358 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.13 -27.56 68.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 4.4 m -46.44 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 0.0 109.99 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 68' ' ' TYR 0.492 7.8 t30 -108.04 117.75 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.411 1.069 . . . . 0.0 109.312 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.911 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 4.0 t -89.82 21.87 3.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 0.0 110.311 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 60' ' ' LEU . 57.1 tttt -86.02 64.36 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.487 1.117 . . . . 0.0 109.287 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.475 1.109 . . . . 0.0 109.296 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.42 6.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 1.097 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.834 HD12 HD21 ' B' ' 70' ' ' ASN . 5.9 mm -68.62 -46.07 80.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.526 1.141 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -62.13 111.64 4.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.285 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 5.1 Cg_exo -75.05 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.454 1.765 . . . . 0.0 111.025 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.86 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.55 1.157 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.65 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.527 0.781 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.449 1.093 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.62 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.5 175.16 4.18 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.95 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.474 1.109 . . . . 0.0 110.006 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.27 146.47 24.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.57 1.169 . . . . 0.0 110.382 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 1.126 . . . . 0.0 109.259 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.459 1.1 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.46 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.14 38.13 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.52 0.776 . . . . 0.0 110.388 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.98 141.5 26.78 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.438 1.757 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.64 20.05 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.459 1.1 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.3 m -104.81 120.11 40.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 0.776 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.66 31.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 111.03 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.88 145.15 49.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.406 1.066 . . . . 0.0 110.016 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.21 -171.59 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.114 . . . . 0.0 110.956 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.495 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 16.3 p90 -171.78 165.46 6.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.543 1.152 . . . . 0.0 110.995 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.54 122.34 35.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.448 1.093 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.627 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 2.9 m -51.38 -50.76 74.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.433 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.9 Cg_endo -75.02 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.234 0 O-C-N 124.492 1.785 . . . . 0.0 111.033 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 63.0 m-70 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.631 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -38.44 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.536 1.147 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.52 -23.8 32.77 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.51 1.131 . . . . 0.0 110.995 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.18 62.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.512 0.772 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.1 1.83 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.456 1.097 . . . . 0.0 110.984 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.526 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.3 ttt -121.54 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 0.73 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.16 153.56 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 109.271 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.76 19.76 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.553 1.158 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.79 162.02 37.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.49 0.759 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.716 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.9 m -105.0 144.56 31.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.422 1.076 . . . . 0.0 110.429 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.31 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.523 1.139 . . . . 0.0 109.315 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.313 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.422 ' CD2' ' HE2' ' B' ' 4' ' ' TYR . 23.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.9 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 1.422 ' HE2' ' CD2' ' B' ' 1' ' ' TYR . 51.7 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 87.1 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.771 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 26.0 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.73 ' HB2' HG21 ' B' ' 233' ' ' VAL . 43.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.541 ' CD ' HD21 ' A' ' 60' ' ' LEU . 3.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.911 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 5.7 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.3 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 65' ' ' SER 0.261 4.7 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 29.8 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.417 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.834 HD21 HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.856 HG13 ' HG ' ' B' ' 115' ' ' LEU . 62.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.851 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.2 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.873 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.2 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.851 ' HB2' HG23 ' B' ' 105' ' ' THR . 70.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.681 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' B' ' 125' ' ' TYR . 39.3 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' B' ' 120' ' ' LEU . 73.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.448 ' CA ' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.697 ' HG3' ' OE1' ' B' ' 59' ' ' GLN . 14.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.032 ' HB3' HG22 ' B' ' 164' ' ' THR . 3.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 44.6 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.634 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.6 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.539 HD21 HH12 ' B' ' 158' ' ' ARG . 37.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.957 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.62 126.8 28.95 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.561 1.163 . . . . 0.0 110.056 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.413 1.071 . . . . 0.0 109.28 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.88 40.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.546 1.154 . . . . 0.0 110.3 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.3 112.12 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.457 1.098 . . . . 0.0 109.355 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.68 133.46 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.466 1.103 . . . . 0.0 109.377 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.584 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 0.0 111.007 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.52 7.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.543 1.152 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -108.1 160.71 15.6 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.478 0.752 . . . . 0.0 110.426 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.85 -15.96 25.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.436 1.085 . . . . 0.0 109.257 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 17.5 mttt -90.59 39.73 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CZ ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.26 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.58 1.175 . . . . 0.0 111.031 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.68 58.17 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 109.278 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 37.3 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.497 1.788 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.4 pp -150.83 151.17 31.88 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.28 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.16 . . . . 0.0 111.018 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.43 134.95 26.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.565 1.166 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.06 140.98 70.28 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.939 0.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.16 -40.17 1.05 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.611 1.194 . . . . 0.0 109.252 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.29 46.09 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.462 1.101 . . . . 0.0 109.309 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.41 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 109.252 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.618 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.94 143.7 50.94 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 110.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.79 -177.44 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.504 1.128 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.37 27.5 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 0.0 110.002 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.15 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.606 1.191 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.52 -7.48 8.44 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.515 1.134 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.13 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 0.753 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.52 154.26 39.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 0.0 110.485 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.509 1.131 . . . . 0.0 109.306 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.274 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.55 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.24 121.38 9.49 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.533 1.146 . . . . 0.0 110.98 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.34 33.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.515 1.134 . . . . 0.0 109.317 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.06 119.22 36.32 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.353 1.033 . . . . 0.0 111.026 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -79.35 -66.05 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 109.255 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.717 ' HD3' ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -168.89 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.44 1.087 . . . . 0.0 109.3 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.4 p 46.08 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.48 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.588 1.18 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.99 -168.86 6.83 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.934 -2.527 . . . . 0.0 110.969 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.735 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.5 m-70 -144.24 -170.33 3.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.542 1.151 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.436 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.4 p30 173.94 166.95 0.2 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.419 1.074 . . . . 0.0 109.355 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.536 1.148 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.626 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.78 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 109.333 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.62 160.59 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.568 1.167 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.571 1.17 . . . . 0.0 109.306 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.024 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.09 72.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 164.25 33.69 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.463 1.77 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 0.0 109.339 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.492 1.12 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.04 -173.34 2.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.593 0.819 . . . . 0.0 110.295 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.2 77.86 1.75 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.511 1.132 . . . . 0.0 109.994 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.024 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.12 -51.76 72.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.11 . . . . 0.0 109.262 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.12 50.86 2.67 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.487 1.783 . . . . 0.0 110.909 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.63 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.584 1.177 . . . . 0.0 109.38 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.16 -27.52 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.117 . . . . 0.0 109.298 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 m -46.46 115.15 0.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 0.0 109.976 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -108.02 117.71 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.438 1.086 . . . . 0.0 109.328 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.141 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 1.5 t -89.81 21.89 3.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.416 1.073 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -86.05 64.4 8.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.491 1.119 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.099 HD21 ' CG ' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -40.39 102.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.55 1.156 . . . . 0.0 109.332 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.38 6.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.579 HG23 HD22 ' B' ' 70' ' ' ASN . 3.5 mt -68.6 -46.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.58 4.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.108 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.98 139.11 23.94 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.457 1.767 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.94 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.522 1.139 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.657 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.485 0.756 . . . . 0.0 109.985 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.16 -86.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.446 1.092 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.59 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.482 1.114 . . . . 0.0 110.029 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.73 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 109.428 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.53 23.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 110.344 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.19 173.06 8.57 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.492 1.12 . . . . 0.0 109.261 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.13 37.87 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 0.0 110.421 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.0 141.5 26.72 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.511 1.795 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.05 -178.67 20.0 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.335 1.022 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.87 120.04 40.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 0.746 . . . . 0.0 110.347 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.838 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.74 140.69 30.95 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.87 145.16 49.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.451 1.094 . . . . 0.0 109.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.23 -171.62 3.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.458 1.099 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.457 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 15.6 p90 -171.78 165.4 6.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.555 1.16 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 122.33 35.8 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.424 1.078 . . . . 0.0 108.326 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.626 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.9 m -51.38 -50.77 74.36 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.499 1.124 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 18.6 Cg_endo -75.03 -62.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 26.3 m80 -74.97 58.0 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.596 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.438 HH22 HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -88.0 -38.55 15.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.556 1.16 . . . . 0.0 110.314 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.45 -23.72 33.18 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.505 1.128 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.719 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.73 -15.21 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 0.768 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.523 1.139 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.584 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.391 0.701 . . . . 0.0 111.021 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.59 30.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.589 1.181 . . . . 0.0 109.272 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.543 1.152 . . . . 0.0 111.006 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.08 36.93 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.426 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 0.0 109.238 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.1 m -105.1 144.57 31.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 110.372 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.32 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.497 1.123 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.56 1.163 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.51 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 16.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.514 ' HB2' HD13 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.984 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 16.2 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 4.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.984 ' HG3' ' O ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.5 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.771 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 7.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.689 ' HB2' HG21 ' B' ' 233' ' ' VAL . 18.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 1.099 ' CG ' HD21 ' A' ' 60' ' ' LEU . 5.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 1.141 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 31.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' B' ' 61' ' ' GLN . 78.4 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 5.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.579 HD22 HG23 ' A' ' 62' ' ' ILE . 6.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.6 ' HA ' HD23 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.755 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.8 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.822 ' CB ' HD22 ' B' ' 83' ' ' LEU . 98.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' B' ' 74' ' ' VAL . 19.0 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.473 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 38.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.482 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.538 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 46.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.8 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.033 ' CB ' HG22 ' B' ' 164' ' ' THR . 3.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.9 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 17.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.632 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.7 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 16.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 11.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.86 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.55 126.8 28.94 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.535 1.147 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.19 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 0.0 109.273 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.87 40.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.14 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.412 1.07 . . . . 0.0 109.346 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.82 133.55 35.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 0.0 109.276 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.613 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.07 6.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 0.0 110.953 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.48 7.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.586 1.179 . . . . 0.0 110.973 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.762 ' CG2' HD11 ' A' ' 15' ' ' LEU . 17.2 p -108.07 160.7 15.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 0.741 . . . . 0.0 110.421 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -59.84 -15.92 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.402 1.064 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 23.9 mttt -90.58 39.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.137 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.639 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 22.9 m-85 38.37 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 0.0 111.015 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.84 117.65 58.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 22.3 Cg_endo -74.98 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.486 1.782 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.762 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.21 31.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 0.0 109.357 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.418 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.34 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.473 1.108 . . . . 0.0 110.967 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.96 26.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.559 1.162 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.98 70.31 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.039 -2.484 . . . . 0.0 110.943 0.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.23 -40.1 1.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.554 1.159 . . . . 0.0 109.274 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.34 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.459 1.1 . . . . 0.0 109.302 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.944 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.29 141.43 31.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.553 1.158 . . . . 0.0 109.225 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.72 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.451 1.094 . . . . 0.0 110.036 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.88 -177.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 0.0 109.219 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.818 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.56 158.31 27.59 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.06 105.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 0.0 109.337 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.446 1.091 . . . . 0.0 110.999 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.25 174.09 11.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 0.747 . . . . 0.0 109.286 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.46 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 0.0 110.475 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.723 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.263 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.85 169.51 18.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.5 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.491 1.12 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.34 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.731 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.1 ttp -98.0 119.27 36.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.359 1.037 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.39 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.109 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.639 ' HE3' ' HA ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -168.88 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.415 1.072 . . . . 0.0 109.279 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.7 p 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.538 1.149 . . . . 0.0 111.027 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.712 ' HD2' ' CE1' ' B' ' 1' ' ' TYR . 59.8 Cg_endo -74.99 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.931 -2.529 . . . . 0.0 110.963 -0.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.731 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.23 -170.4 3.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.569 1.168 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.99 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.07 114.33 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.534 1.146 . . . . 0.0 109.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.9 mm -132.75 75.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.59 160.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 110.98 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.99 -50.15 4.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 109.265 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.47 158.14 72.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.383 1.052 . . . . 0.0 109.291 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.07 164.22 33.67 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.505 1.792 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.19 135.6 1.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 0.0 109.328 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.537 1.148 . . . . 0.0 111.0 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.39 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.561 0.8 . . . . 0.0 110.263 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.46 1.1 . . . . 0.0 109.98 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.042 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.11 -51.75 72.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 0.0 109.269 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.07 50.78 2.64 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.401 1.737 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.65 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.639 1.212 . . . . 0.0 109.381 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.06 -27.54 68.16 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 109.36 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.3 m -46.45 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.965 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.554 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.3 m-80 -108.07 117.73 34.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' B' ' 63' ' ' ASP . 3.3 t -89.82 21.92 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.432 1.082 . . . . 0.0 110.317 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 1.7 tttt -86.04 64.41 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -40.45 102.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 0.0 109.297 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.43 6.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 109.316 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.717 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.69 -46.06 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.594 1.184 . . . . 0.0 109.332 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.63 4.93 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.04 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.473 1.775 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.87 -67.9 0.17 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.591 1.182 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.493 0.761 . . . . 0.0 109.994 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.25 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.417 1.073 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.494 1.121 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.29 20.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.408 1.068 . . . . 0.0 110.015 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 0.0 109.412 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 110.347 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.11 173.08 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.514 1.134 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.488 1.117 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.06 37.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.545 0.791 . . . . 0.0 110.403 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.7 Cg_endo -74.97 141.51 26.82 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.483 1.781 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.441 1.088 . . . . 0.0 111.007 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.9 120.08 40.57 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.484 0.755 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.836 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.68 30.97 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.491 1.119 . . . . 0.0 111.017 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.17 49.3 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 1.08 . . . . 0.0 109.97 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.55 3.74 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.7 p90 -171.86 165.35 6.46 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 122.36 35.81 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.445 1.091 . . . . 0.0 108.284 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.633 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.39 -50.82 74.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.456 1.098 . . . . 0.0 110.356 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 83' ' ' THR . 36.4 Cg_endo -74.93 -62.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.527 1.804 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -74.96 57.93 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 0.0 109.598 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.179 ' HD2' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.97 -38.49 15.49 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.559 1.162 . . . . 0.0 110.318 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.895 ' N ' ' HD2' ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.77 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 0.761 . . . . 0.0 109.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.08 63.17 1.83 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.444 1.09 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.613 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.61 75.03 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.4 0.706 . . . . 0.0 111.066 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.14 153.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.499 1.124 . . . . 0.0 109.305 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.79 19.77 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.571 1.169 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.03 37.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 0.748 . . . . 0.0 110.432 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.723 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.61 122.63 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.02 144.49 31.75 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.427 1.079 . . . . 0.0 110.415 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 96' ' ' VAL . 5.0 t -128.2 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.53 1.144 . . . . 0.0 109.376 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.818 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.087 ' HD2' ' CE2' ' B' ' 4' ' ' TYR . 97.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 1.087 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 24.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.514 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.7 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.782 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 48.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.678 ' HB2' HG21 ' B' ' 233' ' ' VAL . 12.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 87.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.541 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 1.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.541 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 2.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.4 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.716 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.466 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 62' ' ' ILE . 4.9 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.472 HG23 ' CE ' ' B' ' 128' ' ' MET . 20.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.893 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.8 HD23 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.826 ' CB ' HD22 ' B' ' 83' ' ' LEU . 67.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 2.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 73.9 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.967 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.754 ' HB2' HG23 ' B' ' 105' ' ' THR . 52.1 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.843 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.827 HD22 ' CE2' ' B' ' 125' ' ' TYR . 17.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.54 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.827 ' CE2' HD22 ' B' ' 120' ' ' LEU . 41.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.472 ' CE ' HG23 ' B' ' 71' ' ' VAL . 60.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.452 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' B' ' 24' ' ' CYS . 9.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.333 ' CD2' ' HD2' ' B' ' 163' ' ' PRO . 13.1 t80 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 1.333 ' HD2' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.187 ' CG2' ' HB3' ' B' ' 162' ' ' TYR . 0.2 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.815 ' H ' HG23 ' B' ' 164' ' ' THR . 36.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 0.957 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.962 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.957 ' HD3' ' CD2' ' B' ' 189' ' ' PHE 0.26 5.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.62 126.79 28.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.533 1.146 . . . . 0.0 109.99 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.947 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.426 1.079 . . . . 0.0 109.271 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.602 1.189 . . . . 0.0 110.296 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.458 1.099 . . . . 0.0 109.32 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.72 133.46 36.0 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.658 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.1 6.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 110.961 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.5 7.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.605 1.191 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.713 ' CG2' HD11 ' A' ' 15' ' ' LEU . 27.0 p -108.1 160.74 15.57 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.437 0.728 . . . . 0.0 110.398 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 45.5 t0 -59.85 -15.94 24.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.089 . . . . 0.0 109.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 13.1 mttt -90.64 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 38.27 29.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.72 58.07 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.483 1.115 . . . . 0.0 109.326 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HG3' HG21 ' A' ' 36' ' ' VAL . 10.9 Cg_endo -75.0 97.62 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.498 1.788 . . . . 0.0 110.974 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.83 151.19 31.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.511 1.132 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.33 126.18 30.51 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.492 1.12 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.04 140.97 70.24 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.03 -2.488 . . . . 0.0 110.962 0.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.17 -40.1 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.545 1.153 . . . . 0.0 109.295 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.33 46.09 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.947 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.43 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.11 . . . . 0.0 109.226 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 110.029 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.12 . . . . 0.0 109.289 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.819 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.62 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.452 1.095 . . . . 0.0 109.994 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.59 1.181 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.506 1.128 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.17 11.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 0.78 . . . . 0.0 109.288 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.55 154.23 39.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 0.0 110.427 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.592 1.182 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.86 169.49 18.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.17 121.49 9.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 0.0 110.962 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.04 155.28 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.698 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.5 ttp -98.01 119.26 36.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.373 1.046 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.33 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 14' ' ' PRO . 9.8 p 46.04 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.092 . . . . 0.0 109.319 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.91 -172.31 40.63 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.487 1.117 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 56.3 Cg_endo -74.98 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.973 -0.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.698 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 68.8 m-70 -144.26 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.588 1.18 . . . . 0.0 109.574 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 174.01 167.07 0.21 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 109.338 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.16 114.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.586 1.179 . . . . 0.0 109.323 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.324 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.61 160.63 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.562 1.163 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.05 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.046 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.381 1.051 . . . . 0.0 109.257 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 164.27 33.6 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.449 1.763 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.27 135.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 0.0 109.292 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.66 0.72 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.01 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.59 0.818 . . . . 0.0 110.282 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.426 1.079 . . . . 0.0 109.997 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.046 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.83 71.14 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.417 1.073 . . . . 0.0 109.265 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.02 50.79 2.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.447 1.762 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.29 -45.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.659 1.224 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.54 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -46.52 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.945 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -107.97 117.69 34.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.79 21.88 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.38 1.05 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -86.04 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.42 102.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.546 1.154 . . . . 0.0 109.337 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.944 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.64 -46.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.162 . . . . 0.0 109.353 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.04 111.61 4.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 0.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.05 139.15 23.81 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.468 1.772 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.567 1.167 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.7 97.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.438 0.728 . . . . 0.0 109.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.496 1.123 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.52 175.12 4.18 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.467 1.105 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.28 20.94 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.444 1.09 . . . . 0.0 109.988 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.04 137.69 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.106 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.26 146.48 23.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 110.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.11 8.53 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.449 1.093 . . . . 0.0 109.251 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.31 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.07 37.65 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 0.0 110.37 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.97 141.49 26.79 Favored 'Trans proline' 0 C--N 1.359 1.092 0 O-C-N 124.498 1.789 . . . . 0.0 111.107 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.452 1.095 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.02 40.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 0.742 . . . . 0.0 110.339 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.4 m-85 -96.68 140.75 30.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.97 145.16 49.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.56 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.422 1.077 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.1 p90 -171.82 165.41 6.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 1.12 . . . . 0.0 111.018 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.49 122.38 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 0.0 108.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.71 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.34 -50.84 73.84 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.506 1.129 . . . . 0.0 110.373 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CB ' ' OH ' ' B' ' 1' ' ' TYR . 40.2 Cg_endo -74.97 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.465 1.771 . . . . 0.0 111.01 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 2.5 m170 -75.03 58.01 0.85 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.36 HH12 ' CA ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -88.01 -38.46 15.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.57 1.169 . . . . 0.0 110.314 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 1.36 ' CA ' HH12 ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.465 1.103 . . . . 0.0 110.983 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.64 -15.26 62.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 0.751 . . . . 0.0 109.408 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.11 1.83 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.43 1.081 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.56 74.98 1.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.401 0.706 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.12 153.59 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.72 19.72 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.599 1.187 . . . . 0.0 110.984 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.81 162.07 37.01 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 0.793 . . . . 0.0 110.414 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.64 122.63 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.0 m -105.01 144.53 31.69 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.414 1.071 . . . . 0.0 110.404 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.515 1.134 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.819 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.572 1.17 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.751 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.457 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 1.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.2 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.765 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.798 ' CE2' HD13 ' B' ' 69' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.584 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 52.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.895 ' HB2' HG21 ' B' ' 233' ' ' VAL . 3.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.71 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' B' ' 65' ' ' SER . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 69.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.584 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.798 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.89 ' ND2' HG23 ' A' ' 62' ' ' ILE . 2.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.787 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.817 ' CB ' HD22 ' B' ' 83' ' ' LEU . 99.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.83 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.5 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.3 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.5 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.979 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.83 ' HB2' HG23 ' B' ' 105' ' ' THR . 46.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.703 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 9.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.944 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' B' ' 124' ' ' ASP . 4.1 pm0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.553 ' N ' ' HG2' ' B' ' 123' ' ' GLU . 8.7 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 42.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.448 ' CA ' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' B' ' 24' ' ' CYS . 6.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 0.93 ' HB2' HG22 ' B' ' 164' ' ' THR . 19.2 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.021 HG23 ' H ' ' B' ' 166' ' ' GLU . 14.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.021 ' H ' HG23 ' B' ' 164' ' ' THR . 25.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.713 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.568 HD21 ' HA ' ' B' ' 62' ' ' ALA . 10.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 207' ' ' ILE . . . . . 0.474 ' C ' HD13 ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.824 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 8.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.895 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.58 126.79 28.88 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.549 1.155 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.267 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.86 40.25 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.529 1.143 . . . . 0.0 110.315 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.363 1.039 . . . . 0.0 109.267 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.525 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.74 133.47 35.99 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.611 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.69 96.99 6.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.458 1.099 . . . . 0.0 111.036 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.477 1.111 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.4 p -108.09 160.65 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.446 0.733 . . . . 0.0 110.439 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 13.4 t70 -59.78 -15.98 24.44 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.452 1.095 . . . . 0.0 109.361 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 29.1 mttp -90.57 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.313 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' CE2' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.24 29.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 0.0 111.054 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.7 58.12 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.676 ' HG3' HG21 ' A' ' 36' ' ' VAL . 28.0 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.429 1.752 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.81 151.22 31.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.109 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.17 30.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.44 134.82 26.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.406 1.066 . . . . 0.0 110.375 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.12 140.92 69.9 Favored 'Cis proline' 0 C--N 1.36 1.138 0 C-N-CA 121.031 -2.487 . . . . 0.0 110.96 0.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.17 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.32 46.11 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.425 1.078 . . . . 0.0 109.279 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.21 141.4 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.137 . . . . 0.0 109.261 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.611 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 0.0 110.019 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.94 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 0.0 109.287 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.126 . . . . 0.0 109.923 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.525 1.141 . . . . 0.0 109.251 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.43 8.45 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.508 1.13 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.14 174.09 11.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.56 0.8 . . . . 0.0 109.282 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.43 154.29 39.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 110.51 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.52 102.6 6.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.099 . . . . 0.0 109.289 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.53 18.08 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.484 1.115 . . . . 0.0 110.28 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.23 121.39 9.5 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.516 1.135 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.38 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.8 ttp -98.0 119.17 36.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.427 1.079 . . . . 0.0 111.037 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -79.38 -66.05 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.571 1.17 . . . . 0.0 109.223 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.7 p 45.97 54.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.505 1.128 . . . . 0.0 109.321 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.803 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -93.0 -172.37 40.51 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.478 1.111 . . . . 0.0 111.03 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.02 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.97 0.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.613 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.4 m-70 -144.23 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 0.0 109.644 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.62 ' HB3' HD23 ' A' ' 60' ' ' LEU . 1.2 p30 173.97 166.96 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 0.0 109.304 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.8 t -104.12 114.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.938 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.8 mm -132.75 75.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.72 160.59 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.01 -49.94 4.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 0.0 109.276 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.26 143.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.431 1.082 . . . . 0.0 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.14 72.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.39 1.056 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.9 Cg_endo -75.11 164.2 33.61 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.55 1.816 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.16 135.55 1.37 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.097 . . . . 0.0 109.307 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.52 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.566 1.166 . . . . 0.0 110.974 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.24 2.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.607 0.828 . . . . 0.0 110.243 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.27 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.043 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.99 -51.85 70.87 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.473 1.108 . . . . 0.0 109.353 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -74.97 50.71 2.58 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.446 1.761 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.54 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.53 1.144 . . . . 0.0 109.392 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.11 -27.61 68.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.593 1.183 . . . . 0.0 109.252 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.47 115.12 0.94 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.555 1.159 . . . . 0.0 109.995 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 1.006 ' OD1' ' OH ' ' A' ' 68' ' ' TYR 0.964 52.9 p-10 -107.94 117.66 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.442 1.088 . . . . 0.0 109.298 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.82 21.9 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.454 1.096 . . . . 0.0 110.301 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -86.01 64.37 8.54 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 0.0 109.239 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.671 ' CD1' ' HB2' ' B' ' 61' ' ' GLN . 4.4 mt -40.39 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.52 98.49 6.11 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.563 1.164 . . . . 0.0 109.263 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.977 HG22 ' HB3' ' B' ' 121' ' ' PRO . 1.2 mm -68.64 -46.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.11 111.59 4.84 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.951 ' HD3' ' HG3' ' B' ' 121' ' ' PRO . 9.0 Cg_endo -74.97 139.15 24.02 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.466 1.771 . . . . 0.0 111.052 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -67.98 0.17 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.124 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.455 0.738 . . . . 0.0 110.008 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.16 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.463 1.102 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 1.006 ' OH ' ' OD1' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.11 4.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 0.0 111.021 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.57 161.31 20.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.462 1.101 . . . . 0.0 109.975 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.69 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.449 1.093 . . . . 0.0 110.332 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.09 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.518 1.136 . . . . 0.0 109.233 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.34 0.02 OUTLIER Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.577 1.173 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.28 124.11 37.86 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.453 0.737 . . . . 0.0 110.39 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.51 26.77 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.504 1.792 . . . . 0.0 111.054 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.62 20.07 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.422 1.076 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.07 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.556 0.798 . . . . 0.0 110.403 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.58 1.175 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.91 145.16 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.24 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.444 1.09 . . . . 0.0 110.927 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.0 p90 -171.84 165.38 6.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.52 122.27 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.469 1.106 . . . . 0.0 108.29 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.986 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 20.4 m -51.27 -50.79 73.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 110.429 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 30.3 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.554 1.818 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -75.04 57.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.139 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.986 ' CG ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -87.98 -38.5 15.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.558 1.161 . . . . 0.0 110.337 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.5 -23.77 32.91 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.423 1.077 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.31 62.66 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.487 0.757 . . . . 0.0 109.314 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.22 1.82 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.469 1.106 . . . . 0.0 110.979 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.611 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.2 ttt -121.63 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 0.763 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.21 153.49 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.44 1.088 . . . . 0.0 109.298 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.46 -174.69 19.64 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.449 1.093 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.84 162.08 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 0.778 . . . . 0.0 110.382 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.56 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.51 1.131 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.01 144.53 31.68 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 0.0 110.43 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.25 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 0.0 109.283 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.498 1.123 . . . . 0.0 110.347 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.003 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.46 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.804 ' CE2' ' CE1' ' B' ' 1' ' ' TYR . 8.8 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.756 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.55 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 3.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.842 ' HB2' HG21 ' B' ' 233' ' ' VAL . 22.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 76.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.894 ' NE2' ' HB3' ' B' ' 65' ' ' SER . 5.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.685 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.594 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.894 ' HB3' ' NE2' ' B' ' 61' ' ' GLN . 3.2 t -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.539 HD21 HG23 ' B' ' 233' ' ' VAL . 7.5 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.866 ' ND2' HG23 ' A' ' 62' ' ' ILE . 10.0 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' ASP . . . . . 0.605 ' HB2' HD12 ' B' ' 103' ' ' LEU . 80.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 99' ' ' ASP . 1.6 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.962 HG11 HD12 ' B' ' 115' ' ' LEU . 24.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.609 HG23 ' HB2' ' B' ' 116' ' ' LEU . 11.9 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.632 ' CD1' HD11 ' B' ' 116' ' ' LEU . 30.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.962 HD12 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.632 HD11 ' CD1' ' B' ' 107' ' ' TYR . 5.3 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.803 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.7 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' B' ' 125' ' ' TYR . 4.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.977 ' HB3' HG22 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' B' ' 120' ' ' LEU . 43.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.3 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 22.9 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.751 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 36.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.053 ' HB3' HG22 ' B' ' 164' ' ' THR . 6.7 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.053 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.0 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.635 ' H ' HG23 ' B' ' 164' ' ' THR . 46.8 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.499 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.18 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.733 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.18 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.54 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.591 1.182 . . . . 0.0 110.045 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.418 1.074 . . . . 0.0 109.249 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.91 150.91 40.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.521 1.138 . . . . 0.0 110.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.09 38.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.442 1.089 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.71 133.54 35.92 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.701 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.01 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 0.0 110.996 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.52 7.63 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 0.0 110.967 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.423 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.12 160.65 15.64 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.462 0.742 . . . . 0.0 110.371 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.78 -15.98 24.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.402 1.064 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.6 mtpt -90.57 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 111.019 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.63 58.3 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 38.8 Cg_endo -74.97 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.496 1.787 . . . . 0.0 111.028 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD21 ' OG1' ' A' ' 9' ' ' THR . 3.4 pp -150.8 151.19 31.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.5 134.95 26.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 124.498 1.124 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.03 140.96 70.23 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 121.021 -2.491 . . . . 0.0 110.959 0.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.21 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.563 1.165 . . . . 0.0 109.271 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.12 146.3 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.424 1.078 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.44 31.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.115 . . . . 0.0 109.201 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.631 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.69 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.432 1.082 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.226 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.28 27.67 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.006 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.626 1.204 . . . . 0.0 109.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.43 8.46 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.542 1.151 . . . . 0.0 110.987 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.12 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 0.779 . . . . 0.0 109.287 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.5 154.27 39.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.697 HG11 HD13 ' A' ' 94' ' ' ILE . 64.0 t -131.43 102.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.28 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.84 169.49 18.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.531 1.145 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.458 1.099 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.37 33.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 0.0 109.347 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.475 ' SD ' ' HE1' ' A' ' 67' ' ' PHE . 1.1 ttp -98.07 119.28 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.384 1.053 . . . . 0.0 111.032 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.37 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 0.0 109.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.48 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.465 1.103 . . . . 0.0 109.23 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 8.0 p 46.03 54.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 124.415 1.072 . . . . 0.0 109.359 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.494 1.121 . . . . 0.0 111.083 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -74.98 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.929 -2.53 . . . . 0.0 110.995 -0.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.639 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.9 m-70 -144.24 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.461 1.1 . . . . 0.0 109.586 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.499 HD22 HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 173.97 167.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 109.305 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.6 t -104.14 114.37 43.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.513 1.133 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.599 HG13 ' OG1' ' A' ' 83' ' ' THR . 3.2 mm -132.81 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.312 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.55 1.156 . . . . 0.0 111.01 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.0 -50.01 4.79 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.597 1.185 . . . . 0.0 109.257 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.084 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.1 72.82 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.417 1.073 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.04 164.24 33.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.454 1.765 . . . . 0.0 110.994 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.44 1.087 . . . . 0.0 109.328 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.61 0.72 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.564 1.165 . . . . 0.0 111.027 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.36 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.608 0.828 . . . . 0.0 110.289 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.18 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.414 1.071 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.084 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.76 71.82 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.07 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.487 1.782 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.24 -45.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 109.331 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -65.98 -27.62 68.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 0.0 109.369 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.0 m -46.45 115.09 0.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 0.0 110.028 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.0 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.0 t -89.77 21.91 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.382 1.051 . . . . 0.0 110.342 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.438 1.086 . . . . 0.0 109.311 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.536 ' CD1' ' HB3' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.111 . . . . 0.0 109.287 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.42 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.502 1.126 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' NE2' ' B' ' 61' ' ' GLN . 2.6 mm -68.63 -46.08 80.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.568 1.167 . . . . 0.0 109.355 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.63 4.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 0.0 109.298 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -75.03 139.08 23.78 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.422 1.748 . . . . 0.0 111.046 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.9 0.17 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.542 1.151 . . . . 0.0 110.935 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 0.794 . . . . 0.0 109.99 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.23 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.451 1.094 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.52 175.08 4.19 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.478 1.111 . . . . 0.0 110.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.27 20.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.02 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.71 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.381 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.47 24.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.13 . . . . 0.0 110.353 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.12 173.06 8.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.517 1.135 . . . . 0.0 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.1 37.51 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 0.785 . . . . 0.0 110.42 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.6 Cg_endo -74.97 141.44 26.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.415 1.745 . . . . 0.0 111.084 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.63 20.09 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.386 1.054 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.449 0.735 . . . . 0.0 110.378 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.837 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.75 30.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.95 145.19 49.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.57 3.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 0.0 110.98 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -171.81 165.43 6.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 122.31 35.84 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.464 1.102 . . . . 0.0 108.284 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.599 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.1 m -51.36 -50.75 74.42 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 110.392 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.598 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 55.2 Cg_endo -75.08 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.541 1.811 . . . . 0.0 110.964 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 25.5 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.135 . . . . 0.0 109.616 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.943 ' NH1' HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -87.96 -38.53 15.47 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.486 1.116 . . . . 0.0 110.32 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.788 ' N ' ' HD3' ' A' ' 86' ' ' ARG . . . -89.45 -23.83 32.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.895 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.65 -15.21 62.55 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 0.776 . . . . 0.0 109.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.457 1.098 . . . . 0.0 110.983 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.701 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.6 ttt -121.57 75.02 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 0.745 . . . . 0.0 111.068 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.14 153.57 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.251 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.73 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.55 1.156 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 0.778 . . . . 0.0 110.393 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.697 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 0.0 109.273 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.08 144.54 31.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.412 1.07 . . . . 0.0 110.411 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.579 1.175 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.164 . . . . 0.0 110.291 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.465 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 39.8 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.895 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 13.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 34.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.785 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 64.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 1.051 ' HG3' HG22 ' B' ' 233' ' ' VAL . 4.4 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.762 ' HG3' HD13 ' A' ' 60' ' ' LEU . 8.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 1.536 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 3.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.472 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.77 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.77 ' HB2' HG23 ' B' ' 105' ' ' THR . 83.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.685 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.473 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.685 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 82.1 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 66.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 43.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 1.361 ' C ' ' HD1' ' B' ' 162' ' ' TYR . 8.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.361 ' HD1' ' C ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.077 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.077 ' H ' HG23 ' B' ' 164' ' ' THR . 27.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.3 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 8.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 16.2 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 0.28 61.6 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.8 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.722 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 4.8 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 0.85 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 208' ' ' LEU . 3.3 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.85 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.8 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 1.051 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.52 126.85 29.13 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.574 1.171 . . . . 0.0 110.022 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 5.0 m -122.49 177.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.467 1.104 . . . . 0.0 109.295 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.83 40.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 0.0 110.321 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.11 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.434 1.084 . . . . 0.0 109.301 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.72 133.43 36.03 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.583 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.63 96.98 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.444 1.09 . . . . 0.0 111.008 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.57 7.65 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.504 1.127 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.13 160.64 15.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.449 0.735 . . . . 0.0 110.371 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.714 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 7.5 t70 -59.81 -15.91 24.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.448 1.093 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 3.3 ttmt -90.6 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.118 . . . . 0.0 109.311 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.886 ' HD2' HG21 ' B' ' 105' ' ' THR . 0.0 OUTLIER 38.34 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.71 58.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 0.0 109.248 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.869 ' HG3' HG21 ' A' ' 36' ' ' VAL . 16.5 Cg_endo -74.94 97.66 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.407 1.74 . . . . 0.0 111.043 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.81 151.18 31.93 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.43 134.84 26.53 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.391 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.07 140.95 70.09 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.032 -2.487 . . . . 0.0 110.954 0.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.3 tttt -40.19 -40.15 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 0.0 109.358 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.2 141.44 31.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 0.0 109.214 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.616 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.78 50.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.597 1.186 . . . . 0.0 110.052 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.87 -177.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.34 27.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.127 . . . . 0.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.575 1.172 . . . . 0.0 109.322 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.38 -7.25 8.55 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.523 1.14 . . . . 0.0 111.022 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.645 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.18 174.15 11.46 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.567 0.804 . . . . 0.0 109.294 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.61 154.2 39.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 0.0 110.466 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.32 102.59 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.562 1.164 . . . . 0.0 109.33 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.75 169.52 18.11 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.584 1.177 . . . . 0.0 110.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.22 121.48 9.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.597 1.186 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 66' ' ' SER . 4.3 p -125.08 155.34 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.567 1.167 . . . . 0.0 109.276 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.616 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.8 ttt -98.0 119.19 36.19 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.475 1.11 . . . . 0.0 111.026 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.718 ' OD1' ' HD3' ' A' ' 35' ' ' LYS . 2.1 t-20 -79.3 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 0.0 109.26 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.718 ' HD3' ' OD1' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.81 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 0.0 109.346 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.926 HG23 ' HG2' ' B' ' 119' ' ' PRO . 0.9 OUTLIER 45.9 54.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.31 40.54 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.563 1.165 . . . . 0.0 111.062 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.885 ' HD2' ' ND2' ' B' ' 70' ' ' ASN . 73.5 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.974 -2.511 . . . . 0.0 111.062 -0.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.621 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 70.3 m-70 -144.28 -170.37 3.34 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.576 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.483 HD21 ' HD3' ' A' ' 84' ' ' PRO . 4.3 p30 173.99 167.05 0.21 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.421 1.076 . . . . 0.0 109.289 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.11 114.36 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.583 1.177 . . . . 0.0 109.416 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.4 mm -132.84 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.67 160.6 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 111.008 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 4.1 t70 -97.08 -49.92 4.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.25 143.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.551 1.157 . . . . 0.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.073 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.53 158.08 72.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 0.0 109.276 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.0 164.24 33.74 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.408 1.741 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.57 1.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.467 1.104 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.51 -56.48 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.588 1.18 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.13 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.579 0.811 . . . . 0.0 110.295 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.08 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.073 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.06 -51.8 71.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -75.07 50.79 2.64 Favored 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.419 1.747 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.69 0.07 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.52 68.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.601 1.188 . . . . 0.0 109.316 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -46.45 115.13 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 110.008 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 117.6 34.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.365 1.04 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -89.77 21.86 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.404 1.065 . . . . 0.0 110.314 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' LEU . 61.7 tttt -86.04 64.42 8.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.416 1.072 . . . . 0.0 109.27 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.48 102.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.432 1.082 . . . . 0.0 109.335 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.4 98.4 5.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.531 1.144 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' B' ' 121' ' ' PRO . 1.7 mt -68.65 -46.1 80.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 0.0 109.365 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.51 4.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.95 139.19 24.13 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.544 1.813 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.85 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.475 1.109 . . . . 0.0 110.991 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.616 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.753 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 5.0 m-85 -38.28 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.54 175.16 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.42 1.075 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.65 161.4 20.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.54 1.15 . . . . 0.0 109.931 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.15 137.65 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 0.0 109.376 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.2 146.44 24.0 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.376 1.048 . . . . 0.0 110.406 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.09 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 0.0 109.22 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.39 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.573 1.17 . . . . 0.0 110.973 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.11 38.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.533 0.784 . . . . 0.0 110.439 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.51 26.74 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.543 1.812 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.66 20.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 124.501 1.125 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.83 120.05 40.47 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.539 0.788 . . . . 0.0 110.436 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.849 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.83 145.07 49.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.448 1.092 . . . . 0.0 110.028 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.566 1.166 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.415 ' CB ' HG12 ' A' ' 91' ' ' VAL . 53.7 p90 -171.86 165.39 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -93.47 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 0.0 108.344 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 1.277 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 0.8 OUTLIER -51.2 -50.84 73.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.544 1.153 . . . . 0.0 110.47 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.483 ' HD3' HD21 ' A' ' 40' ' ' ASN . 18.1 Cg_endo -75.04 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 30.3 m80 -75.12 57.98 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.581 1.175 . . . . 0.0 109.499 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -87.95 -38.47 15.53 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.523 1.14 . . . . 0.0 110.336 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.51 -23.88 32.53 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.379 1.049 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.19 62.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 0.774 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 63.14 1.83 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.523 1.14 . . . . 0.0 110.979 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.583 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.62 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.418 0.717 . . . . 0.0 111.0 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.0 m -124.19 153.57 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.549 1.156 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.45 -174.73 19.67 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.508 1.13 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.77 162.04 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 0.794 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.696 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.64 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.56 1.163 . . . . 0.0 109.27 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.6 m -105.06 144.56 31.7 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.29 73.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.158 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 O-C-N 124.581 1.176 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.112 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.444 ' HZ ' ' HD2' ' A' ' 11' ' ' LYS . 8.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.768 ' CG ' ' CD2' ' B' ' 1' ' ' TYR 0.283 12.5 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.6 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.759 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.643 ' CE2' HD13 ' B' ' 55' ' ' LEU . 46.8 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.643 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.2 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 2.4 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.672 ' HB2' HG21 ' B' ' 233' ' ' VAL . 26.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.809 ' OE1' ' HB2' ' B' ' 65' ' ' SER . 2.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 1.277 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.809 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 18.4 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 4.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.885 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 2.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 74' ' ' VAL . 8.5 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.789 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.003 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.0 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.6 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.536 ' HD1' ' HG ' ' B' ' 103' ' ' LEU . 1.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.536 ' HG ' ' HD1' ' B' ' 102' ' ' TYR . 11.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.825 ' CB ' HD22 ' B' ' 83' ' ' LEU . 20.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.886 HG21 ' HD2' ' A' ' 12' ' ' TYR . 11.7 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.1 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 0.926 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.678 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 26.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG2' HG23 ' A' ' 36' ' ' VAL . 1.1 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.558 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 8.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 0.956 ' CB ' HG23 ' A' ' 62' ' ' ILE . 2.5 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.546 ' HB3' HD12 ' A' ' 62' ' ' ILE . 4.6 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.764 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 2.4 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 126' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 20.8 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.725 ' CD2' HD22 ' B' ' 75' ' ' LEU . 21.5 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.003 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.616 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.453 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' B' ' 24' ' ' CYS . 13.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.053 ' CB ' HG22 ' B' ' 164' ' ' THR . 22.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.114 HG23 ' H ' ' B' ' 166' ' ' GLU . 4.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.114 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.4 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 60.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.434 HD21 ' NH1' ' B' ' 158' ' ' ARG . 9.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.706 HD22 ' HA ' ' B' ' 232' ' ' ASN . 19.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.475 1.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 62.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.906 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.258 3.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 76.5 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.8 HD22 ' N ' ' B' ' 208' ' ' LEU . 2.4 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 9.4 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 232' ' ' ASN . . . . . 0.706 ' HA ' HD22 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.678 HG23 HD21 ' B' ' 69' ' ' LEU . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.6 126.82 29.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.44 177.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.91 150.87 40.36 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.4 112.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.42 1.075 . . . . 0.0 109.224 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.73 133.51 35.96 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.51 1.131 . . . . 0.0 109.285 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.563 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.01 6.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 0.0 111.001 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 1.028 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.0 144.48 7.65 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 124.501 1.126 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -108.16 160.68 15.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.405 0.709 . . . . 0.0 110.356 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.78 -15.99 24.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 0.0 109.324 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 19.7 mttt -90.58 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.358 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 38.25 29.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 111.059 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.71 58.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.152 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' SD ' ' A' ' 90' ' ' MET . 38.1 Cg_endo -75.06 97.63 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.478 1.778 . . . . 0.0 111.002 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 4.0 pp -150.74 151.31 32.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.496 1.122 . . . . 0.0 109.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.44 126.21 30.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.42 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.427 1.079 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.02 140.98 70.35 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.964 -2.515 . . . . 0.0 110.942 0.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.24 -40.03 1.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.27 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.381 1.051 . . . . 0.0 109.282 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.24 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.158 . . . . 0.0 109.26 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.02 143.81 51.0 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.564 1.165 . . . . 0.0 110.037 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.97 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 0.0 109.32 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.38 27.44 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.476 1.11 . . . . 0.0 109.914 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.16 105.38 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.575 1.172 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.47 -7.39 8.47 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 0.0 111.063 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.24 11.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.568 0.805 . . . . 0.0 109.2 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.574 1.172 . . . . 0.0 110.369 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.38 102.59 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.554 1.159 . . . . 0.0 109.268 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.25 121.52 9.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.08 155.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 0.0 109.302 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.479 ' HG3' ' CD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.01 119.2 36.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 111.005 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 1.028 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -79.34 -66.01 0.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.57 1.169 . . . . 0.0 109.237 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 0.0 109.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' B' ' 3' ' ' PHE . 7.2 p 46.1 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.104 . . . . 0.0 109.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.677 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.3 40.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.52 1.138 . . . . 0.0 111.031 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.022 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 9.2 Cg_endo -74.9 -168.99 6.91 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.986 -2.506 . . . . 0.0 110.998 -0.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.677 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 65.3 m-70 -144.13 -170.34 3.32 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 1.101 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.555 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.8 p30 173.9 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.03 114.29 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 109.394 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 1.8 mm -132.78 76.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.426 1.079 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.67 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.41 1.069 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.0 4.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.032 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.05 72.91 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.231 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 164.29 33.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.522 1.801 . . . . 0.0 111.032 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.29 135.61 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.49 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.548 1.155 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.585 0.815 . . . . 0.0 110.27 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.2 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.388 1.055 . . . . 0.0 109.938 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.032 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.88 70.62 Favored Pre-proline 0 C--N 1.323 -0.572 0 O-C-N 124.509 1.13 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -74.99 50.79 2.62 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.448 1.762 . . . . 0.0 110.966 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.58 1.175 . . . . 0.0 109.283 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.41 115.12 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.534 1.146 . . . . 0.0 110.014 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 6.2 m-20 -107.96 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 1.144 . . . . 0.0 109.303 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.062 HG21 ' CB ' ' B' ' 63' ' ' ASP . 7.2 t -89.75 21.86 3.34 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.379 1.05 . . . . 0.0 110.389 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 19.4 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 109.21 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -40.44 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.49 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.685 HG13 ' ND2' ' B' ' 70' ' ' ASN . 0.1 OUTLIER -68.73 -46.13 80.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 0.0 109.283 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -75.05 139.23 23.92 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.416 1.745 . . . . 0.0 111.001 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.84 -68.0 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.472 1.108 . . . . 0.0 110.955 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.496 0.763 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.49 175.13 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 0.0 109.964 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.65 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.129 . . . . 0.0 109.388 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.19 146.48 23.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.15 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.558 1.161 . . . . 0.0 109.205 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.453 1.095 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.469 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.19 38.32 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.586 0.815 . . . . 0.0 110.413 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -75.07 141.43 26.41 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.543 1.812 . . . . 0.0 111.031 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.62 20.09 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.418 1.074 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.86 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 0.789 . . . . 0.0 110.356 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.78 140.77 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 1.158 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.05 49.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.996 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.46 3.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.497 1.123 . . . . 0.0 110.991 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -171.85 165.45 6.47 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 122.31 35.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.443 1.089 . . . . 0.0 108.245 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.9 OUTLIER -51.25 -50.83 73.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.421 1.075 . . . . 0.0 110.393 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.752 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 19.0 Cg_endo -75.08 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 110.98 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 32.0 m-70 -75.07 57.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 0.0 109.619 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 83' ' ' THR . 2.5 ptm180 -87.96 -38.5 15.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.85 32.7 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.532 1.145 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.24 62.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.472 0.748 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.2 63.2 1.82 Allowed Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.423 1.077 . . . . 0.0 110.868 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.563 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 9.0 ttt -121.68 75.1 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.451 0.736 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.57 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.481 1.113 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.78 19.77 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.46 1.1 . . . . 0.0 111.022 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 161.99 37.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.526 0.78 . . . . 0.0 110.407 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.59 122.61 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.243 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.8 m -105.08 144.56 31.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.458 1.099 . . . . 0.0 109.291 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.791 ' N ' ' HD2' ' B' ' 4' ' ' TYR . 3.6 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 5.3 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.721 ' HB2' HG23 ' A' ' 36' ' ' VAL . 2.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.791 ' HD2' ' N ' ' B' ' 1' ' ' TYR . 44.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 107' ' ' TYR . 47.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 4.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.755 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.9 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.658 ' HB2' HG21 ' B' ' 233' ' ' VAL . 10.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.526 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 89.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.784 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.516 ' HB3' ' OG1' ' A' ' 58' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 1.062 ' CB ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.784 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 28.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.546 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 38.4 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.422 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 0.685 ' ND2' HG13 ' A' ' 62' ' ' ILE . 7.9 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.409 ' HB ' HG11 ' B' ' 51' ' ' VAL . 4.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 7.2 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' B' ' 102' ' ' TYR . 0.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.416 HD21 HD22 ' B' ' 120' ' ' LEU . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 0.832 ' CB ' HD22 ' B' ' 83' ' ' LEU . 55.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 61.9 p -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.4 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.0 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.001 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' B' ' 107' ' ' TYR . 82.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.587 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.022 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.587 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 15.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.427 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.483 ' NH2' ' HB3' ' B' ' 158' ' ' ARG . 0.1 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.451 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' B' ' 24' ' ' CYS . 4.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.075 ' CB ' HG22 ' B' ' 164' ' ' THR . 18.3 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.549 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 5.1 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.075 HG22 ' CB ' ' B' ' 162' ' ' TYR . 5.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 165' ' ' GLY . . . . . 0.481 ' N ' HG23 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.972 ' H ' HG23 ' B' ' 164' ' ' THR . 34.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.594 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.932 ' HB3' ' H ' ' B' ' 170' ' ' ASN 0.684 0.1 OUTLIER -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.932 ' H ' ' HB3' ' B' ' 168' ' ' SER . 13.8 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.046 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.917 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.046 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.59 126.77 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.93 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.4 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 0.0 109.28 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.9 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.434 1.084 . . . . 0.0 109.3 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.79 133.46 36.02 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.53 1.144 . . . . 0.0 109.315 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.688 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.05 6.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 0.0 110.987 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.54 7.66 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.544 1.153 . . . . 0.0 110.992 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 15.9 p -108.04 160.67 15.61 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.389 0.699 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -59.87 -15.94 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 6.0 ttmt -90.57 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.353 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' B' ' 3' ' ' PHE . 0.5 OUTLIER 38.26 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 0.0 111.025 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.77 117.66 58.3 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 109.344 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.685 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 33.2 Cg_endo -74.94 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.551 1.816 . . . . 0.0 111.045 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.84 151.19 31.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.12 . . . . 0.0 109.317 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.27 126.17 30.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.978 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.88 26.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.514 1.134 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.94 70.1 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.033 -2.486 . . . . 0.0 110.971 0.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.554 1.159 . . . . 0.0 109.264 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.32 46.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.428 1.08 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.93 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.38 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 0.0 109.235 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.627 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 0.0 110.065 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.493 1.12 . . . . 0.0 109.284 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.34 27.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 0.0 110.009 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.36 0.27 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.6 1.187 . . . . 0.0 109.298 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.42 8.46 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.431 1.082 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.13 174.14 11.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 0.764 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.54 154.25 39.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 0.0 110.516 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.715 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.41 102.57 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.568 1.167 . . . . 0.0 109.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.54 18.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.41 9.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.12 . . . . 0.0 110.97 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.33 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.895 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.3 ttp -98.01 119.25 36.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.409 1.068 . . . . 0.0 111.0 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.36 -66.09 0.92 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 0.0 109.216 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.269 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.685 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.02 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.419 1.075 . . . . 0.0 109.32 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.98 -172.29 40.52 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.51 1.131 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.277 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -74.99 -168.92 6.88 Favored 'Cis proline' 0 C--N 1.361 1.209 0 C-N-CA 120.919 -2.534 . . . . 0.0 110.975 -0.067 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.94 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 71.0 m-70 -144.19 -170.36 3.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.614 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.518 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.7 p30 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.478 1.111 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.09 114.34 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.599 1.187 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' CZ ' ' A' ' 81' ' ' TYR . 9.0 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 0.0 109.345 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.426 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.65 160.62 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.569 1.168 . . . . 0.0 109.308 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.33 143.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.618 1.199 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.5 158.1 72.81 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.35 1.031 . . . . 0.0 109.25 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.01 164.26 33.7 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.495 1.787 . . . . 0.0 111.046 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.62 1.41 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.56 1.162 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.42 2.24 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.608 0.828 . . . . 0.0 110.26 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.09 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.451 1.095 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.011 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.77 71.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 O-C-N 124.491 1.12 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.04 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.427 1.751 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.25 -45.67 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.604 1.19 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -46.47 115.11 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 1.126 . . . . 0.0 109.976 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 117.68 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 109.348 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -89.8 21.94 3.34 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.401 1.063 . . . . 0.0 110.304 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -86.07 64.45 8.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.277 ' CD1' ' HB2' ' A' ' 38' ' ' PRO . 17.6 tp -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 0.0 109.314 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.4 6.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.809 HG21 ' HG3' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -68.64 -46.09 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 0.0 109.362 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.757 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -62.08 111.59 4.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.273 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.03 139.11 23.82 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.424 1.749 . . . . 0.0 111.05 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.93 -67.99 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.583 1.177 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.656 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.461 0.742 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.0 m-85 -38.23 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -171.5 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.458 1.099 . . . . 0.0 110.028 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.418 1.074 . . . . 0.0 109.403 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.26 146.52 23.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 110.391 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.11 8.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 109.276 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.09 37.61 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.5 0.765 . . . . 0.0 110.366 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -75.01 141.5 26.68 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.48 1.779 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.419 1.074 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.88 120.08 40.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 0.736 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.71 30.94 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.134 . . . . 0.0 111.043 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.94 145.12 49.37 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.461 1.101 . . . . 0.0 109.975 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.13 -171.53 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.428 1.08 . . . . 0.0 110.994 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 55.4 p90 -171.84 165.43 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.499 1.124 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 122.35 35.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.526 1.141 . . . . 0.0 108.328 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -51.33 -50.85 73.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 0.0 110.392 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.648 ' HB2' ' CE2' ' B' ' 162' ' ' TYR . 18.2 Cg_endo -75.0 -62.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.503 1.791 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.42 ' CE1' ' OH ' ' B' ' 4' ' ' TYR . 46.2 m-70 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.0 -38.47 15.48 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.545 1.153 . . . . 0.0 110.322 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.8 32.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.498 1.124 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.67 -15.23 62.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.516 0.774 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.441 1.088 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.688 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.58 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.421 0.718 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.56 ' CG1' HH21 ' A' ' 86' ' ' ARG . 11.5 m -124.16 153.61 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 0.0 109.248 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.59 -174.8 19.83 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.71 162.05 36.97 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 0.764 . . . . 0.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.715 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.59 122.67 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 0.0 109.283 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.07 144.51 31.77 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.382 1.051 . . . . 0.0 110.393 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.27 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 124.584 1.178 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.545 1.153 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.901 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 89.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 79.7 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.447 ' HD1' ' HA ' ' B' ' 4' ' ' TYR . 5.5 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.408 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 42.7 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.793 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.975 ' HG3' ' CG2' ' B' ' 233' ' ' VAL . 1.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.412 HG11 ' HA3' ' B' ' 210' ' ' GLY . 44.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.809 ' HG3' HG21 ' A' ' 62' ' ' ILE . 4.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 1.227 ' HB1' ' CD2' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 14.9 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.579 ' HB2' ' OE1' ' B' ' 58' ' ' GLN 0.26 4.8 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.555 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.473 ' CE2' HD23 ' B' ' 103' ' ' LEU . 9.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.689 HG23 ' HB2' ' B' ' 116' ' ' LEU . 9.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 77.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.491 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.901 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.491 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 87.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.444 ' HA2' ' NE2' ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.763 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 64.4 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' B' ' 24' ' ' CYS . 11.0 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 0.648 ' CE2' ' HB2' ' A' ' 84' ' ' PRO . 2.5 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.409 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.037 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.037 ' H ' HG23 ' B' ' 164' ' ' THR . 4.0 tp10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.708 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.444 HD21 HH22 ' B' ' 158' ' ' ARG . 11.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.602 ' CG ' ' O ' ' B' ' 170' ' ' ASN . 16.9 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.741 ' HB2' ' CD2' ' B' ' 189' ' ' PHE . 5.2 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.309 ' CD1' ' HG3' ' B' ' 209' ' ' PRO . 0.0 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 5.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 83.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.5 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.309 ' HG3' ' CD1' ' B' ' 189' ' ' PHE . 2.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 210' ' ' GLY . . . . . 0.412 ' HA3' HG11 ' B' ' 60' ' ' VAL . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.531 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 19.7 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' ASN . . . . . 0.483 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.975 ' CG2' ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.64 126.83 29.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.575 1.172 . . . . 0.0 110.04 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.934 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.47 177.2 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.431 1.082 . . . . 0.0 109.263 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.99 150.82 40.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 0.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.39 112.17 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.418 1.074 . . . . 0.0 109.213 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.74 133.48 35.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.563 1.165 . . . . 0.0 109.372 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.675 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.67 97.01 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.443 1.089 . . . . 0.0 110.951 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.524 1.14 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -108.08 160.64 15.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 0.743 . . . . 0.0 110.415 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -16.0 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 0.0 109.29 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.9 mttt -90.62 39.66 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.978 ' O ' ' CZ ' ' B' ' 3' ' ' PHE . 0.4 OUTLIER 38.28 29.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 0.0 110.996 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.66 58.21 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 1.057 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 6.3 Cg_exo -75.01 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.482 1.78 . . . . 0.0 111.057 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -150.77 151.22 32.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.18 30.52 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.527 1.142 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.8 26.49 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.09 140.98 70.23 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.009 -2.496 . . . . 0.0 110.951 0.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.2 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 1.124 . . . . 0.0 109.278 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.423 1.077 . . . . 0.0 109.329 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.934 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.43 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.592 1.183 . . . . 0.0 109.209 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.612 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.77 50.97 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.553 1.158 . . . . 0.0 110.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.112 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.981 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.603 1.19 . . . . 0.0 109.321 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.44 -7.27 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.512 1.133 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.582 0.813 . . . . 0.0 109.29 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.62 154.16 39.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.455 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD13 ' A' ' 94' ' ' ILE . 63.4 t -131.3 102.57 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.601 1.188 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.73 169.53 18.09 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.539 1.149 . . . . 0.0 110.311 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.31 121.47 9.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.03 155.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.586 1.178 . . . . 0.0 109.315 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.3 ttp -97.99 119.22 36.24 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' HB3' ' HD3' ' A' ' 35' ' ' LYS 0.324 6.6 m-20 -79.33 -66.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 0.0 109.264 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.86 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.456 1.098 . . . . 0.0 109.396 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.057 ' CG2' ' HG3' ' A' ' 14' ' ' PRO . 2.4 p 45.9 54.89 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.93 -172.29 40.6 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.582 1.176 . . . . 0.0 111.047 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.961 ' HD3' ' CZ ' ' B' ' 1' ' ' TYR . 24.3 Cg_endo -74.94 -168.89 6.84 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 120.953 -2.52 . . . . 0.0 111.054 -0.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.652 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 68.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 1.053 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 167.02 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 0.0 109.258 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.1 114.42 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.914 HG13 ' OG1' ' A' ' 83' ' ' THR . 7.4 mm -132.87 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 0.0 109.311 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.7 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.449 1.093 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' HA ' ' HE2' ' A' ' 81' ' ' TYR . 1.7 t70 -96.98 -49.98 4.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.314 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.31 143.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 0.0 109.352 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.019 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.09 72.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 0.0 109.244 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 164.2 33.8 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.477 1.777 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.31 135.62 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.532 1.145 . . . . 0.0 109.297 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.53 -56.48 0.73 Allowed Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.521 1.138 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.584 0.814 . . . . 0.0 110.294 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.74 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 109.987 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.019 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.86 70.75 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 124.514 1.134 . . . . 0.0 109.306 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.1 Cg_endo -75.03 50.82 2.64 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.45 1.763 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.573 1.171 . . . . 0.0 109.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.54 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.517 1.136 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -46.5 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.445 1.091 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.93 117.61 34.59 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.38 1.05 . . . . 0.0 109.285 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.5 t -89.81 21.89 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.39 1.056 . . . . 0.0 110.341 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 8.4 tttm -86.06 64.47 8.6 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.429 1.081 . . . . 0.0 109.244 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.053 HD22 ' HB3' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -40.46 102.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 0.0 109.344 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.39 6.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.68 -46.04 80.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.565 1.166 . . . . 0.0 109.35 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.04 139.17 23.86 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.527 1.803 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.89 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.504 1.128 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.669 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 0.767 . . . . 0.0 110.02 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 3.6 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.529 1.143 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.53 175.13 4.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.481 1.113 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.39 20.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.552 1.158 . . . . 0.0 109.939 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.67 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.18 146.44 23.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 0.0 109.251 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.546 1.154 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.456 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.12 37.89 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.508 0.77 . . . . 0.0 110.423 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.96 141.46 26.78 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.58 1.832 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.68 20.04 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.494 1.121 . . . . 0.0 110.993 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.439 0.729 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.78 140.75 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.06 49.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.538 1.149 . . . . 0.0 109.98 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.5 3.73 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.817 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 42.4 p90 -171.85 165.38 6.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.547 1.154 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' CYS . . . . . 1.332 ' O ' ' NE ' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -93.48 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.405 1.065 . . . . 0.0 108.326 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.984 ' O ' ' HB ' ' B' ' 164' ' ' THR . 5.7 m -51.23 -50.89 73.15 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.452 1.095 . . . . 0.0 110.396 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.676 ' O ' ' HG2' ' B' ' 163' ' ' PRO . 40.5 Cg_endo -75.0 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 0.0 111.0 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 27.2 m80 -75.09 57.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.491 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.332 ' NE ' ' O ' ' A' ' 82' ' ' CYS . 0.2 OUTLIER -87.94 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.34 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.87 32.79 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.439 1.087 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' B' ' 7' ' ' TYR . . . -65.68 -15.21 62.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.525 0.78 . . . . 0.0 109.292 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.16 1.82 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.675 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.8 ttt -121.65 75.08 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.473 0.749 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 81' ' ' TYR . 14.0 m -124.24 153.61 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.558 1.161 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.72 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.461 1.101 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.77 162.06 37.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.568 0.805 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.6 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.494 1.121 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.1 m -105.07 144.52 31.76 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.396 1.06 . . . . 0.0 110.407 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.24 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.16 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 O-C-N 124.594 1.184 . . . . 0.0 110.34 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.961 ' CZ ' ' HD3' ' A' ' 38' ' ' PRO . 42.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 0.978 ' CZ ' ' O ' ' A' ' 12' ' ' TYR . 1.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' B' ' 4' ' ' TYR . 4.4 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.949 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.909 ' CD1' HG11 ' B' ' 20' ' ' VAL . 85.1 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.909 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASN . . . . . 1.478 ' CB ' ' CA ' ' B' ' 23' ' ' ASN 0.623 4.0 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.492 ' HA ' HG12 ' B' ' 161' ' ' VAL . 47.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.77 ' HB2' HG21 ' B' ' 233' ' ' VAL . 13.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.621 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 99.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.85 ' HG3' ' H ' ' B' ' 62' ' ' ALA . 1.4 tt0 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 0.85 ' H ' ' HG3' ' B' ' 61' ' ' GLN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.568 ' H ' ' HG2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 39.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.547 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 80.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.489 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.753 ' HG3' ' CD2' ' B' ' 1' ' ' TYR . 1.2 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.489 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 90.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.652 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 39.8 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' B' ' 24' ' ' CYS . 0.5 OUTLIER -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.031 ' HB3' HG22 ' B' ' 164' ' ' THR . 9.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.676 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.031 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.5 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 0.901 ' H ' HG23 ' B' ' 164' ' ' THR . 23.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.6 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 168' ' ' SER . . . . . 0.577 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 57.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.424 HD21 HH22 ' B' ' 158' ' ' ARG . 22.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.608 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 16.5 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.88 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.16 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.272 7.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.508 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.553 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.16 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.82 29.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 0.0 110.02 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.959 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.08 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.441 1.088 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.9 150.88 40.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 110.338 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.41 1.069 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.513 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.65 133.46 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.492 1.12 . . . . 0.0 109.351 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.683 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.73 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 111.034 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.45 7.63 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 124.514 1.134 . . . . 0.0 111.064 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.639 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -108.12 160.6 15.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.361 0.683 . . . . 0.0 110.443 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 9.8 t70 -59.79 -15.92 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 0.0 109.303 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 7.5 ttmt -90.64 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.545 1.153 . . . . 0.0 109.351 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.23 29.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.639 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.89 117.66 58.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 44.6 Cg_endo -75.01 97.65 1.1 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 O-C-N 124.471 1.774 . . . . 0.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.3 pp -150.82 151.31 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.318 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.4 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 110.315 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.08 140.97 70.19 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 120.987 -2.505 . . . . 0.0 110.966 0.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 1.15 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.13 146.27 46.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.354 1.034 . . . . 0.0 109.335 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.959 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.25 141.33 31.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.614 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.92 -177.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.563 1.165 . . . . 0.0 109.335 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.805 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 105.44 0.28 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.117 . . . . 0.0 109.303 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.29 8.5 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.48 1.112 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.19 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 0.792 . . . . 0.0 109.232 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.59 154.23 39.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.44 102.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 0.0 109.277 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.462 1.101 . . . . 0.0 110.284 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.25 121.5 9.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.939 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.09 155.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 109.269 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.642 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 12.2 ttp -98.09 119.19 36.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 0.0 111.026 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.28 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 0.0 109.296 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' NZ ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.488 1.117 . . . . 0.0 109.248 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.939 HG23 ' HD2' ' B' ' 119' ' ' PRO . 11.6 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.403 1.064 . . . . 0.0 109.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.32 40.54 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.524 1.14 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.012 ' HD3' ' OD1' ' B' ' 70' ' ' ASN . 3.9 Cg_exo -74.92 -169.03 6.95 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.018 -2.492 . . . . 0.0 110.959 -0.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.658 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.3 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.488 1.117 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.435 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 173.93 166.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 0.0 109.307 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.578 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.37 43.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 0.0 109.343 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 41' ' ' VAL . 1.3 mm -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 87.1 m-85 -47.68 160.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.462 1.101 . . . . 0.0 111.008 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.605 1.191 . . . . 0.0 109.31 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.9 mttt 167.32 143.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.449 1.093 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 157.98 73.2 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.394 1.059 . . . . 0.0 109.265 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.91 164.28 33.78 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.509 1.794 . . . . 0.0 111.054 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.32 135.61 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.5 0.73 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.492 1.12 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.1 -173.29 2.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.567 0.804 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.29 77.83 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.396 1.06 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.005 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.87 70.73 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.563 1.164 . . . . 0.0 109.274 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -75.05 50.81 2.64 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.443 1.759 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.57 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.638 1.212 . . . . 0.0 109.344 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.58 68.15 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 m -46.47 115.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 1.141 . . . . 0.0 109.988 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.91 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.411 1.07 . . . . 0.0 109.322 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -89.69 21.81 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.458 1.099 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -85.95 64.38 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.417 1.073 . . . . 0.0 109.222 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -40.43 102.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.49 98.53 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 0.0 109.29 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.161 HG23 ' CG ' ' B' ' 121' ' ' PRO . 28.7 mt -68.78 -46.07 80.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.61 1.194 . . . . 0.0 109.304 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.18 111.61 4.91 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.117 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -75.0 139.19 23.98 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.413 1.744 . . . . 0.0 111.038 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.379 1.05 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.659 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.509 0.77 . . . . 0.0 110.048 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.11 -86.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.48 175.16 4.19 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.443 1.089 . . . . 0.0 111.014 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.25 20.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.979 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.67 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 0.0 109.412 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.19 146.53 23.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 110.404 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.08 8.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.179 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.539 1.149 . . . . 0.0 110.996 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.458 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.21 37.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.561 0.801 . . . . 0.0 110.409 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.13 141.52 26.38 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.511 1.795 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.06 -178.68 20.0 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.508 1.13 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.81 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 0.764 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.89 145.13 49.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.45 3.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.581 1.176 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.428 ' CB ' HG12 ' A' ' 91' ' ' VAL . 39.5 p90 -171.89 165.39 6.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 111.042 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.59 122.39 35.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.112 . . . . 0.0 108.268 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 1.171 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 1.2 m -51.29 -50.82 73.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.084 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 21.2 Cg_endo -75.06 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.574 1.829 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.3 m80 -75.1 58.05 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.99 -38.59 15.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.135 . . . . 0.0 110.292 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.903 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.48 -23.84 32.74 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.443 1.089 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -65.68 -15.22 62.58 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.528 0.781 . . . . 0.0 109.357 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.503 1.127 . . . . 0.0 110.885 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.683 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.7 75.1 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 0.74 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.3 m -124.14 153.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.473 1.108 . . . . 0.0 109.287 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.513 1.133 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.05 37.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.343 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.7 122.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 109.275 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.46 31.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.455 1.097 . . . . 0.0 110.381 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.21 73.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 109.285 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.805 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.516 1.135 . . . . 0.0 110.325 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.497 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 32.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 4.9 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.702 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 6.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.6 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.764 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.638 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.0 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 20.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.746 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 40.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 1.081 ' NE2' HG21 ' A' ' 83' ' ' THR . 3.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 1.171 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.8 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 16.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.3 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' B' ' 59' ' ' GLN . 9.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ASN . . . . . 1.012 ' OD1' ' HD3' ' A' ' 38' ' ' PRO . 86.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.012 HD11 ' HD2' ' B' ' 131' ' ' PRO . 30.5 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.541 HD23 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.197 ' CG1' HD12 ' B' ' 115' ' ' LEU . 20.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.772 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.4 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.197 HD12 ' CG1' ' B' ' 104' ' ' VAL . 0.0 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.772 ' HB2' HG23 ' B' ' 105' ' ' THR . 16.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.939 ' HD2' HG23 ' A' ' 36' ' ' VAL . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.541 HD11 HD23 ' B' ' 103' ' ' LEU . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' PRO . . . . . 1.161 ' CG ' HG23 ' A' ' 62' ' ' ILE . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.664 ' HB2' HG21 ' A' ' 62' ' ' ILE . 12.9 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 126' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 21.6 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.481 ' HE2' ' CD1' ' B' ' 120' ' ' LEU . 20.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.012 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.746 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 27.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.452 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.048 ' CB ' HG22 ' B' ' 164' ' ' THR . 7.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.702 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.2 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.048 HG22 ' CB ' ' B' ' 162' ' ' TYR . 2.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.02 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.537 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 57.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.822 HD22 ' HA ' ' B' ' 232' ' ' ASN . 17.1 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.503 3.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 66.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.771 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 18.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 1.188 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.27 20.2 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 207' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.662 HD22 ' N ' ' B' ' 208' ' ' LEU . 1.9 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 1.188 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HA ' ' HG3' ' B' ' 231' ' ' PRO . 1.1 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 231' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 2.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 232' ' ' ASN . . . . . 0.822 ' HA ' HD22 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.61 126.83 29.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 1.16 . . . . 0.0 109.999 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.18 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.41 1.069 . . . . 0.0 109.285 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.88 40.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.15 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.387 1.054 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.523 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.77 133.49 35.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.51 1.131 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.627 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.105 . . . . 0.0 110.997 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.49 7.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.594 1.184 . . . . 0.0 110.974 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.06 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.409 0.711 . . . . 0.0 110.417 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.84 -15.94 24.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.322 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.5 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 38.3 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 0.0 111.009 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.72 58.05 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 1.076 ' HG3' ' HE2' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.46 1.769 . . . . 0.0 111.022 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 2.8 pp -150.8 151.25 32.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.46 1.1 . . . . 0.0 109.32 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.413 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.39 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.89 26.59 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.55 1.156 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.99 70.35 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 120.995 -2.502 . . . . 0.0 110.944 0.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.16 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.243 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.05 146.28 46.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 3' ' ' VAL . 10.9 tp -143.28 141.4 31.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.566 1.166 . . . . 0.0 109.202 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 0.0 110.063 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.93 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.54 158.31 27.57 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.602 1.189 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.41 8.46 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.443 1.09 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.11 11.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 0.735 . . . . 0.0 109.3 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 154.27 39.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 1.119 . . . . 0.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 94' ' ' ILE . 63.8 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.143 . . . . 0.0 109.332 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.82 169.52 18.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.39 9.51 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.484 1.115 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.96 155.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.07 119.26 36.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.413 1.07 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.333 6.9 m-20 -79.4 -66.03 0.92 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.412 1.07 . . . . 0.0 109.237 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.473 1.108 . . . . 0.0 109.235 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.652 ' HB ' ' CE2' ' B' ' 3' ' ' PHE . 19.0 m 46.02 54.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.647 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.33 40.62 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.558 1.161 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HD2' ' CE2' ' B' ' 1' ' ' TYR . 19.5 Cg_endo -74.97 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.947 -2.522 . . . . 0.0 110.977 -0.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.647 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.5 m-70 -144.26 -170.36 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.403 1.064 . . . . 0.0 109.327 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.11 114.35 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 109.329 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -132.82 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.61 160.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 0.0 110.959 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 6.9 mttt 167.32 143.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.473 1.108 . . . . 0.0 109.266 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.039 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.5 158.08 72.86 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.393 1.058 . . . . 0.0 109.284 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.03 164.25 33.68 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.42 1.748 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.67 1.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 0.0 109.33 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.485 1.116 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 0.822 . . . . 0.0 110.28 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.1 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 110.042 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.039 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.98 -51.84 70.88 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.441 1.088 . . . . 0.0 109.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.05 50.75 2.62 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.43 1.752 . . . . 0.0 110.966 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.26 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.587 1.179 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.53 68.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -46.52 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.974 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.455 1.097 . . . . 0.0 109.345 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.851 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 4.6 t -89.77 21.84 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.393 1.058 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -86.08 64.44 8.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.171 HD23 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -40.44 102.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.47 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.729 HD11 ' CD1' ' A' ' 60' ' ' LEU . 4.3 mm -68.66 -46.11 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.602 1.189 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 0.0 109.278 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.03 139.1 23.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.431 1.753 . . . . 0.0 111.019 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.552 1.157 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.471 0.748 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.18 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.461 1.101 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.448 1.092 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.29 20.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.448 1.093 . . . . 0.0 109.99 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.72 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 0.0 109.389 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.546 1.154 . . . . 0.0 110.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.1 8.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 1.1 . . . . 0.0 109.235 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.497 1.123 . . . . 0.0 111.045 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.473 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.71 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.543 0.79 . . . . 0.0 110.37 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 141.5 26.7 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.483 1.781 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.415 1.072 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.03 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 0.76 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.69 140.73 30.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.21 -171.55 3.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 42' ' ' ILE . 9.3 p90 -171.83 165.43 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.514 1.134 . . . . 0.0 111.028 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.6 122.35 35.97 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.478 1.111 . . . . 0.0 108.243 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -51.31 -50.81 73.93 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 110.397 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 83' ' ' THR . 49.5 Cg_endo -75.05 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.531 1.806 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.46 ' NE2' ' HE1' ' B' ' 4' ' ' TYR . 27.3 m80 -74.95 57.96 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 0.0 109.601 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.178 ' HE ' ' CA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -88.01 -38.47 15.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.634 1.209 . . . . 0.0 110.276 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.54 -23.76 32.83 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.43 1.081 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.19 62.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 0.765 . . . . 0.0 109.426 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.06 1.83 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.438 1.086 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.627 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.07 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.454 0.738 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.175 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.18 153.62 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.564 1.165 . . . . 0.0 109.289 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.458 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.74 19.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.603 1.189 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 0.79 . . . . 0.0 110.382 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.64 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.255 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.2 m -105.01 144.55 31.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.393 1.058 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.537 1.148 . . . . 0.0 109.303 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 0.0 110.265 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 0.926 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 93.7 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 1.076 ' HE2' ' HG3' ' A' ' 14' ' ' PRO . 12.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.87 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 12.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 9' ' ' TYR . 11.7 t-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.788 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.3 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.2 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.779 ' HB2' HG21 ' B' ' 233' ' ' VAL . 36.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 89.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 0.783 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 1.171 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.704 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.783 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 9.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.432 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.505 ' CD2' HD23 ' B' ' 103' ' ' LEU . 30.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.8 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.72 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 2.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.549 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.0 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.5 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.72 ' HB2' HG23 ' B' ' 105' ' ' THR . 11.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.645 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.645 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 47.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 68.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.651 ' HG3' ' OE1' ' B' ' 59' ' ' GLN . 1.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.423 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' B' ' 24' ' ' CYS . 8.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 0.456 ' HB3' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.015 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.595 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.562 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 18.1 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.962 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 0.962 ' HD1' ' HB2' ' B' ' 187' ' ' ASN . 0.4 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.509 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.559 HD22 ' N ' ' B' ' 208' ' ' LEU . 4.0 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.88 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.63 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 110.03 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.554 1.159 . . . . 0.0 110.342 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.31 112.16 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.408 1.068 . . . . 0.0 109.307 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.75 133.44 36.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.548 1.155 . . . . 0.0 109.306 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.801 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.66 97.0 6.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.469 1.106 . . . . 0.0 111.002 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.03 144.41 7.62 Favored Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.464 1.103 . . . . 0.0 111.074 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.699 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 17.3 p -108.09 160.69 15.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.422 0.719 . . . . 0.0 110.402 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.79 -15.96 24.41 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.441 1.088 . . . . 0.0 109.305 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 5.0 tppt? -90.64 39.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.298 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 1.276 ' CZ ' ' HB2' ' B' ' 3' ' ' PHE . 12.3 m-30 38.29 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.125 . . . . 0.0 111.008 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.81 117.67 58.24 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.487 1.117 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.803 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 1.2 Cg_endo -75.03 97.56 1.09 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.455 1.766 . . . . 0.0 110.99 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' THR . 1.2 pp -150.73 151.29 32.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.41 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 0.0 110.934 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.47 134.91 26.61 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.445 1.091 . . . . 0.0 110.317 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.08 141.0 70.37 Favored 'Cis proline' 0 C--N 1.361 1.22 0 C-N-CA 120.947 -2.522 . . . . 0.0 111.013 0.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.21 -40.13 1.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 0.0 109.181 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.27 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.384 1.052 . . . . 0.0 109.281 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.21 141.41 31.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 0.0 109.216 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.626 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.78 50.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.544 1.152 . . . . 0.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.633 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.92 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.56 158.32 27.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 109.963 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.594 1.184 . . . . 0.0 109.313 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.36 8.46 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.465 1.103 . . . . 0.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.633 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.22 174.16 11.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 0.758 . . . . 0.0 109.182 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.577 1.173 . . . . 0.0 110.371 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.7 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.41 102.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 0.0 109.285 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.86 169.62 17.95 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.128 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.24 121.42 9.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.135 . . . . 0.0 111.008 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.39 33.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 109.281 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.919 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.1 ttp -98.06 119.11 36.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 0.0 111.085 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -79.27 -66.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 109.291 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.461 1.1 . . . . 0.0 109.292 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.881 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 0.0 109.338 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.3 40.54 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.555 1.16 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.038 ' HD2' ' HB2' ' B' ' 62' ' ' ALA . 7.8 Cg_endo -74.95 -168.96 6.9 Favored 'Cis proline' 0 C--N 1.36 1.169 0 C-N-CA 120.992 -2.503 . . . . 0.0 110.986 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.919 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.1 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.413 ' ND2' ' C ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 173.9 166.97 0.2 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 42' ' ' ILE . 61.2 t -104.07 114.35 43.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.566 1.166 . . . . 0.0 109.347 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 41' ' ' VAL . 2.0 mm -132.74 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.432 1.083 . . . . 0.0 109.306 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.427 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.6 160.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.443 1.089 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 9.5 t70 -97.03 -50.01 4.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.595 1.184 . . . . 0.0 109.324 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.2 mttt 167.34 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.143 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.4 m -128.54 158.05 73.04 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.143 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 164.22 33.83 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.476 1.777 . . . . 0.0 111.027 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.33 135.64 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 109.252 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.57 0.72 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.522 1.139 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.61 0.829 . . . . 0.0 110.238 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.15 77.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.371 1.045 . . . . 0.0 110.021 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.029 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.85 70.93 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.486 1.116 . . . . 0.0 109.268 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.01 50.73 2.61 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.562 1.164 . . . . 0.0 109.346 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.52 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.519 1.137 . . . . 0.0 109.344 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -46.48 115.1 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.1 m-80 -107.97 117.67 34.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 0.0 109.293 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.69 HG22 ' OD1' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -89.68 21.78 3.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.412 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -85.93 64.4 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.446 1.091 . . . . 0.0 109.233 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.612 HD23 ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.41 102.45 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 0.0 109.346 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.39 98.46 6.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.342 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 38' ' ' PRO . 5.2 mm -68.7 -46.09 80.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 111.6 4.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.594 1.184 . . . . 0.0 109.303 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -74.99 139.14 23.95 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.384 1.729 . . . . 0.0 111.02 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.96 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.45 1.094 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.69 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 0.744 . . . . 0.0 110.037 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.8 m-85 -38.25 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.128 . . . . 0.0 110.978 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.13 4.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.461 1.1 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.26 20.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 109.994 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.68 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.5 1.125 . . . . 0.0 109.388 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.5 23.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.115 . . . . 0.0 110.426 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 0.0 109.222 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.21 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.501 1.126 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.17 37.96 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.528 0.781 . . . . 0.0 110.411 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.09 141.5 26.45 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.558 1.82 . . . . 0.0 111.014 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.7 20.0 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.444 1.09 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.77 120.08 40.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 0.792 . . . . 0.0 110.405 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.847 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.79 140.74 30.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.61 1.194 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.12 49.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.442 1.089 . . . . 0.0 110.011 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.44 3.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.598 1.186 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.688 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 40.9 p90 -171.91 165.44 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -93.61 122.33 35.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.396 1.06 . . . . 0.0 108.296 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -51.26 -50.79 73.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.436 1.085 . . . . 0.0 110.378 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.658 ' HB3' ' O ' ' B' ' 62' ' ' ALA . 9.2 Cg_endo -75.1 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.564 1.823 . . . . 0.0 110.972 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -75.1 57.99 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.112 . . . . 0.0 109.577 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 1.246 HH22 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -87.97 -38.61 15.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 0.0 110.312 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.42 -23.84 32.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.427 1.079 . . . . 0.0 110.991 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.18 62.56 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.527 0.781 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.497 1.123 . . . . 0.0 110.927 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.801 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.64 75.05 1.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 0.778 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.246 ' CG1' HH22 ' A' ' 86' ' ' ARG . 13.1 m -124.17 153.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.294 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.82 19.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.501 1.126 . . . . 0.0 111.036 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.06 36.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.7 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.63 122.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.57 1.169 . . . . 0.0 109.284 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.08 144.52 31.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 0.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.28 73.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.431 1.082 . . . . 0.0 109.327 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 0.0 110.282 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.002 ' CD2' ' CZ ' ' B' ' 3' ' ' PHE . 2.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 3.7 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 1.276 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.828 ' HE1' ' CB ' ' A' ' 12' ' ' TYR . 60.8 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.56 ' OE1' HD12 ' B' ' 116' ' ' LEU . 18.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.915 ' O ' ' CD1' ' B' ' 7' ' ' TYR . 1.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 55.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.4 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.741 ' HA ' HG12 ' B' ' 161' ' ' VAL . 46.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 75.4 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.3 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.775 ' HG3' HG22 ' B' ' 233' ' ' VAL . 10.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 71.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 1.208 ' HG2' ' O ' ' B' ' 65' ' ' SER . 5.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 1.038 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 1.612 ' CB ' HD23 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 65' ' ' SER . . . . . 1.208 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.461 ' O ' ' NE2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.685 ' HB3' ' CD ' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 68' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.731 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.439 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.439 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.63 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.692 ' CD1' HD11 ' B' ' 116' ' ' LEU . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.731 ' CD2' HG23 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.497 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 0.473 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.497 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 84.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 13.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.403 ' HG3' HE22 ' B' ' 59' ' ' GLN . 29.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.407 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.382 ' O ' ' CD1' ' B' ' 162' ' ' TYR 0.461 0.1 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 1.047 ' N ' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.273 HG22 ' CG ' ' B' ' 162' ' ' TYR . 13.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.025 ' H ' HG23 ' B' ' 164' ' ' THR . 18.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.64 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.2 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 84.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.602 HD21 ' HA ' ' B' ' 62' ' ' ALA . 5.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.611 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 16.6 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.667 ' H ' ' CG2' ' B' ' 228' ' ' THR . 21.1 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.8 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 0.4 OUTLIER -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.684 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 3.0 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 0.945 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' B' ' 187' ' ' ASN . 11.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.871 ' HB3' HG22 ' B' ' 204' ' ' VAL . 18.5 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.729 ' HB ' HG23 ' B' ' 205' ' ' THR . 89.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.729 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 2.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 207' ' ' ILE . . . . . 0.459 HD12 HD21 ' B' ' 213' ' ' LEU . 48.3 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 18.3 mt -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.945 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 213' ' ' LEU . . . . . 0.459 HD21 HD12 ' B' ' 207' ' ' ILE . 54.1 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 54.7 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.667 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.5 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.775 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.63 126.87 29.24 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.517 1.136 . . . . 0.0 110.022 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.916 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.48 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.369 1.043 . . . . 0.0 109.265 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.9 40.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.254 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.505 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.4 112.1 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.081 . . . . 0.0 109.35 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.72 133.55 35.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.485 1.116 . . . . 0.0 109.346 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.545 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.06 6.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 0.0 110.924 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.48 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.579 1.174 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.3 p -108.07 160.68 15.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 0.736 . . . . 0.0 110.431 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.82 -15.93 24.54 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.382 1.051 . . . . 0.0 109.328 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 35.2 mttt -90.63 39.7 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.536 1.148 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 1.346 ' OH ' ' HB2' ' B' ' 3' ' ' PHE . 0.8 OUTLIER 38.21 29.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.503 1.127 . . . . 0.0 111.016 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.631 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.69 58.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 0.0 109.34 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 9.3 Cg_endo -75.0 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.452 1.764 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 9' ' ' THR . 1.4 pp -150.75 151.25 32.1 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 0.0 109.307 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -77.34 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 1.132 . . . . 0.0 110.965 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.92 26.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 124.47 1.106 . . . . 0.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.05 140.97 70.25 Favored 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.013 -2.494 . . . . 0.0 110.932 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.17 -40.16 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.548 1.155 . . . . 0.0 109.281 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.31 46.04 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.403 1.064 . . . . 0.0 109.358 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.38 31.03 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.7 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.461 1.101 . . . . 0.0 110.098 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.87 -177.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.442 1.089 . . . . 0.0 109.259 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.49 158.33 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 105.42 0.28 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.557 1.161 . . . . 0.0 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.47 8.44 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.5 1.125 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.14 11.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 0.754 . . . . 0.0 109.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.49 154.26 39.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.43 102.58 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.576 1.172 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.49 18.15 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.59 1.181 . . . . 0.0 110.299 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.473 1.108 . . . . 0.0 110.953 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.5 ttp -97.99 119.26 36.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 1.057 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.41 -66.04 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.209 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.1 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.27 40.58 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.523 1.139 . . . . 0.0 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 1.018 ' CD ' ' HB2' ' B' ' 62' ' ' ALA . 9.5 Cg_endo -74.96 -168.9 6.86 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.993 -0.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.635 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 72.8 m-70 -144.21 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 0.0 109.584 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.874 ' HB3' ' OD2' ' B' ' 63' ' ' ASP . 0.9 OUTLIER 173.96 166.98 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HD13 ' A' ' 42' ' ' ILE . 60.5 t -104.11 114.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.578 1.174 . . . . 0.0 109.356 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.71 ' CG1' ' OD1' ' A' ' 40' ' ' ASN . 4.3 mm -132.77 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 0.0 109.308 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 0.0 110.939 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 2.5 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 0.0 109.253 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.074 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.45 158.09 72.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.372 1.045 . . . . 0.0 109.286 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 164.2 33.72 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.493 1.786 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.2 135.61 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.446 1.092 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.68 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.535 1.147 . . . . 0.0 111.014 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.496 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.06 -173.32 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.595 0.82 . . . . 0.0 110.303 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.16 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.426 1.079 . . . . 0.0 109.954 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 1.074 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.81 71.33 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.45 1.094 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.08 50.8 2.65 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.491 1.785 . . . . 0.0 110.887 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.23 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.591 1.182 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.05 -27.55 68.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 0.0 109.306 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -46.51 115.08 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.56 1.163 . . . . 0.0 109.988 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.489 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -107.96 117.7 34.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 109.358 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.77 21.94 3.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.438 1.086 . . . . 0.0 110.347 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -86.11 64.43 8.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.453 1.096 . . . . 0.0 109.244 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.198 HD11 ' NE2' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -40.51 102.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.35 98.44 5.97 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -68.7 -46.07 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.326 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.62 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.316 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 27.6 Cg_endo -75.04 139.14 23.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.438 1.757 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.96 0.17 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.505 1.128 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.534 0.785 . . . . 0.0 109.989 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 1.11 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.51 175.1 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.58 161.31 20.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 0.0 109.978 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.475 1.109 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.12 8.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.482 1.114 . . . . 0.0 109.223 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.468 1.105 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.1 37.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.538 0.787 . . . . 0.0 110.412 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.06 141.53 26.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.465 1.771 . . . . 0.0 111.043 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.4 1.062 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -104.88 120.06 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 0.761 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.71 30.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.546 1.154 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.93 145.17 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.462 1.101 . . . . 0.0 109.966 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.2 -171.58 3.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.449 1.093 . . . . 0.0 110.951 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 30.5 p90 -171.84 165.42 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.57 122.38 35.96 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.425 1.078 . . . . 0.0 108.262 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.658 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -51.35 -50.8 74.08 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.398 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.677 ' CD ' HD21 ' A' ' 40' ' ' ASN . 12.8 Cg_endo -75.0 -62.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.237 0 O-C-N 124.498 1.788 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.468 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 22.0 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.751 HH11 ' CG ' ' A' ' 86' ' ' ARG . 2.7 ttt85 -88.01 -38.48 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.536 1.148 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.88 32.74 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.477 1.111 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.62 -15.24 62.55 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.505 0.768 . . . . 0.0 109.406 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.18 1.83 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.449 1.093 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' MET . . . . . 0.545 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.62 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.417 0.716 . . . . 0.0 111.003 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 11.6 m -124.15 153.58 30.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.153 . . . . 0.0 109.277 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.78 19.77 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.73 162.05 37.0 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.485 0.756 . . . . 0.0 110.471 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.65 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 0.0 109.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.1 144.54 31.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.541 1.15 . . . . 0.0 109.333 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 0.0 110.317 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 1' ' ' TYR . . . . . 1.201 ' CZ ' ' HG2' ' B' ' 119' ' ' PRO . 1.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' PHE . . . . . 1.346 ' HB2' ' OH ' ' A' ' 12' ' ' TYR . 23.0 m-85 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' TYR . . . . . 0.685 ' OH ' ' HD1' ' B' ' 162' ' ' TYR 0.347 0.3 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 3' ' ' PHE . 74.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 7.1 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' CYS . . . . . 0.749 ' HA ' HG12 ' B' ' 161' ' ' VAL . 42.1 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLN . . . . . 0.676 ' HB2' HG21 ' B' ' 233' ' ' VAL . 43.6 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 7.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' GLN . . . . . 1.198 ' NE2' HD11 ' A' ' 60' ' ' LEU . 14.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ALA . . . . . 1.018 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ASP . . . . . 0.874 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 5.0 m-20 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 65' ' ' SER . . . . . 0.949 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 10.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.474 ' HG ' ' HB3' ' B' ' 61' ' ' GLN . 54.2 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.403 HD21 HG23 ' B' ' 233' ' ' VAL . 8.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 102' ' ' TYR . . . . . 0.431 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 105' ' ' THR . . . . . 0.675 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.1 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 119' ' ' PRO . . . . . 1.201 ' HG2' ' CZ ' ' B' ' 1' ' ' TYR . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 48.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 123' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' ASP . . . . . 0.436 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 157' ' ' GLY . . . . . 0.456 ' CA ' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 158' ' ' ARG . . . . . 0.429 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 51.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 159' ' ' GLY . . . . . 0.41 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 161' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.6 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 162' ' ' TYR . . . . . 1.043 ' HB3' HG22 ' B' ' 164' ' ' THR . 18.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 163' ' ' PRO . . . . . 0.652 ' HB3' ' CD1' ' B' ' 4' ' ' TYR . 1.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 164' ' ' THR . . . . . 1.043 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 166' ' ' GLU . . . . . 1.0 ' H ' HG23 ' B' ' 164' ' ' THR . 19.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 167' ' ' LEU . . . . . 0.49 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 53.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 169' ' ' ASN . . . . . 0.575 HD21 ' HA ' ' B' ' 62' ' ' ALA . 1.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 170' ' ' ASN . . . . . 0.62 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 12.6 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 39.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 56.1 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 186' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 56.9 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 187' ' ' ASN . . . . . 0.691 ' O ' ' CD1' ' B' ' 189' ' ' PHE . 5.4 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 189' ' ' PHE . . . . . 0.825 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.271 0.5 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 191' ' ' PHE . . . . . 0.416 ' C ' ' CG ' ' B' ' 192' ' ' ASP . 12.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 192' ' ' ASP . . . . . 0.65 ' HB3' HG22 ' B' ' 204' ' ' VAL . 0.0 OUTLIER -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 193' ' ' VAL . . . . . 0.631 ' HA ' HG22 ' B' ' 184' ' ' ILE . 92.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 204' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 205' ' ' THR . . . . . 0.615 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 76.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 208' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 209' ' ' PRO . . . . . 0.825 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.0 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 211' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 3.1 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 233' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.66 126.8 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 109.989 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 124.447 1.092 . . . . 0.0 109.22 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.99 150.8 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 110.318 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.13 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.337 1.023 . . . . 0.0 109.259 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.68 133.49 35.95 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.528 1.143 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 96.99 6.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 0.0 110.955 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.51 7.64 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.491 1.119 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.08 160.63 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.389 0.699 . . . . 0.0 110.391 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.74 -16.03 24.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.399 1.062 . . . . 0.0 109.315 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.2 mttp -90.55 39.64 0.98 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 38.21 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.592 1.182 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.625 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.82 117.7 58.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HG3' ' CE2' ' B' ' 3' ' ' PHE . 36.0 Cg_endo -74.98 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.456 1.766 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.1 pp -150.74 151.24 32.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.119 . . . . 0.0 109.323 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.38 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.556 1.16 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.86 26.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.459 1.1 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.15 140.98 70.19 Favored 'Cis proline' 0 C--N 1.361 1.203 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.96 0.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.5 tttt -40.17 -40.04 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.58 1.175 . . . . 0.0 109.342 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.35 46.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.365 1.041 . . . . 0.0 109.273 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.31 141.32 30.94 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.93 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.554 1.159 . . . . 0.0 110.026 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 0.0 109.26 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.55 158.26 27.7 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.499 1.124 . . . . 0.0 109.968 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.44 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.452 1.095 . . . . 0.0 109.285 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.38 8.48 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.542 1.151 . . . . 0.0 110.961 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.09 174.16 11.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.48 0.753 . . . . 0.0 109.291 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.65 154.28 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.62 1.2 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.9 t -131.47 102.63 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.78 169.57 18.02 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.468 1.105 . . . . 0.0 110.313 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.48 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.515 1.134 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.57 1.169 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.689 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 11.7 ttp -97.96 119.21 36.18 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.433 1.083 . . . . 0.0 111.009 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.332 6.9 m-20 -79.36 -66.04 0.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.589 1.181 . . . . 0.0 109.243 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 14.8 p 46.04 54.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 0.0 109.276 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.47 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.564 1.165 . . . . 0.0 111.033 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.002 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 30.0 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.93 -2.529 . . . . 0.0 111.03 -0.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.499 1.124 . . . . 0.0 109.575 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.95 167.05 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 0.0 109.253 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.623 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.1 t -104.18 114.41 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.163 . . . . 0.0 109.289 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.0 mm -132.82 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.551 1.157 . . . . 0.0 109.305 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.0 m-85 -47.71 160.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.04 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.6 mtpt 167.35 143.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.6 1.187 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.022 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.55 158.08 72.98 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.436 1.085 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.3 Cg_endo -75.03 164.17 33.84 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.538 1.809 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.17 135.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.392 1.058 . . . . 0.0 109.276 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.44 -56.55 0.72 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.578 1.174 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.557 0.798 . . . . 0.0 110.279 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.25 77.76 1.75 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 110.001 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.022 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 109.353 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.01 50.82 2.63 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.466 1.772 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.48 1.113 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.49 68.14 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.502 1.126 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 m -46.55 115.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 109.98 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.7 m120 -108.01 117.63 34.63 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.408 1.067 . . . . 0.0 109.315 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 60' ' ' LEU . 8.8 t -89.73 21.73 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.41 1.069 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -85.87 64.32 8.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.455 1.097 . . . . 0.0 109.264 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.37 102.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.427 1.079 . . . . 0.0 109.351 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.02 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.617 1.198 . . . . 0.0 109.339 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.67 HD11 HD12 ' A' ' 60' ' ' LEU . 2.6 mm -68.65 -46.18 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.596 1.185 . . . . 0.0 109.282 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.63 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 109.265 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.95 139.1 24.01 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.95 -67.97 0.17 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.502 1.126 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.679 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.511 0.771 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.587 1.179 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.42 175.18 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 111.044 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.478 1.112 . . . . 0.0 109.983 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.11 137.69 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 0.0 109.348 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.17 146.46 23.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.18 173.05 8.57 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 0.0 109.231 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.526 1.141 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.13 37.57 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.53 0.782 . . . . 0.0 110.424 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.5 26.8 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.437 1.756 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.6 20.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.93 120.07 40.54 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.571 0.806 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.834 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.74 30.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.545 1.153 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.099 . . . . 0.0 110.01 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.09 -171.48 3.72 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 1.128 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 38.7 p90 -171.9 165.4 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.973 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -93.52 122.27 35.78 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.116 . . . . 0.0 108.335 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.83 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.6 OUTLIER -51.26 -50.82 73.71 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.561 1.163 . . . . 0.0 110.408 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.74 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 37.7 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.576 1.829 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.67 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 25.4 m80 -75.06 57.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.57 1.169 . . . . 0.0 109.562 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.019 ' NH1' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.95 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.577 1.173 . . . . 0.0 110.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.86 32.73 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.462 1.101 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' ' HE1' ' B' ' 4' ' ' TYR . . . -65.65 -15.2 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.489 0.758 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.12 63.14 1.83 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.431 1.082 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 0.798 . . . . 0.0 110.971 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.722 ' CG1' HH22 ' A' ' 86' ' ' ARG . 11.6 m -124.26 153.59 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 0.0 109.227 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.56 -174.75 19.77 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 124.546 1.154 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.82 162.0 37.19 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 0.792 . . . . 0.0 110.432 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.57 122.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.496 1.122 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.9 m -105.07 144.47 31.83 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 124.559 1.162 . . . . 0.0 109.353 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 0.0 110.38 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.868 ' H3 ' ' HD2' ' B' ' 4' ' ' TYR . 18.5 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.522 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.868 ' HD2' ' H3 ' ' B' ' 1' ' ' TYR . 46.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 46.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.71 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.722 HE22 ' HA2' ' B' ' 157' ' ' GLY . 13.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 65' ' ' SER . 7.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 4.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.71 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.2 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.726 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 12.8 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.401 ' CE2' HD23 ' B' ' 103' ' ' LEU . 6.7 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.401 HD23 ' CE2' ' B' ' 102' ' ' TYR . 74.9 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.035 HG13 ' HG ' ' B' ' 115' ' ' LEU . 65.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.777 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.891 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.035 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.891 HD11 ' HA ' ' B' ' 107' ' ' TYR . 1.1 mp -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.002 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.0 OUTLIER -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.402 ' HD3' HG21 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.472 ' CE1' HD22 ' B' ' 120' ' ' LEU . 20.7 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 58.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.722 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.404 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' B' ' 24' ' ' CYS . 1.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' B' ' 168' ' ' SER . 0.4 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.0 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.008 HG22 ' H ' ' B' ' 166' ' ' GLU . 0.4 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.008 ' H ' HG22 ' B' ' 164' ' ' THR . 2.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.678 ' HA ' ' CE1' ' B' ' 162' ' ' TYR . 95.9 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 16.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 55.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 1.9 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.047 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 8.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.803 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 52.2 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.788 HD22 ' H ' ' B' ' 208' ' ' LEU . 1.1 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.047 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.83 29.06 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.466 1.104 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.89 40.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.36 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.407 1.067 . . . . 0.0 109.246 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.45 36.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.533 1.145 . . . . 0.0 109.388 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.618 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.141 . . . . 0.0 111.003 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 1.025 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.14 144.49 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.705 ' CG2' HD11 ' A' ' 15' ' ' LEU . 23.9 p -108.08 160.6 15.67 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.441 0.73 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -15.96 23.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ALA . 14.2 mttt -90.59 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 38.29 29.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 0.0 111.029 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.78 117.71 58.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 0.0 109.318 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 24.7 Cg_endo -75.02 97.72 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.428 1.752 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.705 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.5 pp -150.87 151.26 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.18 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.465 1.103 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.46 134.82 26.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 124.467 1.104 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.92 69.94 Favored 'Cis proline' 0 C--N 1.359 1.12 0 C-N-CA 121.061 -2.474 . . . . 0.0 110.993 0.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.565 1.165 . . . . 0.0 109.306 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.34 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.264 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.03 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.625 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.91 143.83 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.98 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.559 1.162 . . . . 0.0 109.205 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.64 158.28 27.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.531 1.144 . . . . 0.0 109.972 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 105.47 0.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.201 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.31 8.52 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.07 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.527 0.781 . . . . 0.0 109.238 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.47 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.616 1.197 . . . . 0.0 110.491 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.44 102.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 109.322 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.5 18.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.4 9.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.502 1.126 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.32 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.442 1.089 . . . . 0.0 109.276 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.1 ttp -97.93 119.16 36.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.426 1.079 . . . . 0.0 111.046 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.025 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.31 -66.07 0.92 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.624 1.203 . . . . 0.0 109.268 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.454 1.096 . . . . 0.0 109.321 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 7.1 p 46.02 54.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 109.336 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.84 ' O ' ' HD2' ' B' ' 119' ' ' PRO . . . -92.94 -172.31 40.58 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.491 1.12 . . . . 0.0 111.079 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.176 ' HD3' ' O ' ' B' ' 119' ' ' PRO . 58.6 Cg_endo -74.97 -168.9 6.85 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.961 -2.516 . . . . 0.0 110.973 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.671 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.26 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.077 . . . . 0.0 109.617 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.482 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.5 p30 173.97 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.251 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.06 114.27 43.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.571 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.73 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 109.343 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.69 160.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.8 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.1 mttt 167.32 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.121 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.426 1.079 . . . . 0.0 109.21 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.06 164.22 33.67 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.493 1.786 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.2 135.58 1.38 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.444 1.09 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.63 0.72 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.492 1.12 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.26 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 0.816 . . . . 0.0 110.301 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.21 77.75 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.134 . . . . 0.0 110.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.121 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 0.0 109.358 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -74.99 50.74 2.6 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.478 1.778 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 0.0 109.313 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.61 68.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -46.49 115.16 0.95 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.511 1.132 . . . . 0.0 109.966 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.93 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.452 1.095 . . . . 0.0 109.325 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -89.8 21.85 3.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.383 1.052 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 39.7 tttt -86.0 64.37 8.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.57 1.169 . . . . 0.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 60' ' ' LEU . 3.4 mp -40.44 102.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.559 1.162 . . . . 0.0 109.322 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.48 6.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 109.284 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' B' ' 120' ' ' LEU . 0.7 OUTLIER -68.71 -46.15 80.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.601 1.188 . . . . 0.0 109.282 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.88 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 0.0 109.331 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.835 ' HG3' ' CD1' ' B' ' 102' ' ' TYR . 72.3 Cg_endo -75.06 139.16 23.81 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.389 1.731 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -68.01 0.17 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.501 1.126 . . . . 0.0 110.995 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.622 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.449 0.735 . . . . 0.0 110.014 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.1 m-85 -38.23 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.471 1.107 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.55 175.09 4.17 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.093 . . . . 0.0 111.009 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.29 20.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 0.0 109.95 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.08 137.71 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.486 1.116 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.33 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.583 1.177 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.3 mt -124.14 173.1 8.52 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.536 1.148 . . . . 0.0 109.186 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.536 1.147 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.462 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.24 124.11 37.6 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.467 0.745 . . . . 0.0 110.426 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.52 26.8 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.527 1.804 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.62 20.05 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.415 1.072 . . . . 0.0 111.046 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.04 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.776 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.74 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.59 1.181 . . . . 0.0 111.021 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.86 145.17 49.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 110.019 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.52 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.496 1.122 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.42 ' CB ' HG12 ' A' ' 91' ' ' VAL . 38.5 p90 -171.83 165.41 6.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.113 . . . . 0.0 110.959 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.55 122.3 35.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.4 1.063 . . . . 0.0 108.302 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.5 m -51.3 -50.79 73.97 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.482 1.114 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.567 1.825 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m170 -75.0 58.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.542 1.151 . . . . 0.0 109.602 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.512 ' NE ' ' O ' ' A' ' 86' ' ' ARG . 1.5 tpm_? -88.0 -38.53 15.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.128 . . . . 0.0 110.305 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.51 -23.79 32.81 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.438 1.086 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.27 62.62 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.531 0.783 . . . . 0.0 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.21 1.82 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.464 1.103 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.618 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.0 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 0.72 . . . . 0.0 111.067 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 81' ' ' TYR . 14.9 m -124.13 153.59 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.295 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.58 -174.69 19.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.482 1.114 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.83 162.09 36.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 0.772 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.66 122.56 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -104.98 144.51 31.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 0.0 110.435 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.282 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.167 . . . . 0.0 110.3 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.619 ' HE1' HBD1 ' B' ' 250' ' ' HEC . 56.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.789 ' CD2' ' HG3' ' B' ' 163' ' ' PRO . 4.2 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.6 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.559 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 79.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.786 ' HB2' HG21 ' B' ' 233' ' ' VAL . 14.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 15.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.478 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 68.7 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 32.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.7 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.661 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 93.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.77 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.835 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 2.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.722 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.4 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.088 HG13 ' HG ' ' B' ' 115' ' ' LEU . 39.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.088 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.4 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.761 ' N ' HD23 ' B' ' 115' ' ' LEU . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.176 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 1.032 ' HA ' HD11 ' A' ' 62' ' ' ILE . 1.2 mp -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.574 ' HD2' ' HG2' ' B' ' 128' ' ' MET . 0.6 OUTLIER -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.574 ' HG2' ' HD2' ' B' ' 125' ' ' TYR . 10.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.453 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.665 HH22 HD22 ' B' ' 169' ' ' ASN . 33.0 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 0.984 ' CB ' HG22 ' B' ' 164' ' ' THR . 30.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.789 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.117 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.0 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.117 ' H ' HG23 ' B' ' 164' ' ' THR . 42.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 96.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.665 HD22 HH22 ' B' ' 158' ' ' ARG . 4.6 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.462 1.2 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.193 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 25.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.686 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.193 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 11.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.56 126.73 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 0.0 110.098 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.35 177.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.426 1.079 . . . . 0.0 109.263 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -143.05 150.87 40.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.38 112.16 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.398 1.061 . . . . 0.0 109.239 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.48 35.97 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.557 1.161 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.701 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 0.0 111.009 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.668 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.51 7.64 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.58 1.175 . . . . 0.0 110.967 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.03 160.58 15.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.469 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.7 -15.99 23.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.4 ttmt -90.58 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 38.25 29.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.548 1.155 . . . . 0.0 111.048 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.76 117.73 58.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.023 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.5 Cg_endo -75.02 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.492 1.785 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.611 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.2 pp -150.82 151.24 32.0 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.35 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.45 134.86 26.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.381 1.051 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.97 70.22 Favored 'Cis proline' 0 C--N 1.359 1.114 0 C-N-CA 120.989 -2.505 . . . . 0.0 110.949 0.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.19 -40.08 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.566 1.166 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.33 46.13 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.387 1.054 . . . . 0.0 109.24 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 0.0 109.297 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.81 51.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.45 1.094 . . . . 0.0 110.038 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.95 -177.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.566 1.166 . . . . 0.0 109.242 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.809 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.514 1.134 . . . . 0.0 109.969 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.5 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.588 1.18 . . . . 0.0 109.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.39 8.51 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.458 1.099 . . . . 0.0 111.052 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.12 174.11 11.51 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 0.78 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.49 154.27 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 0.0 110.485 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.69 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.83 169.56 18.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.587 1.179 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.1 m-85 -147.24 121.4 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.52 1.138 . . . . 0.0 110.981 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.35 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.248 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.649 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.4 ttp -97.98 119.15 36.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m120 -79.28 -66.09 0.91 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.145 . . . . 0.0 109.248 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.451 1.094 . . . . 0.0 109.333 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.023 HG21 ' HG3' ' A' ' 14' ' ' PRO . 7.4 p 45.93 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.352 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.0 -172.31 40.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.49 1.119 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.157 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 36.2 Cg_endo -75.03 -168.87 6.85 Favored 'Cis proline' 0 C--N 1.361 1.19 0 C-N-CA 120.938 -2.526 . . . . 0.0 111.003 0.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.649 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 73.2 m-70 -144.28 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 60' ' ' LEU . 2.5 p30 173.99 166.95 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.536 1.147 . . . . 0.0 109.271 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.662 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.5 t -104.07 114.41 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 0.0 109.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -132.84 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.414 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.67 160.65 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.507 1.129 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.02 -50.01 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.574 1.171 . . . . 0.0 109.256 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 167.29 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 0.0 109.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.432 1.082 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 164.21 33.82 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.511 1.795 . . . . 0.0 111.008 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.26 135.56 1.41 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.438 1.086 . . . . 0.0 109.313 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.54 0.72 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 0.0 110.972 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.22 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 0.807 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.23 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 110.024 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.013 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.77 71.73 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.444 1.09 . . . . 0.0 109.359 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.04 50.84 2.65 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.452 1.764 . . . . 0.0 110.952 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.38 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.281 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.63 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.542 1.151 . . . . 0.0 109.259 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.2 m -46.44 115.11 0.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.59 1.181 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -107.92 117.68 34.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.335 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.674 HG21 ' OD2' ' B' ' 63' ' ' ASP . 9.1 t -89.81 21.85 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -86.03 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.516 1.135 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -40.4 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 0.0 109.326 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.46 98.44 6.06 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' B' ' 119' ' ' PRO . 3.2 mm -68.73 -46.06 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.554 1.159 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.63 4.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 0.0 109.303 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.04 139.14 23.83 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.43 1.753 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -68.02 0.17 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.471 1.107 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.66 97.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 0.747 . . . . 0.0 109.99 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.19 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.401 1.063 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.49 175.1 4.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 0.0 111.055 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.445 1.091 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.72 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.423 1.077 . . . . 0.0 109.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.32 146.41 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 0.0 110.398 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.06 173.13 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 0.0 109.225 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.518 1.136 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.67 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.525 0.779 . . . . 0.0 110.381 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 141.49 26.73 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.796 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.433 1.083 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.4 m -104.76 120.04 40.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.465 0.744 . . . . 0.0 110.399 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.76 30.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 0.0 111.011 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.9 145.11 49.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 110.032 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.53 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.13 . . . . 0.0 110.989 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 1.374 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 15.3 p90 -171.82 165.45 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.62 122.3 35.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.381 1.051 . . . . 0.0 108.267 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.97 HG21 ' CB ' ' B' ' 62' ' ' ALA . 1.0 OUTLIER -51.25 -50.8 73.76 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.429 1.08 . . . . 0.0 110.466 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.602 1.843 . . . . 0.0 110.992 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.955 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 24.6 m80 -75.06 57.99 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.574 1.171 . . . . 0.0 109.546 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.374 ' NH2' ' HB2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.99 -38.47 15.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.525 1.14 . . . . 0.0 110.313 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 1.049 ' CA ' HG23 ' B' ' 164' ' ' THR . . . -89.49 -23.84 32.74 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.487 1.117 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.22 62.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 0.769 . . . . 0.0 109.346 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.19 1.82 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.701 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.58 74.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 0.0 111.043 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.537 ' CG1' ' NH2' ' A' ' 86' ' ' ARG . 11.7 m -124.18 153.5 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 0.0 109.283 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.5 -174.73 19.71 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.525 1.141 . . . . 0.0 111.004 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.11 36.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 0.0 110.39 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.712 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.65 122.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.561 1.163 . . . . 0.0 109.311 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -105.02 144.52 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.477 1.111 . . . . 0.0 110.426 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.12 . . . . 0.0 109.24 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.809 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 110.349 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.868 ' CZ ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.795 ' CG ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 1.007 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 21.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 2.7 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.146 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.6 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.718 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.811 ' HG3' HG22 ' B' ' 233' ' ' VAL . 12.0 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 86.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.674 ' OD2' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.467 ' HB2' ' OD2' ' B' ' 63' ' ' ASP . 17.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.5 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.651 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 73.2 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.552 ' HD2' HD12 ' B' ' 103' ' ' LEU . 3.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.552 HD12 ' HD2' ' B' ' 102' ' ' TYR . 1.1 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.1 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.842 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.516 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.8 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' B' ' 105' ' ' THR . 71.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.157 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' B' ' 125' ' ' TYR . 7.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.708 ' CE2' HD22 ' B' ' 120' ' ' LEU . 47.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.527 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 54.2 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLN . . . . . 0.484 ' O ' HD13 ' B' ' 167' ' ' LEU . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' B' ' 24' ' ' CYS . 2.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 0.568 ' HB2' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 1.007 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.049 HG23 ' CA ' ' A' ' 87' ' ' GLY . 2.1 p -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.484 HD13 ' O ' ' B' ' 160' ' ' GLN . 4.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.354 16.2 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.565 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 37.9 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 0.994 ' CG ' ' HD3' ' B' ' 209' ' ' PRO 0.278 3.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.565 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.877 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.9 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.994 ' HD3' ' CG ' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.811 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.146 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.57 126.8 28.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.616 1.197 . . . . 0.0 110.06 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.451 1.095 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.81 40.18 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.349 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.38 112.17 38.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.466 1.104 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.78 133.43 36.05 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.309 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.727 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.64 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 0.0 110.996 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.58 7.65 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.449 1.093 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.51 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -108.12 160.64 15.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 0.752 . . . . 0.0 110.413 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.8 -15.94 24.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.9 mttt -90.56 39.59 0.98 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.13 . . . . 0.0 109.371 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.32 29.7 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.489 1.118 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.83 117.71 58.11 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.223 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CB ' ' CD2' ' A' ' 85' ' ' HIS . 25.0 Cg_endo -75.03 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.457 1.767 . . . . 0.0 111.066 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD21 ' OG1' ' A' ' 9' ' ' THR . 2.0 pp -150.77 151.19 31.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.502 1.126 . . . . 0.0 109.322 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.41 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.15 30.47 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.533 1.146 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.48 134.84 26.53 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 0.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.11 140.97 70.16 Favored 'Cis proline' 0 C--N 1.36 1.18 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.938 0.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.15 -40.15 1.04 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.6 1.187 . . . . 0.0 109.267 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.17 146.32 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.361 1.038 . . . . 0.0 109.328 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.23 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.563 1.164 . . . . 0.0 109.219 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.97 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 110.055 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.93 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.807 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.33 27.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 0.0 109.971 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.592 1.183 . . . . 0.0 109.321 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.36 8.49 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.495 1.122 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.657 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.15 174.16 11.46 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.616 0.833 . . . . 0.0 109.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.21 39.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 0.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.37 102.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.8 169.5 18.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 110.319 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.23 121.53 9.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.55 1.156 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.14 155.31 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.654 1.221 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.809 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.2 ttp -98.0 119.21 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.479 1.112 . . . . 0.0 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.326 6.6 m-20 -79.31 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.243 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.906 HG22 ' HE2' ' A' ' 85' ' ' HIS . 11.2 p 45.93 54.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 1.487 ' O ' ' CE1' ' B' ' 1' ' ' TYR . . . -92.9 -172.31 40.65 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.164 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 19.8 Cg_endo -74.93 -168.87 6.82 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 120.998 -2.501 . . . . 0.0 111.018 -0.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.809 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.1 m-70 -144.26 -170.38 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.426 1.079 . . . . 0.0 109.251 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.7 t -104.01 114.33 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.595 1.185 . . . . 0.0 109.414 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mm -132.8 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.7 160.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -49.99 4.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 12.1 mttt 167.22 143.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.57 1.169 . . . . 0.0 109.343 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.034 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.49 158.16 72.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.097 . . . . 0.0 109.275 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 164.26 33.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.427 1.751 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.35 135.67 1.42 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.47 1.106 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.54 0.72 Allowed Glycine 0 CA--C 1.532 1.128 0 O-C-N 124.565 1.166 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.621 0.836 . . . . 0.0 110.305 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.13 77.8 1.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 0.0 110.02 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.79 71.68 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.463 1.102 . . . . 0.0 109.292 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.4 Cg_endo -75.01 50.74 2.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.392 1.733 . . . . 0.0 110.995 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.73 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.609 1.193 . . . . 0.0 109.301 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.48 68.1 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.543 1.152 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.0 m -46.5 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.56 1.162 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.604 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 85.0 m-20 -107.94 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.418 1.074 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.508 HG23 ' NE2' ' B' ' 61' ' ' GLN . 11.6 t -89.82 21.84 3.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.377 1.048 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -85.97 64.43 8.58 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.43 1.082 . . . . 0.0 109.251 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.5 102.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.307 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.37 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.911 HD11 HD12 ' A' ' 60' ' ' LEU . 2.1 mm -68.7 -46.02 80.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.596 1.185 . . . . 0.0 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.12 111.59 4.85 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.33 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -75.06 139.21 23.86 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.515 1.134 . . . . 0.0 110.957 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.539 0.788 . . . . 0.0 110.034 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.24 -86.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.604 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.58 175.12 4.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.359 1.037 . . . . 0.0 110.991 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.32 20.87 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 109.96 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.07 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.47 23.99 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.474 1.109 . . . . 0.0 110.394 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.11 173.06 8.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.464 1.102 . . . . 0.0 109.27 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.505 1.128 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.08 37.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.452 0.736 . . . . 0.0 110.418 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -74.99 141.46 26.69 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.523 1.802 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.59 20.11 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.48 1.112 . . . . 0.0 110.985 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.86 120.07 40.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 0.742 . . . . 0.0 110.367 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.83 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.73 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.517 1.136 . . . . 0.0 110.995 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.85 145.08 49.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 0.0 110.03 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.16 -171.55 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.518 1.136 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.926 ' CB ' ' NH2' ' A' ' 86' ' ' ARG . 16.9 p90 -171.81 165.42 6.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 0.0 110.995 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 0.5 OUTLIER -93.55 122.3 35.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 0.0 108.276 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.758 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.21 -50.86 73.25 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.476 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 83' ' ' THR . 37.4 Cg_endo -75.04 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 0.0 110.953 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.906 ' HE2' HG22 ' A' ' 36' ' ' VAL . 49.1 m80 -75.04 57.94 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.185 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.02 -38.43 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 0.0 110.325 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.91 32.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.433 1.083 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.22 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 0.0 109.33 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.014 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.727 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 0.735 . . . . 0.0 111.018 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.185 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.24 153.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.565 1.166 . . . . 0.0 109.239 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.48 -174.76 19.72 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.525 1.14 . . . . 0.0 111.006 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.79 162.06 37.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 0.735 . . . . 0.0 110.441 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.0 mt -146.65 122.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.52 31.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.441 1.088 . . . . 0.0 110.403 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.547 1.154 . . . . 0.0 109.255 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.807 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 O-C-N 124.604 1.19 . . . . 0.0 110.32 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.487 ' CE1' ' O ' ' A' ' 37' ' ' GLY 0.427 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.493 ' HB3' HD22 ' B' ' 116' ' ' LEU . 3.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 14' ' ' PRO . 71.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 1.612 ' CZ ' ' HG2' ' B' ' 163' ' ' PRO . 0.1 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 52.8 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 47.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.73 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 1.004 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 17.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.434 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 84.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.508 ' NE2' HG23 ' A' ' 58' ' ' THR . 8.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.758 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 26.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.73 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.726 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.0 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.544 ' CD2' HD23 ' B' ' 103' ' ' LEU . 21.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' B' ' 102' ' ' TYR . 45.2 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.044 HG13 ' HG ' ' B' ' 115' ' ' LEU . 79.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.42 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.1 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 25.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.044 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.711 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.164 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.611 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.611 ' CE1' HD22 ' B' ' 120' ' ' LEU . 69.1 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 1.004 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' B' ' 24' ' ' CYS . 7.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.147 ' HB3' HG22 ' B' ' 164' ' ' THR . 0.9 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 1.612 ' HG2' ' CZ ' ' B' ' 4' ' ' TYR . 5.9 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.147 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.993 ' H ' HG23 ' B' ' 164' ' ' THR . 15.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.476 ' N ' HD22 ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 78.2 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.566 HD21 ' HA ' ' B' ' 62' ' ' ALA . 12.2 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.356 16.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.599 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 42.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.183 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 3.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.599 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.6 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.895 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.8 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.183 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 8.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.76 28.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.157 . . . . 0.0 109.998 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.416 1.073 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.82 40.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 110.324 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.404 1.065 . . . . 0.0 109.258 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.7 133.45 36.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.465 1.103 . . . . 0.0 109.323 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.638 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 0.0 110.952 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 1.031 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -108.06 160.58 15.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.417 0.716 . . . . 0.0 110.413 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -59.71 -16.0 23.77 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.375 1.047 . . . . 0.0 109.357 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 20.7 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.521 1.138 . . . . 0.0 109.369 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.529 ' OH ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 0.0 111.022 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.9 117.69 58.1 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 0.0 109.247 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 41.0 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.432 1.754 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.79 151.21 31.99 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.435 1.085 . . . . 0.0 109.299 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.405 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.31 126.19 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.509 1.131 . . . . 0.0 110.991 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.419 0 O-C-N 124.457 1.098 . . . . 0.0 110.323 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.91 69.88 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 121.018 -2.493 . . . . 0.0 110.978 0.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.13 -40.06 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.58 1.175 . . . . 0.0 109.304 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.31 46.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.345 1.028 . . . . 0.0 109.227 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.31 30.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.613 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.92 143.73 50.96 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.519 1.137 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.89 -177.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.823 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.991 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.475 1.11 . . . . 0.0 109.313 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.45 8.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.551 1.157 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.13 174.16 11.47 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 0.745 . . . . 0.0 109.28 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 1.17 . . . . 0.0 110.437 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.718 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.81 169.55 18.05 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.551 1.157 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.53 9.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 0.0 110.888 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.13 155.31 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 0.0 109.275 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.876 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.3 ttp -97.98 119.19 36.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.031 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.37 -65.99 0.93 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 0.0 109.257 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -168.88 -167.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 12.1 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 0.0 109.327 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.03 -172.27 40.44 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.561 1.163 . . . . 0.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.98 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 5.5 Cg_endo -74.96 -168.85 6.81 Favored 'Cis proline' 0 C--N 1.361 1.226 0 C-N-CA 120.9 -2.542 . . . . 0.0 111.072 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.876 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.2 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.518 1.136 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 173.98 167.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 1.135 . . . . 0.0 109.256 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.15 114.39 43.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.566 1.166 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.581 1.175 . . . . 0.0 109.318 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.79 160.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.03 -50.04 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.582 1.176 . . . . 0.0 109.255 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.57 158.12 72.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 109.259 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 164.26 33.53 Favored 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.541 1.811 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.437 1.086 . . . . 0.0 109.319 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.51 0.72 Allowed Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.597 1.186 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 0.784 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.21 77.67 1.74 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 110.035 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.041 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.95 -51.9 70.26 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.427 1.079 . . . . 0.0 109.281 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.5 Cg_endo -74.92 50.8 2.59 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.794 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.598 1.187 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.03 -27.57 68.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 109.285 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.8 m -46.43 115.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.575 1.172 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.95 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.467 1.104 . . . . 0.0 109.36 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.429 HG21 ' HB3' ' B' ' 63' ' ' ASP . 9.1 t -89.75 21.77 3.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.372 1.045 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.3 tttt -85.98 64.36 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.452 1.095 . . . . 0.0 109.238 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.4 102.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.409 1.068 . . . . 0.0 109.388 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.4 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.586 1.178 . . . . 0.0 109.356 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.535 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -68.66 -46.12 80.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.619 1.2 . . . . 0.0 109.318 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.15 111.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 124.547 1.154 . . . . 0.0 109.314 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.07 139.16 23.77 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.549 1.815 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -68.04 0.17 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.439 1.087 . . . . 0.0 110.945 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.66 97.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.438 0.728 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.2 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 0.0 110.932 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.343 1.027 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.32 20.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.476 1.11 . . . . 0.0 109.979 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.7 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.366 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.24 146.46 24.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 0.0 110.374 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.06 8.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.1 -44.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.5 1.125 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.47 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.15 124.08 36.81 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.523 0.778 . . . . 0.0 110.403 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 141.51 26.68 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.468 1.773 . . . . 0.0 111.05 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.15 -178.58 20.13 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.2 m -104.95 120.06 40.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.556 0.798 . . . . 0.0 110.402 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.503 1.127 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.432 1.083 . . . . 0.0 109.999 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.14 -171.5 3.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 14.9 p90 -171.89 165.42 6.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.56 122.26 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 0.0 108.285 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.667 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.25 -50.81 73.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.451 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 83' ' ' THR . 9.2 Cg_endo -75.04 -62.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.508 1.794 . . . . 0.0 111.009 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.9 m80 -75.06 57.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.593 1.183 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -87.89 -38.54 15.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 110.352 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 86' ' ' ARG . . . -89.52 -23.81 32.73 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.416 1.072 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.26 62.62 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.494 0.761 . . . . 0.0 109.325 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.21 1.82 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.458 1.099 . . . . 0.0 110.962 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.638 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 0.772 . . . . 0.0 110.994 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.18 153.59 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.268 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.57 -174.76 19.78 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.604 1.19 . . . . 0.0 110.883 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.04 37.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 0.772 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.61 122.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.459 1.099 . . . . 0.0 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.6 m -105.01 144.51 31.72 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.415 1.072 . . . . 0.0 110.433 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.563 1.165 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.823 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 0.0 110.305 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 15.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.509 ' HE2' ' CE1' ' B' ' 4' ' ' TYR . 0.7 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.724 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 18.9 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.515 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 35.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.717 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 84.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.808 ' HB2' HG21 ' B' ' 233' ' ' VAL . 23.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 85.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.671 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 58' ' ' THR . 15.5 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.5 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.717 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.599 HD21 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.525 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 13.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' B' ' 103' ' ' LEU . 0.1 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.046 HG13 ' HG ' ' B' ' 115' ' ' LEU . 40.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.812 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.5 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.568 ' CD1' HD11 ' B' ' 116' ' ' LEU . 29.1 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 49.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.046 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.812 ' HB2' HG23 ' B' ' 105' ' ' THR . 32.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.98 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.517 ' HB3' HG13 ' A' ' 62' ' ' ILE . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.671 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 49.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.2 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.032 ' CB ' HG22 ' B' ' 164' ' ' THR . 8.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.3 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 38.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.551 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.2 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.879 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.7 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.2 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -57.68 126.85 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 109.999 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.971 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.11 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 0.0 109.27 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.92 150.88 40.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 0.0 109.313 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.7 133.42 36.02 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.533 1.146 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.02 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 0.0 110.995 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.46 7.63 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 124.545 1.153 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.71 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 10.7 p -108.14 160.66 15.64 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.423 0.72 . . . . 0.0 110.41 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.527 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 46.2 t0 -59.8 -15.97 24.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.6 mttt -90.65 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.549 1.156 . . . . 0.0 109.365 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 38.32 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.87 117.67 58.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HG3' ' CZ ' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.46 1.769 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 9' ' ' THR . 3.9 pp -150.76 151.27 32.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 0.0 109.365 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.3 m-85 -77.41 126.2 30.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.95 26.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.401 1.063 . . . . 0.0 110.284 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -74.99 140.94 70.15 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.027 -2.489 . . . . 0.0 110.947 -0.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.13 -40.12 1.03 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.543 1.152 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.414 1.072 . . . . 0.0 109.283 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.971 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.36 31.0 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 0.0 109.264 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.76 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.53 1.144 . . . . 0.0 110.04 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.95 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 0.0 109.324 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.33 27.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 109.936 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.305 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.38 8.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.481 1.113 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.649 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.562 0.801 . . . . 0.0 109.203 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.63 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.589 1.181 . . . . 0.0 110.367 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.711 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.46 102.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 0.0 109.24 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.8 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.531 1.144 . . . . 0.0 110.279 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.46 9.58 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 0.0 110.994 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.32 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.528 1.142 . . . . 0.0 109.25 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.5 ttp -98.04 119.21 36.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.32 -66.03 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 109.286 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.52 0.76 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 36' ' ' VAL . 1.2 p 46.04 54.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 0.0 109.345 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.9 -172.36 40.67 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.532 1.145 . . . . 0.0 111.046 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.126 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 25.3 Cg_endo -74.96 -168.95 6.89 Favored 'Cis proline' 0 C--N 1.361 1.184 0 C-N-CA 120.993 -2.503 . . . . 0.0 110.996 -0.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 71.2 m-70 -144.21 -170.33 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.505 1.128 . . . . 0.0 109.575 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.94 166.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.398 1.061 . . . . 0.0 109.285 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.597 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 1.152 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.617 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -132.82 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.126 . . . . 0.0 109.308 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER 167.29 143.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.0 73.17 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 0.0 109.233 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 164.22 33.86 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.474 1.776 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.28 135.67 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 0.0 109.244 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.43 -56.52 0.73 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.538 1.149 . . . . 0.0 110.981 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.28 2.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 0.819 . . . . 0.0 110.249 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.24 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.382 1.052 . . . . 0.0 109.938 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.018 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.86 70.81 Favored Pre-proline 0 C--N 1.323 -0.552 0 O-C-N 124.489 1.118 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.0 50.77 2.61 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.414 1.744 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.3 -45.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.579 1.174 . . . . 0.0 109.336 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.15 -27.51 68.08 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.316 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 m -46.52 115.13 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.494 1.121 . . . . 0.0 110.009 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -107.92 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.775 HG21 ' HB3' ' B' ' 63' ' ' ASP . 1.4 t -89.75 21.85 3.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 0.0 110.343 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 28.8 tttt -86.04 64.43 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.093 . . . . 0.0 109.233 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 0.0 109.332 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.5 6.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.311 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.717 HD11 HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.69 -46.13 80.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.568 1.168 . . . . 0.0 109.319 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.16 111.61 4.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.48 1.113 . . . . 0.0 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -75.01 139.18 23.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.428 1.752 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.475 1.109 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.673 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.47 0.747 . . . . 0.0 110.06 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.13 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 0.0 111.039 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.51 175.18 4.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.418 1.073 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.69 161.2 21.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.567 1.167 . . . . 0.0 109.964 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.69 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 0.0 109.374 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.22 146.5 23.97 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.439 1.087 . . . . 0.0 110.388 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.19 173.06 8.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.25 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.34 124.28 39.05 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.578 0.811 . . . . 0.0 110.385 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.1 Cg_endo -75.15 141.49 26.3 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.549 1.815 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.66 20.02 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.89 120.05 40.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 0.787 . . . . 0.0 110.407 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.71 140.67 30.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 0.0 111.025 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.84 145.12 49.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.055 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.43 3.72 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.55 1.156 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.617 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 13.1 p90 -171.88 165.47 6.44 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 0.0 111.055 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.67 122.36 36.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 108.202 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.484 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 m -51.3 -50.73 74.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.441 1.088 . . . . 0.0 110.431 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 83' ' ' THR . 41.5 Cg_endo -75.13 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.565 1.824 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.871 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 27.0 m80 -75.03 57.99 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -38.56 15.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.554 1.159 . . . . 0.0 110.287 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.48 -23.85 32.72 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.533 1.146 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.492 0.76 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.16 1.82 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.478 1.111 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.66 75.12 1.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 0.761 . . . . 0.0 110.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.18 153.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.119 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.78 19.74 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.03 37.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.507 0.769 . . . . 0.0 110.425 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.711 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.62 122.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.561 1.163 . . . . 0.0 109.286 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.7 m -105.08 144.56 31.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.457 1.098 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.438 1.086 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 0.0 110.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.783 ' CE2' ' HD2' ' A' ' 38' ' ' PRO . 7.8 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.843 ' CZ ' ' HG3' ' A' ' 14' ' ' PRO . 3.8 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.871 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 1.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 33.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.146 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.72 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.733 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 20.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' B' ' 65' ' ' SER . 15.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.775 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 51.6 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.72 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 2.1 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.664 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 29.5 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.556 ' CE2' HD23 ' B' ' 103' ' ' LEU . 2.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.556 HD23 ' CE2' ' B' ' 102' ' ' TYR . 76.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.031 HG13 ' HG ' ' B' ' 115' ' ' LEU . 68.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.979 ' HA ' HD11 ' B' ' 116' ' ' LEU . 28.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 31.8 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.031 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.979 HD11 ' HA ' ' B' ' 107' ' ' TYR . 0.4 OUTLIER -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.126 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' B' ' 125' ' ' TYR . 10.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' B' ' 120' ' ' LEU . 62.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.733 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 21.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.299 ' OH ' ' HA ' ' B' ' 168' ' ' SER . 3.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.478 ' HG3' ' CG ' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 3.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.938 ' C ' ' HE1' ' B' ' 162' ' ' TYR . 4.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 168' ' ' SER . . . . . 1.299 ' HA ' ' OH ' ' B' ' 162' ' ' TYR . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 16.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 1.581 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.355 16.2 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 59.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.566 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 56.7 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.108 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 5.4 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.566 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.8 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.789 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.108 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 9.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.146 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.65 126.86 29.2 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.531 1.145 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.18 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.418 1.074 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.93 40.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.559 1.162 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.08 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.76 133.49 35.98 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.526 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 110.973 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.53 7.65 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.577 1.173 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.528 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -108.05 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.475 0.75 . . . . 0.0 110.42 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.83 -15.97 24.91 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 0.0 109.356 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -90.57 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 0.0 109.337 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER 38.23 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.169 . . . . 0.0 111.062 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.8 117.71 58.16 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.67 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 34.7 Cg_endo -75.03 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.528 1.804 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.2 pp -150.78 151.23 32.04 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.48 1.113 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.34 126.15 30.47 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.509 1.131 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.41 134.9 26.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.505 1.128 . . . . 0.0 110.351 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.09 140.99 70.28 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 121.007 -2.497 . . . . 0.0 110.909 0.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.22 -40.11 1.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.531 1.145 . . . . 0.0 109.251 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.29 46.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.42 31.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.133 . . . . 0.0 109.247 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.473 1.108 . . . . 0.0 110.059 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.402 1.064 . . . . 0.0 109.259 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.53 158.29 27.62 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 0.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.32 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.44 8.45 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.469 1.105 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.642 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.14 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 0.733 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.53 154.25 39.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 0.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.41 102.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.566 1.167 . . . . 0.0 109.276 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.51 18.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.591 1.182 . . . . 0.0 110.334 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.19 121.46 9.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.562 1.164 . . . . 0.0 110.986 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.01 155.35 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.565 1.166 . . . . 0.0 109.262 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.77 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.2 ttp -98.05 119.26 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.399 1.062 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -79.39 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.181 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.86 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.46 1.1 . . . . 0.0 109.228 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.67 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.3 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.455 1.097 . . . . 0.0 109.323 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.95 -172.3 40.58 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.51 1.131 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HB3' HD13 ' A' ' 62' ' ' ILE . 42.8 Cg_endo -74.95 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.913 -2.536 . . . . 0.0 111.034 -0.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.77 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.7 m-70 -144.23 -170.37 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.568 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.469 1.106 . . . . 0.0 109.338 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.35 43.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.543 1.152 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -132.78 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.539 1.149 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -49.99 4.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.293 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.3 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.061 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.87 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.03 164.22 33.75 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.459 1.768 . . . . 0.0 110.974 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.21 135.62 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.59 0.72 Allowed Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.538 1.149 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.651 0.853 . . . . 0.0 110.25 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.426 1.079 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.061 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.03 -51.81 71.31 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.415 1.072 . . . . 0.0 109.27 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.05 50.78 2.63 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.419 1.747 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.62 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.662 1.226 . . . . 0.0 109.358 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.13 -27.56 68.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 4.4 m -46.44 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 0.0 109.99 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 68' ' ' TYR 0.492 7.8 t30 -108.04 117.75 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.411 1.069 . . . . 0.0 109.312 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.911 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 4.0 t -89.82 21.87 3.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 0.0 110.311 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 60' ' ' LEU . 57.1 tttt -86.02 64.36 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.487 1.117 . . . . 0.0 109.287 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.475 1.109 . . . . 0.0 109.296 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.42 6.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 1.097 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.834 HD12 HD21 ' B' ' 70' ' ' ASN . 5.9 mm -68.62 -46.07 80.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.526 1.141 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -62.13 111.64 4.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.285 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 5.1 Cg_exo -75.05 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.454 1.765 . . . . 0.0 111.025 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.86 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.55 1.157 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.65 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.527 0.781 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.449 1.093 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.62 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.5 175.16 4.18 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.95 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.474 1.109 . . . . 0.0 110.006 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.27 146.47 24.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.57 1.169 . . . . 0.0 110.382 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 1.126 . . . . 0.0 109.259 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.459 1.1 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.46 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.14 38.13 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.52 0.776 . . . . 0.0 110.388 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.98 141.5 26.78 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.438 1.757 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.64 20.05 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.459 1.1 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.3 m -104.81 120.11 40.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 0.776 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.66 31.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 111.03 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.88 145.15 49.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.406 1.066 . . . . 0.0 110.016 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.21 -171.59 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.114 . . . . 0.0 110.956 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.495 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 16.3 p90 -171.78 165.46 6.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.543 1.152 . . . . 0.0 110.995 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.54 122.34 35.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.448 1.093 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.627 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 2.9 m -51.38 -50.76 74.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.433 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.9 Cg_endo -75.02 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.234 0 O-C-N 124.492 1.785 . . . . 0.0 111.033 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.631 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -38.44 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.536 1.147 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.52 -23.8 32.77 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.51 1.131 . . . . 0.0 110.995 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.18 62.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.512 0.772 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.1 1.83 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.456 1.097 . . . . 0.0 110.984 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.526 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.3 ttt -121.54 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 0.73 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.16 153.56 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 109.271 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.76 19.76 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.553 1.158 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.79 162.02 37.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.49 0.759 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.716 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.9 m -105.0 144.56 31.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.422 1.076 . . . . 0.0 110.429 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.31 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.523 1.139 . . . . 0.0 109.315 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.313 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.422 ' CD2' ' HE2' ' B' ' 4' ' ' TYR . 23.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.9 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 1.422 ' HE2' ' CD2' ' B' ' 1' ' ' TYR . 51.7 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 22.6 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 26.0 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.73 ' HB2' HG21 ' B' ' 233' ' ' VAL . 43.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.541 ' CD ' HD21 ' A' ' 60' ' ' LEU . 3.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.911 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 5.7 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.3 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 65' ' ' SER 0.261 4.7 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 29.8 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.417 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.834 HD21 HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.856 HG13 ' HG ' ' B' ' 115' ' ' LEU . 62.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.851 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.2 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.873 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.2 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.851 ' HB2' HG23 ' B' ' 105' ' ' THR . 70.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.744 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' B' ' 125' ' ' TYR . 39.3 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' B' ' 120' ' ' LEU . 73.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.448 ' CA ' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.697 ' HG3' ' OE1' ' B' ' 59' ' ' GLN . 14.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.032 ' HB3' HG22 ' B' ' 164' ' ' THR . 3.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 44.6 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.634 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.6 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.539 HD21 HH12 ' B' ' 158' ' ' ARG . 37.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.957 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.62 126.8 28.95 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.561 1.163 . . . . 0.0 110.056 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.413 1.071 . . . . 0.0 109.28 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.88 40.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.546 1.154 . . . . 0.0 110.3 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.3 112.12 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.457 1.098 . . . . 0.0 109.355 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.68 133.46 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.466 1.103 . . . . 0.0 109.377 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.622 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 0.0 111.007 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.52 7.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.543 1.152 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -108.1 160.71 15.6 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.478 0.752 . . . . 0.0 110.426 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.85 -15.96 25.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.436 1.085 . . . . 0.0 109.257 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 17.5 mttt -90.59 39.73 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CZ ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.26 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.58 1.175 . . . . 0.0 111.031 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.68 58.17 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 109.278 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 37.3 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.497 1.788 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.4 pp -150.83 151.17 31.88 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.28 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.16 . . . . 0.0 111.018 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.43 134.95 26.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.565 1.166 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.06 140.98 70.28 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.939 0.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.16 -40.17 1.05 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.611 1.194 . . . . 0.0 109.252 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.29 46.09 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.462 1.101 . . . . 0.0 109.309 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.41 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 109.252 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.618 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.94 143.7 50.94 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 110.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.79 -177.44 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.504 1.128 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.37 27.5 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 0.0 110.002 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.15 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.606 1.191 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.52 -7.48 8.44 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.515 1.134 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.13 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 0.753 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.52 154.26 39.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 0.0 110.485 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.509 1.131 . . . . 0.0 109.306 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.274 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.55 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.24 121.38 9.49 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.533 1.146 . . . . 0.0 110.98 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.34 33.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.515 1.134 . . . . 0.0 109.317 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.06 119.22 36.32 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.353 1.033 . . . . 0.0 111.026 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -79.35 -66.05 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 109.255 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.717 ' HD3' ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -168.89 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.44 1.087 . . . . 0.0 109.3 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.4 p 46.08 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.48 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.588 1.18 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.99 -168.86 6.83 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.934 -2.527 . . . . 0.0 110.969 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.735 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.5 m-70 -144.24 -170.33 3.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.542 1.151 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.436 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.4 p30 173.94 166.95 0.2 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.419 1.074 . . . . 0.0 109.355 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.536 1.148 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.626 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.78 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 109.333 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.62 160.59 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.568 1.167 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.571 1.17 . . . . 0.0 109.306 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.024 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.09 72.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 164.25 33.69 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.463 1.77 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 0.0 109.339 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.492 1.12 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.04 -173.34 2.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.593 0.819 . . . . 0.0 110.295 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.2 77.86 1.75 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.511 1.132 . . . . 0.0 109.994 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.024 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.12 -51.76 72.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.11 . . . . 0.0 109.262 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.12 50.86 2.67 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.487 1.783 . . . . 0.0 110.909 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.63 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.584 1.177 . . . . 0.0 109.38 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.16 -27.52 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.117 . . . . 0.0 109.298 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 m -46.46 115.15 0.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 0.0 109.976 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.546 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -108.02 117.71 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.438 1.086 . . . . 0.0 109.328 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.141 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 1.5 t -89.81 21.89 3.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.416 1.073 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -86.05 64.4 8.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.491 1.119 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.099 HD21 ' CG ' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -40.39 102.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.55 1.156 . . . . 0.0 109.332 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.38 6.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.579 HG23 HD22 ' B' ' 70' ' ' ASN . 3.5 mt -68.6 -46.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.58 4.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.108 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.98 139.11 23.94 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.457 1.767 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.94 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.522 1.139 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.657 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.485 0.756 . . . . 0.0 109.985 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.16 -86.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.446 1.092 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.59 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.482 1.114 . . . . 0.0 110.029 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.73 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 109.428 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.53 23.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 110.344 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.19 173.06 8.57 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.492 1.12 . . . . 0.0 109.261 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.13 37.87 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 0.0 110.421 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.0 141.5 26.72 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.511 1.795 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.05 -178.67 20.0 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.335 1.022 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.87 120.04 40.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 0.746 . . . . 0.0 110.347 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.838 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.74 140.69 30.95 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.87 145.16 49.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.451 1.094 . . . . 0.0 109.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.23 -171.62 3.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.458 1.099 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.457 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 15.6 p90 -171.78 165.4 6.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.555 1.16 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 122.33 35.8 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.424 1.078 . . . . 0.0 108.326 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.626 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.9 m -51.38 -50.77 74.36 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.499 1.124 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 18.6 Cg_endo -75.03 -62.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 26.3 m80 -74.97 58.0 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.596 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.438 HH22 HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -88.0 -38.55 15.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.556 1.16 . . . . 0.0 110.314 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.45 -23.72 33.18 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.505 1.128 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.719 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.73 -15.21 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 0.768 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.523 1.139 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.622 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.391 0.701 . . . . 0.0 111.021 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.59 30.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.589 1.181 . . . . 0.0 109.272 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.543 1.152 . . . . 0.0 111.006 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.08 36.93 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.426 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 0.0 109.238 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.1 m -105.1 144.57 31.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 110.372 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.32 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.497 1.123 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.56 1.163 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.555 ' OH ' HBD1 ' B' ' 250' ' ' HEC . 16.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.514 ' HB2' HD13 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.984 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 16.2 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 4.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.984 ' HG3' ' O ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.5 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 7.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.689 ' HB2' HG21 ' B' ' 233' ' ' VAL . 18.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 1.099 ' CG ' HD21 ' A' ' 60' ' ' LEU . 5.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 1.141 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 31.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.416 ' HB3' ' OE1' ' B' ' 61' ' ' GLN . 78.4 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 5.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.583 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.6 ' HA ' HD23 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.755 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.8 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.822 ' CB ' HD22 ' B' ' 83' ' ' LEU . 98.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' B' ' 74' ' ' VAL . 19.0 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.738 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 38.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.482 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.562 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 46.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.8 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.033 ' CB ' HG22 ' B' ' 164' ' ' THR . 3.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.9 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 17.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.632 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.7 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 16.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 11.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.86 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.55 126.8 28.94 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.535 1.147 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.19 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 0.0 109.273 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.87 40.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.14 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.412 1.07 . . . . 0.0 109.346 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.82 133.55 35.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 0.0 109.276 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.613 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.07 6.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 0.0 110.953 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.48 7.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.586 1.179 . . . . 0.0 110.973 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.762 ' CG2' HD11 ' A' ' 15' ' ' LEU . 17.2 p -108.07 160.7 15.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 0.741 . . . . 0.0 110.421 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -59.84 -15.92 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.402 1.064 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 23.9 mttt -90.58 39.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.137 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.639 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 22.9 m-85 38.37 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 0.0 111.015 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.84 117.65 58.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 22.3 Cg_endo -74.98 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.486 1.782 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.762 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.21 31.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 0.0 109.357 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.34 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.473 1.108 . . . . 0.0 110.967 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.96 26.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.559 1.162 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.98 70.31 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.039 -2.484 . . . . 0.0 110.943 0.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.23 -40.1 1.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.554 1.159 . . . . 0.0 109.274 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.34 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.459 1.1 . . . . 0.0 109.302 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.944 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.29 141.43 31.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.553 1.158 . . . . 0.0 109.225 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.72 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.451 1.094 . . . . 0.0 110.036 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.88 -177.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 0.0 109.219 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.818 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.56 158.31 27.59 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.06 105.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 0.0 109.337 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.446 1.091 . . . . 0.0 110.999 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.25 174.09 11.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 0.747 . . . . 0.0 109.286 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.46 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 0.0 110.475 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.723 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.263 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.85 169.51 18.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.5 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.491 1.12 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.34 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.731 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.1 ttp -98.0 119.27 36.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.359 1.037 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -79.39 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.109 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.639 ' HE3' ' HA ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -168.88 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.415 1.072 . . . . 0.0 109.279 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.7 p 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.538 1.149 . . . . 0.0 111.027 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.712 ' HD2' ' CE1' ' B' ' 1' ' ' TYR . 59.8 Cg_endo -74.99 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.931 -2.529 . . . . 0.0 110.963 -0.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.731 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.23 -170.4 3.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.569 1.168 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.99 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.07 114.33 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.534 1.146 . . . . 0.0 109.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.9 mm -132.75 75.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.59 160.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 110.98 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.99 -50.15 4.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 109.265 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.47 158.14 72.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.383 1.052 . . . . 0.0 109.291 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.07 164.22 33.67 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.505 1.792 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.19 135.6 1.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 0.0 109.328 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.537 1.148 . . . . 0.0 111.0 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.39 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.561 0.8 . . . . 0.0 110.263 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.46 1.1 . . . . 0.0 109.98 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.042 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.11 -51.75 72.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 0.0 109.269 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.07 50.78 2.64 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.401 1.737 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.65 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.639 1.212 . . . . 0.0 109.381 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.06 -27.54 68.16 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 109.36 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.3 m -46.45 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.965 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.554 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.3 m-80 -108.07 117.73 34.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' B' ' 63' ' ' ASP . 3.3 t -89.82 21.92 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.432 1.082 . . . . 0.0 110.317 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 1.7 tttt -86.04 64.41 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -40.45 102.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 0.0 109.297 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.43 6.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 109.316 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.717 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.69 -46.06 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.594 1.184 . . . . 0.0 109.332 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.63 4.93 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.04 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.473 1.775 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.87 -67.9 0.17 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.591 1.182 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.493 0.761 . . . . 0.0 109.994 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.25 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.417 1.073 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.494 1.121 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.29 20.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.408 1.068 . . . . 0.0 110.015 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 0.0 109.412 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 110.347 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.11 173.08 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.514 1.134 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.488 1.117 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.06 37.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.545 0.791 . . . . 0.0 110.403 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.7 Cg_endo -74.97 141.51 26.82 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.483 1.781 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.441 1.088 . . . . 0.0 111.007 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.9 120.08 40.57 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.484 0.755 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.836 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.68 30.97 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.491 1.119 . . . . 0.0 111.017 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.17 49.3 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 1.08 . . . . 0.0 109.97 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.55 3.74 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.7 p90 -171.86 165.35 6.46 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 122.36 35.81 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.445 1.091 . . . . 0.0 108.284 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.633 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.39 -50.82 74.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.456 1.098 . . . . 0.0 110.356 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 83' ' ' THR . 36.4 Cg_endo -74.93 -62.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.527 1.804 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 29.5 m80 -74.96 57.93 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 0.0 109.598 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.179 ' HD2' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.97 -38.49 15.49 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.559 1.162 . . . . 0.0 110.318 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.895 ' N ' ' HD2' ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.77 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 0.761 . . . . 0.0 109.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.08 63.17 1.83 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.444 1.09 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.613 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.61 75.03 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.4 0.706 . . . . 0.0 111.066 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.14 153.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.499 1.124 . . . . 0.0 109.305 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.79 19.77 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.571 1.169 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.03 37.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 0.748 . . . . 0.0 110.432 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.723 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.61 122.63 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.02 144.49 31.75 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.427 1.079 . . . . 0.0 110.415 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 96' ' ' VAL . 5.0 t -128.2 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.53 1.144 . . . . 0.0 109.376 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.818 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.087 ' HD2' ' CE2' ' B' ' 4' ' ' TYR . 97.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 1.087 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 24.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.514 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.7 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 48.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.678 ' HB2' HG21 ' B' ' 233' ' ' VAL . 12.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 87.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.541 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 1.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.541 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 2.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.4 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.716 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.466 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 62' ' ' ILE . 4.9 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.472 HG23 ' CE ' ' B' ' 128' ' ' MET . 20.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.893 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.8 HD23 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.826 ' CB ' HD22 ' B' ' 83' ' ' LEU . 67.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 2.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 73.9 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.967 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.754 ' HB2' HG23 ' B' ' 105' ' ' THR . 52.1 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.843 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.827 HD22 ' CE2' ' B' ' 125' ' ' TYR . 17.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.54 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.827 ' CE2' HD22 ' B' ' 120' ' ' LEU . 41.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.472 ' CE ' HG23 ' B' ' 71' ' ' VAL . 60.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.516 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 38.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' B' ' 24' ' ' CYS . 9.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.333 ' CD2' ' HD2' ' B' ' 163' ' ' PRO . 13.1 t80 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 1.333 ' HD2' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.187 ' CG2' ' HB3' ' B' ' 162' ' ' TYR . 0.2 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.815 ' H ' HG23 ' B' ' 164' ' ' THR . 36.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 0.957 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.962 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.957 ' HD3' ' CD2' ' B' ' 189' ' ' PHE 0.26 5.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.62 126.79 28.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.533 1.146 . . . . 0.0 109.99 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.947 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.426 1.079 . . . . 0.0 109.271 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.602 1.189 . . . . 0.0 110.296 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.458 1.099 . . . . 0.0 109.32 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.72 133.46 36.0 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.658 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.1 6.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 110.961 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.5 7.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.605 1.191 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.713 ' CG2' HD11 ' A' ' 15' ' ' LEU . 27.0 p -108.1 160.74 15.57 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.437 0.728 . . . . 0.0 110.398 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 45.5 t0 -59.85 -15.94 24.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.089 . . . . 0.0 109.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 13.1 mttt -90.64 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 38.27 29.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.72 58.07 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.483 1.115 . . . . 0.0 109.326 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HG3' HG21 ' A' ' 36' ' ' VAL . 10.9 Cg_endo -75.0 97.62 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.498 1.788 . . . . 0.0 110.974 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.83 151.19 31.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.511 1.132 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.33 126.18 30.51 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.492 1.12 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.04 140.97 70.24 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.03 -2.488 . . . . 0.0 110.962 0.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.17 -40.1 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.545 1.153 . . . . 0.0 109.295 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.33 46.09 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.947 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.43 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.11 . . . . 0.0 109.226 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 110.029 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.12 . . . . 0.0 109.289 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.819 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.62 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.452 1.095 . . . . 0.0 109.994 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.59 1.181 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.506 1.128 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.17 11.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 0.78 . . . . 0.0 109.288 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.55 154.23 39.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 0.0 110.427 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.592 1.182 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.86 169.49 18.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.17 121.49 9.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 0.0 110.962 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.04 155.28 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.698 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.5 ttp -98.01 119.26 36.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.373 1.046 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -79.33 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 14' ' ' PRO . 9.8 p 46.04 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.092 . . . . 0.0 109.319 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.91 -172.31 40.63 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.487 1.117 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 56.3 Cg_endo -74.98 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.973 -0.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.698 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 68.8 m-70 -144.26 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.588 1.18 . . . . 0.0 109.574 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 174.01 167.07 0.21 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 109.338 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.16 114.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.586 1.179 . . . . 0.0 109.323 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.324 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.61 160.63 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.562 1.163 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.05 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.046 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.381 1.051 . . . . 0.0 109.257 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 164.27 33.6 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.449 1.763 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.27 135.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 0.0 109.292 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.66 0.72 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.01 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.59 0.818 . . . . 0.0 110.282 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.426 1.079 . . . . 0.0 109.997 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.046 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.83 71.14 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.417 1.073 . . . . 0.0 109.265 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.02 50.79 2.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.447 1.762 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.29 -45.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.659 1.224 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.54 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -46.52 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.945 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -107.97 117.69 34.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.79 21.88 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.38 1.05 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -86.04 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.42 102.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.546 1.154 . . . . 0.0 109.337 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.944 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.64 -46.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.162 . . . . 0.0 109.353 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.04 111.61 4.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 0.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.05 139.15 23.81 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.468 1.772 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.567 1.167 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.7 97.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.438 0.728 . . . . 0.0 109.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.496 1.123 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.52 175.12 4.18 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.467 1.105 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.28 20.94 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.444 1.09 . . . . 0.0 109.988 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.04 137.69 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.106 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.26 146.48 23.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 110.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.11 8.53 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.449 1.093 . . . . 0.0 109.251 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.31 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.07 37.65 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 0.0 110.37 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.97 141.49 26.79 Favored 'Trans proline' 0 C--N 1.359 1.092 0 O-C-N 124.498 1.789 . . . . 0.0 111.107 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.452 1.095 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.02 40.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 0.742 . . . . 0.0 110.339 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.4 m-85 -96.68 140.75 30.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.97 145.16 49.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.56 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.422 1.077 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.1 p90 -171.82 165.41 6.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 1.12 . . . . 0.0 111.018 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.49 122.38 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 0.0 108.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.71 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.34 -50.84 73.84 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.506 1.129 . . . . 0.0 110.373 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CB ' ' OH ' ' B' ' 1' ' ' TYR . 40.2 Cg_endo -74.97 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.465 1.771 . . . . 0.0 111.01 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 2.5 m170 -75.03 58.01 0.85 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.36 HH12 ' CA ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -88.01 -38.46 15.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.57 1.169 . . . . 0.0 110.314 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 1.36 ' CA ' HH12 ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.465 1.103 . . . . 0.0 110.983 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.64 -15.26 62.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 0.751 . . . . 0.0 109.408 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.11 1.83 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.43 1.081 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.56 74.98 1.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.401 0.706 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.12 153.59 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.72 19.72 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.599 1.187 . . . . 0.0 110.984 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.81 162.07 37.01 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 0.793 . . . . 0.0 110.414 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.64 122.63 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.0 m -105.01 144.53 31.69 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.414 1.071 . . . . 0.0 110.404 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.515 1.134 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.819 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.572 1.17 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.751 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.457 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 1.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.2 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.798 ' CE2' HD13 ' B' ' 69' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.584 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 52.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.895 ' HB2' HG21 ' B' ' 233' ' ' VAL . 3.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.71 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' B' ' 65' ' ' SER . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 69.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.584 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.798 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.89 ' ND2' HG23 ' A' ' 62' ' ' ILE . 2.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.787 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.817 ' CB ' HD22 ' B' ' 83' ' ' LEU . 99.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.83 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.5 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.3 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.5 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.979 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.83 ' HB2' HG23 ' B' ' 105' ' ' THR . 46.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.725 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 1.5 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 9.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.944 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' B' ' 124' ' ' ASP . 4.1 pm0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.553 ' N ' ' HG2' ' B' ' 123' ' ' GLU . 8.7 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 42.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.448 ' CA ' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.449 ' HG2' HAD2 ' B' ' 250' ' ' HEC . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' B' ' 24' ' ' CYS . 6.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 0.93 ' HB2' HG22 ' B' ' 164' ' ' THR . 19.2 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.021 HG23 ' H ' ' B' ' 166' ' ' GLU . 14.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.021 ' H ' HG23 ' B' ' 164' ' ' THR . 25.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.713 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.568 HD21 ' HA ' ' B' ' 62' ' ' ALA . 10.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' ILE . . . . . 0.474 ' C ' HD13 ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.824 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 8.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.895 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.58 126.79 28.88 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.549 1.155 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.267 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.86 40.25 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.529 1.143 . . . . 0.0 110.315 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.363 1.039 . . . . 0.0 109.267 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.74 133.47 35.99 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.611 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.69 96.99 6.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.458 1.099 . . . . 0.0 111.036 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.477 1.111 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.4 p -108.09 160.65 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.446 0.733 . . . . 0.0 110.439 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 13.4 t70 -59.78 -15.98 24.44 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.452 1.095 . . . . 0.0 109.361 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 29.1 mttp -90.57 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.313 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' CE2' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.24 29.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 0.0 111.054 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.7 58.12 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.676 ' HG3' HG21 ' A' ' 36' ' ' VAL . 28.0 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.429 1.752 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.81 151.22 31.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.109 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.17 30.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.44 134.82 26.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.406 1.066 . . . . 0.0 110.375 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.12 140.92 69.9 Favored 'Cis proline' 0 C--N 1.36 1.138 0 C-N-CA 121.031 -2.487 . . . . 0.0 110.96 0.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.17 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.32 46.11 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.425 1.078 . . . . 0.0 109.279 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.21 141.4 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.137 . . . . 0.0 109.261 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.611 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 0.0 110.019 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.94 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 0.0 109.287 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.126 . . . . 0.0 109.923 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.525 1.141 . . . . 0.0 109.251 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.43 8.45 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.508 1.13 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.14 174.09 11.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.56 0.8 . . . . 0.0 109.282 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.43 154.29 39.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 110.51 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.52 102.6 6.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.099 . . . . 0.0 109.289 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.53 18.08 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.484 1.115 . . . . 0.0 110.28 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.23 121.39 9.5 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.516 1.135 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.38 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.8 ttp -98.0 119.17 36.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.427 1.079 . . . . 0.0 111.037 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -79.38 -66.05 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.571 1.17 . . . . 0.0 109.223 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.7 p 45.97 54.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.505 1.128 . . . . 0.0 109.321 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.803 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -93.0 -172.37 40.51 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.478 1.111 . . . . 0.0 111.03 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.02 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.97 0.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.613 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.4 m-70 -144.23 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 0.0 109.644 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.62 ' HB3' HD23 ' A' ' 60' ' ' LEU . 1.2 p30 173.97 166.96 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 0.0 109.304 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.8 t -104.12 114.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.938 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.8 mm -132.75 75.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.72 160.59 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.01 -49.94 4.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 0.0 109.276 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.26 143.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.431 1.082 . . . . 0.0 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.14 72.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.39 1.056 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.9 Cg_endo -75.11 164.2 33.61 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.55 1.816 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.16 135.55 1.37 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.097 . . . . 0.0 109.307 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.52 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.566 1.166 . . . . 0.0 110.974 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.24 2.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.607 0.828 . . . . 0.0 110.243 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.27 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.043 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.99 -51.85 70.87 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.473 1.108 . . . . 0.0 109.353 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -74.97 50.71 2.58 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.446 1.761 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.54 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.53 1.144 . . . . 0.0 109.392 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.11 -27.61 68.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.593 1.183 . . . . 0.0 109.252 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.47 115.12 0.94 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.555 1.159 . . . . 0.0 109.995 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 1.006 ' OD1' ' OH ' ' A' ' 68' ' ' TYR 0.964 52.9 p-10 -107.94 117.66 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.442 1.088 . . . . 0.0 109.298 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.82 21.9 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.454 1.096 . . . . 0.0 110.301 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -86.01 64.37 8.54 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 0.0 109.239 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.671 ' CD1' ' HB2' ' B' ' 61' ' ' GLN . 4.4 mt -40.39 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.52 98.49 6.11 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.563 1.164 . . . . 0.0 109.263 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.977 HG22 ' HB3' ' B' ' 121' ' ' PRO . 1.2 mm -68.64 -46.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.11 111.59 4.84 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.951 ' HD3' ' HG3' ' B' ' 121' ' ' PRO . 9.0 Cg_endo -74.97 139.15 24.02 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.466 1.771 . . . . 0.0 111.052 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -67.98 0.17 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.124 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.455 0.738 . . . . 0.0 110.008 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.16 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.463 1.102 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 1.006 ' OH ' ' OD1' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.11 4.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 0.0 111.021 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.57 161.31 20.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.462 1.101 . . . . 0.0 109.975 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.69 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.449 1.093 . . . . 0.0 110.332 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.09 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.518 1.136 . . . . 0.0 109.233 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.34 0.02 OUTLIER Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.577 1.173 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.28 124.11 37.86 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.453 0.737 . . . . 0.0 110.39 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.51 26.77 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.504 1.792 . . . . 0.0 111.054 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.62 20.07 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.422 1.076 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.07 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.556 0.798 . . . . 0.0 110.403 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.58 1.175 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.91 145.16 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.24 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.444 1.09 . . . . 0.0 110.927 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.0 p90 -171.84 165.38 6.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.52 122.27 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.469 1.106 . . . . 0.0 108.29 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.986 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 20.4 m -51.27 -50.79 73.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 110.429 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 30.3 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.554 1.818 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -75.04 57.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.139 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.986 ' CG ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -87.98 -38.5 15.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.558 1.161 . . . . 0.0 110.337 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.5 -23.77 32.91 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.423 1.077 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.31 62.66 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.487 0.757 . . . . 0.0 109.314 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.22 1.82 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.469 1.106 . . . . 0.0 110.979 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.611 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.2 ttt -121.63 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 0.763 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.21 153.49 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.44 1.088 . . . . 0.0 109.298 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.46 -174.69 19.64 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.449 1.093 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.84 162.08 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 0.778 . . . . 0.0 110.382 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.56 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.51 1.131 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.01 144.53 31.68 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 0.0 110.43 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.25 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 0.0 109.283 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.498 1.123 . . . . 0.0 110.347 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.003 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.46 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.804 ' CE2' ' CE1' ' B' ' 1' ' ' TYR . 8.8 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.55 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 3.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.842 ' HB2' HG21 ' B' ' 233' ' ' VAL . 22.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 76.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.894 ' NE2' ' HB3' ' B' ' 65' ' ' SER . 5.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.685 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.594 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.894 ' HB3' ' NE2' ' B' ' 61' ' ' GLN . 3.2 t -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.551 ' OG ' ' HB3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.539 HD21 HG23 ' B' ' 233' ' ' VAL . 7.5 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.866 ' ND2' HG23 ' A' ' 62' ' ' ILE . 10.0 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' ASP . . . . . 0.605 ' HB2' HD12 ' B' ' 103' ' ' LEU . 80.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 99' ' ' ASP . 1.6 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.962 HG11 HD12 ' B' ' 115' ' ' LEU . 24.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.609 HG23 ' HB2' ' B' ' 116' ' ' LEU . 11.9 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.632 ' CD1' HD11 ' B' ' 116' ' ' LEU . 30.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.962 HD12 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.632 HD11 ' CD1' ' B' ' 107' ' ' TYR . 5.3 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.803 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.7 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' B' ' 125' ' ' TYR . 4.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.977 ' HB3' HG22 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' B' ' 120' ' ' LEU . 43.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.3 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 22.9 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.751 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 36.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.053 ' HB3' HG22 ' B' ' 164' ' ' THR . 6.7 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.053 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.0 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.635 ' H ' HG23 ' B' ' 164' ' ' THR . 46.8 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.499 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.18 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.733 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.18 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.54 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.591 1.182 . . . . 0.0 110.045 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.418 1.074 . . . . 0.0 109.249 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.91 150.91 40.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.521 1.138 . . . . 0.0 110.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.09 38.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.442 1.089 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.71 133.54 35.92 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.699 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.01 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 0.0 110.996 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.52 7.63 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 0.0 110.967 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.423 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.12 160.65 15.64 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.462 0.742 . . . . 0.0 110.371 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.78 -15.98 24.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.402 1.064 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.6 mtpt -90.57 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 111.019 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.63 58.3 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 38.8 Cg_endo -74.97 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.496 1.787 . . . . 0.0 111.028 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD21 ' OG1' ' A' ' 9' ' ' THR . 3.4 pp -150.8 151.19 31.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.5 134.95 26.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 124.498 1.124 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.03 140.96 70.23 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 121.021 -2.491 . . . . 0.0 110.959 0.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.21 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.563 1.165 . . . . 0.0 109.271 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.12 146.3 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.424 1.078 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.44 31.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.115 . . . . 0.0 109.201 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.631 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.69 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.432 1.082 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.226 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.28 27.67 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.006 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.626 1.204 . . . . 0.0 109.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.43 8.46 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.542 1.151 . . . . 0.0 110.987 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.12 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 0.779 . . . . 0.0 109.287 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.5 154.27 39.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.697 HG11 HD13 ' A' ' 94' ' ' ILE . 64.0 t -131.43 102.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.28 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.84 169.49 18.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.531 1.145 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.458 1.099 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.37 33.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 0.0 109.347 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.475 ' SD ' ' HE1' ' A' ' 67' ' ' PHE . 1.1 ttp -98.07 119.28 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.384 1.053 . . . . 0.0 111.032 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.37 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 0.0 109.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.48 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.465 1.103 . . . . 0.0 109.23 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 8.0 p 46.03 54.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 124.415 1.072 . . . . 0.0 109.359 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.494 1.121 . . . . 0.0 111.083 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -74.98 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.929 -2.53 . . . . 0.0 110.995 -0.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.639 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.9 m-70 -144.24 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.461 1.1 . . . . 0.0 109.586 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.499 HD22 HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 173.97 167.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 109.305 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.6 t -104.14 114.37 43.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.513 1.133 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.599 HG13 ' OG1' ' A' ' 83' ' ' THR . 3.2 mm -132.81 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.312 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.55 1.156 . . . . 0.0 111.01 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.0 -50.01 4.79 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.597 1.185 . . . . 0.0 109.257 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.084 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.1 72.82 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.417 1.073 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.04 164.24 33.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.454 1.765 . . . . 0.0 110.994 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.44 1.087 . . . . 0.0 109.328 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.61 0.72 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.564 1.165 . . . . 0.0 111.027 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.36 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.608 0.828 . . . . 0.0 110.289 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.18 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.414 1.071 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.084 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.76 71.82 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.07 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.487 1.782 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.24 -45.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 109.331 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -65.98 -27.62 68.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 0.0 109.369 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.0 m -46.45 115.09 0.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 0.0 110.028 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.0 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.0 t -89.77 21.91 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.382 1.051 . . . . 0.0 110.342 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.438 1.086 . . . . 0.0 109.311 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.536 ' CD1' ' HB3' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.111 . . . . 0.0 109.287 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.42 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.502 1.126 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' NE2' ' B' ' 61' ' ' GLN . 2.6 mm -68.63 -46.08 80.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.568 1.167 . . . . 0.0 109.355 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.63 4.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 0.0 109.298 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -75.03 139.08 23.78 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.422 1.748 . . . . 0.0 111.046 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.9 0.17 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.542 1.151 . . . . 0.0 110.935 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 0.794 . . . . 0.0 109.99 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.23 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.451 1.094 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.52 175.08 4.19 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.478 1.111 . . . . 0.0 110.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.27 20.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.02 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.71 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.381 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.47 24.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.13 . . . . 0.0 110.353 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.12 173.06 8.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.517 1.135 . . . . 0.0 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.1 37.51 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 0.785 . . . . 0.0 110.42 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.6 Cg_endo -74.97 141.44 26.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.415 1.745 . . . . 0.0 111.084 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.63 20.09 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.386 1.054 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.449 0.735 . . . . 0.0 110.378 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.837 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.75 30.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.95 145.19 49.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.57 3.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 0.0 110.98 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -171.81 165.43 6.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 122.31 35.84 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.464 1.102 . . . . 0.0 108.284 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.599 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.1 m -51.36 -50.75 74.42 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 110.392 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.598 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 55.2 Cg_endo -75.08 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.541 1.811 . . . . 0.0 110.964 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 25.5 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.135 . . . . 0.0 109.616 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.943 ' NH1' HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -87.96 -38.53 15.47 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.486 1.116 . . . . 0.0 110.32 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.788 ' N ' ' HD3' ' A' ' 86' ' ' ARG . . . -89.45 -23.83 32.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.895 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.65 -15.21 62.55 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 0.776 . . . . 0.0 109.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.457 1.098 . . . . 0.0 110.983 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.699 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.6 ttt -121.57 75.02 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 0.745 . . . . 0.0 111.068 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.14 153.57 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.251 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.73 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.55 1.156 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 0.778 . . . . 0.0 110.393 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.697 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 0.0 109.273 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.08 144.54 31.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.412 1.07 . . . . 0.0 110.411 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.579 1.175 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.164 . . . . 0.0 110.291 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.595 ' CE1' HBD1 ' B' ' 250' ' ' HEC . 39.8 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.895 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 13.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 34.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 64.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 1.051 ' HG3' HG22 ' B' ' 233' ' ' VAL . 4.4 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.762 ' HG3' HD13 ' A' ' 60' ' ' LEU . 8.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 1.536 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 3.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.472 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.706 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 5.5 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.77 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.77 ' HB2' HG23 ' B' ' 105' ' ' THR . 83.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.685 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.747 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.685 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 82.1 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 66.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 43.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 1.361 ' C ' ' HD1' ' B' ' 162' ' ' TYR . 8.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.361 ' HD1' ' C ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.077 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.077 ' H ' HG23 ' B' ' 164' ' ' THR . 27.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.3 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 8.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 16.2 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 0.28 61.6 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.8 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.722 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 4.8 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 0.85 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 208' ' ' LEU . 3.3 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.85 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.8 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 1.051 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.52 126.85 29.13 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.574 1.171 . . . . 0.0 110.022 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 5.0 m -122.49 177.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.467 1.104 . . . . 0.0 109.295 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.83 40.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 0.0 110.321 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.11 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.434 1.084 . . . . 0.0 109.301 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.72 133.43 36.03 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.583 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.63 96.98 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.444 1.09 . . . . 0.0 111.008 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.57 7.65 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.504 1.127 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.13 160.64 15.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.449 0.735 . . . . 0.0 110.371 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.714 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 7.5 t70 -59.81 -15.91 24.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.448 1.093 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 3.3 ttmt -90.6 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.118 . . . . 0.0 109.311 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.886 ' HD2' HG21 ' B' ' 105' ' ' THR . 0.0 OUTLIER 38.34 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.71 58.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 0.0 109.248 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.869 ' HG3' HG21 ' A' ' 36' ' ' VAL . 16.5 Cg_endo -74.94 97.66 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.407 1.74 . . . . 0.0 111.043 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.81 151.18 31.93 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.43 134.84 26.53 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.391 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.07 140.95 70.09 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.032 -2.487 . . . . 0.0 110.954 0.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.3 tttt -40.19 -40.15 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 0.0 109.358 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.2 141.44 31.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 0.0 109.214 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.616 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.78 50.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.597 1.186 . . . . 0.0 110.052 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.87 -177.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.34 27.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.127 . . . . 0.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.575 1.172 . . . . 0.0 109.322 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.38 -7.25 8.55 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.523 1.14 . . . . 0.0 111.022 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.645 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.18 174.15 11.46 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.567 0.804 . . . . 0.0 109.294 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.61 154.2 39.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 0.0 110.466 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.32 102.59 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.562 1.164 . . . . 0.0 109.33 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.75 169.52 18.11 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.584 1.177 . . . . 0.0 110.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.22 121.48 9.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.597 1.186 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 66' ' ' SER . 4.3 p -125.08 155.34 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.567 1.167 . . . . 0.0 109.276 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.616 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.8 ttt -98.0 119.19 36.19 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.475 1.11 . . . . 0.0 111.026 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.718 ' OD1' ' HD3' ' A' ' 35' ' ' LYS . 2.1 t-20 -79.3 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 0.0 109.26 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.718 ' HD3' ' OD1' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.81 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 0.0 109.346 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.926 HG23 ' HG2' ' B' ' 119' ' ' PRO . 0.9 OUTLIER 45.9 54.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.31 40.54 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.563 1.165 . . . . 0.0 111.062 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.806 ' HD2' ' CG ' ' B' ' 70' ' ' ASN . 73.5 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.974 -2.511 . . . . 0.0 111.062 -0.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.621 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 70.3 m-70 -144.28 -170.37 3.34 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.576 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.483 HD21 ' HD3' ' A' ' 84' ' ' PRO . 4.3 p30 173.99 167.05 0.21 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.421 1.076 . . . . 0.0 109.289 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.11 114.36 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.583 1.177 . . . . 0.0 109.416 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.4 mm -132.84 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.67 160.6 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 111.008 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 4.1 t70 -97.08 -49.92 4.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.25 143.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.551 1.157 . . . . 0.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.073 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.53 158.08 72.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 0.0 109.276 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.0 164.24 33.74 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.408 1.741 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.57 1.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.467 1.104 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.51 -56.48 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.588 1.18 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.13 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.579 0.811 . . . . 0.0 110.295 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.08 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.073 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.06 -51.8 71.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -75.07 50.79 2.64 Favored 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.419 1.747 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.69 0.07 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.52 68.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.601 1.188 . . . . 0.0 109.316 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -46.45 115.13 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 110.008 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 117.6 34.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.365 1.04 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -89.77 21.86 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.404 1.065 . . . . 0.0 110.314 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' LEU . 61.7 tttt -86.04 64.42 8.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.416 1.072 . . . . 0.0 109.27 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.48 102.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.432 1.082 . . . . 0.0 109.335 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.4 98.4 5.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.531 1.144 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' B' ' 121' ' ' PRO . 1.7 mt -68.65 -46.1 80.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 0.0 109.365 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.51 4.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.95 139.19 24.13 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.544 1.813 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.85 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.475 1.109 . . . . 0.0 110.991 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.616 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.753 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 5.0 m-85 -38.28 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.54 175.16 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.42 1.075 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.65 161.4 20.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.54 1.15 . . . . 0.0 109.931 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.15 137.65 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 0.0 109.376 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.2 146.44 24.0 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.376 1.048 . . . . 0.0 110.406 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.09 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 0.0 109.22 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.39 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.573 1.17 . . . . 0.0 110.973 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.11 38.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.533 0.784 . . . . 0.0 110.439 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.51 26.74 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.543 1.812 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.66 20.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 124.501 1.125 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.83 120.05 40.47 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.539 0.788 . . . . 0.0 110.436 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.849 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.83 145.07 49.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.448 1.092 . . . . 0.0 110.028 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.566 1.166 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.415 ' CB ' HG12 ' A' ' 91' ' ' VAL . 53.7 p90 -171.86 165.39 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -93.47 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 0.0 108.344 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 1.277 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 0.8 OUTLIER -51.2 -50.84 73.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.544 1.153 . . . . 0.0 110.47 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.483 ' HD3' HD21 ' A' ' 40' ' ' ASN . 18.1 Cg_endo -75.04 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 30.3 m80 -75.12 57.98 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.581 1.175 . . . . 0.0 109.499 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -87.95 -38.47 15.53 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.523 1.14 . . . . 0.0 110.336 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.51 -23.88 32.53 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.379 1.049 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.19 62.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 0.774 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 63.14 1.83 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.523 1.14 . . . . 0.0 110.979 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.583 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.62 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.418 0.717 . . . . 0.0 111.0 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.0 m -124.19 153.57 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.549 1.156 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.45 -174.73 19.67 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.508 1.13 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.77 162.04 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 0.794 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.696 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.64 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.56 1.163 . . . . 0.0 109.27 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.6 m -105.06 144.56 31.7 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.29 73.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.158 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 O-C-N 124.581 1.176 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.112 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.444 ' HZ ' ' HD2' ' A' ' 11' ' ' LYS . 8.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.768 ' CG ' ' CD2' ' B' ' 1' ' ' TYR 0.283 12.5 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.6 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.155 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.643 ' CE2' HD13 ' B' ' 55' ' ' LEU . 46.8 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.643 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.2 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 2.4 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.672 ' HB2' HG21 ' B' ' 233' ' ' VAL . 26.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.809 ' OE1' ' HB2' ' B' ' 65' ' ' SER . 2.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 1.277 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.809 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 18.4 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 4.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.806 ' CG ' ' HD2' ' A' ' 38' ' ' PRO . 1.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 74' ' ' VAL . 8.5 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.789 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.003 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.0 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.6 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.536 ' HD1' ' HG ' ' B' ' 103' ' ' LEU . 1.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.536 ' HG ' ' HD1' ' B' ' 102' ' ' TYR . 11.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.825 ' CB ' HD22 ' B' ' 83' ' ' LEU . 20.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.886 HG21 ' HD2' ' A' ' 12' ' ' TYR . 11.7 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.1 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 0.926 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.678 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 26.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG2' HG23 ' A' ' 36' ' ' VAL . 1.1 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.558 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 8.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 0.956 ' CB ' HG23 ' A' ' 62' ' ' ILE . 2.5 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.546 ' HB3' HD12 ' A' ' 62' ' ' ILE . 4.6 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.764 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 2.4 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 126' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 20.8 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.725 ' CD2' HD22 ' B' ' 75' ' ' LEU . 21.5 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.003 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.616 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' B' ' 24' ' ' CYS . 13.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.053 ' CB ' HG22 ' B' ' 164' ' ' THR . 22.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.114 HG23 ' H ' ' B' ' 166' ' ' GLU . 4.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.114 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.4 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 60.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.434 HD21 ' NH1' ' B' ' 158' ' ' ARG . 9.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.706 HD22 ' HA ' ' B' ' 232' ' ' ASN . 19.3 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.475 1.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 62.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.906 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.258 3.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 76.5 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.8 HD22 ' N ' ' B' ' 208' ' ' LEU . 2.4 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 9.4 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 232' ' ' ASN . . . . . 0.706 ' HA ' HD22 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.678 HG23 HD21 ' B' ' 69' ' ' LEU . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.155 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.6 126.82 29.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.44 177.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.91 150.87 40.36 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.4 112.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.42 1.075 . . . . 0.0 109.224 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.73 133.51 35.96 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.51 1.131 . . . . 0.0 109.285 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.563 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.01 6.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 0.0 111.001 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 1.028 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.0 144.48 7.65 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 124.501 1.126 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -108.16 160.68 15.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.405 0.709 . . . . 0.0 110.356 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.78 -15.99 24.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 0.0 109.324 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 19.7 mttt -90.58 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.358 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 38.25 29.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 111.059 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.71 58.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.152 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' SD ' ' A' ' 90' ' ' MET . 38.1 Cg_endo -75.06 97.63 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.478 1.778 . . . . 0.0 111.002 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 4.0 pp -150.74 151.31 32.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.496 1.122 . . . . 0.0 109.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.44 126.21 30.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.42 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.427 1.079 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.02 140.98 70.35 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.964 -2.515 . . . . 0.0 110.942 0.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.24 -40.03 1.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.27 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.381 1.051 . . . . 0.0 109.282 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.24 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.158 . . . . 0.0 109.26 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.02 143.81 51.0 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.564 1.165 . . . . 0.0 110.037 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.97 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 0.0 109.32 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.38 27.44 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.476 1.11 . . . . 0.0 109.914 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.16 105.38 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.575 1.172 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.47 -7.39 8.47 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 0.0 111.063 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.24 11.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.568 0.805 . . . . 0.0 109.2 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.574 1.172 . . . . 0.0 110.369 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.38 102.59 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.554 1.159 . . . . 0.0 109.268 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.25 121.52 9.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.08 155.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 0.0 109.302 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.479 ' HG3' ' CD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.01 119.2 36.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 111.005 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 1.028 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -79.34 -66.01 0.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.57 1.169 . . . . 0.0 109.237 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 0.0 109.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' B' ' 3' ' ' PHE . 7.2 p 46.1 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.104 . . . . 0.0 109.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.677 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.3 40.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.52 1.138 . . . . 0.0 111.031 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.022 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 9.2 Cg_endo -74.9 -168.99 6.91 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.986 -2.506 . . . . 0.0 110.998 -0.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.677 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 65.3 m-70 -144.13 -170.34 3.32 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 1.101 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.555 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.8 p30 173.9 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.03 114.29 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 109.394 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 1.8 mm -132.78 76.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.426 1.079 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.67 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.41 1.069 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.0 4.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.032 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.05 72.91 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.231 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 164.29 33.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.522 1.801 . . . . 0.0 111.032 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.29 135.61 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.49 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.548 1.155 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.585 0.815 . . . . 0.0 110.27 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.2 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.388 1.055 . . . . 0.0 109.938 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.032 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.88 70.62 Favored Pre-proline 0 C--N 1.323 -0.572 0 O-C-N 124.509 1.13 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -74.99 50.79 2.62 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.448 1.762 . . . . 0.0 110.966 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.58 1.175 . . . . 0.0 109.283 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.41 115.12 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.534 1.146 . . . . 0.0 110.014 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 6.2 m-20 -107.96 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 1.144 . . . . 0.0 109.303 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.062 HG21 ' CB ' ' B' ' 63' ' ' ASP . 7.2 t -89.75 21.86 3.34 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.379 1.05 . . . . 0.0 110.389 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 19.4 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 109.21 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -40.44 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.49 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.685 HG13 ' ND2' ' B' ' 70' ' ' ASN . 0.1 OUTLIER -68.73 -46.13 80.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 0.0 109.283 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -75.05 139.23 23.92 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.416 1.745 . . . . 0.0 111.001 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.84 -68.0 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.472 1.108 . . . . 0.0 110.955 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.496 0.763 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.49 175.13 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 0.0 109.964 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.65 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.129 . . . . 0.0 109.388 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.19 146.48 23.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.15 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.558 1.161 . . . . 0.0 109.205 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.453 1.095 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.469 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.19 38.32 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.586 0.815 . . . . 0.0 110.413 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -75.07 141.43 26.41 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.543 1.812 . . . . 0.0 111.031 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.62 20.09 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.418 1.074 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.86 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 0.789 . . . . 0.0 110.356 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.78 140.77 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 1.158 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.05 49.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.996 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.46 3.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.497 1.123 . . . . 0.0 110.991 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -171.85 165.45 6.47 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 122.31 35.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.443 1.089 . . . . 0.0 108.245 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.9 OUTLIER -51.25 -50.83 73.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.421 1.075 . . . . 0.0 110.393 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.752 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 19.0 Cg_endo -75.08 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 110.98 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -75.07 57.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 0.0 109.619 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 83' ' ' THR . 2.5 ptm180 -87.96 -38.5 15.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.85 32.7 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.532 1.145 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.24 62.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.472 0.748 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.2 63.2 1.82 Allowed Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.423 1.077 . . . . 0.0 110.868 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.563 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 9.0 ttt -121.68 75.1 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.451 0.736 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.57 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.481 1.113 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.78 19.77 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.46 1.1 . . . . 0.0 111.022 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 161.99 37.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.526 0.78 . . . . 0.0 110.407 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.59 122.61 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.243 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.8 m -105.08 144.56 31.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.458 1.099 . . . . 0.0 109.291 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.791 ' N ' ' HD2' ' B' ' 4' ' ' TYR . 3.6 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 5.3 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.721 ' HB2' HG23 ' A' ' 36' ' ' VAL . 2.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.791 ' HD2' ' N ' ' B' ' 1' ' ' TYR . 44.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 107' ' ' TYR . 47.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 4.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.9 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.658 ' HB2' HG21 ' B' ' 233' ' ' VAL . 10.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.526 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 89.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.784 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.516 ' HB3' ' OG1' ' A' ' 58' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 1.062 ' CB ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.784 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 28.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.546 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 38.4 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.422 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.685 ' ND2' HG13 ' A' ' 62' ' ' ILE . 7.9 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.409 ' HB ' HG11 ' B' ' 51' ' ' VAL . 4.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 7.2 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' B' ' 102' ' ' TYR . 0.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.416 HD21 HD22 ' B' ' 120' ' ' LEU . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 0.832 ' CB ' HD22 ' B' ' 83' ' ' LEU . 55.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 61.9 p -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.4 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.0 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.001 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' B' ' 107' ' ' TYR . 82.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.587 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.022 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.587 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 15.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.1 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.427 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.485 HH21 ' CGD' ' B' ' 250' ' ' HEC . 0.1 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' B' ' 24' ' ' CYS . 4.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.075 ' CB ' HG22 ' B' ' 164' ' ' THR . 18.3 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.549 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 5.1 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.075 HG22 ' CB ' ' B' ' 162' ' ' TYR . 5.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 165' ' ' GLY . . . . . 0.481 ' N ' HG23 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.972 ' H ' HG23 ' B' ' 164' ' ' THR . 34.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.594 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.932 ' HB3' ' H ' ' B' ' 170' ' ' ASN 0.684 0.1 OUTLIER -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.932 ' H ' ' HB3' ' B' ' 168' ' ' SER . 13.8 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.046 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.917 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.046 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.59 126.77 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.93 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.4 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 0.0 109.28 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.9 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.434 1.084 . . . . 0.0 109.3 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.79 133.46 36.02 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.53 1.144 . . . . 0.0 109.315 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.688 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.05 6.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 0.0 110.987 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.54 7.66 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.544 1.153 . . . . 0.0 110.992 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 15.9 p -108.04 160.67 15.61 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.389 0.699 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -59.87 -15.94 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 6.0 ttmt -90.57 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.353 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' B' ' 3' ' ' PHE . 0.5 OUTLIER 38.26 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 0.0 111.025 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.77 117.66 58.3 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 109.344 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.685 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 33.2 Cg_endo -74.94 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.551 1.816 . . . . 0.0 111.045 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.84 151.19 31.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.12 . . . . 0.0 109.317 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.27 126.17 30.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.978 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.88 26.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.514 1.134 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.94 70.1 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.033 -2.486 . . . . 0.0 110.971 0.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.554 1.159 . . . . 0.0 109.264 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.32 46.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.428 1.08 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.93 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.38 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 0.0 109.235 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.627 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 0.0 110.065 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.493 1.12 . . . . 0.0 109.284 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.34 27.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 0.0 110.009 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.36 0.27 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.6 1.187 . . . . 0.0 109.298 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.42 8.46 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.431 1.082 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.13 174.14 11.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 0.764 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.54 154.25 39.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 0.0 110.516 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.715 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.41 102.57 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.568 1.167 . . . . 0.0 109.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.54 18.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.41 9.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.12 . . . . 0.0 110.97 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.33 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.895 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.3 ttp -98.01 119.25 36.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.409 1.068 . . . . 0.0 111.0 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.36 -66.09 0.92 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 0.0 109.216 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.269 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.685 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.02 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.419 1.075 . . . . 0.0 109.32 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.98 -172.29 40.52 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.51 1.131 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.277 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -74.99 -168.92 6.88 Favored 'Cis proline' 0 C--N 1.361 1.209 0 C-N-CA 120.919 -2.534 . . . . 0.0 110.975 -0.067 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.94 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 71.0 m-70 -144.19 -170.36 3.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.614 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.518 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.7 p30 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.478 1.111 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.09 114.34 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.599 1.187 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' CZ ' ' A' ' 81' ' ' TYR . 9.0 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 0.0 109.345 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.426 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.65 160.62 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.569 1.168 . . . . 0.0 109.308 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.33 143.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.618 1.199 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.5 158.1 72.81 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.35 1.031 . . . . 0.0 109.25 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.01 164.26 33.7 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.495 1.787 . . . . 0.0 111.046 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.62 1.41 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.56 1.162 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.42 2.24 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.608 0.828 . . . . 0.0 110.26 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.09 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.451 1.095 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.011 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.77 71.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 O-C-N 124.491 1.12 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.04 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.427 1.751 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.25 -45.67 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.604 1.19 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -46.47 115.11 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 1.126 . . . . 0.0 109.976 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 117.68 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 109.348 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -89.8 21.94 3.34 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.401 1.063 . . . . 0.0 110.304 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -86.07 64.45 8.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.277 ' CD1' ' HB2' ' A' ' 38' ' ' PRO . 17.6 tp -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 0.0 109.314 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.4 6.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.809 HG21 ' HG3' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -68.64 -46.09 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 0.0 109.362 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.757 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -62.08 111.59 4.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.273 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.03 139.11 23.82 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.424 1.749 . . . . 0.0 111.05 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.93 -67.99 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.583 1.177 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.656 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.461 0.742 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.0 m-85 -38.23 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -171.5 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.458 1.099 . . . . 0.0 110.028 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.418 1.074 . . . . 0.0 109.403 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.26 146.52 23.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 110.391 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.11 8.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 109.276 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.09 37.61 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.5 0.765 . . . . 0.0 110.366 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -75.01 141.5 26.68 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.48 1.779 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.419 1.074 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.88 120.08 40.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 0.736 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.71 30.94 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.134 . . . . 0.0 111.043 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.94 145.12 49.37 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.461 1.101 . . . . 0.0 109.975 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.13 -171.53 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.428 1.08 . . . . 0.0 110.994 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 55.4 p90 -171.84 165.43 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.499 1.124 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 122.35 35.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.526 1.141 . . . . 0.0 108.328 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -51.33 -50.85 73.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 0.0 110.392 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.648 ' HB2' ' CE2' ' B' ' 162' ' ' TYR . 18.2 Cg_endo -75.0 -62.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.503 1.791 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 20.8 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.0 -38.47 15.48 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.545 1.153 . . . . 0.0 110.322 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.8 32.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.498 1.124 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.67 -15.23 62.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.516 0.774 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.441 1.088 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.688 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.58 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.421 0.718 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.56 ' CG1' HH21 ' A' ' 86' ' ' ARG . 11.5 m -124.16 153.61 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 0.0 109.248 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.59 -174.8 19.83 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.71 162.05 36.97 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 0.764 . . . . 0.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.715 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.59 122.67 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 0.0 109.283 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.07 144.51 31.77 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.382 1.051 . . . . 0.0 110.393 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.27 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 124.584 1.178 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.545 1.153 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.901 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 89.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 79.7 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.447 ' HD1' ' HA ' ' B' ' 4' ' ' TYR . 5.5 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.408 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 42.7 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.975 ' HG3' ' CG2' ' B' ' 233' ' ' VAL . 1.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.412 HG11 ' HA3' ' B' ' 210' ' ' GLY . 44.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.809 ' HG3' HG21 ' A' ' 62' ' ' ILE . 4.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 1.227 ' HB1' ' CD2' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 14.9 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.579 ' HB2' ' OE1' ' B' ' 58' ' ' GLN 0.26 4.8 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.555 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.731 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.473 ' CE2' HD23 ' B' ' 103' ' ' LEU . 9.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.689 HG23 ' HB2' ' B' ' 116' ' ' LEU . 9.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 77.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.491 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.901 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.491 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 87.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.444 ' HA2' ' NE2' ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.763 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 64.4 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' B' ' 24' ' ' CYS . 11.0 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 0.648 ' CE2' ' HB2' ' A' ' 84' ' ' PRO . 2.5 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.409 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.037 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.037 ' H ' HG23 ' B' ' 164' ' ' THR . 4.0 tp10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.708 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.444 HD21 HH22 ' B' ' 158' ' ' ARG . 11.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.602 ' CG ' ' O ' ' B' ' 170' ' ' ASN . 16.9 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.741 ' HB2' ' CD2' ' B' ' 189' ' ' PHE . 5.2 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.309 ' CD1' ' HG3' ' B' ' 209' ' ' PRO . 0.0 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 5.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 83.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.5 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.309 ' HG3' ' CD1' ' B' ' 189' ' ' PHE . 2.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' GLY . . . . . 0.412 ' HA3' HG11 ' B' ' 60' ' ' VAL . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.531 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 19.7 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' ASN . . . . . 0.483 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.975 ' CG2' ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.64 126.83 29.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.575 1.172 . . . . 0.0 110.04 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.934 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.47 177.2 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.431 1.082 . . . . 0.0 109.263 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.99 150.82 40.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 0.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.39 112.17 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.418 1.074 . . . . 0.0 109.213 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.74 133.48 35.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.563 1.165 . . . . 0.0 109.372 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.675 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.67 97.01 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.443 1.089 . . . . 0.0 110.951 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.524 1.14 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -108.08 160.64 15.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 0.743 . . . . 0.0 110.415 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -16.0 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 0.0 109.29 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.9 mttt -90.62 39.66 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.978 ' O ' ' CZ ' ' B' ' 3' ' ' PHE . 0.4 OUTLIER 38.28 29.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 0.0 110.996 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.66 58.21 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.057 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 6.3 Cg_exo -75.01 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.482 1.78 . . . . 0.0 111.057 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -150.77 151.22 32.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.18 30.52 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.527 1.142 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.8 26.49 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.09 140.98 70.23 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.009 -2.496 . . . . 0.0 110.951 0.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.2 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 1.124 . . . . 0.0 109.278 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.423 1.077 . . . . 0.0 109.329 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.934 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.43 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.592 1.183 . . . . 0.0 109.209 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.612 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.77 50.97 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.553 1.158 . . . . 0.0 110.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.112 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.981 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.603 1.19 . . . . 0.0 109.321 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.44 -7.27 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.512 1.133 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.582 0.813 . . . . 0.0 109.29 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.62 154.16 39.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.455 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD13 ' A' ' 94' ' ' ILE . 63.4 t -131.3 102.57 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.601 1.188 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.73 169.53 18.09 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.539 1.149 . . . . 0.0 110.311 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.31 121.47 9.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.03 155.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.586 1.178 . . . . 0.0 109.315 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.3 ttp -97.99 119.22 36.24 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' HB3' ' HD3' ' A' ' 35' ' ' LYS 0.324 6.6 m-20 -79.33 -66.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 0.0 109.264 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.86 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.456 1.098 . . . . 0.0 109.396 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.057 ' CG2' ' HG3' ' A' ' 14' ' ' PRO . 2.4 p 45.9 54.89 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.93 -172.29 40.6 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.582 1.176 . . . . 0.0 111.047 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.961 ' HD3' ' CZ ' ' B' ' 1' ' ' TYR . 24.3 Cg_endo -74.94 -168.89 6.84 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 120.953 -2.52 . . . . 0.0 111.054 -0.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.652 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 68.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 1.053 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 167.02 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 0.0 109.258 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.1 114.42 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.914 HG13 ' OG1' ' A' ' 83' ' ' THR . 7.4 mm -132.87 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 0.0 109.311 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.7 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.449 1.093 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.47 ' HA ' ' HE2' ' A' ' 81' ' ' TYR . 1.7 t70 -96.98 -49.98 4.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.314 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.31 143.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 0.0 109.352 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.019 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.09 72.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 0.0 109.244 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 164.2 33.8 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.477 1.777 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.31 135.62 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.532 1.145 . . . . 0.0 109.297 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.53 -56.48 0.73 Allowed Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.521 1.138 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.584 0.814 . . . . 0.0 110.294 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.74 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 109.987 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.019 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.86 70.75 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 124.514 1.134 . . . . 0.0 109.306 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.1 Cg_endo -75.03 50.82 2.64 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.45 1.763 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.573 1.171 . . . . 0.0 109.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.54 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.517 1.136 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -46.5 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.445 1.091 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.93 117.61 34.59 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.38 1.05 . . . . 0.0 109.285 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.5 t -89.81 21.89 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.39 1.056 . . . . 0.0 110.341 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 8.4 tttm -86.06 64.47 8.6 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.429 1.081 . . . . 0.0 109.244 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.053 HD22 ' HB3' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -40.46 102.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 0.0 109.344 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.39 6.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.68 -46.04 80.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.565 1.166 . . . . 0.0 109.35 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.04 139.17 23.86 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.527 1.803 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.89 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.504 1.128 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.669 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 0.767 . . . . 0.0 110.02 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 3.6 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.529 1.143 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.53 175.13 4.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.481 1.113 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.39 20.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.552 1.158 . . . . 0.0 109.939 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.67 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.18 146.44 23.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 0.0 109.251 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.546 1.154 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.456 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.12 37.89 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.508 0.77 . . . . 0.0 110.423 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.96 141.46 26.78 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.58 1.832 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.68 20.04 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.494 1.121 . . . . 0.0 110.993 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.439 0.729 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.78 140.75 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.06 49.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.538 1.149 . . . . 0.0 109.98 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.5 3.73 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.817 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 42.4 p90 -171.85 165.38 6.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.547 1.154 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' CYS . . . . . 1.332 ' O ' ' NE ' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -93.48 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.405 1.065 . . . . 0.0 108.326 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.984 ' O ' ' HB ' ' B' ' 164' ' ' THR . 5.7 m -51.23 -50.89 73.15 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.452 1.095 . . . . 0.0 110.396 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.676 ' O ' ' HG2' ' B' ' 163' ' ' PRO . 40.5 Cg_endo -75.0 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 0.0 111.0 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.717 ' HE2' ' HE1' ' B' ' 4' ' ' TYR . 27.2 m80 -75.09 57.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.491 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.332 ' NE ' ' O ' ' A' ' 82' ' ' CYS . 0.2 OUTLIER -87.94 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.34 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.87 32.79 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.439 1.087 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' B' ' 7' ' ' TYR . . . -65.68 -15.21 62.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.525 0.78 . . . . 0.0 109.292 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.16 1.82 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.675 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.8 ttt -121.65 75.08 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.473 0.749 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 81' ' ' TYR . 14.0 m -124.24 153.61 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.558 1.161 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.72 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.461 1.101 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.77 162.06 37.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.568 0.805 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.6 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.494 1.121 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.1 m -105.07 144.52 31.76 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.396 1.06 . . . . 0.0 110.407 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.24 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.16 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 O-C-N 124.594 1.184 . . . . 0.0 110.34 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.961 ' CZ ' ' HD3' ' A' ' 38' ' ' PRO . 42.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.978 ' CZ ' ' O ' ' A' ' 12' ' ' TYR . 1.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.717 ' HE1' ' HE2' ' A' ' 85' ' ' HIS . 4.4 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.949 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.909 ' CD1' HG11 ' B' ' 20' ' ' VAL . 85.1 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.909 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASN . . . . . 1.478 ' CB ' ' CA ' ' B' ' 23' ' ' ASN 0.623 4.0 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 47.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.77 ' HB2' HG21 ' B' ' 233' ' ' VAL . 13.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.621 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 99.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.85 ' HG3' ' H ' ' B' ' 62' ' ' ALA . 1.4 tt0 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 0.85 ' H ' ' HG3' ' B' ' 61' ' ' GLN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.568 ' H ' ' HG2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 39.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.647 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 73.2 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.547 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 80.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.489 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.753 ' HG3' ' CD2' ' B' ' 1' ' ' TYR . 1.2 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.489 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 90.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.662 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 39.8 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' B' ' 24' ' ' CYS . 0.5 OUTLIER -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.031 ' HB3' HG22 ' B' ' 164' ' ' THR . 9.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.676 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.031 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.5 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 0.901 ' H ' HG23 ' B' ' 164' ' ' THR . 23.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.6 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 168' ' ' SER . . . . . 0.577 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 57.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.424 HD21 HH22 ' B' ' 158' ' ' ARG . 22.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.608 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 16.5 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.88 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.16 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.272 7.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.508 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.553 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.16 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.82 29.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 0.0 110.02 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.959 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.08 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.441 1.088 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.9 150.88 40.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 110.338 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.41 1.069 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.65 133.46 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.492 1.12 . . . . 0.0 109.351 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.683 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.73 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 111.034 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.45 7.63 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 124.514 1.134 . . . . 0.0 111.064 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.639 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -108.12 160.6 15.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.361 0.683 . . . . 0.0 110.443 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 9.8 t70 -59.79 -15.92 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 0.0 109.303 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 7.5 ttmt -90.64 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.545 1.153 . . . . 0.0 109.351 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.23 29.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.639 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.89 117.66 58.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 44.6 Cg_endo -75.01 97.65 1.1 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 O-C-N 124.471 1.774 . . . . 0.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.3 pp -150.82 151.31 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.318 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.4 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 110.315 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.08 140.97 70.19 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 120.987 -2.505 . . . . 0.0 110.966 0.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 1.15 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.13 146.27 46.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.354 1.034 . . . . 0.0 109.335 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.959 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.25 141.33 31.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.614 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.92 -177.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.563 1.165 . . . . 0.0 109.335 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.805 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 105.44 0.28 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.117 . . . . 0.0 109.303 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.29 8.5 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.48 1.112 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.19 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 0.792 . . . . 0.0 109.232 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.59 154.23 39.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.44 102.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 0.0 109.277 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.462 1.101 . . . . 0.0 110.284 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.25 121.5 9.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.939 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.09 155.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 109.269 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.642 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 12.2 ttp -98.09 119.19 36.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 0.0 111.026 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -79.28 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 0.0 109.296 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' NZ ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.488 1.117 . . . . 0.0 109.248 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.939 HG23 ' HD2' ' B' ' 119' ' ' PRO . 11.6 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.403 1.064 . . . . 0.0 109.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.32 40.54 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.524 1.14 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.012 ' HD3' ' OD1' ' B' ' 70' ' ' ASN . 3.9 Cg_exo -74.92 -169.03 6.95 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.018 -2.492 . . . . 0.0 110.959 -0.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.658 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.3 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.488 1.117 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.435 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 173.93 166.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 0.0 109.307 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.578 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.37 43.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 0.0 109.343 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 41' ' ' VAL . 1.3 mm -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 87.1 m-85 -47.68 160.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.462 1.101 . . . . 0.0 111.008 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.605 1.191 . . . . 0.0 109.31 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.9 mttt 167.32 143.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.449 1.093 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 157.98 73.2 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.394 1.059 . . . . 0.0 109.265 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.91 164.28 33.78 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.509 1.794 . . . . 0.0 111.054 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.32 135.61 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.5 0.73 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.492 1.12 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.1 -173.29 2.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.567 0.804 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.29 77.83 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.396 1.06 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.005 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.87 70.73 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.563 1.164 . . . . 0.0 109.274 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -75.05 50.81 2.64 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.443 1.759 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.57 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.638 1.212 . . . . 0.0 109.344 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.58 68.15 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 m -46.47 115.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 1.141 . . . . 0.0 109.988 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.91 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.411 1.07 . . . . 0.0 109.322 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -89.69 21.81 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.458 1.099 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -85.95 64.38 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.417 1.073 . . . . 0.0 109.222 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -40.43 102.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.49 98.53 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 0.0 109.29 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.161 HG23 ' CG ' ' B' ' 121' ' ' PRO . 28.7 mt -68.78 -46.07 80.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.61 1.194 . . . . 0.0 109.304 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.18 111.61 4.91 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.117 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -75.0 139.19 23.98 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.413 1.744 . . . . 0.0 111.038 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.379 1.05 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.659 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.509 0.77 . . . . 0.0 110.048 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.11 -86.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.48 175.16 4.19 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.443 1.089 . . . . 0.0 111.014 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.25 20.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.979 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.67 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 0.0 109.412 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.19 146.53 23.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 110.404 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.08 8.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.179 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.539 1.149 . . . . 0.0 110.996 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.458 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.21 37.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.561 0.801 . . . . 0.0 110.409 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.13 141.52 26.38 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.511 1.795 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.06 -178.68 20.0 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.508 1.13 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.81 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 0.764 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.89 145.13 49.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.45 3.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.581 1.176 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.428 ' CB ' HG12 ' A' ' 91' ' ' VAL . 39.5 p90 -171.89 165.39 6.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 111.042 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.59 122.39 35.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.112 . . . . 0.0 108.268 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 1.171 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 1.2 m -51.29 -50.82 73.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.084 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 21.2 Cg_endo -75.06 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.574 1.829 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.3 m80 -75.1 58.05 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.99 -38.59 15.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.135 . . . . 0.0 110.292 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.903 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.48 -23.84 32.74 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.443 1.089 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -65.68 -15.22 62.58 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.528 0.781 . . . . 0.0 109.357 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.503 1.127 . . . . 0.0 110.885 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.683 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.7 75.1 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 0.74 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.3 m -124.14 153.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.473 1.108 . . . . 0.0 109.287 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.513 1.133 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.05 37.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.343 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.7 122.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 109.275 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.46 31.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.455 1.097 . . . . 0.0 110.381 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.21 73.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 109.285 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.805 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.516 1.135 . . . . 0.0 110.325 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.497 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 32.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 4.9 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.702 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 6.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 84.6 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.638 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.0 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 20.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.746 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 40.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 1.081 ' NE2' HG21 ' A' ' 83' ' ' THR . 3.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 1.171 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.8 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 16.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.3 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' B' ' 59' ' ' GLN . 9.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 1.012 ' OD1' ' HD3' ' A' ' 38' ' ' PRO . 86.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.012 HD11 ' HD2' ' B' ' 131' ' ' PRO . 30.5 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.541 HD23 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.197 ' CG1' HD12 ' B' ' 115' ' ' LEU . 20.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.772 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.4 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.197 HD12 ' CG1' ' B' ' 104' ' ' VAL . 0.0 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.772 ' HB2' HG23 ' B' ' 105' ' ' THR . 16.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.939 ' HD2' HG23 ' A' ' 36' ' ' VAL . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.541 HD11 HD23 ' B' ' 103' ' ' LEU . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' PRO . . . . . 1.161 ' CG ' HG23 ' A' ' 62' ' ' ILE . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.664 ' HB2' HG21 ' A' ' 62' ' ' ILE . 12.9 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 126' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 21.6 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.481 ' HE2' ' CD1' ' B' ' 120' ' ' LEU . 20.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.012 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.898 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 27.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.048 ' CB ' HG22 ' B' ' 164' ' ' THR . 7.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.702 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.2 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.048 HG22 ' CB ' ' B' ' 162' ' ' TYR . 2.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.02 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.537 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 57.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.822 HD22 ' HA ' ' B' ' 232' ' ' ASN . 17.1 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.503 3.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 66.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.771 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 18.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 1.188 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.27 20.2 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 207' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.662 HD22 ' N ' ' B' ' 208' ' ' LEU . 1.9 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 1.188 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HA ' ' HG3' ' B' ' 231' ' ' PRO . 1.1 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 231' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 2.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 232' ' ' ASN . . . . . 0.822 ' HA ' HD22 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.61 126.83 29.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 1.16 . . . . 0.0 109.999 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.18 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.41 1.069 . . . . 0.0 109.285 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.88 40.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.15 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.387 1.054 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.523 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.77 133.49 35.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.51 1.131 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.627 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.105 . . . . 0.0 110.997 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.49 7.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.594 1.184 . . . . 0.0 110.974 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.06 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.409 0.711 . . . . 0.0 110.417 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.84 -15.94 24.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.322 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.5 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 38.3 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 0.0 111.009 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.72 58.05 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 1.076 ' HG3' ' HE2' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.46 1.769 . . . . 0.0 111.022 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 2.8 pp -150.8 151.25 32.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.46 1.1 . . . . 0.0 109.32 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.413 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.39 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.89 26.59 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.55 1.156 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.99 70.35 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 120.995 -2.502 . . . . 0.0 110.944 0.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.16 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.243 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.05 146.28 46.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 3' ' ' VAL . 10.9 tp -143.28 141.4 31.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.566 1.166 . . . . 0.0 109.202 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 0.0 110.063 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.93 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.54 158.31 27.57 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.602 1.189 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.41 8.46 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.443 1.09 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.11 11.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 0.735 . . . . 0.0 109.3 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 154.27 39.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 1.119 . . . . 0.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 94' ' ' ILE . 63.8 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.143 . . . . 0.0 109.332 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.82 169.52 18.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.39 9.51 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.484 1.115 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.96 155.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.07 119.26 36.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.413 1.07 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.333 6.9 m-20 -79.4 -66.03 0.92 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.412 1.07 . . . . 0.0 109.237 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.473 1.108 . . . . 0.0 109.235 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.652 ' HB ' ' CE2' ' B' ' 3' ' ' PHE . 19.0 m 46.02 54.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.647 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.33 40.62 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.558 1.161 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HD2' ' CE2' ' B' ' 1' ' ' TYR . 19.5 Cg_endo -74.97 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.947 -2.522 . . . . 0.0 110.977 -0.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.647 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.5 m-70 -144.26 -170.36 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.403 1.064 . . . . 0.0 109.327 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.11 114.35 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 109.329 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -132.82 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.61 160.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 0.0 110.959 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 6.9 mttt 167.32 143.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.473 1.108 . . . . 0.0 109.266 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.039 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.5 158.08 72.86 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.393 1.058 . . . . 0.0 109.284 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.03 164.25 33.68 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.42 1.748 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.67 1.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 0.0 109.33 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.485 1.116 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 0.822 . . . . 0.0 110.28 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.1 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 110.042 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.039 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.98 -51.84 70.88 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.441 1.088 . . . . 0.0 109.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.05 50.75 2.62 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.43 1.752 . . . . 0.0 110.966 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.26 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.587 1.179 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.53 68.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -46.52 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.974 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.455 1.097 . . . . 0.0 109.345 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.851 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 4.6 t -89.77 21.84 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.393 1.058 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -86.08 64.44 8.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.171 HD23 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -40.44 102.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.47 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.729 HD11 ' CD1' ' A' ' 60' ' ' LEU . 4.3 mm -68.66 -46.11 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.602 1.189 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 0.0 109.278 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.03 139.1 23.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.431 1.753 . . . . 0.0 111.019 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.552 1.157 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.471 0.748 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.18 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.461 1.101 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.448 1.092 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.29 20.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.448 1.093 . . . . 0.0 109.99 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.72 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 0.0 109.389 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.546 1.154 . . . . 0.0 110.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.1 8.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 1.1 . . . . 0.0 109.235 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.497 1.123 . . . . 0.0 111.045 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.473 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.71 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.543 0.79 . . . . 0.0 110.37 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 141.5 26.7 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.483 1.781 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.415 1.072 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.03 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 0.76 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.69 140.73 30.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.21 -171.55 3.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 42' ' ' ILE . 9.3 p90 -171.83 165.43 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.514 1.134 . . . . 0.0 111.028 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.6 122.35 35.97 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.478 1.111 . . . . 0.0 108.243 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -51.31 -50.81 73.93 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 110.397 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 83' ' ' THR . 49.5 Cg_endo -75.05 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.531 1.806 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' NE2' ' HE1' ' B' ' 4' ' ' TYR . 27.3 m80 -74.95 57.96 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 0.0 109.601 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.178 ' HE ' ' CA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -88.01 -38.47 15.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.634 1.209 . . . . 0.0 110.276 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.54 -23.76 32.83 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.43 1.081 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.19 62.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 0.765 . . . . 0.0 109.426 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.06 1.83 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.438 1.086 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.627 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.07 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.454 0.738 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.175 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.18 153.62 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.564 1.165 . . . . 0.0 109.289 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.458 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.74 19.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.603 1.189 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 0.79 . . . . 0.0 110.382 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.64 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.255 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.2 m -105.01 144.55 31.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.393 1.058 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.537 1.148 . . . . 0.0 109.303 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 0.0 110.265 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 0.926 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 93.7 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.076 ' HE2' ' HG3' ' A' ' 14' ' ' PRO . 12.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.87 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 12.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 9' ' ' TYR . 11.7 t-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.144 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.3 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.779 ' HB2' HG21 ' B' ' 233' ' ' VAL . 36.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 89.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 0.783 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 1.171 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.704 ' HA ' HG23 ' A' ' 58' ' ' THR . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.783 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 9.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.432 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.644 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 72.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.505 ' CD2' HD23 ' B' ' 103' ' ' LEU . 30.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.8 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.72 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 2.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.549 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.0 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.5 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.72 ' HB2' HG23 ' B' ' 105' ' ' THR . 11.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.645 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.645 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 47.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 68.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.651 ' HG3' ' OE1' ' B' ' 59' ' ' GLN . 1.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' B' ' 24' ' ' CYS . 8.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 0.456 ' HB3' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.015 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.595 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.562 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 18.1 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.962 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 0.962 ' HD1' ' HB2' ' B' ' 187' ' ' ASN . 0.4 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.509 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.559 HD22 ' N ' ' B' ' 208' ' ' LEU . 4.0 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.88 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.144 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.63 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 110.03 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.554 1.159 . . . . 0.0 110.342 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.31 112.16 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.408 1.068 . . . . 0.0 109.307 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.75 133.44 36.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.548 1.155 . . . . 0.0 109.306 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.782 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.66 97.0 6.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.469 1.106 . . . . 0.0 111.002 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.03 144.41 7.62 Favored Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.464 1.103 . . . . 0.0 111.074 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.699 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 17.3 p -108.09 160.69 15.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.422 0.719 . . . . 0.0 110.402 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.79 -15.96 24.41 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.441 1.088 . . . . 0.0 109.305 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 5.0 tppt? -90.64 39.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.298 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 1.276 ' CZ ' ' HB2' ' B' ' 3' ' ' PHE . 12.3 m-30 38.29 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.125 . . . . 0.0 111.008 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.81 117.67 58.24 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.487 1.117 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.803 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 1.2 Cg_endo -75.03 97.56 1.09 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.455 1.766 . . . . 0.0 110.99 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' THR . 1.2 pp -150.73 151.29 32.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.41 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 0.0 110.934 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.47 134.91 26.61 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.445 1.091 . . . . 0.0 110.317 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.08 141.0 70.37 Favored 'Cis proline' 0 C--N 1.361 1.22 0 C-N-CA 120.947 -2.522 . . . . 0.0 111.013 0.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.21 -40.13 1.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 0.0 109.181 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.27 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.384 1.052 . . . . 0.0 109.281 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.21 141.41 31.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 0.0 109.216 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.626 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.78 50.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.544 1.152 . . . . 0.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.633 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.92 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.56 158.32 27.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 109.963 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.594 1.184 . . . . 0.0 109.313 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.36 8.46 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.465 1.103 . . . . 0.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.633 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.22 174.16 11.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 0.758 . . . . 0.0 109.182 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.577 1.173 . . . . 0.0 110.371 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.7 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.41 102.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 0.0 109.285 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.86 169.62 17.95 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.128 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.24 121.42 9.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.135 . . . . 0.0 111.008 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.39 33.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 109.281 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.919 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.1 ttp -98.06 119.11 36.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 0.0 111.085 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -79.27 -66.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 109.291 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.461 1.1 . . . . 0.0 109.292 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.881 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 0.0 109.338 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 1.184 ' O ' ' CGD' ' B' ' 250' ' ' HEC . . . -92.97 -172.3 40.54 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.555 1.16 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.038 ' HD2' ' HB2' ' B' ' 62' ' ' ALA . 7.8 Cg_endo -74.95 -168.96 6.9 Favored 'Cis proline' 0 C--N 1.36 1.169 0 C-N-CA 120.992 -2.503 . . . . 0.0 110.986 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.919 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.1 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.413 ' ND2' ' C ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 173.9 166.97 0.2 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 42' ' ' ILE . 61.2 t -104.07 114.35 43.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.566 1.166 . . . . 0.0 109.347 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 41' ' ' VAL . 2.0 mm -132.74 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.432 1.083 . . . . 0.0 109.306 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.427 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.6 160.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.443 1.089 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 9.5 t70 -97.03 -50.01 4.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.595 1.184 . . . . 0.0 109.324 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.2 mttt 167.34 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.143 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.4 m -128.54 158.05 73.04 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.143 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 164.22 33.83 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.476 1.777 . . . . 0.0 111.027 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.33 135.64 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 109.252 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.57 0.72 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.522 1.139 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.61 0.829 . . . . 0.0 110.238 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.15 77.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.371 1.045 . . . . 0.0 110.021 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.029 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.85 70.93 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.486 1.116 . . . . 0.0 109.268 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.01 50.73 2.61 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.562 1.164 . . . . 0.0 109.346 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.52 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.519 1.137 . . . . 0.0 109.344 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -46.48 115.1 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.1 m-80 -107.97 117.67 34.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 0.0 109.293 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.69 HG22 ' OD1' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -89.68 21.78 3.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.412 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -85.93 64.4 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.446 1.091 . . . . 0.0 109.233 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.612 HD23 ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.41 102.45 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 0.0 109.346 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.39 98.46 6.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.342 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 38' ' ' PRO . 5.2 mm -68.7 -46.09 80.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 111.6 4.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.594 1.184 . . . . 0.0 109.303 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -74.99 139.14 23.95 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.384 1.729 . . . . 0.0 111.02 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.96 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.45 1.094 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.69 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 0.744 . . . . 0.0 110.037 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.8 m-85 -38.25 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.128 . . . . 0.0 110.978 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.13 4.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.461 1.1 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.26 20.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 109.994 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.68 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.5 1.125 . . . . 0.0 109.388 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.5 23.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.115 . . . . 0.0 110.426 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 0.0 109.222 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.21 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.501 1.126 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.17 37.96 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.528 0.781 . . . . 0.0 110.411 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.09 141.5 26.45 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.558 1.82 . . . . 0.0 111.014 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.7 20.0 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.444 1.09 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.77 120.08 40.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 0.792 . . . . 0.0 110.405 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.847 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.79 140.74 30.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.61 1.194 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.12 49.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.442 1.089 . . . . 0.0 110.011 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.44 3.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.598 1.186 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.688 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 40.9 p90 -171.91 165.44 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -93.61 122.33 35.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.396 1.06 . . . . 0.0 108.296 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -51.26 -50.79 73.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.436 1.085 . . . . 0.0 110.378 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.658 ' HB3' ' O ' ' B' ' 62' ' ' ALA . 9.2 Cg_endo -75.1 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.564 1.823 . . . . 0.0 110.972 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -75.1 57.99 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.112 . . . . 0.0 109.577 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 1.246 HH22 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -87.97 -38.61 15.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 0.0 110.312 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.42 -23.84 32.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.427 1.079 . . . . 0.0 110.991 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.18 62.56 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.527 0.781 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.497 1.123 . . . . 0.0 110.927 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.782 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.64 75.05 1.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 0.778 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.246 ' CG1' HH22 ' A' ' 86' ' ' ARG . 13.1 m -124.17 153.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.294 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.82 19.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.501 1.126 . . . . 0.0 111.036 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.06 36.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.7 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.63 122.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.57 1.169 . . . . 0.0 109.284 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.08 144.52 31.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 0.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.28 73.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.431 1.082 . . . . 0.0 109.327 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 0.0 110.282 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.002 ' CD2' ' CZ ' ' B' ' 3' ' ' PHE . 2.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 3.7 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.276 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.828 ' HE1' ' CB ' ' A' ' 12' ' ' TYR . 60.8 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.56 ' OE1' HD12 ' B' ' 116' ' ' LEU . 18.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.915 ' O ' ' CD1' ' B' ' 7' ' ' TYR . 1.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 55.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.4 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.103 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 46.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.3 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.775 ' HG3' HG22 ' B' ' 233' ' ' VAL . 10.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 71.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 1.208 ' HG2' ' O ' ' B' ' 65' ' ' SER . 5.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 1.038 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 1.612 ' CB ' HD23 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 65' ' ' SER . . . . . 1.208 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.461 ' O ' ' NE2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.685 ' HB3' ' CD ' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 68' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.731 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 43.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.731 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.439 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.439 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.63 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.692 ' CD1' HD11 ' B' ' 116' ' ' LEU . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.731 ' CD2' HG23 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.497 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 0.705 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.497 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 84.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 13.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.403 ' HG3' HE22 ' B' ' 59' ' ' GLN . 29.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.382 ' O ' ' CD1' ' B' ' 162' ' ' TYR 0.461 0.1 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 1.047 ' N ' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.273 HG22 ' CG ' ' B' ' 162' ' ' TYR . 13.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.025 ' H ' HG23 ' B' ' 164' ' ' THR . 18.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.64 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.2 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 84.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.602 HD21 ' HA ' ' B' ' 62' ' ' ALA . 5.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.611 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 16.6 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.667 ' H ' ' CG2' ' B' ' 228' ' ' THR . 21.1 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.8 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 0.4 OUTLIER -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.684 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 3.0 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 0.945 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' B' ' 187' ' ' ASN . 11.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.871 ' HB3' HG22 ' B' ' 204' ' ' VAL . 18.5 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.729 ' HB ' HG23 ' B' ' 205' ' ' THR . 89.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.729 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 2.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 207' ' ' ILE . . . . . 0.459 HD12 HD21 ' B' ' 213' ' ' LEU . 48.3 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 18.3 mt -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.945 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 213' ' ' LEU . . . . . 0.459 HD21 HD12 ' B' ' 207' ' ' ILE . 54.1 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 54.7 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.667 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.5 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.775 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.184 ' CGD' ' O ' ' A' ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.63 126.87 29.24 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.517 1.136 . . . . 0.0 110.022 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.916 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.48 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.369 1.043 . . . . 0.0 109.265 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.9 40.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.254 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.505 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.4 112.1 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.081 . . . . 0.0 109.35 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.72 133.55 35.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.485 1.116 . . . . 0.0 109.346 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.549 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.06 6.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 0.0 110.924 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.48 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.579 1.174 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.3 p -108.07 160.68 15.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 0.736 . . . . 0.0 110.431 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.82 -15.93 24.54 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.382 1.051 . . . . 0.0 109.328 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 35.2 mttt -90.63 39.7 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.536 1.148 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 1.346 ' OH ' ' HB2' ' B' ' 3' ' ' PHE . 0.8 OUTLIER 38.21 29.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.503 1.127 . . . . 0.0 111.016 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.631 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.69 58.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 0.0 109.34 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 9.3 Cg_endo -75.0 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.452 1.764 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 9' ' ' THR . 1.4 pp -150.75 151.25 32.1 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 0.0 109.307 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -77.34 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 1.132 . . . . 0.0 110.965 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.92 26.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 124.47 1.106 . . . . 0.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.05 140.97 70.25 Favored 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.013 -2.494 . . . . 0.0 110.932 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.17 -40.16 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.548 1.155 . . . . 0.0 109.281 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.31 46.04 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.403 1.064 . . . . 0.0 109.358 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.38 31.03 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.7 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.461 1.101 . . . . 0.0 110.098 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.87 -177.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.442 1.089 . . . . 0.0 109.259 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.49 158.33 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 105.42 0.28 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.557 1.161 . . . . 0.0 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.47 8.44 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.5 1.125 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.14 11.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 0.754 . . . . 0.0 109.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.49 154.26 39.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.43 102.58 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.576 1.172 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.49 18.15 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.59 1.181 . . . . 0.0 110.299 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.473 1.108 . . . . 0.0 110.953 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.5 ttp -97.99 119.26 36.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 1.057 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.41 -66.04 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.209 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.1 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 1.225 ' O ' ' CGD' ' B' ' 250' ' ' HEC . . . -92.94 -172.27 40.58 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.523 1.139 . . . . 0.0 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 1.018 ' CD ' ' HB2' ' B' ' 62' ' ' ALA . 9.5 Cg_endo -74.96 -168.9 6.86 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.993 -0.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.635 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 72.8 m-70 -144.21 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 0.0 109.584 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.874 ' HB3' ' OD2' ' B' ' 63' ' ' ASP . 0.9 OUTLIER 173.96 166.98 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HD13 ' A' ' 42' ' ' ILE . 60.5 t -104.11 114.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.578 1.174 . . . . 0.0 109.356 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.71 ' CG1' ' OD1' ' A' ' 40' ' ' ASN . 4.3 mm -132.77 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 0.0 109.308 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 0.0 110.939 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 2.5 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 0.0 109.253 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.074 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.45 158.09 72.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.372 1.045 . . . . 0.0 109.286 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 164.2 33.72 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.493 1.786 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.2 135.61 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.446 1.092 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.68 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.535 1.147 . . . . 0.0 111.014 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.06 -173.32 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.595 0.82 . . . . 0.0 110.303 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.16 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.426 1.079 . . . . 0.0 109.954 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 1.074 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.81 71.33 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.45 1.094 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.08 50.8 2.65 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.491 1.785 . . . . 0.0 110.887 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.23 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.591 1.182 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.05 -27.55 68.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 0.0 109.306 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -46.51 115.08 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.56 1.163 . . . . 0.0 109.988 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.489 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -107.96 117.7 34.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 109.358 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.77 21.94 3.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.438 1.086 . . . . 0.0 110.347 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -86.11 64.43 8.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.453 1.096 . . . . 0.0 109.244 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.198 HD11 ' NE2' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -40.51 102.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.35 98.44 5.97 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -68.7 -46.07 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.326 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.62 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.316 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 27.6 Cg_endo -75.04 139.14 23.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.438 1.757 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.96 0.17 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.505 1.128 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.534 0.785 . . . . 0.0 109.989 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 1.11 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.51 175.1 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.58 161.31 20.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 0.0 109.978 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.475 1.109 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.12 8.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.482 1.114 . . . . 0.0 109.223 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.468 1.105 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.1 37.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.538 0.787 . . . . 0.0 110.412 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.06 141.53 26.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.465 1.771 . . . . 0.0 111.043 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.4 1.062 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -104.88 120.06 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 0.761 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.71 30.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.546 1.154 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.93 145.17 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.462 1.101 . . . . 0.0 109.966 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.2 -171.58 3.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.449 1.093 . . . . 0.0 110.951 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 30.5 p90 -171.84 165.42 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.57 122.38 35.96 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.425 1.078 . . . . 0.0 108.262 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.658 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -51.35 -50.8 74.08 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.398 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.677 ' CD ' HD21 ' A' ' 40' ' ' ASN . 12.8 Cg_endo -75.0 -62.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.237 0 O-C-N 124.498 1.788 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.468 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 22.0 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.751 HH11 ' CG ' ' A' ' 86' ' ' ARG . 2.7 ttt85 -88.01 -38.48 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.536 1.148 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.88 32.74 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.477 1.111 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.62 -15.24 62.55 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.505 0.768 . . . . 0.0 109.406 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.18 1.83 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.449 1.093 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' MET . . . . . 0.549 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.62 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.417 0.716 . . . . 0.0 111.003 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 11.6 m -124.15 153.58 30.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.153 . . . . 0.0 109.277 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.78 19.77 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.73 162.05 37.0 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.485 0.756 . . . . 0.0 110.471 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.65 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 0.0 109.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.1 144.54 31.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.541 1.15 . . . . 0.0 109.333 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 0.0 110.317 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 1' ' ' TYR . . . . . 1.201 ' CZ ' ' HG2' ' B' ' 119' ' ' PRO . 1.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 1.346 ' HB2' ' OH ' ' A' ' 12' ' ' TYR . 23.0 m-85 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' TYR . . . . . 0.793 ' CD1' HBC2 ' B' ' 250' ' ' HEC 0.347 0.3 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 3' ' ' PHE . 74.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 7.1 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' ILE . . . . . 0.865 HG12 ' NE2' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' CYS . . . . . 1.116 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 42.1 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLN . . . . . 0.676 ' HB2' HG21 ' B' ' 233' ' ' VAL . 43.6 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 7.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' GLN . . . . . 1.198 ' NE2' HD11 ' A' ' 60' ' ' LEU . 14.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ALA . . . . . 1.018 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ASP . . . . . 0.874 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 5.0 m-20 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 65' ' ' SER . . . . . 0.949 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 10.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.474 ' HG ' ' HB3' ' B' ' 61' ' ' GLN . 54.2 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.403 HD21 HG23 ' B' ' 233' ' ' VAL . 8.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASN . . . . . 0.684 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 3.6 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 102' ' ' TYR . . . . . 0.431 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 103' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 105' ' ' THR . . . . . 0.675 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.1 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 119' ' ' PRO . . . . . 1.201 ' HG2' ' CZ ' ' B' ' 1' ' ' TYR . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 48.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 123' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' ASP . . . . . 0.436 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 30.8 t30 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.456 ' CA ' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 158' ' ' ARG . . . . . 0.584 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 51.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 161' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.6 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 162' ' ' TYR . . . . . 1.043 ' HB3' HG22 ' B' ' 164' ' ' THR . 18.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 163' ' ' PRO . . . . . 0.652 ' HB3' ' CD1' ' B' ' 4' ' ' TYR . 1.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 164' ' ' THR . . . . . 1.043 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 166' ' ' GLU . . . . . 1.0 ' H ' HG23 ' B' ' 164' ' ' THR . 19.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 167' ' ' LEU . . . . . 0.49 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 53.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 169' ' ' ASN . . . . . 0.575 HD21 ' HA ' ' B' ' 62' ' ' ALA . 1.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 170' ' ' ASN . . . . . 0.62 ' O ' ' OD1' ' B' ' 170' ' ' ASN . 12.6 t-20 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 39.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 56.1 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 186' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 56.9 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 187' ' ' ASN . . . . . 0.691 ' O ' ' CD1' ' B' ' 189' ' ' PHE . 5.4 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 189' ' ' PHE . . . . . 0.825 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.271 0.5 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 191' ' ' PHE . . . . . 0.416 ' C ' ' CG ' ' B' ' 192' ' ' ASP . 12.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 192' ' ' ASP . . . . . 0.65 ' HB3' HG22 ' B' ' 204' ' ' VAL . 0.0 OUTLIER -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.631 ' HA ' HG22 ' B' ' 184' ' ' ILE . 92.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 204' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 205' ' ' THR . . . . . 0.615 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 76.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 208' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 209' ' ' PRO . . . . . 0.825 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.0 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 211' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 3.1 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 222' ' ' GLU . . . . . 0.737 ' HB3' ' HG3' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 225' ' ' GLN . . . . . 0.737 ' HG3' ' HB3' ' B' ' 222' ' ' GLU . 60.5 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 233' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 238' ' ' GLN . . . . . 0.865 ' NE2' HG12 ' B' ' 19' ' ' ILE . 33.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 250' ' ' HEC . . . . . 1.225 ' CGD' ' O ' ' A' ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.66 126.8 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 109.989 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 124.447 1.092 . . . . 0.0 109.22 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.99 150.8 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 110.318 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.13 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.337 1.023 . . . . 0.0 109.259 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.68 133.49 35.95 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.528 1.143 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 96.99 6.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 0.0 110.955 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.51 7.64 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.491 1.119 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.08 160.63 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.389 0.699 . . . . 0.0 110.391 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.74 -16.03 24.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.399 1.062 . . . . 0.0 109.315 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.2 mttp -90.55 39.64 0.98 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 38.21 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.592 1.182 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.625 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.82 117.7 58.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HG3' ' CE2' ' B' ' 3' ' ' PHE . 36.0 Cg_endo -74.98 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.456 1.766 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.1 pp -150.74 151.24 32.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.119 . . . . 0.0 109.323 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.38 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.556 1.16 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.86 26.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.459 1.1 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.15 140.98 70.19 Favored 'Cis proline' 0 C--N 1.361 1.203 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.96 0.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.5 tttt -40.17 -40.04 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.58 1.175 . . . . 0.0 109.342 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.35 46.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.365 1.041 . . . . 0.0 109.273 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.31 141.32 30.94 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.93 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.554 1.159 . . . . 0.0 110.026 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 0.0 109.26 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.55 158.26 27.7 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.499 1.124 . . . . 0.0 109.968 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.44 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.452 1.095 . . . . 0.0 109.285 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.38 8.48 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.542 1.151 . . . . 0.0 110.961 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.09 174.16 11.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.48 0.753 . . . . 0.0 109.291 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.65 154.28 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.62 1.2 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.9 t -131.47 102.63 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.78 169.57 18.02 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.468 1.105 . . . . 0.0 110.313 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.48 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.515 1.134 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.57 1.169 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.689 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 11.7 ttp -97.96 119.21 36.18 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.433 1.083 . . . . 0.0 111.009 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.332 6.9 m-20 -79.36 -66.04 0.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.589 1.181 . . . . 0.0 109.243 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 14.8 p 46.04 54.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 0.0 109.276 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.47 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.564 1.165 . . . . 0.0 111.033 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.002 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 30.0 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.93 -2.529 . . . . 0.0 111.03 -0.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.499 1.124 . . . . 0.0 109.575 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.95 167.05 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 0.0 109.253 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.623 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.1 t -104.18 114.41 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.163 . . . . 0.0 109.289 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.0 mm -132.82 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.551 1.157 . . . . 0.0 109.305 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.0 m-85 -47.71 160.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.04 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.6 mtpt 167.35 143.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.6 1.187 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.022 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.55 158.08 72.98 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.436 1.085 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.3 Cg_endo -75.03 164.17 33.84 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.538 1.809 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.17 135.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.392 1.058 . . . . 0.0 109.276 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.44 -56.55 0.72 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.578 1.174 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.557 0.798 . . . . 0.0 110.279 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.25 77.76 1.75 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 110.001 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.022 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 109.353 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.01 50.82 2.63 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.466 1.772 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.48 1.113 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.49 68.14 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.502 1.126 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 m -46.55 115.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 109.98 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.7 m120 -108.01 117.63 34.63 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.408 1.067 . . . . 0.0 109.315 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 60' ' ' LEU . 8.8 t -89.73 21.73 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.41 1.069 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -85.87 64.32 8.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.455 1.097 . . . . 0.0 109.264 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.37 102.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.427 1.079 . . . . 0.0 109.351 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.02 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.617 1.198 . . . . 0.0 109.339 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.67 HD11 HD12 ' A' ' 60' ' ' LEU . 2.6 mm -68.65 -46.18 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.596 1.185 . . . . 0.0 109.282 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.63 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 109.265 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.95 139.1 24.01 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.95 -67.97 0.17 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.502 1.126 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.679 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.511 0.771 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.587 1.179 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.42 175.18 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 111.044 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.478 1.112 . . . . 0.0 109.983 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.11 137.69 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 0.0 109.348 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.17 146.46 23.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.18 173.05 8.57 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 0.0 109.231 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.526 1.141 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.13 37.57 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.53 0.782 . . . . 0.0 110.424 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.5 26.8 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.437 1.756 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.6 20.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.93 120.07 40.54 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.571 0.806 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.834 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.74 30.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.545 1.153 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.099 . . . . 0.0 110.01 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.09 -171.48 3.72 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 1.128 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 38.7 p90 -171.9 165.4 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.973 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -93.52 122.27 35.78 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.116 . . . . 0.0 108.335 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.83 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.6 OUTLIER -51.26 -50.82 73.71 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.561 1.163 . . . . 0.0 110.408 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.74 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 37.7 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.576 1.829 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.67 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 25.4 m80 -75.06 57.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.57 1.169 . . . . 0.0 109.562 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.019 ' NH1' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.95 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.577 1.173 . . . . 0.0 110.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.86 32.73 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.462 1.101 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' ' HE1' ' B' ' 4' ' ' TYR . . . -65.65 -15.2 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.489 0.758 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.12 63.14 1.83 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.431 1.082 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 0.798 . . . . 0.0 110.971 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.722 ' CG1' HH22 ' A' ' 86' ' ' ARG . 11.6 m -124.26 153.59 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 0.0 109.227 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.56 -174.75 19.77 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 124.546 1.154 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.82 162.0 37.19 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 0.792 . . . . 0.0 110.432 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.57 122.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.496 1.122 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.9 m -105.07 144.47 31.83 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 124.559 1.162 . . . . 0.0 109.353 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 0.0 110.38 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.868 ' H3 ' ' HD2' ' B' ' 4' ' ' TYR . 18.5 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.522 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.868 ' HD2' ' H3 ' ' B' ' 1' ' ' TYR . 46.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.602 ' HA ' HG12 ' B' ' 161' ' ' VAL . 46.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.71 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.722 HE22 ' HA2' ' B' ' 157' ' ' GLY . 13.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 65' ' ' SER . 7.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 4.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.71 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.2 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.401 ' CE2' HD23 ' B' ' 103' ' ' LEU . 6.7 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.401 HD23 ' CE2' ' B' ' 102' ' ' TYR . 74.9 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.035 HG13 ' HG ' ' B' ' 115' ' ' LEU . 65.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.777 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.891 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.035 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.891 HD11 ' HA ' ' B' ' 107' ' ' TYR . 1.1 mp -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.002 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.0 OUTLIER -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.402 ' HD3' HG21 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.472 ' CE1' HD22 ' B' ' 120' ' ' LEU . 20.7 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 58.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.722 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.404 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.406 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' B' ' 24' ' ' CYS . 1.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' B' ' 168' ' ' SER . 0.4 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.0 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.008 HG22 ' H ' ' B' ' 166' ' ' GLU . 0.4 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.008 ' H ' HG22 ' B' ' 164' ' ' THR . 2.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.678 ' HA ' ' CE1' ' B' ' 162' ' ' TYR . 95.9 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 55.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 1.9 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.047 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 8.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.803 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 52.2 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.788 HD22 ' H ' ' B' ' 208' ' ' LEU . 1.1 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.047 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.83 29.06 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.466 1.104 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.89 40.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.51 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.36 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.407 1.067 . . . . 0.0 109.246 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.45 36.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.533 1.145 . . . . 0.0 109.388 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.55 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.141 . . . . 0.0 111.003 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 1.025 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.14 144.49 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.705 ' CG2' HD11 ' A' ' 15' ' ' LEU . 23.9 p -108.08 160.6 15.67 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.441 0.73 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -15.96 23.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ALA . 14.2 mttt -90.59 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 38.29 29.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 0.0 111.029 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.78 117.71 58.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 0.0 109.318 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 24.7 Cg_endo -75.02 97.72 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.428 1.752 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.705 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.5 pp -150.87 151.26 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.18 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.465 1.103 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.46 134.82 26.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 124.467 1.104 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.92 69.94 Favored 'Cis proline' 0 C--N 1.359 1.12 0 C-N-CA 121.061 -2.474 . . . . 0.0 110.993 0.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.565 1.165 . . . . 0.0 109.306 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.34 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.264 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.03 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.625 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.91 143.83 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.98 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.559 1.162 . . . . 0.0 109.205 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.64 158.28 27.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.531 1.144 . . . . 0.0 109.972 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 105.47 0.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.201 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.31 8.52 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.07 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.527 0.781 . . . . 0.0 109.238 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.47 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.616 1.197 . . . . 0.0 110.491 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.44 102.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 109.322 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.5 18.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.4 9.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.502 1.126 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.32 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.442 1.089 . . . . 0.0 109.276 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.1 ttp -97.93 119.16 36.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.426 1.079 . . . . 0.0 111.046 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 1.025 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.31 -66.07 0.92 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.624 1.203 . . . . 0.0 109.268 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.539 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.454 1.096 . . . . 0.0 109.321 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 7.1 p 46.02 54.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 109.336 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.84 ' O ' ' HD2' ' B' ' 119' ' ' PRO . . . -92.94 -172.31 40.58 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.491 1.12 . . . . 0.0 111.079 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.176 ' HD3' ' O ' ' B' ' 119' ' ' PRO . 58.6 Cg_endo -74.97 -168.9 6.85 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.961 -2.516 . . . . 0.0 110.973 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.671 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.26 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.077 . . . . 0.0 109.617 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.482 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.5 p30 173.97 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.251 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.06 114.27 43.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.571 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.73 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 109.343 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.69 160.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.8 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.1 mttt 167.32 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.121 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.426 1.079 . . . . 0.0 109.21 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.06 164.22 33.67 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.493 1.786 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.2 135.58 1.38 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.444 1.09 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.63 0.72 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.492 1.12 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.26 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 0.816 . . . . 0.0 110.301 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.21 77.75 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.134 . . . . 0.0 110.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.121 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 0.0 109.358 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -74.99 50.74 2.6 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.478 1.778 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 0.0 109.313 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.61 68.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -46.49 115.16 0.95 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.511 1.132 . . . . 0.0 109.966 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.93 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.452 1.095 . . . . 0.0 109.325 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -89.8 21.85 3.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.383 1.052 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 39.7 tttt -86.0 64.37 8.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.57 1.169 . . . . 0.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 60' ' ' LEU . 3.4 mp -40.44 102.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.559 1.162 . . . . 0.0 109.322 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.48 6.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 109.284 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' B' ' 120' ' ' LEU . 0.7 OUTLIER -68.71 -46.15 80.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.601 1.188 . . . . 0.0 109.282 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.88 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 0.0 109.331 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.835 ' HG3' ' CD1' ' B' ' 102' ' ' TYR . 72.3 Cg_endo -75.06 139.16 23.81 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.389 1.731 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -68.01 0.17 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.501 1.126 . . . . 0.0 110.995 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.622 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.449 0.735 . . . . 0.0 110.014 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.1 m-85 -38.23 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.471 1.107 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.55 175.09 4.17 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.093 . . . . 0.0 111.009 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.29 20.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 0.0 109.95 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.08 137.71 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.486 1.116 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.33 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.583 1.177 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.3 mt -124.14 173.1 8.52 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.536 1.148 . . . . 0.0 109.186 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.536 1.147 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.462 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.24 124.11 37.6 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.467 0.745 . . . . 0.0 110.426 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.52 26.8 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.527 1.804 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.62 20.05 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.415 1.072 . . . . 0.0 111.046 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.04 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.776 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.74 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.59 1.181 . . . . 0.0 111.021 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.86 145.17 49.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 110.019 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.52 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.496 1.122 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.42 ' CB ' HG12 ' A' ' 91' ' ' VAL . 38.5 p90 -171.83 165.41 6.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.113 . . . . 0.0 110.959 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.55 122.3 35.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.4 1.063 . . . . 0.0 108.302 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.5 m -51.3 -50.79 73.97 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.482 1.114 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.567 1.825 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m170 -75.0 58.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.542 1.151 . . . . 0.0 109.602 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.512 ' NE ' ' O ' ' A' ' 86' ' ' ARG . 1.5 tpm_? -88.0 -38.53 15.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.128 . . . . 0.0 110.305 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.51 -23.79 32.81 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.438 1.086 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.27 62.62 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.531 0.783 . . . . 0.0 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.21 1.82 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.464 1.103 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.55 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.0 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 0.72 . . . . 0.0 111.067 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 81' ' ' TYR . 14.9 m -124.13 153.59 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.295 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.58 -174.69 19.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.482 1.114 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.83 162.09 36.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 0.772 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.66 122.56 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -104.98 144.51 31.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 0.0 110.435 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.282 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.167 . . . . 0.0 110.3 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.589 ' CD2' ' HG3' ' B' ' 119' ' ' PRO . 56.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.789 ' CD2' ' HG3' ' B' ' 163' ' ' PRO . 4.2 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.767 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.559 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 79.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.786 ' HB2' HG21 ' B' ' 233' ' ' VAL . 14.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 15.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.478 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 68.7 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 32.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.7 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.77 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.835 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 2.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.722 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.4 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.088 HG13 ' HG ' ' B' ' 115' ' ' LEU . 39.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.088 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.4 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.761 ' N ' HD23 ' B' ' 115' ' ' LEU . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.176 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 1.032 ' HA ' HD11 ' A' ' 62' ' ' ILE . 1.2 mp -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.574 ' HD2' ' HG2' ' B' ' 128' ' ' MET . 0.6 OUTLIER -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.574 ' HG2' ' HD2' ' B' ' 125' ' ' TYR . 10.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.453 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.641 HH12 HD21 ' B' ' 169' ' ' ASN . 33.0 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.452 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 0.984 ' CB ' HG22 ' B' ' 164' ' ' THR . 30.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.789 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.117 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.0 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.117 ' H ' HG23 ' B' ' 164' ' ' THR . 42.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 96.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.641 HD21 HH12 ' B' ' 158' ' ' ARG . 0.8 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.462 1.2 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.193 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 25.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.686 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.193 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 11.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.56 126.73 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 0.0 110.098 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.35 177.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.426 1.079 . . . . 0.0 109.263 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -143.05 150.87 40.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.38 112.16 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.398 1.061 . . . . 0.0 109.239 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.48 35.97 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.557 1.161 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.696 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 0.0 111.009 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.668 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.51 7.64 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.58 1.175 . . . . 0.0 110.967 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.03 160.58 15.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.469 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.7 -15.99 23.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.4 ttmt -90.58 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 38.25 29.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.548 1.155 . . . . 0.0 111.048 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.76 117.73 58.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 1.023 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.5 Cg_endo -75.02 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.492 1.785 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.611 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.2 pp -150.82 151.24 32.0 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.35 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.45 134.86 26.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.381 1.051 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.97 70.22 Favored 'Cis proline' 0 C--N 1.359 1.114 0 C-N-CA 120.989 -2.505 . . . . 0.0 110.949 0.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.19 -40.08 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.566 1.166 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.33 46.13 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.387 1.054 . . . . 0.0 109.24 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 0.0 109.297 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.81 51.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.45 1.094 . . . . 0.0 110.038 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.95 -177.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.566 1.166 . . . . 0.0 109.242 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.809 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.514 1.134 . . . . 0.0 109.969 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.5 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.588 1.18 . . . . 0.0 109.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.39 8.51 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.458 1.099 . . . . 0.0 111.052 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.12 174.11 11.51 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 0.78 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.49 154.27 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 0.0 110.485 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.69 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.83 169.56 18.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.587 1.179 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.1 m-85 -147.24 121.4 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.52 1.138 . . . . 0.0 110.981 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.35 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.248 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.649 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.4 ttp -97.98 119.15 36.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m120 -79.28 -66.09 0.91 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.145 . . . . 0.0 109.248 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.451 1.094 . . . . 0.0 109.333 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.023 HG21 ' HG3' ' A' ' 14' ' ' PRO . 7.4 p 45.93 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.352 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.0 -172.31 40.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.49 1.119 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.157 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 36.2 Cg_endo -75.03 -168.87 6.85 Favored 'Cis proline' 0 C--N 1.361 1.19 0 C-N-CA 120.938 -2.526 . . . . 0.0 111.003 0.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.649 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 73.2 m-70 -144.28 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 60' ' ' LEU . 2.5 p30 173.99 166.95 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.536 1.147 . . . . 0.0 109.271 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.662 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.5 t -104.07 114.41 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 0.0 109.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -132.84 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.414 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.67 160.65 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.507 1.129 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.02 -50.01 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.574 1.171 . . . . 0.0 109.256 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 167.29 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 0.0 109.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.432 1.082 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 164.21 33.82 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.511 1.795 . . . . 0.0 111.008 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.26 135.56 1.41 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.438 1.086 . . . . 0.0 109.313 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.54 0.72 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 0.0 110.972 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.22 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 0.807 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.23 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 110.024 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.013 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.77 71.73 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.444 1.09 . . . . 0.0 109.359 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.04 50.84 2.65 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.452 1.764 . . . . 0.0 110.952 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.38 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.281 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.63 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.542 1.151 . . . . 0.0 109.259 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.2 m -46.44 115.11 0.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.59 1.181 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -107.92 117.68 34.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.335 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.674 HG21 ' OD2' ' B' ' 63' ' ' ASP . 9.1 t -89.81 21.85 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -86.03 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.516 1.135 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -40.4 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 0.0 109.326 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.46 98.44 6.06 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' B' ' 119' ' ' PRO . 3.2 mm -68.73 -46.06 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.554 1.159 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.63 4.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 0.0 109.303 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.04 139.14 23.83 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.43 1.753 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -68.02 0.17 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.471 1.107 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.66 97.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 0.747 . . . . 0.0 109.99 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.19 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.401 1.063 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.49 175.1 4.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 0.0 111.055 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.445 1.091 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.72 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.423 1.077 . . . . 0.0 109.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.32 146.41 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 0.0 110.398 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.06 173.13 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 0.0 109.225 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.518 1.136 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.67 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.525 0.779 . . . . 0.0 110.381 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 141.49 26.73 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.796 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.433 1.083 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.4 m -104.76 120.04 40.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.465 0.744 . . . . 0.0 110.399 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.76 30.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 0.0 111.011 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.9 145.11 49.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 110.032 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.53 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.13 . . . . 0.0 110.989 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 1.374 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 15.3 p90 -171.82 165.45 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.62 122.3 35.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.381 1.051 . . . . 0.0 108.267 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.97 HG21 ' CB ' ' B' ' 62' ' ' ALA . 1.0 OUTLIER -51.25 -50.8 73.76 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.429 1.08 . . . . 0.0 110.466 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.602 1.843 . . . . 0.0 110.992 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.955 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 24.6 m80 -75.06 57.99 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.574 1.171 . . . . 0.0 109.546 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.374 ' NH2' ' HB2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.99 -38.47 15.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.525 1.14 . . . . 0.0 110.313 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 1.049 ' CA ' HG23 ' B' ' 164' ' ' THR . . . -89.49 -23.84 32.74 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.487 1.117 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.22 62.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 0.769 . . . . 0.0 109.346 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.19 1.82 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.696 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.58 74.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 0.0 111.043 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.537 ' CG1' ' NH2' ' A' ' 86' ' ' ARG . 11.7 m -124.18 153.5 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 0.0 109.283 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.5 -174.73 19.71 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.525 1.141 . . . . 0.0 111.004 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.11 36.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 0.0 110.39 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.712 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.65 122.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.561 1.163 . . . . 0.0 109.311 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -105.02 144.52 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.477 1.111 . . . . 0.0 110.426 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.12 . . . . 0.0 109.24 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.809 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 110.349 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.868 ' CZ ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.795 ' CG ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 1.007 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 21.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 2.7 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.662 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.6 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.718 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.811 ' HG3' HG22 ' B' ' 233' ' ' VAL . 12.0 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 86.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.674 ' OD2' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.467 ' HB2' ' OD2' ' B' ' 63' ' ' ASP . 17.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.5 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.552 ' HD2' HD12 ' B' ' 103' ' ' LEU . 3.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.552 HD12 ' HD2' ' B' ' 102' ' ' TYR . 1.1 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.1 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.842 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.516 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.8 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' B' ' 105' ' ' THR . 71.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.157 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' B' ' 125' ' ' TYR . 7.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.708 ' CE2' HD22 ' B' ' 120' ' ' LEU . 47.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 23.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.527 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 54.2 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.425 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.484 ' O ' HD13 ' B' ' 167' ' ' LEU . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' B' ' 24' ' ' CYS . 2.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 0.568 ' HB2' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 1.007 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.049 HG23 ' CA ' ' A' ' 87' ' ' GLY . 2.1 p -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.484 HD13 ' O ' ' B' ' 160' ' ' GLN . 4.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.354 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.565 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 37.9 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 0.994 ' CG ' ' HD3' ' B' ' 209' ' ' PRO 0.278 3.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.565 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.877 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.9 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.994 ' HD3' ' CG ' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.811 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.57 126.8 28.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.616 1.197 . . . . 0.0 110.06 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.451 1.095 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.81 40.18 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.349 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.38 112.17 38.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.466 1.104 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.78 133.43 36.05 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.309 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.727 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.64 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 0.0 110.996 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.58 7.65 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.449 1.093 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.51 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -108.12 160.64 15.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 0.752 . . . . 0.0 110.413 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.8 -15.94 24.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.9 mttt -90.56 39.59 0.98 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.13 . . . . 0.0 109.371 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.32 29.7 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.489 1.118 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.83 117.71 58.11 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.223 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CB ' ' CD2' ' A' ' 85' ' ' HIS . 25.0 Cg_endo -75.03 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.457 1.767 . . . . 0.0 111.066 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD21 ' OG1' ' A' ' 9' ' ' THR . 2.0 pp -150.77 151.19 31.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.502 1.126 . . . . 0.0 109.322 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.41 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.15 30.47 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.533 1.146 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.48 134.84 26.53 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 0.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.11 140.97 70.16 Favored 'Cis proline' 0 C--N 1.36 1.18 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.938 0.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.15 -40.15 1.04 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.6 1.187 . . . . 0.0 109.267 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.17 146.32 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.361 1.038 . . . . 0.0 109.328 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.23 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.563 1.164 . . . . 0.0 109.219 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.97 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 110.055 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.93 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.807 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.33 27.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 0.0 109.971 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.592 1.183 . . . . 0.0 109.321 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.36 8.49 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.495 1.122 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.657 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.15 174.16 11.46 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.616 0.833 . . . . 0.0 109.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.21 39.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 0.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.37 102.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.8 169.5 18.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 110.319 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.23 121.53 9.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.55 1.156 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.14 155.31 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.654 1.221 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.809 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.2 ttp -98.0 119.21 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.479 1.112 . . . . 0.0 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.326 6.6 m-20 -79.31 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.243 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.663 ' O ' ' CE1' ' A' ' 85' ' ' HIS . 11.2 p 45.93 54.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 1.487 ' O ' ' CE1' ' B' ' 1' ' ' TYR . . . -92.9 -172.31 40.65 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.164 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 19.8 Cg_endo -74.93 -168.87 6.82 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 120.998 -2.501 . . . . 0.0 111.018 -0.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.809 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.1 m-70 -144.26 -170.38 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.426 1.079 . . . . 0.0 109.251 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.7 t -104.01 114.33 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.595 1.185 . . . . 0.0 109.414 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mm -132.8 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.7 160.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -49.99 4.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 12.1 mttt 167.22 143.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.57 1.169 . . . . 0.0 109.343 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.034 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.49 158.16 72.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.097 . . . . 0.0 109.275 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 164.26 33.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.427 1.751 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.35 135.67 1.42 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.47 1.106 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.54 0.72 Allowed Glycine 0 CA--C 1.532 1.128 0 O-C-N 124.565 1.166 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.621 0.836 . . . . 0.0 110.305 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.13 77.8 1.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 0.0 110.02 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.79 71.68 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.463 1.102 . . . . 0.0 109.292 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.4 Cg_endo -75.01 50.74 2.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.392 1.733 . . . . 0.0 110.995 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.73 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.609 1.193 . . . . 0.0 109.301 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.48 68.1 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.543 1.152 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.0 m -46.5 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.56 1.162 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.604 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 85.0 m-20 -107.94 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.418 1.074 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.508 HG23 ' NE2' ' B' ' 61' ' ' GLN . 11.6 t -89.82 21.84 3.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.377 1.048 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -85.97 64.43 8.58 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.43 1.082 . . . . 0.0 109.251 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.5 102.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.307 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.37 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.911 HD11 HD12 ' A' ' 60' ' ' LEU . 2.1 mm -68.7 -46.02 80.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.596 1.185 . . . . 0.0 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.12 111.59 4.85 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.33 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -75.06 139.21 23.86 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.515 1.134 . . . . 0.0 110.957 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.539 0.788 . . . . 0.0 110.034 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.24 -86.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.604 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.58 175.12 4.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.359 1.037 . . . . 0.0 110.991 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.32 20.87 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 109.96 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.07 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.47 23.99 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.474 1.109 . . . . 0.0 110.394 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.11 173.06 8.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.464 1.102 . . . . 0.0 109.27 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.505 1.128 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.08 37.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.452 0.736 . . . . 0.0 110.418 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -74.99 141.46 26.69 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.523 1.802 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.59 20.11 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.48 1.112 . . . . 0.0 110.985 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.86 120.07 40.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 0.742 . . . . 0.0 110.367 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.83 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.73 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.517 1.136 . . . . 0.0 110.995 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.85 145.08 49.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 0.0 110.03 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.16 -171.55 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.518 1.136 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.926 ' CB ' ' NH2' ' A' ' 86' ' ' ARG . 16.9 p90 -171.81 165.42 6.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 0.0 110.995 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 0.5 OUTLIER -93.55 122.3 35.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 0.0 108.276 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.758 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.21 -50.86 73.25 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.476 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 83' ' ' THR . 37.4 Cg_endo -75.04 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 0.0 110.953 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.681 ' CD2' ' CB ' ' A' ' 14' ' ' PRO . 49.1 m80 -75.04 57.94 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.185 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.02 -38.43 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 0.0 110.325 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.91 32.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.433 1.083 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.22 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 0.0 109.33 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.014 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.727 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 0.735 . . . . 0.0 111.018 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.185 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.24 153.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.565 1.166 . . . . 0.0 109.239 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.48 -174.76 19.72 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.525 1.14 . . . . 0.0 111.006 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.79 162.06 37.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 0.735 . . . . 0.0 110.441 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.0 mt -146.65 122.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.52 31.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.441 1.088 . . . . 0.0 110.403 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.547 1.154 . . . . 0.0 109.255 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.807 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 O-C-N 124.604 1.19 . . . . 0.0 110.32 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.487 ' CE1' ' O ' ' A' ' 37' ' ' GLY 0.427 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.493 ' HB3' HD22 ' B' ' 116' ' ' LEU . 3.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 14' ' ' PRO . 71.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 1.612 ' CZ ' ' HG2' ' B' ' 163' ' ' PRO . 0.1 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.5 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.751 ' HA ' HG12 ' B' ' 161' ' ' VAL . 47.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.73 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 1.004 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 17.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.434 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 84.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.508 ' NE2' HG23 ' A' ' 58' ' ' THR . 8.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.758 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 26.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.73 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.544 ' CD2' HD23 ' B' ' 103' ' ' LEU . 21.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' B' ' 102' ' ' TYR . 45.2 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.044 HG13 ' HG ' ' B' ' 115' ' ' LEU . 79.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.42 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.1 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 25.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.044 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.711 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.164 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.611 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.611 ' CE1' HD22 ' B' ' 120' ' ' LEU . 69.1 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.9 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 1.004 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' B' ' 24' ' ' CYS . 7.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.147 ' HB3' HG22 ' B' ' 164' ' ' THR . 0.9 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 1.612 ' HG2' ' CZ ' ' B' ' 4' ' ' TYR . 5.9 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.147 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.993 ' H ' HG23 ' B' ' 164' ' ' THR . 15.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.476 ' N ' HD22 ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 78.2 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.566 HD21 ' HA ' ' B' ' 62' ' ' ALA . 12.2 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.356 22.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.599 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 42.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.183 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 3.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.599 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.6 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.895 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.8 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.183 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 8.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.76 28.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.157 . . . . 0.0 109.998 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.416 1.073 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.82 40.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 110.324 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.404 1.065 . . . . 0.0 109.258 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.7 133.45 36.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.465 1.103 . . . . 0.0 109.323 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.638 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 0.0 110.952 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 1.031 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -108.06 160.58 15.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.417 0.716 . . . . 0.0 110.413 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -59.71 -16.0 23.77 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.375 1.047 . . . . 0.0 109.357 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 20.7 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.521 1.138 . . . . 0.0 109.369 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.529 ' OH ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 0.0 111.022 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.9 117.69 58.1 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 0.0 109.247 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 41.0 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.432 1.754 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.79 151.21 31.99 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.435 1.085 . . . . 0.0 109.299 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.405 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.31 126.19 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.509 1.131 . . . . 0.0 110.991 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.419 0 O-C-N 124.457 1.098 . . . . 0.0 110.323 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.91 69.88 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 121.018 -2.493 . . . . 0.0 110.978 0.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.13 -40.06 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.58 1.175 . . . . 0.0 109.304 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.31 46.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.345 1.028 . . . . 0.0 109.227 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.31 30.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.613 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.92 143.73 50.96 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.519 1.137 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.89 -177.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.823 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.991 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.475 1.11 . . . . 0.0 109.313 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.45 8.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.551 1.157 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.13 174.16 11.47 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 0.745 . . . . 0.0 109.28 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 1.17 . . . . 0.0 110.437 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.718 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.81 169.55 18.05 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.551 1.157 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.53 9.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 0.0 110.888 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.13 155.31 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 0.0 109.275 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.876 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.3 ttp -97.98 119.19 36.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 1.031 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.37 -65.99 0.93 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 0.0 109.257 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -168.88 -167.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 12.1 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 0.0 109.327 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.03 -172.27 40.44 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.561 1.163 . . . . 0.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.98 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 5.5 Cg_endo -74.96 -168.85 6.81 Favored 'Cis proline' 0 C--N 1.361 1.226 0 C-N-CA 120.9 -2.542 . . . . 0.0 111.072 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.876 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.2 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.518 1.136 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 173.98 167.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 1.135 . . . . 0.0 109.256 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.15 114.39 43.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.566 1.166 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.581 1.175 . . . . 0.0 109.318 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.79 160.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.03 -50.04 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.582 1.176 . . . . 0.0 109.255 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.57 158.12 72.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 109.259 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 164.26 33.53 Favored 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.541 1.811 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.437 1.086 . . . . 0.0 109.319 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.51 0.72 Allowed Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.597 1.186 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 0.784 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.21 77.67 1.74 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 110.035 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.041 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.95 -51.9 70.26 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.427 1.079 . . . . 0.0 109.281 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.5 Cg_endo -74.92 50.8 2.59 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.794 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.598 1.187 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.03 -27.57 68.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 109.285 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.8 m -46.43 115.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.575 1.172 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.409 HD22 ' CB ' ' A' ' 59' ' ' LYS . 1.6 t30 -107.95 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.467 1.104 . . . . 0.0 109.36 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.429 HG21 ' HB3' ' B' ' 63' ' ' ASP . 9.1 t -89.75 21.77 3.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.372 1.045 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' HD22 ' A' ' 57' ' ' ASN . 4.3 tttt -85.98 64.36 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.452 1.095 . . . . 0.0 109.238 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.4 102.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.409 1.068 . . . . 0.0 109.388 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.4 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.586 1.178 . . . . 0.0 109.356 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.535 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -68.66 -46.12 80.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.619 1.2 . . . . 0.0 109.318 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.15 111.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 124.547 1.154 . . . . 0.0 109.314 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.07 139.16 23.77 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.549 1.815 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -68.04 0.17 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.439 1.087 . . . . 0.0 110.945 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.66 97.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.438 0.728 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.2 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 0.0 110.932 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.343 1.027 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.32 20.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.476 1.11 . . . . 0.0 109.979 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.7 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.366 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.24 146.46 24.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 0.0 110.374 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.06 8.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.1 -44.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.5 1.125 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.47 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.15 124.08 36.81 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.523 0.778 . . . . 0.0 110.403 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 141.51 26.68 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.468 1.773 . . . . 0.0 111.05 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.15 -178.58 20.13 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.2 m -104.95 120.06 40.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.556 0.798 . . . . 0.0 110.402 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.503 1.127 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.432 1.083 . . . . 0.0 109.999 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.14 -171.5 3.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 14.9 p90 -171.89 165.42 6.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.56 122.26 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 0.0 108.285 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.667 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.25 -50.81 73.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.451 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 83' ' ' THR . 9.2 Cg_endo -75.04 -62.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.508 1.794 . . . . 0.0 111.009 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.9 m80 -75.06 57.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.593 1.183 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -87.89 -38.54 15.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 110.352 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 86' ' ' ARG . . . -89.52 -23.81 32.73 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.416 1.072 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.26 62.62 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.494 0.761 . . . . 0.0 109.325 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.21 1.82 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.458 1.099 . . . . 0.0 110.962 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.638 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 0.772 . . . . 0.0 110.994 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.18 153.59 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.268 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.57 -174.76 19.78 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.604 1.19 . . . . 0.0 110.883 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.04 37.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 0.772 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.61 122.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.459 1.099 . . . . 0.0 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.6 m -105.01 144.51 31.72 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.415 1.072 . . . . 0.0 110.433 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.563 1.165 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.823 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 0.0 110.305 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 15.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.509 ' HE2' ' CE1' ' B' ' 4' ' ' TYR . 0.7 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.724 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 18.9 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.515 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 35.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.764 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.717 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 84.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.808 ' HB2' HG21 ' B' ' 233' ' ' VAL . 23.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 85.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.671 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 58' ' ' THR . 15.5 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.5 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.717 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.599 HD21 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.525 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 13.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' B' ' 103' ' ' LEU . 0.1 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.046 HG13 ' HG ' ' B' ' 115' ' ' LEU . 40.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.812 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.5 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.568 ' CD1' HD11 ' B' ' 116' ' ' LEU . 29.1 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 49.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.046 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.812 ' HB2' HG23 ' B' ' 105' ' ' THR . 32.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.98 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.517 ' HB3' HG13 ' A' ' 62' ' ' ILE . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.671 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 49.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.2 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.032 ' CB ' HG22 ' B' ' 164' ' ' THR . 8.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.3 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 38.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.551 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.2 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.879 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.7 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.2 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -57.68 126.85 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 109.999 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.971 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.11 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 0.0 109.27 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.92 150.88 40.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 0.0 109.313 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.7 133.42 36.02 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.533 1.146 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.02 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 0.0 110.995 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.46 7.63 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 124.545 1.153 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.71 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 10.7 p -108.14 160.66 15.64 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.423 0.72 . . . . 0.0 110.41 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.527 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 46.2 t0 -59.8 -15.97 24.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.6 mttt -90.65 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.549 1.156 . . . . 0.0 109.365 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 38.32 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.87 117.67 58.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HG3' ' CZ ' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.46 1.769 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 9' ' ' THR . 3.9 pp -150.76 151.27 32.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 0.0 109.365 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.3 m-85 -77.41 126.2 30.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.95 26.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.401 1.063 . . . . 0.0 110.284 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -74.99 140.94 70.15 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.027 -2.489 . . . . 0.0 110.947 -0.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.13 -40.12 1.03 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.543 1.152 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.414 1.072 . . . . 0.0 109.283 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.971 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.36 31.0 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 0.0 109.264 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.76 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.53 1.144 . . . . 0.0 110.04 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.95 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 0.0 109.324 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.33 27.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 109.936 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.305 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.38 8.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.481 1.113 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.649 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.562 0.801 . . . . 0.0 109.203 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.63 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.589 1.181 . . . . 0.0 110.367 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.711 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.46 102.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 0.0 109.24 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.8 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.531 1.144 . . . . 0.0 110.279 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.46 9.58 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 0.0 110.994 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.32 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.528 1.142 . . . . 0.0 109.25 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.5 ttp -98.04 119.21 36.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.32 -66.03 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 109.286 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.52 0.76 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 36' ' ' VAL . 1.2 p 46.04 54.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 0.0 109.345 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.9 -172.36 40.67 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.532 1.145 . . . . 0.0 111.046 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.126 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 25.3 Cg_endo -74.96 -168.95 6.89 Favored 'Cis proline' 0 C--N 1.361 1.184 0 C-N-CA 120.993 -2.503 . . . . 0.0 110.996 -0.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 71.2 m-70 -144.21 -170.33 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.505 1.128 . . . . 0.0 109.575 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.94 166.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.398 1.061 . . . . 0.0 109.285 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.597 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 1.152 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.617 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -132.82 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.126 . . . . 0.0 109.308 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER 167.29 143.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.0 73.17 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 0.0 109.233 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 164.22 33.86 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.474 1.776 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.28 135.67 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 0.0 109.244 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.43 -56.52 0.73 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.538 1.149 . . . . 0.0 110.981 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.28 2.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 0.819 . . . . 0.0 110.249 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.24 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.382 1.052 . . . . 0.0 109.938 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.018 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.86 70.81 Favored Pre-proline 0 C--N 1.323 -0.552 0 O-C-N 124.489 1.118 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.0 50.77 2.61 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.414 1.744 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.3 -45.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.579 1.174 . . . . 0.0 109.336 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.15 -27.51 68.08 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.316 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 m -46.52 115.13 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.494 1.121 . . . . 0.0 110.009 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 59' ' ' LYS . 21.7 t30 -107.92 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 0.0 109.358 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.775 HG21 ' HB3' ' B' ' 63' ' ' ASP . 1.4 t -89.75 21.85 3.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 0.0 110.343 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 28.8 tttt -86.04 64.43 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.093 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 0.0 109.332 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.5 6.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.311 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.717 HD11 HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.69 -46.13 80.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.568 1.168 . . . . 0.0 109.319 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.16 111.61 4.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.48 1.113 . . . . 0.0 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -75.01 139.18 23.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.428 1.752 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.475 1.109 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.673 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.47 0.747 . . . . 0.0 110.06 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.13 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 0.0 111.039 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.51 175.18 4.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.418 1.073 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.69 161.2 21.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.567 1.167 . . . . 0.0 109.964 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.69 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 0.0 109.374 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.22 146.5 23.97 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.439 1.087 . . . . 0.0 110.388 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.19 173.06 8.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.25 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.34 124.28 39.05 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.578 0.811 . . . . 0.0 110.385 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.1 Cg_endo -75.15 141.49 26.3 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.549 1.815 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.66 20.02 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.89 120.05 40.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 0.787 . . . . 0.0 110.407 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.71 140.67 30.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 0.0 111.025 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.84 145.12 49.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.055 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.43 3.72 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.55 1.156 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.617 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 13.1 p90 -171.88 165.47 6.44 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 0.0 111.055 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.67 122.36 36.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 108.202 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.484 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 m -51.3 -50.73 74.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.441 1.088 . . . . 0.0 110.431 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 83' ' ' THR . 41.5 Cg_endo -75.13 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.565 1.824 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.871 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 27.0 m80 -75.03 57.99 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -38.56 15.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.554 1.159 . . . . 0.0 110.287 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.48 -23.85 32.72 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.533 1.146 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.492 0.76 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.16 1.82 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.478 1.111 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.66 75.12 1.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 0.761 . . . . 0.0 110.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.18 153.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.119 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.457 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.78 19.74 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.03 37.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.507 0.769 . . . . 0.0 110.425 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.711 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.62 122.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.561 1.163 . . . . 0.0 109.286 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.7 m -105.08 144.56 31.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.457 1.098 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.438 1.086 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 0.0 110.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.783 ' CE2' ' HD2' ' A' ' 38' ' ' PRO . 7.8 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.843 ' CZ ' ' HG3' ' A' ' 14' ' ' PRO . 3.8 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.871 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 1.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 33.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.777 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.72 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.733 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 20.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' B' ' 65' ' ' SER . 15.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.775 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 51.6 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.72 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 2.1 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.437 HD21 HD11 ' A' ' 60' ' ' LEU . 69.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.556 ' CE2' HD23 ' B' ' 103' ' ' LEU . 2.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.556 HD23 ' CE2' ' B' ' 102' ' ' TYR . 76.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.031 HG13 ' HG ' ' B' ' 115' ' ' LEU . 68.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.979 ' HA ' HD11 ' B' ' 116' ' ' LEU . 28.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 31.8 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.031 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.979 HD11 ' HA ' ' B' ' 107' ' ' TYR . 0.4 OUTLIER -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.126 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' B' ' 125' ' ' TYR . 10.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' B' ' 120' ' ' LEU . 62.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.733 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 21.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.426 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.299 ' OH ' ' HA ' ' B' ' 168' ' ' SER . 3.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.478 ' HG3' ' CG ' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 3.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.938 ' C ' ' HE1' ' B' ' 162' ' ' TYR . 4.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 1.299 ' HA ' ' OH ' ' B' ' 162' ' ' TYR . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 16.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 1.581 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.355 22.4 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 59.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.566 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 56.7 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.108 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 5.4 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.566 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.8 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.789 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.108 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 9.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.65 126.86 29.2 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.531 1.145 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.18 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.418 1.074 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.93 40.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.559 1.162 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.08 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.76 133.49 35.98 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.526 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 110.973 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.53 7.65 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.577 1.173 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.528 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -108.05 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.475 0.75 . . . . 0.0 110.42 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.83 -15.97 24.91 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 0.0 109.356 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -90.57 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 0.0 109.337 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER 38.23 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.169 . . . . 0.0 111.062 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.8 117.71 58.16 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.67 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 34.7 Cg_endo -75.03 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.528 1.804 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.438 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.2 pp -150.78 151.23 32.04 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.48 1.113 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.34 126.15 30.47 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.509 1.131 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.41 134.9 26.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.505 1.128 . . . . 0.0 110.351 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.09 140.99 70.28 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 121.007 -2.497 . . . . 0.0 110.909 0.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.22 -40.11 1.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.531 1.145 . . . . 0.0 109.251 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.29 46.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.42 31.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.133 . . . . 0.0 109.247 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.473 1.108 . . . . 0.0 110.059 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.402 1.064 . . . . 0.0 109.259 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.53 158.29 27.62 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 0.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.32 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.44 8.45 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.469 1.105 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.642 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.14 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 0.733 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.53 154.25 39.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 0.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.716 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.41 102.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.566 1.167 . . . . 0.0 109.276 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.51 18.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.591 1.182 . . . . 0.0 110.334 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.19 121.46 9.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.562 1.164 . . . . 0.0 110.986 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.01 155.35 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.565 1.166 . . . . 0.0 109.262 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.77 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.2 ttp -98.05 119.26 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.399 1.062 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.39 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.181 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.86 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.46 1.1 . . . . 0.0 109.228 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.67 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.3 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.455 1.097 . . . . 0.0 109.323 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.95 -172.3 40.58 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.51 1.131 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HB3' HD13 ' A' ' 62' ' ' ILE . 42.8 Cg_endo -74.95 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.913 -2.536 . . . . 0.0 111.034 -0.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.77 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.7 m-70 -144.23 -170.37 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.568 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.469 1.106 . . . . 0.0 109.338 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.35 43.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.543 1.152 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -132.78 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.539 1.149 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -49.99 4.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.293 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.3 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.061 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.87 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.03 164.22 33.75 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.459 1.768 . . . . 0.0 110.974 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.21 135.62 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.59 0.72 Allowed Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.538 1.149 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.651 0.853 . . . . 0.0 110.25 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.426 1.079 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.061 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.03 -51.81 71.31 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.415 1.072 . . . . 0.0 109.27 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.05 50.78 2.63 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.419 1.747 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.62 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.662 1.226 . . . . 0.0 109.358 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.13 -27.56 68.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 4.4 m -46.44 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 0.0 109.99 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 68' ' ' TYR 0.492 7.8 t30 -108.04 117.75 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.411 1.069 . . . . 0.0 109.312 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.911 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 4.0 t -89.82 21.87 3.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 0.0 110.311 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 60' ' ' LEU . 57.1 tttt -86.02 64.36 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.487 1.117 . . . . 0.0 109.287 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.475 1.109 . . . . 0.0 109.296 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.42 6.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 1.097 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.834 HD12 HD21 ' B' ' 70' ' ' ASN . 5.9 mm -68.62 -46.07 80.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.526 1.141 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -62.13 111.64 4.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.285 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 5.1 Cg_exo -75.05 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.454 1.765 . . . . 0.0 111.025 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.86 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.55 1.157 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.65 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.527 0.781 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.449 1.093 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.62 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.5 175.16 4.18 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.95 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.474 1.109 . . . . 0.0 110.006 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.27 146.47 24.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.57 1.169 . . . . 0.0 110.382 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 1.126 . . . . 0.0 109.259 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.459 1.1 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.46 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.14 38.13 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.52 0.776 . . . . 0.0 110.388 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.98 141.5 26.78 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.438 1.757 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.64 20.05 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.459 1.1 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.3 m -104.81 120.11 40.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 0.776 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.66 31.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 111.03 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.88 145.15 49.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.406 1.066 . . . . 0.0 110.016 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.21 -171.59 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.114 . . . . 0.0 110.956 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.495 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 16.3 p90 -171.78 165.46 6.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.543 1.152 . . . . 0.0 110.995 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.54 122.34 35.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.448 1.093 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.627 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 2.9 m -51.38 -50.76 74.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.433 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.9 Cg_endo -75.02 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.234 0 O-C-N 124.492 1.785 . . . . 0.0 111.033 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.631 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -38.44 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.536 1.147 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.52 -23.8 32.77 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.51 1.131 . . . . 0.0 110.995 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.18 62.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.512 0.772 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.1 1.83 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.456 1.097 . . . . 0.0 110.984 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.526 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.3 ttt -121.54 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 0.73 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.16 153.56 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 109.271 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.76 19.76 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.553 1.158 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.79 162.02 37.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.49 0.759 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.716 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.9 m -105.0 144.56 31.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.422 1.076 . . . . 0.0 110.429 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.31 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.523 1.139 . . . . 0.0 109.315 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.313 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.422 ' CD2' ' HE2' ' B' ' 4' ' ' TYR . 23.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.9 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 1.422 ' HE2' ' CD2' ' B' ' 1' ' ' TYR . 51.7 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 22.6 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.771 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 26.0 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.852 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.541 ' CD ' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.911 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 5.7 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.3 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 65' ' ' SER 0.261 4.7 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 29.8 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.417 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.834 HD21 HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.856 HG13 ' HG ' ' B' ' 115' ' ' LEU . 62.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.851 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.2 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.873 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.2 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.851 ' HB2' HG23 ' B' ' 105' ' ' THR . 70.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.681 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' B' ' 125' ' ' TYR . 39.3 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' B' ' 120' ' ' LEU . 73.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.487 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.852 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 14.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.032 ' HB3' HG22 ' B' ' 164' ' ' THR . 3.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 44.6 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.634 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.6 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.539 HD21 HH12 ' B' ' 158' ' ' ARG . 37.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.957 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.62 126.8 28.95 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.561 1.163 . . . . 0.0 110.056 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.413 1.071 . . . . 0.0 109.28 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.88 40.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.546 1.154 . . . . 0.0 110.3 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.3 112.12 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.457 1.098 . . . . 0.0 109.355 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.68 133.46 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.466 1.103 . . . . 0.0 109.377 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.584 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 0.0 111.007 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.52 7.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.543 1.152 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -108.1 160.71 15.6 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.478 0.752 . . . . 0.0 110.426 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.85 -15.96 25.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.436 1.085 . . . . 0.0 109.257 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 17.5 mttt -90.59 39.73 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CZ ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.26 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.58 1.175 . . . . 0.0 111.031 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.68 58.17 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 109.278 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 37.3 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.497 1.788 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.4 pp -150.83 151.17 31.88 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.28 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.16 . . . . 0.0 111.018 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.43 134.95 26.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.565 1.166 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.06 140.98 70.28 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.939 0.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.16 -40.17 1.05 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.611 1.194 . . . . 0.0 109.252 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.29 46.09 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.462 1.101 . . . . 0.0 109.309 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.41 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 109.252 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.618 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.94 143.7 50.94 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 110.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.79 -177.44 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.504 1.128 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.37 27.5 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 0.0 110.002 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.15 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.606 1.191 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.52 -7.48 8.44 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.515 1.134 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.13 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 0.753 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.52 154.26 39.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 0.0 110.485 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.509 1.131 . . . . 0.0 109.306 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.274 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.55 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.24 121.38 9.49 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.533 1.146 . . . . 0.0 110.98 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.34 33.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.515 1.134 . . . . 0.0 109.317 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.06 119.22 36.32 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.353 1.033 . . . . 0.0 111.026 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.35 -66.05 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 109.255 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.717 ' HD3' ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -168.89 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.44 1.087 . . . . 0.0 109.3 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.4 p 46.08 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.48 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.588 1.18 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.99 -168.86 6.83 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.934 -2.527 . . . . 0.0 110.969 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.735 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.5 m-70 -144.24 -170.33 3.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.542 1.151 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.436 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.4 p30 173.94 166.95 0.2 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.419 1.074 . . . . 0.0 109.355 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.536 1.148 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.626 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.78 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 109.333 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.62 160.59 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.568 1.167 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.571 1.17 . . . . 0.0 109.306 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.024 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.09 72.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 164.25 33.69 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.463 1.77 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 0.0 109.339 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.492 1.12 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.498 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.04 -173.34 2.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.593 0.819 . . . . 0.0 110.295 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.2 77.86 1.75 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.511 1.132 . . . . 0.0 109.994 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.024 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.12 -51.76 72.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.11 . . . . 0.0 109.262 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.12 50.86 2.67 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.487 1.783 . . . . 0.0 110.909 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.63 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.584 1.177 . . . . 0.0 109.38 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.16 -27.52 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.117 . . . . 0.0 109.298 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 m -46.46 115.15 0.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 0.0 109.976 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.546 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.6 m120 -108.02 117.71 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.438 1.086 . . . . 0.0 109.328 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.141 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 1.5 t -89.81 21.89 3.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.416 1.073 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -86.05 64.4 8.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.491 1.119 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.099 HD21 ' CG ' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -40.39 102.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.55 1.156 . . . . 0.0 109.332 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.38 6.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 HD21 ' B' ' 70' ' ' ASN . 3.5 mt -68.6 -46.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.58 4.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.108 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.98 139.11 23.94 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.457 1.767 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.94 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.522 1.139 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.657 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.485 0.756 . . . . 0.0 109.985 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.16 -86.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.446 1.092 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.59 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.482 1.114 . . . . 0.0 110.029 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.73 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 109.428 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.53 23.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 110.344 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.19 173.06 8.57 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.492 1.12 . . . . 0.0 109.261 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.13 37.87 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 0.0 110.421 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.0 141.5 26.72 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.511 1.795 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.05 -178.67 20.0 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.335 1.022 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.87 120.04 40.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 0.746 . . . . 0.0 110.347 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.838 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.74 140.69 30.95 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.87 145.16 49.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.451 1.094 . . . . 0.0 109.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.23 -171.62 3.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.458 1.099 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.457 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 15.6 p90 -171.78 165.4 6.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.555 1.16 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 122.33 35.8 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.424 1.078 . . . . 0.0 108.326 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.626 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.9 m -51.38 -50.77 74.36 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.499 1.124 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 18.6 Cg_endo -75.03 -62.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 26.3 m80 -74.97 58.0 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.596 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.438 HH22 HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -88.0 -38.55 15.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.556 1.16 . . . . 0.0 110.314 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.45 -23.72 33.18 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.505 1.128 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.719 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.73 -15.21 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 0.768 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.523 1.139 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.584 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.391 0.701 . . . . 0.0 111.021 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.59 30.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.589 1.181 . . . . 0.0 109.272 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.543 1.152 . . . . 0.0 111.006 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.08 36.93 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.426 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 0.0 109.238 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.1 m -105.1 144.57 31.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 110.372 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.32 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.497 1.123 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.56 1.163 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.51 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 16.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.514 ' HB2' HD13 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.984 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 16.2 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 4.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.984 ' HG3' ' O ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.771 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 7.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.689 ' HB2' HG21 ' B' ' 233' ' ' VAL . 18.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 1.099 ' CG ' HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 1.141 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 31.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.557 ' HB3' ' NE2' ' B' ' 61' ' ' GLN . 78.4 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 5.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.552 HD21 HD13 ' A' ' 62' ' ' ILE . 1.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.6 ' HA ' HD23 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.755 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.8 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.822 ' CB ' HD22 ' B' ' 83' ' ' LEU . 98.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' B' ' 74' ' ' VAL . 19.0 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.473 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 38.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.482 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.538 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 46.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.8 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.033 ' CB ' HG22 ' B' ' 164' ' ' THR . 3.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.9 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 17.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.632 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.7 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 11.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.86 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.55 126.8 28.94 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.535 1.147 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.19 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 0.0 109.273 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.87 40.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.14 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.412 1.07 . . . . 0.0 109.346 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.82 133.55 35.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 0.0 109.276 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.613 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.07 6.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 0.0 110.953 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.48 7.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.586 1.179 . . . . 0.0 110.973 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.762 ' CG2' HD11 ' A' ' 15' ' ' LEU . 17.2 p -108.07 160.7 15.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 0.741 . . . . 0.0 110.421 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -59.84 -15.92 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.402 1.064 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 23.9 mttt -90.58 39.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.137 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.639 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 22.9 m-85 38.37 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 0.0 111.015 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.84 117.65 58.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 22.3 Cg_endo -74.98 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.486 1.782 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.762 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.21 31.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 0.0 109.357 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.418 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.34 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.473 1.108 . . . . 0.0 110.967 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.96 26.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.559 1.162 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.98 70.31 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.039 -2.484 . . . . 0.0 110.943 0.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.23 -40.1 1.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.554 1.159 . . . . 0.0 109.274 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.34 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.459 1.1 . . . . 0.0 109.302 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.944 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.29 141.43 31.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.553 1.158 . . . . 0.0 109.225 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.72 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.451 1.094 . . . . 0.0 110.036 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.88 -177.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 0.0 109.219 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.818 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.56 158.31 27.59 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.06 105.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 0.0 109.337 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.446 1.091 . . . . 0.0 110.999 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.25 174.09 11.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 0.747 . . . . 0.0 109.286 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.46 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 0.0 110.475 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.723 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.263 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.85 169.51 18.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.5 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.491 1.12 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.34 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.731 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.1 ttp -98.0 119.27 36.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.359 1.037 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -79.39 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.109 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.639 ' HE3' ' HA ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -168.88 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.415 1.072 . . . . 0.0 109.279 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.7 p 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.538 1.149 . . . . 0.0 111.027 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.712 ' HD2' ' CE1' ' B' ' 1' ' ' TYR . 59.8 Cg_endo -74.99 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.931 -2.529 . . . . 0.0 110.963 -0.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.731 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.23 -170.4 3.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.569 1.168 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.99 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.07 114.33 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.534 1.146 . . . . 0.0 109.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.9 mm -132.75 75.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.408 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.59 160.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 110.98 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.99 -50.15 4.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 109.265 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.47 158.14 72.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.383 1.052 . . . . 0.0 109.291 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.07 164.22 33.67 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.505 1.792 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.19 135.6 1.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 0.0 109.328 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.537 1.148 . . . . 0.0 111.0 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.39 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.561 0.8 . . . . 0.0 110.263 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.46 1.1 . . . . 0.0 109.98 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.042 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.11 -51.75 72.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 0.0 109.269 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.07 50.78 2.64 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.401 1.737 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.65 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.639 1.212 . . . . 0.0 109.381 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.06 -27.54 68.16 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 109.36 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.3 m -46.45 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.965 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.554 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m120 -108.07 117.73 34.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' B' ' 63' ' ' ASP . 3.3 t -89.82 21.92 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.432 1.082 . . . . 0.0 110.317 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 1.7 tttt -86.04 64.41 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -40.45 102.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 0.0 109.297 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.43 6.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 109.316 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.717 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.69 -46.06 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.594 1.184 . . . . 0.0 109.332 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.63 4.93 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.04 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.473 1.775 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.87 -67.9 0.17 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.591 1.182 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.493 0.761 . . . . 0.0 109.994 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.25 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.417 1.073 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.494 1.121 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.29 20.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.408 1.068 . . . . 0.0 110.015 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 0.0 109.412 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 110.347 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.11 173.08 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.514 1.134 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.488 1.117 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.06 37.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.545 0.791 . . . . 0.0 110.403 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.7 Cg_endo -74.97 141.51 26.82 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.483 1.781 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.441 1.088 . . . . 0.0 111.007 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.9 120.08 40.57 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.484 0.755 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.836 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.68 30.97 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.491 1.119 . . . . 0.0 111.017 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.17 49.3 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 1.08 . . . . 0.0 109.97 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.55 3.74 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.7 p90 -171.86 165.35 6.46 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 122.36 35.81 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.445 1.091 . . . . 0.0 108.284 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.633 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.39 -50.82 74.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.456 1.098 . . . . 0.0 110.356 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 83' ' ' THR . 36.4 Cg_endo -74.93 -62.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.527 1.804 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 29.5 m80 -74.96 57.93 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 0.0 109.598 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.179 ' HD2' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.97 -38.49 15.49 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.559 1.162 . . . . 0.0 110.318 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.895 ' N ' ' HD2' ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.77 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 0.761 . . . . 0.0 109.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.08 63.17 1.83 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.444 1.09 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.613 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.61 75.03 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.4 0.706 . . . . 0.0 111.066 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.14 153.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.499 1.124 . . . . 0.0 109.305 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.79 19.77 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.571 1.169 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.03 37.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 0.748 . . . . 0.0 110.432 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.723 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.61 122.63 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.02 144.49 31.75 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.427 1.079 . . . . 0.0 110.415 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 96' ' ' VAL . 5.0 t -128.2 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.53 1.144 . . . . 0.0 109.376 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.818 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.087 ' HD2' ' CE2' ' B' ' 4' ' ' TYR . 97.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 1.087 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 24.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.514 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.7 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.782 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 48.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.678 ' HB2' HG21 ' B' ' 233' ' ' VAL . 12.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 87.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.541 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 1.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.541 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 2.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.4 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.716 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.466 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 62' ' ' ILE . 4.9 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.472 HG23 ' CE ' ' B' ' 128' ' ' MET . 20.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.893 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.8 HD23 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.826 ' CB ' HD22 ' B' ' 83' ' ' LEU . 67.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 2.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 73.9 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.967 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.754 ' HB2' HG23 ' B' ' 105' ' ' THR . 52.1 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.843 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.827 HD22 ' CE2' ' B' ' 125' ' ' TYR . 17.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.54 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.827 ' CE2' HD22 ' B' ' 120' ' ' LEU . 41.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.472 ' CE ' HG23 ' B' ' 71' ' ' VAL . 60.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . . . . . . . . . 38.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.452 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' B' ' 24' ' ' CYS . 9.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.333 ' CD2' ' HD2' ' B' ' 163' ' ' PRO . 13.1 t80 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 1.333 ' HD2' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.187 ' CG2' ' HB3' ' B' ' 162' ' ' TYR . 0.2 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.815 ' H ' HG23 ' B' ' 164' ' ' THR . 36.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 0.957 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.962 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.957 ' HD3' ' CD2' ' B' ' 189' ' ' PHE 0.26 5.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.62 126.79 28.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.533 1.146 . . . . 0.0 109.99 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.947 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.426 1.079 . . . . 0.0 109.271 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.602 1.189 . . . . 0.0 110.296 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.458 1.099 . . . . 0.0 109.32 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.72 133.46 36.0 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.658 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.1 6.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 110.961 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.5 7.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.605 1.191 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.713 ' CG2' HD11 ' A' ' 15' ' ' LEU . 27.0 p -108.1 160.74 15.57 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.437 0.728 . . . . 0.0 110.398 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 45.5 t0 -59.85 -15.94 24.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.089 . . . . 0.0 109.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 13.1 mttt -90.64 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 38.27 29.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.72 58.07 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.483 1.115 . . . . 0.0 109.326 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HG3' HG21 ' A' ' 36' ' ' VAL . 10.9 Cg_endo -75.0 97.62 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.498 1.788 . . . . 0.0 110.974 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.83 151.19 31.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.511 1.132 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.33 126.18 30.51 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.492 1.12 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.04 140.97 70.24 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.03 -2.488 . . . . 0.0 110.962 0.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.17 -40.1 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.545 1.153 . . . . 0.0 109.295 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.33 46.09 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.947 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.43 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.11 . . . . 0.0 109.226 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 110.029 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.12 . . . . 0.0 109.289 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.819 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.62 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.452 1.095 . . . . 0.0 109.994 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.59 1.181 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.506 1.128 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.17 11.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 0.78 . . . . 0.0 109.288 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.55 154.23 39.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 0.0 110.427 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.592 1.182 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.86 169.49 18.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.17 121.49 9.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 0.0 110.962 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.04 155.28 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.698 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.5 ttp -98.01 119.26 36.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.373 1.046 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 35' ' ' LYS . 42.8 t30 -79.33 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 14' ' ' PRO . 9.8 p 46.04 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.092 . . . . 0.0 109.319 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.91 -172.31 40.63 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.487 1.117 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.455 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 56.3 Cg_endo -74.98 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.973 -0.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.698 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 68.8 m-70 -144.26 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.588 1.18 . . . . 0.0 109.574 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 174.01 167.07 0.21 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 109.338 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.16 114.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.586 1.179 . . . . 0.0 109.323 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.324 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.61 160.63 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.562 1.163 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.05 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.046 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.381 1.051 . . . . 0.0 109.257 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 164.27 33.6 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.449 1.763 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.27 135.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 0.0 109.292 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.66 0.72 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.01 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.59 0.818 . . . . 0.0 110.282 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.426 1.079 . . . . 0.0 109.997 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.046 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.83 71.14 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.417 1.073 . . . . 0.0 109.265 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.02 50.79 2.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.447 1.762 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.29 -45.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.659 1.224 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.54 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -46.52 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.945 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -107.97 117.69 34.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.79 21.88 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.38 1.05 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -86.04 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.42 102.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.546 1.154 . . . . 0.0 109.337 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.944 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.64 -46.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.162 . . . . 0.0 109.353 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.04 111.61 4.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 0.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.05 139.15 23.81 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.468 1.772 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.567 1.167 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.7 97.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.438 0.728 . . . . 0.0 109.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.496 1.123 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.52 175.12 4.18 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.467 1.105 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.28 20.94 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.444 1.09 . . . . 0.0 109.988 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.04 137.69 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.106 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.26 146.48 23.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 110.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.11 8.53 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.449 1.093 . . . . 0.0 109.251 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.31 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.07 37.65 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 0.0 110.37 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.97 141.49 26.79 Favored 'Trans proline' 0 C--N 1.359 1.092 0 O-C-N 124.498 1.789 . . . . 0.0 111.107 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.452 1.095 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.02 40.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 0.742 . . . . 0.0 110.339 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.4 m-85 -96.68 140.75 30.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.97 145.16 49.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.56 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.422 1.077 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.1 p90 -171.82 165.41 6.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 1.12 . . . . 0.0 111.018 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.49 122.38 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 0.0 108.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.71 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.34 -50.84 73.84 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.506 1.129 . . . . 0.0 110.373 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CB ' ' OH ' ' B' ' 1' ' ' TYR . 40.2 Cg_endo -74.97 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.465 1.771 . . . . 0.0 111.01 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 2.5 m170 -75.03 58.01 0.85 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.36 HH12 ' CA ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -88.01 -38.46 15.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.57 1.169 . . . . 0.0 110.314 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 1.36 ' CA ' HH12 ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.465 1.103 . . . . 0.0 110.983 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.64 -15.26 62.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 0.751 . . . . 0.0 109.408 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.11 1.83 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.43 1.081 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.56 74.98 1.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.401 0.706 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.12 153.59 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.72 19.72 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.599 1.187 . . . . 0.0 110.984 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.81 162.07 37.01 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 0.793 . . . . 0.0 110.414 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.64 122.63 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.0 m -105.01 144.53 31.69 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.414 1.071 . . . . 0.0 110.404 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.515 1.134 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.819 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.572 1.17 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.751 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.457 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 1.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.2 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.765 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.798 ' CE2' HD13 ' B' ' 69' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.584 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 52.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.895 ' HB2' HG21 ' B' ' 233' ' ' VAL . 7.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.71 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' B' ' 65' ' ' SER . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 69.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.584 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.798 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.89 ' ND2' HG23 ' A' ' 62' ' ' ILE . 2.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.787 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.817 ' CB ' HD22 ' B' ' 83' ' ' LEU . 99.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.83 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.5 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.3 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.5 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.979 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.83 ' HB2' HG23 ' B' ' 105' ' ' THR . 46.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.703 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.5 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 9.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.944 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' B' ' 124' ' ' ASP . 4.1 pm0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.553 ' N ' ' HG2' ' B' ' 123' ' ' GLU . 8.7 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 42.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.533 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' B' ' 24' ' ' CYS . 6.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 0.93 ' HB2' HG22 ' B' ' 164' ' ' THR . 19.2 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.021 HG23 ' H ' ' B' ' 166' ' ' GLU . 14.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.021 ' H ' HG23 ' B' ' 164' ' ' THR . 25.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.713 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.568 HD21 ' HA ' ' B' ' 62' ' ' ALA . 10.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . 0.474 ' C ' HD13 ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.824 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 8.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.895 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.58 126.79 28.88 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.549 1.155 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.267 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.86 40.25 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.529 1.143 . . . . 0.0 110.315 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.363 1.039 . . . . 0.0 109.267 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.525 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.74 133.47 35.99 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.611 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.69 96.99 6.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.458 1.099 . . . . 0.0 111.036 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.477 1.111 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.4 p -108.09 160.65 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.446 0.733 . . . . 0.0 110.439 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 13.4 t70 -59.78 -15.98 24.44 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.452 1.095 . . . . 0.0 109.361 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 29.1 mttp -90.57 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.313 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' CE2' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.24 29.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 0.0 111.054 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.7 58.12 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.676 ' HG3' HG21 ' A' ' 36' ' ' VAL . 28.0 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.429 1.752 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.81 151.22 31.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.109 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.17 30.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.44 134.82 26.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.406 1.066 . . . . 0.0 110.375 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.12 140.92 69.9 Favored 'Cis proline' 0 C--N 1.36 1.138 0 C-N-CA 121.031 -2.487 . . . . 0.0 110.96 0.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.17 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.32 46.11 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.425 1.078 . . . . 0.0 109.279 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.21 141.4 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.137 . . . . 0.0 109.261 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.611 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 0.0 110.019 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.94 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 0.0 109.287 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.126 . . . . 0.0 109.923 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.525 1.141 . . . . 0.0 109.251 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.43 8.45 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.508 1.13 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.14 174.09 11.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.56 0.8 . . . . 0.0 109.282 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.43 154.29 39.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 110.51 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.52 102.6 6.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.099 . . . . 0.0 109.289 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.53 18.08 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.484 1.115 . . . . 0.0 110.28 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.23 121.39 9.5 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.516 1.135 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.38 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.8 ttp -98.0 119.17 36.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.427 1.079 . . . . 0.0 111.037 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -79.38 -66.05 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.571 1.17 . . . . 0.0 109.223 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.7 p 45.97 54.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.505 1.128 . . . . 0.0 109.321 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.803 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -93.0 -172.37 40.51 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.478 1.111 . . . . 0.0 111.03 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HG3' HD21 ' B' ' 70' ' ' ASN . 19.0 Cg_endo -75.02 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.97 0.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.613 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.4 m-70 -144.23 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 0.0 109.644 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.62 ' HB3' HD23 ' A' ' 60' ' ' LEU . 1.2 p30 173.97 166.96 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 0.0 109.304 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.8 t -104.12 114.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.938 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.8 mm -132.75 75.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.72 160.59 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.01 -49.94 4.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 0.0 109.276 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.26 143.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.431 1.082 . . . . 0.0 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.14 72.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.39 1.056 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.9 Cg_endo -75.11 164.2 33.61 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.55 1.816 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.16 135.55 1.37 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.097 . . . . 0.0 109.307 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.52 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.566 1.166 . . . . 0.0 110.974 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.24 2.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.607 0.828 . . . . 0.0 110.243 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.27 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.043 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.99 -51.85 70.87 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.473 1.108 . . . . 0.0 109.353 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -74.97 50.71 2.58 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.446 1.761 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.54 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.53 1.144 . . . . 0.0 109.392 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.11 -27.61 68.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.593 1.183 . . . . 0.0 109.252 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.47 115.12 0.94 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.555 1.159 . . . . 0.0 109.995 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 1.006 ' OD1' ' OH ' ' A' ' 68' ' ' TYR 0.964 52.9 p-10 -107.94 117.66 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.442 1.088 . . . . 0.0 109.298 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.82 21.9 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.454 1.096 . . . . 0.0 110.301 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -86.01 64.37 8.54 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 0.0 109.239 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.671 ' CD1' ' HB2' ' B' ' 61' ' ' GLN . 4.4 mt -40.39 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.52 98.49 6.11 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.563 1.164 . . . . 0.0 109.263 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.977 HG22 ' HB3' ' B' ' 121' ' ' PRO . 1.2 mm -68.64 -46.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.11 111.59 4.84 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.951 ' HD3' ' HG3' ' B' ' 121' ' ' PRO . 9.0 Cg_endo -74.97 139.15 24.02 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.466 1.771 . . . . 0.0 111.052 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -67.98 0.17 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.124 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.455 0.738 . . . . 0.0 110.008 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.16 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.463 1.102 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 1.006 ' OH ' ' OD1' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.11 4.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 0.0 111.021 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.57 161.31 20.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.462 1.101 . . . . 0.0 109.975 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.69 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.449 1.093 . . . . 0.0 110.332 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.09 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.518 1.136 . . . . 0.0 109.233 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.34 0.02 OUTLIER Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.577 1.173 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.28 124.11 37.86 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.453 0.737 . . . . 0.0 110.39 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.51 26.77 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.504 1.792 . . . . 0.0 111.054 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.62 20.07 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.422 1.076 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.07 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.556 0.798 . . . . 0.0 110.403 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.58 1.175 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.91 145.16 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.24 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.444 1.09 . . . . 0.0 110.927 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.0 p90 -171.84 165.38 6.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.52 122.27 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.469 1.106 . . . . 0.0 108.29 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.986 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 20.4 m -51.27 -50.79 73.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 110.429 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 30.3 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.554 1.818 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -75.04 57.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.139 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.986 ' CG ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -87.98 -38.5 15.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.558 1.161 . . . . 0.0 110.337 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.5 -23.77 32.91 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.423 1.077 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.31 62.66 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.487 0.757 . . . . 0.0 109.314 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.22 1.82 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.469 1.106 . . . . 0.0 110.979 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.611 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.2 ttt -121.63 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 0.763 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.21 153.49 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.44 1.088 . . . . 0.0 109.298 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.46 -174.69 19.64 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.449 1.093 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.84 162.08 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 0.778 . . . . 0.0 110.382 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.56 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.51 1.131 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.01 144.53 31.68 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 0.0 110.43 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.25 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 0.0 109.283 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.498 1.123 . . . . 0.0 110.347 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.003 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.46 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.804 ' CE2' ' CE1' ' B' ' 1' ' ' TYR . 8.8 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.756 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.55 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 3.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.842 ' HB2' HG21 ' B' ' 233' ' ' VAL . 22.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 76.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.744 ' OE1' ' HB3' ' B' ' 65' ' ' SER . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.685 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.594 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.744 ' HB3' ' OE1' ' B' ' 61' ' ' GLN . 3.2 t -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.563 ' HG ' ' HB3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.539 HD21 HG23 ' B' ' 233' ' ' VAL . 7.5 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.718 ' OD1' HG23 ' A' ' 62' ' ' ILE . 6.3 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . 0.605 ' HB2' HD12 ' B' ' 103' ' ' LEU . 80.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 99' ' ' ASP . 1.6 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.962 HG11 HD12 ' B' ' 115' ' ' LEU . 24.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.609 HG23 ' HB2' ' B' ' 116' ' ' LEU . 11.9 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.632 ' CD1' HD11 ' B' ' 116' ' ' LEU . 30.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.962 HD12 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.632 HD11 ' CD1' ' B' ' 107' ' ' TYR . 5.3 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.803 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.7 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' B' ' 125' ' ' TYR . 4.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.977 ' HB3' HG22 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' B' ' 120' ' ' LEU . 43.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.3 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 22.9 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.751 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 36.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.053 ' HB3' HG22 ' B' ' 164' ' ' THR . 6.7 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.053 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.0 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.635 ' H ' HG23 ' B' ' 164' ' ' THR . 46.8 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.499 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.18 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.733 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.18 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.54 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.591 1.182 . . . . 0.0 110.045 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.418 1.074 . . . . 0.0 109.249 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.91 150.91 40.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.521 1.138 . . . . 0.0 110.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.09 38.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.442 1.089 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.71 133.54 35.92 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.701 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.01 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 0.0 110.996 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.52 7.63 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 0.0 110.967 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.423 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.12 160.65 15.64 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.462 0.742 . . . . 0.0 110.371 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.78 -15.98 24.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.402 1.064 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.6 mtpt -90.57 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 111.019 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.63 58.3 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 38.8 Cg_endo -74.97 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.496 1.787 . . . . 0.0 111.028 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD21 ' OG1' ' A' ' 9' ' ' THR . 3.4 pp -150.8 151.19 31.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.5 134.95 26.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 124.498 1.124 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.03 140.96 70.23 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 121.021 -2.491 . . . . 0.0 110.959 0.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.21 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.563 1.165 . . . . 0.0 109.271 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.12 146.3 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.424 1.078 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.44 31.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.115 . . . . 0.0 109.201 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.631 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.69 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.432 1.082 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.226 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.28 27.67 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.006 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.626 1.204 . . . . 0.0 109.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.43 8.46 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.542 1.151 . . . . 0.0 110.987 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.12 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 0.779 . . . . 0.0 109.287 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.5 154.27 39.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.697 HG11 HD13 ' A' ' 94' ' ' ILE . 64.0 t -131.43 102.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.28 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.84 169.49 18.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.531 1.145 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.458 1.099 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.37 33.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 0.0 109.347 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.475 ' SD ' ' HE1' ' A' ' 67' ' ' PHE . 1.1 ttp -98.07 119.28 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.384 1.053 . . . . 0.0 111.032 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.37 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 0.0 109.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.48 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.465 1.103 . . . . 0.0 109.23 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 8.0 p 46.03 54.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 124.415 1.072 . . . . 0.0 109.359 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.494 1.121 . . . . 0.0 111.083 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -74.98 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.929 -2.53 . . . . 0.0 110.995 -0.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.639 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.9 m-70 -144.24 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.461 1.1 . . . . 0.0 109.586 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.499 HD22 HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 173.97 167.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 109.305 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.6 t -104.14 114.37 43.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.513 1.133 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.599 HG13 ' OG1' ' A' ' 83' ' ' THR . 3.2 mm -132.81 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.312 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.55 1.156 . . . . 0.0 111.01 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.0 -50.01 4.79 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.597 1.185 . . . . 0.0 109.257 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.084 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.1 72.82 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.417 1.073 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.04 164.24 33.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.454 1.765 . . . . 0.0 110.994 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.44 1.087 . . . . 0.0 109.328 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.61 0.72 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.564 1.165 . . . . 0.0 111.027 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.36 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.608 0.828 . . . . 0.0 110.289 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.18 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.414 1.071 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.084 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.76 71.82 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.07 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.487 1.782 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.24 -45.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 109.331 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -65.98 -27.62 68.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 0.0 109.369 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.0 m -46.45 115.09 0.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 0.0 110.028 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.0 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.0 t -89.77 21.91 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.382 1.051 . . . . 0.0 110.342 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.438 1.086 . . . . 0.0 109.311 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.536 ' CD1' ' HB3' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.111 . . . . 0.0 109.287 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.42 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.502 1.126 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' NE2' ' B' ' 61' ' ' GLN . 2.6 mm -68.63 -46.08 80.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.568 1.167 . . . . 0.0 109.355 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.63 4.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 0.0 109.298 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -75.03 139.08 23.78 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.422 1.748 . . . . 0.0 111.046 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.9 0.17 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.542 1.151 . . . . 0.0 110.935 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 0.794 . . . . 0.0 109.99 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.23 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.451 1.094 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.52 175.08 4.19 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.478 1.111 . . . . 0.0 110.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.27 20.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.02 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.71 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.381 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.47 24.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.13 . . . . 0.0 110.353 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.12 173.06 8.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.517 1.135 . . . . 0.0 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.1 37.51 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 0.785 . . . . 0.0 110.42 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.6 Cg_endo -74.97 141.44 26.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.415 1.745 . . . . 0.0 111.084 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.63 20.09 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.386 1.054 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.449 0.735 . . . . 0.0 110.378 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.837 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.75 30.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.95 145.19 49.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.57 3.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 0.0 110.98 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -171.81 165.43 6.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 122.31 35.84 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.464 1.102 . . . . 0.0 108.284 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.599 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.1 m -51.36 -50.75 74.42 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 110.392 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.598 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 55.2 Cg_endo -75.08 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.541 1.811 . . . . 0.0 110.964 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 25.5 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.135 . . . . 0.0 109.616 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.943 ' NH1' HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -87.96 -38.53 15.47 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.486 1.116 . . . . 0.0 110.32 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.788 ' N ' ' HD3' ' A' ' 86' ' ' ARG . . . -89.45 -23.83 32.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.895 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.65 -15.21 62.55 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 0.776 . . . . 0.0 109.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.457 1.098 . . . . 0.0 110.983 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.701 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.6 ttt -121.57 75.02 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 0.745 . . . . 0.0 111.068 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.14 153.57 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.251 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.73 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.55 1.156 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 0.778 . . . . 0.0 110.393 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.697 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 0.0 109.273 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.08 144.54 31.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.412 1.07 . . . . 0.0 110.411 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.579 1.175 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.164 . . . . 0.0 110.291 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.465 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 39.8 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.895 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 13.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 34.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.785 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 64.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 1.051 ' HG3' HG22 ' B' ' 233' ' ' VAL . 4.4 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.762 ' HG3' HD13 ' A' ' 60' ' ' LEU . 8.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 1.536 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 3.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.472 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.77 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.77 ' HB2' HG23 ' B' ' 105' ' ' THR . 83.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.685 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.473 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.685 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 82.1 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 66.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 43.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 1.361 ' C ' ' HD1' ' B' ' 162' ' ' TYR . 8.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.361 ' HD1' ' C ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.077 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.077 ' H ' HG23 ' B' ' 164' ' ' THR . 27.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.3 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 8.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.8 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 0.28 61.6 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.8 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.722 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 4.8 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 0.85 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 208' ' ' LEU . 3.3 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.85 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.8 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 1.051 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.52 126.85 29.13 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.574 1.171 . . . . 0.0 110.022 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 5.0 m -122.49 177.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.467 1.104 . . . . 0.0 109.295 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.83 40.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 0.0 110.321 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.11 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.434 1.084 . . . . 0.0 109.301 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.72 133.43 36.03 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.583 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.63 96.98 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.444 1.09 . . . . 0.0 111.008 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.57 7.65 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.504 1.127 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.13 160.64 15.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.449 0.735 . . . . 0.0 110.371 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.714 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 7.5 t70 -59.81 -15.91 24.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.448 1.093 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 3.3 ttmt -90.6 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.118 . . . . 0.0 109.311 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.886 ' HD2' HG21 ' B' ' 105' ' ' THR . 0.0 OUTLIER 38.34 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.71 58.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 0.0 109.248 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.869 ' HG3' HG21 ' A' ' 36' ' ' VAL . 16.5 Cg_endo -74.94 97.66 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.407 1.74 . . . . 0.0 111.043 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.81 151.18 31.93 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.43 134.84 26.53 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.391 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.07 140.95 70.09 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.032 -2.487 . . . . 0.0 110.954 0.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.3 tttt -40.19 -40.15 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 0.0 109.358 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.2 141.44 31.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 0.0 109.214 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.616 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.78 50.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.597 1.186 . . . . 0.0 110.052 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.87 -177.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.34 27.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.127 . . . . 0.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.575 1.172 . . . . 0.0 109.322 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.38 -7.25 8.55 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.523 1.14 . . . . 0.0 111.022 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.645 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.18 174.15 11.46 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.567 0.804 . . . . 0.0 109.294 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.61 154.2 39.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 0.0 110.466 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.32 102.59 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.562 1.164 . . . . 0.0 109.33 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.75 169.52 18.11 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.584 1.177 . . . . 0.0 110.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.22 121.48 9.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.597 1.186 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 66' ' ' SER . 4.3 p -125.08 155.34 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.567 1.167 . . . . 0.0 109.276 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.616 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.8 ttt -98.0 119.19 36.19 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.475 1.11 . . . . 0.0 111.026 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.866 ' ND2' ' HD3' ' A' ' 35' ' ' LYS . 11.6 t30 -79.3 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 0.0 109.26 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.866 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.81 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 0.0 109.346 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.926 HG23 ' HG2' ' B' ' 119' ' ' PRO . 0.9 OUTLIER 45.9 54.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.31 40.54 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.563 1.165 . . . . 0.0 111.062 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.885 ' HD2' ' ND2' ' B' ' 70' ' ' ASN . 73.5 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.974 -2.511 . . . . 0.0 111.062 -0.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.621 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 70.3 m-70 -144.28 -170.37 3.34 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.576 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.483 HD21 ' HD3' ' A' ' 84' ' ' PRO . 4.3 p30 173.99 167.05 0.21 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.421 1.076 . . . . 0.0 109.289 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.11 114.36 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.583 1.177 . . . . 0.0 109.416 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.4 mm -132.84 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.67 160.6 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 111.008 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 4.1 t70 -97.08 -49.92 4.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.25 143.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.551 1.157 . . . . 0.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.073 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.53 158.08 72.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 0.0 109.276 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.0 164.24 33.74 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.408 1.741 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.57 1.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.467 1.104 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.51 -56.48 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.588 1.18 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.13 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.579 0.811 . . . . 0.0 110.295 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.08 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.073 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.06 -51.8 71.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -75.07 50.79 2.64 Favored 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.419 1.747 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.69 0.07 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.52 68.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.601 1.188 . . . . 0.0 109.316 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -46.45 115.13 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 110.008 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 117.6 34.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.365 1.04 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -89.77 21.86 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.404 1.065 . . . . 0.0 110.314 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' LEU . 61.7 tttt -86.04 64.42 8.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.416 1.072 . . . . 0.0 109.27 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.48 102.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.432 1.082 . . . . 0.0 109.335 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.4 98.4 5.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.531 1.144 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' B' ' 121' ' ' PRO . 1.7 mt -68.65 -46.1 80.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 0.0 109.365 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.51 4.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.95 139.19 24.13 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.544 1.813 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.85 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.475 1.109 . . . . 0.0 110.991 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.616 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.753 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 5.0 m-85 -38.28 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.54 175.16 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.42 1.075 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.65 161.4 20.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.54 1.15 . . . . 0.0 109.931 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.15 137.65 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 0.0 109.376 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.2 146.44 24.0 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.376 1.048 . . . . 0.0 110.406 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.09 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 0.0 109.22 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.39 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.573 1.17 . . . . 0.0 110.973 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.11 38.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.533 0.784 . . . . 0.0 110.439 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.51 26.74 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.543 1.812 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.66 20.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 124.501 1.125 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.83 120.05 40.47 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.539 0.788 . . . . 0.0 110.436 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.849 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.83 145.07 49.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.448 1.092 . . . . 0.0 110.028 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.566 1.166 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.415 ' CB ' HG12 ' A' ' 91' ' ' VAL . 53.7 p90 -171.86 165.39 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -93.47 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 0.0 108.344 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 1.277 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 0.8 OUTLIER -51.2 -50.84 73.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.544 1.153 . . . . 0.0 110.47 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.483 ' HD3' HD21 ' A' ' 40' ' ' ASN . 18.1 Cg_endo -75.04 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 30.3 m80 -75.12 57.98 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.581 1.175 . . . . 0.0 109.499 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -87.95 -38.47 15.53 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.523 1.14 . . . . 0.0 110.336 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.601 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.51 -23.88 32.53 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.379 1.049 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.19 62.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 0.774 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 63.14 1.83 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.523 1.14 . . . . 0.0 110.979 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.583 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.62 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.418 0.717 . . . . 0.0 111.0 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.0 m -124.19 153.57 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.549 1.156 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.45 -174.73 19.67 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.508 1.13 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.77 162.04 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 0.794 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.696 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.64 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.56 1.163 . . . . 0.0 109.27 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.6 m -105.06 144.56 31.7 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.29 73.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.158 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 O-C-N 124.581 1.176 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.112 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.444 ' HZ ' ' HD2' ' A' ' 11' ' ' LYS . 8.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.768 ' CG ' ' CD2' ' B' ' 1' ' ' TYR 0.283 12.5 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.759 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.643 ' CE2' HD13 ' B' ' 55' ' ' LEU . 46.8 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.643 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.2 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 2.4 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.672 ' HB2' HG21 ' B' ' 233' ' ' VAL . 26.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.809 ' OE1' ' HB2' ' B' ' 65' ' ' SER . 2.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 1.277 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.809 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 18.4 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 4.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.885 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 2.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 74' ' ' VAL . 8.5 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.789 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.003 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.0 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.6 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.536 ' HD1' ' HG ' ' B' ' 103' ' ' LEU . 1.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.536 ' HG ' ' HD1' ' B' ' 102' ' ' TYR . 11.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.825 ' CB ' HD22 ' B' ' 83' ' ' LEU . 20.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.886 HG21 ' HD2' ' A' ' 12' ' ' TYR . 11.7 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.1 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 0.926 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.678 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 26.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG2' HG23 ' A' ' 36' ' ' VAL . 1.1 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.558 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 8.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 0.956 ' CB ' HG23 ' A' ' 62' ' ' ILE . 2.5 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.546 ' HB3' HD12 ' A' ' 62' ' ' ILE . 4.6 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.764 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 2.4 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 20.8 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.725 ' CD2' HD22 ' B' ' 75' ' ' LEU . 21.5 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.003 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.616 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.453 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.449 ' NE2' HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' B' ' 24' ' ' CYS . 13.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.053 ' CB ' HG22 ' B' ' 164' ' ' THR . 22.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.114 HG23 ' H ' ' B' ' 166' ' ' GLU . 4.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.114 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.4 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 60.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.434 HD21 ' NH1' ' B' ' 158' ' ' ARG . 9.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.449 HD22 ' NE2' ' B' ' 160' ' ' GLN . 43.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.475 1.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 62.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.906 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.258 3.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 76.5 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.8 HD22 ' N ' ' B' ' 208' ' ' LEU . 2.4 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 9.4 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.678 HG23 HD21 ' B' ' 69' ' ' LEU . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.6 126.82 29.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.44 177.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.91 150.87 40.36 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.4 112.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.42 1.075 . . . . 0.0 109.224 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.73 133.51 35.96 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.51 1.131 . . . . 0.0 109.285 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.563 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.01 6.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 0.0 111.001 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 1.028 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.0 144.48 7.65 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 124.501 1.126 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -108.16 160.68 15.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.405 0.709 . . . . 0.0 110.356 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.78 -15.99 24.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 0.0 109.324 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 19.7 mttt -90.58 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.358 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 38.25 29.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 111.059 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.71 58.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.152 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' SD ' ' A' ' 90' ' ' MET . 38.1 Cg_endo -75.06 97.63 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.478 1.778 . . . . 0.0 111.002 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.488 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 4.0 pp -150.74 151.31 32.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.496 1.122 . . . . 0.0 109.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.458 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.44 126.21 30.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.42 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.427 1.079 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.02 140.98 70.35 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.964 -2.515 . . . . 0.0 110.942 0.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.24 -40.03 1.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.27 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.381 1.051 . . . . 0.0 109.282 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.24 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.158 . . . . 0.0 109.26 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.02 143.81 51.0 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.564 1.165 . . . . 0.0 110.037 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.97 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 0.0 109.32 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.38 27.44 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.476 1.11 . . . . 0.0 109.914 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.16 105.38 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.575 1.172 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.47 -7.39 8.47 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 0.0 111.063 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.24 11.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.568 0.805 . . . . 0.0 109.2 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.574 1.172 . . . . 0.0 110.369 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.38 102.59 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.554 1.159 . . . . 0.0 109.268 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.25 121.52 9.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.08 155.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 0.0 109.302 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.479 ' HG3' ' CD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.01 119.2 36.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 111.005 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 1.028 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -79.34 -66.01 0.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.57 1.169 . . . . 0.0 109.237 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 0.0 109.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' B' ' 3' ' ' PHE . 7.2 p 46.1 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.104 . . . . 0.0 109.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.677 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.3 40.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.52 1.138 . . . . 0.0 111.031 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.022 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 9.2 Cg_endo -74.9 -168.99 6.91 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.986 -2.506 . . . . 0.0 110.998 -0.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.677 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 65.3 m-70 -144.13 -170.34 3.32 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 1.101 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.555 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.8 p30 173.9 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.03 114.29 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 109.394 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 1.8 mm -132.78 76.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.426 1.079 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.67 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.41 1.069 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.0 4.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.032 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.05 72.91 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.231 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 164.29 33.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.522 1.801 . . . . 0.0 111.032 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.29 135.61 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.49 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.548 1.155 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.508 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.585 0.815 . . . . 0.0 110.27 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.2 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.388 1.055 . . . . 0.0 109.938 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.032 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.88 70.62 Favored Pre-proline 0 C--N 1.323 -0.572 0 O-C-N 124.509 1.13 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -74.99 50.79 2.62 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.448 1.762 . . . . 0.0 110.966 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.58 1.175 . . . . 0.0 109.283 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.41 115.12 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.534 1.146 . . . . 0.0 110.014 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 6.2 m-20 -107.96 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 1.144 . . . . 0.0 109.303 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.062 HG21 ' CB ' ' B' ' 63' ' ' ASP . 7.2 t -89.75 21.86 3.34 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.379 1.05 . . . . 0.0 110.389 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 19.4 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 109.21 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -40.44 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.49 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.819 HD12 ' ND2' ' B' ' 70' ' ' ASN . 0.1 OUTLIER -68.73 -46.13 80.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 0.0 109.283 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -75.05 139.23 23.92 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.416 1.745 . . . . 0.0 111.001 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.84 -68.0 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.472 1.108 . . . . 0.0 110.955 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.496 0.763 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.49 175.13 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 0.0 109.964 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.65 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.129 . . . . 0.0 109.388 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.19 146.48 23.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.15 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.558 1.161 . . . . 0.0 109.205 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.453 1.095 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.469 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.19 38.32 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.586 0.815 . . . . 0.0 110.413 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -75.07 141.43 26.41 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.543 1.812 . . . . 0.0 111.031 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.62 20.09 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.418 1.074 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.86 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 0.789 . . . . 0.0 110.356 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.78 140.77 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 1.158 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.05 49.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.996 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.46 3.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.497 1.123 . . . . 0.0 110.991 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -171.85 165.45 6.47 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 122.31 35.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.443 1.089 . . . . 0.0 108.245 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.9 OUTLIER -51.25 -50.83 73.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.421 1.075 . . . . 0.0 110.393 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.752 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 19.0 Cg_endo -75.08 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 110.98 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -75.07 57.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 0.0 109.619 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 83' ' ' THR . 2.5 ptm180 -87.96 -38.5 15.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.85 32.7 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.532 1.145 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.24 62.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.472 0.748 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.2 63.2 1.82 Allowed Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.423 1.077 . . . . 0.0 110.868 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.563 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 9.0 ttt -121.68 75.1 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.451 0.736 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.57 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.481 1.113 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.78 19.77 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.46 1.1 . . . . 0.0 111.022 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 161.99 37.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.526 0.78 . . . . 0.0 110.407 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.59 122.61 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.243 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.8 m -105.08 144.56 31.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.458 1.099 . . . . 0.0 109.291 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.791 ' N ' ' HD2' ' B' ' 4' ' ' TYR . 3.6 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 5.3 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.721 ' HB2' HG23 ' A' ' 36' ' ' VAL . 2.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.791 ' HD2' ' N ' ' B' ' 1' ' ' TYR . 44.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 107' ' ' TYR . 47.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 1.5 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.755 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.9 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.658 ' HB2' HG21 ' B' ' 233' ' ' VAL . 10.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.526 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 89.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.784 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.516 ' HB3' ' OG1' ' A' ' 58' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 1.062 ' CB ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.784 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 28.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.546 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 38.4 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.422 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 0.819 ' ND2' HD12 ' A' ' 62' ' ' ILE . 36.6 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.409 ' HB ' HG11 ' B' ' 51' ' ' VAL . 4.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 7.2 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' B' ' 102' ' ' TYR . 0.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.416 HD21 HD22 ' B' ' 120' ' ' LEU . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 0.832 ' CB ' HD22 ' B' ' 83' ' ' LEU . 55.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 61.9 p -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.4 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.0 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.001 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' B' ' 107' ' ' TYR . 82.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.587 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.022 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.587 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 15.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.1 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.427 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.483 ' NH2' ' HB3' ' B' ' 158' ' ' ARG . 0.1 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.451 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' B' ' 24' ' ' CYS . 4.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.075 ' CB ' HG22 ' B' ' 164' ' ' THR . 18.3 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.549 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 5.1 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.075 HG22 ' CB ' ' B' ' 162' ' ' TYR . 5.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . 0.481 ' N ' HG23 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.972 ' H ' HG23 ' B' ' 164' ' ' THR . 34.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.594 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.932 ' HB3' ' H ' ' B' ' 170' ' ' ASN 0.684 0.1 OUTLIER -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.932 ' H ' ' HB3' ' B' ' 168' ' ' SER . 46.5 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.046 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.917 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.046 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.59 126.77 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.93 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.4 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 0.0 109.28 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.9 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.434 1.084 . . . . 0.0 109.3 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.79 133.46 36.02 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.53 1.144 . . . . 0.0 109.315 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.688 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.05 6.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 0.0 110.987 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.54 7.66 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.544 1.153 . . . . 0.0 110.992 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 15.9 p -108.04 160.67 15.61 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.389 0.699 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -59.87 -15.94 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 6.0 ttmt -90.57 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.353 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' B' ' 3' ' ' PHE . 0.5 OUTLIER 38.26 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 0.0 111.025 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.77 117.66 58.3 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 109.344 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.685 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 33.2 Cg_endo -74.94 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.551 1.816 . . . . 0.0 111.045 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.84 151.19 31.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.12 . . . . 0.0 109.317 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.27 126.17 30.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.978 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.88 26.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.514 1.134 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.94 70.1 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.033 -2.486 . . . . 0.0 110.971 0.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.554 1.159 . . . . 0.0 109.264 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.32 46.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.428 1.08 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.93 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.38 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 0.0 109.235 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.627 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 0.0 110.065 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.493 1.12 . . . . 0.0 109.284 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.34 27.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 0.0 110.009 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.36 0.27 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.6 1.187 . . . . 0.0 109.298 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.42 8.46 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.431 1.082 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.13 174.14 11.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 0.764 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.54 154.25 39.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 0.0 110.516 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.715 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.41 102.57 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.568 1.167 . . . . 0.0 109.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.54 18.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.41 9.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.12 . . . . 0.0 110.97 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.33 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.895 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.3 ttp -98.01 119.25 36.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.409 1.068 . . . . 0.0 111.0 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.36 -66.09 0.92 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 0.0 109.216 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.269 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.685 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.02 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.419 1.075 . . . . 0.0 109.32 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.98 -172.29 40.52 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.51 1.131 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.277 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -74.99 -168.92 6.88 Favored 'Cis proline' 0 C--N 1.361 1.209 0 C-N-CA 120.919 -2.534 . . . . 0.0 110.975 -0.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.94 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 71.0 m-70 -144.19 -170.36 3.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.614 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.518 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.7 p30 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.478 1.111 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.09 114.34 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.599 1.187 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' CZ ' ' A' ' 81' ' ' TYR . 9.0 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 0.0 109.345 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.426 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.65 160.62 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.569 1.168 . . . . 0.0 109.308 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.33 143.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.618 1.199 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.5 158.1 72.81 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.35 1.031 . . . . 0.0 109.25 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.01 164.26 33.7 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.495 1.787 . . . . 0.0 111.046 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.62 1.41 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.56 1.162 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.42 2.24 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.608 0.828 . . . . 0.0 110.26 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.09 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.451 1.095 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.011 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.77 71.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 O-C-N 124.491 1.12 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.04 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.427 1.751 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.25 -45.67 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.604 1.19 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -46.47 115.11 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 1.126 . . . . 0.0 109.976 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 117.68 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 109.348 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -89.8 21.94 3.34 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.401 1.063 . . . . 0.0 110.304 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -86.07 64.45 8.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.277 ' CD1' ' HB2' ' A' ' 38' ' ' PRO . 17.6 tp -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 0.0 109.314 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.4 6.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.809 HG21 ' HG3' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -68.64 -46.09 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 0.0 109.362 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.757 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -62.08 111.59 4.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.273 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.03 139.11 23.82 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.424 1.749 . . . . 0.0 111.05 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.93 -67.99 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.583 1.177 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.656 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.461 0.742 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.0 m-85 -38.23 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -171.5 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.458 1.099 . . . . 0.0 110.028 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.418 1.074 . . . . 0.0 109.403 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.26 146.52 23.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 110.391 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.11 8.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 109.276 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.09 37.61 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.5 0.765 . . . . 0.0 110.366 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -75.01 141.5 26.68 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.48 1.779 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.419 1.074 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.88 120.08 40.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 0.736 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.71 30.94 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.134 . . . . 0.0 111.043 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.94 145.12 49.37 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.461 1.101 . . . . 0.0 109.975 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.13 -171.53 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.428 1.08 . . . . 0.0 110.994 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 55.4 p90 -171.84 165.43 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.499 1.124 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 122.35 35.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.526 1.141 . . . . 0.0 108.328 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -51.33 -50.85 73.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 0.0 110.392 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.648 ' HB2' ' CE2' ' B' ' 162' ' ' TYR . 18.2 Cg_endo -75.0 -62.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.503 1.791 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 20.8 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.0 -38.47 15.48 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.545 1.153 . . . . 0.0 110.322 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.8 32.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.498 1.124 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.67 -15.23 62.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.516 0.774 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.441 1.088 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.688 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.58 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.421 0.718 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.56 ' CG1' HH21 ' A' ' 86' ' ' ARG . 11.5 m -124.16 153.61 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 0.0 109.248 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.59 -174.8 19.83 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.71 162.05 36.97 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 0.764 . . . . 0.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.715 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.59 122.67 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 0.0 109.283 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.07 144.51 31.77 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.382 1.051 . . . . 0.0 110.393 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.27 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 124.584 1.178 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.545 1.153 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.901 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 89.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 79.7 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.447 ' HD1' ' HA ' ' B' ' 4' ' ' TYR . 5.5 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' B' ' 107' ' ' TYR . 39.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.408 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.8 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.793 ' HA ' HG12 ' B' ' 161' ' ' VAL . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.975 ' HG3' ' CG2' ' B' ' 233' ' ' VAL . 1.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.412 HG11 ' HA3' ' B' ' 210' ' ' GLY . 44.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.809 ' HG3' HG21 ' A' ' 62' ' ' ILE . 4.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 1.227 ' HB1' ' CD2' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 14.9 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.579 ' HB2' ' OE1' ' B' ' 58' ' ' GLN 0.26 4.8 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.555 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.473 ' CE2' HD23 ' B' ' 103' ' ' LEU . 9.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.689 HG23 ' HB2' ' B' ' 116' ' ' LEU . 9.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.639 ' HA ' HE21 ' B' ' 6' ' ' GLN . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 77.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.491 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.901 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.491 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 87.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.444 ' HA2' ' NE2' ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.763 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 64.4 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.473 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' B' ' 24' ' ' CYS . 11.0 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 0.648 ' CE2' ' HB2' ' A' ' 84' ' ' PRO . 2.5 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.409 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.037 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.037 ' H ' HG23 ' B' ' 164' ' ' THR . 4.0 tp10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.708 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.444 HD21 HH22 ' B' ' 158' ' ' ARG . 11.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.602 ' CG ' ' O ' ' B' ' 170' ' ' ASN . 16.9 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.741 ' HB2' ' CD2' ' B' ' 189' ' ' PHE . 5.2 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.309 ' CD1' ' HG3' ' B' ' 209' ' ' PRO . 0.0 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 5.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 83.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.5 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.309 ' HG3' ' CD1' ' B' ' 189' ' ' PHE . 2.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . 0.412 ' HA3' HG11 ' B' ' 60' ' ' VAL . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.531 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 19.7 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . 0.483 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.975 ' CG2' ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.64 126.83 29.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.575 1.172 . . . . 0.0 110.04 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.934 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.47 177.2 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.431 1.082 . . . . 0.0 109.263 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.99 150.82 40.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 0.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.39 112.17 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.418 1.074 . . . . 0.0 109.213 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.74 133.48 35.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.563 1.165 . . . . 0.0 109.372 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.675 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.67 97.01 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.443 1.089 . . . . 0.0 110.951 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.524 1.14 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -108.08 160.64 15.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 0.743 . . . . 0.0 110.415 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -16.0 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 0.0 109.29 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.9 mttt -90.62 39.66 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.978 ' O ' ' CZ ' ' B' ' 3' ' ' PHE . 0.4 OUTLIER 38.28 29.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 0.0 110.996 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.66 58.21 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 1.057 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 6.3 Cg_exo -75.01 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.482 1.78 . . . . 0.0 111.057 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -150.77 151.22 32.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.18 30.52 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.527 1.142 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.8 26.49 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.09 140.98 70.23 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.009 -2.496 . . . . 0.0 110.951 0.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.2 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 1.124 . . . . 0.0 109.278 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.423 1.077 . . . . 0.0 109.329 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.934 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.43 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.592 1.183 . . . . 0.0 109.209 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.612 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.77 50.97 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.553 1.158 . . . . 0.0 110.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.112 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.981 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.603 1.19 . . . . 0.0 109.321 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.44 -7.27 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.512 1.133 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.582 0.813 . . . . 0.0 109.29 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.62 154.16 39.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.455 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD13 ' A' ' 94' ' ' ILE . 63.4 t -131.3 102.57 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.601 1.188 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.73 169.53 18.09 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.539 1.149 . . . . 0.0 110.311 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.31 121.47 9.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.03 155.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.586 1.178 . . . . 0.0 109.315 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.3 ttp -97.99 119.22 36.24 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.65 ' HB3' ' HD3' ' A' ' 35' ' ' LYS 0.324 6.6 m-20 -79.33 -66.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 0.0 109.264 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.86 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.456 1.098 . . . . 0.0 109.396 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.057 ' CG2' ' HG3' ' A' ' 14' ' ' PRO . 2.4 p 45.9 54.89 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.93 -172.29 40.6 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.582 1.176 . . . . 0.0 111.047 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.961 ' HD3' ' CZ ' ' B' ' 1' ' ' TYR . 24.3 Cg_endo -74.94 -168.89 6.84 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 120.953 -2.52 . . . . 0.0 111.054 -0.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.652 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 68.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 1.053 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 167.02 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 0.0 109.258 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.1 114.42 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.914 HG13 ' OG1' ' A' ' 83' ' ' THR . 7.4 mm -132.87 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 0.0 109.311 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.7 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.449 1.093 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' HA ' ' HE2' ' A' ' 81' ' ' TYR . 1.7 t70 -96.98 -49.98 4.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.314 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.31 143.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 0.0 109.352 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.019 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.09 72.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 0.0 109.244 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 164.2 33.8 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.477 1.777 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.31 135.62 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.532 1.145 . . . . 0.0 109.297 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.53 -56.48 0.73 Allowed Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.521 1.138 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.584 0.814 . . . . 0.0 110.294 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.74 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 109.987 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.019 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.86 70.75 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 124.514 1.134 . . . . 0.0 109.306 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.1 Cg_endo -75.03 50.82 2.64 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.45 1.763 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.573 1.171 . . . . 0.0 109.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.503 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.54 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.517 1.136 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -46.5 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.445 1.091 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.93 117.61 34.59 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.38 1.05 . . . . 0.0 109.285 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.5 t -89.81 21.89 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.39 1.056 . . . . 0.0 110.341 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 8.4 tttm -86.06 64.47 8.6 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.429 1.081 . . . . 0.0 109.244 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.053 HD22 ' HB3' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -40.46 102.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 0.0 109.344 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.39 6.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.68 -46.04 80.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.565 1.166 . . . . 0.0 109.35 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.04 139.17 23.86 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.527 1.803 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.89 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.504 1.128 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.669 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 0.767 . . . . 0.0 110.02 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 3.6 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.529 1.143 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.53 175.13 4.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.481 1.113 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.39 20.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.552 1.158 . . . . 0.0 109.939 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.67 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.18 146.44 23.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 0.0 109.251 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.546 1.154 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.456 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.12 37.89 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.508 0.77 . . . . 0.0 110.423 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.96 141.46 26.78 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.58 1.832 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.68 20.04 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.494 1.121 . . . . 0.0 110.993 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.439 0.729 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.78 140.75 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.06 49.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.538 1.149 . . . . 0.0 109.98 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.5 3.73 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.817 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 42.4 p90 -171.85 165.38 6.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.547 1.154 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . 1.332 ' O ' ' NE ' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -93.48 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.405 1.065 . . . . 0.0 108.326 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.984 ' O ' ' HB ' ' B' ' 164' ' ' THR . 5.7 m -51.23 -50.89 73.15 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.452 1.095 . . . . 0.0 110.396 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.676 ' O ' ' HG2' ' B' ' 163' ' ' PRO . 40.5 Cg_endo -75.0 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 0.0 111.0 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 27.2 m80 -75.09 57.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.491 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.332 ' NE ' ' O ' ' A' ' 82' ' ' CYS . 0.2 OUTLIER -87.94 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.34 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.87 32.79 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.439 1.087 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' B' ' 7' ' ' TYR . . . -65.68 -15.21 62.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.525 0.78 . . . . 0.0 109.292 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.16 1.82 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.675 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.8 ttt -121.65 75.08 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.473 0.749 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 81' ' ' TYR . 14.0 m -124.24 153.61 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.558 1.161 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.72 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.461 1.101 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.77 162.06 37.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.568 0.805 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.6 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.494 1.121 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.1 m -105.07 144.52 31.76 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.396 1.06 . . . . 0.0 110.407 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.24 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.16 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 O-C-N 124.594 1.184 . . . . 0.0 110.34 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.961 ' CZ ' ' HD3' ' A' ' 38' ' ' PRO . 42.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 0.978 ' CZ ' ' O ' ' A' ' 12' ' ' TYR . 1.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.583 ' N ' ' CD1' ' B' ' 4' ' ' TYR . 4.4 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.949 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 1.1 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.909 ' CD1' HG11 ' B' ' 20' ' ' VAL . 85.1 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.909 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 1.478 ' CB ' ' CA ' ' B' ' 23' ' ' ASN 0.623 3.4 m-80 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.492 ' HA ' HG12 ' B' ' 161' ' ' VAL . 47.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.77 ' HB2' HG21 ' B' ' 233' ' ' VAL . 13.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.621 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 99.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.85 ' HG3' ' H ' ' B' ' 62' ' ' ALA . 1.4 tt0 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 0.85 ' H ' ' HG3' ' B' ' 61' ' ' GLN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.568 ' H ' ' HG2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 39.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.547 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 80.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.489 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.753 ' HG3' ' CD2' ' B' ' 1' ' ' TYR . 1.2 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.489 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 90.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.652 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 39.8 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.405 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.58 HE21 HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' B' ' 24' ' ' CYS . 0.5 OUTLIER -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.031 ' HB3' HG22 ' B' ' 164' ' ' THR . 9.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.676 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.031 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.5 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 0.901 ' H ' HG23 ' B' ' 164' ' ' THR . 23.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.6 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . 0.577 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 57.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.424 HD21 HH22 ' B' ' 158' ' ' ARG . 22.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.752 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.88 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.16 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.272 7.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.508 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.553 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.16 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.82 29.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 0.0 110.02 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.959 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.08 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.441 1.088 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.9 150.88 40.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 110.338 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.41 1.069 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.513 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.65 133.46 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.492 1.12 . . . . 0.0 109.351 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.683 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.73 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 111.034 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.45 7.63 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 124.514 1.134 . . . . 0.0 111.064 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.639 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -108.12 160.6 15.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.361 0.683 . . . . 0.0 110.443 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 9.8 t70 -59.79 -15.92 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 0.0 109.303 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 7.5 ttmt -90.64 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.545 1.153 . . . . 0.0 109.351 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.23 29.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.639 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.89 117.66 58.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 44.6 Cg_endo -75.01 97.65 1.1 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 O-C-N 124.471 1.774 . . . . 0.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.3 pp -150.82 151.31 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.318 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.4 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 110.315 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.08 140.97 70.19 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 120.987 -2.505 . . . . 0.0 110.966 0.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 1.15 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.13 146.27 46.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.354 1.034 . . . . 0.0 109.335 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.959 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.25 141.33 31.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.614 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.92 -177.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.563 1.165 . . . . 0.0 109.335 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.805 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 105.44 0.28 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.117 . . . . 0.0 109.303 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.29 8.5 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.48 1.112 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.19 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 0.792 . . . . 0.0 109.232 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.59 154.23 39.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.44 102.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 0.0 109.277 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.462 1.101 . . . . 0.0 110.284 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.25 121.5 9.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.939 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.09 155.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 109.269 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.642 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 12.2 ttp -98.09 119.19 36.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 0.0 111.026 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 0.0 109.296 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' NZ ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.488 1.117 . . . . 0.0 109.248 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.939 HG23 ' HD2' ' B' ' 119' ' ' PRO . 11.6 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.403 1.064 . . . . 0.0 109.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.32 40.54 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.524 1.14 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.012 ' HD3' ' OD1' ' B' ' 70' ' ' ASN . 3.9 Cg_exo -74.92 -169.03 6.95 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.018 -2.492 . . . . 0.0 110.959 -0.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.658 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.3 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.488 1.117 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.435 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 173.93 166.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 0.0 109.307 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.578 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.37 43.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 0.0 109.343 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 41' ' ' VAL . 1.3 mm -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 87.1 m-85 -47.68 160.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.462 1.101 . . . . 0.0 111.008 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.605 1.191 . . . . 0.0 109.31 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.9 mttt 167.32 143.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.449 1.093 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 157.98 73.2 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.394 1.059 . . . . 0.0 109.265 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.91 164.28 33.78 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.509 1.794 . . . . 0.0 111.054 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.32 135.61 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.5 0.73 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.492 1.12 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.1 -173.29 2.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.567 0.804 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.29 77.83 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.396 1.06 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.005 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.87 70.73 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.563 1.164 . . . . 0.0 109.274 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -75.05 50.81 2.64 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.443 1.759 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.57 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.638 1.212 . . . . 0.0 109.344 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.58 68.15 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 m -46.47 115.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 1.141 . . . . 0.0 109.988 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.91 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.411 1.07 . . . . 0.0 109.322 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -89.69 21.81 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.458 1.099 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -85.95 64.38 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.417 1.073 . . . . 0.0 109.222 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -40.43 102.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.49 98.53 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 0.0 109.29 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.161 HG23 ' CG ' ' B' ' 121' ' ' PRO . 28.7 mt -68.78 -46.07 80.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.61 1.194 . . . . 0.0 109.304 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.18 111.61 4.91 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.117 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -75.0 139.19 23.98 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.413 1.744 . . . . 0.0 111.038 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.379 1.05 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.659 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.509 0.77 . . . . 0.0 110.048 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.11 -86.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.48 175.16 4.19 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.443 1.089 . . . . 0.0 111.014 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.25 20.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.979 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.67 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 0.0 109.412 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.19 146.53 23.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 110.404 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.08 8.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.179 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.539 1.149 . . . . 0.0 110.996 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.458 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.21 37.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.561 0.801 . . . . 0.0 110.409 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.13 141.52 26.38 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.511 1.795 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.06 -178.68 20.0 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.508 1.13 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.81 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 0.764 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.89 145.13 49.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.45 3.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.581 1.176 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.428 ' CB ' HG12 ' A' ' 91' ' ' VAL . 39.5 p90 -171.89 165.39 6.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 111.042 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.59 122.39 35.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.112 . . . . 0.0 108.268 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 1.171 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 1.2 m -51.29 -50.82 73.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.084 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 21.2 Cg_endo -75.06 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.574 1.829 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.3 m80 -75.1 58.05 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.99 -38.59 15.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.135 . . . . 0.0 110.292 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.903 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.48 -23.84 32.74 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.443 1.089 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -65.68 -15.22 62.58 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.528 0.781 . . . . 0.0 109.357 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.503 1.127 . . . . 0.0 110.885 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.683 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.7 75.1 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 0.74 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.3 m -124.14 153.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.473 1.108 . . . . 0.0 109.287 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.513 1.133 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.05 37.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.343 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.7 122.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 109.275 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.46 31.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.455 1.097 . . . . 0.0 110.381 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.21 73.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 109.285 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.805 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.516 1.135 . . . . 0.0 110.325 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.497 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 32.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 4.9 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.702 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 6.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.764 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.638 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.0 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 20.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.746 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 40.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 1.081 ' NE2' HG21 ' A' ' 83' ' ' THR . 3.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 1.171 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.8 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 16.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.3 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' B' ' 59' ' ' GLN . 9.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . 1.012 ' OD1' ' HD3' ' A' ' 38' ' ' PRO . 86.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.012 HD11 ' HD2' ' B' ' 131' ' ' PRO . 30.5 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.541 HD23 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.197 ' CG1' HD12 ' B' ' 115' ' ' LEU . 20.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.772 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.4 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.197 HD12 ' CG1' ' B' ' 104' ' ' VAL . 0.0 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.772 ' HB2' HG23 ' B' ' 105' ' ' THR . 16.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.939 ' HD2' HG23 ' A' ' 36' ' ' VAL . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.541 HD11 HD23 ' B' ' 103' ' ' LEU . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . 1.161 ' CG ' HG23 ' A' ' 62' ' ' ILE . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.664 ' HB2' HG21 ' A' ' 62' ' ' ILE . 12.9 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 21.6 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.481 ' HE2' ' CD1' ' B' ' 120' ' ' LEU . 20.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.012 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.746 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 27.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.452 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.048 ' CB ' HG22 ' B' ' 164' ' ' THR . 7.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.702 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.2 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.048 HG22 ' CB ' ' B' ' 162' ' ' TYR . 2.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.02 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.537 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 57.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.503 3.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 66.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.771 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 18.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 1.188 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.27 20.2 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.662 HD22 ' N ' ' B' ' 208' ' ' LEU . 1.9 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 1.188 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HA ' ' HG3' ' B' ' 231' ' ' PRO . 1.1 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 2.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.61 126.83 29.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 1.16 . . . . 0.0 109.999 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.18 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.41 1.069 . . . . 0.0 109.285 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.88 40.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.15 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.387 1.054 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.523 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.77 133.49 35.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.51 1.131 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.627 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.105 . . . . 0.0 110.997 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.49 7.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.594 1.184 . . . . 0.0 110.974 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.06 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.409 0.711 . . . . 0.0 110.417 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.84 -15.94 24.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.322 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.5 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 38.3 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 0.0 111.009 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.72 58.05 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 1.076 ' HG3' ' HE2' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.46 1.769 . . . . 0.0 111.022 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 2.8 pp -150.8 151.25 32.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.46 1.1 . . . . 0.0 109.32 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.413 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.39 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.89 26.59 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.55 1.156 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.99 70.35 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 120.995 -2.502 . . . . 0.0 110.944 0.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.16 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.243 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.05 146.28 46.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 3' ' ' VAL . 10.9 tp -143.28 141.4 31.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.566 1.166 . . . . 0.0 109.202 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 0.0 110.063 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.93 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.54 158.31 27.57 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.602 1.189 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.41 8.46 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.443 1.09 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.11 11.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 0.735 . . . . 0.0 109.3 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 154.27 39.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 1.119 . . . . 0.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 94' ' ' ILE . 63.8 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.143 . . . . 0.0 109.332 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.82 169.52 18.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.39 9.51 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.484 1.115 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.96 155.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.07 119.26 36.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.413 1.07 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.333 6.9 m-20 -79.4 -66.03 0.92 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.412 1.07 . . . . 0.0 109.237 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.473 1.108 . . . . 0.0 109.235 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.652 ' HB ' ' CE2' ' B' ' 3' ' ' PHE . 19.0 m 46.02 54.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.647 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.33 40.62 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.558 1.161 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HD2' ' CE2' ' B' ' 1' ' ' TYR . 19.5 Cg_endo -74.97 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.947 -2.522 . . . . 0.0 110.977 -0.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.647 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.5 m-70 -144.26 -170.36 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.403 1.064 . . . . 0.0 109.327 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.11 114.35 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 109.329 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.553 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -132.82 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.61 160.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 0.0 110.959 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 6.9 mttt 167.32 143.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.473 1.108 . . . . 0.0 109.266 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.039 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.5 158.08 72.86 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.393 1.058 . . . . 0.0 109.284 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.03 164.25 33.68 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.42 1.748 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.67 1.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 0.0 109.33 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.485 1.116 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 0.822 . . . . 0.0 110.28 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.1 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 110.042 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.039 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.98 -51.84 70.88 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.441 1.088 . . . . 0.0 109.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.05 50.75 2.62 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.43 1.752 . . . . 0.0 110.966 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.26 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.587 1.179 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.53 68.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -46.52 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.974 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.455 1.097 . . . . 0.0 109.345 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.851 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 4.6 t -89.77 21.84 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.393 1.058 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -86.08 64.44 8.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.171 HD23 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -40.44 102.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.47 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.729 HD11 ' CD1' ' A' ' 60' ' ' LEU . 4.3 mm -68.66 -46.11 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.602 1.189 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 0.0 109.278 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.03 139.1 23.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.431 1.753 . . . . 0.0 111.019 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.552 1.157 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.471 0.748 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.18 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.461 1.101 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.448 1.092 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.29 20.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.448 1.093 . . . . 0.0 109.99 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.72 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 0.0 109.389 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.546 1.154 . . . . 0.0 110.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.1 8.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 1.1 . . . . 0.0 109.235 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.497 1.123 . . . . 0.0 111.045 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.473 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.71 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.543 0.79 . . . . 0.0 110.37 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 141.5 26.7 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.483 1.781 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.415 1.072 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.03 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 0.76 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.69 140.73 30.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.21 -171.55 3.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 42' ' ' ILE . 9.3 p90 -171.83 165.43 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.514 1.134 . . . . 0.0 111.028 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.6 122.35 35.97 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.478 1.111 . . . . 0.0 108.243 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -51.31 -50.81 73.93 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 110.397 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 83' ' ' THR . 49.5 Cg_endo -75.05 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.531 1.806 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.46 ' NE2' ' HE1' ' B' ' 4' ' ' TYR . 27.3 m80 -74.95 57.96 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 0.0 109.601 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.178 ' HE ' ' CA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -88.01 -38.47 15.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.634 1.209 . . . . 0.0 110.276 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.54 -23.76 32.83 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.43 1.081 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.19 62.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 0.765 . . . . 0.0 109.426 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.06 1.83 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.438 1.086 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.627 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.07 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.454 0.738 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.175 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.18 153.62 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.564 1.165 . . . . 0.0 109.289 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.458 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.74 19.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.603 1.189 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 0.79 . . . . 0.0 110.382 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.64 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.255 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.2 m -105.01 144.55 31.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.393 1.058 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.537 1.148 . . . . 0.0 109.303 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 0.0 110.265 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 0.926 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 93.7 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 1.076 ' HE2' ' HG3' ' A' ' 14' ' ' PRO . 12.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.87 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 12.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 9' ' ' TYR . 0.1 OUTLIER -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.788 ' HA ' HG12 ' B' ' 161' ' ' VAL . 43.3 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.799 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 21.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 89.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 0.783 ' HG2' ' O ' ' B' ' 65' ' ' SER . 4.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 1.171 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.734 ' H ' HE21 ' B' ' 61' ' ' GLN . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.783 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 9.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.432 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.505 ' CD2' HD23 ' B' ' 103' ' ' LEU . 30.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.8 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.72 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 2.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.549 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.0 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.5 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.72 ' HB2' HG23 ' B' ' 105' ' ' THR . 11.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.645 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.645 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 47.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 68.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.6 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . 0.587 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.799 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.423 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.746 HE21 HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' B' ' 24' ' ' CYS . 8.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 0.456 ' HB3' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.015 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.595 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.746 HD22 HE21 ' B' ' 160' ' ' GLN . 0.7 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.962 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 0.962 ' HD1' ' HB2' ' B' ' 187' ' ' ASN . 0.4 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.509 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.559 HD22 ' N ' ' B' ' 208' ' ' LEU . 4.0 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.88 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.63 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 110.03 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.554 1.159 . . . . 0.0 110.342 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.31 112.16 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.408 1.068 . . . . 0.0 109.307 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.75 133.44 36.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.548 1.155 . . . . 0.0 109.306 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.786 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.66 97.0 6.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.469 1.106 . . . . 0.0 111.002 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.03 144.41 7.62 Favored Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.464 1.103 . . . . 0.0 111.074 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.699 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 17.3 p -108.09 160.69 15.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.422 0.719 . . . . 0.0 110.402 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.79 -15.96 24.41 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.441 1.088 . . . . 0.0 109.305 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 5.0 tppt? -90.64 39.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.298 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 1.276 ' CZ ' ' HB2' ' B' ' 3' ' ' PHE . 12.3 m-30 38.29 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.125 . . . . 0.0 111.008 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.81 117.67 58.24 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.487 1.117 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.803 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 1.2 Cg_endo -75.03 97.56 1.09 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.455 1.766 . . . . 0.0 110.99 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' THR . 1.2 pp -150.73 151.29 32.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.41 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 0.0 110.934 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.47 134.91 26.61 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.445 1.091 . . . . 0.0 110.317 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.08 141.0 70.37 Favored 'Cis proline' 0 C--N 1.361 1.22 0 C-N-CA 120.947 -2.522 . . . . 0.0 111.013 0.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.21 -40.13 1.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 0.0 109.181 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.27 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.384 1.052 . . . . 0.0 109.281 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.21 141.41 31.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 0.0 109.216 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.626 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.78 50.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.544 1.152 . . . . 0.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.633 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.92 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.56 158.32 27.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 109.963 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.594 1.184 . . . . 0.0 109.313 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.36 8.46 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.465 1.103 . . . . 0.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.633 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.22 174.16 11.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 0.758 . . . . 0.0 109.182 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.577 1.173 . . . . 0.0 110.371 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.7 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.41 102.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 0.0 109.285 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.86 169.62 17.95 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.128 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.24 121.42 9.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.135 . . . . 0.0 111.008 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.39 33.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 109.281 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.919 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.1 ttp -98.06 119.11 36.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 0.0 111.085 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -79.27 -66.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 109.291 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.461 1.1 . . . . 0.0 109.292 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.881 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 0.0 109.338 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.3 40.54 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.555 1.16 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.038 ' HD2' ' HB2' ' B' ' 62' ' ' ALA . 7.8 Cg_endo -74.95 -168.96 6.9 Favored 'Cis proline' 0 C--N 1.36 1.169 0 C-N-CA 120.992 -2.503 . . . . 0.0 110.986 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.919 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.1 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.413 ' ND2' ' C ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 173.9 166.97 0.2 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 42' ' ' ILE . 61.2 t -104.07 114.35 43.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.566 1.166 . . . . 0.0 109.347 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 41' ' ' VAL . 2.0 mm -132.74 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.432 1.083 . . . . 0.0 109.306 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.427 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.6 160.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.443 1.089 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 9.5 t70 -97.03 -50.01 4.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.595 1.184 . . . . 0.0 109.324 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.2 mttt 167.34 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.143 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.4 m -128.54 158.05 73.04 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.143 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 164.22 33.83 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.476 1.777 . . . . 0.0 111.027 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.33 135.64 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 109.252 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.57 0.72 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.522 1.139 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.61 0.829 . . . . 0.0 110.238 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.15 77.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.371 1.045 . . . . 0.0 110.021 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.029 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.85 70.93 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.486 1.116 . . . . 0.0 109.268 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.01 50.73 2.61 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.562 1.164 . . . . 0.0 109.346 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.52 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.519 1.137 . . . . 0.0 109.344 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -46.48 115.1 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.592 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.8 m120 -107.97 117.67 34.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 0.0 109.293 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.69 HG22 ' OD1' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -89.68 21.78 3.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.412 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -85.93 64.4 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.446 1.091 . . . . 0.0 109.233 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.612 HD23 ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.41 102.45 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 0.0 109.346 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.39 98.46 6.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.342 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 38' ' ' PRO . 5.2 mm -68.7 -46.09 80.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 111.6 4.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.594 1.184 . . . . 0.0 109.303 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -74.99 139.14 23.95 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.384 1.729 . . . . 0.0 111.02 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.96 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.45 1.094 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.69 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 0.744 . . . . 0.0 110.037 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.8 m-85 -38.25 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.128 . . . . 0.0 110.978 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.13 4.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.461 1.1 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.26 20.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 109.994 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.68 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.5 1.125 . . . . 0.0 109.388 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.5 23.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.115 . . . . 0.0 110.426 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 0.0 109.222 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.21 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.501 1.126 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.17 37.96 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.528 0.781 . . . . 0.0 110.411 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.09 141.5 26.45 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.558 1.82 . . . . 0.0 111.014 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.7 20.0 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.444 1.09 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.77 120.08 40.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 0.792 . . . . 0.0 110.405 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.847 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.79 140.74 30.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.61 1.194 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.12 49.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.442 1.089 . . . . 0.0 110.011 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.44 3.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.598 1.186 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.688 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 40.9 p90 -171.91 165.44 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -93.61 122.33 35.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.396 1.06 . . . . 0.0 108.296 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -51.26 -50.79 73.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.436 1.085 . . . . 0.0 110.378 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.658 ' HB3' ' O ' ' B' ' 62' ' ' ALA . 9.2 Cg_endo -75.1 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.564 1.823 . . . . 0.0 110.972 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -75.1 57.99 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.112 . . . . 0.0 109.577 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 1.246 HH22 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -87.97 -38.61 15.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 0.0 110.312 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.42 -23.84 32.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.427 1.079 . . . . 0.0 110.991 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.18 62.56 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.527 0.781 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.497 1.123 . . . . 0.0 110.927 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.786 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.64 75.05 1.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 0.778 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.246 ' CG1' HH22 ' A' ' 86' ' ' ARG . 13.1 m -124.17 153.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.294 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.82 19.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.501 1.126 . . . . 0.0 111.036 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.06 36.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.7 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.63 122.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.57 1.169 . . . . 0.0 109.284 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.08 144.52 31.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 0.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.28 73.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.431 1.082 . . . . 0.0 109.327 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 0.0 110.282 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.002 ' CD2' ' CZ ' ' B' ' 3' ' ' PHE . 2.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 3.7 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 1.276 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.828 ' HE1' ' CB ' ' A' ' 12' ' ' TYR . 60.8 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.709 ' NE2' HD12 ' B' ' 116' ' ' LEU . 66.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.915 ' O ' ' CD1' ' B' ' 7' ' ' TYR . 1.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 4.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.4 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.741 ' HA ' HG12 ' B' ' 161' ' ' VAL . 46.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.3 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.775 ' HG3' HG22 ' B' ' 233' ' ' VAL . 10.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 71.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 1.223 ' NE2' ' CD1' ' A' ' 60' ' ' LEU . 1.2 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 1.038 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 1.612 ' CB ' HD23 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 1.208 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.685 ' HB3' ' CD ' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.731 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.439 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.439 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.63 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.692 ' CD1' HD11 ' B' ' 116' ' ' LEU . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.731 ' CD2' HG23 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.497 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 0.473 ' C ' ' HA2' ' B' ' 118' ' ' GLY . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.497 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 84.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 13.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.403 ' HG3' HE22 ' B' ' 59' ' ' GLN . 29.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.407 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.566 HE21 HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.382 ' O ' ' CD1' ' B' ' 162' ' ' TYR 0.461 0.1 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 1.047 ' N ' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.273 HG22 ' CG ' ' B' ' 162' ' ' TYR . 13.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.025 ' H ' HG23 ' B' ' 164' ' ' THR . 18.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.64 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.2 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 84.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.602 HD21 ' HA ' ' B' ' 62' ' ' ALA . 5.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.754 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.667 ' H ' ' CG2' ' B' ' 228' ' ' THR . 21.1 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.8 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 0.4 OUTLIER -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.684 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 3.0 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 0.945 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' B' ' 187' ' ' ASN . 11.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.871 ' HB3' HG22 ' B' ' 204' ' ' VAL . 18.5 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.729 ' HB ' HG23 ' B' ' 205' ' ' THR . 89.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.729 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 2.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . 0.459 HD12 HD21 ' B' ' 213' ' ' LEU . 48.3 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 18.3 mt -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.945 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . 0.459 HD21 HD12 ' B' ' 207' ' ' ILE . 54.1 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 54.7 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.667 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.5 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.775 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.63 126.87 29.24 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.517 1.136 . . . . 0.0 110.022 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.916 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.48 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.369 1.043 . . . . 0.0 109.265 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.9 40.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.254 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.505 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.4 112.1 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.081 . . . . 0.0 109.35 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.72 133.55 35.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.485 1.116 . . . . 0.0 109.346 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.545 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.06 6.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 0.0 110.924 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.48 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.579 1.174 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.3 p -108.07 160.68 15.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 0.736 . . . . 0.0 110.431 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.82 -15.93 24.54 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.382 1.051 . . . . 0.0 109.328 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 35.2 mttt -90.63 39.7 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.536 1.148 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 1.346 ' OH ' ' HB2' ' B' ' 3' ' ' PHE . 0.8 OUTLIER 38.21 29.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.503 1.127 . . . . 0.0 111.016 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.631 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.69 58.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 0.0 109.34 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 9.3 Cg_endo -75.0 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.452 1.764 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 9' ' ' THR . 1.4 pp -150.75 151.25 32.1 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 0.0 109.307 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -77.34 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 1.132 . . . . 0.0 110.965 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.92 26.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 124.47 1.106 . . . . 0.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.05 140.97 70.25 Favored 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.013 -2.494 . . . . 0.0 110.932 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.17 -40.16 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.548 1.155 . . . . 0.0 109.281 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.31 46.04 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.403 1.064 . . . . 0.0 109.358 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.38 31.03 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.7 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.461 1.101 . . . . 0.0 110.098 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.87 -177.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.442 1.089 . . . . 0.0 109.259 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.49 158.33 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 105.42 0.28 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.557 1.161 . . . . 0.0 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.47 8.44 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.5 1.125 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.14 11.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 0.754 . . . . 0.0 109.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.49 154.26 39.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.43 102.58 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.576 1.172 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.49 18.15 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.59 1.181 . . . . 0.0 110.299 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.473 1.108 . . . . 0.0 110.953 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.5 ttp -97.99 119.26 36.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 1.057 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.41 -66.04 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.209 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.1 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.27 40.58 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.523 1.139 . . . . 0.0 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 1.018 ' CD ' ' HB2' ' B' ' 62' ' ' ALA . 9.5 Cg_endo -74.96 -168.9 6.86 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.993 -0.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.635 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 72.8 m-70 -144.21 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 0.0 109.584 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.874 ' HB3' ' OD2' ' B' ' 63' ' ' ASP . 0.9 OUTLIER 173.96 166.98 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HD13 ' A' ' 42' ' ' ILE . 60.5 t -104.11 114.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.578 1.174 . . . . 0.0 109.356 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.71 ' CG1' ' OD1' ' A' ' 40' ' ' ASN . 4.3 mm -132.77 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 0.0 109.308 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 0.0 110.939 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 2.5 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 0.0 109.253 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.074 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.45 158.09 72.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.372 1.045 . . . . 0.0 109.286 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 164.2 33.72 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.493 1.786 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.2 135.61 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.446 1.092 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.68 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.535 1.147 . . . . 0.0 111.014 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.496 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.06 -173.32 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.595 0.82 . . . . 0.0 110.303 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.16 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.426 1.079 . . . . 0.0 109.954 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 1.074 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.81 71.33 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.45 1.094 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.08 50.8 2.65 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.491 1.785 . . . . 0.0 110.887 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.23 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.591 1.182 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.05 -27.55 68.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 0.0 109.306 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -46.51 115.08 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.56 1.163 . . . . 0.0 109.988 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.489 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -107.96 117.7 34.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 109.358 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.77 21.94 3.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.438 1.086 . . . . 0.0 110.347 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -86.11 64.43 8.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.453 1.096 . . . . 0.0 109.244 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.048 HD11 ' OE1' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -40.51 102.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.35 98.44 5.97 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -68.7 -46.07 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.326 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.62 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.316 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 27.6 Cg_endo -75.04 139.14 23.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.438 1.757 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.96 0.17 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.505 1.128 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.534 0.785 . . . . 0.0 109.989 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 1.11 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.51 175.1 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.58 161.31 20.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 0.0 109.978 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.475 1.109 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.12 8.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.482 1.114 . . . . 0.0 109.223 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.468 1.105 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.1 37.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.538 0.787 . . . . 0.0 110.412 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.06 141.53 26.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.465 1.771 . . . . 0.0 111.043 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.4 1.062 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -104.88 120.06 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 0.761 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.71 30.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.546 1.154 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.93 145.17 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.462 1.101 . . . . 0.0 109.966 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.2 -171.58 3.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.449 1.093 . . . . 0.0 110.951 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 30.5 p90 -171.84 165.42 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.57 122.38 35.96 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.425 1.078 . . . . 0.0 108.262 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.658 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -51.35 -50.8 74.08 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.398 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.677 ' CD ' HD21 ' A' ' 40' ' ' ASN . 12.8 Cg_endo -75.0 -62.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.237 0 O-C-N 124.498 1.788 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.468 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 22.0 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.751 HH11 ' CG ' ' A' ' 86' ' ' ARG . 2.7 ttt85 -88.01 -38.48 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.536 1.148 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.88 32.74 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.477 1.111 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.62 -15.24 62.55 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.505 0.768 . . . . 0.0 109.406 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.18 1.83 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.449 1.093 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . 0.545 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.62 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.417 0.716 . . . . 0.0 111.003 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 11.6 m -124.15 153.58 30.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.153 . . . . 0.0 109.277 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.78 19.77 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.73 162.05 37.0 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.485 0.756 . . . . 0.0 110.471 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.65 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 0.0 109.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.1 144.54 31.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.541 1.15 . . . . 0.0 109.333 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 0.0 110.317 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' TYR . . . . . 1.201 ' CZ ' ' HG2' ' B' ' 119' ' ' PRO . 1.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' PHE . . . . . 1.346 ' HB2' ' OH ' ' A' ' 12' ' ' TYR . 23.0 m-85 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' TYR . . . . . 0.685 ' OH ' ' HD1' ' B' ' 162' ' ' TYR 0.347 0.3 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 3' ' ' PHE . 74.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 8.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' CYS . . . . . 0.749 ' HA ' HG12 ' B' ' 161' ' ' VAL . 42.1 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLN . . . . . 0.676 ' HB2' HG21 ' B' ' 233' ' ' VAL . 26.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 7.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' GLN . . . . . 1.048 ' OE1' HD11 ' A' ' 60' ' ' LEU . 2.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ALA . . . . . 1.018 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ASP . . . . . 0.874 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 5.0 m-20 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' SER . . . . . 0.949 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 10.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.46 ' CB ' ' NE2' ' B' ' 61' ' ' GLN . 54.2 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.403 HD21 HG23 ' B' ' 233' ' ' VAL . 8.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' TYR . . . . . 0.431 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' THR . . . . . 0.675 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.1 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' PRO . . . . . 1.201 ' HG2' ' CZ ' ' B' ' 1' ' ' TYR . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 48.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' ASP . . . . . 0.436 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 158' ' ' ARG . . . . . 0.639 ' H ' HE22 ' B' ' 59' ' ' GLN . 51.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 159' ' ' GLY . . . . . 0.41 ' HA3' ' SG ' ' B' ' 24' ' ' CYS . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 160' ' ' GLN . . . . . 0.506 HE21 ' ND2' ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 161' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.6 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 162' ' ' TYR . . . . . 1.043 ' HB3' HG22 ' B' ' 164' ' ' THR . 18.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 163' ' ' PRO . . . . . 0.652 ' HB3' ' CD1' ' B' ' 4' ' ' TYR . 1.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 164' ' ' THR . . . . . 1.043 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 166' ' ' GLU . . . . . 1.0 ' H ' HG23 ' B' ' 164' ' ' THR . 19.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 167' ' ' LEU . . . . . 0.49 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 53.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 169' ' ' ASN . . . . . 0.575 HD21 ' HA ' ' B' ' 62' ' ' ALA . 1.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 170' ' ' ASN . . . . . 0.755 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.1 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 39.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 56.1 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 186' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 56.9 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 187' ' ' ASN . . . . . 0.691 ' O ' ' CD1' ' B' ' 189' ' ' PHE . 5.4 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 189' ' ' PHE . . . . . 0.825 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.271 0.5 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 191' ' ' PHE . . . . . 0.416 ' C ' ' CG ' ' B' ' 192' ' ' ASP . 12.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 192' ' ' ASP . . . . . 0.65 ' HB3' HG22 ' B' ' 204' ' ' VAL . 0.0 OUTLIER -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 193' ' ' VAL . . . . . 0.631 ' HA ' HG22 ' B' ' 184' ' ' ILE . 92.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 204' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 205' ' ' THR . . . . . 0.615 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 76.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 208' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 209' ' ' PRO . . . . . 0.825 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.0 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 211' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 3.1 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 233' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.66 126.8 28.94 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.489 1.118 . . . . 0.0 109.989 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 O-C-N 124.447 1.092 . . . . 0.0 109.22 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.99 150.8 40.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.472 1.107 . . . . 0.0 110.318 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.13 38.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.337 1.023 . . . . 0.0 109.259 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.68 133.49 35.95 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.528 1.143 . . . . 0.0 109.302 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 96.99 6.88 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.513 1.133 . . . . 0.0 110.955 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.51 7.64 Favored Glycine 0 CA--C 1.528 0.87 0 O-C-N 124.491 1.119 . . . . 0.0 111.009 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.625 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.08 160.63 15.65 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.389 0.699 . . . . 0.0 110.391 179.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -59.74 -16.03 24.41 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.399 1.062 . . . . 0.0 109.315 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.2 mttp -90.55 39.64 0.98 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.515 1.134 . . . . 0.0 109.36 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 38.21 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.592 1.182 . . . . 0.0 111.064 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.625 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.82 117.7 58.15 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.522 ' HG3' ' CE2' ' B' ' 3' ' ' PHE . 36.0 Cg_endo -74.98 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.456 1.766 . . . . 0.0 111.037 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' N ' ' SD ' ' A' ' 90' ' ' MET . 3.1 pp -150.74 151.24 32.1 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.491 1.119 . . . . 0.0 109.323 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.409 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.38 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.556 1.16 . . . . 0.0 111.007 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.86 26.55 Favored Pre-proline 0 C--N 1.326 -0.416 0 O-C-N 124.459 1.1 . . . . 0.0 110.318 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.15 140.98 70.19 Favored 'Cis proline' 0 C--N 1.361 1.203 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.96 0.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.5 tttt -40.17 -40.04 1.03 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.58 1.175 . . . . 0.0 109.342 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.35 46.11 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.365 1.041 . . . . 0.0 109.273 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.977 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.31 141.32 30.94 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.491 1.119 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.93 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.554 1.159 . . . . 0.0 110.026 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.542 1.151 . . . . 0.0 109.26 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.55 158.26 27.7 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.499 1.124 . . . . 0.0 109.968 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.44 0.28 Allowed 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.452 1.095 . . . . 0.0 109.285 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.38 8.48 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.542 1.151 . . . . 0.0 110.961 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.09 174.16 11.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.48 0.753 . . . . 0.0 109.291 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.65 154.28 39.58 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.62 1.2 . . . . 0.0 110.464 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.9 t -131.47 102.63 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.51 1.131 . . . . 0.0 109.278 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.78 169.57 18.02 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.468 1.105 . . . . 0.0 110.313 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.48 9.54 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.515 1.134 . . . . 0.0 110.902 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.679 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.28 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.57 1.169 . . . . 0.0 109.301 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.689 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 11.7 ttp -97.96 119.21 36.18 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.433 1.083 . . . . 0.0 111.009 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.332 6.9 m-20 -79.36 -66.04 0.92 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 124.589 1.181 . . . . 0.0 109.243 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.492 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 14.8 p 46.04 54.93 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.552 1.158 . . . . 0.0 109.276 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.628 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.47 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.564 1.165 . . . . 0.0 111.033 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.002 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 30.0 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.361 1.21 0 C-N-CA 120.93 -2.529 . . . . 0.0 111.03 -0.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 124.499 1.124 . . . . 0.0 109.575 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.95 167.05 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.515 1.134 . . . . 0.0 109.253 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.623 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.1 t -104.18 114.41 43.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.56 1.163 . . . . 0.0 109.289 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.623 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.0 mm -132.82 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.551 1.157 . . . . 0.0 109.305 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.0 m-85 -47.71 160.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.488 1.118 . . . . 0.0 110.991 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.04 4.77 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.283 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.446 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.6 mtpt 167.35 143.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.6 1.187 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.022 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.55 158.08 72.98 Favored Pre-proline 0 C--N 1.324 -0.512 0 O-C-N 124.436 1.085 . . . . 0.0 109.297 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.3 Cg_endo -75.03 164.17 33.84 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.538 1.809 . . . . 0.0 111.044 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.17 135.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.392 1.058 . . . . 0.0 109.276 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.44 -56.55 0.72 Allowed Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.578 1.174 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.557 0.798 . . . . 0.0 110.279 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.25 77.76 1.75 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.495 1.122 . . . . 0.0 110.001 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.022 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.42 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.522 1.139 . . . . 0.0 109.353 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.748 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.01 50.82 2.63 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.466 1.772 . . . . 0.0 110.943 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.48 1.113 . . . . 0.0 109.308 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.49 68.14 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.502 1.126 . . . . 0.0 109.339 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 m -46.55 115.14 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.575 1.172 . . . . 0.0 109.98 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.576 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.7 m120 -108.01 117.63 34.63 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.408 1.067 . . . . 0.0 109.315 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.49 ' O ' HD23 ' A' ' 60' ' ' LEU . 8.8 t -89.73 21.73 3.39 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.41 1.069 . . . . 0.0 110.381 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -85.87 64.32 8.53 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.455 1.097 . . . . 0.0 109.264 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.67 HD12 HD11 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -40.37 102.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.427 1.079 . . . . 0.0 109.351 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.02 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 124.617 1.198 . . . . 0.0 109.339 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.67 HD11 HD12 ' A' ' 60' ' ' LEU . 2.6 mm -68.65 -46.18 80.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.596 1.185 . . . . 0.0 109.282 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.63 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.13 . . . . 0.0 109.265 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -74.95 139.1 24.01 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.452 1.764 . . . . 0.0 111.108 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.95 -67.97 0.17 Allowed Glycine 0 CA--C 1.531 1.051 0 O-C-N 124.502 1.126 . . . . 0.0 110.886 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.679 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.511 0.771 . . . . 0.0 110.009 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.587 1.179 . . . . 0.0 110.936 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.42 175.18 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 111.044 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.478 1.112 . . . . 0.0 109.983 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.11 137.69 8.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.526 1.141 . . . . 0.0 109.348 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.17 146.46 23.97 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.444 1.09 . . . . 0.0 110.378 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.4 mt -124.18 173.05 8.57 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.554 1.159 . . . . 0.0 109.231 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.526 1.141 . . . . 0.0 110.944 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.13 37.57 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.53 0.782 . . . . 0.0 110.424 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.97 141.5 26.8 Favored 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.437 1.756 . . . . 0.0 111.023 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.6 20.09 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.93 120.07 40.54 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.571 0.806 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.834 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.74 30.92 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.545 1.153 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.94 145.04 49.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.458 1.099 . . . . 0.0 110.01 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.09 -171.48 3.72 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.504 1.128 . . . . 0.0 110.943 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.763 ' HB2' ' NH1' ' A' ' 86' ' ' ARG . 38.7 p90 -171.9 165.4 6.41 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.505 1.128 . . . . 0.0 110.973 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.2 OUTLIER -93.52 122.27 35.78 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.485 1.116 . . . . 0.0 108.335 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.83 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.6 OUTLIER -51.26 -50.82 73.71 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.561 1.163 . . . . 0.0 110.408 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.74 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 37.7 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.576 1.829 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.67 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 25.4 m80 -75.06 57.91 0.85 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.57 1.169 . . . . 0.0 109.562 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.019 ' NH1' ' HG2' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.95 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.577 1.173 . . . . 0.0 110.315 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.86 32.73 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.462 1.101 . . . . 0.0 110.923 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.458 ' HB2' ' HE1' ' B' ' 4' ' ' TYR . . . -65.65 -15.2 62.54 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.489 0.758 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.12 63.14 1.83 Allowed Glycine 0 CA--C 1.531 1.043 0 O-C-N 124.431 1.082 . . . . 0.0 110.974 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.07 1.16 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 0.798 . . . . 0.0 110.971 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.722 ' CG1' HH22 ' A' ' 86' ' ' ARG . 11.6 m -124.26 153.59 30.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.473 1.108 . . . . 0.0 109.227 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.56 -174.75 19.77 Favored Glycine 0 CA--C 1.532 1.115 0 O-C-N 124.546 1.154 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.82 162.0 37.19 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.547 0.792 . . . . 0.0 110.432 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.57 122.63 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 O-C-N 124.496 1.122 . . . . 0.0 109.296 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.443 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.9 m -105.07 144.47 31.83 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.436 1.085 . . . . 0.0 110.403 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.76 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 O-C-N 124.559 1.162 . . . . 0.0 109.353 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.525 1.14 . . . . 0.0 110.38 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.868 ' H3 ' ' HD2' ' B' ' 4' ' ' TYR . 18.5 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.522 ' CE2' ' HG3' ' A' ' 14' ' ' PRO . 0.6 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.868 ' HD2' ' H3 ' ' B' ' 1' ' ' TYR . 46.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.4 m-20 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 46.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.71 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.722 HE22 ' HA2' ' B' ' 157' ' ' GLY . 13.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 65' ' ' SER . 7.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.83 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.453 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 4.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.71 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.2 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.726 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 40.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 31.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.401 ' CE2' HD23 ' B' ' 103' ' ' LEU . 6.7 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.401 HD23 ' CE2' ' B' ' 102' ' ' TYR . 74.9 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.035 HG13 ' HG ' ' B' ' 115' ' ' LEU . 65.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.777 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.891 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.035 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.891 HD11 ' HA ' ' B' ' 107' ' ' TYR . 1.1 mp -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.002 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.472 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.0 OUTLIER -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.402 ' HD3' HG21 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.472 ' CE1' HD22 ' B' ' 120' ' ' LEU . 20.7 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 58.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.722 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.404 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' B' ' 24' ' ' CYS . 1.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' B' ' 168' ' ' SER . 0.4 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.0 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.008 HG22 ' H ' ' B' ' 166' ' ' GLU . 0.4 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.008 ' H ' HG22 ' B' ' 164' ' ' THR . 2.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.452 HD13 ' HA ' ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.678 ' HA ' ' CE1' ' B' ' 162' ' ' TYR . 95.9 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 36.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 55.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 1.9 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.047 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 8.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.803 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 52.2 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.788 HD22 ' H ' ' B' ' 208' ' ' LEU . 1.1 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.047 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.669 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.83 29.06 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.466 1.104 . . . . 0.0 110.057 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.13 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.451 1.095 . . . . 0.0 109.256 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.89 40.28 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.483 1.114 . . . . 0.0 110.272 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.36 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 124.407 1.067 . . . . 0.0 109.246 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.515 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.45 36.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.533 1.145 . . . . 0.0 109.388 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.618 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.525 1.141 . . . . 0.0 111.003 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 1.025 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.14 144.49 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.949 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.705 ' CG2' HD11 ' A' ' 15' ' ' LEU . 23.9 p -108.08 160.6 15.67 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.441 0.73 . . . . 0.0 110.402 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -15.96 23.95 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.436 1.085 . . . . 0.0 109.36 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' O ' ' N ' ' A' ' 13' ' ' ALA . 14.2 mttt -90.59 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.49 1.119 . . . . 0.0 109.308 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 38.29 29.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.536 1.147 . . . . 0.0 111.029 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.78 117.71 58.17 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.484 1.115 . . . . 0.0 109.318 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 24.7 Cg_endo -75.02 97.72 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.128 0 O-C-N 124.428 1.752 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.705 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.5 pp -150.87 151.26 31.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.484 1.115 . . . . 0.0 109.31 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.18 30.51 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.465 1.103 . . . . 0.0 110.96 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.534 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.46 134.82 26.51 Favored Pre-proline 0 C--N 1.326 -0.426 0 O-C-N 124.467 1.104 . . . . 0.0 110.364 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.92 69.94 Favored 'Cis proline' 0 C--N 1.359 1.12 0 C-N-CA 121.061 -2.474 . . . . 0.0 110.993 0.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.08 1.05 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.565 1.165 . . . . 0.0 109.306 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.34 46.08 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.451 1.094 . . . . 0.0 109.264 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.03 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.625 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.91 143.83 51.0 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.543 1.152 . . . . 0.0 110.069 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.659 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.98 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 124.559 1.162 . . . . 0.0 109.205 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.64 158.28 27.74 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.531 1.144 . . . . 0.0 109.972 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.13 105.47 0.28 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.549 1.156 . . . . 0.0 109.201 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.31 8.52 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.659 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.07 11.52 Favored 'General case' 0 C--N 1.323 -0.567 0 O-C-N 124.527 0.781 . . . . 0.0 109.238 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.47 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.616 1.197 . . . . 0.0 110.491 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.44 102.61 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.489 1.118 . . . . 0.0 109.322 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.5 18.12 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 110.223 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.4 9.54 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.502 1.126 . . . . 0.0 110.936 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.622 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.32 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.442 1.089 . . . . 0.0 109.276 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.1 ttp -97.93 119.16 36.06 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.426 1.079 . . . . 0.0 111.046 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.025 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.31 -66.07 0.92 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.624 1.203 . . . . 0.0 109.268 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.539 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.454 1.096 . . . . 0.0 109.321 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 7.1 p 46.02 54.82 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 109.336 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.84 ' O ' ' HD2' ' B' ' 119' ' ' PRO . . . -92.94 -172.31 40.58 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.491 1.12 . . . . 0.0 111.079 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.176 ' HD3' ' O ' ' B' ' 119' ' ' PRO . 58.6 Cg_endo -74.97 -168.9 6.85 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.961 -2.516 . . . . 0.0 110.973 -0.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.671 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.26 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.077 . . . . 0.0 109.617 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.482 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.5 p30 173.97 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.251 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.06 114.27 43.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.502 1.126 . . . . 0.0 109.418 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.571 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.73 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 109.343 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.69 160.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 111.0 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.448 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.8 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.527 1.142 . . . . 0.0 109.276 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.1 mttt 167.32 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.121 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.85 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.426 1.079 . . . . 0.0 109.21 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.06 164.22 33.67 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.493 1.786 . . . . 0.0 110.965 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.2 135.58 1.38 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.444 1.09 . . . . 0.0 109.345 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.462 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.63 0.72 Allowed Glycine 0 CA--C 1.531 1.068 0 O-C-N 124.492 1.12 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.26 2.2 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.586 0.816 . . . . 0.0 110.301 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.21 77.75 1.75 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.515 1.134 . . . . 0.0 110.031 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.121 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.8 71.41 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.469 1.106 . . . . 0.0 109.358 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -74.99 50.74 2.6 Favored 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.478 1.778 . . . . 0.0 110.988 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.64 0.07 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.537 1.148 . . . . 0.0 109.313 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.61 68.21 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 109.264 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 6.0 m -46.49 115.16 0.95 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.511 1.132 . . . . 0.0 109.966 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.93 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.452 1.095 . . . . 0.0 109.325 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 t -89.8 21.85 3.38 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.383 1.052 . . . . 0.0 110.307 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 39.7 tttt -86.0 64.37 8.55 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.57 1.169 . . . . 0.0 109.219 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.531 HD12 ' H ' ' A' ' 60' ' ' LEU . 3.4 mp -40.44 102.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.559 1.162 . . . . 0.0 109.322 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.743 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.48 6.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.553 1.158 . . . . 0.0 109.284 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.032 HD11 ' HA ' ' B' ' 120' ' ' LEU . 0.7 OUTLIER -68.71 -46.15 80.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 O-C-N 124.601 1.188 . . . . 0.0 109.282 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.88 Favored Pre-proline 0 C--N 1.326 -0.453 0 O-C-N 124.456 1.098 . . . . 0.0 109.331 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.835 ' HG3' ' CD1' ' B' ' 102' ' ' TYR . 72.3 Cg_endo -75.06 139.16 23.81 Favored 'Trans proline' 0 C--N 1.361 1.21 0 O-C-N 124.389 1.731 . . . . 0.0 111.005 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -68.01 0.17 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.501 1.126 . . . . 0.0 110.995 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.622 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.449 0.735 . . . . 0.0 110.014 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.743 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.1 m-85 -38.23 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.471 1.107 . . . . 0.0 110.965 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.55 175.09 4.17 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.448 1.093 . . . . 0.0 111.009 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.29 20.86 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.451 1.094 . . . . 0.0 109.95 -179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.08 137.71 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.486 1.116 . . . . 0.0 109.402 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.33 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.583 1.177 . . . . 0.0 110.381 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.3 mt -124.14 173.1 8.52 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.536 1.148 . . . . 0.0 109.186 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.023 0 O-C-N 124.536 1.147 . . . . 0.0 110.923 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.462 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.24 124.11 37.6 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.467 0.745 . . . . 0.0 110.426 -179.969 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.52 26.8 Favored 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.527 1.804 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.62 20.05 Favored Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.415 1.072 . . . . 0.0 111.046 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.04 40.45 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.518 0.776 . . . . 0.0 110.378 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.74 30.9 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.59 1.181 . . . . 0.0 111.021 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.86 145.17 49.29 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.155 . . . . 0.0 110.019 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.52 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.496 1.122 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.42 ' CB ' HG12 ' A' ' 91' ' ' VAL . 38.5 p90 -171.83 165.41 6.5 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.48 1.113 . . . . 0.0 110.959 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.55 122.3 35.84 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.4 1.063 . . . . 0.0 108.302 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.574 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.5 m -51.3 -50.79 73.97 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.482 1.114 . . . . 0.0 110.427 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.574 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.567 1.825 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 5.4 m170 -75.0 58.03 0.84 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.542 1.151 . . . . 0.0 109.602 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.512 ' NE ' ' O ' ' A' ' 86' ' ' ARG . 1.5 tpm_? -88.0 -38.53 15.43 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.506 1.128 . . . . 0.0 110.305 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.51 -23.79 32.81 Favored Glycine 0 CA--C 1.531 1.036 0 O-C-N 124.438 1.086 . . . . 0.0 110.973 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.27 62.62 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.531 0.783 . . . . 0.0 109.333 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.21 1.82 Allowed Glycine 0 CA--C 1.529 0.937 0 O-C-N 124.464 1.103 . . . . 0.0 110.964 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.618 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.0 1.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.424 0.72 . . . . 0.0 111.067 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.42 HG12 ' CB ' ' A' ' 81' ' ' TYR . 14.9 m -124.13 153.59 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.505 1.128 . . . . 0.0 109.295 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.58 -174.69 19.73 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.482 1.114 . . . . 0.0 110.981 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.83 162.09 36.98 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 0.772 . . . . 0.0 110.313 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.66 122.56 3.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -104.98 144.51 31.71 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 1.124 . . . . 0.0 110.435 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.282 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.568 1.167 . . . . 0.0 110.3 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.619 ' HE1' HBD1 ' B' ' 250' ' ' HEC . 56.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.789 ' CD2' ' HG3' ' B' ' 163' ' ' PRO . 4.2 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.9 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.559 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.559 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 79.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.786 ' HB2' HG21 ' B' ' 233' ' ' VAL . 14.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.503 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 15.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.478 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 0.5 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.478 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 68.7 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 32.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 5.7 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.661 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 93.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 4.9 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.77 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.835 ' CD1' ' HG3' ' A' ' 64' ' ' PRO . 2.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.722 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.4 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.088 HG13 ' HG ' ' B' ' 115' ' ' LEU . 39.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.495 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 31.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.088 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.4 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.761 ' N ' HD23 ' B' ' 115' ' ' LEU . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.176 ' O ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 1.032 ' HA ' HD11 ' A' ' 62' ' ' ILE . 1.2 mp -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.574 ' HD2' ' HG2' ' B' ' 128' ' ' MET . 0.6 OUTLIER -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.574 ' HG2' ' HD2' ' B' ' 125' ' ' TYR . 10.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.453 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.641 HH12 HD21 ' B' ' 169' ' ' ASN . 33.0 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.767 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 0.984 ' CB ' HG22 ' B' ' 164' ' ' THR . 30.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.789 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.117 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.0 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.117 ' H ' HG23 ' B' ' 164' ' ' THR . 42.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.665 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 96.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.641 HD21 HH12 ' B' ' 158' ' ' ARG . 0.8 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.462 1.2 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.193 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 25.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.686 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.193 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.53 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 20.0 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . 0.522 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 11.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.56 126.73 28.61 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.498 1.124 . . . . 0.0 110.098 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.972 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.35 177.2 3.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.426 1.079 . . . . 0.0 109.263 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -143.05 150.87 40.15 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.515 1.134 . . . . 0.0 110.29 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.516 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.38 112.16 38.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.398 1.061 . . . . 0.0 109.239 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.69 133.48 35.97 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.557 1.161 . . . . 0.0 109.352 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.701 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 96.98 6.88 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.464 1.103 . . . . 0.0 111.009 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.668 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.51 7.64 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.58 1.175 . . . . 0.0 110.967 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.614 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.7 OUTLIER -108.03 160.58 15.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.457 0.74 . . . . 0.0 110.469 179.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -59.7 -15.99 23.71 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.516 1.135 . . . . 0.0 109.36 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.4 ttmt -90.58 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.296 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 38.25 29.57 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.548 1.155 . . . . 0.0 111.048 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.614 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.76 117.73 58.13 Favored Pre-proline 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.023 ' HG3' HG21 ' A' ' 36' ' ' VAL . 8.5 Cg_endo -75.02 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.492 1.785 . . . . 0.0 110.984 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.611 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.2 pp -150.82 151.24 32.0 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.494 1.121 . . . . 0.0 109.348 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.35 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.526 1.141 . . . . 0.0 110.992 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.45 134.86 26.56 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.381 1.051 . . . . 0.0 110.35 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.06 140.97 70.22 Favored 'Cis proline' 0 C--N 1.359 1.114 0 C-N-CA 120.989 -2.505 . . . . 0.0 110.949 0.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.19 -40.08 1.04 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.566 1.166 . . . . 0.0 109.279 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.33 46.13 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.387 1.054 . . . . 0.0 109.24 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.972 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.24 141.34 31.05 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.51 1.131 . . . . 0.0 109.297 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.81 51.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.45 1.094 . . . . 0.0 110.038 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.95 -177.52 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.566 1.166 . . . . 0.0 109.242 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.809 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.514 1.134 . . . . 0.0 109.969 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.5 0.28 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.588 1.18 . . . . 0.0 109.262 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.41 -7.39 8.51 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.458 1.099 . . . . 0.0 111.052 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.12 174.11 11.51 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.526 0.78 . . . . 0.0 109.311 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.49 154.27 39.36 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.513 1.133 . . . . 0.0 110.485 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.69 6.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.507 1.129 . . . . 0.0 109.317 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.83 169.56 18.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.587 1.179 . . . . 0.0 110.228 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.562 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.1 m-85 -147.24 121.4 9.5 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.52 1.138 . . . . 0.0 110.981 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.35 33.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.486 1.116 . . . . 0.0 109.248 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.649 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.4 ttp -97.98 119.15 36.09 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m120 -79.28 -66.09 0.91 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.531 1.145 . . . . 0.0 109.248 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.501 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.5 0.76 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.451 1.094 . . . . 0.0 109.333 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.023 HG21 ' HG3' ' A' ' 14' ' ' PRO . 7.4 p 45.93 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.521 1.138 . . . . 0.0 109.352 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.562 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.0 -172.31 40.5 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.49 1.119 . . . . 0.0 111.036 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.157 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 36.2 Cg_endo -75.03 -168.87 6.85 Favored 'Cis proline' 0 C--N 1.361 1.19 0 C-N-CA 120.938 -2.526 . . . . 0.0 111.003 0.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.649 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 73.2 m-70 -144.28 -170.35 3.34 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.492 1.12 . . . . 0.0 109.592 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.643 HD22 HD22 ' A' ' 60' ' ' LEU . 2.5 p30 173.99 166.95 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.536 1.147 . . . . 0.0 109.271 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.662 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.5 t -104.07 114.41 43.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.511 1.132 . . . . 0.0 109.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.662 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.7 OUTLIER -132.84 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.503 1.127 . . . . 0.0 109.311 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.414 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.67 160.65 0.12 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.507 1.129 . . . . 0.0 110.935 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.02 -50.01 4.78 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.574 1.171 . . . . 0.0 109.256 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER 167.29 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.49 1.119 . . . . 0.0 109.261 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.013 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.12 72.87 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.432 1.082 . . . . 0.0 109.278 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.98 164.21 33.82 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.511 1.795 . . . . 0.0 111.008 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.26 135.56 1.41 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.438 1.086 . . . . 0.0 109.313 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.54 0.72 Allowed Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.518 1.136 . . . . 0.0 110.972 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.22 2.19 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 0.807 . . . . 0.0 110.227 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.23 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.492 1.12 . . . . 0.0 110.024 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.013 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.77 71.73 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.444 1.09 . . . . 0.0 109.359 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.04 50.84 2.65 Favored 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.452 1.764 . . . . 0.0 110.952 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.38 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.504 1.128 . . . . 0.0 109.281 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.63 68.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.542 1.151 . . . . 0.0 109.259 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.2 m -46.44 115.11 0.94 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.59 1.181 . . . . 0.0 110.056 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -107.92 117.68 34.75 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.453 1.096 . . . . 0.0 109.335 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.674 HG21 ' OD2' ' B' ' 63' ' ' ASP . 9.1 t -89.81 21.85 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.501 1.126 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -86.03 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.516 1.135 . . . . 0.0 109.246 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.643 HD22 HD22 ' A' ' 40' ' ' ASN . 0.1 OUTLIER -40.4 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.508 1.13 . . . . 0.0 109.326 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.46 98.44 6.06 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.58 1.175 . . . . 0.0 109.294 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' B' ' 119' ' ' PRO . 3.2 mm -68.73 -46.06 80.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.554 1.159 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.63 4.92 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.534 1.146 . . . . 0.0 109.303 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.04 139.14 23.83 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.43 1.753 . . . . 0.0 111.042 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -68.02 0.17 Allowed Glycine 0 CA--C 1.53 1.001 0 O-C-N 124.471 1.107 . . . . 0.0 111.006 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.66 97.36 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.47 0.747 . . . . 0.0 109.99 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.19 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.401 1.063 . . . . 0.0 110.953 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.49 175.1 4.2 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.475 1.109 . . . . 0.0 111.055 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.33 20.83 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.445 1.091 . . . . 0.0 109.927 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.72 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.423 1.077 . . . . 0.0 109.38 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.32 146.41 24.06 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.49 1.119 . . . . 0.0 110.398 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.06 173.13 8.47 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.501 1.126 . . . . 0.0 109.225 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.518 1.136 . . . . 0.0 110.947 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.67 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.525 0.779 . . . . 0.0 110.381 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.99 141.49 26.73 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.511 1.796 . . . . 0.0 111.054 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.433 1.083 . . . . 0.0 111.018 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.4 m -104.76 120.04 40.44 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.465 0.744 . . . . 0.0 110.399 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.79 140.76 30.89 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.575 1.172 . . . . 0.0 111.011 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.9 145.11 49.35 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.535 1.147 . . . . 0.0 110.032 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.515 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.53 3.74 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.509 1.13 . . . . 0.0 110.989 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 1.374 ' HB2' ' NH2' ' A' ' 86' ' ' ARG . 15.3 p90 -171.82 165.45 6.51 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.56 1.163 . . . . 0.0 110.967 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.62 122.3 35.93 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.381 1.051 . . . . 0.0 108.267 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.97 HG21 ' CB ' ' B' ' 62' ' ' ALA . 1.0 OUTLIER -51.25 -50.8 73.76 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.429 1.08 . . . . 0.0 110.466 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.497 ' CD ' ' N ' ' A' ' 83' ' ' THR . 19.3 Cg_endo -75.05 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.602 1.843 . . . . 0.0 110.992 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.955 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 24.6 m80 -75.06 57.99 0.86 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.574 1.171 . . . . 0.0 109.546 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.374 ' NH2' ' HB2' ' A' ' 81' ' ' TYR . 0.0 OUTLIER -87.99 -38.47 15.49 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.525 1.14 . . . . 0.0 110.313 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 1.049 ' CA ' HG23 ' B' ' 164' ' ' THR . . . -89.49 -23.84 32.74 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.487 1.117 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.22 62.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.508 0.769 . . . . 0.0 109.346 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.19 1.82 Allowed Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.701 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.58 74.96 1.15 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.48 0.753 . . . . 0.0 111.043 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.537 ' CG1' ' NH2' ' A' ' 86' ' ' ARG . 11.7 m -124.18 153.5 30.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.497 1.123 . . . . 0.0 109.283 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.46 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.5 -174.73 19.71 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.525 1.141 . . . . 0.0 111.004 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.11 36.88 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 0.761 . . . . 0.0 110.39 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.712 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.65 122.53 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 O-C-N 124.561 1.163 . . . . 0.0 109.311 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.4 m -105.02 144.52 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.477 1.111 . . . . 0.0 110.426 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.22 73.77 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.491 1.12 . . . . 0.0 109.24 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.809 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.492 1.12 . . . . 0.0 110.349 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.868 ' CZ ' ' HD2' ' A' ' 38' ' ' PRO . 19.4 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.795 ' CG ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 1.007 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 21.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.486 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 2.7 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.146 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.6 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.718 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.811 ' HG3' HG22 ' B' ' 233' ' ' VAL . 12.0 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.47 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 86.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.97 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.674 ' OD2' HG21 ' A' ' 58' ' ' THR . 0.2 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.467 ' HB2' ' OD2' ' B' ' 63' ' ' ASP . 17.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.5 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 8.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.651 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 73.2 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.552 ' HD2' HD12 ' B' ' 103' ' ' LEU . 3.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.552 HD12 ' HD2' ' B' ' 102' ' ' TYR . 1.1 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.1 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.842 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.516 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.8 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.842 ' HB2' HG23 ' B' ' 105' ' ' THR . 71.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.157 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.708 HD22 ' CE2' ' B' ' 125' ' ' TYR . 7.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.708 ' CE2' HD22 ' B' ' 120' ' ' LEU . 47.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.5 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 23.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.527 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 54.2 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.484 ' O ' HD13 ' B' ' 167' ' ' LEU . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.662 HG12 ' HA ' ' B' ' 24' ' ' CYS . 2.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 0.568 ' HB2' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 1.007 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.049 HG23 ' CA ' ' A' ' 87' ' ' GLY . 2.1 p -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.484 HD13 ' O ' ' B' ' 160' ' ' GLN . 4.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.0 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.354 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.0 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.565 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 37.9 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 0.994 ' CG ' ' HD3' ' B' ' 209' ' ' PRO 0.278 3.0 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.565 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.877 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.9 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.994 ' HD3' ' CG ' ' B' ' 189' ' ' PHE . 12.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.811 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.146 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.57 126.8 28.95 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.616 1.197 . . . . 0.0 110.06 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.17 3.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.451 1.095 . . . . 0.0 109.246 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.81 40.18 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.487 1.117 . . . . 0.0 110.349 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.38 112.17 38.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.466 1.104 . . . . 0.0 109.245 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.505 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.78 133.43 36.05 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 1.156 . . . . 0.0 109.309 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.727 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.64 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.475 1.109 . . . . 0.0 110.996 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.58 7.65 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.449 1.093 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.51 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -108.12 160.64 15.65 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.479 0.752 . . . . 0.0 110.413 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.8 -15.94 24.49 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.523 1.139 . . . . 0.0 109.28 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.9 mttt -90.56 39.59 0.98 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.507 1.13 . . . . 0.0 109.371 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.32 29.7 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.489 1.118 . . . . 0.0 110.977 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.83 117.71 58.11 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.223 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.681 ' CB ' ' CD2' ' A' ' 85' ' ' HIS . 25.0 Cg_endo -75.03 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.457 1.767 . . . . 0.0 111.066 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD21 ' OG1' ' A' ' 9' ' ' THR . 2.0 pp -150.77 151.19 31.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.502 1.126 . . . . 0.0 109.322 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.41 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.15 30.47 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 124.533 1.146 . . . . 0.0 111.008 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.48 134.84 26.53 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.533 1.146 . . . . 0.0 110.319 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.11 140.97 70.16 Favored 'Cis proline' 0 C--N 1.36 1.18 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.938 0.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.15 -40.15 1.04 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.6 1.187 . . . . 0.0 109.267 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.17 146.32 46.12 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.361 1.038 . . . . 0.0 109.328 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.23 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.563 1.164 . . . . 0.0 109.219 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.97 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 110.055 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.657 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.93 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.807 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.33 27.56 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.487 1.117 . . . . 0.0 109.971 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.17 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.592 1.183 . . . . 0.0 109.321 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.36 8.49 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.495 1.122 . . . . 0.0 111.025 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.657 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.15 174.16 11.46 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.616 0.833 . . . . 0.0 109.296 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.21 39.59 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.478 1.111 . . . . 0.0 110.464 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.37 102.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.527 1.142 . . . . 0.0 109.297 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.8 169.5 18.13 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 110.319 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.23 121.53 9.6 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.55 1.156 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.14 155.31 33.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.654 1.221 . . . . 0.0 109.252 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.809 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.2 ttp -98.0 119.21 36.22 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.479 1.112 . . . . 0.0 111.022 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.326 6.6 m-20 -79.31 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.243 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 -179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.906 HG22 ' HE2' ' A' ' 85' ' ' HIS . 11.2 p 45.93 54.87 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.468 1.105 . . . . 0.0 109.332 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 1.487 ' O ' ' CE1' ' B' ' 1' ' ' TYR . . . -92.9 -172.31 40.65 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.539 1.149 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.164 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 19.8 Cg_endo -74.93 -168.87 6.82 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 120.998 -2.501 . . . . 0.0 111.018 -0.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.809 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.1 m-70 -144.26 -170.38 3.34 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.482 1.113 . . . . 0.0 109.609 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.426 1.079 . . . . 0.0 109.251 179.944 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 56.7 t -104.01 114.33 43.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.595 1.185 . . . . 0.0 109.414 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.0 mm -132.8 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.508 1.13 . . . . 0.0 109.256 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.429 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.7 160.59 0.12 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.472 1.108 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -49.99 4.8 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.546 1.154 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 12.1 mttt 167.22 143.49 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.57 1.169 . . . . 0.0 109.343 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.034 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.49 158.16 72.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.456 1.097 . . . . 0.0 109.275 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 164.26 33.54 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.427 1.751 . . . . 0.0 110.938 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.35 135.67 1.42 Allowed 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.47 1.106 . . . . 0.0 109.279 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.463 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.54 0.72 Allowed Glycine 0 CA--C 1.532 1.128 0 O-C-N 124.565 1.166 . . . . 0.0 110.955 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.621 0.836 . . . . 0.0 110.305 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.13 77.8 1.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.492 1.12 . . . . 0.0 110.02 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.034 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.79 71.68 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.463 1.102 . . . . 0.0 109.292 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.4 Cg_endo -75.01 50.74 2.61 Favored 'Trans proline' 0 C--N 1.359 1.099 0 O-C-N 124.392 1.733 . . . . 0.0 110.995 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.73 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.609 1.193 . . . . 0.0 109.301 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.48 68.1 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.543 1.152 . . . . 0.0 109.3 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 75.0 m -46.5 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.56 1.162 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.604 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 85.0 m-20 -107.94 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.418 1.074 . . . . 0.0 109.311 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.508 HG23 ' NE2' ' B' ' 61' ' ' GLN . 11.6 t -89.82 21.84 3.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.377 1.048 . . . . 0.0 110.317 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 50.5 tttt -85.97 64.43 8.58 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.43 1.082 . . . . 0.0 109.251 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.911 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.5 102.44 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.509 1.131 . . . . 0.0 109.307 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.37 5.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.553 1.158 . . . . 0.0 109.31 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.911 HD11 HD12 ' A' ' 60' ' ' LEU . 2.1 mm -68.7 -46.02 80.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.596 1.185 . . . . 0.0 109.337 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.12 111.59 4.85 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.46 1.1 . . . . 0.0 109.33 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -75.06 139.21 23.86 Favored 'Trans proline' 0 C--N 1.36 1.143 0 O-C-N 124.539 1.81 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.493 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.515 1.134 . . . . 0.0 110.957 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.69 97.35 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.539 0.788 . . . . 0.0 110.034 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.24 -86.65 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.532 1.145 . . . . 0.0 110.953 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.604 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.58 175.12 4.14 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.359 1.037 . . . . 0.0 110.991 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.32 20.87 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.531 1.144 . . . . 0.0 109.96 -179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.07 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.4 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.47 23.99 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.474 1.109 . . . . 0.0 110.394 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.11 173.06 8.54 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.464 1.102 . . . . 0.0 109.27 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.41 0.02 OUTLIER Glycine 0 CA--C 1.529 0.909 0 O-C-N 124.505 1.128 . . . . 0.0 110.955 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.463 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.08 37.34 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.452 0.736 . . . . 0.0 110.418 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -74.99 141.46 26.69 Favored 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.523 1.802 . . . . 0.0 110.953 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.59 20.11 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.48 1.112 . . . . 0.0 110.985 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.86 120.07 40.52 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.461 0.742 . . . . 0.0 110.367 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.83 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.73 30.91 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.517 1.136 . . . . 0.0 110.995 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.85 145.08 49.34 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.516 1.135 . . . . 0.0 110.03 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.16 -171.55 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.518 1.136 . . . . 0.0 110.962 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.926 ' CB ' ' NH2' ' A' ' 86' ' ' ARG . 16.9 p90 -171.81 165.42 6.53 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 1.122 . . . . 0.0 110.995 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 85' ' ' HIS . 0.5 OUTLIER -93.55 122.3 35.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.468 1.105 . . . . 0.0 108.276 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.758 HG21 ' HB2' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.21 -50.86 73.25 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.508 1.13 . . . . 0.0 110.476 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' CD ' ' N ' ' A' ' 83' ' ' THR . 37.4 Cg_endo -75.04 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.111 0 O-C-N 124.534 1.807 . . . . 0.0 110.953 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.906 ' HE2' HG22 ' A' ' 36' ' ' VAL . 49.1 m80 -75.04 57.94 0.85 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.574 1.171 . . . . 0.0 109.503 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.185 HH12 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.02 -38.43 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.531 1.144 . . . . 0.0 110.325 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.91 32.52 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 124.433 1.083 . . . . 0.0 110.942 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.22 62.56 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.523 0.778 . . . . 0.0 109.33 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.529 0.952 0 O-C-N 124.509 1.131 . . . . 0.0 111.014 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.727 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.6 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.449 0.735 . . . . 0.0 111.018 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.185 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.24 153.61 30.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.565 1.166 . . . . 0.0 109.239 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.48 -174.76 19.72 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.525 1.14 . . . . 0.0 111.006 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.79 162.06 37.01 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.45 0.735 . . . . 0.0 110.441 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.0 mt -146.65 122.64 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.52 31.78 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.441 1.088 . . . . 0.0 110.403 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.547 1.154 . . . . 0.0 109.255 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.807 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.566 0 O-C-N 124.604 1.19 . . . . 0.0 110.32 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.487 ' CE1' ' O ' ' A' ' 37' ' ' GLY 0.427 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.493 ' HB3' HD22 ' B' ' 116' ' ' LEU . 3.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 14' ' ' PRO . 71.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 1.612 ' CZ ' ' HG2' ' B' ' 163' ' ' PRO . 0.1 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.426 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.539 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.5 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 47.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.73 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 1.004 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 17.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.434 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 84.5 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.508 ' NE2' HG23 ' A' ' 58' ' ' THR . 8.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.758 ' HB2' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.439 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 26.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.73 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.726 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.0 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.544 ' CD2' HD23 ' B' ' 103' ' ' LEU . 21.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.544 HD23 ' CD2' ' B' ' 102' ' ' TYR . 45.2 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.044 HG13 ' HG ' ' B' ' 115' ' ' LEU . 79.7 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.42 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.1 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.505 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 25.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.044 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.711 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.6 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.164 ' HG2' ' CD ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.611 HD22 ' CE1' ' B' ' 125' ' ' TYR . 1.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.611 ' CE1' HD22 ' B' ' 120' ' ' LEU . 69.1 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.9 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 1.004 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.751 HG12 ' HA ' ' B' ' 24' ' ' CYS . 7.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.147 ' HB3' HG22 ' B' ' 164' ' ' THR . 0.9 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 1.612 ' HG2' ' CZ ' ' B' ' 4' ' ' TYR . 5.9 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.147 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.993 ' H ' HG23 ' B' ' 164' ' ' THR . 15.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.476 ' N ' HD22 ' B' ' 167' ' ' LEU . 4.5 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 78.2 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.566 HD21 ' HA ' ' B' ' 62' ' ' ALA . 12.2 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.356 22.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.599 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 42.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.183 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 3.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.599 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 54.6 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.895 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.8 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.183 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 8.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.794 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.76 28.76 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.55 1.157 . . . . 0.0 109.998 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.8 m -122.48 177.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.416 1.073 . . . . 0.0 109.265 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.82 40.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 110.324 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.34 112.11 38.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.404 1.065 . . . . 0.0 109.258 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.7 133.45 36.0 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.465 1.103 . . . . 0.0 109.323 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.638 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.454 1.096 . . . . 0.0 110.952 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 1.031 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.08 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.919 0 O-C-N 124.464 1.102 . . . . 0.0 111.008 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.553 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -108.06 160.58 15.69 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.417 0.716 . . . . 0.0 110.413 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -59.71 -16.0 23.77 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.375 1.047 . . . . 0.0 109.357 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 20.7 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.521 1.138 . . . . 0.0 109.369 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.529 ' OH ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.556 1.16 . . . . 0.0 111.022 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.553 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.9 117.69 58.1 Favored Pre-proline 0 C--N 1.325 -0.484 0 O-C-N 124.49 1.119 . . . . 0.0 109.247 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.57 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 41.0 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 O-C-N 124.432 1.754 . . . . 0.0 111.021 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.7 pp -150.79 151.21 31.99 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.435 1.085 . . . . 0.0 109.299 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.405 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.31 126.19 30.53 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.509 1.131 . . . . 0.0 110.991 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.536 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.419 0 O-C-N 124.457 1.098 . . . . 0.0 110.323 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.91 69.88 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 121.018 -2.493 . . . . 0.0 110.978 0.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -40.13 -40.06 1.02 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.58 1.175 . . . . 0.0 109.304 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.21 146.31 46.16 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.345 1.028 . . . . 0.0 109.227 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.31 30.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.492 1.12 . . . . 0.0 109.288 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.613 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.92 143.73 50.96 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.519 1.137 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.89 -177.51 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.476 1.11 . . . . 0.0 109.33 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.823 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.991 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.475 1.11 . . . . 0.0 109.313 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.45 8.46 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.551 1.157 . . . . 0.0 110.976 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.13 174.16 11.47 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.466 0.745 . . . . 0.0 109.28 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.572 1.17 . . . . 0.0 110.437 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.718 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.47 102.71 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.81 169.55 18.05 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.551 1.157 . . . . 0.0 110.251 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.27 121.53 9.57 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.514 1.134 . . . . 0.0 110.888 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.13 155.31 33.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.552 1.158 . . . . 0.0 109.275 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.876 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.3 ttp -97.98 119.19 36.17 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.489 1.118 . . . . 0.0 111.015 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.031 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.0 OUTLIER -79.37 -65.99 0.93 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.548 1.155 . . . . 0.0 109.257 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.2 OUTLIER -168.88 -167.57 0.76 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.57 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 12.1 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.548 1.155 . . . . 0.0 109.327 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.616 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.03 -172.27 40.44 Favored Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.561 1.163 . . . . 0.0 111.042 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.98 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 5.5 Cg_endo -74.96 -168.85 6.81 Favored 'Cis proline' 0 C--N 1.361 1.226 0 C-N-CA 120.9 -2.542 . . . . 0.0 111.072 -0.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.876 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.5 m-70 -144.2 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.518 1.136 . . . . 0.0 109.578 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 p30 173.98 167.04 0.21 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.516 1.135 . . . . 0.0 109.256 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.594 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.15 114.39 43.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.566 1.166 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.594 HD13 ' O ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.581 1.175 . . . . 0.0 109.318 -179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.79 160.68 0.12 Allowed 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.5 1.125 . . . . 0.0 110.967 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.03 -50.04 4.77 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.475 1.109 . . . . 0.0 109.261 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.63 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.582 1.176 . . . . 0.0 109.255 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.041 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.3 m -128.57 158.12 72.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.483 1.114 . . . . 0.0 109.259 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.1 164.26 33.53 Favored 'Trans proline' 0 C--N 1.361 1.198 0 O-C-N 124.541 1.811 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.53 1.39 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.437 1.086 . . . . 0.0 109.319 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.51 0.72 Allowed Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.597 1.186 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.533 0.784 . . . . 0.0 110.26 -179.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.21 77.67 1.74 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 110.035 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.041 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.95 -51.9 70.26 Favored Pre-proline 0 C--N 1.325 -0.495 0 O-C-N 124.427 1.079 . . . . 0.0 109.281 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.769 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.5 Cg_endo -74.92 50.8 2.59 Favored 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.508 1.794 . . . . 0.0 110.972 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.32 -45.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.598 1.187 . . . . 0.0 109.314 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.03 -27.57 68.21 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 109.285 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 74.8 m -46.43 115.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.575 1.172 . . . . 0.0 110.02 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.409 HD22 ' CB ' ' A' ' 59' ' ' LYS . 1.6 t30 -107.95 117.63 34.64 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.467 1.104 . . . . 0.0 109.36 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.429 HG21 ' HB3' ' B' ' 63' ' ' ASP . 9.1 t -89.75 21.77 3.39 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.372 1.045 . . . . 0.0 110.389 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' HD22 ' A' ' 57' ' ' ASN . 4.3 tttt -85.98 64.36 8.55 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.452 1.095 . . . . 0.0 109.238 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -40.4 102.44 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.409 1.068 . . . . 0.0 109.388 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.4 6.02 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.586 1.178 . . . . 0.0 109.356 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.535 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.0 OUTLIER -68.66 -46.12 80.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.619 1.2 . . . . 0.0 109.318 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.15 111.69 5.04 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 124.547 1.154 . . . . 0.0 109.314 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -75.07 139.16 23.77 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.549 1.815 . . . . 0.0 111.073 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.95 -68.04 0.17 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.439 1.087 . . . . 0.0 110.945 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.66 97.34 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.438 0.728 . . . . 0.0 110.07 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.2 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.52 1.138 . . . . 0.0 110.932 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.343 1.027 . . . . 0.0 110.997 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.32 20.84 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.476 1.11 . . . . 0.0 109.979 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.7 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.469 1.106 . . . . 0.0 109.366 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.24 146.46 24.0 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.48 1.112 . . . . 0.0 110.374 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.06 8.55 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.552 1.157 . . . . 0.0 109.304 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.1 -44.44 0.02 OUTLIER Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.5 1.125 . . . . 0.0 110.953 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.47 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.15 124.08 36.81 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.523 0.778 . . . . 0.0 110.403 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.02 141.51 26.68 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.468 1.773 . . . . 0.0 111.05 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.15 -178.58 20.13 Favored Glycine 0 CA--C 1.531 1.073 0 O-C-N 124.451 1.094 . . . . 0.0 110.991 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.2 m -104.95 120.06 40.54 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.556 0.798 . . . . 0.0 110.402 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.503 1.127 . . . . 0.0 110.98 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.91 145.08 49.38 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.432 1.083 . . . . 0.0 109.999 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.14 -171.5 3.73 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.428 1.08 . . . . 0.0 110.919 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 14.9 p90 -171.89 165.42 6.43 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.989 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.56 122.26 35.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.442 1.089 . . . . 0.0 108.285 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.667 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.25 -50.81 73.68 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.451 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' CD ' ' N ' ' A' ' 83' ' ' THR . 9.2 Cg_endo -75.04 -62.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.508 1.794 . . . . 0.0 111.009 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.423 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.9 m80 -75.06 57.88 0.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.593 1.183 . . . . 0.0 109.587 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 87' ' ' GLY . 0.1 OUTLIER -87.89 -38.54 15.54 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.525 1.141 . . . . 0.0 110.352 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.465 ' N ' ' HG3' ' A' ' 86' ' ' ARG . . . -89.52 -23.81 32.73 Favored Glycine 0 CA--C 1.531 1.038 0 O-C-N 124.416 1.072 . . . . 0.0 110.925 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.26 62.62 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.494 0.761 . . . . 0.0 109.325 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.21 1.82 Allowed Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.458 1.099 . . . . 0.0 110.962 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.638 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.56 75.0 1.15 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.513 0.772 . . . . 0.0 110.994 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.18 153.59 30.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.461 1.101 . . . . 0.0 109.268 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.459 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.57 -174.76 19.78 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.604 1.19 . . . . 0.0 110.883 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.04 37.09 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.513 0.772 . . . . 0.0 110.367 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.718 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.61 122.6 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 O-C-N 124.459 1.099 . . . . 0.0 109.3 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.422 ' O ' ' N ' ' A' ' 23' ' ' ILE . 46.6 m -105.01 144.51 31.72 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.415 1.072 . . . . 0.0 110.433 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.748 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 O-C-N 124.563 1.165 . . . . 0.0 109.361 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.823 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.152 . . . . 0.0 110.305 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.56 ' HB3' ' HD2' ' B' ' 2' ' ' PRO . 15.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.56 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.509 ' HE2' ' CE1' ' B' ' 4' ' ' TYR . 0.7 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.724 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 18.9 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.548 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.515 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 35.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.717 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 84.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.808 ' HB2' HG21 ' B' ' 233' ' ' VAL . 23.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 85.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.671 ' HA ' ' NH2' ' B' ' 158' ' ' ARG . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.429 ' HB3' HG21 ' A' ' 58' ' ' THR . 15.5 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.5 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.717 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.599 HD21 HG23 ' B' ' 233' ' ' VAL . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.525 ' CG ' HG21 ' A' ' 62' ' ' ILE . 0.7 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 13.7 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.569 ' CD2' HD12 ' B' ' 103' ' ' LEU . 0.1 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.569 HD12 ' CD2' ' B' ' 102' ' ' TYR . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.046 HG13 ' HG ' ' B' ' 115' ' ' LEU . 40.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.812 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.5 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.568 ' CD1' HD11 ' B' ' 116' ' ' LEU . 29.1 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 49.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.046 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.812 ' HB2' HG23 ' B' ' 105' ' ' THR . 32.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.98 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.517 ' HB3' HG13 ' A' ' 62' ' ' ILE . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 13.7 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.671 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 49.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.2 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.032 ' CB ' HG22 ' B' ' 164' ' ' THR . 8.4 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.724 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.3 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 38.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.551 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.2 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.879 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.7 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.2 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.808 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -57.68 126.85 29.15 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.548 1.155 . . . . 0.0 109.999 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.971 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.11 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.505 1.128 . . . . 0.0 109.27 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.92 150.88 40.35 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.543 1.152 . . . . 0.0 110.319 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.476 1.11 . . . . 0.0 109.313 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.8 mttt -92.7 133.42 36.02 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.533 1.146 . . . . 0.0 109.327 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.609 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.02 6.91 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.454 1.096 . . . . 0.0 110.995 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.46 7.63 Favored Glycine 0 CA--C 1.529 0.913 0 O-C-N 124.545 1.153 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.71 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 10.7 p -108.14 160.66 15.64 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.423 0.72 . . . . 0.0 110.41 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.527 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 46.2 t0 -59.8 -15.97 24.62 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.463 1.102 . . . . 0.0 109.278 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 16.6 mttt -90.65 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.549 1.156 . . . . 0.0 109.365 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 38.32 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.513 1.133 . . . . 0.0 111.029 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.87 117.67 58.18 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.843 ' HG3' ' CZ ' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.46 1.769 . . . . 0.0 111.019 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.557 HD21 HG21 ' A' ' 9' ' ' THR . 3.9 pp -150.76 151.27 32.12 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.513 1.133 . . . . 0.0 109.365 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.403 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.3 m-85 -77.41 126.2 30.54 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.547 1.154 . . . . 0.0 110.932 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.95 26.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.401 1.063 . . . . 0.0 110.284 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -74.99 140.94 70.15 Favored 'Cis proline' 0 C--N 1.361 1.201 0 C-N-CA 121.027 -2.489 . . . . 0.0 110.947 -0.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.13 -40.12 1.03 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.543 1.152 . . . . 0.0 109.239 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.414 1.072 . . . . 0.0 109.283 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.971 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.36 31.0 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.5 1.125 . . . . 0.0 109.264 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.76 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 124.53 1.144 . . . . 0.0 110.04 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.95 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 O-C-N 124.522 1.139 . . . . 0.0 109.324 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.8 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.33 27.55 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 109.936 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.511 1.132 . . . . 0.0 109.305 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.38 8.47 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.481 1.113 . . . . 0.0 110.994 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.649 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.562 0.801 . . . . 0.0 109.203 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.63 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.589 1.181 . . . . 0.0 110.367 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.711 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.46 102.59 6.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.507 1.129 . . . . 0.0 109.24 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.8 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.531 1.144 . . . . 0.0 110.279 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.46 9.58 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.459 1.099 . . . . 0.0 110.994 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.673 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.32 33.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.528 1.142 . . . . 0.0 109.25 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.561 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.5 ttp -98.04 119.21 36.26 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 111.038 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -79.32 -66.03 0.92 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 109.286 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.52 0.76 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.53 1.144 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.866 HG22 ' O ' ' A' ' 36' ' ' VAL . 1.2 p 46.04 54.79 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.477 1.111 . . . . 0.0 109.345 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.9 -172.36 40.67 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.532 1.145 . . . . 0.0 111.046 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.126 ' HD3' ' HG2' ' B' ' 119' ' ' PRO . 25.3 Cg_endo -74.96 -168.95 6.89 Favored 'Cis proline' 0 C--N 1.361 1.184 0 C-N-CA 120.993 -2.503 . . . . 0.0 110.996 -0.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.609 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 71.2 m-70 -144.21 -170.33 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 124.505 1.128 . . . . 0.0 109.575 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.525 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.94 166.99 0.2 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.398 1.061 . . . . 0.0 109.285 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.597 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.543 1.152 . . . . 0.0 109.355 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.617 ' HB ' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -132.82 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.502 1.126 . . . . 0.0 109.308 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.416 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.6 0.11 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.5 1.125 . . . . 0.0 111.001 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.435 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.32 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 0.7 OUTLIER 167.29 143.58 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.338 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.018 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.0 73.17 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.449 1.093 . . . . 0.0 109.233 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 164.22 33.86 Favored 'Trans proline' 0 C--N 1.36 1.137 0 O-C-N 124.474 1.776 . . . . 0.0 111.045 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.28 135.67 1.39 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.499 1.125 . . . . 0.0 109.244 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.43 -56.52 0.73 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.538 1.149 . . . . 0.0 110.981 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.28 2.21 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.592 0.819 . . . . 0.0 110.249 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.24 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.382 1.052 . . . . 0.0 109.938 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.018 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.01 -51.86 70.81 Favored Pre-proline 0 C--N 1.323 -0.552 0 O-C-N 124.489 1.118 . . . . 0.0 109.288 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.8 Cg_endo -75.0 50.77 2.61 Favored 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.414 1.744 . . . . 0.0 110.923 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.3 -45.65 0.07 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.579 1.174 . . . . 0.0 109.336 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.15 -27.51 68.08 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.316 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.1 m -46.52 115.13 0.95 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.494 1.121 . . . . 0.0 110.009 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.438 ' ND2' ' HB3' ' A' ' 59' ' ' LYS . 21.7 t30 -107.92 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.412 1.07 . . . . 0.0 109.358 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.775 HG21 ' HB3' ' B' ' 63' ' ' ASP . 1.4 t -89.75 21.85 3.35 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.436 1.085 . . . . 0.0 110.343 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' HB3' ' ND2' ' A' ' 57' ' ' ASN . 28.8 tttt -86.04 64.43 8.58 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.448 1.093 . . . . 0.0 109.233 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.717 HD12 HD11 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.519 1.137 . . . . 0.0 109.332 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.5 6.04 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.311 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.717 HD11 HD12 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -68.69 -46.13 80.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.568 1.168 . . . . 0.0 109.319 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.16 111.61 4.9 Favored Pre-proline 0 C--N 1.326 -0.433 0 O-C-N 124.48 1.113 . . . . 0.0 109.326 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -75.01 139.18 23.96 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.428 1.752 . . . . 0.0 110.999 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.85 -67.91 0.17 Allowed Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.475 1.109 . . . . 0.0 110.969 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.673 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.47 0.747 . . . . 0.0 110.06 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.13 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.483 1.114 . . . . 0.0 111.039 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.51 175.18 4.17 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.418 1.073 . . . . 0.0 110.957 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.69 161.2 21.1 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.567 1.167 . . . . 0.0 109.964 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.69 8.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.473 1.108 . . . . 0.0 109.374 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.22 146.5 23.97 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.439 1.087 . . . . 0.0 110.388 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.19 173.06 8.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.25 0.02 OUTLIER Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.34 124.28 39.05 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.578 0.811 . . . . 0.0 110.385 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.1 Cg_endo -75.15 141.49 26.3 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.549 1.815 . . . . 0.0 110.976 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.66 20.02 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.461 1.101 . . . . 0.0 111.068 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.89 120.05 40.48 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.539 0.787 . . . . 0.0 110.407 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.833 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.71 140.67 30.96 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.552 1.158 . . . . 0.0 111.025 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.84 145.12 49.31 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.451 1.095 . . . . 0.0 110.055 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.43 3.72 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.55 1.156 . . . . 0.0 110.935 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.617 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 13.1 p90 -171.88 165.47 6.44 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.476 1.11 . . . . 0.0 111.055 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.67 122.36 36.04 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.459 1.099 . . . . 0.0 108.202 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.484 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 1.1 m -51.3 -50.73 74.33 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.441 1.088 . . . . 0.0 110.431 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' CD ' ' N ' ' A' ' 83' ' ' THR . 41.5 Cg_endo -75.13 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.565 1.824 . . . . 0.0 110.988 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.871 ' HA ' ' OH ' ' B' ' 4' ' ' TYR . 27.0 m80 -75.03 57.99 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.51 1.131 . . . . 0.0 109.576 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.98 -38.56 15.42 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.554 1.159 . . . . 0.0 110.287 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.48 -23.85 32.72 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.533 1.146 . . . . 0.0 110.979 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.492 0.76 . . . . 0.0 109.345 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.16 1.82 Allowed Glycine 0 CA--C 1.531 1.074 0 O-C-N 124.478 1.111 . . . . 0.0 110.912 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.609 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.0 ttt -121.66 75.12 1.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.494 0.761 . . . . 0.0 110.967 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.18 153.54 30.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.119 . . . . 0.0 109.344 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.457 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.78 19.74 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.462 1.101 . . . . 0.0 111.019 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 162.03 37.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.507 0.769 . . . . 0.0 110.425 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.711 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.62 122.58 3.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.561 1.163 . . . . 0.0 109.286 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.7 m -105.08 144.56 31.71 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.457 1.098 . . . . 0.0 110.405 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.86 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.438 1.086 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.8 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.448 0 O-C-N 124.523 1.139 . . . . 0.0 110.277 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.783 ' CE2' ' HD2' ' A' ' 38' ' ' PRO . 7.8 m-30 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.843 ' CZ ' ' HG3' ' A' ' 14' ' ' PRO . 3.8 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.871 ' OH ' ' HA ' ' A' ' 85' ' ' HIS . 1.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.535 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.519 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 33.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.146 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.72 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.733 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 20.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 85.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.592 ' HG2' ' O ' ' B' ' 65' ' ' SER . 15.6 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.775 ' HB3' HG21 ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.592 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 51.6 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.72 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.524 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 2.1 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.524 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.664 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 69.8 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.556 ' CE2' HD23 ' B' ' 103' ' ' LEU . 2.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.556 HD23 ' CE2' ' B' ' 102' ' ' TYR . 76.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.031 HG13 ' HG ' ' B' ' 115' ' ' LEU . 68.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.979 ' HA ' HD11 ' B' ' 116' ' ' LEU . 28.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 31.8 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.031 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.979 HD11 ' HA ' ' B' ' 107' ' ' TYR . 0.4 OUTLIER -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.126 ' HG2' ' HD3' ' A' ' 38' ' ' PRO . 1.8 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.799 HD22 ' CE2' ' B' ' 125' ' ' TYR . 10.0 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.799 ' CE2' HD22 ' B' ' 120' ' ' LEU . 62.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 63.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.733 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 21.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.777 HG12 ' HA ' ' B' ' 24' ' ' CYS . 5.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.299 ' OH ' ' HA ' ' B' ' 168' ' ' SER . 3.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.478 ' HG3' ' CG ' ' B' ' 4' ' ' TYR . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 3.2 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.938 ' C ' ' HE1' ' B' ' 162' ' ' TYR . 4.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 1.299 ' HA ' ' OH ' ' B' ' 162' ' ' TYR . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 16.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 1.581 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.355 22.4 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 59.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.566 ' CG ' ' HE1' ' B' ' 191' ' ' PHE . 56.7 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.108 ' CE1' ' HG3' ' B' ' 209' ' ' PRO 0.278 5.4 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.566 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.8 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.789 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 1.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.108 ' HG3' ' CE1' ' B' ' 189' ' ' PHE . 9.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.146 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.65 126.86 29.2 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.531 1.145 . . . . 0.0 110.003 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.952 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.18 3.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.418 1.074 . . . . 0.0 109.26 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.93 40.35 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.559 1.162 . . . . 0.0 110.355 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.08 38.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.473 1.108 . . . . 0.0 109.345 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.526 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.76 133.49 35.98 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.48 1.113 . . . . 0.0 109.317 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.526 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.75 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.498 1.124 . . . . 0.0 110.973 -179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.53 7.65 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.577 1.173 . . . . 0.0 110.97 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.528 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -108.05 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.475 0.75 . . . . 0.0 110.42 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -59.83 -15.97 24.91 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.447 1.092 . . . . 0.0 109.356 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 0.2 OUTLIER -90.57 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.501 1.126 . . . . 0.0 109.337 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 0.8 OUTLIER 38.23 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.571 1.169 . . . . 0.0 111.062 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.528 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.8 117.71 58.16 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.499 1.124 . . . . 0.0 109.282 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.67 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 34.7 Cg_endo -75.03 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.528 1.804 . . . . 0.0 110.999 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.2 pp -150.78 151.23 32.04 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.48 1.113 . . . . 0.0 109.329 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.34 126.15 30.47 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 124.509 1.131 . . . . 0.0 110.994 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.538 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.41 134.9 26.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 124.505 1.128 . . . . 0.0 110.351 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.538 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.09 140.99 70.28 Favored 'Cis proline' 0 C--N 1.36 1.16 0 C-N-CA 121.007 -2.497 . . . . 0.0 110.909 0.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.22 -40.11 1.06 Allowed 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.531 1.145 . . . . 0.0 109.251 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.29 46.08 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.421 1.076 . . . . 0.0 109.349 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.952 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.42 31.01 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.512 1.133 . . . . 0.0 109.247 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.635 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.473 1.108 . . . . 0.0 110.059 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.402 1.064 . . . . 0.0 109.259 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.53 158.29 27.62 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.525 1.14 . . . . 0.0 110.03 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.32 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.44 8.45 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.469 1.105 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.642 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.21 174.14 11.46 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 0.733 . . . . 0.0 109.308 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.53 154.25 39.45 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.513 1.133 . . . . 0.0 110.436 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.716 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.41 102.59 6.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.566 1.167 . . . . 0.0 109.276 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.51 18.11 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.591 1.182 . . . . 0.0 110.334 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.19 121.46 9.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.562 1.164 . . . . 0.0 110.986 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.01 155.35 33.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.565 1.166 . . . . 0.0 109.262 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.77 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.2 ttp -98.05 119.26 36.36 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.399 1.062 . . . . 0.0 111.028 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -79.39 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.48 1.112 . . . . 0.0 109.181 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.86 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.46 1.1 . . . . 0.0 109.228 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.67 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.3 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.455 1.097 . . . . 0.0 109.323 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.681 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.95 -172.3 40.58 Favored Glycine 0 CA--C 1.529 0.963 0 O-C-N 124.51 1.131 . . . . 0.0 111.044 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HB3' HD13 ' A' ' 62' ' ' ILE . 42.8 Cg_endo -74.95 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.36 1.154 0 C-N-CA 120.913 -2.536 . . . . 0.0 111.034 -0.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.77 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.7 m-70 -144.23 -170.37 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.543 1.152 . . . . 0.0 109.596 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.568 ' HB2' HD11 ' A' ' 42' ' ' ILE . 0.2 OUTLIER 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.469 1.106 . . . . 0.0 109.338 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.532 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.35 43.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.543 1.152 . . . . 0.0 109.415 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -132.78 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.476 1.11 . . . . 0.0 109.322 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.62 0.12 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.539 1.149 . . . . 0.0 110.949 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -49.99 4.79 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.293 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.3 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.597 1.185 . . . . 0.0 109.27 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.061 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.87 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.03 164.22 33.75 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.459 1.768 . . . . 0.0 110.974 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.21 135.62 1.37 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.444 1.09 . . . . 0.0 109.321 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.46 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.59 0.72 Allowed Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.538 1.149 . . . . 0.0 111.01 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.651 0.853 . . . . 0.0 110.25 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.426 1.079 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.061 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.03 -51.81 71.31 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.415 1.072 . . . . 0.0 109.27 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.05 50.78 2.63 Favored 'Trans proline' 0 C--N 1.361 1.193 0 O-C-N 124.419 1.747 . . . . 0.0 110.898 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.62 0.07 Allowed 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.662 1.226 . . . . 0.0 109.358 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.13 -27.56 68.13 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 4.4 m -46.44 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.492 1.12 . . . . 0.0 109.99 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.62 ' ND2' ' CE2' ' A' ' 68' ' ' TYR 0.492 7.8 t30 -108.04 117.75 34.95 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.411 1.069 . . . . 0.0 109.312 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.911 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 4.0 t -89.82 21.87 3.37 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.406 1.066 . . . . 0.0 110.311 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 60' ' ' LEU . 57.1 tttt -86.02 64.36 8.54 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.487 1.117 . . . . 0.0 109.287 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' H ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.475 1.109 . . . . 0.0 109.296 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.45 98.42 6.04 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 1.097 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.834 HD12 HD21 ' B' ' 70' ' ' ASN . 5.9 mm -68.62 -46.07 80.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.526 1.141 . . . . 0.0 109.4 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 64' ' ' PRO . . . -62.13 111.64 4.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.469 1.106 . . . . 0.0 109.285 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 63' ' ' ALA . 5.1 Cg_exo -75.05 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.454 1.765 . . . . 0.0 111.025 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.86 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.55 1.157 . . . . 0.0 110.932 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.675 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.65 97.37 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.527 0.781 . . . . 0.0 109.967 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.551 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.449 1.093 . . . . 0.0 110.943 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.62 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.5 175.16 4.18 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.468 1.105 . . . . 0.0 110.956 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.95 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.474 1.109 . . . . 0.0 110.006 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.72 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.489 1.118 . . . . 0.0 109.427 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.27 146.47 24.0 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.57 1.169 . . . . 0.0 110.382 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.501 1.126 . . . . 0.0 109.259 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.459 1.1 . . . . 0.0 110.98 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.46 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.14 38.13 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.52 0.776 . . . . 0.0 110.388 -179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.98 141.5 26.78 Favored 'Trans proline' 0 C--N 1.359 1.131 0 O-C-N 124.438 1.757 . . . . 0.0 111.056 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.64 20.05 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.459 1.1 . . . . 0.0 110.986 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.3 m -104.81 120.11 40.6 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.52 0.776 . . . . 0.0 110.349 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.66 31.01 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.521 1.138 . . . . 0.0 111.03 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.88 145.15 49.31 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.406 1.066 . . . . 0.0 110.016 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.21 -171.59 3.75 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.483 1.114 . . . . 0.0 110.956 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.495 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 16.3 p90 -171.78 165.46 6.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.543 1.152 . . . . 0.0 110.995 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.54 122.34 35.87 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.448 1.093 . . . . 0.0 108.295 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.627 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 2.9 m -51.38 -50.76 74.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.492 1.12 . . . . 0.0 110.433 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.627 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 19.9 Cg_endo -75.02 -62.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.234 0 O-C-N 124.492 1.785 . . . . 0.0 111.033 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.538 1.149 . . . . 0.0 109.631 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -38.44 15.49 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 124.536 1.147 . . . . 0.0 110.342 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.52 -23.8 32.77 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.51 1.131 . . . . 0.0 110.995 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.18 62.55 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.512 0.772 . . . . 0.0 109.405 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.1 1.83 Allowed Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.456 1.097 . . . . 0.0 110.984 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.526 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.3 ttt -121.54 75.06 1.16 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.441 0.73 . . . . 0.0 111.08 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.16 153.56 30.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.546 1.154 . . . . 0.0 109.271 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.76 19.76 Favored Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.553 1.158 . . . . 0.0 110.983 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.79 162.02 37.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.49 0.759 . . . . 0.0 110.411 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.716 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.63 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 O-C-N 124.476 1.11 . . . . 0.0 109.265 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.441 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.9 m -105.0 144.56 31.65 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.422 1.076 . . . . 0.0 110.429 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.31 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.523 1.139 . . . . 0.0 109.315 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.313 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.422 ' CD2' ' HE2' ' B' ' 4' ' ' TYR . 23.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.9 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 1.422 ' HE2' ' CD2' ' B' ' 1' ' ' TYR . 51.7 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 22.6 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 26.0 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.852 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 84.1 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.541 ' CD ' HD21 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.911 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 5.7 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.3 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' B' ' 65' ' ' SER 0.261 4.7 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.417 ' OG ' ' N ' ' B' ' 68' ' ' GLY . 29.8 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.417 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.834 HD21 HD12 ' A' ' 62' ' ' ILE . 1.0 OUTLIER -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 33.4 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.856 HG13 ' HG ' ' B' ' 115' ' ' LEU . 62.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.851 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.2 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.873 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.2 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.851 ' HB2' HG23 ' B' ' 105' ' ' THR . 70.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.744 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.438 HD22 ' CE1' ' B' ' 125' ' ' TYR . 39.3 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.438 ' CE1' HD22 ' B' ' 120' ' ' LEU . 73.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.487 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.852 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 14.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.032 ' HB3' HG22 ' B' ' 164' ' ' THR . 3.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.084 HG23 ' H ' ' B' ' 166' ' ' GLU . 5.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.084 ' H ' HG23 ' B' ' 164' ' ' THR . 44.6 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.634 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.6 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.539 HD21 HH12 ' B' ' 158' ' ' ARG . 37.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.957 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.73 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.62 126.8 28.95 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.561 1.163 . . . . 0.0 110.056 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.974 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.413 1.071 . . . . 0.0 109.28 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.88 40.26 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.546 1.154 . . . . 0.0 110.3 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.3 112.12 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 124.457 1.098 . . . . 0.0 109.355 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.517 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.68 133.46 35.98 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.466 1.103 . . . . 0.0 109.377 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.622 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.06 6.94 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.48 1.112 . . . . 0.0 111.007 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.52 7.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.543 1.152 . . . . 0.0 111.016 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -108.1 160.71 15.6 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.478 0.752 . . . . 0.0 110.426 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -59.85 -15.96 25.18 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.436 1.085 . . . . 0.0 109.257 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 13' ' ' ALA . 17.5 mttt -90.59 39.73 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.542 1.151 . . . . 0.0 109.336 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.416 ' CZ ' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.26 29.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.58 1.175 . . . . 0.0 111.031 179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.68 58.17 Favored Pre-proline 0 C--N 1.325 -0.474 0 O-C-N 124.502 1.126 . . . . 0.0 109.278 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.61 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 37.3 Cg_endo -74.99 97.66 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.178 0 O-C-N 124.497 1.788 . . . . 0.0 111.009 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 3.4 pp -150.83 151.17 31.88 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.479 1.112 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.28 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.557 1.16 . . . . 0.0 111.018 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.43 134.95 26.67 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.565 1.166 . . . . 0.0 110.332 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.06 140.98 70.28 Favored 'Cis proline' 0 C--N 1.36 1.159 0 C-N-CA 121.015 -2.494 . . . . 0.0 110.939 0.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.16 -40.17 1.05 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.611 1.194 . . . . 0.0 109.252 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.29 46.09 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.462 1.101 . . . . 0.0 109.309 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.974 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.41 31.04 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 109.252 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.618 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.94 143.7 50.94 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.503 1.127 . . . . 0.0 110.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.79 -177.44 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.504 1.128 . . . . 0.0 109.284 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.37 27.5 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.491 1.119 . . . . 0.0 110.002 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.15 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.606 1.191 . . . . 0.0 109.332 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.52 -7.48 8.44 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.515 1.134 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.647 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.13 11.48 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.479 0.753 . . . . 0.0 109.319 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.52 154.26 39.43 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.532 1.145 . . . . 0.0 110.485 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 94' ' ' ILE . 64.2 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.509 1.131 . . . . 0.0 109.306 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.54 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.496 1.123 . . . . 0.0 110.274 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.55 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.24 121.38 9.49 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.533 1.146 . . . . 0.0 110.98 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.657 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.34 33.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.515 1.134 . . . . 0.0 109.317 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.06 119.22 36.32 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.353 1.033 . . . . 0.0 111.026 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.35 -66.05 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.521 1.138 . . . . 0.0 109.255 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.717 ' HD3' ' O ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -168.89 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.44 1.087 . . . . 0.0 109.3 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.61 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.4 p 46.08 54.76 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.479 1.112 . . . . 0.0 109.337 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.635 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -93.01 -172.29 40.48 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.588 1.18 . . . . 0.0 110.992 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.99 -168.86 6.83 Favored 'Cis proline' 0 C--N 1.36 1.175 0 C-N-CA 120.934 -2.527 . . . . 0.0 110.969 -0.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.735 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.5 m-70 -144.24 -170.33 3.33 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.542 1.151 . . . . 0.0 109.627 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.436 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.4 p30 173.94 166.95 0.2 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.419 1.074 . . . . 0.0 109.355 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.595 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 t -104.05 114.34 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 O-C-N 124.536 1.148 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.626 HG13 ' OG1' ' A' ' 83' ' ' THR . 0.5 OUTLIER -132.78 75.94 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.507 1.13 . . . . 0.0 109.333 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.62 160.59 0.11 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.568 1.167 . . . . 0.0 110.948 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.548 1.155 . . . . 0.0 109.295 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.48 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.571 1.17 . . . . 0.0 109.306 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.024 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.09 72.81 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.426 1.079 . . . . 0.0 109.236 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.02 164.25 33.69 Favored 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.463 1.77 . . . . 0.0 111.018 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.21 135.6 1.38 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.468 1.105 . . . . 0.0 109.339 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.492 1.12 . . . . 0.0 110.982 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.498 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.04 -173.34 2.22 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.593 0.819 . . . . 0.0 110.295 -179.927 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.2 77.86 1.75 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.511 1.132 . . . . 0.0 109.994 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.024 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.12 -51.76 72.06 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.11 . . . . 0.0 109.262 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.8 Cg_endo -75.12 50.86 2.67 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.487 1.783 . . . . 0.0 110.909 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.63 0.07 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.584 1.177 . . . . 0.0 109.38 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.16 -27.52 68.08 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.488 1.117 . . . . 0.0 109.298 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 47.7 m -46.46 115.15 0.95 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.543 1.152 . . . . 0.0 109.976 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.546 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.6 m120 -108.02 117.71 34.84 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.438 1.086 . . . . 0.0 109.328 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.141 ' OG1' ' HB2' ' B' ' 63' ' ' ASP . 1.5 t -89.81 21.89 3.37 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.416 1.073 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.1 tttt -86.05 64.4 8.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.491 1.119 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.099 HD21 ' CG ' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -40.39 102.47 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.55 1.156 . . . . 0.0 109.332 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.38 6.01 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.518 1.136 . . . . 0.0 109.343 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.552 HD13 HD21 ' B' ' 70' ' ' ASN . 3.5 mt -68.6 -46.1 80.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.552 1.157 . . . . 0.0 109.354 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.09 111.58 4.82 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.474 1.108 . . . . 0.0 109.308 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -74.98 139.11 23.94 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.457 1.767 . . . . 0.0 111.003 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.94 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.522 1.139 . . . . 0.0 110.925 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.657 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.485 0.756 . . . . 0.0 109.985 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.575 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.16 -86.78 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.446 1.092 . . . . 0.0 110.895 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.492 1.12 . . . . 0.0 110.97 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.59 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.482 1.114 . . . . 0.0 110.029 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.73 8.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.474 1.109 . . . . 0.0 109.428 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.53 23.97 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.492 1.12 . . . . 0.0 110.344 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.19 173.06 8.57 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.492 1.12 . . . . 0.0 109.261 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.07 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.442 1.089 . . . . 0.0 111.002 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.13 37.87 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.504 0.767 . . . . 0.0 110.421 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.0 141.5 26.72 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.511 1.795 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.05 -178.67 20.0 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.335 1.022 . . . . 0.0 111.016 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.4 m -104.87 120.04 40.47 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.468 0.746 . . . . 0.0 110.347 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.838 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.74 140.69 30.95 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 111.014 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.87 145.16 49.3 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.451 1.094 . . . . 0.0 109.995 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.23 -171.62 3.76 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.458 1.099 . . . . 0.0 110.996 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.457 ' CE1' ' HB ' ' A' ' 42' ' ' ILE . 15.6 p90 -171.78 165.4 6.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.555 1.16 . . . . 0.0 111.021 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.48 122.33 35.8 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.424 1.078 . . . . 0.0 108.326 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.626 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.9 m -51.38 -50.77 74.36 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 124.499 1.124 . . . . 0.0 110.384 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 18.6 Cg_endo -75.03 -62.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.195 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 26.3 m80 -74.97 58.0 0.83 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.529 1.143 . . . . 0.0 109.596 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.438 HH22 HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -88.0 -38.55 15.41 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.556 1.16 . . . . 0.0 110.314 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.45 -23.72 33.18 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.505 1.128 . . . . 0.0 111.044 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.719 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.73 -15.21 62.61 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.506 0.768 . . . . 0.0 109.396 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.1 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.523 1.139 . . . . 0.0 110.982 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.622 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.14 1.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.391 0.701 . . . . 0.0 111.021 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.59 30.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 O-C-N 124.589 1.181 . . . . 0.0 109.272 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.53 1.02 0 O-C-N 124.543 1.152 . . . . 0.0 111.006 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.08 36.93 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.426 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.702 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.48 1.113 . . . . 0.0 109.238 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.1 m -105.1 144.57 31.72 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.423 1.077 . . . . 0.0 110.372 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.32 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 O-C-N 124.497 1.123 . . . . 0.0 109.314 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 O-C-N 124.56 1.163 . . . . 0.0 110.277 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.555 ' OH ' HBD1 ' B' ' 250' ' ' HEC . 16.9 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.514 ' HB2' HD13 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.984 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 16.2 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.719 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 4.1 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.984 ' HG3' ' O ' ' B' ' 3' ' ' PHE . 0.0 OUTLIER -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.507 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.558 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.558 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 7.2 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.689 ' HB2' HG21 ' B' ' 233' ' ' VAL . 18.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 24.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 1.099 ' CG ' HD21 ' A' ' 60' ' ' LEU . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.589 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 1.141 ' HB2' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.446 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 31.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.4 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.557 ' HB3' ' NE2' ' B' ' 61' ' ' GLN . 78.4 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 5.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.583 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 1.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.6 ' HA ' HD23 ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.755 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.8 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 88.4 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.822 ' CB ' HD22 ' B' ' 83' ' ' LEU . 98.0 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.416 HG21 ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.487 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.7 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.2 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.891 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.6 HD23 ' HA ' ' B' ' 74' ' ' VAL . 19.0 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.766 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.738 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.766 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 38.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.4 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.482 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.562 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 46.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' B' ' 24' ' ' CYS . 10.8 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.033 ' CB ' HG22 ' B' ' 164' ' ' THR . 3.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.439 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.072 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.9 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.072 ' H ' HG23 ' B' ' 164' ' ' THR . 17.5 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.632 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.7 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 69.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.7 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 11.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 37.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.86 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.55 126.8 28.94 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.535 1.147 . . . . 0.0 110.09 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.944 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.19 3.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.442 1.089 . . . . 0.0 109.273 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.97 150.87 40.25 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.583 1.177 . . . . 0.0 110.303 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.14 38.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.412 1.07 . . . . 0.0 109.346 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.82 133.55 35.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.467 1.105 . . . . 0.0 109.276 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.613 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.07 6.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.503 1.127 . . . . 0.0 110.953 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.07 144.48 7.63 Favored Glycine 0 CA--C 1.53 1.021 0 O-C-N 124.586 1.179 . . . . 0.0 110.973 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.762 ' CG2' HD11 ' A' ' 15' ' ' LEU . 17.2 p -108.07 160.7 15.59 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 0.741 . . . . 0.0 110.421 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -59.84 -15.92 24.74 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.402 1.064 . . . . 0.0 109.293 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 23.9 mttt -90.58 39.57 0.98 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.52 1.137 . . . . 0.0 109.326 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.639 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 22.9 m-85 38.37 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.542 1.151 . . . . 0.0 111.015 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.84 117.65 58.26 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.47 1.106 . . . . 0.0 109.319 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.665 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 22.3 Cg_endo -74.98 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.486 1.782 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.762 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.1 pp -150.81 151.21 31.96 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.542 1.151 . . . . 0.0 109.357 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.418 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.34 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.473 1.108 . . . . 0.0 110.967 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.96 26.67 Favored Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.559 1.162 . . . . 0.0 110.335 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.98 70.31 Favored 'Cis proline' 0 C--N 1.359 1.102 0 C-N-CA 121.039 -2.484 . . . . 0.0 110.943 0.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.23 -40.1 1.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.554 1.159 . . . . 0.0 109.274 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.34 46.04 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.459 1.1 . . . . 0.0 109.302 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.944 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.29 141.43 31.01 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.553 1.158 . . . . 0.0 109.225 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.72 50.95 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.451 1.094 . . . . 0.0 110.036 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.64 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.88 -177.47 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.439 1.087 . . . . 0.0 109.219 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.818 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.56 158.31 27.59 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 109.987 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.06 105.42 0.27 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.562 1.164 . . . . 0.0 109.337 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.446 1.091 . . . . 0.0 110.999 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.64 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.25 174.09 11.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.471 0.747 . . . . 0.0 109.286 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.46 154.24 39.38 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.493 1.121 . . . . 0.0 110.475 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.723 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.42 102.63 6.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.55 1.156 . . . . 0.0 109.263 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.85 169.51 18.12 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.263 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.18 121.5 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.491 1.12 . . . . 0.0 110.911 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.05 155.34 33.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.524 1.14 . . . . 0.0 109.334 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.731 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 4.1 ttp -98.0 119.27 36.33 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.359 1.037 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -79.39 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.474 1.109 . . . . 0.0 109.204 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.639 ' HE3' ' HA ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -168.88 -167.53 0.76 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.415 1.072 . . . . 0.0 109.279 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.665 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.7 p 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.449 1.093 . . . . 0.0 109.301 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.637 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.538 1.149 . . . . 0.0 111.027 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.712 ' HD2' ' CE1' ' B' ' 1' ' ' TYR . 59.8 Cg_endo -74.99 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.931 -2.529 . . . . 0.0 110.963 -0.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.731 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 70.6 m-70 -144.23 -170.4 3.34 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.569 1.168 . . . . 0.0 109.619 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.99 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.8 t -104.07 114.33 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 O-C-N 124.534 1.146 . . . . 0.0 109.388 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.9 mm -132.75 75.93 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.487 1.117 . . . . 0.0 109.356 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.59 160.64 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.511 1.132 . . . . 0.0 110.98 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.99 -50.15 4.74 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.551 1.157 . . . . 0.0 109.265 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.54 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.508 1.13 . . . . 0.0 109.295 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.042 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.47 158.14 72.64 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.383 1.052 . . . . 0.0 109.291 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.8 Cg_endo -75.07 164.22 33.67 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.505 1.792 . . . . 0.0 110.993 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.19 135.6 1.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.436 1.085 . . . . 0.0 109.328 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.537 1.148 . . . . 0.0 111.0 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.511 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.39 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.561 0.8 . . . . 0.0 110.263 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.14 77.82 1.75 Allowed 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.46 1.1 . . . . 0.0 109.98 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.042 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.11 -51.75 72.06 Favored Pre-proline 0 C--N 1.324 -0.501 0 O-C-N 124.471 1.107 . . . . 0.0 109.269 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.07 50.78 2.64 Favored 'Trans proline' 0 C--N 1.361 1.214 0 O-C-N 124.401 1.737 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.65 0.07 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.639 1.212 . . . . 0.0 109.381 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.06 -27.54 68.16 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 109.36 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 45.3 m -46.45 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.503 1.127 . . . . 0.0 109.965 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.554 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m120 -108.07 117.73 34.91 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 1.113 . . . . 0.0 109.281 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.459 ' CB ' ' HB2' ' B' ' 63' ' ' ASP . 3.3 t -89.82 21.92 3.36 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.432 1.082 . . . . 0.0 110.317 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 1.7 tttt -86.04 64.41 8.57 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.423 1.077 . . . . 0.0 109.283 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.404 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -40.45 102.47 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.492 1.12 . . . . 0.0 109.297 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.43 6.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.537 1.148 . . . . 0.0 109.316 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.717 ' H ' HD12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.69 -46.06 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.594 1.184 . . . . 0.0 109.332 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.63 4.93 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.482 1.114 . . . . 0.0 109.286 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -75.04 139.11 23.79 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.473 1.775 . . . . 0.0 111.049 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.87 -67.9 0.17 Allowed Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.591 1.182 . . . . 0.0 110.963 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.493 0.761 . . . . 0.0 109.994 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.25 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.417 1.073 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.554 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.494 1.121 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.507 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.61 161.29 20.9 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.408 1.068 . . . . 0.0 110.015 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.101 . . . . 0.0 109.412 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.495 1.122 . . . . 0.0 110.347 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.1 mt -124.11 173.08 8.52 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.514 1.134 . . . . 0.0 109.255 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.488 1.117 . . . . 0.0 110.963 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.06 37.59 Favored Pre-proline 0 C--N 1.324 -0.519 0 O-C-N 124.545 0.791 . . . . 0.0 110.403 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.7 Cg_endo -74.97 141.51 26.82 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.483 1.781 . . . . 0.0 111.09 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.441 1.088 . . . . 0.0 111.007 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.1 m -104.9 120.08 40.57 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.484 0.755 . . . . 0.0 110.305 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.836 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.76 140.68 30.97 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.491 1.119 . . . . 0.0 111.017 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.17 49.3 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.428 1.08 . . . . 0.0 109.97 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.55 3.74 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.459 1.1 . . . . 0.0 110.931 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.409 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.7 p90 -171.86 165.35 6.46 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.531 1.144 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -93.46 122.36 35.81 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.445 1.091 . . . . 0.0 108.284 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.633 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.39 -50.82 74.13 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.456 1.098 . . . . 0.0 110.356 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 83' ' ' THR . 36.4 Cg_endo -74.93 -62.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.177 0 O-C-N 124.527 1.804 . . . . 0.0 110.999 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.465 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 29.5 m80 -74.96 57.93 0.83 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.518 1.136 . . . . 0.0 109.598 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.179 ' HD2' ' C ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.97 -38.49 15.49 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.559 1.162 . . . . 0.0 110.318 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.895 ' N ' ' HD2' ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.77 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.496 1.123 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.61 -15.25 62.56 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.493 0.761 . . . . 0.0 109.425 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.08 63.17 1.83 Allowed Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.444 1.09 . . . . 0.0 110.984 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.613 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.61 75.03 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.4 0.706 . . . . 0.0 111.066 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -124.14 153.58 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.499 1.124 . . . . 0.0 109.305 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.79 19.77 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.571 1.169 . . . . 0.0 110.986 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.74 162.03 37.04 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.472 0.748 . . . . 0.0 110.432 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.723 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.61 122.63 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.507 1.129 . . . . 0.0 109.284 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.02 144.49 31.75 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.427 1.079 . . . . 0.0 110.415 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 96' ' ' VAL . 5.0 t -128.2 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 O-C-N 124.53 1.144 . . . . 0.0 109.376 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.818 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.506 0 O-C-N 124.543 1.152 . . . . 0.0 110.279 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.087 ' HD2' ' CE2' ' B' ' 4' ' ' TYR . 97.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.544 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 1.087 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 24.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 2.1 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.514 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.7 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.527 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.716 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 48.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.678 ' HB2' HG21 ' B' ' 233' ' ' VAL . 12.7 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.439 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 87.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.541 ' HG3' ' H ' ' B' ' 63' ' ' ASP . 1.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.633 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.541 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 2.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.467 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 0.4 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.716 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.466 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.694 ' ND2' HG23 ' A' ' 62' ' ' ILE . 4.9 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.472 HG23 ' CE ' ' B' ' 128' ' ' MET . 20.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.893 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.8 HD23 HD11 ' B' ' 120' ' ' LEU . 0.6 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.826 ' CB ' HD22 ' B' ' 83' ' ' LEU . 67.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.754 HG23 ' HB2' ' B' ' 116' ' ' LEU . 2.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 73.9 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.967 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.754 ' HB2' HG23 ' B' ' 105' ' ' THR . 52.1 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.843 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.827 HD22 ' CE2' ' B' ' 125' ' ' TYR . 17.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.54 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.827 ' CE2' HD22 ' B' ' 120' ' ' LEU . 41.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.472 ' CE ' HG23 ' B' ' 71' ' ' VAL . 60.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.51 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.516 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 38.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.782 HG12 ' HA ' ' B' ' 24' ' ' CYS . 9.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.333 ' CD2' ' HD2' ' B' ' 163' ' ' PRO . 13.1 t80 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 1.333 ' HD2' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.187 ' CG2' ' HB3' ' B' ' 162' ' ' TYR . 0.2 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.815 ' H ' HG23 ' B' ' 164' ' ' THR . 36.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.533 HD13 ' HA ' ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 40.1 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 0.957 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.962 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.957 ' HD3' ' CD2' ' B' ' 189' ' ' PHE 0.26 5.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.678 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.62 126.79 28.91 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.533 1.146 . . . . 0.0 109.99 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.947 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.46 177.16 3.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.426 1.079 . . . . 0.0 109.271 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.602 1.189 . . . . 0.0 110.296 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.11 38.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.458 1.099 . . . . 0.0 109.32 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.72 133.46 36.0 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.543 1.152 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.658 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.68 97.1 6.98 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 110.961 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.05 144.5 7.64 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.605 1.191 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.713 ' CG2' HD11 ' A' ' 15' ' ' LEU . 27.0 p -108.1 160.74 15.57 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.437 0.728 . . . . 0.0 110.398 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.494 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 45.5 t0 -59.85 -15.94 24.92 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.442 1.089 . . . . 0.0 109.313 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 13.1 mttt -90.64 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.516 1.135 . . . . 0.0 109.304 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 38.27 29.66 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.5 1.125 . . . . 0.0 111.042 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.664 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.72 58.07 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.483 1.115 . . . . 0.0 109.326 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.697 ' HG3' HG21 ' A' ' 36' ' ' VAL . 10.9 Cg_endo -75.0 97.62 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.498 1.788 . . . . 0.0 110.974 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.713 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.83 151.19 31.91 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.511 1.132 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.33 126.18 30.51 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.492 1.12 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.93 26.64 Favored Pre-proline 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 110.334 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.04 140.97 70.24 Favored 'Cis proline' 0 C--N 1.359 1.118 0 C-N-CA 121.03 -2.488 . . . . 0.0 110.962 0.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.17 -40.1 1.04 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.545 1.153 . . . . 0.0 109.295 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.33 46.09 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.465 1.103 . . . . 0.0 109.328 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.947 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.43 31.02 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.475 1.11 . . . . 0.0 109.226 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.63 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.0 143.71 50.94 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.137 . . . . 0.0 110.029 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.636 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.493 1.12 . . . . 0.0 109.289 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.819 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.62 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.452 1.095 . . . . 0.0 109.994 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.05 105.4 0.27 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.59 1.181 . . . . 0.0 109.313 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.46 -7.41 8.48 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.506 1.128 . . . . 0.0 110.977 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.636 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.17 11.45 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 0.78 . . . . 0.0 109.288 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.55 154.23 39.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.473 1.108 . . . . 0.0 110.427 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 O-C-N 124.592 1.182 . . . . 0.0 109.311 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.86 169.49 18.14 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.551 1.157 . . . . 0.0 110.338 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.17 121.49 9.61 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.138 . . . . 0.0 110.962 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.682 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.04 155.28 33.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.698 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 8.5 ttp -98.01 119.26 36.32 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.373 1.046 . . . . 0.0 110.989 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' ND2' ' CD ' ' A' ' 35' ' ' LYS . 42.8 t30 -79.33 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.499 1.124 . . . . 0.0 109.283 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.564 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.46 0.75 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 124.464 1.102 . . . . 0.0 109.307 179.926 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.697 HG21 ' HG3' ' A' ' 14' ' ' PRO . 9.8 p 46.04 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.092 . . . . 0.0 109.319 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.703 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -92.91 -172.31 40.63 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.487 1.117 . . . . 0.0 111.026 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.455 ' CD ' ' HG2' ' B' ' 119' ' ' PRO . 56.3 Cg_endo -74.98 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.36 1.167 0 C-N-CA 120.948 -2.522 . . . . 0.0 110.973 -0.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.698 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 68.8 m-70 -144.26 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.588 1.18 . . . . 0.0 109.574 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 174.01 167.07 0.21 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.457 1.098 . . . . 0.0 109.338 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.16 114.32 43.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 O-C-N 124.586 1.179 . . . . 0.0 109.323 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 1.1 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.324 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.61 160.63 0.11 Allowed 'General case' 0 C--N 1.323 -0.556 0 O-C-N 124.562 1.163 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.04 -50.05 4.77 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.533 1.146 . . . . 0.0 109.288 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.35 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.538 1.149 . . . . 0.0 109.267 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.046 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.53 158.1 72.88 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.381 1.051 . . . . 0.0 109.257 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 164.27 33.6 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.449 1.763 . . . . 0.0 111.045 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.27 135.64 1.4 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.45 1.094 . . . . 0.0 109.292 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.48 -56.66 0.72 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.532 1.145 . . . . 0.0 111.008 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.01 -173.29 2.21 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.59 0.818 . . . . 0.0 110.282 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.422 0 O-C-N 124.426 1.079 . . . . 0.0 109.997 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.046 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.04 -51.83 71.14 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.417 1.073 . . . . 0.0 109.265 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.02 50.79 2.63 Favored 'Trans proline' 0 C--N 1.36 1.133 0 O-C-N 124.447 1.762 . . . . 0.0 110.933 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.29 -45.66 0.07 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.659 1.224 . . . . 0.0 109.348 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.07 -27.54 68.16 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.536 1.147 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 15.8 m -46.52 115.1 0.94 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.945 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 0.8 OUTLIER -107.97 117.69 34.8 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 109.343 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.8 t -89.79 21.88 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.38 1.05 . . . . 0.0 110.308 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' O ' ' C ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -86.04 64.39 8.56 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.497 1.123 . . . . 0.0 109.297 179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.42 102.46 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.546 1.154 . . . . 0.0 109.337 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.42 98.42 6.01 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.514 1.134 . . . . 0.0 109.317 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.944 ' HB ' ' HG3' ' B' ' 121' ' ' PRO . 0.0 OUTLIER -68.64 -46.12 80.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.56 1.162 . . . . 0.0 109.353 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.04 111.61 4.85 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.494 1.121 . . . . 0.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.05 139.15 23.81 Favored 'Trans proline' 0 C--N 1.36 1.183 0 O-C-N 124.468 1.772 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.567 1.167 . . . . 0.0 110.94 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.682 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.7 97.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.438 0.728 . . . . 0.0 109.989 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.21 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.496 1.123 . . . . 0.0 110.876 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.471 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.52 175.12 4.18 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.467 1.105 . . . . 0.0 110.974 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.506 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.28 20.94 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.444 1.09 . . . . 0.0 109.988 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.506 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.04 137.69 8.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.47 1.106 . . . . 0.0 109.427 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.26 146.48 23.99 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 110.331 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.11 8.53 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 124.449 1.093 . . . . 0.0 109.251 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.31 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.488 1.117 . . . . 0.0 110.977 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.07 37.65 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.533 0.784 . . . . 0.0 110.37 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.97 141.49 26.79 Favored 'Trans proline' 0 C--N 1.359 1.092 0 O-C-N 124.498 1.789 . . . . 0.0 111.107 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.62 20.07 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.452 1.095 . . . . 0.0 110.948 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.02 40.39 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.461 0.742 . . . . 0.0 110.339 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.4 m-85 -96.68 140.75 30.82 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.522 1.139 . . . . 0.0 111.058 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.97 145.16 49.36 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.484 1.115 . . . . 0.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.56 3.75 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.422 1.077 . . . . 0.0 110.94 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.41 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.1 p90 -171.82 165.41 6.51 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.492 1.12 . . . . 0.0 111.018 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.49 122.38 35.86 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.465 1.103 . . . . 0.0 108.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.71 HG21 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -51.34 -50.84 73.84 Favored Pre-proline 0 C--N 1.325 -0.5 0 O-C-N 124.506 1.129 . . . . 0.0 110.373 -179.989 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.523 ' CB ' ' OH ' ' B' ' 1' ' ' TYR . 40.2 Cg_endo -74.97 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.196 0 O-C-N 124.465 1.771 . . . . 0.0 111.01 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.53 ' CD2' ' N ' ' A' ' 85' ' ' HIS . 2.5 m170 -75.03 58.01 0.85 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.509 1.131 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.36 HH12 ' CA ' ' A' ' 87' ' ' GLY . 0.0 OUTLIER -88.01 -38.46 15.48 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.57 1.169 . . . . 0.0 110.314 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 1.36 ' CA ' HH12 ' A' ' 86' ' ' ARG . . . -89.49 -23.82 32.78 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.465 1.103 . . . . 0.0 110.983 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.64 -15.26 62.59 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 0.751 . . . . 0.0 109.408 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.13 63.11 1.83 Allowed Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.43 1.081 . . . . 0.0 110.981 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.658 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.56 74.98 1.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.401 0.706 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.12 153.59 30.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.487 1.117 . . . . 0.0 109.256 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.465 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.72 19.72 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.599 1.187 . . . . 0.0 110.984 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.81 162.07 37.01 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.547 0.793 . . . . 0.0 110.414 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.64 122.63 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.479 1.112 . . . . 0.0 109.268 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.0 m -105.01 144.53 31.69 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.414 1.071 . . . . 0.0 110.404 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.29 73.74 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.515 1.134 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.819 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.572 1.17 . . . . 0.0 110.284 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.751 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . . . . . . . . . 14.3 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.457 ' HD1' ' HA ' ' B' ' 7' ' ' TYR . 1.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 32.2 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.798 ' CE2' HD13 ' B' ' 69' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.584 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 52.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.895 ' HB2' HG21 ' B' ' 233' ' ' VAL . 7.2 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 98.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' B' ' 65' ' ' SER . 8.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.71 ' CB ' HG21 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.439 ' OD1' ' HB2' ' B' ' 65' ' ' SER . 0.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.647 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 69.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.584 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 47.2 t -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.798 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.89 ' ND2' HG23 ' A' ' 62' ' ' ILE . 2.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 27.8 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.787 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 1.2 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.817 ' CB ' HD22 ' B' ' 83' ' ' LEU . 99.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.83 HG23 ' HB2' ' B' ' 116' ' ' LEU . 1.5 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.3 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.5 ' CD1' HD11 ' B' ' 116' ' ' LEU . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.979 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.83 ' HB2' HG23 ' B' ' 105' ' ' THR . 46.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.478 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.725 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 1.5 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.478 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 9.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.944 ' HG3' ' HB ' ' A' ' 62' ' ' ILE . 2.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.553 ' HG2' ' N ' ' B' ' 124' ' ' ASP . 4.1 pm0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.553 ' N ' ' HG2' ' B' ' 123' ' ' GLU . 8.7 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 42.8 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.8 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.533 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.765 HG12 ' HA ' ' B' ' 24' ' ' CYS . 6.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 0.93 ' HB2' HG22 ' B' ' 164' ' ' THR . 19.2 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.021 HG23 ' H ' ' B' ' 166' ' ' GLU . 14.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.021 ' H ' HG23 ' B' ' 164' ' ' THR . 25.7 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.713 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.3 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 54.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.568 HD21 ' HA ' ' B' ' 62' ' ' ALA . 10.0 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.199 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . 0.474 ' C ' HD13 ' B' ' 208' ' ' LEU . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.824 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.0 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.199 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 8.4 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.895 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.58 126.79 28.88 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.549 1.155 . . . . 0.0 110.028 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.943 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.39 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.267 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.86 40.25 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.529 1.143 . . . . 0.0 110.315 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.32 112.12 38.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.363 1.039 . . . . 0.0 109.267 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.525 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.74 133.47 35.99 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.509 1.131 . . . . 0.0 109.364 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.611 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.69 96.99 6.88 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.458 1.099 . . . . 0.0 111.036 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.529 0.964 0 O-C-N 124.477 1.111 . . . . 0.0 110.977 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.4 p -108.09 160.65 15.63 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.446 0.733 . . . . 0.0 110.439 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.518 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 13.4 t70 -59.78 -15.98 24.44 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.452 1.095 . . . . 0.0 109.361 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 29.1 mttp -90.57 39.71 0.99 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.453 1.096 . . . . 0.0 109.313 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' CE2' HG21 ' B' ' 105' ' ' THR . 0.2 OUTLIER 38.24 29.64 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.532 1.145 . . . . 0.0 111.054 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.85 117.7 58.12 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.532 1.145 . . . . 0.0 109.282 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.676 ' HG3' HG21 ' A' ' 36' ' ' VAL . 28.0 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.429 1.752 . . . . 0.0 111.032 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.81 151.22 31.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.475 1.109 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.34 126.17 30.49 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.432 1.082 . . . . 0.0 110.974 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.44 134.82 26.52 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.406 1.066 . . . . 0.0 110.375 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.12 140.92 69.9 Favored 'Cis proline' 0 C--N 1.36 1.138 0 C-N-CA 121.031 -2.487 . . . . 0.0 110.96 0.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.17 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.16 146.32 46.11 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.425 1.078 . . . . 0.0 109.279 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.943 HD11 HG21 ' A' ' 3' ' ' VAL . 11.1 tp -143.21 141.4 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.52 1.137 . . . . 0.0 109.261 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.611 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.482 1.114 . . . . 0.0 110.019 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.94 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.499 1.124 . . . . 0.0 109.287 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.808 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.59 158.32 27.62 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.502 1.126 . . . . 0.0 109.923 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.42 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.525 1.141 . . . . 0.0 109.251 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.43 8.45 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.508 1.13 . . . . 0.0 111.032 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.658 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.14 174.09 11.52 Favored 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.56 0.8 . . . . 0.0 109.282 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.43 154.29 39.27 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.535 1.147 . . . . 0.0 110.51 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.695 HG11 HD13 ' A' ' 94' ' ' ILE . 63.7 t -131.52 102.6 6.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.459 1.099 . . . . 0.0 109.289 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.53 18.08 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.484 1.115 . . . . 0.0 110.28 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.23 121.39 9.5 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.516 1.135 . . . . 0.0 110.974 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.685 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.38 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.488 1.118 . . . . 0.0 109.326 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.548 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 6.8 ttp -98.0 119.17 36.16 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.427 1.079 . . . . 0.0 111.037 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -79.38 -66.05 0.92 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.571 1.17 . . . . 0.0 109.223 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.89 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.526 1.141 . . . . 0.0 109.31 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG22 ' O ' ' A' ' 36' ' ' VAL . 2.7 p 45.97 54.9 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.505 1.128 . . . . 0.0 109.321 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.803 ' O ' ' HG2' ' B' ' 119' ' ' PRO . . . -93.0 -172.37 40.51 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.478 1.111 . . . . 0.0 111.03 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HG3' HD21 ' B' ' 70' ' ' ASN . 19.0 Cg_endo -75.02 -168.89 6.86 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.97 0.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.613 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.4 m-70 -144.23 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.508 1.13 . . . . 0.0 109.644 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.62 ' HB3' HD23 ' A' ' 60' ' ' LEU . 1.2 p30 173.97 166.96 0.21 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.478 1.111 . . . . 0.0 109.304 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.419 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.8 t -104.12 114.3 43.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.556 1.16 . . . . 0.0 109.357 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.938 HG13 ' OG1' ' A' ' 83' ' ' THR . 2.8 mm -132.75 75.99 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.485 1.116 . . . . 0.0 109.326 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 84.9 m-85 -47.72 160.59 0.12 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.49 1.119 . . . . 0.0 110.959 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.01 -49.94 4.81 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.533 1.146 . . . . 0.0 109.276 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.453 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.26 143.55 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.431 1.082 . . . . 0.0 109.281 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.043 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.56 158.14 72.79 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.39 1.056 . . . . 0.0 109.239 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 17.9 Cg_endo -75.11 164.2 33.61 Favored 'Trans proline' 0 C--N 1.36 1.158 0 O-C-N 124.55 1.816 . . . . 0.0 110.973 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.16 135.55 1.37 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.454 1.097 . . . . 0.0 109.307 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.468 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.52 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.031 0 O-C-N 124.566 1.166 . . . . 0.0 110.974 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.504 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.24 2.2 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.607 0.828 . . . . 0.0 110.243 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.27 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.501 1.126 . . . . 0.0 109.963 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.043 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.99 -51.85 70.87 Favored Pre-proline 0 C--N 1.324 -0.528 0 O-C-N 124.473 1.108 . . . . 0.0 109.353 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.759 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -74.97 50.71 2.58 Favored 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.446 1.761 . . . . 0.0 110.954 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.54 0.07 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.53 1.144 . . . . 0.0 109.392 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.504 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.4 mt -66.11 -27.61 68.18 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.593 1.183 . . . . 0.0 109.252 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.47 115.12 0.94 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.555 1.159 . . . . 0.0 109.995 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 1.006 ' OD1' ' OH ' ' A' ' 68' ' ' TYR 0.964 52.9 p-10 -107.94 117.66 34.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.442 1.088 . . . . 0.0 109.298 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.82 21.9 3.37 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.454 1.096 . . . . 0.0 110.301 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.6 tttt -86.01 64.37 8.54 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.516 1.135 . . . . 0.0 109.239 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.671 ' CD1' ' HB2' ' B' ' 61' ' ' GLN . 4.4 mt -40.39 102.5 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 109.309 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.52 98.49 6.11 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.563 1.164 . . . . 0.0 109.263 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.977 HG22 ' HB3' ' B' ' 121' ' ' PRO . 1.2 mm -68.64 -46.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.518 1.136 . . . . 0.0 109.313 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.11 111.59 4.84 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.951 ' HD3' ' HG3' ' B' ' 121' ' ' PRO . 9.0 Cg_endo -74.97 139.15 24.02 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.466 1.771 . . . . 0.0 111.052 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.88 -67.98 0.17 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.499 1.124 . . . . 0.0 110.984 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.685 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.455 0.738 . . . . 0.0 110.008 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.16 -86.74 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.463 1.102 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 1.006 ' OH ' ' OD1' ' A' ' 57' ' ' ASN . 3.6 p90 -171.52 175.11 4.18 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.479 1.112 . . . . 0.0 111.021 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.57 161.31 20.83 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.462 1.101 . . . . 0.0 109.975 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.69 8.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.459 1.099 . . . . 0.0 109.398 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.28 146.49 23.99 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.449 1.093 . . . . 0.0 110.332 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.14 173.09 8.53 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.518 1.136 . . . . 0.0 109.233 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.12 -44.34 0.02 OUTLIER Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.577 1.173 . . . . 0.0 110.953 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.468 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.28 124.11 37.86 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.453 0.737 . . . . 0.0 110.39 -179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.98 141.51 26.77 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.504 1.792 . . . . 0.0 111.054 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.09 -178.62 20.07 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.422 1.076 . . . . 0.0 111.101 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.83 120.07 40.51 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.556 0.798 . . . . 0.0 110.403 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.843 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.81 140.79 30.86 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.58 1.175 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.91 145.16 49.32 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.504 1.127 . . . . 0.0 110.02 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.24 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.444 1.09 . . . . 0.0 110.927 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.408 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 15.0 p90 -171.84 165.38 6.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.974 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.52 122.27 35.79 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 124.469 1.106 . . . . 0.0 108.29 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.986 ' O ' ' CG ' ' A' ' 86' ' ' ARG . 20.4 m -51.27 -50.79 73.86 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.518 1.136 . . . . 0.0 110.429 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 30.3 Cg_endo -75.04 -62.5 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.174 0 O-C-N 124.554 1.818 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -75.04 57.99 0.85 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.523 1.139 . . . . 0.0 109.596 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.986 ' CG ' ' O ' ' A' ' 83' ' ' THR . 0.0 OUTLIER -87.98 -38.5 15.47 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 124.558 1.161 . . . . 0.0 110.337 179.924 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.5 -23.77 32.91 Favored Glycine 0 CA--C 1.531 1.044 0 O-C-N 124.423 1.077 . . . . 0.0 110.973 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.66 -15.31 62.66 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.487 0.757 . . . . 0.0 109.314 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.22 1.82 Allowed Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.469 1.106 . . . . 0.0 110.979 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.611 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.2 ttt -121.63 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.498 0.763 . . . . 0.0 111.0 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.8 m -124.21 153.49 30.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.44 1.088 . . . . 0.0 109.298 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.46 -174.69 19.64 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.449 1.093 . . . . 0.0 111.025 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.84 162.08 37.0 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.523 0.778 . . . . 0.0 110.382 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.695 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.63 122.56 3.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.51 1.131 . . . . 0.0 109.286 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.01 144.53 31.68 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.108 . . . . 0.0 110.43 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.75 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.25 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.511 1.132 . . . . 0.0 109.283 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.808 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.495 0 O-C-N 124.498 1.123 . . . . 0.0 110.347 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.003 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.46 ' HB3' HD22 ' B' ' 116' ' ' LEU . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.804 ' CE2' ' CE1' ' B' ' 1' ' ' TYR . 8.8 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.55 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.55 HD13 ' CE2' ' B' ' 53' ' ' TYR . 2.6 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 3.8 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.842 ' HB2' HG21 ' B' ' 233' ' ' VAL . 22.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.487 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 76.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.744 ' OE1' ' HB3' ' B' ' 65' ' ' SER . 0.4 OUTLIER -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.685 ' HB1' HG22 ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.594 ' H ' ' HG3' ' B' ' 61' ' ' GLN . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.744 ' HB3' ' OE1' ' B' ' 61' ' ' GLN . 3.2 t -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.6 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.563 ' HG ' ' HB3' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.539 HD21 HG23 ' B' ' 233' ' ' VAL . 7.5 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.718 ' OD1' HG23 ' A' ' 62' ' ' ILE . 6.3 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 21.3 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . 0.605 ' HB2' HD12 ' B' ' 103' ' ' LEU . 80.1 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 99' ' ' ASP . 1.6 mp -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.962 HG11 HD12 ' B' ' 115' ' ' LEU . 24.6 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.609 HG23 ' HB2' ' B' ' 116' ' ' LEU . 11.9 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.632 ' CD1' HD11 ' B' ' 116' ' ' LEU . 30.9 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.962 HD12 HG11 ' B' ' 104' ' ' VAL . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.632 HD11 ' CD1' ' B' ' 107' ' ' TYR . 5.3 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.803 ' HG2' ' O ' ' A' ' 37' ' ' GLY . 1.7 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' B' ' 125' ' ' TYR . 4.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.977 ' HB3' HG22 ' A' ' 62' ' ' ILE . 2.2 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' B' ' 120' ' ' LEU . 43.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.3 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 22.9 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.7 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.751 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 36.0 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.756 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.053 ' HB3' HG22 ' B' ' 164' ' ' THR . 6.7 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.559 ' HG3' ' CD2' ' B' ' 4' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.053 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.0 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.635 ' H ' HG23 ' B' ' 164' ' ' THR . 46.8 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.499 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 60.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.45 HD21 ' HA ' ' B' ' 232' ' ' ASN . 56.2 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.18 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 46.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.733 HD13 ' N ' ' B' ' 208' ' ' LEU . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.18 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.5 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.54 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.591 1.182 . . . . 0.0 110.045 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.49 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.418 1.074 . . . . 0.0 109.249 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.91 150.91 40.41 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.521 1.138 . . . . 0.0 110.317 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.09 38.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 O-C-N 124.442 1.089 . . . . 0.0 109.327 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.509 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.9 mttt -92.71 133.54 35.92 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.699 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.76 97.01 6.89 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.512 1.132 . . . . 0.0 110.996 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.12 144.52 7.63 Favored Glycine 0 CA--C 1.53 0.988 0 O-C-N 124.474 1.109 . . . . 0.0 110.967 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.423 ' OG1' HD21 ' A' ' 15' ' ' LEU . 0.1 OUTLIER -108.12 160.65 15.64 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.462 0.742 . . . . 0.0 110.371 179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -59.78 -15.98 24.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.402 1.064 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.6 mtpt -90.57 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.502 1.126 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 38.28 29.69 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.534 1.146 . . . . 0.0 111.019 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.86 117.63 58.3 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.502 1.126 . . . . 0.0 109.312 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.628 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 38.8 Cg_endo -74.97 97.63 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.148 0 O-C-N 124.496 1.787 . . . . 0.0 111.028 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD21 ' OG1' ' A' ' 9' ' ' THR . 3.4 pp -150.8 151.19 31.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.503 1.127 . . . . 0.0 109.323 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.21 30.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.537 1.148 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.527 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.5 134.95 26.65 Favored Pre-proline 0 C--N 1.327 -0.398 0 O-C-N 124.498 1.124 . . . . 0.0 110.301 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.03 140.96 70.23 Favored 'Cis proline' 0 C--N 1.36 1.136 0 C-N-CA 121.021 -2.491 . . . . 0.0 110.959 0.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.21 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.563 1.165 . . . . 0.0 109.271 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.12 146.3 46.1 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.424 1.078 . . . . 0.0 109.318 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.44 31.1 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.485 1.115 . . . . 0.0 109.201 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.631 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.69 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.432 1.082 . . . . 0.0 110.076 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.651 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.82 -177.45 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.501 1.126 . . . . 0.0 109.226 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.28 27.67 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.006 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.1 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.626 1.204 . . . . 0.0 109.36 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.49 -7.43 8.46 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.542 1.151 . . . . 0.0 110.987 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.651 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.12 11.49 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.524 0.779 . . . . 0.0 109.287 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.5 154.27 39.38 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.492 1.12 . . . . 0.0 110.472 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.697 HG11 HD13 ' A' ' 94' ' ' ILE . 64.0 t -131.43 102.6 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 O-C-N 124.492 1.12 . . . . 0.0 109.28 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.84 169.49 18.14 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.531 1.145 . . . . 0.0 110.279 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.458 1.099 . . . . 0.0 110.93 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.0 155.37 33.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.586 1.179 . . . . 0.0 109.347 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.475 ' SD ' ' HE1' ' A' ' 67' ' ' PHE . 1.1 ttp -98.07 119.28 36.43 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.384 1.053 . . . . 0.0 111.032 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.37 -66.07 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.497 1.123 . . . . 0.0 109.222 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.48 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.465 1.103 . . . . 0.0 109.23 179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.628 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 8.0 p 46.03 54.74 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 124.415 1.072 . . . . 0.0 109.359 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.3 40.62 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.494 1.121 . . . . 0.0 111.083 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -74.98 -168.87 6.84 Favored 'Cis proline' 0 C--N 1.36 1.171 0 C-N-CA 120.929 -2.53 . . . . 0.0 110.995 -0.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.639 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.9 m-70 -144.24 -170.34 3.33 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.461 1.1 . . . . 0.0 109.586 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.499 HD22 HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 173.97 167.03 0.2 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.446 1.091 . . . . 0.0 109.305 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.411 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.6 t -104.14 114.37 43.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.513 1.133 . . . . 0.0 109.34 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.599 HG13 ' OG1' ' A' ' 83' ' ' THR . 3.2 mm -132.81 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.524 1.14 . . . . 0.0 109.312 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.3 m-85 -47.55 160.56 0.11 Allowed 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.55 1.156 . . . . 0.0 111.01 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.445 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -97.0 -50.01 4.79 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.489 1.118 . . . . 0.0 109.326 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.34 143.55 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.597 1.185 . . . . 0.0 109.257 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.084 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.1 72.82 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.417 1.073 . . . . 0.0 109.275 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.04 164.24 33.67 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.454 1.765 . . . . 0.0 110.994 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.63 1.38 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.44 1.087 . . . . 0.0 109.328 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.472 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.5 -56.61 0.72 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.564 1.165 . . . . 0.0 111.027 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.497 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.09 -173.36 2.22 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.608 0.828 . . . . 0.0 110.289 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.18 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.414 1.071 . . . . 0.0 109.989 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.084 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.76 71.82 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.07 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.181 0 O-C-N 124.487 1.782 . . . . 0.0 110.913 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.24 -45.71 0.07 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 109.331 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -65.98 -27.62 68.28 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.504 1.128 . . . . 0.0 109.369 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.0 m -46.45 115.09 0.93 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.517 1.136 . . . . 0.0 110.028 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.0 117.64 34.67 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.434 1.084 . . . . 0.0 109.327 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.0 t -89.77 21.91 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.382 1.051 . . . . 0.0 110.342 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.438 1.086 . . . . 0.0 109.311 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.536 ' CD1' ' HB3' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.49 102.49 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.477 1.111 . . . . 0.0 109.287 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.43 98.42 6.02 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.502 1.126 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.634 HD11 ' NE2' ' B' ' 61' ' ' GLN . 2.6 mm -68.63 -46.08 80.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.568 1.167 . . . . 0.0 109.355 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.63 4.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.456 1.097 . . . . 0.0 109.298 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -75.03 139.08 23.78 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.422 1.748 . . . . 0.0 111.046 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.9 0.17 Allowed Glycine 0 CA--C 1.531 1.042 0 O-C-N 124.542 1.151 . . . . 0.0 110.935 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.66 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.55 0.794 . . . . 0.0 109.99 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.23 -86.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.451 1.094 . . . . 0.0 110.883 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.52 175.08 4.19 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.478 1.111 . . . . 0.0 110.982 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.502 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.56 161.27 20.89 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.02 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.502 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.71 8.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.494 1.121 . . . . 0.0 109.381 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.3 146.47 24.01 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.13 . . . . 0.0 110.353 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.12 173.06 8.54 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.484 1.115 . . . . 0.0 109.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.09 -44.4 0.02 OUTLIER Glycine 0 CA--C 1.529 0.928 0 O-C-N 124.517 1.135 . . . . 0.0 111.0 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.472 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.1 37.51 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.535 0.785 . . . . 0.0 110.42 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.6 Cg_endo -74.97 141.44 26.72 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.415 1.745 . . . . 0.0 111.084 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.14 -178.63 20.09 Favored Glycine 0 CA--C 1.529 0.957 0 O-C-N 124.386 1.054 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.449 0.735 . . . . 0.0 110.378 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.837 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.75 30.88 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.545 1.153 . . . . 0.0 111.042 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.95 145.19 49.33 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.473 1.108 . . . . 0.0 109.982 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.22 -171.57 3.75 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.479 1.112 . . . . 0.0 110.98 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -171.81 165.43 6.52 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 111.011 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.53 122.31 35.84 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.464 1.102 . . . . 0.0 108.284 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.599 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.1 m -51.36 -50.75 74.42 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 110.392 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.598 ' O ' ' HG3' ' A' ' 86' ' ' ARG . 55.2 Cg_endo -75.08 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.541 1.811 . . . . 0.0 110.964 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.444 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 25.5 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.517 1.135 . . . . 0.0 109.616 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.943 ' NH1' HG21 ' B' ' 164' ' ' THR . 0.0 OUTLIER -87.96 -38.53 15.47 Favored 'General case' 0 C--N 1.327 -0.408 0 O-C-N 124.486 1.116 . . . . 0.0 110.32 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.788 ' N ' ' HD3' ' A' ' 86' ' ' ARG . . . -89.45 -23.83 32.85 Favored Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.529 1.143 . . . . 0.0 111.0 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.895 ' HB2' ' OH ' ' B' ' 4' ' ' TYR . . . -65.65 -15.21 62.55 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.519 0.776 . . . . 0.0 109.416 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.14 1.83 Allowed Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.457 1.098 . . . . 0.0 110.983 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.699 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.6 ttt -121.57 75.02 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.467 0.745 . . . . 0.0 111.068 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.14 153.57 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.251 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.73 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.55 1.156 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.92 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.522 0.778 . . . . 0.0 110.393 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.697 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.67 3.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.522 1.139 . . . . 0.0 109.273 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 23' ' ' ILE . 47.6 m -105.08 144.54 31.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.412 1.07 . . . . 0.0 110.411 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.24 73.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.579 1.175 . . . . 0.0 109.37 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.563 1.164 . . . . 0.0 110.291 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.595 ' CE1' HBD1 ' B' ' 250' ' ' HEC . 39.8 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.465 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.895 ' OH ' ' HB2' ' A' ' 88' ' ' ALA . 13.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.506 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 34.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 64.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 1.051 ' HG3' HG22 ' B' ' 233' ' ' VAL . 4.4 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.762 ' HG3' HD13 ' A' ' 60' ' ' LEU . 8.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.583 ' HA ' HD21 ' B' ' 169' ' ' ASN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 1.536 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 1.1 t70 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.463 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 3.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.472 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.706 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 2.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 8.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.77 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.77 ' HB2' HG23 ' B' ' 105' ' ' THR . 83.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.685 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.747 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.685 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 82.1 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.411 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 66.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.524 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 43.7 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 1.361 ' C ' ' HD1' ' B' ' 162' ' ' TYR . 8.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.361 ' HD1' ' C ' ' B' ' 161' ' ' VAL . 0.6 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.077 HG23 ' H ' ' B' ' 166' ' ' GLU . 3.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.077 ' H ' HG23 ' B' ' 164' ' ' THR . 27.3 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 24.3 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.583 HD21 ' HA ' ' B' ' 62' ' ' ALA . 8.8 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 1.582 ' CB ' ' CA ' ' B' ' 170' ' ' ASN 0.352 22.8 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 0.28 61.6 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 53.8 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.722 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 4.8 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 0.85 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.722 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 8.1 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.54 HD22 ' N ' ' B' ' 208' ' ' LEU . 3.3 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.85 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.8 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 1.051 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.52 126.85 29.13 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.574 1.171 . . . . 0.0 110.022 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.965 HG21 HD11 ' A' ' 21' ' ' LEU . 5.0 m -122.49 177.16 3.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 124.467 1.104 . . . . 0.0 109.295 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.83 40.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.442 1.089 . . . . 0.0 110.321 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.514 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.34 112.11 38.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.434 1.084 . . . . 0.0 109.301 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.7 mttt -92.72 133.43 36.03 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 109.363 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.583 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.63 96.98 6.88 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.444 1.09 . . . . 0.0 111.008 -179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.57 7.65 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.504 1.127 . . . . 0.0 110.973 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.413 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.13 160.64 15.65 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.449 0.735 . . . . 0.0 110.371 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.714 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 7.5 t70 -59.81 -15.91 24.26 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.448 1.093 . . . . 0.0 109.325 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 3.3 ttmt -90.6 39.64 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.118 . . . . 0.0 109.311 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.886 ' HD2' HG21 ' B' ' 105' ' ' THR . 0.0 OUTLIER 38.34 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.548 1.155 . . . . 0.0 111.023 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.71 58.09 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.497 1.123 . . . . 0.0 109.248 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.869 ' HG3' HG21 ' A' ' 36' ' ' VAL . 16.5 Cg_endo -74.94 97.66 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.407 1.74 . . . . 0.0 111.043 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.1 pp -150.81 151.18 31.93 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.535 1.147 . . . . 0.0 109.319 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.5 m-85 -77.25 126.12 30.43 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.486 1.116 . . . . 0.0 111.006 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.3 tt0 -130.43 134.84 26.53 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.501 1.126 . . . . 0.0 110.391 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.07 140.95 70.09 Favored 'Cis proline' 0 C--N 1.36 1.14 0 C-N-CA 121.032 -2.487 . . . . 0.0 110.954 0.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.3 tttt -40.19 -40.15 1.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.545 1.153 . . . . 0.0 109.272 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.14 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.385 1.053 . . . . 0.0 109.358 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.965 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.2 141.44 31.12 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.574 1.171 . . . . 0.0 109.214 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.616 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.01 143.78 50.98 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.597 1.186 . . . . 0.0 110.052 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.645 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.2 pt -154.87 -177.49 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.519 1.137 . . . . 0.0 109.351 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.821 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.6 158.34 27.58 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.504 1.127 . . . . 0.0 109.927 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.48 0.28 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.575 1.172 . . . . 0.0 109.322 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.38 -7.25 8.55 Favored Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.523 1.14 . . . . 0.0 111.022 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.645 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.18 174.15 11.46 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.567 0.804 . . . . 0.0 109.294 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.1 m -123.61 154.2 39.63 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.506 1.129 . . . . 0.0 110.466 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.696 HG11 HD13 ' A' ' 94' ' ' ILE . 63.6 t -131.32 102.59 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 O-C-N 124.562 1.164 . . . . 0.0 109.33 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.432 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.75 169.52 18.11 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.584 1.177 . . . . 0.0 110.374 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.551 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.22 121.48 9.56 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.597 1.186 . . . . 0.0 110.951 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.616 HG23 ' HA ' ' A' ' 66' ' ' SER . 4.3 p -125.08 155.34 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.567 1.167 . . . . 0.0 109.276 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.616 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.8 ttt -98.0 119.19 36.19 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.475 1.11 . . . . 0.0 111.026 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.866 ' ND2' ' HD3' ' A' ' 35' ' ' LYS . 11.6 t30 -79.3 -66.1 0.91 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.483 1.114 . . . . 0.0 109.26 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.866 ' HD3' ' ND2' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.81 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.482 1.114 . . . . 0.0 109.346 -179.983 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.926 HG23 ' HG2' ' B' ' 119' ' ' PRO . 0.9 OUTLIER 45.9 54.95 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.621 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.31 40.54 Favored Glycine 0 CA--C 1.529 0.955 0 O-C-N 124.563 1.165 . . . . 0.0 111.062 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.885 ' HD2' ' ND2' ' B' ' 70' ' ' ASN . 73.5 Cg_endo -74.94 -168.86 6.82 Favored 'Cis proline' 0 C--N 1.36 1.162 0 C-N-CA 120.974 -2.511 . . . . 0.0 111.062 -0.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.621 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 70.3 m-70 -144.28 -170.37 3.34 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.576 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.483 HD21 ' HD3' ' A' ' 84' ' ' PRO . 4.3 p30 173.99 167.05 0.21 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.421 1.076 . . . . 0.0 109.289 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.7 t -104.11 114.36 43.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.583 1.177 . . . . 0.0 109.416 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 41' ' ' VAL . 3.4 mm -132.84 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.501 1.126 . . . . 0.0 109.286 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.415 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.67 160.6 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.477 1.111 . . . . 0.0 111.008 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 4.1 t70 -97.08 -49.92 4.81 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.499 1.124 . . . . 0.0 109.248 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.25 143.53 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.551 1.157 . . . . 0.0 109.343 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.073 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.53 158.08 72.94 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.514 1.134 . . . . 0.0 109.276 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.0 164.24 33.74 Favored 'Trans proline' 0 C--N 1.361 1.218 0 O-C-N 124.408 1.741 . . . . 0.0 110.969 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.24 135.57 1.4 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.467 1.104 . . . . 0.0 109.294 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.51 -56.48 0.73 Allowed Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.588 1.18 . . . . 0.0 110.984 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.13 -173.37 2.23 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.579 0.811 . . . . 0.0 110.295 179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.7 m -133.08 77.77 1.75 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 110.006 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.073 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.06 -51.8 71.53 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -75.07 50.79 2.64 Favored 'Trans proline' 0 C--N 1.359 1.118 0 O-C-N 124.419 1.747 . . . . 0.0 110.967 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.28 -45.69 0.07 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.534 1.146 . . . . 0.0 109.324 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.52 68.13 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.601 1.188 . . . . 0.0 109.316 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.7 m -46.45 115.13 0.94 Allowed 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.54 1.15 . . . . 0.0 110.008 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 117.6 34.56 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.365 1.04 . . . . 0.0 109.29 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.7 t -89.77 21.86 3.36 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.404 1.065 . . . . 0.0 110.314 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.402 ' O ' ' C ' ' A' ' 60' ' ' LEU . 61.7 tttt -86.04 64.42 8.57 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.416 1.072 . . . . 0.0 109.27 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 0.6 OUTLIER -40.48 102.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 O-C-N 124.432 1.082 . . . . 0.0 109.335 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.702 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.4 98.4 5.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.531 1.144 . . . . 0.0 109.325 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.956 HG23 ' CB ' ' B' ' 121' ' ' PRO . 1.7 mt -68.65 -46.1 80.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.57 1.169 . . . . 0.0 109.365 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.05 111.51 4.69 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.492 1.12 . . . . 0.0 109.35 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -74.95 139.19 24.13 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.544 1.813 . . . . 0.0 111.04 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.85 -67.92 0.17 Allowed Glycine 0 CA--C 1.529 0.941 0 O-C-N 124.475 1.109 . . . . 0.0 110.991 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.616 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.35 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 0.753 . . . . 0.0 109.998 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.702 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 5.0 m-85 -38.28 -86.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.501 1.125 . . . . 0.0 110.941 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.54 175.16 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.42 1.075 . . . . 0.0 110.964 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.503 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.65 161.4 20.74 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.54 1.15 . . . . 0.0 109.931 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.503 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.15 137.65 8.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.463 1.102 . . . . 0.0 109.376 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.2 146.44 24.0 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.376 1.048 . . . . 0.0 110.406 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.09 8.51 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.521 1.138 . . . . 0.0 109.22 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.39 0.02 OUTLIER Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.573 1.17 . . . . 0.0 110.973 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.11 38.01 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 124.533 0.784 . . . . 0.0 110.439 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.0 141.51 26.74 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.543 1.812 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.12 -178.66 20.05 Favored Glycine 0 CA--C 1.531 1.084 0 O-C-N 124.501 1.125 . . . . 0.0 110.97 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.83 120.05 40.47 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 124.539 0.788 . . . . 0.0 110.436 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.849 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.512 1.132 . . . . 0.0 110.987 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.83 145.07 49.34 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.448 1.092 . . . . 0.0 110.028 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.524 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.54 3.74 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.566 1.166 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.415 ' CB ' HG12 ' A' ' 91' ' ' VAL . 53.7 p90 -171.86 165.39 6.46 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.548 1.155 . . . . 0.0 111.028 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 0.717 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.3 OUTLIER -93.47 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.486 1.116 . . . . 0.0 108.344 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 1.277 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 0.8 OUTLIER -51.2 -50.84 73.33 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.544 1.153 . . . . 0.0 110.47 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.483 ' HD3' HD21 ' A' ' 40' ' ' ASN . 18.1 Cg_endo -75.04 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.498 1.789 . . . . 0.0 111.012 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.483 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 30.3 m80 -75.12 57.98 0.87 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.581 1.175 . . . . 0.0 109.499 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.717 ' HG2' ' O ' ' A' ' 82' ' ' CYS . 0.0 OUTLIER -87.95 -38.47 15.53 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.523 1.14 . . . . 0.0 110.336 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.601 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.51 -23.88 32.53 Favored Glycine 0 CA--C 1.53 0.977 0 O-C-N 124.379 1.049 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.68 -15.19 62.56 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.517 0.774 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.17 63.14 1.83 Allowed Glycine 0 CA--C 1.529 0.931 0 O-C-N 124.523 1.14 . . . . 0.0 110.979 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.583 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.1 ttt -121.62 75.04 1.16 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.418 0.717 . . . . 0.0 111.0 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.415 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.0 m -124.19 153.57 30.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 O-C-N 124.549 1.156 . . . . 0.0 109.218 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.466 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.45 -174.73 19.67 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 124.508 1.13 . . . . 0.0 111.0 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.7 m -143.77 162.04 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.55 0.794 . . . . 0.0 110.43 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.696 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.64 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.56 1.163 . . . . 0.0 109.27 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.6 m -105.06 144.56 31.7 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.418 1.074 . . . . 0.0 110.395 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.29 73.87 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.552 1.158 . . . . 0.0 109.248 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.821 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.554 0 O-C-N 124.581 1.176 . . . . 0.0 110.285 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.112 ' N ' ' CD1' ' B' ' 1' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.444 ' HZ ' ' HD2' ' A' ' 11' ' ' LYS . 8.4 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.768 ' CG ' ' CD2' ' B' ' 1' ' ' TYR 0.283 12.5 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 7.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.155 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.7 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.491 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.643 ' CE2' HD13 ' B' ' 55' ' ' LEU . 46.8 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.643 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.2 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 2.4 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.672 ' HB2' HG21 ' B' ' 233' ' ' VAL . 26.5 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . . . . . . . . . 50.7 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.809 ' OE1' ' HB2' ' B' ' 65' ' ' SER . 2.9 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 1.277 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.809 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 18.4 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.678 HD21 HG23 ' B' ' 233' ' ' VAL . 4.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.885 ' ND2' ' HD2' ' A' ' 38' ' ' PRO . 2.5 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 9.2 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.499 HG13 ' O ' ' B' ' 74' ' ' VAL . 8.5 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.789 ' HB3' HD22 ' B' ' 115' ' ' LEU . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.003 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.0 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.6 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.536 ' HD1' ' HG ' ' B' ' 103' ' ' LEU . 1.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.536 ' HG ' ' HD1' ' B' ' 102' ' ' TYR . 11.3 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.825 ' CB ' HD22 ' B' ' 83' ' ' LEU . 20.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.886 HG21 ' HD2' ' A' ' 12' ' ' TYR . 11.7 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.493 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 28.3 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.1 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 0.926 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.678 ' HB2' ' CG2' ' B' ' 105' ' ' THR . 26.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.558 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG2' HG23 ' A' ' 36' ' ' VAL . 1.1 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.558 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 8.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 0.956 ' CB ' HG23 ' A' ' 62' ' ' ILE . 2.5 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.546 ' HB3' HD12 ' A' ' 62' ' ' ILE . 4.6 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.764 ' HB2' ' CG2' ' A' ' 62' ' ' ILE . 2.4 t70 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 20.8 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 36.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.725 ' CD2' HD22 ' B' ' 75' ' ' LEU . 21.5 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.003 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.4 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.616 ' H ' ' NE2' ' B' ' 59' ' ' GLN . 0.0 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.449 ' NE2' HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' B' ' 24' ' ' CYS . 13.3 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.053 ' CB ' HG22 ' B' ' 164' ' ' THR . 22.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.114 HG23 ' H ' ' B' ' 166' ' ' GLU . 4.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.114 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.541 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.9 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.4 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 60.1 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.434 HD21 ' NH1' ' B' ' 158' ' ' ARG . 9.8 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.449 HD22 ' NE2' ' B' ' 160' ' ' GLN . 43.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.475 1.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 62.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.906 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.116 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.258 3.6 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . 0.459 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 76.5 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.8 HD22 ' N ' ' B' ' 208' ' ' LEU . 2.4 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.116 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.7 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . 0.518 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 9.4 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.678 HG23 HD21 ' B' ' 69' ' ' LEU . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.155 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.338 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.6 126.82 29.0 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.508 1.13 . . . . 0.0 110.059 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.44 177.12 3.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.91 150.87 40.36 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.518 1.136 . . . . 0.0 110.328 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.508 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.4 112.19 38.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.42 1.075 . . . . 0.0 109.224 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.518 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.73 133.51 35.96 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.51 1.131 . . . . 0.0 109.285 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.563 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.71 97.01 6.9 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.468 1.105 . . . . 0.0 111.001 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 1.028 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 118.0 144.48 7.65 Favored Glycine 0 CA--C 1.528 0.881 0 O-C-N 124.501 1.126 . . . . 0.0 111.061 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.596 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.5 OUTLIER -108.16 160.68 15.63 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.405 0.709 . . . . 0.0 110.356 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -59.78 -15.99 24.54 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.489 1.118 . . . . 0.0 109.324 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' ALA . 19.7 mttt -90.58 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.547 1.154 . . . . 0.0 109.358 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 38.25 29.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 111.059 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.596 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.71 58.08 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.544 1.152 . . . . 0.0 109.232 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.474 ' C ' ' SD ' ' A' ' 90' ' ' MET . 38.1 Cg_endo -75.06 97.63 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.081 0 O-C-N 124.478 1.778 . . . . 0.0 111.002 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.488 ' HA ' ' HG3' ' A' ' 90' ' ' MET . 4.0 pp -150.74 151.31 32.19 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.496 1.122 . . . . 0.0 109.405 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.458 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.44 126.21 30.55 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.494 1.121 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.42 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.427 1.079 . . . . 0.0 110.304 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.02 140.98 70.35 Favored 'Cis proline' 0 C--N 1.361 1.206 0 C-N-CA 120.964 -2.515 . . . . 0.0 110.942 0.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.24 -40.03 1.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.521 1.138 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.2 146.27 46.18 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.381 1.051 . . . . 0.0 109.282 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.951 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.24 141.38 31.06 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.158 . . . . 0.0 109.26 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.02 143.81 51.0 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 124.564 1.165 . . . . 0.0 110.037 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.97 -177.49 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 124.448 1.093 . . . . 0.0 109.32 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.7 m -120.55 158.38 27.44 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.476 1.11 . . . . 0.0 109.914 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.16 105.38 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.575 1.172 . . . . 0.0 109.304 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.47 -7.39 8.47 Favored Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.554 1.159 . . . . 0.0 111.063 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.641 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.24 11.38 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.568 0.805 . . . . 0.0 109.2 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.66 154.26 39.62 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.574 1.172 . . . . 0.0 110.369 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.722 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.38 102.59 6.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 O-C-N 124.554 1.159 . . . . 0.0 109.268 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.547 1.154 . . . . 0.0 110.286 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.25 121.52 9.58 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.532 1.145 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.08 155.32 33.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.517 1.135 . . . . 0.0 109.302 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.479 ' HG3' ' CD2' ' A' ' 39' ' ' HIS . 6.2 ttp -98.01 119.2 36.22 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.503 1.127 . . . . 0.0 111.005 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 1.028 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 1.1 m-20 -79.34 -66.01 0.93 Allowed 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.57 1.169 . . . . 0.0 109.237 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD2' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.92 -167.56 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.507 1.129 . . . . 0.0 109.297 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.721 HG23 ' HB2' ' B' ' 3' ' ' PHE . 7.2 p 46.1 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 124.467 1.104 . . . . 0.0 109.309 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.677 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.94 -172.3 40.58 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.52 1.138 . . . . 0.0 111.031 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.022 ' HD3' ' CG ' ' B' ' 119' ' ' PRO . 9.2 Cg_endo -74.9 -168.99 6.91 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.986 -2.506 . . . . 0.0 110.998 -0.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.677 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 65.3 m-70 -144.13 -170.34 3.32 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.461 1.101 . . . . 0.0 109.633 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.555 HD21 ' HD3' ' A' ' 84' ' ' PRO . 1.8 p30 173.9 166.94 0.2 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.419 1.074 . . . . 0.0 109.306 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.9 t -104.03 114.29 43.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 109.394 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.468 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 1.8 mm -132.78 76.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.426 1.079 . . . . 0.0 109.27 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.67 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.41 1.069 . . . . 0.0 111.014 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.449 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.0 4.8 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.517 1.136 . . . . 0.0 109.334 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.483 1.114 . . . . 0.0 109.331 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.032 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.6 m -128.48 158.05 72.91 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 109.231 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -74.97 164.29 33.69 Favored 'Trans proline' 0 C--N 1.36 1.147 0 O-C-N 124.522 1.801 . . . . 0.0 111.032 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.29 135.61 1.41 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.477 1.111 . . . . 0.0 109.278 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.469 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.49 0.73 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.548 1.155 . . . . 0.0 111.009 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.508 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.12 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.585 0.815 . . . . 0.0 110.27 -179.959 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.2 77.76 1.75 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.388 1.055 . . . . 0.0 109.938 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.032 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.88 70.62 Favored Pre-proline 0 C--N 1.323 -0.572 0 O-C-N 124.509 1.13 . . . . 0.0 109.306 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.3 Cg_endo -74.99 50.79 2.62 Favored 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.448 1.762 . . . . 0.0 110.966 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.58 1.175 . . . . 0.0 109.283 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.535 1.147 . . . . 0.0 109.308 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 42' ' ' ILE . 1.8 m -46.41 115.12 0.94 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.534 1.146 . . . . 0.0 110.014 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.603 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 6.2 m-20 -107.96 117.65 34.69 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 1.144 . . . . 0.0 109.303 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.062 HG21 ' CB ' ' B' ' 63' ' ' ASP . 7.2 t -89.75 21.86 3.34 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.379 1.05 . . . . 0.0 110.389 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 19.4 tttt -86.05 64.43 8.57 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 109.21 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -40.44 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.123 . . . . 0.0 109.335 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.49 6.05 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.512 1.132 . . . . 0.0 109.292 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.819 HD12 ' ND2' ' B' ' 70' ' ' ASN . 0.1 OUTLIER -68.73 -46.13 80.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.525 1.14 . . . . 0.0 109.283 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.13 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.431 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -75.05 139.23 23.92 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.416 1.745 . . . . 0.0 111.001 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.51 ' O ' HG23 ' A' ' 32' ' ' VAL . . . 168.84 -68.0 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.472 1.108 . . . . 0.0 110.955 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.72 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.496 0.763 . . . . 0.0 110.054 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.556 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.3 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.492 1.12 . . . . 0.0 111.001 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.603 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.49 175.13 4.19 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.458 1.099 . . . . 0.0 110.988 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.509 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.63 161.27 20.94 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.471 1.107 . . . . 0.0 109.964 -179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.509 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.65 8.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.506 1.129 . . . . 0.0 109.388 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.19 146.48 23.97 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.446 1.091 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.8 mt -124.15 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.558 1.161 . . . . 0.0 109.205 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.15 -44.33 0.02 OUTLIER Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.453 1.095 . . . . 0.0 110.987 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.469 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.29 124.19 38.32 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.586 0.815 . . . . 0.0 110.413 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.4 Cg_endo -75.07 141.43 26.41 Favored 'Trans proline' 0 C--N 1.359 1.091 0 O-C-N 124.543 1.812 . . . . 0.0 111.031 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.62 20.09 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 124.418 1.074 . . . . 0.0 110.971 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.86 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.541 0.789 . . . . 0.0 110.356 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.844 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.78 140.77 30.87 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.552 1.158 . . . . 0.0 110.975 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.05 49.39 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.996 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.525 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.15 -171.46 3.72 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.497 1.123 . . . . 0.0 110.991 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -171.85 165.45 6.47 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.535 1.147 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.63 122.31 35.96 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.443 1.089 . . . . 0.0 108.245 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.599 ' O ' ' HG2' ' A' ' 86' ' ' ARG . 0.9 OUTLIER -51.25 -50.83 73.57 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.421 1.075 . . . . 0.0 110.393 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.752 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . 19.0 Cg_endo -75.08 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.545 1.813 . . . . 0.0 110.98 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 14.6 m80 -75.07 57.95 0.85 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.487 1.117 . . . . 0.0 109.619 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.599 ' HG2' ' O ' ' A' ' 83' ' ' THR . 2.5 ptm180 -87.96 -38.5 15.5 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.519 1.137 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.49 -23.85 32.7 Favored Glycine 0 CA--C 1.529 0.927 0 O-C-N 124.532 1.145 . . . . 0.0 110.979 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.65 -15.24 62.58 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.472 0.748 . . . . 0.0 109.392 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.2 63.2 1.82 Allowed Glycine 0 CA--C 1.531 1.069 0 O-C-N 124.423 1.077 . . . . 0.0 110.868 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.563 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 9.0 ttt -121.68 75.1 1.17 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.451 0.736 . . . . 0.0 111.018 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.6 m -124.19 153.57 30.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.481 1.113 . . . . 0.0 109.311 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.78 19.77 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.46 1.1 . . . . 0.0 111.022 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.8 161.99 37.2 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.526 0.78 . . . . 0.0 110.407 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.722 HD13 HG11 ' A' ' 29' ' ' VAL . 92.2 mt -146.59 122.61 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 124.515 1.134 . . . . 0.0 109.243 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.438 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.8 m -105.08 144.56 31.72 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.516 1.135 . . . . 0.0 110.412 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.731 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.27 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.458 1.099 . . . . 0.0 109.291 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.504 1.128 . . . . 0.0 110.306 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.791 ' N ' ' HD2' ' B' ' 4' ' ' TYR . 3.6 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 5.3 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.721 ' HB2' HG23 ' A' ' 36' ' ' VAL . 2.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.791 ' HD2' ' N ' ' B' ' 1' ' ' TYR . 44.2 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' B' ' 107' ' ' TYR . 47.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.518 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 1.5 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.9 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.546 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.658 ' HB2' HG21 ' B' ' 233' ' ' VAL . 10.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.526 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 89.8 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.784 ' HG2' ' O ' ' B' ' 65' ' ' SER . 2.7 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.516 ' HB3' ' OG1' ' A' ' 58' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 1.062 ' CB ' HG21 ' A' ' 58' ' ' THR . 0.4 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.784 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 28.2 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.546 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 38.4 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.422 HD12 ' N ' ' B' ' 69' ' ' LEU . 6.0 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.819 ' ND2' HD12 ' A' ' 62' ' ' ILE . 36.6 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.409 ' HB ' HG11 ' B' ' 51' ' ' VAL . 4.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 7.2 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.503 ' C ' ' CD1' ' B' ' 102' ' ' TYR . 0.0 OUTLIER -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.416 HD21 HD22 ' B' ' 120' ' ' LEU . 0.2 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 0.832 ' CB ' HD22 ' B' ' 83' ' ' LEU . 55.9 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 61.9 p -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 29.4 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 50.0 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.001 HD23 ' O ' ' B' ' 115' ' ' LEU . 0.1 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.47 HD11 ' CD1' ' B' ' 107' ' ' TYR . 82.2 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.587 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.022 ' CG ' ' HD3' ' A' ' 38' ' ' PRO . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.587 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 1.9 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 15.1 mtm -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 24.1 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.427 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.485 HH21 ' CGD' ' B' ' 250' ' ' HEC . 0.1 OUTLIER -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.755 HG12 ' HA ' ' B' ' 24' ' ' CYS . 4.4 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.075 ' CB ' HG22 ' B' ' 164' ' ' THR . 18.3 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.549 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 5.1 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.075 HG22 ' CB ' ' B' ' 162' ' ' TYR . 5.6 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . 0.481 ' N ' HG23 ' B' ' 164' ' ' THR . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.972 ' H ' HG23 ' B' ' 164' ' ' THR . 34.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.594 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.932 ' HB3' ' H ' ' B' ' 170' ' ' ASN 0.684 0.1 OUTLIER -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 11.6 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.932 ' H ' ' HB3' ' B' ' 168' ' ' SER . 46.5 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.046 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.278 21.8 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.498 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.917 HD22 ' H ' ' B' ' 208' ' ' LEU . 0.4 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.046 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.45 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.658 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.59 126.77 28.81 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.532 1.145 . . . . 0.0 110.058 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.93 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.4 177.17 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.454 1.096 . . . . 0.0 109.28 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.96 150.9 40.31 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.519 1.137 . . . . 0.0 110.321 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.14 38.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 O-C-N 124.434 1.084 . . . . 0.0 109.3 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.514 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.79 133.46 36.02 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.53 1.144 . . . . 0.0 109.315 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.688 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.05 6.94 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.5 1.125 . . . . 0.0 110.987 -179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.54 7.66 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.544 1.153 . . . . 0.0 110.992 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.703 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 15.9 p -108.04 160.67 15.61 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.389 0.699 . . . . 0.0 110.414 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -59.87 -15.94 25.15 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.426 1.079 . . . . 0.0 109.276 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 6.0 ttmt -90.57 39.68 0.99 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.353 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.513 ' HB3' ' CE1' ' B' ' 3' ' ' PHE . 0.5 OUTLIER 38.26 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.494 1.121 . . . . 0.0 111.025 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.77 117.66 58.3 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.512 1.133 . . . . 0.0 109.344 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.685 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 33.2 Cg_endo -74.94 97.61 1.09 Allowed 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.551 1.816 . . . . 0.0 111.045 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.661 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.2 pp -150.84 151.19 31.9 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.493 1.12 . . . . 0.0 109.317 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.27 126.17 30.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.471 1.107 . . . . 0.0 110.978 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.44 134.88 26.59 Favored Pre-proline 0 C--N 1.326 -0.444 0 O-C-N 124.514 1.134 . . . . 0.0 110.319 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.542 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.03 140.94 70.1 Favored 'Cis proline' 0 C--N 1.359 1.125 0 C-N-CA 121.033 -2.486 . . . . 0.0 110.971 0.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.11 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.554 1.159 . . . . 0.0 109.264 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.11 146.32 46.06 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.428 1.08 . . . . 0.0 109.325 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.93 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.28 141.38 31.0 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.583 1.177 . . . . 0.0 109.235 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.627 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.98 143.75 50.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.465 1.103 . . . . 0.0 110.065 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.85 -177.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 124.493 1.12 . . . . 0.0 109.284 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.826 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.57 158.34 27.56 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.489 1.118 . . . . 0.0 110.009 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.11 105.36 0.27 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.6 1.187 . . . . 0.0 109.298 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.42 8.46 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.431 1.082 . . . . 0.0 110.975 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.638 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.13 174.14 11.48 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.499 0.764 . . . . 0.0 109.33 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.54 154.25 39.46 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.485 1.116 . . . . 0.0 110.516 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.715 HG11 HD13 ' A' ' 94' ' ' ILE . 64.4 t -131.41 102.57 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 O-C-N 124.568 1.167 . . . . 0.0 109.308 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.425 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.81 169.54 18.07 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.539 1.15 . . . . 0.0 110.299 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.566 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.41 9.53 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.12 . . . . 0.0 110.97 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.97 155.33 33.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 O-C-N 124.54 1.15 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.895 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 3.3 ttp -98.01 119.25 36.32 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.409 1.068 . . . . 0.0 111.0 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -79.36 -66.09 0.92 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.46 1.1 . . . . 0.0 109.216 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.85 -167.49 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.489 1.118 . . . . 0.0 109.269 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.685 ' CG1' ' HB3' ' A' ' 14' ' ' PRO . 9.8 p 46.02 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 O-C-N 124.419 1.075 . . . . 0.0 109.32 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.603 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.98 -172.29 40.52 Favored Glycine 0 CA--C 1.53 1.0 0 O-C-N 124.51 1.131 . . . . 0.0 111.009 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.277 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.9 OUTLIER -74.99 -168.92 6.88 Favored 'Cis proline' 0 C--N 1.361 1.209 0 C-N-CA 120.919 -2.534 . . . . 0.0 110.975 -0.067 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.94 ' O ' ' CD1' ' A' ' 60' ' ' LEU . 71.0 m-70 -144.19 -170.36 3.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.554 1.159 . . . . 0.0 109.614 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.518 HD21 ' HD3' ' A' ' 84' ' ' PRO . 3.7 p30 173.99 166.99 0.21 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.478 1.111 . . . . 0.0 109.355 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.09 114.34 43.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 O-C-N 124.599 1.187 . . . . 0.0 109.374 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG22 ' CZ ' ' A' ' 81' ' ' TYR . 9.0 mm -132.77 75.95 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.541 1.15 . . . . 0.0 109.345 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.426 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.65 160.62 0.11 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 110.985 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.96 -50.05 4.78 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.569 1.168 . . . . 0.0 109.308 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.33 143.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.618 1.199 . . . . 0.0 109.317 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.011 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.7 m -128.5 158.1 72.81 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.35 1.031 . . . . 0.0 109.25 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.0 Cg_endo -75.01 164.26 33.7 Favored 'Trans proline' 0 C--N 1.36 1.136 0 O-C-N 124.495 1.787 . . . . 0.0 111.046 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.62 1.41 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.57 0.72 Allowed Glycine 0 CA--C 1.53 1.018 0 O-C-N 124.56 1.162 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.42 2.24 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.608 0.828 . . . . 0.0 110.26 -179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.09 77.81 1.75 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.451 1.095 . . . . 0.0 110.042 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.011 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.08 -51.77 71.81 Favored Pre-proline 0 C--N 1.324 -0.535 0 O-C-N 124.491 1.12 . . . . 0.0 109.267 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.04 50.77 2.63 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.427 1.751 . . . . 0.0 110.885 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.25 -45.67 0.07 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.604 1.19 . . . . 0.0 109.377 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.08 -27.57 68.17 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.497 1.123 . . . . 0.0 109.303 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.3 m -46.47 115.11 0.94 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 1.126 . . . . 0.0 109.976 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.0 117.68 34.76 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.486 1.116 . . . . 0.0 109.348 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 t -89.8 21.94 3.34 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.401 1.063 . . . . 0.0 110.304 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -86.07 64.45 8.58 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.473 1.108 . . . . 0.0 109.317 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.277 ' CD1' ' HB2' ' A' ' 38' ' ' PRO . 17.6 tp -40.47 102.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.522 1.139 . . . . 0.0 109.314 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.719 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.41 98.4 6.0 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.511 1.132 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.809 HG21 ' HG3' ' B' ' 61' ' ' GLN . 0.1 OUTLIER -68.64 -46.09 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.555 1.159 . . . . 0.0 109.362 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.757 ' H ' HD13 ' A' ' 62' ' ' ILE . . . -62.08 111.59 4.83 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.509 1.131 . . . . 0.0 109.273 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -75.03 139.11 23.82 Favored 'Trans proline' 0 C--N 1.36 1.167 0 O-C-N 124.424 1.749 . . . . 0.0 111.05 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.93 -67.99 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.583 1.177 . . . . 0.0 110.925 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.656 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.36 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.461 0.742 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.719 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.0 m-85 -38.23 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.44 1.088 . . . . 0.0 110.871 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -171.5 175.11 4.19 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.436 1.085 . . . . 0.0 111.006 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.499 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.6 161.3 20.87 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.458 1.099 . . . . 0.0 110.028 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.73 8.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.418 1.074 . . . . 0.0 109.403 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.26 146.52 23.97 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.463 1.102 . . . . 0.0 110.391 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.11 8.54 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.493 1.121 . . . . 0.0 109.276 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.13 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.53 0.996 0 O-C-N 124.46 1.1 . . . . 0.0 110.977 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.09 37.61 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.5 0.765 . . . . 0.0 110.366 -179.941 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -75.01 141.5 26.68 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.48 1.779 . . . . 0.0 111.091 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.419 1.074 . . . . 0.0 110.974 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.5 m -104.88 120.08 40.55 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.451 0.736 . . . . 0.0 110.326 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.77 140.71 30.94 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.515 1.134 . . . . 0.0 111.043 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.94 145.12 49.37 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.461 1.101 . . . . 0.0 109.975 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.516 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.13 -171.53 3.74 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.428 1.08 . . . . 0.0 110.994 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 55.4 p90 -171.84 165.43 6.49 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.499 1.124 . . . . 0.0 110.995 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.54 122.35 35.89 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.526 1.141 . . . . 0.0 108.328 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.498 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -51.33 -50.85 73.74 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.484 1.115 . . . . 0.0 110.392 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.648 ' HB2' ' CE2' ' B' ' 162' ' ' TYR . 18.2 Cg_endo -75.0 -62.56 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.503 1.791 . . . . 0.0 110.949 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 20.8 m80 -74.93 57.93 0.82 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.492 1.12 . . . . 0.0 109.575 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.56 HH21 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.0 -38.47 15.48 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.545 1.153 . . . . 0.0 110.322 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.47 -23.8 32.88 Favored Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.498 1.124 . . . . 0.0 111.002 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.67 -15.23 62.58 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.516 0.774 . . . . 0.0 109.406 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.09 63.15 1.83 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.441 1.088 . . . . 0.0 110.959 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.688 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.7 ttt -121.58 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.421 0.718 . . . . 0.0 111.026 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.56 ' CG1' HH21 ' A' ' 86' ' ' ARG . 11.5 m -124.16 153.61 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.503 1.127 . . . . 0.0 109.248 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.461 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.59 -174.8 19.83 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.564 1.165 . . . . 0.0 110.991 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.71 162.05 36.97 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.499 0.764 . . . . 0.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.715 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.59 122.67 3.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 O-C-N 124.532 1.145 . . . . 0.0 109.283 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.0 m -105.07 144.51 31.77 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.382 1.051 . . . . 0.0 110.393 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.759 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.27 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 O-C-N 124.584 1.178 . . . . 0.0 109.312 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.826 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.505 0 O-C-N 124.545 1.153 . . . . 0.0 110.295 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.901 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 89.1 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.435 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 2.7 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE1' ' HB3' ' A' ' 12' ' ' TYR . 79.7 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.447 ' HD1' ' HA ' ' B' ' 4' ' ' TYR . 5.5 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.639 HE21 ' HA ' ' B' ' 107' ' ' TYR . 39.3 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.408 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 3.8 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.174 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 35.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.975 ' HG3' ' CG2' ' B' ' 233' ' ' VAL . 1.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.412 HG11 ' HA3' ' B' ' 210' ' ' GLY . 44.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.809 ' HG3' HG21 ' A' ' 62' ' ' ILE . 4.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 1.227 ' HB1' ' CD2' ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.434 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 14.9 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.579 ' HB2' ' OE1' ' B' ' 58' ' ' GLN 0.26 4.8 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.555 ' HB2' ' OE1' ' B' ' 61' ' ' GLN . 0.2 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.731 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 6.6 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.473 ' CE2' HD23 ' B' ' 103' ' ' LEU . 9.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.473 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.689 HG23 ' HB2' ' B' ' 116' ' ' LEU . 9.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.639 ' HA ' HE21 ' B' ' 6' ' ' GLN . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 77.4 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.491 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.901 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.0 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.491 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 87.5 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.444 ' HA2' ' NE2' ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.763 ' NH2' ' HA ' ' B' ' 62' ' ' ALA . 64.4 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.793 HG12 ' HA ' ' B' ' 24' ' ' CYS . 11.0 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 0.648 ' CE2' ' HB2' ' A' ' 84' ' ' PRO . 2.5 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.409 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 2.8 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.037 HG23 ' H ' ' B' ' 166' ' ' GLU . 2.7 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.037 ' H ' HG23 ' B' ' 164' ' ' THR . 4.0 tp10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.708 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 90.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.444 HD21 HH22 ' B' ' 158' ' ' ARG . 11.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.602 ' CG ' ' O ' ' B' ' 170' ' ' ASN . 16.9 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.741 ' HB2' ' CD2' ' B' ' 189' ' ' PHE . 5.2 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.309 ' CD1' ' HG3' ' B' ' 209' ' ' PRO . 0.0 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 5.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 83.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.59 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 2.5 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.309 ' HG3' ' CD1' ' B' ' 189' ' ' PHE . 2.1 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . 0.412 ' HA3' HG11 ' B' ' 60' ' ' VAL . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.531 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 19.7 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . 0.483 ' HA ' HD21 ' B' ' 170' ' ' ASN . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.975 ' CG2' ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.174 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -57.64 126.83 29.09 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.575 1.172 . . . . 0.0 110.04 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.934 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.47 177.2 3.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.431 1.082 . . . . 0.0 109.263 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.99 150.82 40.16 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.452 1.095 . . . . 0.0 110.357 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.509 HG21 ' CE2' ' A' ' 31' ' ' PHE . 8.9 mm -115.39 112.17 38.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 124.418 1.074 . . . . 0.0 109.213 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.74 133.48 35.99 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.563 1.165 . . . . 0.0 109.372 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.675 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.67 97.01 6.9 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.443 1.089 . . . . 0.0 110.951 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.09 144.53 7.64 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.524 1.14 . . . . 0.0 110.989 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.654 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.0 OUTLIER -108.08 160.64 15.64 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.463 0.743 . . . . 0.0 110.415 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.74 -16.0 24.18 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.43 1.081 . . . . 0.0 109.29 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 8.9 mttt -90.62 39.66 0.99 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.561 1.163 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.978 ' O ' ' CZ ' ' B' ' 3' ' ' PHE . 0.4 OUTLIER 38.28 29.68 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.523 1.139 . . . . 0.0 110.996 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.654 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.66 58.21 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 124.473 1.108 . . . . 0.0 109.243 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.057 ' HG3' ' CG2' ' A' ' 36' ' ' VAL . 6.3 Cg_exo -75.01 97.68 1.1 Allowed 'Trans proline' 0 C--N 1.36 1.132 0 O-C-N 124.482 1.78 . . . . 0.0 111.057 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -150.77 151.22 32.03 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.476 1.11 . . . . 0.0 109.375 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.3 126.18 30.52 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.527 1.142 . . . . 0.0 110.959 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.541 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.8 26.49 Favored Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.526 1.141 . . . . 0.0 110.341 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.541 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.09 140.98 70.23 Favored 'Cis proline' 0 C--N 1.36 1.151 0 C-N-CA 121.009 -2.496 . . . . 0.0 110.951 0.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.2 -40.11 1.05 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.499 1.124 . . . . 0.0 109.278 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.15 146.29 46.12 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.423 1.077 . . . . 0.0 109.329 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.934 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.22 141.43 31.09 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.592 1.183 . . . . 0.0 109.209 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.612 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.77 50.97 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.553 1.158 . . . . 0.0 110.067 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.91 -177.48 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.112 . . . . 0.0 109.307 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.828 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.58 158.33 27.59 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.447 1.092 . . . . 0.0 109.981 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.19 105.42 0.28 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.603 1.19 . . . . 0.0 109.321 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.44 -7.27 8.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.512 1.133 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.655 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.2 11.4 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.582 0.813 . . . . 0.0 109.29 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.2 m -123.62 154.16 39.7 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.477 1.111 . . . . 0.0 110.455 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.693 HG11 HD13 ' A' ' 94' ' ' ILE . 63.4 t -131.3 102.57 6.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 O-C-N 124.601 1.188 . . . . 0.0 109.354 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.73 169.53 18.09 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.539 1.149 . . . . 0.0 110.311 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.56 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.31 121.47 9.51 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.514 1.134 . . . . 0.0 110.943 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.669 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.03 155.29 33.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 124.586 1.178 . . . . 0.0 109.315 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.3 ttp -97.99 119.22 36.24 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.485 1.116 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.65 ' HB3' ' HD3' ' A' ' 35' ' ' LYS 0.324 6.6 m-20 -79.33 -66.02 0.92 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.509 1.131 . . . . 0.0 109.264 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HD3' ' HB3' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -168.86 -167.5 0.76 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.456 1.098 . . . . 0.0 109.396 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.057 ' CG2' ' HG3' ' A' ' 14' ' ' PRO . 2.4 p 45.9 54.89 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.511 1.132 . . . . 0.0 109.343 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.652 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.93 -172.29 40.6 Favored Glycine 0 CA--C 1.529 0.93 0 O-C-N 124.582 1.176 . . . . 0.0 111.047 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.961 ' HD3' ' CZ ' ' B' ' 1' ' ' TYR . 24.3 Cg_endo -74.94 -168.89 6.84 Favored 'Cis proline' 0 C--N 1.361 1.187 0 C-N-CA 120.953 -2.52 . . . . 0.0 111.054 -0.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.652 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 68.6 m-70 -144.24 -170.32 3.33 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.539 1.149 . . . . 0.0 109.596 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 1.053 ' HB3' HD22 ' A' ' 60' ' ' LEU . 0.2 OUTLIER 173.98 167.02 0.21 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.446 1.091 . . . . 0.0 109.258 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.7 t -104.1 114.42 43.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.561 1.163 . . . . 0.0 109.399 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.914 HG13 ' OG1' ' A' ' 83' ' ' THR . 7.4 mm -132.87 75.96 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 O-C-N 124.496 1.123 . . . . 0.0 109.311 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.431 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.7 160.61 0.12 Allowed 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.449 1.093 . . . . 0.0 111.013 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.47 ' HA ' ' HE2' ' A' ' 81' ' ' TYR . 1.7 t70 -96.98 -49.98 4.81 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.534 1.146 . . . . 0.0 109.314 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.31 143.51 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.498 1.124 . . . . 0.0 109.352 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.019 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 158.09 72.84 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.397 1.061 . . . . 0.0 109.244 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.02 164.2 33.8 Favored 'Trans proline' 0 C--N 1.36 1.179 0 O-C-N 124.477 1.777 . . . . 0.0 110.987 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.31 135.62 1.42 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.532 1.145 . . . . 0.0 109.297 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.53 -56.48 0.73 Allowed Glycine 0 CA--C 1.531 1.082 0 O-C-N 124.521 1.138 . . . . 0.0 110.957 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.503 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.07 -173.3 2.21 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.584 0.814 . . . . 0.0 110.294 -179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.2 77.74 1.75 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 109.987 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.019 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.86 70.75 Favored Pre-proline 0 C--N 1.323 -0.548 0 O-C-N 124.514 1.134 . . . . 0.0 109.306 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.768 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.1 Cg_endo -75.03 50.82 2.64 Favored 'Trans proline' 0 C--N 1.359 1.104 0 O-C-N 124.45 1.763 . . . . 0.0 110.967 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.31 -45.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.573 1.171 . . . . 0.0 109.315 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.503 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.09 -27.54 68.14 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.517 1.136 . . . . 0.0 109.314 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.0 m -46.5 115.14 0.95 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.445 1.091 . . . . 0.0 110.002 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -107.93 117.61 34.59 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.38 1.05 . . . . 0.0 109.285 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.5 t -89.81 21.89 3.36 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.39 1.056 . . . . 0.0 110.341 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 60' ' ' LEU . 8.4 tttm -86.06 64.47 8.6 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.429 1.081 . . . . 0.0 109.244 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.053 HD22 ' HB3' ' A' ' 40' ' ' ASN . 0.7 OUTLIER -40.46 102.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.526 1.141 . . . . 0.0 109.344 179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.602 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.39 6.02 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 124.559 1.162 . . . . 0.0 109.307 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.479 ' H ' HG12 ' A' ' 62' ' ' ILE . 0.6 OUTLIER -68.68 -46.04 80.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 124.565 1.166 . . . . 0.0 109.35 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.6 4.87 Favored Pre-proline 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -75.04 139.17 23.86 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.527 1.803 . . . . 0.0 111.045 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.89 -67.89 0.17 Allowed Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.504 1.128 . . . . 0.0 110.998 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.669 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.75 97.36 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.504 0.767 . . . . 0.0 110.02 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 3.6 m-85 -38.21 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.529 1.143 . . . . 0.0 110.959 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.53 175.13 4.17 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.481 1.113 . . . . 0.0 110.939 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.505 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.39 20.74 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.552 1.158 . . . . 0.0 109.939 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.1 137.67 8.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.536 1.147 . . . . 0.0 109.359 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.18 146.44 23.99 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.454 1.096 . . . . 0.0 110.433 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.2 mt -124.1 173.07 8.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.483 1.115 . . . . 0.0 109.251 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.11 -44.36 0.02 OUTLIER Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.546 1.154 . . . . 0.0 110.948 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.456 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.27 124.12 37.89 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.508 0.77 . . . . 0.0 110.423 -179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' VAL . 18.5 Cg_endo -74.96 141.46 26.78 Favored 'Trans proline' 0 C--N 1.359 1.101 0 O-C-N 124.58 1.832 . . . . 0.0 111.041 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.13 -178.68 20.04 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.494 1.121 . . . . 0.0 110.993 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.82 120.03 40.42 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.439 0.729 . . . . 0.0 110.414 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.78 140.75 30.89 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.516 1.135 . . . . 0.0 110.971 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.88 145.06 49.38 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.538 1.149 . . . . 0.0 109.98 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.19 -171.5 3.73 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.509 1.131 . . . . 0.0 110.933 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.817 ' HB2' ' CZ ' ' A' ' 86' ' ' ARG . 42.4 p90 -171.85 165.38 6.48 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.547 1.154 . . . . 0.0 111.012 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . 1.332 ' O ' ' NE ' ' A' ' 86' ' ' ARG . 0.4 OUTLIER -93.48 122.28 35.74 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.405 1.065 . . . . 0.0 108.326 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.984 ' O ' ' HB ' ' B' ' 164' ' ' THR . 5.7 m -51.23 -50.89 73.15 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.452 1.095 . . . . 0.0 110.396 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.676 ' O ' ' HG2' ' B' ' 163' ' ' PRO . 40.5 Cg_endo -75.0 -62.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.524 1.802 . . . . 0.0 111.0 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.717 ' HE2' ' HE1' ' B' ' 4' ' ' TYR . 27.2 m80 -75.09 57.94 0.86 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.489 1.118 . . . . 0.0 109.491 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.332 ' NE ' ' O ' ' A' ' 82' ' ' CYS . 0.2 OUTLIER -87.94 -38.53 15.49 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.542 1.151 . . . . 0.0 110.34 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.87 32.79 Favored Glycine 0 CA--C 1.53 0.997 0 O-C-N 124.439 1.087 . . . . 0.0 110.969 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.74 ' HB1' ' CE2' ' B' ' 7' ' ' TYR . . . -65.68 -15.21 62.58 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.525 0.78 . . . . 0.0 109.292 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.16 1.82 Allowed Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.513 1.133 . . . . 0.0 110.957 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.675 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.8 ttt -121.65 75.08 1.17 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.473 0.749 . . . . 0.0 110.984 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.454 HG12 ' HB3' ' A' ' 81' ' ' TYR . 14.0 m -124.24 153.61 30.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.558 1.161 . . . . 0.0 109.225 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.76 19.72 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.461 1.101 . . . . 0.0 111.008 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.77 162.06 37.0 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.568 0.805 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.693 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.67 122.6 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 O-C-N 124.494 1.121 . . . . 0.0 109.32 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 23' ' ' ILE . 49.1 m -105.07 144.52 31.76 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.396 1.06 . . . . 0.0 110.407 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.8 t -128.24 73.75 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.557 1.16 . . . . 0.0 109.232 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.828 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.323 -0.552 0 O-C-N 124.594 1.184 . . . . 0.0 110.34 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.961 ' CZ ' ' HD3' ' A' ' 38' ' ' PRO . 42.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 3.1 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.978 ' CZ ' ' O ' ' A' ' 12' ' ' TYR . 1.6 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.717 ' HE1' ' HE2' ' A' ' 85' ' ' HIS . 4.4 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.949 ' HE2' ' HD2' ' A' ' 14' ' ' PRO . 0.5 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.589 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 1.1 m-80 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.909 ' CD1' HG11 ' B' ' 20' ' ' VAL . 85.1 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.909 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 1.478 ' CB ' ' CA ' ' B' ' 23' ' ' ASN 0.623 3.4 m-80 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.101 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 47.0 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.77 ' HB2' HG21 ' B' ' 233' ' ' VAL . 13.3 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.621 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 99.4 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.85 ' HG3' ' H ' ' B' ' 62' ' ' ALA . 1.4 tt0 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 0.85 ' H ' ' HG3' ' B' ' 61' ' ' GLN . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.568 ' H ' ' HG2' ' B' ' 61' ' ' GLN . 1.0 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.427 ' HA ' ' HD3' ' B' ' 66' ' ' PRO . 39.8 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 6.4 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.647 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 73.2 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.09 HG13 ' HG ' ' B' ' 115' ' ' LEU . 54.4 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.547 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.2 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.09 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 80.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.489 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.753 ' HG3' ' CD2' ' B' ' 1' ' ' TYR . 1.2 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.489 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 90.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.662 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 39.8 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.58 HE21 HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.492 HG12 ' HA ' ' B' ' 24' ' ' CYS . 0.5 OUTLIER -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.031 ' HB3' HG22 ' B' ' 164' ' ' THR . 9.1 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.676 ' HG2' ' O ' ' A' ' 84' ' ' PRO . 2.7 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.031 HG22 ' HB3' ' B' ' 162' ' ' TYR . 0.5 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 0.901 ' H ' HG23 ' B' ' 164' ' ' THR . 23.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.55 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.6 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . 0.577 ' CB ' ' HE1' ' B' ' 162' ' ' TYR . 57.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.424 HD21 HH22 ' B' ' 158' ' ' ARG . 22.3 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.752 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.88 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.16 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.272 7.7 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.508 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 53.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 38.7 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.553 ' HB3' ' HD2' ' B' ' 209' ' ' PRO . 0.3 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.16 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.101 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.64 126.82 29.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.559 1.162 . . . . 0.0 110.02 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.959 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.08 3.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.441 1.088 . . . . 0.0 109.322 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.9 150.88 40.39 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.475 1.109 . . . . 0.0 110.338 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.515 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.33 112.12 38.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.41 1.069 . . . . 0.0 109.315 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.513 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.65 133.46 35.97 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.492 1.12 . . . . 0.0 109.351 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.683 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.73 97.03 6.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.422 1.076 . . . . 0.0 111.034 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.04 144.45 7.63 Favored Glycine 0 CA--C 1.527 0.832 0 O-C-N 124.514 1.134 . . . . 0.0 111.064 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.639 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.9 OUTLIER -108.12 160.6 15.68 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.361 0.683 . . . . 0.0 110.443 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.524 ' HA ' ' NZ ' ' A' ' 35' ' ' LYS . 9.8 t70 -59.79 -15.92 24.12 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.463 1.102 . . . . 0.0 109.303 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 13' ' ' ALA . 7.5 ttmt -90.64 39.7 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.545 1.153 . . . . 0.0 109.351 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 38.23 29.73 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.485 1.116 . . . . 0.0 111.03 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.639 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.89 117.66 58.19 Favored Pre-proline 0 C--N 1.324 -0.515 0 O-C-N 124.496 1.123 . . . . 0.0 109.276 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.455 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 44.6 Cg_endo -75.01 97.65 1.1 Allowed 'Trans proline' 0 C--N 1.358 1.064 0 O-C-N 124.471 1.774 . . . . 0.0 111.019 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.504 HD11 ' CG2' ' A' ' 9' ' ' THR . 1.3 pp -150.82 151.31 32.1 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.487 1.117 . . . . 0.0 109.318 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.408 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.4 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.441 1.088 . . . . 0.0 110.942 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.92 26.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.445 1.091 . . . . 0.0 110.315 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.0 Cg_endo -75.08 140.97 70.19 Favored 'Cis proline' 0 C--N 1.361 1.235 0 C-N-CA 120.987 -2.505 . . . . 0.0 110.966 0.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.19 -40.09 1.04 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.54 1.15 . . . . 0.0 109.251 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.13 146.27 46.13 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.354 1.034 . . . . 0.0 109.335 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.959 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.25 141.33 31.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.537 1.148 . . . . 0.0 109.224 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.614 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.96 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 124.491 1.119 . . . . 0.0 110.045 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.4 pt -154.92 -177.44 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.563 1.165 . . . . 0.0 109.335 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.805 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.57 158.31 27.61 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 109.918 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.21 105.44 0.28 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.488 1.117 . . . . 0.0 109.303 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.45 -7.29 8.5 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.48 1.112 . . . . 0.0 111.004 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.1 m-20 -82.2 174.19 11.41 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.546 0.792 . . . . 0.0 109.232 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 m -123.59 154.23 39.57 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.518 1.136 . . . . 0.0 110.409 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.71 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.44 102.62 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.453 1.096 . . . . 0.0 109.277 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.84 169.57 18.01 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.462 1.101 . . . . 0.0 110.284 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.563 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.7 m-85 -147.25 121.5 9.56 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.493 1.121 . . . . 0.0 110.939 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.09 155.34 33.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.528 1.142 . . . . 0.0 109.269 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.642 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 12.2 ttp -98.09 119.19 36.29 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.1 . . . . 0.0 111.026 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.28 -66.04 0.92 Allowed 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.492 1.12 . . . . 0.0 109.296 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' NZ ' ' HA ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -168.87 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.488 1.117 . . . . 0.0 109.248 179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.939 HG23 ' HD2' ' B' ' 119' ' ' PRO . 11.6 p 46.0 54.88 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 124.403 1.064 . . . . 0.0 109.32 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.658 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.97 -172.32 40.54 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.524 1.14 . . . . 0.0 110.986 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.012 ' HD3' ' OD1' ' B' ' 70' ' ' ASN . 3.9 Cg_exo -74.92 -169.03 6.95 Favored 'Cis proline' 0 C--N 1.36 1.15 0 C-N-CA 121.018 -2.492 . . . . 0.0 110.959 -0.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.658 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.3 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.488 1.117 . . . . 0.0 109.555 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.435 ' CG ' ' C ' ' A' ' 39' ' ' HIS . 0.2 OUTLIER 173.93 166.96 0.2 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.424 1.077 . . . . 0.0 109.307 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.578 ' O ' HD13 ' A' ' 42' ' ' ILE . 58.9 t -104.06 114.37 43.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.576 1.172 . . . . 0.0 109.343 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.578 HD13 ' O ' ' A' ' 41' ' ' VAL . 1.3 mm -132.79 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.448 1.093 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 87.1 m-85 -47.68 160.62 0.12 Allowed 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.462 1.101 . . . . 0.0 111.008 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.97 -50.06 4.78 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.605 1.191 . . . . 0.0 109.31 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 1.9 mttt 167.32 143.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.449 1.093 . . . . 0.0 109.344 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.005 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.51 157.98 73.2 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.394 1.059 . . . . 0.0 109.265 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.91 164.28 33.78 Favored 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.509 1.794 . . . . 0.0 111.054 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.32 135.61 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 109.285 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.458 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.5 0.73 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.492 1.12 . . . . 0.0 111.04 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.505 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.1 -173.29 2.21 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.567 0.804 . . . . 0.0 110.252 -179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.4 m -133.29 77.83 1.75 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.396 1.06 . . . . 0.0 109.945 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.005 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.0 -51.87 70.73 Favored Pre-proline 0 C--N 1.324 -0.525 0 O-C-N 124.563 1.164 . . . . 0.0 109.274 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.766 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.2 Cg_endo -75.05 50.81 2.64 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.443 1.759 . . . . 0.0 110.935 -179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.34 -45.57 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.638 1.212 . . . . 0.0 109.344 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.505 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.58 68.15 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.544 1.152 . . . . 0.0 109.299 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.8 m -46.47 115.09 0.93 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.526 1.141 . . . . 0.0 109.988 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.91 117.65 34.68 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.411 1.07 . . . . 0.0 109.322 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.8 t -89.69 21.81 3.34 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.458 1.099 . . . . 0.0 110.398 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -85.95 64.38 8.56 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.417 1.073 . . . . 0.0 109.222 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.649 ' HG ' ' O ' ' A' ' 60' ' ' LEU . 1.0 OUTLIER -40.43 102.49 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.534 1.146 . . . . 0.0 109.334 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.49 98.53 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.508 1.13 . . . . 0.0 109.29 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.161 HG23 ' CG ' ' B' ' 121' ' ' PRO . 28.7 mt -68.78 -46.07 80.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.61 1.194 . . . . 0.0 109.304 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.18 111.61 4.91 Favored Pre-proline 0 C--N 1.325 -0.475 0 O-C-N 124.488 1.117 . . . . 0.0 109.27 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -75.0 139.19 23.98 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.413 1.744 . . . . 0.0 111.038 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.84 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.379 1.05 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.659 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.73 97.38 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.509 0.77 . . . . 0.0 110.048 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.11 -86.76 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.501 1.126 . . . . 0.0 110.99 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.48 175.16 4.19 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.443 1.089 . . . . 0.0 111.014 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.501 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.25 20.99 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.488 1.117 . . . . 0.0 109.979 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.67 8.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.487 1.117 . . . . 0.0 109.412 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.19 146.53 23.93 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.458 1.099 . . . . 0.0 110.404 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 77.9 mt -124.18 173.08 8.56 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.55 1.156 . . . . 0.0 109.179 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.539 1.149 . . . . 0.0 110.996 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.458 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.23 124.21 37.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.561 0.801 . . . . 0.0 110.409 -179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.13 141.52 26.38 Favored 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.511 1.795 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.06 -178.68 20.0 Favored Glycine 0 CA--C 1.53 0.969 0 O-C-N 124.508 1.13 . . . . 0.0 111.043 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.0 m -104.81 120.08 40.54 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.499 0.764 . . . . 0.0 110.409 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.846 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.6 m-85 -96.8 140.75 30.91 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 111.011 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.89 145.13 49.33 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.496 1.122 . . . . 0.0 109.988 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.0 p90 -146.21 -171.45 3.72 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.581 1.176 . . . . 0.0 110.882 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.428 ' CB ' HG12 ' A' ' 91' ' ' VAL . 39.5 p90 -171.89 165.39 6.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.519 1.137 . . . . 0.0 111.042 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -93.59 122.39 35.99 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.478 1.112 . . . . 0.0 108.268 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 1.171 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 1.2 m -51.29 -50.82 73.78 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.084 . . . . 0.0 110.394 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.537 ' HD3' ' HB ' ' A' ' 83' ' ' THR . 21.2 Cg_endo -75.06 -62.46 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.574 1.829 . . . . 0.0 110.987 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 23.3 m80 -75.1 58.05 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.524 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.548 ' HD2' ' O ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -87.99 -38.59 15.39 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.515 1.135 . . . . 0.0 110.292 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.903 ' HA3' ' HE2' ' B' ' 162' ' ' TYR . . . -89.48 -23.84 32.74 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 124.443 1.089 . . . . 0.0 110.943 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' B' ' 1' ' ' TYR . . . -65.68 -15.22 62.58 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 124.528 0.781 . . . . 0.0 109.357 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.18 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.086 0 O-C-N 124.503 1.127 . . . . 0.0 110.885 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.683 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.7 75.1 1.17 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.458 0.74 . . . . 0.0 110.974 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 15.3 m -124.14 153.56 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 O-C-N 124.473 1.108 . . . . 0.0 109.287 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.464 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.52 -174.77 19.76 Favored Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.513 1.133 . . . . 0.0 111.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.78 162.05 37.03 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.513 0.772 . . . . 0.0 110.343 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.71 HD13 HG11 ' A' ' 29' ' ' VAL . 92.5 mt -146.7 122.61 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 O-C-N 124.515 1.135 . . . . 0.0 109.275 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.5 m -105.09 144.46 31.86 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.455 1.097 . . . . 0.0 110.381 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.21 73.88 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.481 1.113 . . . . 0.0 109.285 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.805 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.516 1.135 . . . . 0.0 110.325 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.497 ' HE2' ' HB2' ' A' ' 88' ' ' ALA . 32.3 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' B' ' 1' ' ' TYR . 4.9 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.702 ' CD1' ' HG3' ' B' ' 163' ' ' PRO . 6.6 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.511 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 12.4 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.154 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.8 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.638 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.638 HD13 ' CE2' ' B' ' 53' ' ' TYR . 3.0 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 20.5 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.746 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 23.9 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.487 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 40.3 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 1.081 ' NE2' HG21 ' A' ' 83' ' ' THR . 3.4 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 1.171 ' HB3' ' O ' ' A' ' 83' ' ' THR . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.8 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 16.0 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 2.3 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' B' ' 59' ' ' GLN . 9.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 1.012 ' OD1' ' HD3' ' A' ' 38' ' ' PRO . 86.7 m-20 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.012 HD11 ' HD2' ' B' ' 131' ' ' PRO . 30.5 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE2' ' HG3' ' B' ' 86' ' ' PRO . 6.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.541 HD23 HD11 ' B' ' 120' ' ' LEU . 0.9 OUTLIER -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.197 ' CG1' HD12 ' B' ' 115' ' ' LEU . 20.3 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.772 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.0 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 1.4 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.197 HD12 ' CG1' ' B' ' 104' ' ' VAL . 0.0 OUTLIER -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.772 ' HB2' HG23 ' B' ' 105' ' ' THR . 16.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.939 ' HD2' HG23 ' A' ' 36' ' ' VAL . 1.9 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.541 HD11 HD23 ' B' ' 103' ' ' LEU . 2.4 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . 1.161 ' CG ' HG23 ' A' ' 62' ' ' ILE . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.664 ' HB2' HG21 ' A' ' 62' ' ' ILE . 12.9 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' B' ' 126' ' ' GLN . 21.6 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.481 ' HE2' ' CD1' ' B' ' 120' ' ' LEU . 20.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 23.0 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.012 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.898 ' HE ' ' CGD' ' B' ' 250' ' ' HEC . 27.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.764 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.048 ' CB ' HG22 ' B' ' 164' ' ' THR . 7.9 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.702 ' HG3' ' CD1' ' B' ' 4' ' ' TYR . 3.2 Cg_exo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.048 HG22 ' CB ' ' B' ' 162' ' ' TYR . 2.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.02 ' H ' HG23 ' B' ' 164' ' ' THR . 42.1 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.537 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.1 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 57.0 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . 1.503 3.1 m-80 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 66.6 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.771 ' HB2' ' HE1' ' B' ' 191' ' ' PHE . 18.3 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 1.188 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.27 20.2 m-85 -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.771 ' HE1' ' HB2' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . 0.497 ' CG2' ' HG2' ' B' ' 211' ' ' PRO . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.662 HD22 ' N ' ' B' ' 208' ' ' LEU . 1.9 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 1.188 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 1.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.596 ' HA ' ' HG3' ' B' ' 231' ' ' PRO . 1.1 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . 0.596 ' HG3' ' HA ' ' B' ' 211' ' ' PRO . 2.1 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.694 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.154 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.61 126.83 29.07 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.555 1.16 . . . . 0.0 109.999 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.963 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.42 177.18 3.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.41 1.069 . . . . 0.0 109.285 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.98 150.88 40.25 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.562 1.164 . . . . 0.0 110.323 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.507 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.35 112.15 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.387 1.054 . . . . 0.0 109.341 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.523 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.8 mttt -92.77 133.49 35.99 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 124.51 1.131 . . . . 0.0 109.303 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.627 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.7 97.0 6.89 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.469 1.105 . . . . 0.0 110.997 -179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.49 7.63 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.594 1.184 . . . . 0.0 110.974 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.441 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -108.06 160.71 15.58 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 124.409 0.711 . . . . 0.0 110.417 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -59.84 -15.94 24.85 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.449 1.093 . . . . 0.0 109.322 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 13' ' ' ALA . 10.5 mttt -90.61 39.65 0.99 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.346 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER 38.3 29.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 1.113 . . . . 0.0 111.009 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' LYS . . . -104.87 117.72 58.05 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.501 1.126 . . . . 0.0 109.271 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 1.076 ' HG3' ' HE2' ' B' ' 3' ' ' PHE . 58.9 Cg_endo -75.01 97.64 1.1 Allowed 'Trans proline' 0 C--N 1.361 1.189 0 O-C-N 124.46 1.769 . . . . 0.0 111.022 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HA ' ' CG ' ' A' ' 90' ' ' MET . 2.8 pp -150.8 151.25 32.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.46 1.1 . . . . 0.0 109.32 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.413 ' N ' ' HG3' ' A' ' 90' ' ' MET . 5.4 m-85 -77.39 126.19 30.52 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.522 1.139 . . . . 0.0 110.944 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.543 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.46 134.89 26.59 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 124.55 1.156 . . . . 0.0 110.368 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.2 Cg_endo -75.06 140.99 70.35 Favored 'Cis proline' 0 C--N 1.359 1.101 0 C-N-CA 120.995 -2.502 . . . . 0.0 110.944 0.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 tttt -40.22 -40.16 1.07 Allowed 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.243 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.05 146.28 46.05 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.411 1.069 . . . . 0.0 109.365 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.963 HD11 HG21 ' A' ' 3' ' ' VAL . 10.9 tp -143.28 141.4 31.01 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.566 1.166 . . . . 0.0 109.202 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.615 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.79 50.98 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.472 1.107 . . . . 0.0 110.063 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.653 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.93 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.496 1.122 . . . . 0.0 109.244 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.54 158.31 27.57 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.497 1.123 . . . . 0.0 110.02 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.12 105.42 0.27 Allowed 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.602 1.189 . . . . 0.0 109.299 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.48 -7.41 8.46 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.443 1.09 . . . . 0.0 110.937 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.653 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.17 174.11 11.5 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.449 0.735 . . . . 0.0 109.3 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.44 154.27 39.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.49 1.119 . . . . 0.0 110.535 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.691 HG11 HD13 ' A' ' 94' ' ' ILE . 63.8 t -131.45 102.58 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.528 1.143 . . . . 0.0 109.332 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.42 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.82 169.52 18.1 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.527 1.142 . . . . 0.0 110.249 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.558 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.9 m-85 -147.21 121.39 9.51 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.484 1.115 . . . . 0.0 110.964 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.96 155.37 33.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.555 1.159 . . . . 0.0 109.328 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.8 ttp -98.07 119.26 36.4 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.413 1.07 . . . . 0.0 110.993 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . 0.333 6.9 m-20 -79.4 -66.03 0.92 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.412 1.07 . . . . 0.0 109.237 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.49 0.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.473 1.108 . . . . 0.0 109.235 179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.652 ' HB ' ' CE2' ' B' ' 3' ' ' PHE . 19.0 m 46.02 54.81 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.647 ' HA2' ' CD2' ' A' ' 39' ' ' HIS . . . -92.92 -172.33 40.62 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.558 1.161 . . . . 0.0 111.009 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.655 ' HD2' ' CE2' ' B' ' 1' ' ' TYR . 19.5 Cg_endo -74.97 -168.87 6.83 Favored 'Cis proline' 0 C--N 1.361 1.224 0 C-N-CA 120.947 -2.522 . . . . 0.0 110.977 -0.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.647 ' CD2' ' HA2' ' A' ' 37' ' ' GLY . 69.5 m-70 -144.26 -170.36 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.53 1.144 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 173.98 166.98 0.21 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.403 1.064 . . . . 0.0 109.327 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.11 114.35 43.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.519 1.137 . . . . 0.0 109.329 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.553 ' O ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -132.82 76.03 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.483 1.115 . . . . 0.0 109.284 179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.2 m-85 -47.61 160.58 0.11 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.544 1.153 . . . . 0.0 110.959 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 1.7 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.511 1.132 . . . . 0.0 109.274 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 6.9 mttt 167.32 143.53 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.473 1.108 . . . . 0.0 109.266 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.039 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.5 158.08 72.86 Favored Pre-proline 0 C--N 1.325 -0.457 0 O-C-N 124.393 1.058 . . . . 0.0 109.284 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' A' ' 48' ' ' ALA . 18.1 Cg_endo -75.03 164.25 33.68 Favored 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.42 1.748 . . . . 0.0 110.992 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 47' ' ' PRO . . . -40.3 135.67 1.4 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.509 1.13 . . . . 0.0 109.33 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.473 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.47 -56.65 0.72 Allowed Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.485 1.116 . . . . 0.0 111.035 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.51 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.08 -173.38 2.23 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 0.822 . . . . 0.0 110.28 -179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.5 m -133.1 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.439 1.087 . . . . 0.0 110.042 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.039 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -52.98 -51.84 70.88 Favored Pre-proline 0 C--N 1.324 -0.511 0 O-C-N 124.441 1.088 . . . . 0.0 109.273 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.05 50.75 2.62 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.43 1.752 . . . . 0.0 110.966 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.26 -45.67 0.07 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.587 1.179 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.04 -27.53 68.17 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.489 1.118 . . . . 0.0 109.396 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.9 m -46.52 115.15 0.95 Allowed 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.49 1.119 . . . . 0.0 109.974 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.99 117.69 34.79 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.455 1.097 . . . . 0.0 109.345 179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.851 ' O ' ' HB3' ' B' ' 62' ' ' ALA . 4.6 t -89.77 21.84 3.36 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.393 1.058 . . . . 0.0 110.332 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.6 tttt -86.08 64.44 8.58 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.458 1.099 . . . . 0.0 109.29 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.171 HD23 ' CB ' ' B' ' 62' ' ' ALA . 0.9 OUTLIER -40.44 102.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.515 1.135 . . . . 0.0 109.287 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.57 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.44 98.47 6.05 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.48 1.113 . . . . 0.0 109.312 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.729 HD11 ' CD1' ' A' ' 60' ' ' LEU . 4.3 mm -68.66 -46.11 80.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.602 1.189 . . . . 0.0 109.351 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.08 111.62 4.87 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.455 1.097 . . . . 0.0 109.278 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -75.03 139.1 23.81 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.431 1.753 . . . . 0.0 111.019 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.499 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.94 0.17 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.552 1.157 . . . . 0.0 110.939 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.663 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.67 97.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.543 0 O-C-N 124.471 0.748 . . . . 0.0 110.011 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.57 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.2 m-85 -38.18 -86.77 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.461 1.101 . . . . 0.0 110.88 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -171.5 175.12 4.19 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.448 1.092 . . . . 0.0 110.992 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.5 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.64 161.29 20.92 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.448 1.093 . . . . 0.0 109.99 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.03 137.72 8.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.465 1.103 . . . . 0.0 109.389 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.546 1.154 . . . . 0.0 110.353 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.1 8.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.46 1.1 . . . . 0.0 109.235 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.14 -44.38 0.02 OUTLIER Glycine 0 CA--C 1.529 0.968 0 O-C-N 124.497 1.123 . . . . 0.0 111.045 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.473 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.25 124.11 37.71 Favored Pre-proline 0 C--N 1.324 -0.51 0 O-C-N 124.543 0.79 . . . . 0.0 110.37 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.0 141.5 26.7 Favored 'Trans proline' 0 C--N 1.36 1.138 0 O-C-N 124.483 1.781 . . . . 0.0 111.119 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.1 -178.65 20.05 Favored Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.415 1.072 . . . . 0.0 110.959 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.7 m -104.84 120.03 40.43 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.492 0.76 . . . . 0.0 110.379 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.845 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.69 140.73 30.85 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.514 1.134 . . . . 0.0 111.07 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.95 145.16 49.35 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 109.98 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.526 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.21 -171.55 3.74 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.476 1.11 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.553 ' CD1' ' O ' ' A' ' 42' ' ' ILE . 9.3 p90 -171.83 165.43 6.49 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.514 1.134 . . . . 0.0 111.028 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.6 122.35 35.97 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.478 1.111 . . . . 0.0 108.243 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.487 ' N ' ' HD2' ' A' ' 84' ' ' PRO . 0.9 OUTLIER -51.31 -50.81 73.93 Favored Pre-proline 0 C--N 1.325 -0.477 0 O-C-N 124.519 1.137 . . . . 0.0 110.397 -179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 83' ' ' THR . 49.5 Cg_endo -75.05 -62.53 0.03 OUTLIER 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.531 1.806 . . . . 0.0 110.979 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.46 ' NE2' ' HE1' ' B' ' 4' ' ' TYR . 27.3 m80 -74.95 57.96 0.83 Allowed 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.547 1.154 . . . . 0.0 109.601 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.178 ' HE ' ' CA ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -88.01 -38.47 15.47 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.634 1.209 . . . . 0.0 110.276 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.54 -23.76 32.83 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 124.43 1.081 . . . . 0.0 110.982 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.69 -15.19 62.56 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.501 0.765 . . . . 0.0 109.426 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.14 63.06 1.83 Allowed Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.438 1.086 . . . . 0.0 110.985 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.627 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.59 75.07 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.454 0.738 . . . . 0.0 110.993 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.175 ' CG1' HH12 ' A' ' 86' ' ' ARG . 11.5 m -124.18 153.62 30.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.564 1.165 . . . . 0.0 109.289 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.458 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.74 19.73 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.603 1.189 . . . . 0.0 110.941 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.09 36.91 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.544 0.79 . . . . 0.0 110.382 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.691 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.68 122.64 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.518 1.136 . . . . 0.0 109.255 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.453 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.2 m -105.01 144.55 31.66 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.393 1.058 . . . . 0.0 110.383 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.732 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.8 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 O-C-N 124.537 1.148 . . . . 0.0 109.303 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 O-C-N 124.545 1.153 . . . . 0.0 110.265 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 0.926 ' HD1' ' HG3' ' B' ' 119' ' ' PRO . 93.7 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.076 ' HE2' ' HG3' ' A' ' 14' ' ' PRO . 12.9 t80 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.87 ' CE2' ' HD2' ' B' ' 1' ' ' TYR . 12.0 m-30 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.628 ' HB3' ' CD1' ' B' ' 9' ' ' TYR . 0.1 OUTLIER -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 73.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.144 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 43.3 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.493 ' OE1' ' HB2' ' B' ' 66' ' ' PRO . 83.9 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.799 ' NE2' ' HG3' ' B' ' 158' ' ' ARG . 21.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' B' ' 59' ' ' GLN . 89.2 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 0.783 ' HG2' ' O ' ' B' ' 65' ' ' SER . 4.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 1.171 ' CB ' HD23 ' A' ' 60' ' ' LEU . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.734 ' H ' HE21 ' B' ' 61' ' ' GLN . 0.3 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.783 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 9.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.493 ' HB2' ' OE1' ' B' ' 58' ' ' GLN . 58.0 Cg_exo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 4.0 m -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.432 HD12 ' N ' ' B' ' 69' ' ' LEU . 7.8 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.644 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 33.1 m120 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 35.0 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.505 ' CD2' HD23 ' B' ' 103' ' ' LEU . 30.5 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.036 HG13 ' HG ' ' B' ' 115' ' ' LEU . 69.8 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.72 HG23 ' HB2' ' B' ' 116' ' ' LEU . 0.1 OUTLIER -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 105' ' ' THR . 2.2 Cg_endo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.549 ' HA ' HD11 ' B' ' 116' ' ' LEU . 29.0 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 48.5 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.036 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.72 ' HB2' HG23 ' B' ' 105' ' ' THR . 11.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.645 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.926 ' HG3' ' HD1' ' B' ' 1' ' ' TYR . 2.3 Cg_endo -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.645 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 47.8 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' B' ' 125' ' ' TYR . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . 0.403 ' CD1' ' HB3' ' B' ' 124' ' ' ASP . 68.6 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . . . . . . . . . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.6 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.587 ' HA2' HE22 ' B' ' 59' ' ' GLN . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.799 ' HG3' ' NE2' ' B' ' 59' ' ' GLN . 1.6 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.746 HE21 HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' B' ' 24' ' ' CYS . 8.5 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 0.456 ' HB3' ' OG1' ' B' ' 164' ' ' THR . 19.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.015 HG23 ' HB3' ' A' ' 86' ' ' ARG . 0.1 OUTLIER -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.595 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.8 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 88.7 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.746 HD22 HE21 ' B' ' 160' ' ' GLN . 0.7 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 60.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.628 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.6 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 57.0 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.962 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 53.8 m-20 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 0.962 ' HD1' ' HB2' ' B' ' 187' ' ' ASN . 0.4 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.509 ' HE1' ' CG ' ' B' ' 187' ' ' ASN . 58.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.943 ' HB3' HG22 ' B' ' 204' ' ' VAL . 44.3 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.632 ' HB ' ' CG2' ' B' ' 205' ' ' THR . 85.3 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.943 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.3 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.717 HG21 ' CD1' ' B' ' 227' ' ' LEU . 11.5 t -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 47.9 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 72.0 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.559 HD22 ' N ' ' B' ' 208' ' ' LEU . 4.0 mm? -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.88 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.6 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 213' ' ' LEU . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . 0.717 ' CD1' HG21 ' B' ' 205' ' ' THR . 75.4 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.144 ' CHD' ' SG ' ' B' ' 24' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -57.63 126.82 29.03 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 110.03 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.936 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.41 177.12 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.442 1.089 . . . . 0.0 109.27 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -142.93 150.85 40.3 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.554 1.159 . . . . 0.0 110.342 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.512 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.31 112.16 38.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 124.408 1.068 . . . . 0.0 109.307 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.511 ' HG3' HG12 ' A' ' 32' ' ' VAL . 22.7 mttt -92.75 133.44 36.03 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.548 1.155 . . . . 0.0 109.306 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.782 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.66 97.0 6.89 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.469 1.106 . . . . 0.0 111.002 -179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.03 144.41 7.62 Favored Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.464 1.103 . . . . 0.0 111.074 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.699 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 17.3 p -108.09 160.69 15.61 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.422 0.719 . . . . 0.0 110.402 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -59.79 -15.96 24.41 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.441 1.088 . . . . 0.0 109.305 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 13' ' ' ALA . 5.0 tppt? -90.64 39.69 0.99 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.555 1.159 . . . . 0.0 109.298 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 1.276 ' CZ ' ' HB2' ' B' ' 3' ' ' PHE . 12.3 m-30 38.29 29.62 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.499 1.125 . . . . 0.0 111.008 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.81 117.67 58.24 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.487 1.117 . . . . 0.0 109.24 -179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.803 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 1.2 Cg_endo -75.03 97.56 1.09 Allowed 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.455 1.766 . . . . 0.0 110.99 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' THR . 1.2 pp -150.73 151.29 32.18 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.358 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -77.41 126.23 30.59 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.451 1.095 . . . . 0.0 110.934 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.47 134.91 26.61 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.445 1.091 . . . . 0.0 110.317 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.539 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.1 Cg_endo -75.08 141.0 70.37 Favored 'Cis proline' 0 C--N 1.361 1.22 0 C-N-CA 120.947 -2.522 . . . . 0.0 111.013 0.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -40.21 -40.13 1.06 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 1.128 . . . . 0.0 109.181 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.1 146.27 46.1 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.384 1.052 . . . . 0.0 109.281 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.936 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.21 141.41 31.09 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.526 1.141 . . . . 0.0 109.216 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.626 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -130.03 143.78 50.98 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 124.544 1.152 . . . . 0.0 110.033 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.633 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.92 -177.48 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.524 1.14 . . . . 0.0 109.321 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.6 m -120.56 158.32 27.58 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.495 1.122 . . . . 0.0 109.963 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.14 105.41 0.27 Allowed 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.594 1.184 . . . . 0.0 109.313 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.5 -7.36 8.46 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.465 1.103 . . . . 0.0 110.981 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.633 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.22 174.16 11.43 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.488 0.758 . . . . 0.0 109.182 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.3 m -123.59 154.28 39.5 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.577 1.173 . . . . 0.0 110.371 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.7 HG11 HD13 ' A' ' 94' ' ' ILE . 64.1 t -131.41 102.59 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.488 1.117 . . . . 0.0 109.285 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.2 tt0 -78.86 169.62 17.95 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.504 1.128 . . . . 0.0 110.244 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE1' HG12 ' A' ' 29' ' ' VAL . 64.0 m-85 -147.24 121.42 9.52 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.515 1.135 . . . . 0.0 111.008 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -125.02 155.39 33.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 109.281 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.919 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.1 ttp -98.06 119.11 36.13 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.481 1.113 . . . . 0.0 111.085 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -79.27 -66.03 0.92 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.529 1.143 . . . . 0.0 109.291 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.511 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.88 -167.52 0.76 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.461 1.1 . . . . 0.0 109.292 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.881 ' O ' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER 46.05 54.83 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.448 1.092 . . . . 0.0 109.338 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 1.184 ' O ' ' CGD' ' B' ' 250' ' ' HEC . . . -92.97 -172.3 40.54 Favored Glycine 0 CA--C 1.53 1.002 0 O-C-N 124.555 1.16 . . . . 0.0 111.001 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.038 ' HD2' ' HB2' ' B' ' 62' ' ' ALA . 7.8 Cg_endo -74.95 -168.96 6.9 Favored 'Cis proline' 0 C--N 1.36 1.169 0 C-N-CA 120.992 -2.503 . . . . 0.0 110.986 -0.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.919 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 71.1 m-70 -144.16 -170.32 3.32 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.527 1.142 . . . . 0.0 109.637 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.413 ' ND2' ' C ' ' A' ' 39' ' ' HIS . 0.8 OUTLIER 173.9 166.97 0.2 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.449 1.093 . . . . 0.0 109.317 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.439 ' O ' HD13 ' A' ' 42' ' ' ILE . 61.2 t -104.07 114.35 43.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 O-C-N 124.566 1.166 . . . . 0.0 109.347 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 41' ' ' VAL . 2.0 mm -132.74 75.97 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.432 1.083 . . . . 0.0 109.306 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.427 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.6 160.62 0.11 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.443 1.089 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 9.5 t70 -97.03 -50.01 4.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.595 1.184 . . . . 0.0 109.324 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.2 mttt 167.34 143.57 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 1.143 . . . . 0.0 109.355 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.029 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.4 m -128.54 158.05 73.04 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.53 1.143 . . . . 0.0 109.273 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 164.22 33.83 Favored 'Trans proline' 0 C--N 1.359 1.125 0 O-C-N 124.476 1.777 . . . . 0.0 111.027 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.33 135.64 1.42 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.468 1.105 . . . . 0.0 109.252 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.467 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.57 0.72 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.522 1.139 . . . . 0.0 110.93 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.507 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.11 -173.31 2.21 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.61 0.829 . . . . 0.0 110.238 -179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.6 m -133.15 77.83 1.75 Allowed 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.371 1.045 . . . . 0.0 110.021 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.029 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.85 70.93 Favored Pre-proline 0 C--N 1.324 -0.536 0 O-C-N 124.486 1.116 . . . . 0.0 109.268 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 18.0 Cg_endo -75.01 50.73 2.61 Favored 'Trans proline' 0 C--N 1.36 1.163 0 O-C-N 124.457 1.767 . . . . 0.0 110.925 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.27 -45.64 0.07 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.562 1.164 . . . . 0.0 109.346 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.507 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.12 -27.52 68.1 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.519 1.137 . . . . 0.0 109.344 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.5 m -46.48 115.1 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.487 1.117 . . . . 0.0 109.975 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.592 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.8 m120 -107.97 117.67 34.73 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.517 1.135 . . . . 0.0 109.293 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.69 HG22 ' OD1' ' B' ' 63' ' ' ASP . 0.1 OUTLIER -89.68 21.78 3.35 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.401 1.063 . . . . 0.0 110.412 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -85.93 64.4 8.57 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.446 1.091 . . . . 0.0 109.233 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.612 HD23 ' CB ' ' B' ' 63' ' ' ASP . 0.0 OUTLIER -40.41 102.45 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.544 1.152 . . . . 0.0 109.346 179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.667 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.39 98.46 6.01 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.53 1.144 . . . . 0.0 109.342 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.649 HD12 ' HG3' ' A' ' 38' ' ' PRO . 5.2 mm -68.7 -46.09 80.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.548 1.155 . . . . 0.0 109.331 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.2 111.6 4.9 Favored Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.594 1.184 . . . . 0.0 109.303 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -74.99 139.14 23.95 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.384 1.729 . . . . 0.0 111.02 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.497 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.91 -67.96 0.17 Allowed Glycine 0 CA--C 1.529 0.945 0 O-C-N 124.45 1.094 . . . . 0.0 110.953 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.672 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.8 t -178.69 97.39 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 0.744 . . . . 0.0 110.037 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.667 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.8 m-85 -38.25 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.504 1.128 . . . . 0.0 110.978 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.592 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.6 p90 -171.51 175.13 4.18 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.461 1.1 . . . . 0.0 110.972 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.496 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.62 161.26 20.96 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.455 1.097 . . . . 0.0 109.994 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.05 137.68 8.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 124.5 1.125 . . . . 0.0 109.388 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.8 m -94.22 146.5 23.96 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.483 1.115 . . . . 0.0 110.426 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.16 173.1 8.53 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.511 1.132 . . . . 0.0 109.222 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.21 -44.32 0.02 OUTLIER Glycine 0 CA--C 1.53 1.01 0 O-C-N 124.501 1.126 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.467 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.26 124.17 37.96 Favored Pre-proline 0 C--N 1.325 -0.466 0 O-C-N 124.528 0.781 . . . . 0.0 110.411 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -75.09 141.5 26.45 Favored 'Trans proline' 0 C--N 1.359 1.105 0 O-C-N 124.558 1.82 . . . . 0.0 111.014 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.07 -178.7 20.0 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 124.444 1.09 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.9 m -104.77 120.08 40.53 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.546 0.792 . . . . 0.0 110.405 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.847 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.7 m-85 -96.79 140.74 30.91 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.61 1.194 . . . . 0.0 111.03 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.2 p -123.9 145.12 49.34 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.442 1.089 . . . . 0.0 110.011 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.1 p90 -146.18 -171.44 3.72 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.598 1.186 . . . . 0.0 110.918 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.688 ' HB3' ' NH2' ' A' ' 86' ' ' ARG . 40.9 p90 -171.91 165.44 6.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.534 1.146 . . . . 0.0 111.066 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -93.61 122.33 35.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.396 1.06 . . . . 0.0 108.296 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.522 ' HB ' ' HD3' ' A' ' 84' ' ' PRO . 1.0 OUTLIER -51.26 -50.79 73.82 Favored Pre-proline 0 C--N 1.325 -0.494 0 O-C-N 124.436 1.085 . . . . 0.0 110.378 -179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.658 ' HB3' ' O ' ' B' ' 62' ' ' ALA . 9.2 Cg_endo -75.1 -62.45 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.564 1.823 . . . . 0.0 110.972 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.8 m170 -75.1 57.99 0.87 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.48 1.112 . . . . 0.0 109.577 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 1.246 HH22 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -87.97 -38.61 15.4 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.52 1.138 . . . . 0.0 110.312 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.42 -23.84 32.91 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.427 1.079 . . . . 0.0 110.991 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.7 -15.18 62.56 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.527 0.781 . . . . 0.0 109.386 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 63.19 1.82 Allowed Glycine 0 CA--C 1.531 1.062 0 O-C-N 124.497 1.123 . . . . 0.0 110.927 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.782 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 7.9 ttt -121.64 75.05 1.16 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.522 0.778 . . . . 0.0 111.005 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.246 ' CG1' HH22 ' A' ' 86' ' ' ARG . 13.1 m -124.17 153.54 30.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.503 1.127 . . . . 0.0 109.294 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.467 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.49 -174.82 19.78 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.501 1.126 . . . . 0.0 111.036 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.76 162.06 36.99 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.573 0.808 . . . . 0.0 110.358 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.7 HD13 HG11 ' A' ' 29' ' ' VAL . 92.3 mt -146.63 122.6 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 O-C-N 124.57 1.169 . . . . 0.0 109.284 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.08 144.52 31.77 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.497 1.123 . . . . 0.0 110.368 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.733 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.28 73.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 124.431 1.082 . . . . 0.0 109.327 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.477 0 O-C-N 124.54 1.15 . . . . 0.0 110.282 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.002 ' CD2' ' CZ ' ' B' ' 3' ' ' PHE . 2.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . 0.553 ' O ' ' HG3' ' B' ' 6' ' ' GLN . 3.7 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.276 ' HB2' ' CZ ' ' A' ' 12' ' ' TYR . 0.1 OUTLIER -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.828 ' HE1' ' CB ' ' A' ' 12' ' ' TYR . 60.8 m-85 -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.709 ' NE2' HD12 ' B' ' 116' ' ' LEU . 66.4 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.915 ' O ' ' CD1' ' B' ' 7' ' ' TYR . 1.1 t80 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.46 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 4.1 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.4 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.103 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 46.2 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.3 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.775 ' HG3' HG22 ' B' ' 233' ' ' VAL . 10.1 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.52 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 71.6 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 1.223 ' NE2' ' CD1' ' A' ' 60' ' ' LEU . 1.2 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 1.038 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 1.612 ' CB ' HD23 ' A' ' 60' ' ' LEU . 0.7 OUTLIER -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 1.208 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 0.6 OUTLIER -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.0 OUTLIER -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.685 ' HB3' ' CD ' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . 0.505 ' N ' ' OG ' ' B' ' 67' ' ' SER . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . . . . . . . . . 7.9 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.731 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 43.7 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.731 HG23 ' CD2' ' B' ' 116' ' ' LEU . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.439 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.439 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.63 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.0 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.692 ' CD1' HD11 ' B' ' 116' ' ' LEU . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.731 ' CD2' HG23 ' B' ' 74' ' ' VAL . 19.5 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.497 ' HA2' ' HG ' ' B' ' 120' ' ' LEU . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 0.705 ' HB3' HMA2 ' B' ' 250' ' ' HEC . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.497 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 84.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.446 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 13.3 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.446 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.403 ' HG3' HE22 ' B' ' 59' ' ' GLN . 29.5 mtp-105 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.566 HE21 HD22 ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.741 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.1 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.382 ' O ' ' CD1' ' B' ' 162' ' ' TYR 0.461 0.1 OUTLIER -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 1.047 ' N ' ' CD2' ' B' ' 162' ' ' TYR . 2.9 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.273 HG22 ' CG ' ' B' ' 162' ' ' TYR . 13.2 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.025 ' H ' HG23 ' B' ' 164' ' ' THR . 18.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.64 ' N ' HD22 ' B' ' 167' ' ' LEU . 2.2 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 84.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.602 HD21 ' HA ' ' B' ' 62' ' ' ALA . 5.9 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.754 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.3 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.667 ' H ' ' CG2' ' B' ' 228' ' ' THR . 21.1 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.63 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 55.8 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.505 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 0.4 OUTLIER -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.684 ' HB2' ' HD1' ' B' ' 189' ' ' PHE . 3.0 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 0.945 ' CD2' ' HD3' ' B' ' 209' ' ' PRO . 0.7 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.438 ' CZ ' ' HB2' ' B' ' 187' ' ' ASN . 11.1 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.871 ' HB3' HG22 ' B' ' 204' ' ' VAL . 18.5 m-20 -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.729 ' HB ' HG23 ' B' ' 205' ' ' THR . 89.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.871 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.729 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 2.0 t -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . 0.459 HD12 HD21 ' B' ' 213' ' ' LEU . 48.3 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.593 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 18.3 mt -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.945 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.9 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.593 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 1.7 Cg_endo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . 0.459 HD21 HD12 ' B' ' 207' ' ' ILE . 54.1 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 54.7 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.667 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.5 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.775 HG22 ' HG3' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.184 ' CGD' ' O ' ' A' ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -57.63 126.87 29.24 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 124.517 1.136 . . . . 0.0 110.022 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.916 HG21 HD11 ' A' ' 21' ' ' LEU . 4.9 m -122.48 177.15 3.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.369 1.043 . . . . 0.0 109.265 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -142.93 150.9 40.38 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.55 1.156 . . . . 0.0 110.254 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.505 HG21 ' CE2' ' A' ' 31' ' ' PHE . 9.0 mm -115.4 112.1 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.429 1.081 . . . . 0.0 109.35 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.512 ' CG ' ' CG1' ' A' ' 32' ' ' VAL . 22.9 mttt -92.72 133.55 35.91 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.485 1.116 . . . . 0.0 109.346 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.549 ' HB3' ' HE1' ' A' ' 90' ' ' MET . 0.0 OUTLIER -105.78 97.06 6.93 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.513 1.133 . . . . 0.0 110.924 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.11 144.48 7.62 Favored Glycine 0 CA--C 1.53 0.973 0 O-C-N 124.579 1.174 . . . . 0.0 110.969 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.631 ' OG1' ' HB3' ' A' ' 13' ' ' ALA . 1.3 p -108.07 160.68 15.6 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.451 0.736 . . . . 0.0 110.431 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.82 -15.93 24.54 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.382 1.051 . . . . 0.0 109.328 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' ALA . 35.2 mttt -90.63 39.7 0.99 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.536 1.148 . . . . 0.0 109.336 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 1.346 ' OH ' ' HB2' ' B' ' 3' ' ' PHE . 0.8 OUTLIER 38.21 29.7 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.503 1.127 . . . . 0.0 111.016 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.631 ' HB3' ' OG1' ' A' ' 9' ' ' THR . . . -104.86 117.69 58.13 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.489 1.118 . . . . 0.0 109.34 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.711 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . 9.3 Cg_endo -75.0 97.59 1.09 Allowed 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.452 1.764 . . . . 0.0 110.999 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.574 HD11 HG21 ' A' ' 9' ' ' THR . 1.4 pp -150.75 151.25 32.1 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.491 1.12 . . . . 0.0 109.307 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -77.34 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.512 1.132 . . . . 0.0 110.965 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.54 ' CG ' ' HA ' ' A' ' 18' ' ' PRO . 21.4 tt0 -130.45 134.92 26.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 124.47 1.106 . . . . 0.0 110.315 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 17' ' ' GLU . 18.3 Cg_endo -75.05 140.97 70.25 Favored 'Cis proline' 0 C--N 1.36 1.146 0 C-N-CA 121.013 -2.494 . . . . 0.0 110.932 0.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 18' ' ' PRO . 18.4 tttt -40.17 -40.16 1.05 Allowed 'General case' 0 C--N 1.326 -0.427 0 O-C-N 124.548 1.155 . . . . 0.0 109.281 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.08 146.31 46.04 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.403 1.064 . . . . 0.0 109.358 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.916 HD11 HG21 ' A' ' 3' ' ' VAL . 11.0 tp -143.26 141.38 31.03 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.545 1.153 . . . . 0.0 109.234 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.628 ' H ' HD12 ' A' ' 21' ' ' LEU . 8.7 t -129.95 143.7 50.94 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 124.461 1.101 . . . . 0.0 110.098 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.625 HD12 ' HB2' ' A' ' 27' ' ' ASP . 11.3 pt -154.87 -177.52 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 O-C-N 124.442 1.089 . . . . 0.0 109.259 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.824 ' HA ' ' OXT' ' A' ' 97' ' ' GLU . 6.5 m -120.49 158.33 27.48 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.469 1.106 . . . . 0.0 110.054 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -58.18 105.42 0.28 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.557 1.161 . . . . 0.0 109.297 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 124.51 -7.47 8.44 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 124.5 1.125 . . . . 0.0 110.989 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.625 ' HB2' HD12 ' A' ' 23' ' ' ILE . 9.0 m-20 -82.16 174.14 11.47 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.482 0.754 . . . . 0.0 109.247 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.9 m -123.49 154.26 39.38 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.472 1.108 . . . . 0.0 110.544 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 94' ' ' ILE . 64.3 t -131.43 102.58 6.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.576 1.172 . . . . 0.0 109.256 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' N ' ' A' ' 5' ' ' ILE . 11.1 tt0 -78.82 169.49 18.15 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.59 1.181 . . . . 0.0 110.299 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE1' HG12 ' A' ' 29' ' ' VAL . 63.8 m-85 -147.16 121.44 9.58 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.473 1.108 . . . . 0.0 110.953 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 66' ' ' SER . 3.8 p -124.99 155.32 33.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.564 1.165 . . . . 0.0 109.345 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.635 ' SD ' ' HD2' ' A' ' 39' ' ' HIS . 1.5 ttp -97.99 119.26 36.3 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.392 1.057 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.41 -66.04 0.92 Allowed 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.56 1.163 . . . . 0.0 109.209 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' HG12 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -168.89 -167.51 0.76 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.454 1.096 . . . . 0.0 109.287 179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.732 ' O ' HG13 ' A' ' 36' ' ' VAL . 5.1 p 46.11 54.77 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.453 1.096 . . . . 0.0 109.298 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 1.225 ' O ' ' CGD' ' B' ' 250' ' ' HEC . . . -92.94 -172.27 40.58 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.523 1.139 . . . . 0.0 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 1.018 ' CD ' ' HB2' ' B' ' 62' ' ' ALA . 9.5 Cg_endo -74.96 -168.9 6.86 Favored 'Cis proline' 0 C--N 1.361 1.185 0 C-N-CA 120.954 -2.519 . . . . 0.0 110.993 -0.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.635 ' HD2' ' SD ' ' A' ' 33' ' ' MET . 72.8 m-70 -144.21 -170.36 3.33 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.5 1.125 . . . . 0.0 109.584 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.874 ' HB3' ' OD2' ' B' ' 63' ' ' ASP . 0.9 OUTLIER 173.96 166.98 0.2 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' HD13 ' A' ' 42' ' ' ILE . 60.5 t -104.11 114.32 43.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 O-C-N 124.578 1.174 . . . . 0.0 109.356 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.71 ' CG1' ' OD1' ' A' ' 40' ' ' ASN . 4.3 mm -132.77 75.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 O-C-N 124.524 1.14 . . . . 0.0 109.308 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 85.1 m-85 -47.66 160.65 0.11 Allowed 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.549 1.156 . . . . 0.0 110.939 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.459 ' O ' ' CB ' ' A' ' 45' ' ' LYS . 2.5 t70 -96.98 -50.04 4.78 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.519 1.137 . . . . 0.0 109.314 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 44' ' ' ASP . 7.0 mttt 167.29 143.52 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.495 1.122 . . . . 0.0 109.253 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.074 HG13 ' HB2' ' A' ' 52' ' ' ALA . 14.5 m -128.45 158.09 72.73 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.372 1.045 . . . . 0.0 109.286 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.05 164.2 33.72 Favored 'Trans proline' 0 C--N 1.36 1.164 0 O-C-N 124.493 1.786 . . . . 0.0 111.05 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.2 135.61 1.37 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.446 1.092 . . . . 0.0 109.283 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.471 ' HA3' ' CG2' ' A' ' 74' ' ' THR . . . 133.46 -56.68 0.72 Allowed Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.535 1.147 . . . . 0.0 111.014 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.496 ' OE1' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -111.06 -173.32 2.21 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.595 0.82 . . . . 0.0 110.303 -179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -133.16 77.78 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.426 1.079 . . . . 0.0 109.954 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 1.074 ' HB2' HG13 ' A' ' 46' ' ' VAL . . . -53.02 -51.81 71.33 Favored Pre-proline 0 C--N 1.324 -0.507 0 O-C-N 124.45 1.094 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 52' ' ' ALA . 17.9 Cg_endo -75.08 50.8 2.65 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.491 1.785 . . . . 0.0 110.887 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -157.23 -45.72 0.07 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.591 1.182 . . . . 0.0 109.402 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD12 ' OE1' ' A' ' 50' ' ' GLU . 12.5 mt -66.05 -27.55 68.18 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.527 1.142 . . . . 0.0 109.306 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 10.0 m -46.51 115.08 0.93 Allowed 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.56 1.163 . . . . 0.0 109.988 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.489 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -107.96 117.7 34.83 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 109.358 179.906 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -89.77 21.94 3.32 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.438 1.086 . . . . 0.0 110.347 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.8 tttt -86.11 64.43 8.57 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.453 1.096 . . . . 0.0 109.244 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.048 HD11 ' OE1' ' B' ' 61' ' ' GLN . 0.0 OUTLIER -40.51 102.45 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.497 1.123 . . . . 0.0 109.316 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -78.35 98.44 5.97 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.513 1.133 . . . . 0.0 109.329 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.501 HG12 HD23 ' A' ' 60' ' ' LEU . 0.2 OUTLIER -68.7 -46.07 80.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 O-C-N 124.569 1.168 . . . . 0.0 109.326 179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.14 111.62 4.9 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.316 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HB3' ' CE ' ' A' ' 33' ' ' MET . 27.6 Cg_endo -75.04 139.14 23.85 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.438 1.757 . . . . 0.0 110.974 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.488 ' O ' ' CG2' ' A' ' 32' ' ' VAL . . . 168.88 -67.96 0.17 Allowed Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.505 1.128 . . . . 0.0 110.95 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.665 ' HA ' HG23 ' A' ' 32' ' ' VAL . 22.9 t -178.68 97.33 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 O-C-N 124.534 0.785 . . . . 0.0 109.989 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 61' ' ' ALA . 4.4 m-85 -38.19 -86.72 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.475 1.11 . . . . 0.0 110.931 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.489 ' OH ' ' HB2' ' A' ' 57' ' ' ASN . 3.7 p90 -171.51 175.1 4.19 Favored 'General case' 0 C--N 1.327 -0.407 0 O-C-N 124.474 1.109 . . . . 0.0 111.031 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.508 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -119.58 161.31 20.84 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.45 1.094 . . . . 0.0 109.978 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 69' ' ' SER . 3.1 m -154.06 137.69 8.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.475 1.109 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.9 m -94.3 146.52 23.98 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.521 1.138 . . . . 0.0 110.387 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.18 173.12 8.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 124.482 1.114 . . . . 0.0 109.223 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.16 -44.35 0.02 OUTLIER Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.468 1.105 . . . . 0.0 110.953 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.471 ' CG2' ' HA3' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -53.22 124.1 37.37 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.538 0.787 . . . . 0.0 110.412 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.06 141.53 26.57 Favored 'Trans proline' 0 C--N 1.359 1.1 0 O-C-N 124.465 1.771 . . . . 0.0 111.043 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 141.11 -178.61 20.08 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.4 1.062 . . . . 0.0 110.963 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 29.6 m -104.88 120.06 40.5 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.494 0.761 . . . . 0.0 110.318 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.839 ' CD2' HG11 ' A' ' 46' ' ' VAL . 6.5 m-85 -96.75 140.71 30.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.546 1.154 . . . . 0.0 111.038 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.1 p -123.93 145.17 49.33 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.462 1.101 . . . . 0.0 109.966 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.522 ' N ' ' CD1' ' A' ' 80' ' ' PHE . 2.2 p90 -146.2 -171.58 3.75 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.449 1.093 . . . . 0.0 110.951 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.438 ' CD1' ' C ' ' A' ' 81' ' ' TYR . 30.5 p90 -171.84 165.42 6.48 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.493 1.121 . . . . 0.0 111.019 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -93.57 122.38 35.96 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.425 1.078 . . . . 0.0 108.262 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.658 ' OG1' HG13 ' A' ' 42' ' ' ILE . 1.0 OUTLIER -51.35 -50.8 74.08 Favored Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.398 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.677 ' CD ' HD21 ' A' ' 40' ' ' ASN . 12.8 Cg_endo -75.0 -62.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.362 1.237 0 O-C-N 124.498 1.788 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.468 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 22.0 m80 -74.98 57.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.496 1.123 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.751 HH11 ' CG ' ' A' ' 86' ' ' ARG . 2.7 ttt85 -88.01 -38.48 15.46 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 124.536 1.148 . . . . 0.0 110.345 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -89.43 -23.88 32.74 Favored Glycine 0 CA--C 1.53 0.971 0 O-C-N 124.477 1.111 . . . . 0.0 111.002 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.62 -15.24 62.55 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.505 0.768 . . . . 0.0 109.406 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.11 63.18 1.83 Allowed Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.449 1.093 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . 0.549 ' HE1' ' HB3' ' A' ' 7' ' ' MET . 8.2 ttt -121.62 75.05 1.16 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.417 0.716 . . . . 0.0 111.003 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.428 HG12 ' CB ' ' A' ' 81' ' ' TYR . 11.6 m -124.15 153.58 30.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.544 1.153 . . . . 0.0 109.277 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' C ' ' CE1' ' A' ' 80' ' ' PHE . . . -147.53 -174.78 19.77 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.551 1.157 . . . . 0.0 111.022 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.8 m -143.73 162.05 37.0 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 124.485 0.756 . . . . 0.0 110.471 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 29' ' ' VAL . 92.4 mt -146.67 122.65 3.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.531 1.144 . . . . 0.0 109.233 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 23' ' ' ILE . 48.6 m -105.1 144.54 31.76 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.467 1.104 . . . . 0.0 110.399 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.755 HG12 ' O ' ' A' ' 96' ' ' VAL . 4.9 t -128.26 73.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 124.541 1.15 . . . . 0.0 109.333 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . 0.824 ' OXT' ' HA ' ' A' ' 24' ' ' SER . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.557 1.161 . . . . 0.0 110.317 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' TYR . . . . . 1.201 ' CZ ' ' HG2' ' B' ' 119' ' ' PRO . 1.2 m-85 . . . . . 0 N--CA 1.485 1.276 0 N-CA-C 109.788 -0.449 . . . . 97.549999999999997 109.788 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -62.57 -28.46 77.31 Favored 'Trans proline' 0 N--CA 1.435 -1.961 0 N-CA-C 109.554 -0.979 . . . . 67.909999999999997 109.554 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 1.346 ' HB2' ' OH ' ' A' ' 12' ' ' TYR . 23.0 m-85 -61.85 -41.83 98.3 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.878 -1.156 . . . . 47.520000000000003 107.878 -178.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' TYR . . . . . 0.793 ' CD1' HBC2 ' B' ' 250' ' ' HEC 0.347 0.3 OUTLIER -64.88 -36.55 84.72 Favored 'General case' 0 N--CA 1.433 -1.307 0 C-N-CA 123.293 0.637 . . . . 108.14 109.547 -178.102 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.21 -42.4 99.28 Favored 'General case' 0 N--CA 1.437 -1.084 0 C-N-CA 119.417 -0.913 . . . . 36.780000000000001 108.705 177.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLN . . . . . 0.446 ' OE1' ' HA ' ' B' ' 3' ' ' PHE . 74.5 mt-30 -61.63 -43.09 99.51 Favored 'General case' 0 N--CA 1.438 -1.065 0 O-C-N 121.37 -0.831 . . . . 45.649999999999999 110.83 -176.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -66.55 -42.02 87.8 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 118.21 -1.396 . . . . 115.86 112.601 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.555 ' HB3' ' CE1' ' B' ' 9' ' ' TYR . 8.9 m120 -74.98 -41.53 59.35 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 114.306 1.224 . . . . 97.079999999999998 114.306 -175.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . 0.873 ' CD1' HG11 ' B' ' 20' ' ' VAL . 78.6 m-85 -130.03 129.9 44.27 Favored 'General case' 0 CA--C 1.494 -1.193 0 C-N-CA 116.671 -2.012 . . . . 138.06999999999999 111.34 -171.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -67.28 -41.42 85.5 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 107.715 -1.217 . . . . 73.909999999999997 107.715 178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.427 ' HA ' ' HD2' ' B' ' 12' ' ' PRO . 95.9 p -110.83 121.24 41.49 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 108.048 -1.093 . . . . 89.579999999999998 108.048 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' PRO . . . . . 0.678 ' O ' HG23 ' B' ' 20' ' ' VAL . 18.1 Cg_endo -73.4 -14.54 25.24 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 123.072 2.515 . . . . 89.25 114.635 -178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ARG . . . . . 0.507 ' HB2' ' SD ' ' B' ' 76' ' ' MET . 48.8 ttt-85 -117.27 125.23 50.76 Favored 'General case' 0 CA--C 1.493 -1.223 0 N-CA-C 107.582 -1.266 . . . . 63.350000000000001 107.582 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -79.13 165.45 23.31 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.745 -1.206 . . . . 65.950000000000003 107.745 -178.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.77 -36.58 76.98 Favored 'General case' 0 CA--C 1.492 -1.274 0 N-CA-C 108.287 -1.005 . . . . 28.780000000000001 108.287 -176.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 69.6 p -64.02 -28.33 69.73 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 107.417 -1.327 . . . . 36.030000000000001 107.417 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.52 -4.05 31.01 Favored Glycine 0 N--CA 1.434 -1.49 0 N-CA-C 107.166 -2.373 . . . . 24.109999999999999 107.166 -178.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' LYS . . . . . 0.498 ' NZ ' ' HB3' ' B' ' 22' ' ' ALA . 26.4 ttpp -73.03 137.68 45.51 Favored 'General case' 0 N--CA 1.429 -1.475 0 N-CA-C 108.026 -1.101 . . . . 93.609999999999999 108.026 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' ILE . . . . . 0.715 HG12 ' OE1' ' B' ' 238' ' ' GLN . 41.5 mm -89.87 139.2 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.11 -1.441 . . . . 129.03 107.11 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.873 HG11 ' CD1' ' B' ' 9' ' ' TYR . 62.3 t -58.74 -25.81 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 126.247 1.819 . . . . 146.38 113.908 -170.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' CYS . . . . . 0.479 ' H ' HG22 ' B' ' 19' ' ' ILE . 61.5 m -57.63 -27.66 62.98 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 120.823 -1.173 . . . . 59.140000000000001 108.477 -176.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ALA . . . . . 0.498 ' HB3' ' NZ ' ' B' ' 18' ' ' LYS . . . -59.41 -29.72 67.95 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 124.31 1.044 . . . . 55.539999999999999 110.402 -176.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASN . . . . . 0.574 HD22 HG13 ' B' ' 20' ' ' VAL . 79.3 m-20 -59.19 -44.67 92.2 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 118.753 -1.179 . . . . 73.0 110.032 -176.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' CYS . . . . . 1.116 ' SG ' ' CHD' ' B' ' 250' ' ' HEC . 42.1 t -83.48 -43.3 15.93 Favored 'General case' 0 CA--C 1.507 -0.704 0 N-CA-C 115.93 1.826 . . . . 136.30000000000001 115.93 177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -99.07 96.85 8.08 Favored 'General case' 0 CA--C 1.487 -1.47 0 N-CA-C 106.598 -1.63 . . . . 80.519999999999996 106.598 -174.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 51.0 mt -69.11 -35.6 76.61 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 116.132 1.901 . . . . 82.349999999999994 116.132 -170.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.95 151.89 23.39 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-N 119.584 1.084 . . . . 46.950000000000003 111.92 -173.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.36 135.54 42.67 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.437 0.637 . . . . 128.06 109.418 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.652 ' HD2' ' C ' ' B' ' 234' ' ' GLY . 24.1 mttp -142.61 163.86 31.67 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 106.057 -1.831 . . . . 115.98 106.057 176.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.839 ' CG2' ' HG2' ' B' ' 52' ' ' PRO . 13.2 t -74.61 154.9 38.34 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-O 122.046 0.927 . . . . 111.68000000000001 112.739 -172.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.697 HG11 ' O ' ' B' ' 237' ' ' GLY . 26.8 m -137.1 138.98 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.187 0 N-CA-C 105.649 -1.982 . . . . 107.04000000000001 105.649 173.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.938 ' HA ' ' CE ' ' B' ' 239' ' ' MET . 54.9 mp0 -128.37 144.01 51.08 Favored 'General case' 0 CA--C 1.493 -1.238 0 C-N-CA 119.013 -1.075 . . . . 82.409999999999997 109.594 -179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' ILE . . . . . 0.457 ' O ' HG23 ' B' ' 33' ' ' ILE . 19.4 tt -143.39 136.26 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 N-CA-C 108.877 -0.786 . . . . 53.990000000000002 108.877 177.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -129.68 136.89 50.25 Favored 'General case' 0 CA--C 1.494 -1.184 0 N-CA-C 108.951 -0.759 . . . . 76.209999999999994 108.951 176.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' B' ' 47' ' ' ALA . 35.7 m -143.55 165.92 22.48 Favored Pre-proline 0 N--CA 1.437 -1.113 0 N-CA-C 106.872 -1.529 . . . . 42.719999999999999 106.872 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -69.61 159.73 52.4 Favored 'Trans proline' 0 N--CA 1.44 -1.67 0 O-C-N 122.096 0.524 . . . . 60.469999999999999 111.388 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -62.58 -45.92 90.67 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 108.029 -1.1 . . . . 85.670000000000002 108.029 -178.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.96 159.53 43.12 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.632 -0.877 . . . . 36.200000000000003 108.632 -177.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.634 HG13 HD11 ' B' ' 243' ' ' ILE . 27.3 m -141.33 149.5 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 108.944 -0.762 . . . . 44.090000000000003 108.944 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.948 ' HB3' ' HD2' ' B' ' 41' ' ' PRO . 5.8 mp -81.93 158.63 67.3 Favored Pre-proline 0 CA--C 1.501 -0.935 0 N-CA-C 107.978 -1.119 . . . . 106.67 107.978 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' B' ' 40' ' ' LEU . 56.5 Cg_endo -42.21 -96.46 0.0 OUTLIER 'Trans proline' 0 CA--C 1.493 -1.564 0 N-CA-C 119.206 2.733 . . . . 211.88 119.206 -172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.89 ' OD1' HD11 ' B' ' 133' ' ' LEU . 11.5 t0 -85.51 79.18 9.5 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 123.067 2.667 . . . . 175.88999999999999 107.562 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.602 HG22 ' O ' ' B' ' 40' ' ' LEU . 7.3 t -131.58 160.14 36.17 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 109.076 -0.713 . . . . 115.62 109.076 -177.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' B' ' 132' ' ' ILE . 93.5 t -108.12 138.24 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 108.287 -1.005 . . . . 43.219999999999999 108.287 -178.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -142.51 166.52 24.44 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.632 -1.247 . . . . 61.960000000000001 107.632 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.952 ' HG2' HD11 ' B' ' 129' ' ' ILE . 0.0 OUTLIER -105.19 139.9 39.15 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 119.586 -0.845 . . . . 138.59 111.0 -176.3 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HA ' HG12 ' B' ' 35' ' ' VAL . . . -113.9 121.17 43.14 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 103.997 -2.594 . . . . 49.030000000000001 103.997 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' VAL . . . . . 0.698 HG13 ' CG ' ' B' ' 127' ' ' GLU . 68.4 t -103.21 127.73 56.85 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 N-CA-C 108.967 -0.753 . . . . 51.630000000000003 108.967 -176.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' VAL . . . . . 0.442 HG21 ' CE2' ' B' ' 130' ' ' PHE . 69.8 t -119.41 137.41 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.032 0 N-CA-C 109.458 -0.571 . . . . 50.490000000000002 109.458 -177.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -134.28 142.83 47.43 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.242 -1.022 . . . . 49.409999999999997 108.242 177.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' VAL . . . . . 0.586 ' O ' HG13 ' B' ' 51' ' ' VAL . 3.5 p -132.27 90.52 34.16 Favored Pre-proline 0 N--CA 1.441 -0.902 0 N-CA-C 108.538 -0.912 . . . . 132.40000000000001 108.538 179.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.839 ' HG2' ' CG2' ' B' ' 30' ' ' THR . 12.2 Cg_endo -75.44 142.47 26.61 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 N-CA-C 118.523 2.47 . . . . 103.15000000000001 118.523 -173.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' TYR . . . . . 0.516 ' CE2' HD13 ' B' ' 55' ' ' LEU . 47.2 p90 -160.68 163.44 32.47 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.339 -1.726 . . . . 72.799999999999997 106.339 171.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.679 ' O ' HG22 ' B' ' 57' ' ' ILE . 31.2 t0 -80.67 117.96 21.81 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 107.254 -1.387 . . . . 44.109999999999999 107.254 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' LEU . . . . . 0.528 HD22 ' N ' ' B' ' 55' ' ' LEU . 2.3 mm? -63.93 -27.37 69.1 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.803 0.841 . . . . 93.620000000000005 109.682 -177.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -66.21 -26.58 67.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 121.613 -0.679 . . . . 128.94999999999999 112.152 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ILE . . . . . 0.679 HG22 ' O ' ' B' ' 54' ' ' ASP . 20.7 tt -92.18 132.21 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 119.353 0.979 . . . . 94.780000000000001 111.737 -173.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.4 ' O ' HG11 ' B' ' 233' ' ' VAL . 75.6 mt-30 -95.71 159.62 14.9 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.002 0.921 . . . . 51.609999999999999 109.396 -178.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLN . . . . . 0.676 ' HB2' HG21 ' B' ' 233' ' ' VAL . 26.8 tt0 -118.05 156.85 27.9 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 125.051 1.341 . . . . 133.97 109.83 -175.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' B' ' 59' ' ' GLN . 7.9 t -75.6 132.07 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 N-CA-C 106.209 -1.774 . . . . 46.710000000000001 106.209 177.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' GLN . . . . . 1.048 ' OE1' HD11 ' A' ' 60' ' ' LEU . 2.1 pt20 -102.39 -178.14 3.6 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 108.967 -0.753 . . . . 127.55 108.967 -179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ALA . . . . . 1.018 ' HB2' ' CD ' ' A' ' 38' ' ' PRO . . . -58.73 -39.36 80.67 Favored 'General case' 0 N--CA 1.435 -1.176 0 O-C-N 122.076 -0.39 . . . . 54.25 110.997 -174.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ASP . . . . . 0.874 ' OD2' ' HB3' ' A' ' 40' ' ' ASN . 5.0 m-20 -73.96 -16.97 61.06 Favored 'General case' 0 N--CA 1.442 -0.857 0 O-C-N 121.633 -0.667 . . . . 90.829999999999998 111.587 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLY . . . . . . . . . . . . . . . 108.32 -13.98 36.44 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 109.593 -1.403 . . . . 48.049999999999997 109.593 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' SER . . . . . 0.949 ' O ' ' HG2' ' B' ' 61' ' ' GLN . 10.3 m -80.84 161.61 62.97 Favored Pre-proline 0 N--CA 1.443 -0.792 0 CA-C-O 122.215 1.007 . . . . 101.44 110.192 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 65' ' ' SER . 1.7 Cg_endo -80.22 147.47 18.42 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 122.449 0.71 . . . . 164.53 113.64 177.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.46 ' CB ' ' NE2' ' B' ' 61' ' ' GLN . 54.2 p -162.95 -175.43 4.37 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.989 -0.745 . . . . 43.149999999999999 108.989 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -79.04 171.44 55.08 Favored Glycine 0 C--N 1.353 1.493 0 N-CA-C 109.995 -1.242 . . . . 21.960000000000001 109.995 -176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.403 HD21 HG23 ' B' ' 233' ' ' VAL . 8.2 mp -105.71 153.16 22.23 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 109.231 -0.655 . . . . 94.260000000000005 109.231 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASN . . . . . 0.684 ' HB2' ' CGA' ' B' ' 250' ' ' HEC . 1.1 m-80 -114.55 155.98 25.49 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 105.308 -2.108 . . . . 44.719999999999999 105.308 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . 0.425 ' CG2' ' CE ' ' B' ' 128' ' ' MET . 34.7 m -127.97 163.21 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.195 0 N-CA-C 109.04 -0.726 . . . . 38.920000000000002 109.04 -177.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.29 167.04 39.64 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 107.282 -2.327 . . . . 23.600000000000001 107.282 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -161.16 164.1 30.78 Favored 'General case' 0 N--CA 1.434 -1.27 0 C-N-CA 117.798 -1.561 . . . . 43.130000000000003 110.184 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' VAL . . . . . 0.517 HG13 ' O ' ' B' ' 74' ' ' VAL . 7.1 p -122.4 126.71 74.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.245 0 N-CA-C 104.52 -2.4 . . . . 108.59 104.52 173.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.735 HD22 ' CD2' ' B' ' 130' ' ' PHE . 62.7 tp -116.61 115.62 26.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 N-CA-C 106.462 -1.681 . . . . 65.030000000000001 106.462 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' MET . . . . . 0.507 ' SD ' ' HB2' ' B' ' 13' ' ' ARG . 91.4 mtp -101.22 113.12 25.88 Favored 'General case' 0 N--CA 1.432 -1.37 0 C-N-CA 118.952 -1.099 . . . . 59.439999999999998 108.757 -176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.525 HD11 HD13 ' B' ' 132' ' ' ILE . 86.0 mt -96.6 167.35 12.36 Favored Pre-proline 0 N--CA 1.433 -1.276 0 N-CA-C 108.37 -0.974 . . . . 62.280000000000001 108.37 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' PRO . . . . . 0.558 ' HB2' ' CE1' ' B' ' 81' ' ' PHE . 75.8 Cg_exo -70.78 164.95 33.72 Favored 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 120.908 1.072 . . . . 70.989999999999995 110.703 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -57.05 138.65 54.12 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 109.086 -0.709 . . . . 115.06999999999999 109.086 -179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.96 -20.41 45.84 Favored Glycine 0 N--CA 1.434 -1.467 0 N-CA-C 111.245 -0.742 . . . . 41.43 111.245 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' B' ' 78' ' ' PRO . 48.1 m-85 -80.08 144.71 32.91 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.618 -0.882 . . . . 73.200000000000003 108.618 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' LYS . . . . . . . . . . . . . 1.3 ptpp? -148.97 169.18 21.17 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.176 -1.046 . . . . 145.03999999999999 108.176 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 1.005 HD11 ' HD2' ' B' ' 131' ' ' PRO . 31.7 tp -69.01 144.82 53.98 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 103.698 -2.704 . . . . 90.25 103.698 177.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' ALA . . . . . . . . . . . . . . . -77.34 143.51 69.11 Favored Pre-proline 0 CA--C 1.491 -1.304 0 C-N-CA 120.096 -0.642 . . . . 48.520000000000003 110.85 -175.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' PRO . . . . . 0.723 ' HG2' ' HG2' ' B' ' 88' ' ' ARG . 10.5 Cg_endo -74.4 151.75 43.09 Favored 'Trans proline' 0 N--CA 1.437 -1.851 0 N-CA-C 107.42 -1.8 . . . . 85.219999999999999 107.42 176.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' PRO . . . . . 0.95 ' HB3' ' CE2' ' B' ' 100' ' ' PHE . 77.4 Cg_endo -54.47 -38.28 89.84 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 C-N-CA 121.775 1.65 . . . . 117.84 111.909 -176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' GLU . . . . . . . . . . . . . 87.3 mt-10 -64.34 -34.68 78.7 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 109.06 -0.718 . . . . 54.700000000000003 109.06 -173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.723 ' HG2' ' HG2' ' B' ' 85' ' ' PRO . 26.2 mmt180 -72.81 -25.91 61.31 Favored 'General case' 0 N--CA 1.433 -1.301 0 C-N-CA 125.368 1.467 . . . . 162.31 113.415 -177.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' VAL . . . . . 0.438 HG12 ' O ' ' B' ' 90' ' ' ASP . 73.0 t -73.36 127.5 35.34 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.113 0 C-N-CA 118.786 -1.165 . . . . 56.460000000000001 111.199 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' ASP . . . . . 0.748 ' OD1' HD13 ' B' ' 93' ' ' LEU . 39.6 p-10 -71.59 162.89 28.74 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 119.028 -1.069 . . . . 101.48 110.501 -178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -62.33 -46.1 90.21 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.123 1.157 . . . . 100.92 114.123 -168.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' GLU . . . . . 0.409 ' HB3' HD12 ' B' ' 93' ' ' LEU . 42.3 tt0 -62.19 -39.67 93.51 Favored 'General case' 0 N--CA 1.437 -1.11 0 C-N-CA 118.123 -1.431 . . . . 51.689999999999998 109.19 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' LEU . . . . . 0.748 HD23 ' HD2' ' B' ' 46' ' ' LYS . 6.9 mp -69.96 -30.7 68.14 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 116.608 2.077 . . . . 126.69 116.608 -173.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 67.9 mtm -55.12 -41.66 71.99 Favored 'General case' 0 CA--C 1.499 -0.997 0 CA-C-N 119.513 1.051 . . . . 95.049999999999997 112.258 -168.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -69.77 -30.75 68.39 Favored 'General case' 0 N--CA 1.435 -1.204 0 O-C-N 121.158 -0.964 . . . . 96.120000000000005 111.474 -178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' GLU . . . . . 0.67 ' O ' HG21 ' B' ' 129' ' ' ILE . 93.6 mt-10 -69.29 -25.22 64.14 Favored 'General case' 0 CA--C 1.503 -0.831 0 C-N-CA 125.878 1.671 . . . . 72.950000000000003 112.987 -175.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' VAL . . . . . 0.875 ' HA ' ' CG2' ' B' ' 129' ' ' ILE . 63.9 t -100.54 158.78 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 O-C-N 120.953 -1.092 . . . . 57.310000000000002 110.301 -172.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' GLY . . . . . 0.719 ' H ' HG23 ' B' ' 129' ' ' ILE . . . -61.51 159.5 30.08 Favored Glycine 0 CA--C 1.479 -2.177 0 N-CA-C 105.167 -3.173 . . . . 46.079999999999998 105.167 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -54.98 107.83 0.34 Allowed 'General case' 0 CA--C 1.473 -1.988 0 N-CA-C 102.397 -3.186 . . . . 68.079999999999998 102.397 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' PHE . . . . . 0.95 ' CE2' ' HB3' ' B' ' 86' ' ' PRO . 6.4 p90 -57.15 -49.99 74.23 Favored 'General case' 0 N--CA 1.413 -2.295 0 CA-C-N 113.179 -1.828 . . . . 145.21000000000001 109.317 -167.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.768 ' HE1' ' HG3' ' B' ' 86' ' ' PRO . 17.4 m-85 -71.19 -55.91 7.15 Favored 'General case' 0 N--CA 1.418 -2.049 1 C-N-CA 109.951 -4.7 . . . . 138.36000000000001 114.38 -174.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' TYR . . . . . 0.431 ' CE2' HD23 ' B' ' 103' ' ' LEU . 11.8 t80 -60.06 -46.47 89.44 Favored 'General case' 0 N--CA 1.431 -1.393 0 N-CA-C 114.735 1.383 . . . . 109.22 114.735 -163.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' B' ' 102' ' ' TYR . 84.0 mt -66.95 -32.6 73.96 Favored 'General case' 0 N--CA 1.432 -1.341 0 O-C-N 121.644 -0.66 . . . . 58.340000000000003 112.516 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' VAL . . . . . 1.097 HG13 ' HG ' ' B' ' 115' ' ' LEU . 51.5 t -99.4 132.73 44.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.859 0 N-CA-C 115.182 1.549 . . . . 58.159999999999997 115.182 -169.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' THR . . . . . 0.675 ' CG2' ' HB2' ' B' ' 116' ' ' LEU . 15.1 t -127.68 139.37 35.09 Favored Pre-proline 0 C--N 1.357 0.925 0 N-CA-C 109.138 -0.69 . . . . 108.0 109.138 177.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.493 ' HB3' ' HA ' ' B' ' 112' ' ' GLU . 78.2 Cg_exo -75.3 151.32 38.08 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 N-CA-C 110.217 -0.724 . . . . 158.62 110.217 178.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' TYR . . . . . 0.489 ' HB3' ' HB3' ' B' ' 111' ' ' ASP . 31.2 t80 -65.63 -42.37 91.58 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.97 -1.122 . . . . 63.719999999999999 107.97 -177.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' SER . . . . . 0.515 ' N ' ' HB2' ' B' ' 111' ' ' ASP . 72.4 m -157.52 173.54 16.73 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 106.432 -1.692 . . . . 81.310000000000002 106.432 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 29.4 mm-40 -62.02 -43.84 97.99 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 109.319 -0.623 . . . . 61.43 109.319 -177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' THR . . . . . 0.487 HG23 ' OD1' ' B' ' 111' ' ' ASP . 12.8 t -72.66 -30.18 64.06 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 124.227 1.011 . . . . 120.06 111.85 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' N ' ' B' ' 108' ' ' SER . 91.0 m-20 -83.37 20.52 1.31 Allowed 'General case' 0 CA--C 1.509 -0.613 1 C-N-CA 134.465 5.106 . . . . 131.69999999999999 118.143 -173.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.493 ' HA ' ' HB3' ' B' ' 106' ' ' PRO . 29.7 mt-10 -54.22 -24.73 19.62 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 120.845 1.657 . . . . 97.269999999999996 112.855 -173.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . 0.657 ' CG ' HD12 ' B' ' 114' ' ' ILE . 20.5 p-10 -69.12 -20.25 64.05 Favored 'General case' 0 N--CA 1.441 -0.908 0 O-C-N 121.06 -1.025 . . . . 82.230000000000004 110.963 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.657 HD12 ' CG ' ' B' ' 113' ' ' ASN . 2.3 mp -100.98 118.07 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.862 0 N-CA-C 108.024 -1.102 . . . . 103.23999999999999 108.024 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' LEU . . . . . 1.097 ' HG ' HG13 ' B' ' 104' ' ' VAL . 3.5 tt -109.61 135.41 50.63 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.256 1.023 . . . . 112.11 110.506 -173.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' LEU . . . . . 0.706 ' N ' HD23 ' B' ' 115' ' ' LEU . 72.7 mt -116.52 144.14 44.72 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.225 -1.028 . . . . 54.880000000000003 108.225 179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' ALA . . . . . . . . . . . . . . . -140.33 149.44 42.75 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.677 -1.601 . . . . 35.130000000000003 106.677 176.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' GLY . . . . . 0.473 ' HA2' ' C ' ' B' ' 119' ' ' PRO . . . 97.66 172.26 33.28 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 110.882 -0.887 . . . . 31.609999999999999 110.882 176.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' PRO . . . . . 1.201 ' HG2' ' CZ ' ' B' ' 1' ' ' TYR . 1.0 OUTLIER -72.0 145.57 83.51 Favored 'Cis proline' 0 N--CA 1.442 -1.554 0 C-N-CA 120.581 -2.674 . . . . 173.24000000000001 115.309 0.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' LEU . . . . . 0.466 ' HG ' ' HA2' ' B' ' 118' ' ' GLY . 48.6 mt -130.56 156.13 80.15 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 106.191 -1.781 . . . . 61.640000000000001 106.191 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.91 130.71 22.29 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 N-CA-C 109.149 -1.135 . . . . 80.930000000000007 109.149 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' GLY . . . . . . . . . . . . . . . -64.82 -36.98 93.75 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 111.477 -0.649 . . . . 30.440000000000001 111.477 -175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' B' ' 124' ' ' ASP . 15.6 pt-20 -64.78 -36.85 85.65 Favored 'General case' 0 N--CA 1.433 -1.275 0 O-C-N 121.599 -0.942 . . . . 87.260000000000005 110.242 -176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' ASP . . . . . 0.436 ' N ' ' HG3' ' B' ' 123' ' ' GLU . 15.4 t0 -71.75 -40.73 69.16 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 123.661 0.784 . . . . 94.969999999999999 112.835 -177.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -111.26 91.81 3.8 Favored 'General case' 0 CA--C 1.497 -1.085 0 C-N-CA 117.564 -1.654 . . . . 73.920000000000002 111.878 -172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -72.13 -35.85 69.22 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.99 -1.115 . . . . 133.88999999999999 107.99 175.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' GLU . . . . . 0.698 ' CG ' HG13 ' B' ' 48' ' ' VAL . 48.4 tt0 -132.9 139.04 47.18 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 105.713 -1.958 . . . . 98.980000000000004 105.713 -177.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' MET . . . . . 0.425 ' CE ' ' CG2' ' B' ' 71' ' ' VAL . 56.2 mtt -115.98 119.6 36.44 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 104.012 -2.588 . . . . 95.230000000000004 104.012 176.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' B' ' 46' ' ' LYS . 19.7 tt -110.29 118.39 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.125 0 C-N-CA 117.984 -1.486 . . . . 103.93000000000001 110.355 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PHE . . . . . 0.735 ' CD2' HD22 ' B' ' 75' ' ' LEU . 25.7 m-85 -98.08 126.32 40.65 Favored Pre-proline 0 N--CA 1.439 -0.998 0 N-CA-C 108.982 -0.747 . . . . 145.24000000000001 108.982 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' PRO . . . . . 1.005 ' HD2' HD11 ' B' ' 83' ' ' LEU . 94.6 Cg_endo -77.14 124.3 7.19 Favored 'Trans proline' 0 N--CA 1.441 -1.603 0 N-CA-C 104.843 -2.791 . . . . 110.95999999999999 104.843 175.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ILE . . . . . 0.525 HD13 HD11 ' B' ' 77' ' ' LEU . 89.1 mt -125.83 139.08 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 C-N-CA 116.532 -2.067 . . . . 51.719999999999999 110.019 -176.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' LEU . . . . . 0.89 HD11 ' OD1' ' B' ' 42' ' ' ASP . 58.4 tp -108.27 123.98 49.62 Favored 'General case' 0 CA--C 1.504 -0.793 0 N-CA-C 109.202 -0.666 . . . . 63.100000000000001 109.202 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' SER . . . . . 0.707 ' HB2' ' O ' ' B' ' 41' ' ' PRO . 67.3 m -77.79 155.65 80.55 Favored Pre-proline 0 CA--C 1.506 -0.727 0 O-C-N 121.599 -0.688 . . . . 105.79000000000001 109.739 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' B' ' 81' ' ' PHE . 27.5 Cg_endo -79.56 173.82 12.59 Favored 'Trans proline' 0 N--CA 1.444 -1.385 0 C-N-CA 123.365 2.71 . . . . 103.36 111.503 178.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.7 110.09 28.01 Favored Pre-proline 0 N--CA 1.44 -0.971 0 N-CA-C 107.445 -1.317 . . . . 65.569999999999993 107.445 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.424 ' HG3' HG23 ' B' ' 143' ' ' VAL . 85.5 Cg_exo -64.91 -25.86 59.6 Favored 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 120.663 0.909 . . . . 80.420000000000002 114.313 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.65 -45.52 92.46 Favored 'General case' 0 N--CA 1.433 -1.304 0 C-N-CA 117.859 -1.536 . . . . 35.399999999999999 107.658 -178.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' THR . . . . . . . . . . . . . 64.7 p -76.26 -36.82 58.28 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.075 -0.512 . . . . 53.969999999999999 111.528 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -109.37 116.34 31.66 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-O 121.264 0.554 . . . . 56.810000000000002 110.727 -172.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.93 -35.87 81.8 Favored 'General case' 0 CA--C 1.5 -0.971 0 C-N-CA 126.505 1.922 . . . . 36.960000000000001 111.191 -178.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.09 -31.5 76.97 Favored Glycine 0 N--CA 1.434 -1.461 0 N-CA-C 110.959 -0.856 . . . . 42.259999999999998 110.959 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' B' ' 137' ' ' PRO . 30.2 m -114.76 149.62 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 C-N-CA 118.854 -1.138 . . . . 124.63 111.202 -176.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -129.22 166.72 18.85 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 107.538 -1.282 . . . . 52.909999999999997 107.538 178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -75.56 148.93 38.48 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.63 -1.619 . . . . 52.880000000000003 106.63 178.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.87 -174.37 35.87 Favored Glycine 0 N--CA 1.435 -1.391 0 N-CA-C 107.698 -2.161 . . . . 22.649999999999999 107.698 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -95.23 137.56 34.12 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 107.502 -1.296 . . . . 67.579999999999998 107.502 -179.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -133.06 161.28 34.81 Favored 'General case' 0 N--CA 1.436 -1.132 0 C-N-CA 119.141 -1.023 . . . . 64.189999999999998 110.292 -177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' SER . . . . . . . . . . . . . 64.1 m -106.86 147.93 29.16 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.912 -0.773 . . . . 34.789999999999999 108.912 -178.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' ILE . . . . . 0.435 HG23 HD23 ' B' ' 77' ' ' LEU . 88.0 mt -121.81 136.31 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.217 0 N-CA-C 104.946 -2.242 . . . . 42.340000000000003 104.946 178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.78 132.25 56.74 Favored 'General case' 0 CA--C 1.496 -1.129 0 C-N-CA 119.045 -1.062 . . . . 50.329999999999998 108.703 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' LEU . . . . . 0.431 HD21 HG13 ' B' ' 49' ' ' VAL . 66.9 tp -117.05 138.4 51.62 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.368 -0.605 . . . . 51.119999999999997 109.368 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLY . . . . . . . . . . . . . . . -127.73 121.76 3.91 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 104.093 -3.603 . . . . 38.82 104.093 174.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' GLY . . . . . . . . . . . . . . . -133.96 137.5 9.36 Favored Glycine 0 C--N 1.352 1.431 0 C-N-CA 118.336 -1.887 . . . . 46.920000000000002 110.328 -175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ASN . . . . . 0.754 ' HB2' ' HD1' ' B' ' 236' ' ' PHE . 25.0 t-20 -131.46 154.16 49.0 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-O 121.82 0.819 . . . . 95.989999999999995 111.879 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 156' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' B' ' 235' ' ' GLY . 0.6 OUTLIER -139.76 140.41 36.7 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 104.646 -2.353 . . . . 183.94 104.646 173.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . . . . . . . . . . . 90.82 158.65 34.89 Favored Glycine 0 C--N 1.347 1.153 0 C-N-CA 120.109 -1.043 . . . . 44.729999999999997 111.494 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 158' ' ' ARG . . . . . 0.639 ' H ' HE22 ' B' ' 59' ' ' GLN . 51.3 mtp180 -71.93 145.69 48.3 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 124.967 1.307 . . . . 106.01000000000001 111.054 -176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . 0.54 ' H ' ' C3D' ' B' ' 250' ' ' HEC . . . -80.05 164.89 48.5 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 110.687 -0.965 . . . . 39.380000000000003 110.687 -177.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 160' ' ' GLN . . . . . 0.506 HE21 ' ND2' ' B' ' 170' ' ' ASN . 12.5 mp0 -80.79 -34.17 34.32 Favored 'General case' 0 N--CA 1.438 -1.053 0 C-N-CA 127.643 2.377 . . . . 129.94999999999999 113.75 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . 0.749 HG12 ' HA ' ' B' ' 24' ' ' CYS . 14.6 p -128.55 157.8 40.99 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.086 0 C-N-CA 119.985 -0.686 . . . . 106.48999999999999 109.625 -173.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 162' ' ' TYR . . . . . 1.043 ' HB3' HG22 ' B' ' 164' ' ' THR . 18.8 m-85 -108.41 162.07 21.24 Favored Pre-proline 0 N--CA 1.435 -1.223 0 N-CA-C 106.145 -1.798 . . . . 87.900000000000006 106.145 -177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 163' ' ' PRO . . . . . 0.652 ' HB3' ' CD1' ' B' ' 4' ' ' TYR . 1.5 Cg_endo -63.31 -15.51 48.74 Favored 'Trans proline' 0 N--CA 1.437 -1.826 0 N-CA-C 108.818 -1.262 . . . . 81.670000000000002 108.818 177.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 164' ' ' THR . . . . . 1.043 HG22 ' HB3' ' B' ' 162' ' ' TYR . 1.5 t -64.7 -34.75 79.05 Favored 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 106.542 -1.651 . . . . 111.73999999999999 106.542 174.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.44 -8.69 44.46 Favored Glycine 0 N--CA 1.432 -1.615 0 N-CA-C 107.634 -2.186 . . . . 24.27 107.634 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 166' ' ' GLU . . . . . 1.0 ' H ' HG23 ' B' ' 164' ' ' THR . 19.9 mt-10 -87.39 153.35 21.52 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.984 -0.747 . . . . 54.840000000000003 108.984 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 167' ' ' LEU . . . . . 0.49 ' N ' HD22 ' B' ' 167' ' ' LEU . 3.0 mm? -77.7 148.49 34.92 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-O 121.369 0.604 . . . . 82.859999999999999 110.191 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 168' ' ' SER . . . . . . . . . . . . . 53.8 p -88.23 177.29 6.92 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.572 -1.27 . . . . 42.609999999999999 107.572 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 169' ' ' ASN . . . . . 0.575 HD21 ' HA ' ' B' ' 62' ' ' ALA . 1.1 p30 -74.97 -13.83 60.56 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 124.057 0.943 . . . . 93.519999999999996 110.034 178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 170' ' ' ASN . . . . . 0.755 ' O ' ' ND2' ' B' ' 170' ' ' ASN . 0.1 OUTLIER -96.65 60.36 1.83 Allowed 'General case' 0 N--CA 1.44 -0.967 0 O-C-N 121.196 -0.94 . . . . 142.77000000000001 108.872 -179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -157.5 166.16 33.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.904 -0.776 . . . . 105.45999999999999 108.904 -177.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 172' ' ' ALA . . . . . . . . . . . . . . . -82.17 144.49 30.68 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 109.5 -0.556 . . . . 47.609999999999999 109.5 178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 173' ' ' PHE . . . . . 0.683 ' H ' ' CG2' ' B' ' 228' ' ' THR . 39.2 m-85 -116.03 139.51 50.21 Favored 'General case' 0 CA--C 1.504 -0.813 0 N-CA-C 107.379 -1.341 . . . . 64.709999999999994 107.379 177.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 174' ' ' SER . . . . . . . . . . . . . 99.7 p -120.73 156.1 32.51 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.995 0.902 . . . . 85.079999999999998 112.141 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.73 127.19 30.49 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 121.945 0.879 . . . . 43.18 108.933 -179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 176' ' ' SER . . . . . . . . . . . . . 68.2 m -70.35 -27.36 64.28 Favored 'General case' 0 N--CA 1.432 -1.351 0 CA-C-N 115.302 -0.863 . . . . 88.030000000000001 108.814 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.691 HG22 HG11 ' B' ' 203' ' ' VAL . 20.3 tt -152.18 160.52 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.044 0 C-N-CA 119.95 -0.7 . . . . 97.939999999999998 109.292 -179.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . 0.497 ' N ' HG12 ' B' ' 177' ' ' ILE . . . -81.18 149.1 29.23 Favored 'General case' 0 CA--C 1.497 -1.072 0 N-CA-C 109.004 -0.739 . . . . 37.420000000000002 109.004 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . 160.42 -161.44 32.61 Favored Glycine 0 C--N 1.352 1.443 0 N-CA-C 108.8 -1.72 . . . . 24.57 108.8 178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 61.4 p -114.65 147.07 40.1 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 108.336 -0.987 . . . . 110.84999999999999 108.336 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.434 ' O ' HG13 ' B' ' 217' ' ' VAL . 95.1 mt -89.03 105.59 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.241 0 N-CA-C 109.093 -0.706 . . . . 57.829999999999998 109.093 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 182' ' ' ALA . . . . . 0.632 ' HB3' ' CG2' ' B' ' 194' ' ' THR . . . -69.77 -42.15 74.21 Favored 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 123.741 0.817 . . . . 48.079999999999998 111.297 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.535 ' H ' HG22 ' B' ' 194' ' ' THR . . . -166.32 164.74 17.57 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 117.695 -1.602 . . . . 49.700000000000003 109.99 -177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.631 HG22 ' HA ' ' B' ' 193' ' ' VAL . 44.9 pt -140.94 139.42 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 N-CA-C 108.961 -0.755 . . . . 138.63999999999999 108.961 175.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . 0.512 ' O ' ' HA2' ' B' ' 190' ' ' GLY . 56.1 mt-10 -114.53 157.15 23.38 Favored 'General case' 0 C--N 1.365 1.241 0 CA-C-O 117.501 -1.238 . . . . 105.54000000000001 109.558 -176.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 186' ' ' ASP . . . . . 0.471 ' HA ' ' O ' ' B' ' 189' ' ' PHE . 56.9 m-20 -151.2 114.95 4.92 Favored 'General case' 0 C--N 1.388 2.257 1 N-CA-C 122.568 4.285 . . . . 243.88999999999999 122.568 -172.088 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 187' ' ' ASN . . . . . 0.691 ' O ' ' CD1' ' B' ' 189' ' ' PHE . 5.4 m120 -116.03 40.15 2.89 Favored 'General case' 0 C--N 1.37 1.475 0 N-CA-C 105.351 -2.092 . . . . 218.52000000000001 105.351 168.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.7 -45.01 2.72 Favored Glycine 0 N--CA 1.419 -2.497 1 N-CA-C 101.813 -4.515 . . . . 65.950000000000003 101.813 -172.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 189' ' ' PHE . . . . . 0.825 ' CD2' ' HD3' ' B' ' 209' ' ' PRO 0.271 0.5 OUTLIER -77.53 141.62 39.49 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.937 -2.616 . . . . 89.890000000000001 103.937 176.574 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' B' B ' 190' ' ' GLY . . . . . 0.512 ' HA2' ' O ' ' B' ' 185' ' ' GLU . . . -99.37 102.79 2.61 Favored Glycine 0 CA--C 1.451 -3.96 1 N-CA-C 95.783 -6.927 . . . . 89.010000000000005 95.783 168.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 191' ' ' PHE . . . . . 0.416 ' C ' ' CG ' ' B' ' 192' ' ' ASP . 12.9 m-85 -56.1 -37.3 69.2 Favored 'General case' 0 CA--C 1.461 -2.442 0 N-CA-C 101.338 -3.579 . . . . 58.659999999999997 101.338 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 192' ' ' ASP . . . . . 0.65 ' HB3' HG22 ' B' ' 204' ' ' VAL . 0.0 OUTLIER -159.59 144.28 15.21 Favored 'General case' 0 N--CA 1.406 -2.65 0 C-N-CA 112.732 -3.587 . . . . 130.87 113.314 178.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.631 ' HA ' HG22 ' B' ' 184' ' ' ILE . 92.4 t -106.56 120.24 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.987 0 N-CA-C 101.019 -3.697 . . . . 58.479999999999997 101.019 164.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 194' ' ' THR . . . . . 0.632 ' CG2' ' HB3' ' B' ' 182' ' ' ALA . 15.2 t -97.35 129.59 44.59 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 107.222 -1.399 . . . . 106.55 107.222 -178.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 195' ' ' ILE . . . . . 0.544 ' O ' ' HD3' ' B' ' 197' ' ' PRO . 88.2 mt -120.05 136.63 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 108.182 -1.044 . . . . 41.600000000000001 108.182 -177.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -101.16 111.19 63.14 Favored Pre-proline 0 N--CA 1.434 -1.258 0 N-CA-C 107.412 -1.329 . . . . 51.689999999999998 107.412 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 197' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' B' ' 201' ' ' ASP . 67.4 Cg_exo -70.72 172.66 13.14 Favored 'Trans proline' 0 N--CA 1.433 -2.087 0 N-CA-C 115.3 1.231 . . . . 146.50999999999999 115.3 177.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 198' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' B' ' 198' ' ' GLU . 45.1 mp0 -56.67 -29.67 62.57 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 127.007 2.123 . . . . 133.90000000000001 110.886 -171.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -124.61 49.44 1.82 Allowed 'General case' 0 N--CA 1.434 -1.264 0 C-N-CA 116.091 -2.244 . . . . 197.00999999999999 114.117 -175.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 200' ' ' GLY . . . . . . . . . . . . . . . 96.33 -29.04 10.8 Favored Glycine 0 C--N 1.349 1.296 0 C-N-CA 120.654 -0.784 . . . . 59.789999999999999 113.597 169.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 201' ' ' ASP . . . . . 0.61 ' O ' ' HD2' ' B' ' 197' ' ' PRO . 61.1 m-20 -69.95 159.23 34.12 Favored 'General case' 0 CA--C 1.496 -1.104 0 CA-C-N 119.142 1.471 . . . . 45.890000000000001 109.961 -174.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -132.69 131.32 41.16 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.73 -1.581 . . . . 42.57 106.73 175.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 203' ' ' VAL . . . . . 0.691 HG11 HG22 ' B' ' 177' ' ' ILE . 14.7 p -122.24 158.82 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.268 0 N-CA-C 108.053 -1.092 . . . . 96.230000000000004 108.053 -177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . 0.65 HG22 ' HB3' ' B' ' 192' ' ' ASP . 0.4 OUTLIER -128.39 130.63 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.586 0 C-N-CA 117.388 -1.725 . . . . 112.84999999999999 108.835 -177.292 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 205' ' ' THR . . . . . 0.615 HG23 ' HB ' ' B' ' 193' ' ' VAL . 0.5 OUTLIER -113.75 127.01 55.85 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 106.82 -1.548 . . . . 115.69 106.82 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 206' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.49 134.4 42.43 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 108.974 -0.75 . . . . 77.920000000000002 108.974 -176.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 207' ' ' ILE . . . . . . . . . . . . . 76.7 mt -126.18 141.01 47.03 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 105.796 -1.927 . . . . 73.140000000000001 105.796 178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 208' ' ' LEU . . . . . 0.609 ' O ' ' HD2' ' B' ' 211' ' ' PRO . 0.2 OUTLIER -81.01 164.06 52.41 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 109.336 -0.616 . . . . 114.84999999999999 109.336 -178.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 209' ' ' PRO . . . . . 0.825 ' HD3' ' CD2' ' B' ' 189' ' ' PHE . 2.0 Cg_endo -61.79 147.96 94.12 Favored 'Trans proline' 0 N--CA 1.439 -1.705 0 C-N-CA 122.435 2.09 . . . . 116.27 107.876 178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 210' ' ' GLY . . . . . . . . . . . . . . . 122.78 -59.26 0.6 Allowed Glycine 0 C--N 1.35 1.331 0 CA-C-O 119.093 -0.837 . . . . 57.869999999999997 111.891 176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 211' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' B' ' 208' ' ' LEU . 3.1 Cg_exo -71.12 152.76 62.53 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 CA-C-N 120.29 2.045 . . . . 83.569999999999993 108.035 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . 0.811 ' HG2' ' CG2' ' B' ' 229' ' ' THR . 12.7 pt-20 -105.79 131.19 53.44 Favored 'General case' 0 CA--C 1.496 -1.121 0 C-N-CA 119.086 -1.046 . . . . 107.02 109.513 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 56.6 mt -68.8 126.64 30.4 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-O 122.001 0.905 . . . . 90.670000000000002 110.128 -177.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' B' ' 228' ' ' THR . 40.3 mm -79.5 -30.76 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.377 0 C-N-CA 128.85 2.86 . . . . 224.66999999999999 110.76 175.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 215' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.79 163.38 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 CA-C-O 122.281 1.039 . . . . 73.959999999999994 112.682 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 216' ' ' ALA . . . . . . . . . . . . . . . -127.94 160.07 33.02 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.888 -1.152 . . . . 35.490000000000002 107.888 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 217' ' ' VAL . . . . . 0.434 HG13 ' O ' ' B' ' 181' ' ' ILE . 96.2 t -65.2 144.17 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 108.101 -1.074 . . . . 33.090000000000003 108.101 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . 0.403 ' N ' HG12 ' B' ' 217' ' ' VAL . . . 88.51 5.33 75.4 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 108.703 -1.759 . . . . 21.059999999999999 108.703 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 219' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -98.92 142.75 30.04 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 119.832 -0.747 . . . . 76.849999999999994 109.258 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 220' ' ' THR . . . . . 0.418 HG22 ' N ' ' B' ' 221' ' ' VAL . 94.0 m -89.81 146.88 24.14 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.991 -1.115 . . . . 32.640000000000001 107.991 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 221' ' ' VAL . . . . . 0.592 ' CG2' ' HB2' ' B' ' 225' ' ' GLN . 12.5 p -140.8 146.03 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 N-CA-C 108.755 -0.832 . . . . 91.780000000000001 108.755 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 222' ' ' GLU . . . . . 0.78 ' H ' ' NE2' ' B' ' 225' ' ' GLN . 75.3 tt0 -87.55 161.17 17.91 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.675 -1.232 . . . . 72.909999999999997 107.675 178.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . 0.427 ' N ' ' HG2' ' B' ' 222' ' ' GLU . . . -66.75 137.76 56.89 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.174 -1.047 . . . . 26.48 108.174 -178.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.94 -3.89 84.39 Favored Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.952 -1.259 . . . . 22.079999999999998 109.952 176.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 225' ' ' GLN . . . . . 0.78 ' NE2' ' H ' ' B' ' 222' ' ' GLU . 24.3 mt-30 -73.61 156.11 38.38 Favored 'General case' 0 N--CA 1.433 -1.291 0 C-N-CA 117.244 -1.782 . . . . 100.90000000000001 109.12 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 226' ' ' LEU . . . . . 0.53 ' N ' HD12 ' B' ' 226' ' ' LEU . 5.9 mp -77.24 125.39 29.25 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.955 0.884 . . . . 155.69999999999999 111.541 -174.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 227' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.93 -28.37 39.75 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 127.189 2.196 . . . . 83.780000000000001 110.138 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 228' ' ' THR . . . . . 0.683 ' CG2' ' H ' ' B' ' 173' ' ' PHE . 4.9 t -136.43 170.3 16.27 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.485 0.659 . . . . 124.20999999999999 110.145 -173.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 229' ' ' THR . . . . . 0.811 ' CG2' ' HG2' ' B' ' 212' ' ' GLU . 14.0 t -80.73 -174.28 4.65 Favored 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 105.415 -2.069 . . . . 102.20999999999999 105.415 177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 230' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -105.36 108.48 61.51 Favored Pre-proline 0 N--CA 1.432 -1.348 0 N-CA-C 104.257 -2.497 . . . . 53.939999999999998 104.257 174.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 231' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -73.55 -11.91 24.53 Favored 'Trans proline' 0 C--N 1.301 -1.925 0 C-N-CA 122.508 2.138 . . . . 88.670000000000002 114.28 -177.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 232' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -59.46 119.54 7.68 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 118.701 0.682 . . . . 80.040000000000006 111.856 -174.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 233' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' B' ' 59' ' ' GLN . 27.1 m -94.13 -23.22 5.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 128.684 2.793 . . . . 110.41 114.682 174.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 234' ' ' GLY . . . . . 0.652 ' C ' ' HD2' ' B' ' 29' ' ' LYS . . . -103.98 -157.25 24.2 Favored Glycine 0 C--N 1.351 1.394 0 C-N-CA 120.896 -0.668 . . . . 40.590000000000003 112.18 -170.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 235' ' ' GLY . . . . . 0.678 ' O ' ' HD2' ' B' ' 156' ' ' ARG . . . 170.91 170.14 34.76 Favored Glycine 0 C--N 1.354 1.571 0 C-N-CA 118.942 -1.599 . . . . 29.77 110.304 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 236' ' ' PHE . . . . . 0.754 ' HD1' ' HB2' ' B' ' 155' ' ' ASN . 94.0 t80 -123.97 139.14 54.24 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.527 -1.286 . . . . 65.569999999999993 107.527 -178.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 237' ' ' GLY . . . . . 0.697 ' O ' HG11 ' B' ' 31' ' ' VAL . . . -141.09 164.04 26.56 Favored Glycine 0 C--N 1.354 1.555 0 N-CA-C 109.174 -1.571 . . . . 22.739999999999998 109.174 -178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 238' ' ' GLN . . . . . 0.715 ' OE1' HG12 ' B' ' 19' ' ' ILE . 75.8 mt-30 -132.87 150.88 52.12 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.675 -0.861 . . . . 55.960000000000001 108.675 -179.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 239' ' ' MET . . . . . 0.938 ' CE ' ' HA ' ' B' ' 32' ' ' GLU . 33.2 ttp -152.28 144.71 24.08 Favored 'General case' 0 N--CA 1.432 -1.357 0 N-CA-C 107.596 -1.261 . . . . 61.159999999999997 107.596 175.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 240' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -114.83 151.14 34.39 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.095 -1.076 . . . . 42.909999999999997 108.095 -177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 241' ' ' SER . . . . . . . . . . . . . 91.6 p -144.65 168.29 20.53 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 105.896 -1.89 . . . . 79.780000000000001 105.896 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 242' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -126.65 153.41 45.41 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.852 -1.166 . . . . 42.630000000000003 107.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 243' ' ' ILE . . . . . 0.634 HD11 HG13 ' B' ' 39' ' ' VAL . 21.1 tt -140.96 148.03 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 107.374 -1.343 . . . . 45.770000000000003 107.374 177.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 244' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.19 124.61 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 108.896 -0.779 . . . . 39.25 108.896 -177.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 245' ' ' LEU . . . . . . . . . . . . . 57.1 tp -87.42 109.47 19.59 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 103.018 -2.956 . . . . 76.629999999999995 103.018 177.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 246' ' ' GLN . . . . . 0.43 ' HG2' ' N ' ' B' ' 247' ' ' SER . 16.5 tt0 -99.79 158.22 15.94 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-O 121.835 0.826 . . . . 67.670000000000002 112.783 -168.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 247' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' B' ' 246' ' ' GLN . 74.5 m -94.91 139.03 31.89 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 106.748 -1.575 . . . . 36.109999999999999 106.748 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 248' ' ' SER . . . . . . . . . . . . . 97.4 p -65.45 157.31 29.8 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-O 122.024 0.916 . . . . 77.530000000000001 109.073 -176.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 249' ' ' SER . . . . . . . . . . . . . 68.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 107.49 -1.3 . . . . 25.940000000000001 107.49 179.44 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 250' ' ' HEC . . . . . 1.225 ' CGD' ' O ' ' A' ' 37' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_